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Preface to “Nutrients in Infancy” 
This monograph based on a special issue of Nutrients contains 31 papers: 5 reviews and 26 original 
publications that reflect the wide spectrum of current research on nutrients and infancy. The papers 
include populations from many countries including Australia, Canada, China, Ireland, Italy, Malaysia, 
Mexico, Netherlands, Norway, Singapore, Spain, Sweden, Thailand, United Kingdom and USA. The 
largest group of papers are on the nutrient composition of breastmilk and the timing and factors that 
influence the nutrient content of breastfeeding.  The age range of the subjects studied was from preterm 
VLBW babies to older infants. 
There are two key objectives for infant nutrition: survival and to lay the foundations for growth and 
development that will optimise health throughout a long lifespan. Besides the ethical problems associated 
with infant research there is the obvious difficulty of conducting lifespan research in humans[1]. 
Continued infant nutrition research will rely on retrospective epidemiological studies and increasing 
knowledge of health and lifespan biomarkers.  
In compiling this special issue there were two issues that the editors found to be important. 
Definitions have always been central to successful research and the definition used determines the results 
presented in relation to breastfeeding and complementary feeds. Much has been written about definitions 
of breastfeeding, but there is still little standardisation in publications[2–4]. At the very least authors 
should adhere to the standard WHO definitions of exclusive breastfeeding, but then describe what they 
have actually done to allow others to accurately interpret their results. 
The ethics of research are always important in all publications, but particularly so in the area of 
infant nutrition. The editors of this monograph summarised the ethical principles involved in infant 
nutrition research[5]. In recent years the influence of early nutrition on later health and longevity has been 
increasingly studied. This means that extra care must be taken with any early life intervention studies. 
One third of the articles are on breastmilk composition from countries around the globe and several 
more on factors associated with breastfeeding duration. This reflects the centrality of breastmilk to the 
supply of nutrients in infancy, its importance for lifelong health and development and that we still have to 
learn. The results of several studies have implications for public health nutrition programs. It is estimated 
that 1.9 billion people live in areas of the world subject to subclinical iodine deficiency which is important 
for cognitive development in infancy?[6]. The study by Jorgenson and her colleagues demonstrate that in 
Australia with a food fortification program and the recommendation of pregnant women to take 150mcg 
iodine supplements daily the iodine content of breastmilk is generally adequate[7].  
In the NHANES study from the USA an analysis of NHANES data on iron, calcium, and zinc 
among children in the second year of life using two days of dietary intake data found that one in four 
children and one in ten children had usual intakes below the RDA for iron and calcium, respectively[8]. 
The relationship between nutrients and growth will be a continued area of interest. The prevalence 
of stunting is still relatively high in some world regions and is a priority of the UN Sustainable 
Development Goals (SDGs)[9]. At the other end of the continuum of development child obesity is now a 
major problem and is also an important target[9]. Micro nutrient deficiency may influence stunting and 
undernutrition but more research is still required to complete our understanding. The review on iron and 
zinc supplementation found that low dose of daily iron and zinc use during 6–23 months of age had a 
positive effect on child’s iron and zinc status[10]. However, this did not translate into a reduction in the 
proportion of children with stunting. Further research is required into stunting to achieve the UNSDGs. 
The role of protein in over nutrition and the development of obesity has been a fertile area of research[11]. 
The lower protein level of breastmilk compared to the higher protein levels of many infant formulae 
provides a biological basis for understanding the protective effects of breastmilk against obesity[12]. 
An area of continued interest is the relationship between the human microbiomes and nutrition.            
In 2007 the National Institutes of Health launched the Human Microbiome Project to promote research 
into the ways in which health outcomes are linked to changes in the microbiome[13,14]. The human 
microbiome is exceedingly complex, both in its composition and in its interrelation with nutrients. 




metabolism[15]. It is now well understood that infant feeding method, mechanism of delivery and the use 
of perinatal antibiotics can influence the composition of the microbiome[16]. One of the mechanisms 
responsible for protection against obesity provided by breastfeeding may be by through the development 
of a healthy microbiome[17]. There is increasing evidence of links between early development 
(particularly in the perinatal period) and later mental illness[18,19]. Again this linkage may be through 
changes to the human microbiome[20–22]. The use of pre-lacteal feeds and complementary feeds (i.e., not 
exclusively breastfeeding), C-section delivery and use of antibiotics (particularly in the perinatal period) 
changes the composition of the microbiome[23,24]. From a public health perspective the increasing rates 
of operative delivery, widespread antibiotic use and low rates of exclusive breastfeeding may be 
associated with increased rates of obesity, diabetes and other metabolic disorders and mental illness. 
Exclusive breastfeeding remains as important as ever as the basis of infant and maternal health[25]. As 
long term changes to the microbiome may be one mechanism by which early life dietary intake can 
modify health in later life, research into nutrients and microbiome health will be important. 
We believe this collection is a useful summary of progress in many areas of infant nutrition. It also 
points to many research needs to better understand infant nutrient requirements, growth and healthy 
development. With the present rate of progress it may only be few years before another volume is 
required. 
Colin Binns, Mi Kyung Lee and Masaharu Kagawa 
Special Issue Editors 
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Abstract: Probiotics have been linked to a reduction in the incidence of necrotizing enterocolitis
and late-onset sepsis in preterm infants. Recently, probiotics have also proved to reduce time to
achieve full enteral feeding (FEF). However, the relationship between FEF achievement and type of
feeding in infants treated with probiotics has not been explored yet. The aim of this systematic
review and meta-analysis was to evaluate the effect of probiotics in reducing time to achieve
FEF in preterm infants, according to type of feeding (exclusive human milk (HM) vs. formula).
Randomized-controlled trials involving preterm infants receiving probiotics, and reporting on time
to reach FEF were included in the systematic review. Trials reporting on outcome according to
type of feeding (exclusive HM vs. formula) were included in the meta-analysis. Fixed-effect or
random-effects models were used as appropriate. Results were expressed as mean difference (MD)
with 95% confidence interval (CI). Twenty-five studies were included in the systematic review. In the
five studies recruiting exclusively HM-fed preterm infants, those treated with probiotics reached FEF
approximately 3 days before controls (MD ´3.15 days (95% CI ´5.25/´1.05), p = 0.003). None of
the two studies reporting on exclusively formula-fed infants showed any difference between infants
receiving probiotics and controls in terms of FEF achievement. The limited number of included
studies did not allow testing for other subgroup differences between HM and formula-fed infants.
However, if confirmed in further studies, the 3-days reduction in time to achieve FEF in exclusively
HM-fed preterm infants might have significant implications for their clinical management.
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1. Introduction
Nutrition during critical time windows in early life can affect long-term health [1]. Early provision of
optimal enteral nutrition to preterm infants might improve neurodevelopmental outcome by decreasing
the rate of several complications of prematurity, such as extrauterine growth restriction, necrotizing
enterocolitis (NEC), sepsis, bronchopulmonary dysplasia, and retinopathy of prematurity [2].
Late introduction and slow advancement of enteral feeding may alter gastrointestinal motility
and disrupt microbial colonization [3], leading to a delay in establishing full enteral feeding (FEF).
The consequent prolonged need for parenteral nutrition can have serious infectious and metabolic
complications, which might prolong hospital stay, increase morbidity and mortality, and affect growth
and development [4].
Several clinical variables and interventions have been proposed as predictors of the time to
FEF achievement in preterm and very-low-birth-weight (VLBW) infants. Among these variables,
the influence of type of feeding was also documented, as FEF achievement was delayed in formula-fed
infants compared to human milk (HM)-fed infants [5].
Recently, probiotic use has been associated with a reduced time to achieve FEF and better
feeding tolerance [6], as well as a reduction of NEC [7,8] and late-onset sepsis [9]. Probiotics are
live microorganisms which, when ingested in adequate amounts, confer a health benefit to the host,
by modifying the composition and function of gut microbiota and the immunological responses in
the host [10]. The role of probiotics in attaining a more rapid achievement of FEF could be related
to their favorable effect on the physiological intestinal dysbiosis of preterm infants [11], which is the
result of the exposure to a unique environment and to several iatrogenic manipulations, such as broad
spectrum antibiotics [12]. It is well known that gut microbiota in HM-fed infants is different compared
to formula-fed infants [13]; data from an observational study also suggest a feeding-dependent effect of
probiotics, as in that study NEC incidence was reduced in infants treated with probiotics and receiving
HM, but not in those exclusively formula-fed [14]. However, the relationship between probiotics and
type of feeding in attaining a more rapid achievement of FEF has not been explored yet, even in the
most recent meta-analysis on this topic [6].
Thus, the aim of the present paper was to evaluate the effect of probiotics on time to FEF
achievement according to type of feeding (exclusive HM vs. formula), by performing a systematic
review and meta-analysis of currently available literature on this topic.
2. Materials and Methods
2.1. Literature Search
The study protocol was designed by the members of the Task Force on Probiotics of the Italian
Society of Neonatology. PRISMA guidelines [15] were followed in order to perform a systematic review
of published studies reporting the relationship between probiotic use and time to FEF achievement in
preterm infants according to type of feeding.
In order to be included in the meta-analysis, studies had to meet the following inclusion
criteria: randomized or quasi-randomized clinical trials involving preterm infants (gestational age
(GA) <37 weeks) who received, within one month of age, any probiotic compared to placebo or no
treatment, and reporting on type of feeding. The outcome of interest was time for FEF achievement
(any definition). Only English-written studies and studies involving humans were included in the
meta-analysis.
A search was conducted for studies published before 2 March 2016 in PubMed [16], the Cochrane
Library [17], and Embase [18]. The following search string was used for the PubMed search:
((preterm infant OR pre-term infant) OR (preterm infants OR pre-term infants) OR (preterm neonate
OR pre-term neonate) OR (preterm neonates OR pre-term neonates) OR (preterm newborn OR pre-term
newborn) OR (preterm newborns OR pre-term newborns) OR (premature infant OR premature infants)
OR (premature neonate OR premature neonates) OR (premature newborn OR premature newborns)
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OR infant, extremely premature (MeSH Heading (MH)) OR premature birth (MH) OR infant, low birth
weight (MH) OR infant, very low birth weight (MH)) AND (full enteral* OR feed*) AND (probiotic OR
probiotics OR pro-biotic OR pro-biotics OR probio*)) NOT (animals (MH) NOT humans (MH).
The string was built up by combining all the terms related to probiotics and FEF achievement:
PubMed MeSH terms, free-text words, and their combinations obtained through the most proper
Boolean operators were used. The same criteria were used for searching the Cochrane Library
and Embase.
Arianna Aceti and Luigi Corvaglia performed the literature search: relevant studies were
identified from the abstract; full-texts of relevant studies were examined, as well as their reference lists
in order to identify additional studies.
2.2. Data Extraction and Meta-Analysis
Study details (population, characteristics of probiotic and placebo, type of feeding, and outcome
assessment) were evaluated independently by Arianna Aceti and Luigi Corvaglia, and checked by
Davide Gori. Study quality was evaluated independently by Arianna Aceti and Davide Gori using the
risk of bias tool as proposed by the Cochrane collaboration (Chapter 8 of the Cochrane Handbook of
Systematic Reviews) [19].
The corresponding authors of the studies in which days to FEF achievement were not reported as
mean ˘ standard deviation (SD) were contacted by email. When data were not provided, the study
was not included in the meta-analysis.
The association between probiotic use and FEF achievement according to type of feeding
was evaluated by a meta-analysis conducted by AA and DG using the RevMan software
(Cochrane Informatics and Knowledge Management Department, version 5.3.5) downloaded from
the Cochrane website [20]. Mean difference (MD) in days to achieve FEF between infants receiving
probiotics and those receiving placebo or no treatment was calculated using the inverse variance
method, and reported with 95% confidence interval (CI).
For the analysis, we planned to use at first a fixed effect model. Heterogeneity was measured
using the I2 test: if significant heterogeneity was present (p < 0.05 from the χ2 test) and/or the number
of studies was ď5, a random-effects model was used instead.
3. Results
Literature Search
Overall, 372 papers were identified through the literature search, 155 in PubMed [16], 73 in the
Cochrane Library [17], and 144 in Embase [18].
As shown in Figure 1, 35 studies met the inclusion criteria [21–55]. Fourteen additional papers
were identified from the reference lists of included studies or by “snowballing” techniques [52,56–68].
Twenty-four studies were excluded after examining the full-texts [28,29,31–33,35,42–47,51,53–55,57–59,
62,63,65,69]. Twenty-five studies were then suitable for inclusion in the systematic review (Table 1) [21–27,
30,34,36–41,48–50,56,60,61,64,66,68,70].
Among them, only eight studies reported FEF achievement according to type of feeding:
infants were fed exclusively HM, either own mother’s (OMM) or donor human milk (DHM), in six
studies [22,38,50,56,60,70], while two studies reported FEF in exclusively formula-fed infants [41,61].
The corresponding authors of four of these papers were contacted by email, as data for FEF
achievement were not suitable for inclusion in the meta-analysis: mean ˘ SD of days for FEF
achievement were provided for one study [22], while data were unavailable for three studies [41,61,70];
these three studies were thus excluded from the meta-analysis.
Overall, five studies were included in the meta-analysis: in all these studies, infants were fed
exclusively HM, either OMM or DHM (Figure 1) [22,38,50,56,60].
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Figure 1. Flow chart of the search strategy used for the systematic review. The relevant number of
papers at each point is given.
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Data from 359 infants in the probiotic group and 360 infants in the control group were evaluated:
probiotic use was associated with a reduction in the time for FEF achievement (MD ´3.15 days
(95% CI ´5.25/´1.05), p = 0.003; Figure 2a). The funnel plot did not show any clear asymmetry
(Figure 2b).
Figure 2. Forest plot (2a) and funnel plot (2b) showing the association between the use of
probiotics and achievement of full enteral feeding in exclusively human milk-fed preterm infants.
IV: inverse variance method.
Three studies were not included in the meta-analysis because data on FEF were not available as
mean ˘ SD [41,61,70]. One study reported the use of Bacillus clausii in preterm infants with GA < 34 weeks,
fed expressed breast milk or DHM [70] and stratified as extreme preterm (GA 27–30 + 6 weeks) and
very preterm (GA 31–33 + 6 weeks). In both groups, probiotic use was associated with a reduced time
to achieve FEF (risk ratio 0.82 (95% CI 0.74–0.88) and 0.67 (95% CI 0.32–0.77), respectively).
The other two studies reported probiotic use in exclusively formula-fed infants: in the study by
Costalos et al., infants born at 28–32 weeks gestation and fed exclusively preterm formula received
Saccharomyces boulardii or placebo for approximately 30 days [41]. In the study by Stratiki et al.,
formula-fed infants with a similar gestational age (27–32 weeks) received Bifidobacterium lactis vs.
no treatment [61]. Neither of these two studies reported any significant difference between groups in
terms of time to FEF achievement.
All the studies included in the meta-analysis, except one [50], recruited exclusively infants with
birth weight <1500 g. The study by Roy et al. [50] reported specific data for extremely low birth weight
(ELBW) infants: time to reach FEF in ELBW infants treated with probiotics was significantly lower
than in controls (mean ˘ SD 13.22 ˘ 5.04 vs. 17.41 ˘ 8.07, respectively, p = 0.014). None of the studies
included in the meta-analysis reported separate data on intrauterine growth restricted (IUGR) infants.
In all the studies, except one [56], a probiotic mix was used: the meta-analysis performed after
the exclusion of the study by Manzoni et al., where a single-strain product containing Lactobacillus
GG was used, confirmed the results of the overall analysis (MD ´3.33 days (95% CI ´5.63/´1.04),
p ď 0.004).
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4. Methodological Study Quality
Evaluation of the quality of the studies included in the meta-analysis according to the risk of bias
tool as proposed by the Cochrane Collaboration [19] is shown in Table 2.
Table 2. Evaluation of the quality of the studies included in the meta-analysis according to the risk of













Braga, 2011 [60] Low Low Low Low Unclear Low
Manzoni, 2006 [56] Low Low Low Unclear Unclear Low
Roy, 2014 [50] Low Unclear Low Low Unclear Unclear
Samanta, 2008 [38] Low Low Low Unclear Unclear Unclear
Van Niekerk, 2014 [22] Low Unclear Low Unclear Unclear Unclear
5. Discussion
The present meta-analysis shows that the use of probiotics in preterm, VLBW infants fed
exclusively HM is associated with 3-days reduction in the time to FEF achievement. The only two
studies included in the present systematic review in which infants were exclusively formula-fed did
not report any difference between the probiotic and the control group.
The single previous meta-analysis investigating FEF as primary outcome showed an overall
smaller reduction in the time to FEF achievement, but did not report separate data for HM-fed and
formula-fed infants [6]. The studies included in the meta-analysis by Athalye-Jape et al. are almost
the same as those included in our systematic review; quite surprisingly, in the majority of the studies
included in these two reviews, both HM and formula-fed infants were recruited, but no detailed
information on the relationship between type of feeding and outcome was provided.
Type of feeding might modulate the relationship between probiotics and neonatal clinical
outcome [14]. It has been previously shown that HM feeding is associated with shorter time to
achieve FEF compared to formula feeding [5]. Our meta-analysis, which included only studies where
infants were exclusively HM-fed, showed a significant reduction in the time to achieve FEF attributable
to probiotics. Despite the limitation given by the small number of studies, a probiotic-related 3-days
reduction in time to achieve FEF in preterm infants fed exclusively HM has strong clinical implications
and deserves further consideration. When OMM is not available or contraindicated, the use of
pasteurized DHM is recommended for preterm infants: pasteurization inactivates most viral and
bacterial agents, but at the same time affects some nutritional and immunological properties of HM,
including endogenous probiotics [71]. It can be speculated that the beneficial effect of probiotics
documented in exclusively HM-fed infants could be attributed to a synergic action exerted by the
prebiotic components of HM and the exogenous probiotic, which partially restores the symbiotic
properties of naïve HM [72]. In the present meta-analysis, no separate data for OMM-fed and DHM-fed
infants were available; for this reason, it is not possible to clarify whether the beneficial effect of HM
on FEF achievement applies both to OMM and to DHM.
Heterogeneity among included studies was high; however, given the small number of papers, our
ability to explore sources of heterogeneity was limited. In the five included studies, different probiotic
strains were used. We aimed to perform strain-specific sub-meta-analyses, in order to clarify whether
there was any probiotic product showing a significant benefit in terms of reduction in the time to
achieve FEF. However, such analyses were not feasible, as none of the studies used the same probiotic
strain or mix. Similarly, it was not possible to explore additional sources of heterogeneity, such as
the characteristics of probiotic administration (dose, duration, infant age at probiotic initiation, etc.).
In addition, we were unable to test for subgroup differences between HM-fed and formula-fed infants,
which might have partially explained the different results in terms of FEF achievement.
11
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Apparently, studies were homogeneous in terms of included populations, as almost all of them
recruited only VLBW infants. However, few data on “high-risk” infants, such as ELBW and IUGR
infants, could be extrapolated from the main results of the included studies.
The use of probiotics should be weighed against their potential side effects. There are some reports
about the occurrence of sepsis in preterm newborns, potentially linked to probiotic administration [73].
However, none of the studies included in the systematic review reported any side effect related to
the use of probiotics.
6. Conclusions
According to the results of the present meta-analysis, the use of probiotics is linked to 3-days
reduction in time to achieve FEF in preterm VLBW infants fed exclusively HM. If confirmed in further
studies, this reduction might have strong clinical implications for this high-risk population.
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Abstract: Infants have a complex set of nutrient requirements to meet the demands of their high
metabolic rate, growth, and immunological and cognitive development. Infant nutrition lays
the foundation for health throughout life. While infant feeding research is essential, it must be
conducted to the highest ethical standards. The objective of this paper is to discuss the implications
of developments in infant nutrition for the ethics of infant feeding research and the implications for
obtaining informed consent. A search was undertaken of the papers in the medical literature using
the PubMed, Science Direct, Web of Knowledge, Proquest, and CINAHL databases. From a total of
9303 papers identified, the full text of 87 articles that contained discussion of issues in consent in
infant feeding trials were obtained and read and after further screening 42 papers were included in the
results and discussion. Recent developments in infant nutrition of significance to ethics assessment
include the improved survival of low birth weight infants, increasing evidence of the value of
breastfeeding and evidence of the lifelong importance of infant feeding and development in the first
1000 days of life in chronic disease epidemiology. Informed consent is a difficult issue, but should
always include information on the value of preserving breastfeeding options. Project monitoring
should be cognisant of the long term implications of growth rates and early life nutrition.
Keywords: Infant feeding; research; ethics; consent; breastfeeding; trials
1. Introduction
Infants are not just small adults. They have a complex set of nutrient requirements and interactions
to account for the high metabolic rate, growth, immunological and cognitive development, etc.
Infant nutrition lays the foundation for a healthy life. Centuries of observation and research have
described the relationship between appropriate nutrition and child growth and survival. In the past
century major advances have been made in understanding basic nutrient needs and applying this data
to the benefit of humanity and particularly to infants and children. It is appropriate that the collection of
original research papers and reviews on infant nutrition is being published in this volume of “Nutrients”
at the beginning of the United Nations Decade of Action on Nutrition 2016–2025 [1]. The goals of
the decade include increasing rates of exclusive breastfeeding to six months, reducing wasting and
stunting and reducing the rates of low birthweight. However the progress in infant nutrition has only
served to make the ethical issues around research in this age group even more complex. In this review
and discussion paper we will outline progress in infant nutrition and the ethical issues facing infant
nutrition researchers and the wider scientific community, particularly the difficulties in defining an
adequate consent process.
Nutrients 2017, 9, 59 17 www.mdpi.com/journal/nutrients
Nutrients 2017, 9, 59
Progress in Infant Nutrition
This year our world will welcome 131 million new infants, but around 5.5 million will die before
reaching the age of five years. While this number is still unacceptably high it is only one fifth of the
number dying 50 years ago [2]. The global under-5 years mortality rate has fallen by 53% since 1990 to
42.5 per 1000 live births in 2015, still a heavy burden for families to bear. The difference between regions
is great with an under-5 years death rate of 98.7 in West Africa compared to 17.1 in Europe. In some
individual countries, such as China, Korea, and Vietnam, the rate of decline has been more rapid than
the average improvement for the developing world. In the Republic of Korea the under-5 mortality
dropped from 330 per 1000 live births to 3.8 between 1950 and 2014, an unrivalled rate of progress.
While the improvement has been rapid, the present rates are still far too high and should be seen as a
call to further action to improve infant nutrition and health.
One of the most important factors in declining child mortality has been in the improvements
made to the food supply and the scientific understanding of the global food supply and nutrient
requirements [3,4]. The history of nutrition is a fascinating journey that encompasses a wide spectrum
of scientific disciplines from epidemiology and public health to biochemistry and genomics [5]. Many of
the advances in nutrition have been driven by clinical necessity as exploring the causation of deficiency
syndromes has led to understanding the roles of specific nutrients. Good examples are vitamin C,
vitamin A, and thiamin where clinical syndromes led eventually to the understanding of biochemical
pathways [6–9]. During the 19th and 20th centuries the role of nutrients in producing structural,
biochemical and behavioural deficiencies was unravelled [10,11]. The bone deformities of children
with vitamin D deficiencies have almost gone from the industrialised world and knowledge of iodine
and folate has meant that supplementation can reduce the neurological deficiencies they cause [12–16].
In the last half of the 20th century the work of Scrimshaw, the Jelliffes, and Widdowson improved the
understanding of the relationships between poor nutrition, growth and infectious diseases, a major
factor in the decline of child deaths [17–21].
The simple models of a linear relationship between nutrient intake and function has been replaced
with the knowledge that it is often a U-shaped curve that may be made more complex by genomics
or interactions with other nutrients [22]. There are many nutrients where a deficiency or an excess
of a nutrient, such as vitamin A, can have pathological effects, while amounts consistent with the
nutrient reference values (or dietary reference values) result in optimal health outcomes [23,24].
For many infants in vitamin A-deficient regions supplementation has been of considerable benefit.
However while vitamin A supplementation in mothers and infants has been widely practised its
benefits on a broad scale are still being evaluated [25–28]. Vitamin D supplementation reduces bone
pathology in deficient infants and is recommended in breastfed infants in some countries but, again,
the longer-term outcomes of country programs are uncertain [29].
As food supplies have improved and utilisation efficiency has increased with the control of
infections, excess of energy intake over expenditure has resulted in our current epidemics of obesity.
The double burden of nutrition has made nutrition education so much more complex as we grapple
with the difficulty of discussing deficient and excess energy intakes within the same country or even
within the same family [30].
While probiotics have been in use for many years the complexity of the human microbiome and the
relationships of any changes to nutritional status has been the subject of much recent research. In 2007
the National Institutes of Health launched the Human Microbiome Project to stimulate research in an
area with potential for human health benefits and much progress has been made in our understanding
of this area [31]. Disruption of the human microbiome is now recognised as a potentially important
mechanism in the development of obesity in in infants and children [32,33]. The behavioural sciences
have always been important in nutrition. New generations are forgetting what “normal” infants and
children look like and the image of overweight or obesity has become the new idealised normal [34].
Parents and health professionals have to be re-educated about the importance of growth management
as a component of paediatric nutrition.
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One of the most far reaching developments has been our understanding of the relationships
between early growth and development and later disease, the Developmental Origins of Health and
Disease (DOHAD) hypothesis [35–39]. The structure of health care has been segmented by ages and
paediatricians never get to see the cardiac problems of middle age. But this can no longer be the case.
The way infants and children are managed has implications for lifelong health, leading to the emphasis
on the first 1000 days from conception [40]. If antibiotics are used at birth (and in parts of Asia 100% of
mothers receive antibiotics during childbirth) or infant formula is given as the first feed it may disrupt
the microbiome with potential lifelong implications for conditions such as obesity or diabetes [41–43].
Long term changes to the microbiome may be one mechanism by which early life dietary intake can
modify health in later life [44,45].
The development of the knowledge-base of infant nutrition has made many advances in the last
decade confirming the supremacy of breastmilk over other sources of infant nutrition. Information is
now available on the short- and long-term results of infant feeding decisions making research into infant
nutrition very complex as any intervention that diminishes the likelihood of exclusive breastfeeding to
six months is likely to be unethical. Once breastfeeding has stopped or been compromised by partial
supplementation, it is very difficult, if not impossible, to resume full breastfeeding. The task of those
involved in infant nutrition research is to ensure that the highest ethical standards are followed so that
breastfeeding is not compromised.
The ethical issues of infant nutrition research extend into the way that human milk substitutes are
sometimes marketed [46–49]. Infant nutrition is being subjected to an unprecedented amount of advertising
to parents and promotion to health professionals and formula sales are increasing [49–51]. Parents in the
newly-rich countries seek to give their children the best possible start in life. Advertisers often distort
advances in science. For example if a nutrient is present in breastmilk the formula companies assume that
it will be equally beneficial if added as a pure chemical to a manufactured milk mixture. This ignores the
complexity of breastmilk which contains thousands of complex chemicals, living cells, and probiotics [52].
The international news media are quick to draw attention to the existence of any contaminants in breastmilk,
ignoring the fact that it is still safer and more beneficial than artificial formula. Professionals involved in
human lactation and infant formula research should ensure that their work is not misused in marketing in
contravention of the WHO Code [53,54].
Several centuries of infant nutrition research can be summarised in two phrases: “Breast is best”
and “Babies were born to breastfeed” [55–57]. All international and national infant feeding guidelines
reiterate the premier role of breastfeeding, including the benefits of promoting breastmilk for low
birth-weight and preterm infants in neonatal intensive care units [58]. The objective of this paper is to
discuss the implications of developments in infant nutrition for the ethics of infant feeding research
and the implications for obtaining informed consent.
2. Materials and Methods
To compile this narrative review a search of databases for papers relevant to infant feeding research
ethics was undertaken for publications in the past 25 years. The databases searched were PubMed,
Science Direct, Web of Knowledge, Proquest, and CINAHL using combinations of the keywords “Infant
Feeding”, “Ethics”, “Trial(s)”, “Research”, “Guidelines”, and “Consent”. Additional searches were
made in several relevant journals including the Journal of Human Lactation, Breastfeeding Medicine,
Breastfeeding Review, Public Health Ethics, Hastings Review, New England Medical Journal, JAMA,
and Pediatrics. The policy documents from selected regulators in the USA, European Union, Canada,
and Australia were reviewed. An additional database of infant feeding studies (5846 entries)
continuously compiled by the authors was also used. From the potential 9303 papers identified
the full text of 87 articles that contained discussion of issues of consent in infant feeding trials were
obtained and read. The papers were further assessed and when issues related to the principles of
ethical decisions in infant feeding studies were discussed they have been included in this review.
Papers were excluded if they were related to adults, children (not infants), or were not directly related
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to consent in infant feeding trials. A further 45 papers were excluded in this way, leaving 42 papers
that were included in the narrative review.
3. Results and Discussion
3.1. The Ethics of Infant Nutrition Research
In order for infants to benefit from an improved understanding of nutrition and possible
improvements in clinical outcomes research must ultimately be conducted on human subjects, and this
means research using infants. The ethics of infant nutritional research are becoming more complex.
Ethical approval prior to research commencement is a universal requirement for publication and all of
the papers describing trials that were read for this review had received ethical approval. The major
principles of medical research have evolved over many centuries and include the minimisation of
risk to participants, informed consent, confidentiality, and the right to withdrawal without prejudice.
The National Health and Medical Research Council (Australia) states that the values in human research
include “respect for human beings, research merit and integrity, justice, and beneficence” and these
help to shape the research relationship “as one of trust, mutual responsibility and ethical equality” [59].
The practical implementation of these principles has in the past lagged behind the theory and in the
1950s and 1960s, Pappworth (in the UK and Europe), and Beecher on the opposite side of the Atlantic,
drew attention to the violations of ethical research practices occurring on a daily basis [60–64]. In the
19th and early 20th centuries, for example, it was convenient to use children in institutions, invariably
from lower socio-economic backgrounds for trials, including smallpox and pertussis vaccination and
the transmission of hepatitis and HIV [65,66]. There were many further examples found of research
that were clearly unethical on which discussions could be based [67]. The widespread discussion of
ethical issues in human research that resulted led to a tightening of research ethics requirements for
all research involving humans and the publication of the Helsinki Declaration [68]. Human research
ethics committees became mandatory and no journal editor today would knowingly publish a study
where there was doubt about the ethics of the study. The International Committee of Medical Journal
Editors has built on the Helsinki declaration and has standards for the publication of journal articles
that include reference to the ethics of research [69,70]. However, these do not have any special reference
to research on infants, other than inclusion as one of the especially dependent groups.
More recently attention has been given to research ethics guidelines that specifically include
infants [71]. The Early Nutrition Academy (ENA) and the European Society for Pediatric
Gastroenterology, Hepatology, and Nutrition (ESPGHAN) have developed a position statement on
infant feeding research [72]. The statement recognises the need for special considerations for infants
and breastfeeding mothers. They include an important statement on breastfeeding:
“Breast-feeding is recognised as the optimal feeding choice for healthy infants and should be
actively protected and promoted. Conditions of studies performed in breastfeeding women and infants,
in particular the strategies for subject recruitment and the interaction with parents and health care
professionals, should ensure that there is no interference with breastfeeding [72]”. The statement
reiterates in a useful way, the many established principles of human subject research. However there
are several issues of infant feeding research ethics that are not mentioned in detail. These include
who can give consent, what does informed consent mean in the context of breastfeeding, and how
are potential life-long effects of not-breastfeeding to be accounted for. In a review of the standards
for intervention trials on feeding of infants, Woodside et al. recommend that “trial duration must be
long enough to show changes in the primary outcome measure” [73]. No papers were found which
mentioned monitoring to minimise possible long term adverse outcomes such as early signs of obesity.
3.2. Breastfeeding and Randomised Controlled Trials
In most clinical research randomised controlled trials are ranked higher than cohort studies and
other observational research, but the random allocation of a control group to “non-breastfeeding” is
20
Nutrients 2017, 9, 59
not ethical and usually other study designs must be used. Perhaps the best known study of health
outcomes of breastfeeding is the PROBIT trial conducted in Belarus which overcame the ethical issues
in a unique way [74]. This was a cluster randomised controlled trial of a breastfeeding promotion
intervention, which resulted in higher rates of exclusive breastfeeding in the trial hospitals. As well as
analysing the results by hospital (intention to treat analysis), analyses were done where the infants who
were exclusively breastfed were compared to those who were breastfed, but not exclusively. Individual
breastfeeding status was measured at one month and this could have resulted in misclassification
if prelacteal, or other early complementary feeds, had been given. The potential misallocation is
important as it is now known that the microbiome can be modified by even short-term formula use.
This study design overcame the important ethical issues that would have been involved if infants had
been directly allocated to breastfeeding and non-breastfeeding groups, but eliminated a true control
group of non-breastfed infants. There are also issues of consent to be considered as some individual
choice is lost in cluster randomisation [75]. In the case of PROBIT, the trial is really of a breastfeeding
education intervention, but it may be the most practical design for an ethical breastfeeding randomized
controlled trial (RCT). However the PROBIT data is also analysed as a comparison of longer and more
exclusive breastfeeding versus shorter and less exclusive breastfeeding. In this case the allocation to
groups at one month may be a critical distinction since even a short duration of breastfeeding could be
protective against certain diseases or adverse outcomes, if compared with no breastfeeding at all, as in
the Pima studies [76,77].
3.3. Consent in Infant Feeding Trials
Consent in infant feeding studies is a basic ethics consideration. Noel-Weiss discusses studies
of lactation and describes how the USA distinguishes between studies that would benefit only the
neonate or both the infant and mother (infant mother breastfeeding dyad) [78]. In the former case both
parents are required to give consent while the involvement of the mother-infant dyad requires only
the consent of the mother [79]. In Canada there are similar requirements and Menon and colleagues
have documented the consent process in studies of children in critical care studies [80,81]. One of their
concerns was how a lower rate of consent may bias results of the study. The situations they studied
raise similar issues to infant feeding studies in neonatal intensive care units and demonstrate the
potential conflict between the desire to obtain informed consent and the needs of the research project
to obtain a high consent rate to minimise bias.
In Europe the study must comply with usual ethical principles with an emphasis on potential
benefit to the participants and community [82,83]. In Australia the National Health and Medical
Research Council oversees the implementation of the National Ethical statement which requires the
consent on one parent [59]. There is no reference to the situation where parents have separated and a
family court (or equivalent judicial body) mandated joint custody agreement is in place.
Consent implies that it is informed and parents must be given adequate and accurate information.
There is no dispute; breastfeeding is best for infants. However, is there an inherent right of an infant
to be breastfed? There are some medical contraindications to breastfeeding [84]. There are also the
rights of the mother to make an informed decision about breastfeeding. In all cases of infant feeding
trials the benefit to an infant to be breastfed should not be interfered with. In preterm infants there is
benefit to infants who are breastfed, although some may require additional special feeding regimes.
Mothers should be encouraged to continue to express breastmilk to maintain their supply, so that
breastfeeding can ultimately be commenced (and continued?).
Screening for metabolic disorders and nutritional deficiencies is now routine in neonatal
paediatrics. When a new disease or deficiency is added to a routine screening program, commonly
referred to as a pilot study this should be considered to be research and ethics approval and informed
consent are required [85].
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3.4. Beneficence
Beneficence literally means “doing good to others” and in the context of research ethics also
includes “non-maleficence”, avoiding doing harm [59]. The National Health and Medical Research
Council then concludes this section (4.2.5) “the circumstances in which the research is conducted should
provide for the child’s safety, emotional and psychological security, and wellbeing” and (Section 4.2.13)
“Before including a child in research, researchers must establish that there is no reason to believe that
such participation is contrary to that child’s best interest [59]”.
In light of the research into the disadvantages of not breastfeeding and the advantages of
breastfeeding the principle of beneficence means that, wherever possible, an infant should receive
breastmilk. Ideally the recommendations of the WHO should be followed: “exclusive breastfeeding
for six months followed by continued breastfeeding while complementary foods are also given” [56].
Where this is not possible any breastfeeding is better than none [56]. In any infant nutrition research it
is important that there be no interference with the mother’s intention to breastfeed [86].
3.5. Monitoring of Infant Feeding Trials
The principle of beneficence extends to longer term risk. Fewtrell describes the change in infant
nutrition research from just eliminating nutritional deficiencies to promoting optimal health which
then requires a longer term perspective. “This approach necessitates identifying appropriate outcome
measures for both safety and efficacy, and also introduces the additional challenges of longer-term
follow-up of study participants [87]. There is increasing evidence for early life influences, including
nutrition, on later health, the developmental origins of health and disease (DOHAD) [35–39]. The rate
of infant growth, too slow or too rapid may be related to later health.
Research that involves the use of human milk substitutes in both preterm and term infants has
used growth and survival as primary objectives for evaluation. To these should also be added longer
term objectives including potential for excessive growth (obesity), alterations to and disruptions of the
microbiome and longer term chronic disease outcomes (DOHAD). Infant feeding researchers need
to be cognisant of possible life-long implications of their research. For example the development of
protocols to promote rapid catch up growth in low birth weight infants may possibly be related to
increased adult morbidity [88,89].
Further research into relevant clinical markers of long term outcomes is required, but those known
to be significant are growth, growth velocity and, perhaps, microbiome alterations. The role of an
independent monitoring committee should include checking the rate of individual growth to ensure
that it is not too rapid and would increase risk of obesity or later chronic morbidity. “Catch-up growth”
of very low birth weight (VLBW) infants is important to ensure survival, but until more is known about
long-term risk. A prudent policy is to aim for growth in the middle centile. It is obviously impractical
to monitor infant feeding trials for a lifetime for adverse effects, but monitoring of growth rates and
signs of early obesity is important. The role and challenges of monitoring committees in clinical trials
has been described by De Mets and colleagues [90]. Monitoring of the impact of nutrition interventions
on the microbiome may also become advisable as the available technology improves. The principles of
ethics applicable to infant feeding studies will need to be kept under review as nutrition science makes
further progress.
4. Conclusions
A balanced approach to infant nutrition is required. Some infants will require an infant formula
and some mothers will choose not to breastfeed. There is no doubt that advances in infant nutrition
applied to infant formula have substantially improved infant and child health outcomes. It is
essential that this research continues within the constraints of research ethics and the public health
imperative of continuing to promote breastfeeding. For infant feeding research involving breastmilk
substitutes, the strict implementation of research guidelines is required. As knowledge of the benefits
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of breastfeeding and the importance of early nutrition, growth, and development on later health,
this has increased the responsibility of researchers to strictly apply the ethical principles of beneficence
by improving the quality of the information given when obtaining informed consent. This particularly
includes the provision of information for informed consent that includes the benefits of breastfeeding
and the importance of maintaining lactation. The principle of beneficence would seem to require
long-term monitoring of growth and metabolic parameters to minimise any risk to long-term health.
In the future, the requirements for ethics approval and longer term monitoring of research outcomes
are likely to be strengthened as further advances in research occur.
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Abstract: Background. Nutrition in early life is increasingly considered to be an important factor
influencing later health. Food preferences are formed in infancy, are tracked into childhood and
beyond, and complementary feeding practices are crucial to prevent obesity later in life. Methods.
Through a literature search strategy, we have investigated the role of breastfeeding, of complementary
feeding, and the parental and sociocultural factors which contribute to set food preferences early in
life. Results. Children are predisposed to prefer high-energy, -sugar, and -salt foods, and in pre-school
age to reject new foods (food neophobia). While genetically determined individual differences
exist, repeated offering of foods can modify innate preferences. Conclusions. Starting in the prenatal
period, a varied exposure through amniotic fluid and repeated experiences with novel flavors during
breastfeeding and complementary feeding increase children’s willingness to try new foods within a
positive social environment.
Keywords: early taste; food preferences; breastfeeding; complementary feeding; feeding strategy;
children obesity; food choices
1. Introduction
Childhood is a period of very rapid growth and development. In this critical phase,
food preferences are formed, are tracked into childhood and beyond, and foundations are laid for
a healthy adult life [1]. The characterization of feeding practices is important for the determination
of which factors of the early environment can be modified and thus are amenable to intervention.
Since early life exposures may contribute to the risk of obesity [2], the topic is highly recognized to be
of social and public health interest [3,4].
Infants’ and children’s eating and activity behaviors are influenced by both intrinsic (genetics, age,
gender) and environmental (family, peers, community, and society) factors [5]. These factors are fully
displayed in Figure 1.
Firstly, prenatal exposure, and then breastfeeding, have been associated with flavor stimulation
and moderately lower childhood obesity risk in many studies [2,6,7]. Later on, the period of
complementary feeding is also crucial, both for obesity prevention and for setting taste preferences
and infant attitude towards food. Parents act by teaching children in different ways how, what, when,
and how much to eat and by transmitting cultural and familial beliefs and practices surrounding food
and eating [8]. Parents’ influence is significant: it is reflected both by what is on the plate and the
context in which it is offered [9].
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Figure 1. Environmental factors that influence child eating behavior.
Obesity is a burden social disease, linked to lifestyle and food choices changes, characterized by
low level of physical activity, high energy density, and free sugar-rich food. As nutritional habits are
tracked from infancy to adulthood, we investigated factors inside the child milieu, possibly connected
to flavor learning and feeding practices. In particular, we focused on strictly child-related factors.
Parental influence is only described in terms of food offering feeding style, while parental modeling is
not a topic of our review. We reviewed (1) the biological and social early-life exposures; (2) the prenatal
influence of the amniotic fluid; (3) how breast milk and formula may influence taste development;
(4) the role of complementary feeding; (5) the parental and sociocultural factors associated with
trajectories of health in adulthood.
2. Methods—Literature Search Strategy
Electronic databases (Pubmed, Medline, Embase, Google Scholar) were searched to locate and
appraise relevant studies. We carried out the search to identify articles published in English on
the relation between children’s early taste experiences and their food choices during childhood.
Relevant articles published after 2005 and up to August 2016 were identified using the following search
words in various combinations. The literature search was not aimed to conduct a systematic review or
meta-analysis of all of the available literature on this topic, but to explore the pertinent observations in
a period of 10 years. Our work is a narrative review, and search terms were inserted individually and
using the booleans AND and OR. The following terms were included in the search strategy: (“early taste
experiences” OR “early food preferences”) & (“food choices in childhood”) OR (“parental feeding
practices” OR “parent’s feeding strategies” OR “parental modeling”) & (“family environmental
factors” OR “family eating environments”) & (“early exposure” AND “obesity risk” AND “childhood
obesity risk factors”) & (“amniotic fluid” OR “breast milk” AND “taste AND flavor development”)
& (“early diet experiences” OR “development of eating habits”) & (“Food choices”). More than
5000 references matched the terms of the search, and around 1500 had been published in the past
10 years. The authors selected the articles and assessed the potentially relevant ones.
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2.1. Effects of Early Taste Experiences
According to a working hypothesis, the first thousand days of life represent a sensitive period
for the development of healthy eating habits, and for this reason, interventions are likely to have
a strong impact on health outcomes later during childhood and adulthood. This critical period
starts with feeding through the cord during gestation, passes toward oral feeding with milk, and
then the complementary feeding begins and the infant discovers a variety of foods and flavors.
Humans generally have inborn positive responses to sugar and salt, and negative responses to bitter
taste [10]. Genetically determined individual differences also exist, and interact with experience to
ensure that children are not genetically restricted to a narrow range of foodstuffs [11]. Children are also
predisposed to prefer high-energy foods, to reject new foods, and to learn associations between food
flavors and the post-ingestive consequences of eating [12]. This genetic predisposition appears to have
evolved over thousands of years when foods—especially those high in energy density—were scarce.
Few children—PROP (6-n-propylthiouracil) tasters—are sensitive to bitter taste and have higher liking
and consumption of bitter foods, such as cruciferous vegetables. Additionally, those children who
are unable to taste PROP (nontasters) like and consume more dietary fat and are prone to obesity;
thus, genetic variation in the ability to taste bitter compounds may have important implications as a
marker for dietary patterns and chronic health in children. The available literature suggests that some
children may require additional strategies to accept and consume bitter-tasting fruits and vegetables
and that genetic predisposition may be modified by repeated exposures [13,14].
2.2. Amniotic Fluid and Breast Milk
The ability to recognize a variety of flavors involves multiple chemosensory sensations, primarily
the sense of taste and smell. Food experiences begin prenatally, since chemosensory systems have
an adaptive and evolutionary role and are functional before birth [10]. The exposure to an in utero
environment may cause permanent effects on the developing tissue. These effects are referred to as
“programming”, and are important risk factors for chronic diseases in later adulthood [15].
Children usually prefer foods that are high in sugar and salt over those which are sour and
bitter tasting, such as some vegetables. Preferences for salt and the refusal of bitter can be modified
early through repeated exposure to flavors in amniotic fluid, mother’s milk, and solid foods during
complementary feeding. Flavor senses are well developed at birth, and continue to change throughout
childhood and adolescence, serving as gatekeepers throughout the life span, controlling whether to
accept or reject a foreign substance. Since amniotic fluid and breast milk both reflect to a variable
degree the food composition of the maternal diet, a repeated exposure to their flavors increases infants’
acceptance of foods [16]. While the knowledge of the influence of the maternal diet on breast milk is
mostly indirect [17], the sensory experiences with food flavors in mothers who ate a varied diet may
explain why their breastfed children tend to be less picky [18] and more willing to try new foods during
childhood [11,19,20]. A cohort study [21] on 1160 mother–infant pairs showed that preponderance of
breastfeeding in the first 6 months of life and breastfeeding duration were associated with less maternal
restrictive behavior and less pressure to eat. Accordingly, compared with bottle-feeding, breastfeeding
may promote maternal feeding styles that are less controlling and more responsive to infant cues of
hunger and satiety, thereby allowing infants to develop a greater self-regulation of energy intake [21].
2.3. Formula-Fed Infants
The early flavor experience of formula-fed infants is markedly different from that of breast-fed
infants. Exclusively formula-fed children do not benefit from the ever-changing flavor profile of breast
milk. Their flavor experience is more monotone and lacks the flavors of the foods of the mother’s
diet. There are striking differences in flavors among the different types of formulas and brands of
formulas, and formula-fed infants learn to prefer the flavors of the formula they are fed and foods
containing these flavors [11]. There is a plethora of infant formulas on the market that differ in
30
Nutrients 2017, 9, 107
macronutrient composition. When evaluating the effect of diet composition on growth and health
outcomes, it may no longer be appropriate to consider all formula-fed infants as a homogeneous group,
because infant formulas may also differ in both fat and carbohydrate composition/structure as well
as protein composition, and these differences may in turn affect growth and flavor development [22].
Consequently, it is important to understand the composition of the diet to which breastfeeding is being
compared before drawing conclusions. European and US populations reveal an association between
breastfeeding and a reduced prevalence of obesity in a meta-analysis; however, in a large randomized
controlled trial, there was no effect of breastfeeding on body mass index in later childhood [23].
When infants are fed with a formula that is more similar in protein content to breast milk (lower vs.
higher protein), their weight-for-length at 24 months of age does not differ from breastfed infants [24].
Another difference is found in infants consuming protein hydrolysate formula when compared with
cow’s milk formula: they are satiated sooner and have a less excessive rates of weight gain [25].
The mechanism of this effect is currently unknown, but is hypothesized to be related to differences in
free glutamate (which is abundant in human breast milk) [26,27].
2.4. Complementary Feeding and Future Consumption of Fruits and Vegetables during Childhood
Early learning about flavours continues during the complementary feeding period, through the
introduction of solids and changing exposures to a variety of new foods. In this peculiar time of
the child’s life, there is the transition from breast/formula feeding to a complementary solid diet,
and infants discover the sensory (texture, taste, and flavour) and nutritional properties (energy density)
of the foods that will ultimately compose their adult diet [28]. Being exposed to a variety of foods
during the complementary feeding period helps modulate the acceptance of new foods in the first year,
whereas exposure in the second year may have a more limited impact [29].
Young children (especially 2–5 years old) exhibit heightened levels of food neophobia during this
time. This means that they are unwilling to eat novel foods; it is interpreted as an adaptive behaviour,
ensuring children consume foods that are familiar and safe [30].
Distaste—dislike of the sensory characteristics of a food—appears to be the strongest driver
of neophobia in young children [31]. Indeed, the two strongest predictors of young children’s food
preferences are familiarity and sweetness, reflecting unlearned preferences. However, these innate
tendencies are paired with a predisposition to learn from early experiences through associative
learning and repeated exposure, allowing the child to learn how to accept and prefer the foods that
are available within his particular environment [30]. Repeated exposures to a food increase their
familiarity, and it is one of the primary determinants of its acceptance. Several studies have shown that
a food is consumed more and is judged as more liked by the infant after several offers. For instance,
an increase in acceptance of a new green vegetable was observed after at least eight exposures to this
food [31]. The effect of repeated exposure is potent enough to increase the acceptance of foods which
had been previously identified by the mother as being refused by her infant during the beginning
of the complementary feeding, which were most often green vegetables, but also pumpkin [32].
However, despite the efficacy of this mechanism, foods are most often only presented a limited number
of times (often less than five times) before the parents decide that the infant dislikes this food [33–35].
Reactions towards new foods differ according to food groups [28]. Lange et al. (2013) asked
mothers to report their infant’s reactions to new foods at the beginning of complementary feeding,
and they found that fruits and vegetables, which are firstly offered to infants, are less accepted than
other food groups [36].
A study of de Launzon et al. investigated the long-term effects of early parental feeding practices
on fruit and vegetable intake. The study used data from four European cohorts, in which data
on fruits and vegetables consumption were assessed with a questionnaire. These cohorts reported
different findings. Fruit and vegetable intake in early childhood varied with an average intake of
<1 vegetable/day in the Greek EuroPrevall study and >3 vegetables/day in the Generation XXI Birth
Cohort. Moreover, longer breastfeeding duration was found in Generation XXI than in the others.
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The timing of complementary feeding varied too: complementary foods were introduced mainly
between 3 and 4 months of age in ALSPAC (British Avon Longitudinal Study of Parents and Children),
at ≈4 months in Generation XXI, and at ≈5 months in Greek Euro-Prevall. In EDEN (French Etude
des De’terminants pre et postnatals de la sante’ et du de’veloppement de l’Enfant), there was no peak
age for introduction to complementary foods.
A concordant positive association between breastfeeding duration and fruit and vegetable intake
was found in different cultural contexts, with a longer breastfeeding duration consistently related to
higher fruit and vegetable intake in young children, whereas the associations with age of introduction
to fruit and vegetable intake were weaker and less consistent [37].
Similarly, 2- to 8-year old children who were breastfed for three or more months were more likely
to eat vegetables, as compared to children who were breastfed for a shorter time [28,38]. Taste may
impact the acceptance of new foods, since vegetables added with salt or a salty ingredient are more
easily accepted [39]. However, this observation should not encourage parents to use salt or salty
ingredients, because sodium is not recommended for infants [2,35]. Furthermore, acceptance of green
beans appears more difficult than that of carrot, in part due to the difference in the tastes of the
two vegetables, since carrots are sweeter than beans [35].
Therefore, the attraction towards new foods in the absence of imprinting and/or learning seems to
depend on their tastes and on the sensory properties of foods. At the same time, some individuals may
be more sensitive to taste features. In particular, for the sour, sweet, and umami tastes, the individual
sensitivity to taste in water solutions at the age of 6 months was predictive of the positive reaction
towards foods bearing these tastes [39].
Nicklaus and coworkers in 2014 studied the effect of repeated exposure and of flavor-flavor
learning on toddlers’ (2–4 years) acceptance of a non-familiar vegetable, and concluded that repeated
exposure is the simplest choice to increase vegetable intake in the short and long term [29,35].
The NOURISH is a randomized controlled trial which evaluated an intervention commencing in infancy
to provide anticipatory guidance to first-time mothers on a “protective” pattern of complementary
feeding practices that were hypothesized to reduce childhood obesity risk. In agreement with the
results, investing in early advice on training mothers about responsive complementary feeding can
improve maternal feeding practices, and suggests that complementary feeding practices promoting
the self-regulation of intake and preference for healthy foods may have positive effects on obesity risk
up to 5 years of age [15,40].
Early experiences with nutritious foods and flavour variety may maximize the likelihood that
children will choose a healthier diet as they grow, because they like the tastes and the variety of the
foods it contains. A recent investigation demonstrated that early exposure to a rotation of vegetable
flavours first added to milk and then to cereals increased the intake and liking of these vegetables.
Infants assigned to the intervention ate more of the target vegetables in the laboratory and at home
than those assigned to the control group [12].
During childhood, the strongest predictors of what foods young children eat are (1) whether
they like how the foods taste; (2) how long they were breastfed and whether their mothers ate these
foods; and (3) whether they had been eating these foods from an early age [20,41]. During early
childhood, infants are more likely to accept new foods, and parents should promote a varied diet and
the child’s curiosity towards food to reduce neophobia in toddlers [41,42]. After the age of 3–4 years,
reported dietary patterns/food habits remained quite stable, further highlighting the importance of
getting children on the right track from the initial stages of learning to eat [43].
2.5. Sociocultural and Family Environment
Social support plays a key role starting from birth. Accordingly, the initiation and continuation of
breastfeeding and cultural beliefs—shared through kin, friend, and neighbors networks—may serve to
promote or limit breastfeeding [2]. Parents create food environments for children’s early experiences
with food and eating, and also influence their children’s eating by modeling their own eating
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behaviors, taste preferences, and food choices. As children grow and become more independent,
familial influences on eating behavior may diminish, and other factors such as those of peers may
become more influential [44]. Parents and caregivers play a role in structuring early feeding, which in
turn is embedded in the larger micro- and macro-environments that shape parental beliefs, decisions,
and practices [45]. It has been shown that forcing a child to eat a particular food will decrease the
liking for that food, and that restricting access to particular foods increases rather than decreases
preferences [14].
Social influences become increasingly important for the development of food preferences
throughout infancy, and may either support or contrast the preferences learned during the prenatal and
early postnatal periods [30]. Beauchamp and Moran [46] examined the preference for sweet solutions
versus water in approximately 200 infants. At birth, all of the infants preferred sweet solutions to
water, but by 6 months of age, the preference for sweetened water was linked to the infants’ dietary
experience. Infants who were routinely fed sweetened water by their mothers showed a greater
preference for it than did infants who were not. Therefore, offering complementary foods without
added sugars and salt may be advisable not only for short-term health but also to set the infant’s
threshold for sweet and salty tastes at lower levels later in life [14]. Neophobic tendencies can be
reduced and preferences can be increased by exposing infants and young children repeatedly to novel
foods. Children need to be exposed to a novel food between 6 and 15 times before increases in intake
and preferences are seen. A recent study found that repeatedly exposing children to a novel food
within a positive social environment was especially effective in increasing children’s willingness to try
it. These findings suggest the importance of both the act of repeatedly exposing children to new foods
and the context within which this exposure occurs [30].
3. Discussion
The prevalence of childhood obesity is rising, and multiple studies indicate that most of the
risk factors develop during the early phases of life. These factors may range from the prenatal to
postnatal period.
Within this context, strategies to successfully promote better acceptance of vegetables should be
identified. In spite of a huge body of literature, practical aspects and the results of their application
are still poorly understood. This is due to the high complexity related to physiological mechanisms
underlying early sensory experiences and the development of sensory preferences.
Breast-fed infants more easily accept a new vegetable, and have higher acceptance of new foods
as they are introduced into the infant’s diet. There are many factors which influence infants’ feeding
behaviours; they interact and contribute to the creation of future eating habits. Mothers who consume
an array of healthy foods themselves throughout pregnancy and lactation—and subsequently feed
their children these foods at the complementary feeding period—can promote healthful eating habits in
their children and families. Although a large part of food-preference development occurs during early
childhood, food preferences continue to change during adolescence up to adulthood, and the factors
that influence these changes become more complex through the years [30]. While it is emphasized that
an excessive intake of foods high in salt and refined sugars early in life may be associated with later
non-communicable disorders, the individual genetic background and sensitivity to specific nutrients
makes it difficult to substantiate a precise cause and effect dose-dependent relationship.
On the other side, food likes and dislikes are learned, and the learning process begins early and
depends on biological and sociocultural attitudes.
4. Conclusions
Attention should be paid to the different socio-cultural contexts of eating in future studies,
and cohort studies are needed to quantify the effect of early stimulation of taste and preferences.
Randomized controlled trials on early diet, focusing on both caregivers and children’s behaviours
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and adjusted for food-related genotype are also essential for understanding how preferences can be
modified to promote healthful diets across the life course [30].
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Abstract: Arachidonic acid (ARA, 20:4n-6) is an n-6 polyunsaturated 20-carbon fatty acid formed by
the biosynthesis from linoleic acid (LA, 18:2n-6). This review considers the essential role that ARA
plays in infant development. ARA is always present in human milk at a relatively fixed level and is
accumulated in tissues throughout the body where it serves several important functions. Without the
provision of preformed ARA in human milk or infant formula the growing infant cannot maintain
ARA levels from synthetic pathways alone that are sufficient to meet metabolic demand. During
late infancy and early childhood the amount of dietary ARA provided by solid foods is low. ARA
serves as a precursor to leukotrienes, prostaglandins, and thromboxanes, collectively known as
eicosanoids which are important for immunity and immune response. There is strong evidence based
on animal and human studies that ARA is critical for infant growth, brain development, and health.
These studies also demonstrate the importance of balancing the amounts of ARA and DHA as too
much DHA may suppress the benefits provided by ARA. Both ARA and DHA have been added
to infant formulas and follow-on formulas for more than two decades. The amounts and ratios of
ARA and DHA needed in infant formula are discussed based on an in depth review of the available
scientific evidence.
Keywords: arachidonic acid; docosahexaenoic acid; infant formula; growth; human milk; long-chain
polyunsaturated fatty acids
1. Introduction
During the first year of life, infants have special nutritional requirements to maintain a healthy
body and support rapid growth and development. Human milk is typically the sole source of nutrition
that must supply the infant with appropriate amounts of energy and nutrients. The long-chain
polyunsaturated fatty acids (LCPUFA), docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid
(ARA, 20:4n-6) are always present in human milk. These fatty acids play key roles in the structure and
function of human tissues, immune function, and brain and retinal development during gestation and
infancy [1,2]. Although breastfeeding is considered the ideal way to nourish infants, recent nutrition
surveys report that the majority of infants in developed countries receive at least some infant formula
during the first year of life [3,4].
Both ARA and DHA have been added to infant formulas in the United States since 2001, although
supplementation began in Europe much earlier. Most infant formulas contain 0.2% to 0.4% of total
fatty acids as DHA and between 0.35% and 0.7% of total fatty acids as ARA based on worldwide
averages of DHA and ARA content in human milk [5] and the recommendations from a number of
international expert groups [6–9]. Thus, all commercially available infant formulas contain preformed
Nutrients 2016, 8, 216 37 www.mdpi.com/journal/nutrients
Nutrients 2016, 8, 216
ARA at levels equal to or higher than the DHA content in order to maintain adequate DHA and ARA
status in non-breastfed infants.
Both α-linolenic acid (ALA, 18:3n-3) and linoleic acid (LA, 18:2n-6) are regarded as nutritionally
essential fatty acids [10]. However, as Lauritzen et al. [10] point out, all classic signs of essential
fatty acid (EFA) deficiency can be completely reversed by the administration of n-6 fatty acids alone,
particularly ARA. With respect to infants, the presence of a relatively fixed level of preformed ARA in
human milk and the active accumulation of ARA by tissues throughout the body support the concept
of the essentiality of ARA. Previously, a description of the essentiality of ARA during infancy has not
been considered in detail, although a brief outline of the essentiality of n-6 and n-3 polyunsaturated
fatty acids was presented by Lauritzen et al. [10] in 2001.
The purpose of this paper is to review the essentiality of ARA for infant growth and development.
We consider both animal models and human studies of ARA. We describe: (1) ARA accumulation and
function in brain and tissues; (2) ARA content in human milk and in various tissues, including rates
of accretion during gestation and early infancy; (3) the structure and biosynthesis of ARA from LA
and its role as a precursor to leukotrienes, prostaglandins, and thromboxanes, collectively known as
eicosanoids; (4) dietary intakes of ARA during late infancy and early childhood when non-breast milk
food items are introduced into the diet; (5) immune system development and the dual role of PGE2
and its receptors in modulating the inflammatory response during infancy; (6) bone metabolism and
growth; (7) regulation of cardiac function; (8) consequences of ARA deficiency; (9) the importance
of ARA for optimal brain and central nervous system development; (10) the history, reasons for,
and nutritional effects of adding both DHA and ARA to infant formulas, with an emphasis on the
effects of ARA; (11) the importance of ARA in infant health; and (12) the regulatory requirements for
ARA and DHA in infant formulas. Based on a detailed review of the scientific literature presented
herein, recommendations for dietary intakes ARA during infancy are provided.
2. ARA Accumulation and Function in Brain and Tissue
Over the last decade, there has been increased understanding of the molecular roles that the n-3
and n-6 PUFA play in brain and cellular function. The variety of functions shown to be related to ARA
indicates its importance and essentiality in the metabolic chain of events leading to brain structural
lipid development, signaling, and many basic cellular functions.
ARA is indispensable for brain growth where it plays an important role in cell division and
signaling [11]. The brain in mammals consists of 60% fat, which requires DHA and ARA for its growth
and function [12]. Across different species of mammals there is little variation in DHA and ARA
composition of the brain. ARA is one of the most abundant fatty acids in the brain, and compared
with DHA, ARA is present in similar quantities [13,14]. The two fatty acids account for approximately
~25% of its total fatty acid content predominately in the form of phospholipids and thus are major
structural components of neural cellular membranes.
ARA rapidly accumulates in the brain during development [1,14,15] which takes place from the
beginning of the third trimester of gestation up to about 2 years of age [16] (Figure 1). As shown in
brain kinetics in fetal baboons, [17] in addition to maternal preformed ARA, LA may be transported
across the blood-brain barrier despite its very low content within brain lipids. The brain has an active
desaturation/elongation system that converts LA to ARA [17]. ARA activity is higher in brain than in
other organs such as the liver. However, the conversion of LA to ARA is low (see below).
The maximum rate of brain growth is primarily associated with myelination [14]. In animal
models, approximately 50% of the adult amounts of ARA and DHA accumulate in rat brain during the
period before myelination and at 15 days after birth when myelination has just started [14]. Diets low in
LCPUFA adversely affect the development of the myelin lipids needed early in brain development [14].
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Figure 1. Long-chain polyunsaturated fatty acids (LCPUFA) accretion in the human brain during
perinatal development (Data from Martinez [15]).
ARA has several functions in the brain. ARA mediates neuronal firing [18], signaling [19],
and long-term potentiation [20]. ARA also helps maintain membrane order and hippocampal
plasticity [21], defends the brain against oxidative stress in the hippocampus by activating the
peroxisome proliferator-activated receptor gamma (PPARγ), and aids in the synthesis of new protein
in tissue [22].
A potentially important aspect of ARA metabolism in vivo is its function as an immediate
precursor for adrenic acid (22:4n-6) [23]. Adrenic acid is the third most abundant PUFA in the brain
that is found in large quantities in myelin lipids, particularly in phosphatidylethanolamine (PE) [1].
Rapid accumulation of adrenic acid, like ARA, occurs during the early post-natal period of the brain
growth spurt in infants. The conversion of ARA to adrenic acid may represent an important pathway
for ARA utilization in infants in order to meet the rapid increase of adrenic acid needed for neural
tissue development.
Using a single dose of U-13C-labeled ARA to investigate preformed ARA utilization in baboon
neonates, Wijendran et al. [23] reported that a major portion of ARA consumed (79%–93%) was
accumulated as ARA in tissue lipids, consistent with its primary function as a principal constituent of
membrane lipids. Approximately 5% to 16% of ARA was converted to adrenic acid. Based on tracer
data, net accretion of ARA and adrenic acid during the first 4 weeks of age in the neonate baboon brain
was 17% and 8%, respectively, corresponding to efficiencies (i.e., percentage of dose recovered in brain)
of 0.48% and 0.54% of dietary levels, respectively.
To determine the effects that differing DHA to ARA ratios have on tissue fatty acids,
twelve-week-old full term baboons were randomized to one of three diets: control (no DHA or ARA),
moderate (0.33% DHA, 0.67% ARA) and high LCPUFA (1.00% DHA, 0.67% ARA) [24]. In all groups,
DHA levels increased significantly in liver, heart, plasma and in the central nervous system (CNS)
regions (precentral gyrus, frontal cortex, inferior and superior colliculi, globus pallidus, and caudate).
The formula with the highest level of DHA significantly reduced ARA levels in two areas of the brain
(superior colliculus and globus pallidus), indicating its competition with ARA and the importance of a
proper balance of DHA to ARA.
Phosphatidylcholine (PC) is a lipid class that is a major component of most intracellular
membranes [25]. Some intracellular lipid bilayers include PC containing ARA (ARA-PC). ARA-PC
functions as a retrograde messenger in long-term potentiation of synapses in the hippocampus CA1
region [26] and is involved in migration of neurons in the cerebral cortex [27].
Using imaging mass spectrometry, Yang et al. [25] characterized the distribution of ARA-PC within
cultured neurons of the superior cervical ganglia and found an increasing gradient of ARA-PC along
the proximodistal axonal axis that may provide a source for free ARA release [25]. Released free ARA
is known to activate protein kinases and ion channels, inhibit neurotransmitter uptake, and enhance
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synaptic transmission [11]. Free ARA therefore modulates neuronal excitability. As ARA mediates
intracellular signaling the concentration of free ARA must be maintained at precise levels within the
cells. A higher concentration of ARA-PC near the axon terminal might provide a timely source of ARA
when needed during the activated period [25].
ARA also is responsible for the activation of syntaxin-3 (STX-3), a plasma membrane protein
involved in the growth and repair of neurites [28]. Growth of neurite processes from the cell body is
a critical step in neuronal development. STX-3 serves as a single effector molecule and direct target for
ARA [28]. Neurite growth closely correlates with the ability of ARA to activate STX-3 in membrane
expansion at growth cones [28].
ARA also enhances the engagement of STX-3 with the fusogenic soluble N-ethylmaleimide-
sensitive factor attachment protein receptors (SNARE complex), proteins that form a ternary complex
that drives exocytosis [29]. In the brain, at the neuromuscular junction, and in endocrine organs, a set
of three SNARE proteins has a primary role in producing fusion of vesicular and plasma membranes.
The formation of this SNARE complex drives membrane fusion which leads to the release of vesicular
cargo into the extracellular spaces [29]. Darios and colleagues [29] report that α-synuclein, a synaptic
modulatory protein implicated in the development of Parkinson disease, can sequester ARA and
thereby block the activation of the SNARE complex. This finding underlines the importance of ARA
for the regulation of synaptic transmission and transport.
Detergent resistant microdomains, also referred to as lipid rafts, are specialized regions within
plasma membranes [30]. These microdomains serve as platforms for biomechanical interactions
between the lipid and protein components of signal transduction pathways [30–32]. The outer leaflet of
lipid rafts is highly enriched with glycol-sphingolipids and cholesterol [32]. The inner, or cytosol facing
leaflet is enriched with alkenyl forms of PE which have been termed plasmenylethanolamine. Electrospray
ionization/mass spectrometric analysis has shown that the ARA-containing plasmenylethanolamine
represents as much as 50% of the phospholipids of the cytosolic leaflet [31]. This is consistent with
a role of PE as an important source of ARA within the cell.
Stearoyl-2-arachidonoyl is a highly abundant species of phosphatidylinositol (PI) found in the
phosphorylated forms of PI, the phosphoinositides [33–38]. In addition to serving as a substrate
for phospholipase C to produce inositol-triphosphate and diacylglycerol, phosphoinositides serve
important biochemical functions including lipid signaling, cell signaling and membrane trafficking.
Phosphoinositides perform these roles in part by serving as adaptors for protein-protein and
protein-membrane interactions in order to facilitate and/or regulate G-receptor protein activity and
signal transduction, and trafficking of various metabolites such as cholesterol or calcium, or other
ions, between cellular compartments [39–43]. These biochemical functions of ARA demonstrate its
importance for cell signaling, trafficking and regulation of spatial-temporal interactions between
cellular structures.
3. Levels of ARA in Human Milk, Brain, and Tissues
Fat is a critical component of human milk that provides energy and nutrients needed for the
development of the CNS [10]. DHA and ARA are the principal LCPUFA found in human milk.
The synthesis of DHA and ARA is limited in infants [5] and both DHA and ARA must be obtained
from dietary sources. Amounts of DHA and ARA in human milk tend to vary by diet, nutritional
status, and other factors [5]. Based on data from 65 studies of human milk from 2474 women,
the mean concentration of ARA (by weight) was 0.47% ˘ 0.13% (range 0.24% to 1.0%) whereas the
mean concentration of DHA was 0.32% ˘ 0.22% (range 0.06% to 1.4%) [5]. The DHA concentration
in human milk is lower and more variable than ARA. The level of ARA in human milk is much
more stable. The relatively stable content of ARA in human milk is biologically important because it
provides preformed ARA consistently at a time when brain growth and development is most critical.
The majority of ARA in human milk does not derive from dietary LA but rather from maternal stores
of ARA [44]. The correlation between DHA and ARA is low, which may reflect a higher degree of
variability in the ratio of DHA to ARA in individual human milk samples [5].
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The composition of the brain is dominated by ARA and DHA [45]. During pregnancy, both ARA
and DHA are preferentially transferred across the placenta [46] and sequestered in the developing
brain from the earliest phases of its growth. After birth, human milk provides both DHA and ARA to
the breastfed infant [47] with a rapid rise towards adult levels of DHA and ARA in the brain within the
first two years of life [48]. ARA is found at a level comparable to that of DHA in neural membranes,
particularly those of the brain [49].
Based on estimated total body content of ARA from fetal organ weights during the last trimester
of pregnancy and early infancy the relative amount of brain ARA decreases, but because of brain
growth the absolute amount of ARA increases [50]. In fact, the absolute amount of ARA increases in
all organs with increasing gestational age while the relative contribution (g per 100 g fatty acids; g %)
decreases [50]. At 25 weeks gestation, the whole fetal body contains about 1.1 g ARA which increases
to 4.2 g ARA at 35 weeks gestation. A full-term infant (3500 g) has about 7.6 g of ARA. The accretion
rate of ARA is estimated to be 6.1 mg/day during the first 25 weeks and increases to 95.2 mg/day by
35–40 weeks gestation. The fetal accretion rate for ARA is 2-fold that of DHA [50]. Most of the bodily
ARA at 25 and 40 weeks is located in skeletal muscle, adipose tissue and the brain, in that order [50].
In human infant central nervous tissue (cerebral cortex and retina) ARA comprises approximately
10%–12% of total fatty acids [49]. The amount of ARA in central nervous tissue appears to be influenced
to a greater extent by postnatal age than by dietary ARA supply [49]. Samples of frontal cerebral
cortex obtained from 58 human autopsies (mean age 40 ˘ 29 years) indicated that the relative levels of
PUFA expressed as a percentage of total fatty acids generally decrease with age with the exception of
DHA [51].
The distribution of n-6 and n-3 PUFA was determined in various viscera and tissues within the
whole body of rats fed a diet containing 10 wt % fat (15% linoleate and 3% α-linolenate) until 7 weeks
of age when they were sacrificed [52] (Figure 2).
The rat whole body was comprised of primarily saturated fatty acids (48.4% of total fatty acids)
while the monounsaturated fatty acids were present in the second greatest amount (34.8%). The total
amount of n-6 PUFA was 12.0% and was more than 5-fold greater than the total n-3 PUFA. The n-6
PUFA with the highest content was LA (10.1%) followed by ARA (1.4%). ARA was the major PUFA
in nearly every tissue and was the major PUFA in most internal organs. The tissues with the highest
content of ARA were plasma (25.3%) followed by kidney, red blood cells (RBC), and spleen, ranging
from 18.7% to 23.5%. Brown adipose, white adipose and the eye contained very low amounts of ARA
(<1.0%). For each compartment in the rat body, the total ARA/organ was highest for muscle, then liver,
adipose, and carcass. In terms of fatty acid composition expressed as a percentage, ARA was highest
in the circulation, kidney, and the spleen.
As shown in rat pups, when tissues are deprived of n-3 PUFA, the accretion of ARA from
LA is increased and ARA is further metabolized to produce docosapentaenoic acid (22:5n-6, DPA)
which accumulates in tissues [53], particularly in the nervous system. The accumulated DPA in turn
reciprocally replaces lost DHA in tissue [53].
Pigs fed varying amounts of ARA and DHA levels after birth and then sacrificed at day 28 showed
that dietary ARA had little effect on tissue DHA accretion [54], but heart tissue was particularly
sensitive to ARA intake. These observations are particularly notable because the pigs were fed ARA at
a level of 0.53% of total fatty acids. This level is slightly above the worldwide ARA mean in human
milk and 0.67% of total fatty acids is the level currently added to many infant formulas and is near the
high end of human milk ARA levels [5]. Neonatal pigs serve as a practical biomedical model of human
infant development due to their similar metabolic responses, genetics of the fatty acid desaturases,
and rates of perinatal brain growth [5]. The importance of ARA for the heart is discussed in greater
detail in Section 8.
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Figure 2. Distribution of fatty acids in 25 different tissue compartments in young male rats.
Abbreviations: ATL, adrenal gland, thyroid gland, mandibular gland, and lymph nodes; RBC, red blood
cell; SG, salivary gland; ADB, brown adipose tissue; ADW, white adipose tissue (from Salem et al. [52]).
4. ARA Biosynthesis and Metabolism
ARA is an n-6 polyunsaturated 20-carbon essential fatty acid formed by biosynthesis from
LA [10]. ARA is a precursor to leukotrienes, prostaglandins, and thromboxanes, collectively known as
eicosanoids [55,56]. ARA is found in membrane phospholipids throughout the body and is particularly
abundant in the brain, muscles and liver. The metabolic pathways of the n-6 series and n-3 series are
shown in Figure 3.
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Figure 3. Metabolic pathways of linoleic and α-linolenic acid (Adapted from Lauritzen et al. [10]).
The use of stable isotope labelled fatty acids to investigate essential fatty acid metabolism was
pioneered in the 1930s with the first identifiable study done by Schoenheimer and Rittenberg [57].
Several decades later, Nichaman et al. [58] gave four adult subjects 14C-labeled LA and found a very
small but significant incorporation into plasma phospholipid ARA acid based on responses in
gas-radiochromatography. Similarly, 14C-labeled LA was shown to be converted to 14C-ARA in
human fetal liver microsomes, in vitro [59]. El Boustani et al. [60] studied the conversion of deuterated
dihommo-gamma linoleic acid (20:3n-6, DGLA) into ARA in plasma phospholipid and triglyceride
fractions in vivo in diabetic patients. After a 2 g isotope ingestion, a maximum of 5 mg of labelled
ARA/L was observed in plasma. The authors stated that “this was consistent with the very low Δ5
desaturase activity observed in vitro in the human liver”.
In the 1980s, Emken and colleagues [61] developed stable isotope technology in adult humans.
In an early study of deuterated-LA metabolism in vivo, when a large dose of over 14 g of isotope was
given, the authors concluded that “interconversion products such as deuterium-labeled . . . 20:3 and
20:4 were not detected in any of the lipid classes” [62]. They calculated that a conversion of as little as
0.00012% would have been detectable. The absence of any LA metabolism to ARA was confirmed in
a subsequent study even where labelled-ALA was clearly incorporated into EPA and DHA [61].
In 1995, Demmelmair et al. [63] used natural abundance 13C measurements in corn oil fed infants
to demonstrate LA conversion to ARA. They observed conversion but concluded that “the activity
of the enzyme system seems to be limited”. Shortly afterwards, the conversion of LA to ARA was
conclusively and directly demonstrated in newborn infants using stable isotope technology by Salem
et al. [64]. The D5-LA was used together with a highly sensitive NCI GC/MS method after PFB
derivatization [65]. With this new methodology, the deuterated fatty acid could be chromatographically
separated from its corresponding endogenous analogue and so the signal of the stable isotope labeled
metabolite would not be obscured by the much larger signal from the endogenous fatty acid. A crude
estimate was made of the net accretion of ARA over the six day period of the study which was 53 mg,
or about 9 mg ARA/day. Such estimates of “net synthesis” treated the organism as if the synthesis
was occurring within the bloodstream and this is clearly not the case. In addition, what was being
measured is the synthesis, minus the catabolism, plus the transport/release into a compartment such
as the bloodstream where it can be sampled. Carnielli et al. [66] used a similar methodology to confirm
the conversion of LA to ARA in very low birth-weight infants using 13C-labeled LA.
Pawlosky et al. [67] studied stable isotope labeled LA and DGLA metabolism to ARA in
10 newborn human infants within the first week of life in vivo and performed compartmental modeling
to provide an estimate of the synthetic rates. Formula and breast milk intakes were considered so that
ARA and other PUFA intake could be estimated; LA and ARA intake was estimated at 3 g/kg/day and
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2.8 mg/kg/day, respectively. They concluded that “the mean daily rate of synthesis and turnover of
20:4n-6 in plasma of infants were estimated to be from 0.06 to 2.1 mg/day . . . and from 0 to 51 mg/day
(mean 10.2)” [67]. They went on to say that “such rates of synthesis are incapable of sustaining plasma
20:4n-6 concentrations in nearly all of these subjects necessitating an intake of ~4 mg/kg/day from
either human milk or a supplement”. The fractional rate of conversion (FRC) observed in this study
was 2.7% which is even more than that observed by Sauerwald et al. [68] who calculated an FSR of
0.4% to 1.1% depending upon the ALA content of the formula.
Carnielli and colleagues in 2007 [69] studied LA conversion to ARA using natural abundance 13C
measurements in preterm infants in vivo in those fed LCPUFA or no LCPUFA-containing formulas
at 1, 3 and 7 months of age. These authors show that ARA synthesis is decreasing with age as it fell
from 26.7 mg/kg/day to 14.4 mg/kg/day and then to 11.6 mg/kg/day from 1 to 3 to 7 months of age,
respectively. It seems that the endogenous synthesis rate in these infants was inadequate as the ARA
plasma phospholipid level fell from 5.6 mol% in the ARA fed group to 1.9 mol% in the no ARA group,
a 66% drop. This underlines the inadequacy of LA alone as a source of ARA and the requirement
for preformed ARA in the infant diet if blood levels of ARA are to be maintained similar to those in
breastfed infants.
5. Global Intake of ARA in Early Life
In contrast to n-3 LCPUFA, there are few data relating to dietary intakes of n-6 LCPUFA in early
life. In relation to dietary ARA, many regulatory agencies have tended to assume that beyond the
age of 6 months, the endogenous synthesis of ARA will meet the needs of infants and young children
during this period of rapid growth and development [70,71]. However, studies have shown that the
endogenous synthesis of both DHA and ARA may be insufficient with evidence of blood and tissue
concentrations decreasing after birth if there is not an exogenous supply [49,72].
The World Health Organization (WHO) [73,74] and the American Academy of Pediatrics [75]
recommend that infants should be exclusively breastfed for the first six months of life to achieve optimal
growth, development and health. Thereafter, to meet their dietary requirements during growth,
infants should receive nutritionally adequate and safe complementary foods while breastfeeding
continues for up to two years of age or beyond [73,74]. However, there is widespread variation in
compliance with this recommendation in both developed and developing countries. In an evaluation
of 33 developing countries, where the health benefits of this policy could have the greatest impact,
exclusive breastfeeding occurred in 46% of countries, the median duration of breastfeeding was
18.6 months and over 30% received complementary foods before 6 months of age [76]. The extent
to which variation in feeding practices may influence global intakes of ARA and infant growth and
development in early life needs to be further evaluated.
5.1. ARA Intake from Human Milk
In exclusively breastfed infants, the mean human milk intake at 6 months has been measured to be
854 g/day [73,74]. Based on those data and an estimation that 4.2% of human milk is composed of fatty
acids [77] the average ARA and DHA intakes in exclusively breastfed infants at 6 months of age are
about 169 mg/day and 115 mg/day, respectively. Moreover, many infants continue to receive human
milk throughout the first year of life and longer. It is estimated that at 12 months of age the intake of
human milk is in the range of 600–900 g/day [73,74]. This amount provides infants with an ARA intake
from human milk in the range of 118–178 mg/day. The mean estimated ARA intake is approximately
12–18 mg/kg/day when adjusted for body weight using weight-for-age percentiles [78].
5.2. ARA Intake from Infant Formula
Infant formulas typically contain levels of ARA and DHA at 140 mg/day and 100 mg/day,
respectfully, based on worldwide averages of ARA and DHA content in human milk [5].
Therefore, intakes of ARA and DHA from infant formula are similar to those provided from human milk.
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5.3. ARA Intake from Weaning Foods
In both developed and developing countries weaning foods contain low amounts of fat,
which results in a sharp transition from adequate fat intake during breastfeeding to significantly lower
fat intake when children are weaned from the breast [79,80]. The main food sources of ARA are beef,
poultry, eggs and seafood. Complementary foods in low-income countries are typically cereal-based
and therefore LCPUFA dietary intake from these weaning foods may be minimal [79]. Countries with
the lowest gross national product (GNP) (e.g., Malawi, Ethiopia, Bangladesh, Burkina Faso, Ghana and
India) had a mean percentage of total PUFA from animal source foods of 4.9% vs. countries with
a higher GNP (Vietnam, Bolivia, Indonesia, Guatemala, China, South Africa, Mexico) where the mean
percentage of total PUFA from animal food sources was 18.1% [79].
Intakes of ARA (mean mg/day and estimated mean mg/kg/day) from several developing and
developed countries are presented in Table 1. In the village of Keneba, Gambia, estimated mean intake
of ARA during the period of 0–6 months when infants are predominantly breastfed was 90 mg/day and
as complementary foods were introduced the ARA intake fell steadily to 10 mg/day at 24 months [81].
In Heqing County, Yunnan Province China, the mean intake of ARA was 55 mg/day at 1 to 3 years of
age and 50 mg/day at 4 to 5 years of age [82].
Vulnerable infants and young children need energy- and nutrient-dense foods to grow and
develop both physically and mentally [83]. For these reasons, dietary diversity is now included
as a specific recommendation in the guidance for complementary feeding of the breastfed child
aged 6 to 23 months [83]. Many factors contribute to limited dietary diversity including economic
limitations, religious beliefs, and a concern that infants under 1 year of age cannot digest animal
sourced foods [84,85]. There is also a widely held perception by parents that fish may be associated
with allergic reactions [85,86].
Even in developed countries where dietary diversity is higher and meat and eggs contribute
more to the complementary diet, the detrimental impact of the introduction of complementary feeding
with low amounts of ARA and DHA content is evident. For example, mean ARA intake in German
infants/toddlers decreased from 72 mg/day at 6 months of age to 24 mg/day at 9 months of age [87]
(Table 1). In a separate study, these authors reported that predominately breastfed German infants had
an ARA intake of 103 mg/day at 3 months of age and this amount declined to 24 mg/day at 9 months
when human milk represented only 20% of the diet [88].
One hundred-seventy-four Italian breastfed children were followed from birth to 12 months
of age [89]. Human milk samples were analyzed. The mean ARA intake from human milk
was 95.6 mg/day at 1 month, 109.6 mg/day at 2 months, and 101.1 mg/day at 3 months.
However, at 6 months of age, ARA intake sharply declined to 58.7 mg/day.
In Belgium, mean intakes of ARA were very low at 2.5 to 3 years of age and at 4 to 6.5 years of age
(17 and 18 mg/day, respectively) [90] (Table 1). In Australia, national intake data indicated that 2 to
3 year-old and 4 to 7 year-old children consumed 16 mg/day and 22 mg/day of ARA, respectively [91].
Much higher mean ARA intakes were reported for Canadian children living in Vancouver where
intakes ranged from 133 to 260 mg/day among children 1.5 to 5 years of age [92]. However, in children
aged 4 to 7 years of age from Ontario, Canada, mean intake of ARA was lower (57 mg/day) [93].
Based on food records from the National Health and Nutrition Examination Survey (NHANES
2003–2008), the mean intake of ARA in American children at 1 to 4 years of age was 60 mg/day [94].
Most of the ARA was obtained from poultry (32.5%), eggs (27.5%), and meat dishes (20.9%). The latest
NHANES data from 2015 indicate that the mean ARA intake of American children at 2 to 5 years of
age increased to 80 mg/day [95].
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2–3 years 1-day weighed food record 16 (1.3)
1-day weighed food record 22 (1.8)
Belgium [90] 2–5 years 3 days food record 17 (1.4)
4–6.5 years 3 days food record 18 (1.0)
Canada [92,93]
1.5–2 years 1 day food frequency 133 (11.0)
2.1–3 years I day food frequency 260 (22.0)
3.1–5 years 1 day food frequency 226 (15.0)
4–7 years 3-days food records 57 (2.9)
China [82]
1–3 years 3 days 24 h recall 55 (4.6)
4–5 years 3 days 24 h recall 50 (2.5)
Gambia [82]
0–6 months 1 day weighed food monthly 90 (15.0)
7–12 months 1 day weighed food monthly 70 (7.8)
13–17 months 1 day weighed food monthly 60 (6.7)
24 months 1 day weighed food monthly 10 (0.8)
Germany [87,88] 6 months 3 days weighed food record 72 (12.0)
9 months 3 days weighed food record 24 (2.7)
Italy [89]
1 month Human milk composition 95.6 (29.0)
2 months Human milk composition 109.6 (33.0)
3 months Human milk composition 101.1 (16.9)
6 months Human milk composition 58.7 (9.8)
U.S. 2003–2008 [94] 1–4 years 1 day weighed food record 60 (5.0)
U.S. 2015 [95] 2–5 years 1 day weighed food record 80 (6.7)
Notes: 1 Estimated mean intake for ARA (9 mg/kg/day) for ages 0 month to 3 years was calculated using
median weight-for-age percentiles for boys, birth to 36 months, and from median body mass index for ages 4
through 19 years; from the Centers for Disease Control and Prevention-Growth Charts (CDC, [78]).
Based on these dietary intakes from local and national surveys, it is clear that the diets of young
children contain low levels of ARA. Reported mean intakes of ARA at 10 to 18 mg/day in developing
and developed countries are only about 10% of the amount of ARA available to infants fed human
milk or infant formulas containing DHA and ARA.
Birch et al. [96] reported that despite the introduction of a variety of solid foods at 17 weeks of
age, infants who did not receive an infant formula supplemented with ARA and DHA throughout
the first year of life had significantly lower levels of both of these fatty acids in plasma. The clinical
consequences of low intake of ARA have not been adequately investigated.
6. ARA and Its Role in Immune System Development and Function
There is growing evidence from preclinical and clinical studies that ARA plays an important
role in maintaining infant health through its effects on the immune system and through the
modulation of the inflammatory response [97]. The eicosanoids that ARA produces serve as both
mediators and regulators of inflammation [98] (Table 2). These immunomodulatory effects have
generated much interest in the potential roles that LCPUFA in general and ARA in particular have in
common inflammatory conditions in childhood such as asthma, eczema, atopic dermatitis, and food
allergies [97].
In cell membranes, ARA contributes to membrane order, has roles in signal transduction,
and gene expression, and provides substrate for production of important chemical mediators [99].
Although ARA has been widely viewed as a pro-inflammatory agent, the eicosanoids that ARA
produces serve as both mediators and regulators of inflammation [98]. ARA-derived eicosanoids, and
other oxidized derivatives [98] are generated by the metabolic processes as shown in Figure 4.
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Enhances pain caused by other agents
Anti-inflammatory
Inhibits production of TNF and IL-1
Inhibits 5-LOX (decreases 4-series LT production




Enhances local blood flow
Chemotactic agent for leukocytes
Induces release of lysomal enzymes
Induces release of oxygen species by granulocytes
Increases production of TNF, IL-8, and IL-6
Notes: 1 IL, interleukin; LOX, lipoxygenase; TNF, tumor necrosis factor. From Calder [98].
Figure 4. Generalized pathway for the conversion of ARA to eicosanoids. COX, cyclooxygenase;
HETE, hydroxyeicosatetraenoic acid; HPETE, hydroperoxyeicosatetraenoic acid; LOX, lipoxygenase;
LT, leukotriene; PG, prostaglandin; TX, thromboxane (from Calder [98]).
Another example of the dual role of PGE2 and its receptors in modulating the inflammatory
response has been described by Riccioti and FitzGerald [100]. During neuro-inflammation, the
LPS-induced PGE2 synthesis causes adverse effects in neurons resulting in lesions and enhanced
pain [101]. However, PGE2 also mediates bradykinin-induced neuroprotection by blocking
LPS and ATP-induced cytokine synthesis in microglia and in neuron-glia co-cultures [102].
The anti-inflammatory and neuro-protective effects of PGE2 are mediated by microglial EP2- and
EP4-receptors [100].
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ARA is the substrate for the biosynthesis of prostaglandins. Prostaglandins and thromboxane A2
are collectively called prostanoids. Prostanoids are formed when ARA is released from the plasma
membrane by phospholipase and metabolized by the sequential actions of prostaglandin G/H
synthase, or cyclooxygenase (COX), and by respective synthesis [100]. Prostanoids serve a variety of
functions. The adhesion-type prostaglandins as well as prostacyclin are important in vasodilation and
in anti-thrombus formation [103]. The E series prostaglandins act to dilate arterioles and capillaries
to bring about a drop in blood pressure, relax vascular smooth muscle, open the bronchi of the
lungs, and enhance blood flow through the kidney [104]. Prostaglandins are also involved in sleep
regulation [105], febrile response [106], and in pain perception [107].
As discussed by Calder [98], the overall physiologic (or pathophysiologic) outcome associated
with the production of eicosanoids depends on the cells present, the nature of the stimulus,
the timing of eicosanoid production, and the sensitivity of the target cells and tissues to the type
of eicosanoids that are produced [98,108]. For example, studies have shown that prostaglandin
PGE2, acting as a pro-inflammatory agent, induces cyclooxygenase 2 (COX-2) in fibroblast cells and
by doing so up-regulates its own production [109] which in turn stimulates the production of IL-6
by macrophages (see Astudillo et al. [108] for a review of ARA metabolism by inflammatory cells).
As an anti-inflammatory agent, PGE2 inhibits 5-lipoxygenase (5-LOX) thereby decreasing production
of the 4-series leukotrienes [110].These 4-series leukotrienes induce 15-LOX which in turn promotes
the formation of lipoxins that aid the resolution phase of inflammation [110]. Thus, the ARA-derived
PGE2 has both pro- and anti-inflammatory effects (Table 2).
Leukotrienes, eoxins, lipoxins, and hydroperoxyeicosatetranoic acids (HPETEs) are synthesized
from ARA by lipoxgenase enzymes and metabolized to LTA4 [108]. LTA4 is unstable and can
be rapidly converted into LTB4 or LTC4. These three leukotrienes constitute the slow-reacting
substances involved in anaphylaxis that act in allergic response [111]. They contract smooth muscle
and affect vascular permeability. Eoxins are generally proinflammatory and are produced in the
same manner as leukotrienes, but by the action of 15-lipoxgenase [108]. Lipoxins are produced by
transcellular biosynthesis and have anti-inflammatory properties and are involved in the resolution of
inflammation [112].
In vitro and animal studies suggest that ARA has a critical role in immune cell growth in the
thymus, and in differentiation, migration, and proliferation of immune cells [98]. During early growth,
there is substantial accretion of ARA in the mouse thymus which corresponds to the enrichment of the
placental ARA for the fetus [98].
The immune system is composed of an integrated network of organs, tissues, cells and molecules
that work together to resist infection, but maintain tolerance to harmless factors such as “self”, antigens,
and allergens [113]. When a challenge is detected (e.g., an allergen or pathogen), cell signaling
between immune cells produces a coordinated immune response involving the release of cytokines
and eicosanoids, which under normal circumstances allows cells to communicate with each other to
neutralize and eliminate the challenge [114,115].
ARA is highly abundant in platelet membranes and is closely linked to many platelet
functions [116]. Due to their high numbers (i.e., normal platelet count of 1.50–4.00 ˆ 1011 platelets
per liter of blood [117] and their ability to release inflammatory mediators, platelets perform several
sentinel tasks and can quickly communicate with the cells of the immune system [118]. For example, in
inflammatory skin disorders, platelets recognize bacterial pathogens through interactions with Toll-like
receptors leading to the elimination of bacteria by release of antimicrobial peptides or by aggregation
of platelets around the bacteria [119]. An array of receptors present on platelet membranes facilitate
transduction of signals and coordinate release of chemokines, cytokines, and other inflammatory
mediators to regulate inflammation and respond to invading pathogens [118,119].
Inflammation is the immune’s systems response to infection and injury [98]. Inflammation disorders
are observed in infants, particularly those born prematurely [120]. Inflammation is characterized by the
production of inflammatory cytokines, inflammatory agents such as reactive oxygen species, adhesion
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molecules, and the ARA-derived eicosanoids, and other oxidized derivatives [98]. N-3 LCPUFA decrease
the production of the inflammatory mediators (eicosanoids, cytokines, and reactive oxygen species)
and expression of adhesion molecules [98] by replacing ARA as an eicosanoid substrate and inhibiting
ARA metabolism [98,121]. Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) also inhibit the
cyclooxygenase-catalyzed conversion of ARA to prostaglandins [122].
Although inflammation is perceived to be a serious health problem, the inflammation process is
in fact an intrinsically beneficial event. Offending factors are removed or destroyed and as a result
the affected tissues and physiological functions are restored. During the acute phase of inflammation,
there is a rapid influx of blood granulocytes, typically neutrophils, followed by monocytes that
mature into inflammatory macrophages [100]. The macrophages proliferate and affect the functions
of resident tissue macrophages. This initial acute phase causes the usual signs of inflammation:
redness, heat, swelling, and pain [100]. Once the initial adverse stimulus is removed via phagocytosis,
the inflammation reaction typically decreases and ultimately resolves. During the resolution phase of
inflammation, granulocytes are eliminated and macrophages and lymphocytes return to their normal
pre-inflammatory levels [100]. The usual outcome of the acute inflammatory process is successful
resolution and repair of tissue damage.
Eicosanoids and Their Effects on Hormones and Bone Formation
The typical definition of a hormone is a chemical substance produced in the body that
controls and regulates the activity of certain cells or organs [123]. Many hormones are secreted
by special glands, such as thyroid hormone produced by the thyroid gland. Eicosanoids are
recognized as different from hormones because they are not synthesized or stored in select tissues
or endocrine organs. Eicosanoids are synthesized in almost all tissues and exert their biological
effect near the site of their synthesis rather at a distance such as other hormones [124]. Despite these
differences, eicosanoids are generally classified as hormones [125]. Eicosanoids directly affect other
hormones including glycoprotein hormones. The glycoprotein hormones include luteinizing hormone,
somatostatin, and glucagon. Somatostatin is an important growth hormone that controls and regulates
growth and cell division [126]. It is the main hormone that stimulates cell proliferation and growth,
and this hormone must be regulated so that growth is controlled [126]. Insulin and glucagon release
are also affected by the eicosanoid derivatives, epoxy-eicosatrienoic acids [124].
ARA also plays an important role in the hormonal regulation of normal bone formation and whole
body mineral metabolism during infant and childhood growth (Table 3). During skeletal development,
the eicosanoids relay cellular, organ, and systemic signals to balance the calcium and phosphate needs
for bone formation and other metabolic activities [127,128]. During long bone growth, when bone
tissue is created, [127–130] ARA mediates vitamin D3-regulated chondrocyte maturation [131] and
proliferation [127,132–134] for the mineralization of skeletal growth plates (Figure 5).
A product of ARA, prostaglandin PGE2 is a potent regulator of cartilage formation or
chondrogenesis and resorption [135–139]. At low levels, PGE2 stimulates bone formation by increasing
the production of insulin-like growth factor, a powerful growth stimulator for bone, cartilage,
and muscle [140]. At high levels, PGE2 has the opposite effect: bone formation is reduced and
resorption is increased [140].
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Figure 5. The role of ARA in bone development and homeostatic regulation of vitamin D3 and
parathyroid hormone (PTH) levels along the parathyroid gland-kidney axis during growth. ARA and
vitamin D3 are acquired from the diet and/or from endogenous sources. ARA mediates vitamin
D3 regulation of chondrocyte proliferation and growth plate mineralization during bone elongation.
As vitamin D3 is metabolized and levels subside, ARA-dependent PTH suppression is diminished
and PTH production by the parathyroid gland is upregulated. This results in increased periosteal
bone mineral content (appositional bone growth). In kidney, PTH induces the ARA-mediated increase
in vitamin D3 activation and secretion, elevating the amount of vitamin D3 in circulation. The cycle
continues as the restoration of vitamin D3 results in the ARA-dependent suppression of PTH and
stimulates longitudinal bone growth.
These differential effects of osteoclast formation and resorption are mediated through multiple
subtypes of G-protein coupled PGE2 cell surface receptors (EP1, EP2, and EP4) [141]. Activation of the
EP2 and EP4 receptor subtypes are linked to an elevated level of cyclic adenosine monophosphate
(cAMP) and bone formation. EP2 also acts as a selective agonist which has the ability to heal long bone
fractures as demonstrated in animal models [141,142].
PGE2 is also critically important for bone strength [141]. When different doses (3 or 6 mg
PGE2/kg/day) of prostaglandin PGE2 were given to Sprague-Dawley rats for 3 weeks an increase in
bone and hard tissue mass, calcified cartilage cores, and a decrease in osteoclasts were observed [143].
PGE2 increased metaphyseal calcified tissue mass by depressing hard tissue resorption and stimulating
the replication and differentiation of osteoblast precursors to form new bone [143].
Other prostaglandins play multiple roles for bone metabolism and remodeling by regulating
various signaling pathways [144]. For example, PGF2α, through the activation of protein kinase C
(PKC), stimulates the Na-dependent inorganic phosphate transport in osteoblasts [144]. PGF2α also
up-regulates interleukin (IL-6) to stimulate osteoclast formation and increases vascular endothelial
growth factor (VEGF) associated with the growth of blood vessels from pre-existing vasculature [144].
PKCα, in particular, appears to play a critical role in the regulation of osteoblastic function
under load-bearing conditions [145]. During exposure to mechanical strain, PKCα is activated in
osteoblast-like cells [146] while PKC signaling has been implicated in the regulation of various
mechanically response genes including the osteoblast differentiation marker osteocalcin [147,148].
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Table 3. Roles of ARA in bone formation, metabolism, and mineral balance.
Metabolic Effector Physiological Roles of ARA
ARA [149] Maintain normal balance between bone mineral accrualand bone resorption during infant development
ARA, growth hormones [150,151] Increase insulin-like growth factor gene expression andinduction of osteoblast-dependent bone formation
Vitamin D3 [128,133]
Mediate vitamin D3 coordination of chondrocyte
proliferation in the epiphyseal growth plates of long
bones. Parathyroid hormone secretion
Calcium and phosphorous [152] Regulation of parathyroid hormone secretion in responseto blood mineral concentrations
Parathyroid hormone [149,150] ARA mediated/activated pathway involved in theactivation and secretion of vitamin D3 by kidneys
Physical activity [153]
ARA mediates bone adaptation to changes in physical
stress through mechanisms which mediate resorption
and remodeling
In studies of piglets fed formulas with differing levels of ARA (0.30%, 0.45%, 0.60% or 0.75% of
fat) plus the same level of DHA (0.1% of fat), proportions of ARA in plasma, liver and adipose were
dose dependent but bone modeling was not [150]. Whole-body bone mineral content was elevated
in the piglets fed the highest levels of ARA (0.60% and 0.75%) and was best predicted by dietary
ARA [150,154]. In addition, the 0.60% and 0.75% ARA groups had bone mineral content values closest
to that of a reference group of suckled piglets [150,155].
Overall, dietary provision of ARA serves a number of important roles in skeletal metabolism.
ARA functions as an important modulator of vitamin D regulation of chondrocyte proliferation and
growth plate mineralization. ARA derived metabolites are important inducers of osteoclast [156,157]
and osteoblast differentiation [158,159], and in modulating resorption of bone [139,149] by increasing
IGF-1 gene expression [104,151] and circulating levels of IGF-1 [150]. ARA also responds to changes
in stress and mechanical loading [153,160], and accelerates bone repair and healing [142,161].
Additionally, in term infants, cord blood ARA levels correlate positively with bone mineral
density [155]. Thus, ARA represents an important nutrient for infant and childhood bone development
and metabolism.
7. ARA in Skeletal and Cardiac Muscle
Several animal studies have shown that the concentration of ARA in the heart is highly
sensitive to levels and ratios of ARA and DHA of the diet [24,54,162–164]. The amount of ARA
in cardiac tissue muscle is at concentrations 2 to 3 times greater than observed in skeletal muscle [52].
Analysis of the phospholipid composition of skeletal muscle biopsies collected from 56 children
<2 years of age indicated that ARA represented 16.5% of the total percentage of LCPUFA in muscle
phospholipids [165].
Repetitive force loading and unloading during ATP-dependent contraction of actin filaments are
major mechanical functions of heart muscle, and to a lesser extent, skeletal muscle [166]. ARA is critical
for muscle contraction [166–168]. In skeletal muscle, excitation–contraction coupling is the process by
which muscles contract [166] when a muscle action potential in the muscle fiber causes the myofibrils
to contract [169]. Excitation–contraction coupling relies on a direct coupling between key proteins,
the sarcoplasmic reticulum calcium release channel (the release of Ca2+ ions), and the voltage-gated
L-type calcium channels [170]. The release of Ca2+ ions from the sarcoplasmic reticulum causes binding
between actin and myosin to induce muscle contraction. This cycle is reset as calcium declines back
to resting levels [166]. Cardiac and skeletal muscle require tight regulation of voltage-gated calcium
channels and calcium homeostasis to coordinate the excitation-contraction coupling process [170].
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Phosphatidylinositol (4,5) bisphosphate (PIP2), a phospholipid component of cell membranes,
serves as an important regulator for Ca2+ release from the sarcoplasmic reticulum and assists in the
maintenance of normal calcium signaling to control contractile forces [167,168,171]. The fatty acids of
PIP2 are variable in different species and tissues, but studies show the most common fatty acids are
stearic in position 1 and ARA in position 2 [37].
Calcium homeostasis, regulation and maintenance are critical elements for normal muscle
function. Wolf et al. [34] have shown that the endoplasmic reticulum is directly responsible for
the regulation of intracellular Ca2+ concentrations. ARA plays an important cooperative role with
myo-inositol 1,4,5-triphosphate (IP3) in glucose-induced calcium mobilization and insulin secretion by
pancreatic islets.
PIP2 and phosphatidylinositol 3,4,5-triphosphate (PIP3) are also critical for cardiac function [172].
In the heart, PIP2, as a key second messenger, controls the activity of ion channels involved with
the modulation of heart rhythm. PIP3, on the other hand, is primarily involved in the control
of cardiomyocyte apoptosis, hypertrophy, and contractility [172]. In adults, deregulation of the
phosphoinositide metabolism is associated with the onset and progression of several cardiovascular
pathologies including atherosclerosis and heart failure [172].
Muscle growth and atrophy depend on the balance between the rates of protein synthesis and
degradation [173]. In vitro experiments with animal and human skeletal and cardiac muscle tissue
indicate that prostaglandins are involved in the regulation of protein synthesis and degradation in
various types of striated muscle [173,174]. While PGE2 increases degradation of muscle in young rats
and causes net protein balance to become more negative, PGF2α causes a large stimulation of protein
synthesis in muscle tissue [173]. These findings are consistent with the many important roles played
by prostaglandins PGE2 and PGF2α in muscle protein balance and indicate that overall, ARA serves
multiple functions in cardiac and skeletal muscle function and physiology.
8. Biomagnification and Accretion of ARA in Infants
Biomagnification is when infants have higher levels of LCPUFA in plasma lipid fractions and
erythrocytes as compared with their mothers [45]. Biomagnification can be especially marked for ARA
with levels more than 2-fold of that from the maternal side and independent from the amount of its
precursor LA available maternally. The stability of LA content implies that any conversion to ARA
is not keeping up with the fetal demand for ARA [45]. Biomagnification by the placenta serves to
preferentially obtain preformed ARA and DHA from the mother in order to deliver it to and nourish
the fetus [45].
As shown by Kuipers et al. [175], biomagnification is independent of maternal ARA status at both
delivery and at 3 months of age and is found to be similar across different populations with differing
diets. These findings indicate that biomagnification as a biological process seeks to achieve a uniform
ARA status in infants at the expense of their mothers. The process of biomagnification suggests that
a certain level of infant prenatal ARA status must be maintained for optimal infant growth.
Infants with the lowest birthweights have the lowest levels of ARA, and those born earliest have
the lowest levels of DHA [45]. The process of biomagnification initially protects vascular growth
which is a requirement for brain growth. Vascular growth must precede brain growth to meet the
brain’s demand for energy, which can be as high as 70% of the total fetal demand for energy in the last
trimester of pregnancy [45].
At delivery, as shown by Luxwolda et al. [176], the maternal RBC-ARA content is consistently
higher than that at 3 months postpartum. At delivery, infant RBC-ARA content is similar or higher
than their mother’s RBC-ARA contents. From delivery to 3 months postpartum, maternal RBC-ARA
increases while infant RBC-ARA decreases. The decrease in RBC-ARA content may be due to a lower
conversion of LA to ARA since the infant’s capacity to synthesize LCPUFA decreases dramatically
after delivery [69] and has been shown to decrease with gestational age at birth [64].
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There appears to be a tightly regulated synergism between DHA and ARA at low DHA status
and an antagonism at high DHA status [50]. Intrauterine DHA biomagnification in mothers with low
fish intakes aims at a synergistic increase of fetal DHA to maintain a balance with ARA. Bioattenuation
at higher DHA status may in turn prevent abundant passage of DHA across the placenta that leads to
antagonism with ARA. Since ARA is important for fetal growth [177] and is rapidly accreted in the
fetal brain [178,179] any competition from gestational DHA must be tightly regulated and balanced
for optimal neurodevelopment after birth [50]. Dietary depletion of ARA in early infancy may have
adverse consequences for brain development [178,179].
9. Consequences of ARA Deficiency
Essential fatty acid (EFA) deficiency impairs lipid and energy metabolism, cell membrane
structures, lipid signaling pathways, and ultimately leads to death [180,181]. Mammals are dependent
on a dietary supply of LA and ALA which are converted into n-6 and n-3 PUFA, respectively. Δ6-fatty
acid desaturase (FADS2) converts LA to γ-linolenic acid (C18:3n-6) and Δ5-fatty acid desaturase
(FADS1) converts dihommo-γ-linolenic acid (C20:3n-6) to ARA [182].
Early studies of EFA deficiency considered the effect that various dose levels of intake of LA,
ARA and ALA esters (0% to 10% of total calories for 100 days) had on the fatty acid composition in
the liver of rats [183]. Fat deficiency symptoms (necrotic tail and scaly feet) appeared in all animals
fed LA at less than 0.6% of calories and ARA at less than 0.25% of calories. ARA was 3-fold more
effective than LA in liver incorporation and mitigating deficiency. Fat deficiency symptoms affecting
the skin were not surprising. In the skin, as in all organs, EFA are principally found in glycolipids
and phospholipids. Most of the epidermal fatty acid PUFA is ARA [184]. EFA deficiency causes skin
flaking in humans, dogs, and mice, symptoms that can be restored with LA dietary therapy [184].
Since LA deficiency results in disruption of the skin’s water barrier function [185] and heat
loss from skin [186] the side effects make it difficult to distinguish the specific effects of ARA
deficiency independent from those related to LA deficiency. The fads2´/´ mouse allows for the
specific investigation of ARA deficiency without the underlying complications of LA deficiency [181].
The mutation eliminates Δ-6 desaturase activity leading to a dramatic decrease in the accumulation of
ARA in tissues and subsequently, ARA conversion to PGE, TXB, prostacyclin and leukotrienes. Platelet
aggregation and thrombosis are therefore also limited.
When fads2´/´ mice were followed for several weeks and fed a diet lacking Δ6-fatty acid
desaturase products but containing ample amounts of LA, the lack of PUFA and eicosanoids did
not impair lifespan but all the mice were sterile, developed ulcerative dermatitis, splenomegaly, and
ulceration in the duodenum and ileocecal junction [182]. Liver levels of ARA and DHA declined by
95% and somewhat smaller decreases were observed in the brain and testes (~50%). The absence
of γ-linolenic conversion in the fads2´/´ mouse deprived the cyclooxygenase and lipoxygenase
pathways of their substrates, including the elimination of PGE synthesis, the failure of synthesis
of TXBs by thrombocytes, and the failure to produce leukotrienes [181]. PUFA supplementation
completely restored the adverse symptoms observed in fads2´/´ mice. The mechanism by which
ARA prevented dermatitis may be due, at least in part, to lower levels of prostaglandin D2 (PGD2)
when skin ARA is decreased [182].
The ulceration of the small intestine in the fads2´/´ mouse may have been associated with
the decline of prostaglandin synthesis, similar to the effect often seen with the long-term use of
NSAIDs [187]. NSAIDs block prostaglandin synthesis by inhibiting cyclooxygenases, leading to
an erosion and then ulceration of the mucosal layer of the stomach and small intestine. However,
loss of organized stratification of proliferating cells into defined zones is a common feature of EFA
deficiency [188].
The Δ6-fatty acid desaturase gene FADS2 was cloned in 1999 [189]. An adult human case of
Δ6-fatty acid desaturase deficiency was identified and described in the literature [190]. The patient
exhibited growth retardation accompanied by skin abnormalities, corneal ulceration, and feeding
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intolerance. Treatment with dietary DHA and ARA restored normal growth and eliminated most of
the symptoms [190].
A novel genetic model, the FADS1 (Δ5 desaturase) knockout mouse was used to determine the
role that the ARA-derived 2-series eicosanoids had in mucosal physiology and inflammation [191].
Fads1´/´ mice have very low levels of ARA in tissues (colon mucosa, liver, spleen, serum and fatty
acid profiles). The deficiency in ARA resulted in a massive enhancement of dihomo-y-linolenic acid,
the 1-series prostaglandin substrate in tissues and a decrease in 2-series-derived prostaglandins or
PGE2. Fads1´/´ mice failed to thrive, gradually dying at 5 to 6 weeks of age with no survivors past
12 weeks of age [191]. The lack of PGE2 was associated with disturbed intestinal crypt proliferation,
altered immune cell homeostasis, and a heightened sensitivity to acute inflammatory challenge [191].
Dietary supplementation with ARA extended the longevity of fads1´/´ mice to levels comparable
with normal wild-type mice (Figure 6).
Figure 6. Kaplan-Meier survival curves of Fads1 mice, AA = ARA. (A) Fads1 null mice exhibited low
viability when fed a standard AA-free diet; n = 37 for wild-type, n = 44 for heterozygous, n = 11 for
Null; (B) Dietary supplementation with AA (0.1% and 0.4%, w/w) partially reversed the Fads1 null
mouse phenotype; n = 5 for Null + 0.1% AA, n = 3 for Null + 0.4% AA. Supplementation with 2.0% AA
completely reverse the Null phenotype; n = 4 for Null ˘ 2% AA (from Fan et al. [191]).
Although fads1´/´ and fad2´/´ mice are useful to examine the function of ARA in vivo PUFA
are transferred through the placenta from the heterozygous mother into the homozygous fetus.
Additionally, the amount of DHA and ARA in the brain tends to remain tightly controlled even
under conditions of PUFA deprivation, but at the expense of other tissues to protect the brain [182].
Lpiat1´/´ mice have a mutation that affects the synthesis of ARA-containing PI. PI is unique in its
fatty acid composition, i.e., most of the fatty acid that is attached to the sn-2 position of PI is ARA [33].
Other membrane phospholipids such as PC and PE contain other PUFA including DHA.
Lee et al. [33] showed that Lpiat1´/´ mice had a reduced content of ARA in PI and had deficits in
cortical lamination during brain development, delayed neuronal processes in the cortex, and reduced
neurite outgrowth in vitro. Lpiat1´/´ mice died within a month and showed atrophy of the cerebral
cortex and hippocampus. These results demonstrate the importance of ARA-containing PI in normal
cortical development in mice. By eliminating LPIAT1 in Lpiat1´/´ mice, the enzyme responsible
for the incorporation of ARA into PI, it was shown that the ARA-containing PI is essential for brain
development in mammals [33].
54
Nutrients 2016, 8, 216
Newborn pups of Δ6-fatty acid desaturase knockout mice were administered artificial milks
that contained 3.7% ALA and 16% LA with or without 1.2% ARA and/or 1.2% DHA for 18 days
immediately after birth [192]. Compared with wild-type mice, the body weight of the mice fed the
control diet was significantly lower, particularly after 6 weeks of age. However, body weights of
knockout mice fed milks with DHA and ARA+DHA were similar to that of the wild-type mice. Motor
activities of the knockout mice fed ARA were elevated compared with the wild-type mice and those fed
the control diet. Better motor performance was also observed in knockout mice fed the ARA + DHA
diet. The authors concluded that ARA corrected the decrease in body weight and the combination of
ARA and DHA improved the motor dysfunction caused by the deficit of Δ6-fatty acid desaturase.
Taken together, results from these investigations indicate the importance of ARA and its
derivatives for the coordination of cellular differentiation, organogenesis, and function during early
growth and development.
10. Animal Studies of ARA Supplementation
10.1. Immunomodulatory Effects of ARA and DHA Supplementation
The activation of peroxisomal proliferator-activated receptors (PPARs) has been shown to be
protective in brain ischemic and oxidative injury and in many neurological diseases that may affect
infants [193] (Figure 7). In addition, transcription of the gene for the Major Facilitator Superfamily of
the domain-containing protein 2a (MFSD2A) has been identified as being an important transporter
for the uptake of DHA across the blood brain barrier [194] and is under the control of PPAR [195].
Studies indicate that LCPUFA and their metabolites are ligands to PPARs. Diets containing an n-6:n-3
ratio of about 1-2:1 supplied during pregnancy and lactation appear to be optimal for the expression of
neuron-specific enolase, glial fibrillary acidic protein and myelin basic protein, markers related to the
growth and maturation of neurons, astrocytes and myelin [193].
To investigate the immunomodulatory effects of different PUFA, weanling rats were fed a high-fat
diet (178 g/kg) that contained 4.4 g of ALA, γ-linolenic, ARA, EPA, or DHA/100 g total diet [196] for
6 weeks. The proportion of total PUFA content (~35 wt %) was held constant and the n-6 to n-3 ratio was
maintained at 5.8 to 7.0. PGE2 production was enhanced in leukocytes from rats fed the ARA-rich diet
and was decreased from leukocytes in rats fed the EPA or DHA diets. ARA did not affect lymphocyte
proliferation, NK cell activity, or the cell-mediated immune response. Lack of an effect on T-lymphocyte
proliferation and Con A in splenocyte cultures was also observed in mice fed a safflower oil ethyl ester
diet +1% ARA for 10 days [197]. The lack of an immunological effect of ARA agrees with findings
from a human study that considered 1.5 g of ARA/day for 50 days on the proliferation response
of peripheral blood mononuclear cells to Con A, phytohemagglutinin, or poke-weed mitogen [198].
Human peripheral blood NK activity was also unaffected by the consumption of ARA.
Prostaglandins which are involved in inflammatory processes also play a major role in the recovery
of intestinal barrier function in ischemia-injured porcine ileum by converting ARA to PGH2 [199].
The importance of ARA and ARA-derived eicosanoids in the intestinal epithelium was reviewed by
Ferrer and Moreno [200]. In a study that considered the effect of supplemental ARA on intestinal
barrier repair in ischemia-injured porcine ileum pigs were fed a formula containing no LCPUFA
(0% ARA), 0.5% ARA, 5% ARA, or 5% EPA for 10 days. Piglets that were fed 5% ARA exhibited
enhanced recovery compared with piglets fed 0% ARA or 0.5% ARA [201]. The EPA-fed piglets had
enhanced recovery comparable with piglets fed 0% ARA. The enhanced recovery response observed
with 5% ARA was supported by reduction in the mucosal-to-serosal flux of 3H-mannitol and 14C-inulin
compared with the other dietary groups. Jacobi et al. [201] concluded that piglets fed a high-ARA
diet are less susceptible to ischemia-induced epithelial cell sloughing and that feeding elevated levels
of LCPUFA, including ARA, enhances acute recovery of ischemia-injured porcine ileum. For infants
affected by necrotizing enterocolitis (NEC) where physiological repair of the intestines is necessary
elevated LCPUFA intake including ARA enhances recovery of damaged tissues [201].
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Figure 7. Schematic summary of molecular events and functional outcomes involved in metabolism
of ARA. ARA is derived from endogenous synthesis or directly from the diet and is incorporated
into cellular membrane complex lipids. Within the lipid bilayer, ARA is enriched in PE and
PI in the inner membrane. Coordination of spatial-temporal interactions between molecular and
cellular components and activities are mediated by metabolites of, or molecules associated with
metabolism of ARA. Metabolism of ARA is triggered by activation of transmembrane receptors as a
result of binding a ligand. A few examples of receptor-mediated activation of ARA metabolism
include glucose, vitamin D3, Ca2+, or antigen presentation or detection by immune cells. ARA
released from the membrane by the actions of PLA2 or metabolized by enzymes such as COX,
CYP450, and/or LOX can act directly or serve as a substrate for various enzymes to produce
second-messengers. ARA-derived eicosanoids, including prostaglandins, leukotrienes, lipoxins, and
HETEs regulate numerous activities including passage of ions between subcellular compartments,
interactions between various structures or cells, and nuclear regulation of gene transcription by
PPARs activators. Within the inner leaflet of cell membranes, ARA is enriched in micro-domains
and is involved in regulation of receptor mediated activities. In addition, micro-domains serve as
foundations for biophysical interactions between subcellular structures such as microtubules and other
cytoskeletal activities including vesicular transport. The consequences of temporal-spatial regulation
include coordinated release of hormones, expression of various cell functions, and/or alterations in
phenotypes, and cellular motility. Examples of PPAR-regulated gene products involved tissue uptake of
LCPUFA and oxidation of stored lipids: MFSD2A, major facilitator of superfamily domain-containing
protein 2A. Membrane components: Chol, cholesterol; Gang, gangliosides; PC, phosphatidylcholine;
PE, phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; SPM, Sphingomyelin.
Nuclear transcription factors: PPAR, peroxisome-proliferator activator receptors; RXR, retinoid X
receptors. TM, transmembrane receptors. Enzymes: COX, cyclooxygenase; CYP450, cytochrome
P450; LOX, lipoxygenase; PLA2, Phospholipase A2; PLC, Phospholipase C. Signaling molecules: PG,
prostaglandin (Adapted from Pike [32]).
EFA deficiency also leads to hepatic steatosis. When rats were administered varying amounts of
DHA and ARA to determine whether exclusive supplementation with DHA or ARA could prevent
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EFA deficiency and inhibit the development of hepatic steatosis mice fed at least 2% of their calories
from DHA and 1% of the calories from ARA did not develop clinical or biochemical evidence of EFA
deficiency disease or hepatic steatosis [202]. Although hepatic steatosis is an adult disease, the fact
that mice fed at least 2% of their calories from DHA and 1% of the calories from ARA prevent the
development of EFA deficiency suggests the importance of ARA throughout the lifespan.
To investigate the ability of ARA- and ARA + DHA-enriched formula to modulate immune
response in neonatal piglets to an inactivated influenza virus vaccine Bassaganya-Riera et al. [203]
considered a diet with ARA + DHA in sow milk fed at birth. The diet modulated antigen-specific T-cell
responses to an inactivated influenza virus and up-regulated IL-10 expression [203]. Although ARA
and DHA have been suggested to elicit opposing immunomodulatory actions, the immunologic
outcome in the study was beneficial [203]. The authors concluded that ARA + DHA enriched formulas,
with the approximate 2:1 ratio fed during the neonatal period, may prevent or manage autoimmune
and allergic reactions in infants by down-modulating T-cell reactions.
10.2. Retinal and Neurodevelopmental Effects of ARA and DHA Supplementation
The retinal DHA content in guinea pigs was considered in relation to diets containing different
n-6:n-3 ratios (from 72.0 to 2.5) [204]. Not surprisingly, diets with the highest n-6:n-3 PUFA ratios
had the highest n-6 retinal fatty acid profiles. Weisinger et al. [204] reported that retinal function was
altered by tissue DHA levels and responded according to an inverted “U-shaped” function. As DHA
levels increased past an optimal amount found to be 19%, the result was poorer electroretinographic
scores. However, there was no mention that as DHA increased there was a corresponding decrease in
ARA levels due to ARA antagonism. The marked decrease in ARA levels may have been the variable
of interest that was not fully considered and responsible for the electroretinographic changes at high
DHA intakes.
Champoux et al. [205] used a neurodevelopmental battery to test the neurological behavior in
rhesus macaques neonates fed a control formula without LCPUFA or a LCPUFA-supplemented formula
with 1 wt % each of DHA and ARA. Macaque neonates fed the supplemented formula obtained higher
scores on motor maturity and orientation than those fed a control formula. Champoux et al. [205]
concluded that the results supported the view that preformed DHA and ARA in infant formulas are
required for optimal neurological development.
Learning behavior in rats fed a diet supplemented with 3% safflower oil (Safflower, n-3 fatty acid
deficient, high LA acid) was compared to those fed 3% perilla oil (Perilla, high ALA) [206]. Through two
generations, the n-3 fatty acid deficient group exhibited decreased correct response ratios in
a brightness-discrimination behavior test. The altered learning ability in the brightness-discrimination
test was restored with supplementation of DHA after weaning, only after levels of ARA in the brain
lipids were normalized. The authors concluded that n-3 fatty acid is essential for the maintenance
of learning performance and that n-3 deficiency in the presence of n-6 fatty acid during gestation
did not lead to irreversible damage to the brain [206]. Thus, both DHA and ARA affected learning
performance and a balance of ARA and DHA levels must be maintained.
To investigate the effects that varying dietary levels of LCPUFA have on growth, brain fatty
acid composition and behavior in mice, 5 groups of pregnant and lactating mice were fed diets with
either very high n-6 to n-3 ratio of 49 (n-3 deficient), a more usual ratio of 4.0, or a low ratio of 0.32
for 15 weeks [207]. There was no effect of diet on birth weights of pups, but on days 15 and 22 the
pups in the low n-6 to n-3 groups weighed less than those in the other treatment groups. Increasing
levels of DHA in the diet increased brain DHA and decreased brain ARA. The differing ratios of
n-6 to n-3 had no effect on the ability of mice to learn the place test or perform in the Morris water
maze. However, the mice fed the low n-6 to n-3 ratio swam more slowly, unless ARA was substituted
for LA as the source of the n-6. The lower body weight in the high n-6 to n-3 fed mice was not
attributed to simply n-6 deficiency. The high n-3 to n-6 ratio led to the inhibition of Δ6-desaturase [207].
Thus, the conversion of LA to ARA was impeded and ARA became unavailable for growth. Mice fed
57
Nutrients 2016, 8, 216
high levels of DHA also had high levels of EPA showing a considerable amount of retroconversion.
The findings showed the importance of balancing the amounts of ARA to DHA and that some deficits
can be overcome if LA is replaced by ARA as the source of n-6 fatty acid [207]. Wainright et al. [208]
also reported that ARA supplementation increased ARA levels and decreased DHA levels in forebrain
membrane phospholipids in Long-Evans rats, whereas DHA supplementation increased DHA levels
and decreased ARA levels. Correlational analyses did not show a relationship between DHA and ARA
levels in the forebrain and working memory performance [208,209].
Newborn infants of diabetic mothers have lower ARA and DHA levels in cord blood than
newborns of normal mothers [210]. The lower levels of the LCPUFA in the newborns of diabetic
mothers were associated with impaired and altered sensory-cognitive and psychomotor functions at
birth and reduced visual and memory performance at 8 and 12 months [211,212]. Compared with
normal controls, most rat models of diabetes are characterized by a lower level of brain ARA
only and not a lower level of DHA [213]. Even though both ARA and DHA are important for
neurodevelopment, brain accretion of ARA exceeds that of DHA during gestation [214], especially in
the first two trimesters during the period of rapid proliferation of neuronal and glial elements [179,215].
When Sprague-Dawley diabetic, pregnant rats were fed either a control diet or an ARA (0.5%)
supplemented diet throughout reproduction, the weaned offspring in the ARA group performed
significantly better in the water maze and rotarod tests and showed greater exploratory behavior
than control-diet offspring [216]. The results indicated that maternal hyperglycemia has long-term
consequences during the initial stages of learning and that maternal supplementation with ARA
positively influences learning outcomes.
Amusquivar et al. [217] reported that rat pups of dams fed diets with n-3 fatty acids from fish oil
compared with those fed n-6 fatty acids from olive oil during pregnancy and lactation had smaller
increases in postnatal body weight and length, and delayed body and psychomotor maturation indices.
Slower growth and brain development occurred when both dams and fetuses were fed a moderate
amount of fish oil (10%) as the only fat source [217]. In the study, the ARA level was lower than
the DHA level in brain tissue of the offspring of dams fed high n-3 fatty acid diets. The differences
in postnatal development disappeared when the fish oil was supplemented with γ-linolenic acid,
a precursor of ARA. The growth deficits were also eliminated by the inclusion of ARA in the diet [207].
The studies demonstrate the importance of maintaining adequate levels of ARA during development,
and suggest that diets too high in n-3 fatty acids during development may have negative effects on
development by reducing tissue levels of ARA [218].
To investigate the effects that a DHA-rich maternal diet compared with an ARA-only diet have
on brain fatty acid composition of Sprague-Dawley rats, Elsherbiny et al. [219] considered a control
diet containing ARA (0.4 g/100 g of total fatty acid) vs. a DHA + ARA diet (0.9 g/100 of DHA and
0.4 g/100 g of ARA of total fatty acid). The results indicated that at three weeks postnatally the
DHA-rich diet increased levels of DHA in the brain and decreased ARA by 12.8%. The brain of
a three-week-old rat is at a comparable stage as that of a human toddler at 2–3 years of age [219]. At six
weeks (comparable to a 12–18 years old human), the DHA-induced decreases in ARA were reversed
and disappeared when DHA was continued (i.e., DHA/control group). Thus, elevated dietary levels
of DHA decrease the amount of ARA in brain without an adequate supply of dietary ARA.
Prepulse inhibition (PPI) is a normal suppression of a startle response when a low intensity
stimulus that elicits little or no behavioral response immediately precedes an unexpected stronger
startling response [220]. Deficits in PPI have been reported in individuals that have mental disorders
including schizophrenia [220]. Various brain regions including the hippocampus have been associated
with PPI problems. To determine whether dietary administration of LCPUFA enhances neurogenesis in
the rat hippocampus and improves PPI response in wild-type mice and Pax6+/´ mice (that exhibit PPI
deficits) a control diet or diets supplemented with ARA (4%), DHA (4%) or ARA (4%) + DHA (4%) were
administered [220]. Compared with the other diets, the administration of the ARA diet successfully
increased neurogenesis not only in the Pax6+/´ mice but also in the wild-type mice. Treating the
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Pax6+/´ mice with ARA also resulted in alleviating their PPI deficits. The authors suggested that the
ARA diet as compared with the DHA or ARA + DHA diets positively affected postnatal neurogenesis
in several regions of the brain including the hippocampus by influencing the fluidity of neuronal
membranes and by regulating neuronal transmission [220].
11. Introduction of DHA and ARA in Infant Formulas
Both DHA and ARA have been added to infant formulas in the United States since 2001. In Europe,
the addition of DHA and ARA in infant formulas began much earlier in 1994. Most infant formulas
contain 0.2% to 0.4% total fatty acids of DHA and between 0.35% and 0.7% total fatty acids of ARA
based on worldwide averages of DHA and ARA content in human milk [5]. Several international
expert groups [6–9] support the addition of these levels of DHA and ARA in infant formulas to ensure
optimal infant growth and development. Thus, all commercially available infant formulas contain
preformed ARA at levels equal to or higher than the DHA content in formulas where these LCPUFA
are added.
To determine the necessity of adding LCPUFA to infant formula, several studies were performed
in the 1990s with preterm and term infants fed formulas containing DHA or EPA with and without ARA
(see Fleith and Clandinin [221] for a review). No studies have examined supplementation of infant
formula with ARA alone. In most studies, a control group without LCPUFA and/or a breastfed group
were included. Studies also investigated the effect of adding ALA to ensure a sufficient endogenous
synthesis of DHA [222,223], but not surprisingly, due to the limited conversion of ALA to DHA,
the added ALA was not effective in raising DHA plasma status to the same level as that observed
in breastfed infants ([223]. Some studies also considered experimental formulas containing added
γ-linolenic acid from black current-seed oil, borage oil, or evening primrose oil, DHA and EPA from
marine oil, and ARA from egg phospholipids [223–229]. The effects of feeding formula supplemented
with soy oil and marine oils containing DHA/EPA showed no abnormalities on growth, tolerance,
clotting function, erythrocyte membrane fluidity and vitamin A or E levels in low-birth-weight-term
infants [230].
Infant formulas containing DHA and ARA from single cell oils (DHASCO® and ARASCO®,
DSM, Columbia, MD, USA), respectively, were evaluated and found to maintain both DHA and
ARA status in infants [178,231–233]. After 2001, DHASCO and ARASCO (DSM, Columbia, MD, USA)
became predominant as the sources of DHA and ARA added to infant formulas in the United States.
Both DHASCO and ARASCO are general recognized as safe (GRAS) for use in infant formulas in the
United States and approved as novel foods in Canada [234,235]. DHASCO and ARASCO have an
established history of use in Europe, Australia and New Zealand and are not considered novel foods
and can be added to infant formulas (see Ryan et al. [236] for a review of the safety of single-cell oils).
The clinical studies used to evaluate the effects of DHA and ARA added to infant formulas
measured infant growth, body and fatty acid composition, behavioral and sensory functions (retinal
function, visual acuity and auditory function). Many of the early studies focused on preterm infants
because they provided an opportunity to evaluate the effects of DHA- and ARA-enriched formulas
in infants who may be deficient in these LCPUFA. Transfer across the placenta and accretion of
ARA and DHA in the developing human brain and retina occurs mainly during the last trimester
of pregnancy [179,215] when the rate of brain growth is most rapid [237]. Infants born prematurely
thus may have an increased need for dietary ARA due to the interrupted supply during the last
trimester [220,238,239].
Four studies with preterm infants considered formulas without added preformed ARA [240–243].
Each was influential in recognizing the importance of ARA for optimal growth. Two of the studies
reported an increase in visual acuity at 2 or 4 months postmenstrual age (PMA) in preterm infants fed
formulas supplemented with DHA and EPA from fish oil with a low or high ratio of DHA to EPA (2:1,
5:1, respectively) and no ARA [241,244–246].
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In one study [240], infants fed formula with a low ratio of DHA to EPA until 79 weeks
PMA, compared with controls, had significantly lower z-score values for weight, length and head
circumference beginning at 40 weeks PMA. Poorer growth was also associated with lower scores of
psychomotor development [244]. The supplemented group also had lower blood levels of ARA [177]
suggesting that the effects of growth may have been related to the reduced availability of ARA as
a result of the competitive inhibition by the high levels of EPA in marine oil. This finding was supported
in a second study [241] in which preterm infants were fed formula with a high DHA to EPA ratio until
48 weeks PMA. Compared with controls, preterm infants fed a high ratio of DHA to EPA and with no
ARA consistently had lower mean weight-for-length values at 2, 6, 9, and 12 months PMA, weighed
less at 6 and 9 months PMA, and had smaller head circumferences at 9 months PMA [246].
In a third study, three premature infant formulas were compared in a double-blind parallel-group
study of the growth of healthy, very-low-birth-weight infants (846–1560 g at birth) [242]. The DHA
formula contained 0.34% of fat as DHA and the DHA +ARA formula contained 0.33% as DHA
and 0.60% as ARA. The control formula contained no DHA or ARA. A reference group consisted
of term infants who were predominately breastfed. Results indicated that infants fed formula
with DHA + ARA gained significantly more weight than infants fed formula without DHA+ARA.
At 48 and 57 weeks, weight of infants in the DHA + ARA group did not differ from the reference
group of term infants. Length of infants in the DHA + ARA group was significantly greater than
that of infants fed DHA alone at 40 and 48 weeks, but not at 57 weeks. The authors concluded that
supplementation with ARA in addition to DHA supported growth of preterm infants [242].
In a fourth study [243], male but not female preterm infants fed formula with DHA and EPA from
fish oil (0.2 wt %, 5:1 ratio) and no ARA, or a control formula to 59 weeks PMA, had significantly
smaller gains in weight, length, and head circumference and lower fat-free mass as determined from
total body electrical conductivity (TOBEC).
In the Carlson et al. [177,240] studies that reported slower growth in preterm infants a positive
association between plasma ARA concentration and measures of growth (weight, length, z-score,
weight-to-length, and head circumference) was observed. In the 1990s, when the studies were
conducted, it was unknown whether the negative effects of DHA and/or EPA supplementation
on growth could be overcome by adding ARA to infant formulas [177]. However, it was known that
the bioactive metabolites of ARA mediate the secretion of several hormones associated with growth
and basic metabolic functions [247]. These include luteinizing hormone, prolactin, adrenocorticotropic
hormone (ATCH), and corticotropin-releasing hormone (CRH) [241] which could influence growth.
ARA and its second messengers also appear to be involved in bone formation and resorption [248].
To maintain ARA status in preterm infants, additional studies were performed with infant
formulas containing both ARA and DHA [221]. The addition of ARA at levels found in breast milk
produced growth comparable to that observed in breastfed infants [221]. Adding both ARA and DHA
to preterm infant formulas also resulted in beneficial effects on visual acuity as compared with infants
fed a control formula [221].
Concern with a high level of DHA without a concomitant increase of ARA was raised in
a randomized, controlled clinical trial of term infants administered formula with no LCPUFA,
or differing levels of DHA intakes of 0.32%, 0.64% and 0.96% at the same ARA level of 0.64% [249,250].
There were no formula effects on tests of behavioral and psychophysiological indices of attention
at 4, 6, and 9 months of age. However, infants supplemented at the two lower doses of DHA
spent proportionately more time engaged in active stimulating processes (increased attention) than
infants in the unsupplemented group [249]. Positive results were also observed on vocabulary
(Peabody Picture Vocabulary), a card-shorting task, and an intelligence test (Wechler Primary Preschool
Scales of Intelligence) at 3 to 6 years of age in the two lower doses of DHA (0.32% and 0.64%) [250].
However, performance of infants and children who were administered the highest dose of DHA
(0.96%) but with a reduced ratio of ARA to DHA was attenuated [250]. The results demonstrated that
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a proper balance of DHA and ARA is needed for optimal cognitive performance as too much DHA
may suppress the benefits provided by ARA.
The effects that different ratios of n-6 to n-3 had on preterm infant neurodevelopment were
recently considered by Alshweki et al. [251]. Preterm infants (<1500 g and/or <32 weeks gestational
age) were given infant formula with an n-6 to n-3 ratio of 2:1 or 1:1. The infants were followed for up
to 2 years. Preterm infants fed formula with a 2:1 ratio of ARA to DHA had higher ARA blood levels
during the first year of life and better psychomotor development compared with those fed a 1:1 ratio
of ARA to DHA. However, despite the fact that one group received twice the amount of ARA than
DHA (66% vs. 33%), there was almost no difference between the two groups in plasma n-6 to n-3 ratio.
The balance between n-6 and n-3 is very complex, but appears to be maintained at a steady level when
adequate supplementation of ARA and DHA are available [251].
To date, several systematic reviews of the literature and meta-analyses have been published
to evaluate the effects of LCPUFA in preterm and term infants [221,229,252] on various outcomes
including growth, cognition and vision. The reviews considered both the earlier and more recent
studies on LCPUFA. Fleith and Clandinin [221], in one of the earliest reviews, reported that collectively
the body of literature supported the view that LCPUFA are important for growth and development of
preterm and term infants. Formula levels of ARA and DHA should be in the same range as those found
in human milk and with the same ratio [221]. There needs to be a dietary supply of ARA and DHA to
achieve similar accretion levels in plasma and in RBC as compared with breastfed infants [221,253,254].
A Cochrane review of LCPUFA supplementation in term infants reported that there was
little evidence that supplementation conferred a benefit on visual or cognitive development [229].
In a recent meta-analysis of four clinical trials including data for preterm and term infants,
LCPUFA supplementation was also shown to have no effect on Bailey Developmental scores at
18 months of age [252]. However, as pointed out by Colombo et al. [250], the lack of an observed effect
at 18 months of age is consistent with the view that the Bailey Scales of Infant Development are not
very sensitive to the effects of LCPUFA supplementation. The Bailey Scales of Infant Development
yield a composite score obtained from the infant’s attainment of normal developmental milestones and
may not be able to provide detailed assays of specific cognitive mechanisms that are measured using
more sophisticated laboratory tasks [250]. This raises the question of whether the Bailey Scales are
appropriate for measuring the effects of LCPUFA on cognitive development in older infants/toddlers.
A systematic review of 20 randomized, controlled trials of term infants who received DHA and
ARA supplemented formula or a control formula indicated that infants given formulas containing
DHA levels close to the worldwide human milk mean of 0.32% of total fatty acids were more likely to
yield positive results on cognitive and visual tests [255]. There was also clinical evidence to suggest
than an ARA:DHA ratio greater than 1:1 was associated with improved cognitive outcomes [255].
Since the publication of the Hoffman et al. [255] review, several epidemiological and interventional
studies of LCPUFA supplementation during infancy have appeared in the literature. These recent
publications have been reviewed by Ryan et al. [256]. The most recent data indicate that
maternal supplementation during pregnancy and/or lactation support the role for LCPUFA in
the neurodevelopment of infants [256]. Supplementation with LCPUFA-containing infant formula
for more than 6 months increased the likelihood of observing improved cognitive function during
infancy [256,257].
The reasons that some studies failed to show a statistically significant association between
LCPUFA intake and better neurological performance may have been related to limitations of study
design and the use of varying amounts and sources of LCPUFA. For example, in the United States, most
of the recent studies that have considered both neurocognitive function and growth have used infant
formulas for preterm and term infants that contain DHA and ARA from single cell oils (DHASCO®
and ARASCO®). Outside the United States, DHA may be obtained from fish oil [258,259] and ARA
may be obtained from eggs [260,261]. As mentioned above, the early studies of the 1990s used
a variety of experimental formulas with different sources and amounts of LCPUFA (many of these
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studies are cited by EFSA in their review, [71]). This is noteworthy because only DHA and ARA from
single cell oils have been recently shown to enhance neurodevelopment in both preterm [262–264]
and term infants [257,265]. The source of the oil is important because it significantly affects growth.
Clandinin et al. [264] have shown that body weight at 118 days and length at 79 and 92 weeks of age in
preterm infants fed formula containing ARA and DHA from single-cell oils were greater than in those
than those fed a formula containing DHA from tuna oil. Additionally, for both weight and length,
there were no differences between breastfed infants and those fed ARA and DHA from single-cell
oils [264]. The possibility that ARA and DHA derived from single-cell oils or fish oil have differing
effects on growth and neurodevelopment may also be due to the EPA at too high a level in fish oil and
its propensity to antagonize ARA [257]. An ARA:DHA ratio greater than 1:1 with up to 0.65% of ARA
of total fatty acids is associated with improved cognitive performance [255] and balances the potential
competition caused by high levels of DHA.
12. The Benefits of ARA for Infant Health
LCPUFA are not only important for growth and neurodevelopment, but recent studies have shown
that LCPUFA are also critical for infant health. In an early study, infants fed formula with ARA and
DHA developed significantly less stage II and III NEC than those fed a control formula but had similar
rates of bronchopulmonary dysplasia, septicemia and retinopathy of prematurity (ROP) [266]. In a
recent retrospective cohort study of premature infants (<30 weeks gestation), the relationship between
fatty acid profiles during the first postnatal month and infant morbidity due to chronic lung disease,
ROP, and late-onset sepsis was analyzed [120]. Results indicated that fatty acid levels of DHA and ARA
declined rapidly with a concomitant increase in LA. While the decreased DHA level was associated
with increased risk of chronic lung disease, decreased ARA was associated with increased risk of
late-onset sepsis. The authors noted that in premature infants, low levels of DHA and ARA contribute
to dysregulation of immune and inflammatory responses, predisposing these infants to chronic lung
disease and late-onset sepsis [120]. The DHA-derived resolvins decrease neutrophil infiltration and
enhance macrophage phagocytosis [267]. DHA also downregulates nuclear factor kB activity in
cells either directly or by stimulating the activation of peroxisome proliferator-activated receptors
thereby limiting the pro-inflammatory signaling mediated by ARA [267]. Thus, a low level of DHA
would predispose these infants to an increased inflammatory response as seen in chronic lung disease.
In late-onset sepsis, a decreased ARA level increases the risk of inhibiting the innate immune response
through decreased production of eicosanoids, particularly leukotrienes, which enhance chemotaxis
of leukocytes, neutrophil activation, and activity of natural killer cells [97,120]. As a consequence,
in premature infants, a balance of DHA and ARA levels must be maintained to help reduce the
development of morbidity due to prematurity.
Studies have demonstrated that LCPUFA in human milk can modulate immunological responses
and affect the T-helper cell (Th) type-1 (Th1)/Th2 balance [268,269]. Th1 cell effectors produce
interferon-γ (IFN-γ) and TNF-α which regulate cellular immunity against infection whereas Th2
cells produce interleukin (IL)-4, IL-5, and IL-13 which help mediate immunity against parasitic
infections [270,271]. For example, Barakat et al. [272] reported that supplementation for 14 days
with 10 mg/kg of ARA in Schistosoma mansoni-infected schoolchildren induced moderate cure rates
(50%) in children with light infection and modest cure rates (21%) in those with high infection.
The cure rates associated with ARA were comparable to those produced by 40 mg/kg of praziquantel.
The combination of ARA and praziquantel elicited 83% and 78% cure rates in children with light and
heavy infections, respectively [272].
The relationship between maternal fatty acid desaturase (FADS) genotype and LCPUFA levels
in human milk on infant blood T-cell profiles and cytokine production in 6-month old infants was
recently considered [271]. LCPUFA levels in human milk were measured at 4 weeks of age and the
FADS genotype was determined in both mothers and infants. Results indicated that ARA levels in
human milk were inversely correlated with the production of the cytokines IL-10, IL-17, IL-5 and IL-13
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and EPA levels were positively associated with counts of regulatory T-cells and cytotoxic T-cells and
decreased T-helper cell counts. The minor FADS alleles were associated with lower ARA and EPA
levels in human milk and a higher production of IL-10, Il-17, and IL-5. The major FADS alleles were
associated with an increase in the level of ARA in human milk (19%–22%) compared with the minor
alleles. There were no association between T-cell distribution and maternal or infant gene variants.
Also, there was no relationship between cytokine levels in plasma and levels of LA, EPA, or DHA in
human milk.
It has been shown that the FADs gene polymorphism may influence the risk of developing
allergies in children [273]. In the study by Muc et al. [271] the strongest association between LCPUFA
levels and cytokines was observed among those related to the activity of type-2 and type-17 vs. those
from type-1 responses. The expression of type-2 and type-17 cells have been linked to increased airway
inflammation in severe asthma [274]. By reducing type-2 and type-17 activity, LCPUFA including ARA
found in human milk may help reduce the risk of childhood asthma and allergies [271].
Notably, Th17 cytokines were initially identified as key factors in the induction of inflammation
and tissue destruction associated with a variety of autoimmune response such as multiple sclerosis,
arthritis, colitis, celiac disease, and gluten sensitivity [275,276]. However, it is becoming apparent that
T17 cells also provide protective immunity against various pathogens at different mucosal sites [270].
Thus, there is a fine balance between protection and pathological manifestation of Th17 responses.
As a consequence, a balance of LCPUFA levels similar to that found in human milk is needed to help
reduce the risk of developing autoimmune diseases in childhood.
Two studies have compared the frequency of common illnesses in infants fed formula with and
without DHA and ARA [277,278]. Both studies used the same LCPUFA-supplemented formula that
contained 0.32% DHA and 0.64% ARA of total fatty acids (17 mg of DHA/100 kcal and 34 mg of
ARA/100 kcal). In the first study, infants fed the LCPUFA-supplemented formula experienced a lower
incidence of bronchiolitis/bronchitis compared with infants fed formula without DHA and ARA [277].
The results from the second study were similar to those of the first. Infants who consumed formula
with DHA and ARA had a lower incidence of bronchiolitis/bronchitis, nasal congestion, cough and
diarrhea requiring medical attention than infants fed formula without DHA and ARA. The authors
indicated that DHA and ARA at present levels in infant formula and follow-on formulas may have
a positive effect on moderate to severe common infant illnesses, including diarrhea [277,278].
Two cohorts of children who had previously completed randomized, double-blind trials
(one published [72], one unpublished) in which they received a LCPUFA-supplemented formula that
contained 0.32%–0.36% DHA and 0.64%–0.72% ARA of total fatty acids or an unsupplemented formula
(control) fed during the first year of life were followed up to 3 years of age to determine the incidence of
allergies and common respiratory illnesses [279]. The LCPUFA-supplemented group had a significantly
lower risk for developing upper respiratory infections, wheezing/asthma, atopic dermatitis,
any allergy, and a longer time to first diagnosis than those given an unsupplemented formula.
A subset of children from the Kansas City cohort of the DIAMOND (DHA Intake and
Measurement of Neural Development) study [96] were followed to 4 years of age to determine
the incidence of childhood allergies [280]. As infants, they were fed either a control unsupplemented
formula or one of three formulas with either 0.32%, 0.64% or 0.96% of total fatty acids as DHA with the
same amount of ARA (0.64% of total fatty acids). All the different DHA dose and ARA supplemented
subjects were pooled into a single supplemented cohort. Results indicated that the incidence of allergic
illnesses in the first year of life was lower in the combined LCPUFA group compared with the control.
By 4 years of age, LCPUFA supplementation significantly delayed time to first allergic illness and
skin allergic illness. LCPUFA supplementation also reduced the risk of any allergic diseases and
skin allergic diseases. If the mother had allergies, LCPUFA supplementation reduced the incidence
of wheezing/asthma in her offspring. The results of these allergy studies add to the evidence that
supplementation of infant formula with both ARA and DHA in the first year of life delays the onset of
allergy and may have a protective effect against allergy in early childhood.
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Crawford et al. [45] reviewed the potential role that ARA and DHA play in protecting against
some central nervous system injuries in preterm infants. Deficits of ARA and DHA may contribute
to the complications related to prematurity [45]. The mechanism of action responsible for central
nervous system injury is reduced vascular or endothelial integrity leading to hemorrhage or ischemia.
ARA acts as an endothelial relaxation factor and plays a dominant role in endothelial membrane
lipids. The inner cell membrane lipid of the endothelium is especially rich in ARA which provides for
membrane properties, signaling and protein kinase C activation [281]. ARA is also a precursor for a
range of small molecules that play a key role in cell trafficking, communication and vaso-regulation.
As a result, any ARA or DHA deficiency in very preterm infants will be exacerbated after birth during
a period of rapid growth. This deficiency may then lead to fragile, leaking vessels and rupture as seen
in ROP [45].
The proportion of ARA the placenta delivers to the fetus ranges from 14% to 20% [45].
Infant formula for preterm infants only delivers ~0.4%–0.6% of ARA. For DHA, the placenta delivery
to the fetus is ~6% whereas infant formula delivers ~0.3%. That is a 50-fold reduction in ARA and a
>10-fold reduction in DHA compared with the infant’s apparent physiological need. When plasma
levels of ARA and DHA are followed from birth, they continue to decrease to about one third of that
of the fetus. Crawford et al. [45] argue that higher intakes of ARA and DHA are needed to correct for
deficiency during the first year of life.
To explore the impact that deficiency of ARA and DHA may have on immune cell function
Moodley et al. [282] examined the fatty acid profile and main phosphoglyceride content of cord blood
mononuclear cell (CBMC) membranes in healthy preterm infants (30 to 35 weeks) and term infants
(37 to 40+ weeks). Results indicated that ARA was the dominant LCPUFA present in both PC and PE
membrane fractions of CBMCs in both preterm and term infants. The proportions of ARA, DHA and
other LCPUFA were significantly lower in PE and PC of preterm infants compared with those in term
infants. The dominance of ARA was consistent with the process of biomagnification that preferentially
selects ARA rather than other LCPUFA for transfer to the fetus. Preterm infants also had significantly
lower absolute numbers of CD4+ leukocytes and CD4+ and CD8+ naïve T-cells. At birth, there is
a period of transition from a sterile environment to one of higher infectious risk. The elevated levels
of ARA in CBMCs concomitant with lower levels of other LCPUFA suggest that the acquisition of
ARA is needed in preparation for a responsive immune system after birth. These findings indicate
that in preterm infants a deficiency in the supply of ARA exists which may compromise their immune
system [282].
Infants with mildly abnormal physical movements at 12 weeks of age are reported to have
lower ARA content in erythrocyte membranes [283]. This abnormality occurred with maternal
supplementation of DHA alone but was not seen when DHA was combined with ARA during
pregnancy and lactation [283]. Mildly abnormal movements have been also observed during infancy
and linked to increased prevalence of minor neurologic dysfunction and attention deficits at school
age [284]. These findings imply that during early brain development of neonates, a supply of ARA
is critical.
The effects that feeding preterm infants human milk (HM), infant formula without DHA and ARA
(F) or formula with DHA (0.35%) and ARA (0.49%) have on isolated peripheral blood lymphocytes
and lipid composition was evaluated by Field et al. [285]. Adding DHA and ARA to a preterm infant
formula resulted in lymphocyte and cytokine production, phospholipid composition, and antigen
maturity similar to those observed in infants fed human milk. These findings suggest that the addition
of both DHA and ARA may improve the ability of the infant to respond to immune challenges in
a manner similar to breastfed infants [285].
Several epidemiological studies have shown that individuals with learning disorders including
attention deficit hyperactivity disorder (ADHD), dyslexia, and autism have signs of EFA deficiency
or have lower than normal blood levels of DHA and ARA [286–289]. A meta-analysis of pooled data
from RBC and plasma/serum samples indicated that ARA and DHA concentrations were significantly
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lower than normal in individuals with learning/developmental disorders [290]. In absolute amounts,
the level of ARA was as severely depressed as DHA within RBC (both ~0.58 mg/100 mg of fatty acid
below normal) but much lower than DHA within plasma/serum (´0.71 vs. ´0.34). The reason for
lower than normal blood levels of ARA in children with learning disorders is unknown but could
be related to a low dietary intake of ARA relative to metabolic requirements or that ARA is not
synthesized efficiently from precursor fatty acids, or not delivered or properly incorporated into the
brain [290].
The effects of subnormal ARA on brain function seems to be independent of those associated with
n-3 deficiency. In Japan where intakes of n-3 fatty acids are relatively high, the incidence of dyslexia
in children is similar to that observed in Westernized countries (~6%) [291]. Therefore, although the
Japanese population consumes sufficient amounts of n-3 fatty acids, there still may be insufficient
intake of ARA to meet the needs for normal brain function during childhood [290]. The important
role of ARA in normal growth and development requires as much research emphasis as DHA has
received. ARA should be the focus of preclinical and clinical research for a detailed assessment of
dietary requirements.
13. The Regulatory Requirements for ARA and DHA in Infant Formulas
A joint International Expert Consultation of the Food and Agricultural Organization of the United
Nations (FAO) and the WHO was assembled in 1976 to review the literature on “The Role of Dietary
Fats and Oils in Human Nutrition” [292]. The section dealing with infant growth and development
indicated that the ideal recommendation for infant formulas would be to match the essential fatty acids
found in human milk with respect to LCPUFA content [292]. The FAO further stated that LCPUFA were
particularly important during fetal and infant growth when there is a high demand for the synthesis of
cell structured lipid [292]. FAO issued a follow-up report in 1994 which provided additional supportive
recommendations for adding both ARA and DHA to infant formulas. The FAO stated that “the n-6
and n-3 fatty acids have critical roles in the membrane structure and as precursors of eicosanoids,
which are potent and highly reactive compounds. Various eicosanoids have widely divergent, and
often opposing effects on, for example, smooth muscle cells, platelet aggregation, vascular parameters
(permeability, contractility), and on the inflammatory processes and the immune system. Since they
compete for the same enzymes and have different biological roles, the balance between the n-6 and the
n-3 fatty acids in the diet can be of considerable importance” [293]. In a follow-up report in 2008–2010,
the FAO/WHO Expert Consultancy on Fats and Fatty Acids further concluded that “There can be little
doubt about the essentiality of DHA and ARA for the brain” [294].
A global standard for infant formula was established by the Codex Alimentarius Commission in
1981, and revised over the years [295]. The latest revision was issued in 2007 and the latest amendment
was added in 2015 [296]. The standard includes details on essential composition of nutrients and a list
of food additives that are allowed to be added. Quality control measures such as labeling, packaging,
contaminants and hygiene are also specified. In the United States, standards for infant formula are the
responsibility of the U.S. Food and Drug Administration (FDA). The U.S. Code of Federal Regulations
Title 21, Part 106 specifies infant formula quality control procedures and Part 107 lists the nutrient
requirements and other rules concerning labeling for infant formulas. Not surprisingly, the quality
and safety standards for infant formulas are extremely high, exceeding most requirements for other
food products [297].
In the European Union (EU), the legislation on infant formula and follow-on formulas was
adopted in 2006 [298] and at the time of this writing is being revised. Before revising the legislation
the European Commission requested the European Food Safety Authority (EFSA) Panel on Dietetic
Products, Nutrition and Allergies to provide their scientific advice on the essential nutrient composition
of infant and follow-on formulas [70,71]. In the first report of 2013, dedicated to nutrient requirements
and dietary intakes of infants and young children in the EU, the EFSA Panel reviewed a variety of
nutrients, including the levels of DHA and ARA. In the 2013 EFSA report, adequate intakes were
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defined as 100 mg/day of DHA and 140 mg/day of ARA from birth to six months of age. From 6
to 24 months of age, 100 mg/day of DHA were considered adequate. These recommendations were
also supported by a global expert panel, based on a systematic review of the available scientific
literature [299]. However, in the subsequent report of 2014, dedicated to essential composition of
infant and follow-on formulae, the EFSA Panel advised that infant and follow-on formulas should
contain relatively higher amounts of DHA (20–50 mg/100 kcal). Mandatory addition of ARA was
not supported in this EFSA report. Still, the Panel noted that feeding an infant formula containing
DHA alone resulted in lower concentration of ARA in erythrocytes compared with a control formula
without DHA.
At an assumed mean fat content of 5.2 g 100 kcal in a typical infant formula, this means that
the recommendation of higher levels of DHA would result in a DHA content of 0.38% to 0.96% of
fatty acids, higher than the 0.2% to 0.3% of DHA currently found in most infant formulas available in
the marketplace [2]. Notably, PUFA-supplemented commercially available infant formulas contain
preformed ARA at levels equal to or higher than the DHA content. The ESFA Panel’s advice of
providing up to 1% DHA and no ARA is a unique approach and directly opposite to a consensus
reached by international expert groups who have recommended that infant formulas for term infants
should contain ARA at levels that range from 0.4% to 0.7% fatty acids (at a 1:1–2:1 ratio to DHA) based
on the median worldwide range of ARA and DHA concentrations in breast milk [6–9].
14. Discussion
ARA is the principle LCPUFA in the inner cell membrane lipid of muscle, heart, vascular
endothelium, adrenals, kidneys, liver, the placenta, and in almost all other organs [300]. ARA is
essential for cell integrity. The cell membrane separates the interior structures of cells from the outside
environment. It also controls the movement of substances in and out of the cell [300]. These membranes
contain signalers, receptors, ion channels, antioxidant defense enzymes, and rafts. Changing any
aspect of the composition of the cell membrane may alter its function [300]).
ARA has very different biological functions than DHA [300]. While DHA controls signaling
membranes in the photoreceptor, brain and nervous system, ARA is indispensable in the vasculature
and in specific aspects of immunity. ARA is important for brain growth during gestation and early
infancy where it plays a critical role in cell division and signaling [11]. A potentially important aspect
of ARA metabolism is its function as a precursor for leukotrienes, prostaglandins, and thromboxanes,
collectively known as eicosanoids. Eicosanoids have numerous critical and specific functions occurring
in almost every tissue of the body. Eicosanoids function to modulate the release of somatostatin,
the principal hormone that stimulates cell proliferation and growth. Eicosanoids also have important
roles in immunity and inflammation.
This review focused on the essentiality of ARA for infant growth and development.
Animal studies demonstrated the importance of ARA for growth and maturation of neurons and myelin
and the resolution of inflammation in models of NEC, influenza and EFA deficiency. These studies also
provided compelling evidence that both preformed DHA and ARA are required for optimal cognitive
and neurological development. The ratio of ARA and DHA added as supplements really matters.
Brain tissue analysis of neonatal baboons fed formula with a high level of 0.96% DHA significantly
reduced ARA levels in two regions of the brain indicating the importance of a proper balance of DHA
and ARA [24].
For over 10 years, both DHA and ARA have been added to infant formulas worldwide
in an attempt to match the nutrient supply and functional benefits achieved with human milk.
The combination of ARA and DHA in infant formulas has been shown to be safe in many millions of
infants globally. The DHA concentration in human milk is lower and more variable than for ARA and
the level of ARA in human milk is more stable [5]. The relatively stability of the ARA level in human
milk is biologically important because it provides preformed ARA consistently at a time when brain
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growth and development is most critical [300]. Although DHA is more variable than ARA it is always
present in human milk and the balance between ARA and DHA can be as much as 2 to 1.
The biosynthetic capability for providing ARA and DHA for brain growth is low and preformed
ARA and DHA are preferentially incorporated into the brain during gestation and early infancy [2,46].
Infant formulas devoid of ARA results in a dramatic decrease of up to 40% of ARA in plasma
shortly after birth [223,230,238,239,300,301], especially in preterm infants who do not receive the third
trimester’s maternal supply of ARA and DHA. The finding that there is a decrease in ARA shortly after
birth shows that biosynthetic capability is insufficient to meet the infant’s demand [300]. The process
of biomagnification and its resulting fatty acid profile further highlights the importance of ARA in
infant growth [45]. In several clinical studies, the provision of high amounts of DHA/EPA without
a concomitant supply of ARA has been associated with adverse effects on growth in premature
infants [240–243].
EFSA [71] recently concluded that “there is no necessity to add ARA to infant formula even in
the presence of DHA”. This recommendation needs further explanation. One of the possible reasons
for this recommendation is that it is generally believed that LA is converted into ARA in sufficient
quantities, even though EFSA noted that feeding an infant formula containing DHA alone resulted in
lower concentration of ARA in erythrocytes compared with a control formula without DHA. From the
limited dietary intake data presented here for non-breastfed infants and young children (Table 1)
living in developing and developed countries there is evidence that intakes of ARA from dietary
sources are very low, much lower than the average amount of ARA available in human milk or infant
formulas containing ARA and DHA. The composition of infant formulas and follow-on formulas
should therefore not only be based on human milk composition but also on food/nutrient intake data
to address the assumption that complementary foods fill nutrient gaps.
The EFSA Panel’s advice of providing higher amounts of DHA (20–50 mg/100 kcal, 0.38% to
0.96% of fatty acids) without a concomitant supply of ARA is also questionable. As discussed here,
DHA suppresses ARA concentration in membranes and its function. As a result, an infant formula
with DHA and no ARA may result in a potential higher risk of morbidity due to the suppression of
favorable eicosanoids that play a key role in cell trafficking, communication and vaso-regulation [45].
EFSA did not take into account the original FAO/WHO publications as well as the earlier
2008–2010 publication which strongly concluded “There can be little doubt about the essentiality of
DHA and ARA for the brain” [294]. When infants are exclusively breastfed during the first 6 months
of life, “there is evidence of a requirement for preformed ARA and DHA after 6 months of life” [294].
According to the 2010 FAO/WHO statement, DHA and ARA should be included in infant formula
with DHA (from 0.2% to 0.5% of total fatty acids) and added ARA should be at least equal to the
amount of DHA [294].
The clinical trials considered by EFSA were not designed to consider the specific physiological
outcomes related to ARA. Most studies included both ARA and DHA. There were no clinical trials that
evaluated the effects of ARA in the absence of DHA. The benefits of ARA + DHA supplementation
cannot be ascribed to DHA alone but logically must be ascribed to the variables used in most of
these studies, the combination of the two. The combination of ARA and DHA has shown benefits for
cognitive development, visual function, and blood pressure well beyond the period of supplementation
and into early childhood [249,302].
EFSA’s lack of support of ARA in DHA-containing formulas relied almost exclusively on the
meta-analysis of infant growth conducted by Makrides et al. [303]. However, the meta-analysis of
Makrides et al. [303] was not comprehensive. The majority of subjects (n = 1050) included in the
meta-analysis participated in 8 clinical trials using formula containing both DHA and ARA. Only 341
subjects in the 8 trials were provided infant formula with DHA/EPA without ARA. At 12 months of
age, only 99 subjects were supplemented with DHA in the absence of ARA. Additionally, the analysis
excluded studies that included preterm infants who are most vulnerable to growth faltering due to
nutrition, and excluded studies in which DHA plus ARA supplementation was less than 3 months
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during which growth velocity is particularly sensitive to nutritional inadequacy. The reason for
excluding these studies was not reported.
In the meta-analysis, Makrides et al. [303] noted that the results were inconclusive,
i.e., LCPUFA supplementation had no detrimental effect on growth. The importance of ARA as
a structural and metabolically active lipid, was not addressed. Better visual and mental performance
was attributed to the contribution of DHA. However, in one of the studies considered, DHA plus ARA
improved mental function [265] compared with an unsupplemented control. In fact, in one study,
DHA alone did not perform better than did the unsupplemented controls [72].
Clinical evidence to support the safe removal of ARA from infant formula and follow-on formula
containing DHA is lacking. The human and nonhuman primate studies described herein question
the EFSA recommendation to provide infant formula from birth with up to 1% of DHA without
a proportional amount of ARA [2]. Any major change in infant formula composition should be
subjected to a full preclinical and clinical evaluation of safety and nutritional adequacy before its
introduction into the marketplace [2]. Without such an assessment, and in light of the universal
presence of ARA in human milk and the numerous essential ARA functions for cell structure and
function, the most judicious approach is to include ARA in DHA-containing infant formulas to promote
optimal infant growth and development.
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Abstract: Adequate supply of micronutrients during the first 1000 days is essential for normal
development and healthy life. We aimed to investigate if interventions administering dietary doses
up to the recommended nutrient intake (RNI) of iron and zinc within the window from conception
to age 2 years have the potential to influence nutritional status and development of children.
To address this objective, a systematic review and meta-analysis of randomized and quasi-randomized
fortification, biofortification, and supplementation trials in women (pregnant and lactating) and
children (6–23 months) delivering iron or zinc in doses up to the recommended nutrient intake (RNI)
levels was conducted. Supplying iron or zinc during pregnancy had no effects on birth outcomes.
There were limited or no data on the effects of iron/zinc during pregnancy and lactation on child
iron/zinc status, growth, morbidity, and psychomotor and mental development. Delivering up to
15 mg iron/day during infancy increased mean hemoglobin by 4 g/L (p < 0.001) and mean serum
ferritin concentration by 17.6 μg/L (p < 0.001) and reduced the risk for anemia by 41% (p < 0.001),
iron deficiency by 78% (ID; p < 0.001) and iron deficiency anemia by 80% (IDA; p < 0.001), but had
no effect on growth or psychomotor development. Providing up to 10 mg of additional zinc during
infancy increased plasma zinc concentration by 2.03 μmol/L (p < 0.001) and reduced the risk of zinc
deficiency by 47% (p < 0.001). Further, we observed positive effects on child weight for age z-score
(WAZ) (p < 0.05), weight for height z-score (WHZ) (p < 0.05), but not on height for age z-score (HAZ)
or the risk for stunting, wasting, and underweight. There are no studies covering the full 1000 days
window and the effects of iron and zinc delivered during pregnancy and lactation on child outcomes
are ambiguous, but low dose daily iron and zinc use during 6–23 months of age has a positive effect
on child iron and zinc status.
Keywords: Iron; zinc; iron status; zinc status; 1000 days window; infant and young child nutrition;
fortification; biofortification
1. Introduction
Globally iron and zinc deficiencies are among the most widespread micronutrient deficiencies.
While people of all ages are at risk, children and women of reproductive age are at elevated
risk of experiencing concurrent deficiencies, especially in low-income countries [1,2]. Even mild
deficiencies of one or both nutrients may contribute to increased morbidity and mortality [1].
The first 1000 days of life—the period from conception to the child’s 2nd birthday—are most crucial,
since some developmental and functional delays during this period are either irreversible or only
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partly reversible [3]. In utero exposure to iron deficiency has been associated with impaired brain
maturation of the fetus [4,5], while during infancy and childhood, iron deficiency could lead to
impaired cognitive and physical functionality and increased risk of mortality [1,6]. Zinc is essential for
cellular differentiation and maturation and maternal zinc deficiency could lead to growth retardation
and other developmental defects of the fetus [7]. Further, zinc deficient infants and young children are
prone to infections and growth retardation [8].
The major cause of micronutrient malnutrition is a diet consisting mainly of staple foods
and lacking in animal sources [9]. When compounded by exposure to environments laden with
pathogens, there is a synergistic worsening of the malnutrition burden [10,11]. Although high
dose supplementation has been successful in reducing the prevalence of micronutrient deficiencies,
programs often only inadequately reach rural or marginalized populations; also high dose iron
supplementation has been exposed to criticism in the past decade in malaria endemic areas [12].
Other interventions such as fortification and biofortification, delivering smaller amounts of
micronutrients on a daily basis, might be more effective in reducing the prevalence of micronutrient
deficiencies in populations at risk; yet, their effect on the infant during the first 1000 days of life starting
from pregnancy until 23 months of age has hardly been investigated.
The objective of this work was thus to evaluate the potential of interventions delivering daily
doses of iron and zinc in concentrations up to approximately the Recommended Nutrient Intake (RNI)
in diets with low bioavailability [1] during the first 1000 days of life on child micronutrient status
and health.
For this we used data from randomized and quasi-randomized trials of fortification,
supplementation or biofortification interventions, in which iron and zinc were provided more than
three times a week in concentrations up to approximately the (RNI) for women (iron: 45 mg/day;
zinc 20 mg/day) and children 6–23 months (iron: 15 mg/day; zinc: 10 mg/day).
2. Materials and Methods
2.1. Search Strategy
We searched the WHO e-Library of Evidence for Nutrition Actions, the Cochrane Central
library, Web of Science, and MEDLINE/PUBMED databases to identify systematic reviews and
meta-analyses that investigated the effects of iron and zinc interventions (fortification, supplementation,
or biofortification interventions) on nutritional, developmental and health outcomes of children.
We restricted the search to reviews published from 2005 to 2015. The following search strategy was
adapted for each database: (Fortification OR biofortification OR supplementation) AND (iron OR zinc
OR multiple micronutrients OR micronutrient powder) AND (women OR children OR infants OR
toddlers). For the relevant topics, 82 potentially useful reviews and meta-analyses published from
2005 to 2015 were identified, the most recent ones conducting their literature searches up until 2014.
We searched their reference lists for suitable original studies. Additional searches for original studies
published between 2011 and October 2015 were conducted in Web of Science and MEDLINE/PubMed
using the following strategies for each age group of interest:
(a) Children: (Biofortification OR fortification OR supplementation) AND (iron OR zinc OR
micronutrient powder OR multiple micronutrients) AND (children OR infants OR toddlers)
AND (trial OR study OR survey OR assessment).
(b) Pregnant women: (Biofortification OR fortification OR supplementation) AND (pregnant women
OR lactating women OR maternal) AND (iron OR zinc OR micronutrient powder OR multiple
micronutrients) AND (trial OR study OR survey OR assessment).
(c) Lactating women: (Biofortification OR fortification OR supplementation) AND lactating women
AND (zinc OR iron OR micronutrient powder OR multiple micronutrients OR breast milk) AND
(trial OR study OR survey OR assessment).
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2.2. Inclusion and Exclusion Criteria
Types of trials and interventions: Randomized controlled trials (RCTs) and quasi-experimental
studies were included in the review. Studies were eligible if they assessed the impact of iron or zinc
supplementation, fortification or biofortification interventions on the micronutrient status, growth or
health outcomes of children (details below). Only studies where the daily iron and zinc dose did not
exceed 15 mg and 10 mg, respectively for children and 45 mg and 21 mg, respectively for women,
were included. We considered micronutrient powders and crushable tablets (foodlets) as fortification,
since they are consumed as part of a normal meal. Furthermore, we included studies investigating
the effects of iron or zinc supplements, as long as they were within the dose range we specified.
We defined supplements as compounds, which are routinely consumed separately from a normal meal,
including tablets, pills, drops, capsules, syrups, drinks, biscuits, and lipid-based supplement (LNS).
Only studies administering the micronutrients >3 times a week were included.
Types of participants: For interventions administered to the mother, we included studies that
provided interventions to pregnant women or lactating women, regardless of their health status.
For interventions administered to children, we were interested in effects on young children, thus only
studies where over 50% of participating children were 6–23 months old were included. Only studies
involving apparently healthy children were considered, with the exception that studies including
malnourished (underweight, stunted, wasted) children and children suffering from anemia or
deficiencies of iron and zinc were included. We did not include therapeutic studies, such as short term
zinc supplementation studies to treat acute diarrhea.
2.3. Study Design and Comparison Groups
The control groups of the included fortification trials either received unfortified foods or regular
diets. Studies were also included if both the control and intervention groups received the same
fortified foods, but either with different iron or zinc concentrations, or if the control group received
an identical micronutrient compound given to the intervention group, but without iron or zinc.
For supplementation, the control groups of the included trials either received no supplements,
placebo, a lower concentration of iron or zinc or different micronutrients identical to intervention
group preparations, except that they excluded zinc and/or iron.
Studies were only included in meta-analyses if the data for outcomes of interest were presented
in a manner that allowed inclusion in the meta-analysis (i.e., data could only be used when presented
as mean (SD or SE), mean (95% CI), median (95% CI), or median (range), but not when reported as
median (IQR)). Where studies did not report on the average daily micronutrient intake, but instead
stated the micronutrient concentration per 100 mL/100 g or the daily micronutrient intake in mg/kg
body weight, we calculated the average intake as appropriate.
2.4. Outcome Measures
Only child outcomes were of interest, even when interventions were administered to pregnant
or lactating women. For example, with regard to effects of prenatal iron supplementation on anemia,
maternal anemia was not the focus of this analysis; rather, the infant/child anemia was of relevance
even if the mother received the intervention.
Outcomes evaluated include: (1) hemoglobin (Hb) concentration (g/dL); (2) anemia (%; defined as
Hb <110 g/L); (3) serum ferritin concentration (μg/L); (4) iron deficiency (%; defined as serum
ferritin <10 μg/L or <12 μg/L); (5) iron deficiency anemia (%; defined as hb <105 g/L or <110 g/L
and serum ferritin <10 μg/L or <12 μg/L); (6) serum or plasma zinc (μmol/L); (7) zinc deficiency
(%; defined as serum zinc <10.7 μmol/L); (8) birth outcomes (birth weight in g; prevalence of
low birth weight in %, defined as weight <2500 g); (9) infant anthropometric measures (height
for age z-score (HAZ); weight for age z-score (WAZ); weight for height z-score (WHZ); stunting
(≤−2 HAZ scores), wasting (≤−2 WHZ scores) underweight (≤−2 WAZ scores)); (10) mental and
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motor development (Bayley mental development index (MDI); Bayley psychomotor development
index (PDI)); (11) morbidity (diarrhea, fever and respiratory infection).
2.5. Data Synthesis and Statistical Analysis
From each eligible study, we extracted all data that would allow the estimation of the effects
of interest. For example, for zinc studies, data were extracted for groups assigned to zinc alone
compared with placebo, as well as data from groups assigned to more than one nutrient including
zinc compared with a group assigned to the identical nutrient combination but excluding zinc. Where
the total number of comparisons was sufficiently large, we examined the influence of combining such
comparisons into one meta-analysis, and where possible, conducted sub-group analyses examining
the possibility of nutrient interactions. Additionally, where studies had more than one group assigned
to the nutrient of interest (for instance, different nutrient dosages) but only one suitable comparison
group, we included such data as separate estimates for the meta-analysis. For that, we divided the
comparison group into two groups (or more, when required) with smaller sample sizes, so the same
children were not involved in more than one comparison. To examine if this decision affected the
results, we conducted sensitivity analyses combining all relevant control groups of affected studies
into a single comparison group, and combining all relevant intervention groups into a single group, for
some outcomes. As results were very similar, we chose to continue analyses with the sub-groups. When
studies reported outcomes at multiple time points, we selected only the results reported at the study
end (or the latest time point) for the meta-analyses. Most studies were individually randomized trials,
but where cluster randomized trials were eligible for inclusion, we estimated design effects to adjust
for the influence of intra-cluster correlations on the precision of estimates as appropriate. To maximize
the number of studies that could contribute to meta-analyses of continuous outcomes, we converted
medians (reported with ranges) and geometric means (reported with standard deviations, standard
errors or confidence intervals) to arithmetic means and standard deviations using methods developed
by Hozo et al. [13] and Higgins et al. [14] and examined the effect that combining transformed and
untransformed estimates had on pooled results. Studies were excluded from meta-analyses if published
reports presented insufficient information for estimating desired effect estimates and variances.
For continuous outcomes, we estimated pooled mean differences or standardized mean differences
and confidence intervals, as appropriate, while for categorical outcomes, we estimated pooled
risk ratios and confidence intervals. Study-level effect estimates were pooled using the random
effects meta-analysis method by DerSimonian and Laird [15]. We assessed heterogeneity among
studies, and used the method proposed by Higgins et al. to measure the inconsistency (I2) of
effect estimates across studies [16]. Heterogeneity among study estimates was considered to be
substantial if the I2 exceeded 50%. For outcomes having at least 10 comparisons per variable of
interest, we explored sources of heterogeneity by conducting pre-specified sub-group analyses and
meta-regressions, to examine whether effects were modified by the study-level factors: micronutrient
doses provided, type of intervention (whether fortification or supplementation), study quality and
baseline micronutrient status. Funnel plots were constructed for visual assessment of the variability of
individual study estimates and to evaluate the possibility of publication bias, and when appropriate,
Egger’s tests were used to examine if effect estimates varied with study sample size.
All analyses were conducted using the metafor package [17] of the R statistical program
(R version 3.1.3 (2015-03-09), The R Foundation, Vienna, Austria, 2015).
2.6. Assessment of Quality and Risk of Bias
We assessed study quality in three areas—random sequence generation, adequacy of blinding
of study participants and personnel and completeness of outcomes assessment—but did not exclude
studies based on the assessment of quality. Studies were categorized as being of the ‘highest quality’ if
interventions were randomly assigned, both participants and study personnel were adequately blinded
to the intervention assignment, and if outcomes were assessed in at least 75% of the enrolled study
population. Intermediate quality trials were randomized trials for which only one of the remaining
87
Nutrients 2016, 8, 773
two criteria was suboptimal, lowest quality trials were randomized trials for which both the remaining
criteria were suboptimal, and quasi-experimental trials (although rarely included) were given the very
lowest rating. The effect of pooling results from studies of different quality was examined in sub-group
analyses where possible.
The quality of the evidence resulting from each analysis was assessed using the
Grading of Recommendations Assessment, Development, and Evaluation (GRADE) method [18].
Domains included: risk of bias within studies (internal validity), inconsistency or heterogeneity of
results across studies, indirectness or use of proxy populations, interventions or outcomes measures,
imprecision (large variability and wide confidence intervals), number of studies and risk of publication
bias. The evidence was judged as high quality if further research studies were unlikely to change
the pooled estimate obtained; moderate quality if further research could alter the current estimate;
low quality if further research was needed to confirm the magnitude and direction of the true effect;
and very low quality if there was great uncertainty about the validity of the pooled estimate. It should
be noted that because the GRADE method considers several domains and not just internal study
validity, confidence in pooled estimates could be ‘low’ or ‘very low’ even if all studies that contributed
to the estimate were well conducted.
3. Results
3.1. Literature Search
We identified and screened 4542 records, reviewed 326 full-texts for eligibility and finally
included 90 studies in the review (Figure S1). Identified studies were supplementation or fortification
studies—no biofortification studies qualified for inclusion. Thirty-three iron intervention studies and
47 zinc intervention studies involving children 6–23 months old met our inclusion criteria. Of the
prenatal intervention studies that reported child outcomes, seven iron studies and 10 zinc studies met
our inclusion criteria. Additionally, we identified one eligible study that delivered zinc to lactating
women. The major reasons for excluding studies were: (a) micronutrient doses higher than our selected
threshold; (b) ineligible ages, e.g., more than half of participating children over 23 months old and
(c) dosing frequencies less than our threshold.
3.2. Effects of Low-Dose Iron Interventions during Pregnancy and Lactation on Child Outcomes
Six studies reported birth weights of infants [19–24] while five studies reported on the effects
of iron on the prevalence of low birth weight (Table 1; [19,21–24]). Exclusively supplementation
trials contributed to the analyses, delivering daily 18–30 mg of iron. We found that low dose iron
interventions during pregnancy do not significantly change birth weights (p = 0.17; Figure S2) or
the prevalence of low birth weight (p = 0.23; Figure S3) among the offspring. We did not identify
any studies investigating the effects of prenatal iron interventions on child micronutrient status or
child growth within the first two years of life. We identified a study by Li and colleagues [25] that
investigated the effects of prenatal iron and folic acid compared with folic acid alone on PDI and
MDI scores of children at 3, 6, and 12 months of age. No differences were detected between the
iron/folic acid group and the folic acid only group. The main results of the meta-analysis of prenatal
iron interventions are summarized in Table 1.
Table 1. Effects of prenatal iron interventions supplying ≤45 mg/day iron on birth weight and








p Difference between Pooled
Intervention and Control Groups
Birth outcomes
Birthweight (g) 38 (−16; 91) 6, 13,627 58.2 0.17
Low birth weight (%) 0.69 (0.38; 1.26) 5, 12,845 63.1 0.23
1 95% CI in parenthesis.
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3.3. Iron Interventions in Children 6–23 Months of Age
The results of meta- analyses of iron intervention studies involving children are presented below
and summarized in Tables 2 and 3.
Table 2. Effects of daily iron administration (≤15 mg/day) to children 6–23 months on levels of








p Difference between Pooled
Intervention and Control
Groups (Bold Font) and
Subgroups (Regular Font)
Hb overall (g/dL) 4.1 (2.8; 5.3) 30, 6569 81.5 <0.001
Iron dose
<6 mg/day −0.7 (−6.1; 4.7) 2, 220 73.1
0.12
6–8 mg/day 4.4 (2.1; 6.8) 7, 1864 83.9
>8–10 mg/day 5.5 (3.4; 7.6) 13, 3068 83.8
11–15 mg/day 2.7 (1.2; 4.2) 4, 403 80.7
Type of intervention
Supplementation 5.6 (3.4; 7.7) 15, 3516 86.4
<0.01Fortification 3 2.6 (1.3; 3.9) 16, 3053 67.4
RCT, quality rating
highest 5.5 (3.3; 7.6) 12, 3403 87.1
<0.05intermediate 3.2 (1.6; 4.8) 14, 2623 73.1
lowest 1.3 (−2.9; 5.4) 4, 375 80.3
Anemia overall 0.59 (0.49; 0.70) 22, (5647) 73.8 <0.0001
Iron dose
6–8 mg/day 0.54 (0.44; 0.66) 7, 2089 18.4
0.32>8–10 mg/day 0.59 (0.45; 0.77) 9, 2575 85.2
11–15 mg/day 0.82 (0.51; 1.30) 3, 489 31.0
Serum ferritin (μg/dL) 17.3 (13.5; 21.2) 21, (4291) 95.1 <0.0001
Iron dose
<6 mg/day 5.8 (−14.8; 26.3) 2, 222 90.9
<0.016–8 mg/day 12.1 (2.6; 21.7) 5, 1261 96.4
>8–10 mg/day 27.5 (16.0; 39.0) 9, 2068 96.4
Type of intervention
Supplementation 27.2 (18.2; 36.3) 8, 1747 90.1
<0.001Fortification 11.3 (13.7; 21.4) 13, 2544 95.2
RCT, quality rating
highest 22.8 (15.2; 30.4) 9, 2351 93.0
0.08intermediate 11.4 (6.6; 16.1) 9, 1619 93.0
lowest 15.0 (7.0; 23.0) 3, 321 92.0
Baseline ID prevalence
Low (<15%) 27.0 (13.6; 40.4) 4, 276 60.5
0.76High (≥15%) 32.4 (8.9; 55.9) 4, 1226 98.3
Baseline mean serum ferritin 4
Low (<29.2 μg/L) 18.5 (11.7; 25.3) 9, 1352 76.4
0.99High (≥29.2 μg/L) 21.2 (11.5; 30.9) 8, 1698 94.0
ID overall 0.22 (0.14; 0.35) 13, 3698 86.3 <0.0001
IDA overall 0.20 (0.11; 0.37) 8, 3464 64.2 <0.0001
1 Hb, hemoglobin, ID, iron deficiency; IDA, iron deficiency anemia; RCT, randomized controlled trial; 2 95% CI
in parenthesis; 3 Includes micronutrient powders and crushable tablets (foodlets); 4 Low is defined as below
50th percentile of all reported serum ferritin means; high is equal or above 50th percentile.
Effect on hemoglobin concentration: We identified 30 RCTs [26–55], contributing 43 comparisons,
for evaluating the effect of up to 15 mg of additional iron daily on hemoglobin levels of children
6–23 months of age. In total, 6569 children contributed to the pooled estimate. The iron interventions
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led to significantly higher hemoglobin concentrations in children, compared with no iron (pooled mean
difference 4.07 g/L (95% CI: 2.82, 5.33; Figure S4), although there was significant heterogeneity of
results (I2 82.5%; p < 0.0001). To examine the heterogeneity, we conducted meta-regression analyses
and sub-group analyses investigating whether effect sizes were different for pre-specified sub-groups
defined by the intervention dose (Figure S5), type of intervention (fortification vs. supplementation;
Figure S6) and study quality (Figure S7). The increases in hemoglobin concentrations resulting from the
intervention were significantly higher for supplementation trials than fortification trials (p < 0.01) and
significantly lower as study quality worsened (p < 0.05). There was no significant difference in effect
sizes by intervention dose (p = 0.12). Adjusting for these variables simultaneously did not substantially
explain the observed heterogeneity (residual I2 81%, p < 0.0001).
Effect on anemia prevalence: 22 RCTs involving a total of 5647 children
contributed [26,27,29–32,34–39,43–45,47,48,51,52,54–56] to the meta-analysis. The iron interventions
resulted in a 41% reduction in children’s risk of anemia compared with no iron (pooled relative risk
(RR) 0.59 (95% CI: 0.49, 0.70), Figure S8), although there was considerable heterogeneity of results,
I2: 73.8% (p value 0.0008). We investigated the influence of the intervention dose on effect sizes
(Figure S9) and while it appears that interventions delivering 6–8 mg and >8–10 mg iron per day
reduce the risk of anemia by 46% and 41%, respectively, intervention dose did not significantly explain
the differences in study effect sizes (p = 0.32). This agrees with the results of sub-group analyses for
hemoglobin outcomes, where the largest effect sizes were observed for iron interventions delivering
between 6 mg and 10 mg per day (Figure S5).
Effect on serum ferritin: Twenty-one RCTs [26–28,31–34,36–38,40,42,44,45,48–54], contributing
25 comparisons, provided sufficient data for the meta-analysis of the effect of low dose iron
interventions on serum ferritin concentrations in young children. In total, 4291 children contributed to
the pooled estimate. After pooling the results, the iron intervention resulted in significantly higher
serum ferritin concentrations compared with controls (mean difference 17.3 μg/L (95% CI: 13.1,
21.2; Figure S10), although there was significant heterogeneity, I2 95.1% (p < 0.001). To understand
the substantial heterogeneity in the results, we conducted meta-regression analyses and sub-group
analyses investigating the influence of the dose (Figure S11), type of intervention (fortification vs.
supplementation; Figure S12) and quality of interventions (Figure S13) on the effect size estimates.
The effect sizes resulting from the intervention were significantly higher for higher doses (p < 0.01)
and for supplementation trials compared with fortification trials (p < 0.001). Meta-regression results
suggested that effects diminished as study quality worsened, although not significantly (p = 0.08).
However, adjusting for dose, study quality, and intervention type simultaneously did not explain much
of the observed heterogeneity (residual I2 88%) and the change in effect size associated with increasing
doses was no longer significant after adjusting for the quality of studies and type of intervention.
We further examined the effect of baseline iron deficiency (categorized as low prevalence if <15%
and high prevalence if ≥15%) on serum ferritin results. Only nine comparisons had information on
baseline iron status. The pooled mean difference in serum ferritin for comparisons where baseline
iron deficiency was high was not considerably different from the comparisons where baseline iron
deficiency was low (Figure S14), and baseline iron deficiency did not explain the heterogeneity in
serum ferritin results (p value = 0.76). Yet, with the limited number of studies, inadequate power
could be a problem. In order to maximize the number of studies in the sub-group analysis, we created
an ‘in-house’ measure of baseline iron status: from all reported mean serum ferritin concentrations,
we took the 50th percentile (29.2 ug/L). Studies were categorized as having low iron status if mean
serum ferritin was <29.2 and adequate if mean serum ferritin ≥29.2. This variable could be created for
21 comparisons. However, even so, we did not detect a significant effect of baseline iron status and it
did not account for the observed heterogeneity of serum ferritin results (Figure S15; p value = 0.99).
The created variable may be an inadequate surrogate for participants’ baseline iron deficiency levels.
Effect on prevalence of ID and IDA: Thirteen trials [26,29,31,32,34,36,38,39,43,45,48,52,54] and eight
trials [26,29,34–36,40,43,48] conducted mainly in Asia, provided 17 and 13 comparisons, respectively,
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that could be included in meta-analyses investigating the effect of the iron interventions on the risk
of ID and IDA respectively among children 6–23 months old. The majority of trials defined ID as
serum ferritin concentrations <12 μg/L or <10 μg/L while IDA was mainly defined as hemoglobin
<110 g/L with serum ferritin concentrations <12 μg/L. The pooled relative risk from the random effects
meta-analysis was 0.22 (95% CI: 0.14, 0.35), I2: 86.3% (Figure S16) for ID and 0.20 (95% CI: 0.11, 0.37),
I2: 64.2% (Figure S17) for IDA, meaning that providing children 6–23 months old with up to 15 mg of
iron daily significantly reduced their risk of ID and IDA by 78% (95% CI: 65% to 86% reduction) and
80% (95% CI: 63% to 89% reduction) respectively.
Effect on growth: Ten RCTs examined the effect of iron on WAZ [35–38,41,43,44,48,52]; nine
studies each contributed to the meta-analyses of the iron effect on WHZ [35–38,42–44,48,52] and
HAZ [35–38,41,43,44,48,52]. There was no significant effect of iron on WAZ (Figure S18; Table 3;
p = 0.69), WHZ (Figure S19; Table 3; p = 0.62) or HAZ (Figure S20; Table 3; p = 0.59). Similarly, random
effects meta-analysis indicated (Figures S21 and S22; Table 3) that there was no effect of iron on the risk
for stunting [35–37,48] or wasting [35–37,48].
Effect on diarrhea, fever and respiratory infection: We identified eight eligible studies [27,38,42,44,48,
49,57,58], with a total of 11 comparisons, reporting on the impact of iron use on diarrhea, respiratory
infection and/or fever. Given the variability of methods and outcome measures in the studies reviewed,
it was not possible to conduct a meta-analysis without introducing a selection bias. The effect of iron
alone was compared to placebo in seven RCTs, three compared the effect of iron and zinc to zinc alone,
and one study compared the effect of MNP with and without iron on morbidity. Seven studies looked
at the impact of iron on diarrhea, seven on respiratory infection and five on fever. None of the studies
reported a beneficial effect of iron on any of the morbidities.
Effect on mental and motor development: Four eligible studies (five comparisons) reported children’s
Bayley mental development index (MDI; [27,36,51,54]) and Bayley psychomotor development index
(PDI; [27,36,51,54]) scores. Children included in the analysis received daily 5–10 mg fortification or
supplementation iron for 3–9 months. The analyses indicated that interventions delivering dietary
doses of iron have no effect on mental development (p = 0.6; Figure S23; Table 3) and psychomotor
development scores (p = 0.5; Figure S24; Table 3).
Table 3. Effects of daily iron administration (≤15 mg/day) to children 6–23 months on growth and
mental and development outcomes 1.








WAZ −0.01 (−0.08; 0.05) 10, 3511 12.5 0.69
WHZ 0.02 (−0.06; 0.09) 9, 3297 36.8 0.62
HAZ −0.02 (−0.08; 0.04) 10, 3511 8.2 0.57
Stunting 1.09 (0.92; 1.29) 4, 2159 0 0.33
Wasting 1.11 (0.84; 1.47) 4, 1975 0 0.45
Mental and motor development
MDI 0.4 (−0.9; 1.7) 4, 1062 19.9 0.60
PDI 0.6 (−1.2; 2.4) 4, 1062 61.9 0.50
1 HAZ, height for age z-score; MDI, Bayley mental development index; PDI, Bayley psychomotor development
index; WAZ, weight for age z-score; WHZ, weight for height z-score; 2 95% CI in parenthesis.
3.4. Zinc Interventions during Pregnancy and Lactation
Few data on the effect of maternal supplementation on infant outcomes are available during
pregnancy and the lactation period for most of the outcomes of interest and thus a meta-analysis was
only conducted for birth outcomes. Results of single studies investigating growth and micronutrient
status are discussed in the section below.
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3.4.1. Effect on Birth Weight and Prevalence of Low Birth Weight
The results of meta- analyses of studies conducted in pregnant women are summarized in Table 4.
Eight studies [59–66] and nine comparisons contributed to the meta-analysis for the effect of
prenatal zinc use on birth weight, and six studies (seven comparisons) contributed to the meta-analysis
of prenatal zinc and low birth weight prevalence [59,61–63,65,67]. We found that delivering up to
21 mg of zinc daily during pregnancy has no significant effect on birth weights of offspring (p = 0.94;
Figure S25) or the prevalence of low birth weight (p = 0.83; Figure S26).
Table 4. Effects of administering ≤21 mg/day zinc to pregnant women on birth weights and prevalence












Birthweight (g) 1 (−32; 35) 8, 3457 0 0.94
Low birth weight 0.96 (0.67; 1.37) 6, 2518 0 0.83
1 95% CI in parenthesis.
3.4.2. Effect on Infant Growth and Micronutrient Status
Two studies examining child growth outcomes and one study examining the zinc status of
children were identified. Prawirohartono et al. [60] looked at growth of infants whose mothers
received either 20 mg zinc only, vitamin A only, 20 mg zinc and vitamin A or placebo during
pregnancy. They monitored growth until 23 months of age. Zinc had a significant beneficial effect
on HAZ at 6 months. No effects on any other growth parameters at any time point were observed.
Iannotti et al. [68] administered 15 mg zinc daily to pregnant women from gestational week 16 until
1 month after delivery and measured infant growth from birth to 12 months of age. They did not assess
any predefined outcomes, but observed differences between intervention and control group in weight,
calf, chest, mid-upper arm circumferences, and skinfold thicknesses from age 6 month to 12 month;
and no effect on length or head circumference.
Caulfield and colleagues [59] looked at the zinc status of neonates after zinc supplementation of
pregnant women. Women were included at gestational ages of 10–24 weeks and received a daily dose
of 15 mg zinc. They reported a significantly higher cord blood zinc concentration in neonates whose
mothers received zinc supplementation, compared with controls.
Only one study was identified that investigated the effects of maternal zinc supplementation/
fortification during the lactation period on infant outcomes. The effect of maternal zinc supplementation
on serum zinc concentration and growth in children after birth to 9 months of age was investigated by
Salmenpera et al. [69]. They gave two different zinc doses (20 mg, 40 mg daily) to lactating women
and compared the impact to a control group. Breast milk zinc concentration did not differ between
groups at 0, 2, and 4 months after delivery, but was higher at 6 and 7.5 months in the group receiving
40 mg/day of zinc. When analyses were restricted to exclusively breastfed infants, no difference in
serum zinc concentration was detected between intervention and control groups at any time point and
maternal zinc supplementation had no effect on infant growth.
3.5. Zinc Interventions in Children 6–23 Months of Age
3.5.1. Effect on Serum or Plasma Zinc Concentrations and Zinc Deficiency
The main results of the meta-analyses of studies in children investigating the effect of zinc
administration on serum zinc and zinc status are presented in Table 5.
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Table 5. Effects of daily zinc administration (≤10 mg) to children 6–23 month on serum zinc and
prevalence of zinc deficiency in children 1.




p Difference between Pooled
Intervention and Control
Groups (Bold Font) and
Subgroups (Regular Font)
Serum zinc
overall (μmol/L) 2.0 (1.2; 2.9) 23, 8848 96.1 <0.0001
Zinc dose
<4 mg/day 0.81 (−0.07; 1.68) 1, 256 55.5
0.054–<7 mg/day 0.9 (0.08; 1.71) 7, 1296 92.4
7–10 mg/day 3.0 (1.5; 4.5) 14, 6867 98.5
Type of intervention
Supplementation 2.4 (1.5; 3.4) 19, 7732 98.5
<0.05Fortification 3 0.3 (−0.1; 0.8) 6, 816 98.1
Baseline ZD prevalence
Low (<25%) 2.9 (0.2; 5.7) 4, 1231 97.8
0.15High (≥25%) 2.8 (1.7; 3.9) 4, 2372 95.5
Baseline mean serum zinc 4
Low (<10.75 μg/L) 2.4 (0.7; 4.2) 7, 5635 98.7
0.96High (≥10.75
μg/L) 2.3 (0.7; 3.9) 9, 2200 96.9
ZD overall 0.47 (0.32; 0.69) 12, 6666 92.2 <0.001
1 RCT, randomized controlled trial; ZD, zinc deficiency; 2 95% CI in parenthesis; 3 Includes micronutrient
powders and crushable tablets (foodlets); 4 Low is defined as below 50th percentile of all reported serum zinc
means; high is equal or above 50th percentile.
Twenty-three [36,43,48,59,70–88] RCTs (contributing 35 comparisons) provided sufficient
information to be included in the meta-analysis summarizing the effect of up to 10 mg of additional
zinc daily on the serum or plasma zinc concentrations of children 6–23 months old.
The pooled estimate suggests that the zinc interventions significantly increased serum or plasma
zinc concentrations by 2.03 μmol/L compared with no zinc (95% CI 1.21, 2.85 μmol/L; p < 0.0001,
Figure S27), but with significant heterogeneity (I2 98%). Meta-regression analyses suggest that
effect sizes were larger at higher doses (p < 0.05, Figure S28), and for supplementation compared
with fortification trials (p = 0.05, Figure S29), while study quality did not significantly explain the
heterogeneity. Dose, intervention type and study quality together did little to explain the heterogeneity
of findings (residual I2 97.9%). Subgroup analyses stratified by dose suggested that the strongest effect
on serum zinc was obtained in studies delivering daily 7–10 mg (3.0 μmol/L; (95% CI 1.51, 4.48)).
A small but significant effect was also detected in studies administering 4–<7 mg/day (0.9 μmol/L
(95% CI 0.08, 1.71; Figure S28)). Stratification by intervention type revealed that the pooled effect size of
fortification trials on serum zinc concentrations was small and not statistically significant (0.31 μmol/L
(95% CI −0.12, 0.75; Figure S29), whereas supplementation showed a larger and significant difference
(2.07 μmol/L (95% CI 1.5, 3.4).
Baseline zinc deficiency levels were reported for 12 comparisons with serum zinc as the
outcome. We categorized baseline zinc deficiency as low prevalence if <25% and high prevalence
if ≥25%. The pooled mean difference in serum zinc was similar regardless of baseline zinc deficiency
status (Figure S30), and baseline zinc deficiency explains 8.4% of the heterogeneity in serum zinc
results (p value = 0.15). In order to maximize the number of studies in the sub-group analysis,
we created a measure of baseline zinc status: from all reported serum zinc means, we took the
50th percentile (10.75 μmol/L). Studies were categorized as having low zinc status if mean serum
zinc was <10.75 μmol/L and adequate if mean serum zinc ≥10.75. This variable could be created
for 25 comparisons. It did not explain any of the observed heterogeneity of serum zinc results
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(p value = 0.96; Figure S32). The created variable may be an inadequate surrogate for participants’
baseline zinc deficiency levels.
For the effect of zinc interventions on the risk of zinc deficiency among children 6–23 months
old, 12 RCTs [35,39,43,48,71,72,74,77,78,81,84,87], which provided 22 comparisons, contributed to the
meta-analysis. Half defined zinc deficiency as serum or plasma zinc concentrations <10.7 μmol/L,
while the others defined it using a cutoff of <~9.9 μmol/L.
The pooled relative risk from the random effects meta-analysis was 0.47 (95% CI 0.32, 0.69),
I2: 92%, meaning that providing children 6–23 months old with up to 10 mg of zinc daily significantly
reduced their risk of zinc deficiency by 53% (95% CI 25% to 64% reduction; Figure S32).
3.5.2. Effect on Growth
Results of studies investigating effects of zinc interventions on child growth are summarized in
Table 6.












WAZ 0.05 (0.00; 0.10) 21, 7440 39.4 0.04
WHZ 0.04 (0.00; 0.08) 16, 6875 22.3 0.04
HAZ 0.00 (−0.04; 0.03) 20, 7340 9.2 0.80
Stunting 0.97 (0.90; 1.04) 6, 5443 0 0.39
Wasting 0.98 (0.79; 1.21) 6, 5441 32.0 0.82
Underweight 0.99 (0.90; 1.09) 5, 4793 10.7 0.83
1 HAZ, height for age z-score; WAZ, weight for age z-score; WHZ, weight for height z-score; 2 95% CI in parenthesis.
Twenty-one [36,37,43,48,74,75,78,83–86,88–97] studies (31 comparisons) contributed to
meta-analyses of zinc effects on WAZ, and 20 studies yielding 30 comparisons [36,37,43,48,74,75,
78,82–86,88–92,94,95,97] reported HAZ outcomes. The WHZ meta-analysis included 16 studies [36,37,
43,48,74,75,78,82,84,85,88–92,97] with 25 comparisons. After pooling the studies, zinc interventions
compared with placebo or no zinc slightly but significantly increased WAZ (mean difference:
0.05, 95% CI 0.0, 0.1) and WHZ (mean difference: 0.04, 95% CI 0.0, 0.08), while the HAZ result
was not significant (mean difference: 0.00, 95% CI −0.04, 0.03; Figures S33–S35).
Fewer studies categorized children as stunted, wasted or underweight. Six studies with
10 comparisons [36,37,48,74,76,79] were included in the meta-analysis for the effect of zinc interventions
on childhood stunting (HAZ <−2), five studies with eight comparisons [37,74,76,79] in the
meta-analysis for childhood underweight, and six studies yielding 10 comparisons [36,37,48,74,76,79]
in the meta-analysis for childhood wasting.
The zinc interventions were not associated with significant reductions in the risk of child
stunting (RR 0.97, 95% CI 0.9, 1.04), wasting (RR 0.98, 95% CI 0.79, 1.21) or underweight (RR 0.99,
95% CI 0.90, 1.09; Figures S36–S38).
3.5.3. Effects on Diarrhea, Fever, and Respiratory Infections
In total, we identified 24 studies [48,57,70,71,73–77,79,82,85,87–91,93,97–103], with 33 comparisons,
meeting our inclusion criteria and reporting on the impact of zinc on diarrhea, respiratory infections
and fever. Twenty-one studies were individually randomized and three studies cluster randomized
trials. We decided not to do a meta-analysis given the considerable variability of methods and outcome
measures in the studies reviewed: more than half of the studies could not have been included in the
analysis and thus, results might have been biased.
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Similar to previous reviews, we found conflicting results for the effect of zinc intake
on diarrhea, but not on respiratory infection and fever prevalence and/or incidence. Of the
16 studies [48,57,70,75,82,85,87,88,91,97,99,100,102–105] reporting on fever and/or respiratory
infections, only 3 [82,91,104] found a positive effect of zinc intake. Out of the 24 studies investigating
the effect of zinc on diarrhea, 11 studies [48,57,70,74–76,79,85,87,88,99] found no effect at all.
Ten [71,73,89–91,93,97,100–102] reported a positive effect of zinc use on the prevalence and or incidence
of diarrhea. Two [82,103] found a significant positive effect of zinc on diarrhea in the stunted sub-group,
and Sazawal et al. [77] reported only a significant effect of zinc in children with low serum zinc
concentrations and children older than 11 month of age. Age dependency has also been reported by
Wuehler et al. [97], with a strong effect in the age group of 11.5–17.4 months and no effect in older
children (17.5–30 months).
3.5.4. Effects on Mental and Motor Development
Three [57,106,107] eligible studies reported MDI and PDI scores and found no significant impact
of zinc interventions on the two outcomes.
3.6. The Interaction of Iron and Zinc in Interventions in Children 6–23 Months of Age
3.6.1. Effect of Zinc on Serum Ferritin
Sub-group analyses of the 21 RCTs [26–28,31–34,36–38,40,42,44,45,48–54] reporting on the effect of
iron interventions on serum ferritin indicated that iron has the strongest beneficial effect when it is the
sole micronutrient administered (mean increase of 26.1 μg/L) and that it has a smaller, albeit significant,
effect on serum ferritin when it is administered in combination with zinc (Figure 1).
Figure 1. Forest plot summarizing the interactions of iron and zinc, supplying up to 15 mg of additional
iron daily to children 6–23 months old on serum ferritin.
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3.6.2. The Effect of Iron on Serum Zinc
We found 23 studies [36,43,48,59,70–88], with 35 comparisons, 14 of them comparing zinc alone to
placebo, 17 of them comparing zinc in combination with iron to iron only and four of them comparing
zinc and other micronutrients to other micronutrients. Sub-group analyses showed that if iron was part
of the intervention, the effect of zinc on serum/plasma zinc concentrations was considerably lower
(1.02 μmol/L, 95% CI 0.28, 1.76), compared to interventions delivering zinc alone (3.04 μmol/L, 95% CI
1.16, 4.92) and to interventions delivering zinc and other micronutrients, excluding iron (2.77 μmol/L,
95% CI 0.13, 5.42; Figure 2).
Figure 2. Forest plot summarizing the effect of interventions supplying up to 10 mg of additional
zinc daily to children 6–23 months old, on serum or plasma zinc concentrations, stratified by
micronutrient composition.
3.7. Quality of the Evidence across Studies
We used the GRADE approach to assess the quality of evidence across studies (Table S1).
We considered that a publication bias or imprecision was unlikely for all outcomes. In contrast,
the large heterogeneity, the lack of studies, and indirectness were considered important factors in the
quality of evidence across studies. For indirectness of evidence we rated down in case ≥50% of the
included studies was not food based interventions. For interventions delivering iron compared to
a placebo group, the overall quality of evidence was found to be high for iron status (using serum
ferritin concentration), ID and IDA; moderate for hemoglobin, HAZ, WAZ, and WHZ; low for anemia,
stunting and wasting, whereas for birth weight, low birth weight, MDI and PDI the quality of evidence
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was very low. For interventions administering zinc compared to placebo the quality of evidence was
moderate for birth weight, prevalence of low birth weight, zinc deficiency, zinc status (using serum
zinc concentration), stunting, wasting, HAZ, WAZ, and WHZ, and low for underweight.
4. Discussion
We found that interventions delivering iron and zinc in concentrations up to the RNI during the
1000 days window from the prenatal period to the first 2 years of a child’s life can have positive impacts
on the iron and zinc status of young children. In particular, when interventions were conducted in
children aged 6–23 months old, their hemoglobin levels, and iron and zinc status improved. For both
nutrients, supplementation triggered a significantly stronger response than fortification even when
doses were similar. For other outcomes assessed—birth weight, growth in childhood, psychomotor
development—findings are less conclusive, partly due to the limited number of studies.
We show that low dose iron and zinc interventions providing no more than 45 mg/day of iron
and 20 mg/day of zinc during pregnancy may not have an impact on children’s birth weights and
prevalence of low birth weight. Similar to our results, other meta-analyses found no effect of zinc
on birth weight and prevalence of low birth weight [108,109]. Most of the studies included in those
analyses did not meet our inclusion criteria because they gave higher doses of zinc than we were
interested in. For iron, our results are also in accordance with a recent meta-analysis, which only
observed beneficial effects at iron doses exceeding our threshold [110]. However, due to the scarcity
of studies having follow-up data extending beyond the perinatal period, it is unclear if any growth
advantages of routine iron and zinc ingestion during pregnancy could manifest later in infancy or
early childhood.
We found that the use of iron in dietary doses (no more than 15 mg/day) during infancy and early
childhood had positive effects on hemoglobin levels, anemia prevalence, and iron status (serum ferritin,
ID and IDA prevalence), which agrees with a systematic review published in 2012 assessing the effect
of micronutrient-fortified milk and cereal foods on infants and children [111] and a meta-analysis of
supplementation trials in children 6–23 month of age, published in 2013 [112]. We did not find an
effect of iron interventions on child growth or morbidity, suggesting that food-based iron interventions
at doses investigated here have no beneficial impact on the occurrence of childhood morbidities.
Limited effects of iron can be expected regarding mental and motor development until the age of 2 years
(we focused on the Bayley’s scales for mental and motor development due to more consistent reporting).
We conducted sub-group analyses stratified by type of intervention (fortification/
supplementation), intervention dose, a measure of baseline micronutrient status, as well as study
quality. Sub-group analyses demonstrated that iron administered as fortificants significantly increased
serum ferritin and hemoglobin levels, although to a lesser extent than supplements. This could be
due to the presence of absorption inhibitors in fortified foods. For biofortification, the magnitude of
the effect on iron and zinc status is unclear as to date no biofortification trials have been conducted
with a focus on the 1000 days window. Yet, we would expect comparable effects as observed from
fortification since both approaches deliver the micronutrients together with other dietary components.
Sub-group analysis stratified by dose showed that daily iron doses as low as 6–8 mg increased
serum ferritin levels. Larger effect sizes were observed for higher daily iron doses (8–10 mg),
however, such doses might be difficult to attain for infants by dietary diversification or biofortification
interventions alone. Surprisingly, baseline iron status did not explain much of the heterogeneity of the
findings in our analysis. This is somewhat in contrast to previously published data [113,114] and could
be ascribed to other factors influencing iron absorption and utilization in contexts of high exposure
to inflammation [115]. But also, the categorization of studies into iron deficient versus iron sufficient
population had to be done in a relatively crude manner.
We found that zinc supplementation at doses no higher than 10 mg/day increased the serum zinc
concentrations of children and reduced the risk of suffering from zinc deficiency, whereas the effect of
zinc administered in fortification trials, although in comparable concentrations as supplemental zinc,
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had no significant effect on serum zinc levels. We did not find any modification of the zinc intervention
effects by child baseline zinc status. Sub-group analysis stratified by dose showed that daily zinc doses
of 4–6 mg increased serum zinc by 0.9 μmol/L while larger effect sizes were observed for higher zinc
doses 7–10 mg, which might be difficult to reach in children 6–23 months old through dietary means
alone. Effects of zinc were significant for WHZ and WAZ, although the differences remained rather
small, compared with controls. Zinc interventions probably do not have a measurable effect on the
occurrence of respiratory infections and fever and effects on diarrhea are inconclusive.
Lastly, we found that, when zinc and iron were given together, their beneficial effects on serum
zinc and serum iron levels were weaker than when each nutrient was given alone, suggesting that iron
and zinc compete for absorption from the gut, a finding that has previously been posited [116].
Possible limitations of the review should be noted. First, many results exhibit large amounts of
heterogeneity, which could not be explained by the factors we explored, and which are probably due
to the differences in study design, the different types of interventions and reporting. Thus, the pooled
estimates of some of the effects shown may be imprecise and results have to be interpreted with caution.
Second, none of the studies meeting our inclusion criteria covered the full 1000 days window meaning
that the impacts of the micronutrients could not be assessed holistically across the different life stages,
but only in a compartmentalized manner. Thus, no statements can be made about whether a holistic
approach covering the full 1000 days (iron and zinc interventions starting during pregnancy and
continuing until 2 years of age) would have a synergistic or additive effect on certain outcome measures.
To illustrate this using ferritin levels and the Psychomotor Development Index, the absorption and
utilization of dietary iron is affected by the subject’s iron status [117,118]. Thus, if an iron intervention
given to pregnant women suffering from moderate to severe dietary iron deficiency anemia has a
positive effect on the fetus’s iron status, infants born to such women would have a better iron status
than control peers of the same age whose mothers received no iron [119]. Continuing the higher iron
regime into infancy could actually decrease iron absorption/utilization by children in the intervention
group, assuming they had benefited from exposure to prenatal use, while children in the prenatal
control group who start receiving iron after birth may more efficiently absorb and utilize the little
iron available. Taken together, it is possible that only small differences in iron status would be
observed between the two groups at the age of two years. In contrast, with regard to the Psychomotor
Development Index, one could imagine that a 1000-day intervention could lead to a synergistic effect,
since some early neurodevelopmental constraints are partly irreversible [120]. Thus, a child exposed
to prenatal iron would be primed for a better start early in life. Third, only few studies assessed
the inflammatory status of the children and reported prevalence of inflammation and therefore it
was not possible to stratify studies by level of inflammation. During inflammation the human body
down regulates iron absorption, and thus studies with a high proportion of subjects suffering from
inflammation would be expected to show less effects of iron on iron status. Also, in those populations,
an effect of iron on hemoglobin and anemia prevalence could be masked by anemia of inflammation in
the same subject.
To conclude, providing dietary or relatively low daily doses of iron and zinc to young children
could be beneficial for their iron and zinc status, indicating that food based approaches can be
useful tools to reduce the prevalence of iron and zinc deficiencies. However, it is questionable if
an intervention would affect child outcomes throughout the whole 1000 days period, not least because
of breast milk iron and zinc homeostasis [121–124]. More research assessing the impact of iron and
zinc holistically over the different life stages (pregnancy, lactation, and early childhood) is required to
understand the potential role of interventions provided throughout the 1000 days window.
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Abstract: Preterm infants are at significant risk to develop reduced bone mineralization based on
inadequate supply of calcium and phosphorus (Ca-P). Biochemical parameters can be used to evaluate
the nutritional intake. The direct effect of nutritional intake on changes in biochemical parameters has
not been studied. Our objective was to evaluate the effect of Ca-P supplementation on biochemical
markers as serum (s)/urinary (u) Ca and P; alkaline phosphatase (ALP); tubular reabsorption of P
(TrP); and urinary ratios for Ca/creatinin (creat) and P/creatinin in Very-Low-Birth-Weight infants
on Postnatal Days 1, 3, 5, 7, 10, and 14. This observational study compared two groups with High
(n = 30) and Low (n = 40) intake of Ca-P. Birth weight: median (IRQ) 948 (772–1225) vs. 939 (776–1163)
grams; and gestational age: 28.2 (26.5–29.6) vs. 27.8 (26.1–29.4) weeks. Daily median concentrations
of biochemical parameter were not different between the groups but linear regression mixed model
analyses showed that Ca intake increased the uCa and TrP (p = 0.04) and decreased ALP (p = 0.00).
Phosphorus intake increased sP, uP and uP/creat ratio and ALP (p ≤ 0.02) and caused decrease
in TrP (p = 0.00). Protein intake decreased sP (p = 0.000), while low gestational age and male
gender increased renal excretion of P (p < 0.03). Standardized repeated measurements showed that
biochemical parameters were affected by nutritional intake, gestational age and gender.
Keywords: blood; bone mineralization; minerals; monitoring; nutrition; renal tubular reabsorption;
supplementation; urine
1. Introduction
Bone development is one of the key processes of intrauterine and postnatal growth [1].
Preterm infants are at significant risk to develop reduced bone mineral content based on inadequate
supply of calcium and phosphorus (Ca-P) [2,3]. During normal pregnancies in healthy mothers,
there is an active, placental transfer of Ca-P to the fetus leading to a high mineral accretion during
the last trimester, while after birth the infant is dependent on nutritional supply of minerals [4,5].
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In clinical practice, postnatally it is difficult to meet the high fetal needs, because of limited solubility
of parenteral fluids, low content of Ca-P of human milk and impaired intestinal absorption through
formula feeding [6–9]. Studies tried to define nutritional requirements, but, in clinical practice, it is
often uncertain whether the nutritional intake of Ca-P provided to preterm infants is sufficient and is
actually used for bone mineralization [10–12].
Assuming that biochemical parameters of Ca-P homeostasis within a normal range will lead
to optimal bone mineralization, evaluation of electrolyte disturbances is standard of care in many
neonatal units [13–28]. However, there is currently neither a consensus on the appropriateness of
either parameter or the frequency of measurements [29,30]. A recent survey among U.S. neonatologists
showed a great lack of consensus and variation in practices regarding definition and screening methods
for metabolic bone disease [31]. Reference values in relation to adequate nutritional intake have not
been developed. Urinary excretion of minerals in spot urine samples has been shown to be an easy
tool for routine evaluation. Pohlandt proposed to aim for a small “surplus of minerals” in urine
samples, while Aladangady et al. developed reference values for urinary Ca-P/creatinine ratios for
preterm infants [17,23]. Staub et al. compared both methods with regard to an agreement between their
results and found neither method to be superior [32]. None of the studies evaluated the direct effect of
nutritional intake on biochemical parameter of Ca-P homeostasis. It is not sure whether biochemical
parameters are able to indicate sufficiency of nutritional intake.
The aim of this study was to evaluate changes in biochemical parameters of the Ca-P homeostasis
in blood and urine in relation to different nutritional intake during the first 14 days of life in Very
Low Birth Weight (VLBW) infants. Our hypothesis was that the nutritional intake of calcium and
phosphorus would have an effect on biochemical parameters of the calcium–phosphorus homeostasis.
2. Materials and Methods
2.1. Study Design and Randomization
The current study (Early Supplementation Study (ESS)) was part of the Early Nutrition Study
(ENS), a multi-center double-blinded randomized controlled trial.While the ENS evaluated the effects
of human milk on postnatal outcome, the primary objective of the ESS was bone mineralization in
relation to early and late enteral supplementation of minerals [33]. The studies were approved by the
Ethical Committee of the VU university medical center (Amsterdam, The Netherlands), 13 September
2013 (CMO file number: NL37296.029.11, Dutch Trial Registry: NTR 3225). Patients were distributed
into three groups through two steps of randomization. The first step randomized eligible infants
either into the early supplementation group (High) or the late supplementation group (Low) being
part of the ENS. The second step of the randomization was only performed if infants were assigned
to late supplementation and randomized them to either “ENS A” or “ENS B” as part of the ENS.
Both randomization steps were performed before the first enteral nutrition was administered resulting
in basically three groups.
2.2. Study Population
Participants for the ENS/ESS were recruited at the level III neonatal intensive care unit of the
Radboud university medical center (Radboudumc), Nijmegen, The Netherlands. The inclusion criteria
were a birth weight below 1500 grams and written informed consent of both parents. The exclusion
criteria were maternal drugs and/or alcohol use during pregnancy, birth defects, congenital infection
within 72 h after birth, perinatal asphyxia with a pH < 7.0 and any intake of cow’s milk based products
prior to randomization. For the current study, infants who died or were discharged before the end of
the study period of 14 days were excluded from analysis.
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2.3. Intervention and Nutritional Protocol
Parenteral nutrition (PN) was started directly within the first hour after birth. The PN
solution consisted of 2.5 mmol/dL calcium-gluconate (calcium-gluconate 10%; B. Braun, Melsungen,
Germany) and 1.6 mmol/dL sodium-glycerophosphate (Glycophos; Fresenius Kabi BV, Zeist,
The Netherlands) and 2.25 grams/dL amino acids (Primene; Clintec, Brussels). Additional parenteral
supplementation with 10% calcium-gluconate or sodium glycero-phosphate was administrated
depending on biochemical parameters. Table A1 presents the standard protocol for PN. The decision
to start additional supplementation was left to the attending neonatologist based on biochemical
parameter as being a standard procedure of our department.
Enteral feeding was started on the first day of life with daily increments, while PN was gradually
reduced to maintain a daily fluid intake within the protocol range. Late supplementation was assumed
to provide a low intake of nutrients because “Group Low”, comprising of group ENS A and ENS B,
received no additional enteral supplementation or fortification of human milk during the first 10 days
of life. Group ENS A received donor milk if mother’s own milk (MOM) was not available. Group ENS B
received preterm formula (Hero Baby Prematuur Start; Hero Kindervoeding, Breda, The Netherlands) if
MOM was not available, containing 2.4 mmol/dL calcium, 1.7 mmol/dL phosphorus and 2.6 grams/dL
proteins. The additional nutrition in ENS A and ENS B was blinded to all caretakers and parents.
After 10 days, all infants received nutrition according to the standard protocol of the Radboudumc.
Early supplementation was assumed to provide a high intake (Group High). This group received
enteral nutrition from Day 1 onwards according to the local protocol. They received additional
enteral supplementation and human milk fortifier (Nutrilon Neonatal BMF; Nutricia, Zoetermeer,
The Netherlands; BMF) by the time the enteral intake was 50 mL per day. The human milk fortifier
added 1.65 mmol/dL calcium, 1.22 mmol/dL phosphorus and 0.8 grams/dL protein to human milk.
They received preterm formula if MOM was not available. The decision to start additional enteral
supplementation was left to the attending neonatologist based on biochemical parameter and postnatal
growth as being a standard procedure of our department. The additional enteral supplementation could
comprise of either a supplement of protein (Nutrilon Nenatal Protein Fortifier; Nutricia, Zoetermeer,
The Netherlands) or a potassium phosphate (KPO4) and calcium chloride (CaCl2) suspension for
enteral supplementation.
Group ENS A received 100% human milk during the first 10 days and reflected a group with low
intake of minerals and protein, because human milk has a very low nutrient content. Group High
reflected a high intake of nutrients, because human milk was enriched with minerals and protein as
soon as possible. Group ENS B could be considered as intermediate depending on the amount of
MOM or preterm formula an infant received, since preterm formula contained approximately the same
amount of minerals as fortified human milk.
2.4. Biochemical Parameters of Bone Mineralization
For this study, blood and urine samples were analyzed according to the local protocol
of the department. Samples were taken on Days 1, 3, 5, 7, 10 and 14 after birth. Urine was
collected through spot samples [25]. The following parameters were analyzed: serum calcium (sCa),
serum phosphorus (sP), serum alkaline phosphatase (ALP), urine calcium (uCa), urine phosphorus (uP),
urine calcium/creatinin ratio (uCa/Creat), urine phosphorus/creatinin ratio (uP/Creat), and tubular
reabsorption of phosphorus (TrP).
2.5. Data Registration and Handling
Patient characteristics, clinical course, growth and intake of all nutrients were recorded daily
from the patient records and abstracted for this study. Amounts of enteral, parenteral and additional
supplementation (parenteral and enteral) of all nutrients were calculated separately for each patient.
The total intakes were calculated per kg per day per infant. The intake through human milk was
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calculated based on the reference of Gidrewicz et al. [34]. The calcium/phosphorus ratio was calculated
per day by dividing the daily intake of calcium in mmol/kg through the daily intake of phosphorus
in mmol/kg.
After closure of patient enrollment and de-blinding of the ENS, we performed a reallocation
procedure for the intermediate group ENS B. Infants who received more than 90% MOM were
considered to reflect a low intake of minerals and were allocated to group Low together with the
infants of group ENS A. Infants who received more than 90% of preterm formula were considered to
reflect a high intake of minerals and were allocated to High. Infants in between these extremes were
not included in the analyses.
2.6. Statistical Analysis
The primary objective of the ESS was bone mineralization in relation to mineral supplementation,
and the original power calculation was based on bone mineral content at term corrected age. For the
evaluation of changes in biochemical parameters in relation to nutritional intake the power calculation
was based on sP. In a previous evaluation of our nutritional protocol performed at our department,
we found a mean 1.7 mmol/L of sP during the first week [35]. A concentration of 2.0 mmol/L was
defined as target for optimal bone mineralization by Hellstern et al. [20]. Assuming an expected mean
of 1.7 mmol/L, we determined that 24 infants were required in each group to find a difference of
0.3 mmol/L in sP between High and Low with α = 0.05 (two-sided) and a power of β = 0.80.
The statistical analyses were performed using IBM SPSS statistics 22.0 for Windows (IBM SPSS Inc.,
Chicago, IL, USA). Differences in patient characteristics, nutritional characteristics and biochemical
parameters between the High and Low group were determined using the Mann-Whitney U test or the
chi-square test, depending on the variable under examination. Due to non-normality of the continuous
variables, the data were presented as median (with interquartile range (IQR)), unless otherwise
indicated. A p-value < 0.05 was considered statistically significant.
To account for repeated outcome measurements, we used a mixed model analysis to determine
the effects of daily nutritional intake of calcium and phosphorus on each biochemical parameter.
We included the total intake of Ca/P and protein, the percentage of enteral amount of Ca/P
intake, and a number of clinical parameter that could affect the Ca/P homeostasis such as birth
weight, gestational age, gender, caesarian section, multiple births, sepsis, and days of caffeine,
furosemide, steroids, and sedation during the first two weeks as co-variables in the initial models.
Necrotizing enterocolitis was not included as co-variable because of small numbers. Using manual
backward selection, variables were kept in the model when they contributed statistically significantly
with a p-value < 0.1.
3. Results
3.1. Patient Characteristics
Enrollment of patients occurred between January 2013 and December 2014. The distribution
of the infants is presented in the consort diagram (Figure 1). Finally, 109 infants were randomized,
eithe to Late Supplementation (Low; n = 72; distributed into Group ENS A (n = 40) and ENS B (n = 32)
or Early Supplementation (High; n = 37).
The characteristics of all infants included in the three groups of the ENS/ESS study are presented
in Table A2. After de-blinding of group Low, four infants of group ENS B were reallocated to High and
13 to Low so that Low and High consisted of 53 and 41 infants, respectively. Infants who died or were
discharged before postnatal Day 14 (13 in Low, 11 in High) were excluded. Finally, data of 40 infants of
Low and 30 of High were analyzed. The baseline patient characteristics, morbidity, medication and
nutritional characteristics for these patients are presented in Table 1. Infant characteristics were well
balanced between the groups Low and High and comparable to the original groups.
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Figure 1. Consort diagram.
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Table 1. Patient characteristics, morbidity, medication, and nutritional characteristics.
Low (n = 40) High (n = 30) p-Value
Characteristics
Birth weight, grams; median (IQR) 948 (772–1225) 939 (776–1163) 0.85
<1000 gram, n (%) 22 (55.0) 16 (53.3) 0.89
Gestational age, median (IQR) 28.2 (26.5–29.6) 27.8 (26.1–29.4) 0.76
SGA, n (%) 8 (20.0) 4 (13.3) 0.46
Male, n (%) 19 (47.5) 15 (50.0) 0.84
Singletons, n (%) 28 (70.0) 16 (53.3) 0.15
Cesarean section, n (%) 18 (45.0) 20 (66.7) 0.07
Apgar score (5 min), median (IQR) 7.0 (6.3–9.0) 7.5 (7.0–8.0) 0.71
Apgar score (5 min) <7, n (%) 10 (25.0%) 6 (20.0%) 0.62
Morbidity
Sepsis, n (%) 8 (20.0%) 9 (30.0%) 0.33
NEC ≥ stage 2, n (%) 1 (2.5%) 2 (6.7%) 0.39
IVH Grade 3–4 n (%) 5 (12.5) 3 (10) 0.75
Medication
Caffeïne; n (%) 39 (97.5%) 28 (93.3%) 0.39
Furosemide, n (%) 3 (7.5%) 4 (13.3%) 0.42
Corticosteroids 3 (7.5) 1 (3.3) 0.46
Sedation, n (%) 8 (20.0%) 9 (30.0%) 0.33
Nutritional characteristics
PN, days, median (IQR) 11.0 (9.0–14.0) 12.0 (10.0–14.0) 0.10
150 mL/kg enteral, study day, median (IQR) 12.0 (9.8–17.0) 13.0 (10.5–20.0) 0.59
Start day of BMF, median (IQR) 11 (11.0–13.0) 7.9 (5.0–10.0) 0.00
Human milk in mL/kg/day *, median (IQR) 50.9 (24.0–82.2) 30.0 (8.5–54.6) 0.01
Formula in mL/kg/day *, median (IQR) 0.0 (0.0–0.2) 1.1 (0.1–7.3) 0.00
Nutritional intake
Ca (total) W1, mmol/kg; median (IQR) 10.7 (9.9–12.0) 13.1 (11.1–14.6) 0.00
Ca (total) W2, mmol/kg; median (IQR) 16.4 (12.9–17.7) 21.7 (15.3–24.4) 0.00
P (total) W1, mmol/kg; median (IQR) 10.8 (9.3–12.4 12.3 (11.1–14.2) 0.00
P (total) W2, mmol/kg; median (IQR) 16.4 (12.9–19.6) 18.2 (16.0–22.1) 0.02
Prot (total) W1, grams/kg; median (IQR) 18.6 (15.9–21.1) 20.0 (16.9–23.4) 0.16
Prot (total) W2, grams/kg; median (IQR) 23.2 (21.0–26.6) 27.0 (24.1–30.6) 0.00
Low: no enteral supplementation of human milk before Day 11; High: standard protocol:
enteral supplementation of human milk if intake was ≥50 mL/day; IQR: Interquartile range; SGA: small for
gestational age: <p10; Sepsis: >72 h postnatally and positive blood culture, prevalence within the first
14 days; NEC: necrotizing enterocolitis according to Bell stage [36], prevalence within the first 14 days;
IVH: Intraventricular hemorrhage (grade according to Papile) [37]; PN: parenteral nutrition; BMF: breast milk
fortifier; *: during the intervention period; Ca: calcium; P: phosphorus; Prot: protein; W1: Week 1; W2: Week 2.
3.2. Nutritional Intake
The nutritional characteristics and intake of calcium, phosphorus and protein during Weeks 1
and 2 are presented in Table 1. The median and interquartile range (IQR) for the duration of PN was
12.0 (10.0–14.0) versus 11.0 (9.0–14.0) days for High versus Low, while the median day of reaching
an enteral intake of 150 mL/kg was Day 13.0 (10.5–20.0) versus Day 12.0 (9.8–17.0), respectively.
In accordance with the study protocol, Low received a higher amount of human milk. The median
start day of BMF in groups High and Low was 7.9 (5.0–10.0) and 11.0 (11.0–13.0) respectively. As a
result, High received a significant higher total intake of calcium and phosphorus during the first
two weeks and of protein during Week 2 compared to Low. Table A3 presents the nutritional intake
divided into four routes of administrations: parenteral, enteral and additional supplementation either
par- or enteral. This shows that differences in intake were mainly based on differences in enteral intake.
Further, both groups received additional parenteral supplementation of phosphorus, based on low
sP concentrations.
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Figure 2 presents the daily changes in nutritional intake during the first 14 days. Figure 2A,B,D
demonstrate the total calcium, phosphorus and protein intake. High had a steady increase in
intake during the study period, whereas Low showed a temporary decrease, and plateau at the
end of the observational period, probably due to the decreasing amount of PN and increasing
amount of unfortified human milk. Except for Day 1, both groups received a median total calcium,
phosphorus and protein intake according to the ESPGHAN recommendations for parenteral and
enteral nutrition [38,39]. The calcium/phosphorus ratios were highly variable. Both groups showed a
decrease in the calcium/phosphorus ratio on Day 5 that lasted until Day 11 (Figure 2C), most likely
caused by the transition from parenteral nutrition to enteral nutrition. For both groups, the ratio was
below the recommendations of ESPGHAN on all days [38,39].
Figure 2. Nutritional intake during the first 14 days: white bars: Low; black bars: High; The horizontal
black bars with * indicate the days on which the intake was statistically significant different. (A) Daily
intake of calcium in mmol/kg/day; * = p < 0.05; (B) daily intake of phosphorus in mmol/kg/day;
* = p < 0.05; (C) daily intake of protein in gram/kg/day; * = p < 0.05; and (D) ratio calcium intake
to phosphorus intake; * = p < 0.05 Data are presented as median, interquartile range and upper and
lower limits.
3.3. Biochemical Parameters
Table A4 summarizes the median daily values of both groups for all biochemical parameters.
The median serum concentrations of Ca en P were within the normal range and only showed slight
differences between the two groups and an overall increase during the study period [40]. Except for
the first day, the median sP concentrations remained below our target of 2 mmol/L until Days 5 and 10
for High and Low, respectively. The median uCa and uP values were above the recommended surplus
(uCa > 1.2 mmol/L, uP > 0.4 mmol/L) during the entire observational period [23]. The median TrP
values were above the lower normal range of 85% until Day 5, and decreased thereafter, reflecting a
higher loss of phosphorus. The median ALP values were within the normal range (80–330 U/L) until
Day 5, but increased steadily thereafter [40]. In both groups, the uCa/Creat ratios were above the
reference value (0.5 mmol/mmol) during the complete study period [32]. The uP/Creat ratios were
below the reference value (4.0 mmol/mmol) until Day 5, but above the reference thereafter [32].
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The results of the mixed model analyses are summarized in Table 2.
• The sCa concentration was not related to intake of Ca/P and was only marginally affected by a
number of co-variables except for daily protein intake that caused an increase of 0.107 mmol/L
per gram/kg protein.
• The sP concentration increased in relation to phosphorus intake (0.13 mmol/L per mmol/kg
phosphorus) and birth weight (0.0004 mmol/L per gram birth weight), whereas protein intake
(−0.13 mmol/L per gram/kg/day protein), gestational age (−0.05 mmol/L per week), furosemide
(−0.11 mmol/L per day) and caffeine (−0.02 mmol/L per day) decreased in sP concentration.
• The urinary excretion of Ca seemed to increase in relation to Calcium intake (0.35 mmol/L per
mmol/kg calcium), and increased in relation to protein (0.36 mmol/L per gram/kg protein) and
being born by cesarean section (0.65 mmol/L if born by cesarean section), whereas it was not
affected by the phosphorus intake.
• The urinary excretion of P increased in relation to daily phosphorus intake (3.18 mmol/L per
mmol/kg phosphorus) and gender (1.88 mmol/L if infant was a boy), whereas P excretion
lowered in relation to daily intake of protein (−1.18 mmol/L per mmol/kg protein), gestational
age (−0.71 mmol/L per week) and caffeine (−0.29 mmol/L per day). Calcium intake did not
affect the urinary P excretion.
• The TrP increased in relation the daily Calcium intake (3.10% per mmol/kg calcium) and
gestational age (3.05% per week). The reabsorption of phosphorus lowered in relation to daily
phosphorus intake (−6.21% per mmol/kg phosphorus), gender (−4.60% if infant was a boy),
being born by cesarean section (−5.12%), and sepsis (−6.78%).
• The ALP increased in relation protein intake (30.54 U/L per mmol/kg) and daily intake of
phosphorus (23.64 U/L per mmol/kg phosphorus). A decrease in ALP was related to calcium
intake (−44.94 U/L per mmol/kg calcium), gestational age (−20.71 U/L per week) and the
number of days of steroid use (−23.86 U/L per day).
• The uCa/creat ratio increased in relation to daily protein intake (0.54 L/L per gram/day protein)
and sepsis (0.66 L/L), but it was not affected by the total calcium and phosphorus intake.
• The uP/creat ratio increased in relation to daily phosphorus intake (4.01 L/L per mmol/kg
phosphorus), gender (2.31 L/L if infant was a boy), while the P/creat ratio seemed lower in
relation to daily protein intake (−0.81 L/L per gram/kg protein), and decreased with gestational
age (−0.94 L/L per week), and caffeine (−0.30 L/L per day).
Table 2. Mixed Model analysis: Effect of nutritional intake and clinical characteristics on
biochemical parameter.
Dependant Variable Covariates Estimate 95% CI p-Value
Serum Calcium Total intake of Ca (mmol/kg/day) 0.004 −0.046–0.054 0.89
Total intake of P (mmol/kg/day) −0.036 −0.073–0.002 0.06
Enteral intake of P (%) 0.001 −0.000–0.001 0.06
Intake of protein (grams/kg /day) 0.107 0.075–0.139 0.00
Gestational age (weeks) 0.027 0.013–0.042 0.00
Singleton (yes) 0.081 0.021–0.140 0.01
Sepsis (yes) −0.092 −0.167–−0.019 0.02
Sedation (days) −0.007 −0.016–0.001 0.07
Serum Phosphorus Total intake of Ca (mmol/kg/day) 0.0345 −0.0473–0.1164 0.41
Total intake of P (mmol/kg/day) 0.1252 0.0586–0.1918 0.00
Enteral intake of Ca (%) 0.0035 0.0023–0.0048 0.00
Intake of protein (grams/kg/day) −0.1274 −0.1825–−0.0723 0.00
Birth weight (grams) 0.0004 0.0002–0.0006 0.00
Gestational age (weeks) −0.0479 −0.0701–−0.0258 0.00
Gender (boy) −0.0698 −0.1493–0.096 0.08
Caffeine (days) −0.0215 −0.0354–−0.0075 0.00
Furosemide (days) −0.1116 −0.2029–−0.0203 0.02
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Table 2. Cont.
Dependant Variable Covariates Estimate 95% CI p-Value
Urine Calcium Total intake of Ca (mmol/kg/day) 0.35 0.01–0.70 0.05
Total intake of P (mmol/kg/day) −0.01 −0.29–0.27 0.94
Enteral intake of Ca (%) −0.02 −0.02–−0.01 0.00
Intake of protein (grams/kg/day) 0.36 0.12–0.61 0.00
Cesarean section (yes) 0.65 0.32–0.98 0.00
Urine Phosphorus Total intake of Ca (mmol/kg/day) −0.05 −1.56–1.45 0.94
Total intake of P (mmol/kg/day) 3.18 2.06–4.30 0.00
Enteral intake of P (%) 0.07 0.04–0.09 0.00
Intake of protein (grams/kg/day) −1.18 −2.20–−0.16 0.02
Gestational age (weeks) −0.71 −1.09–−0.33 0.00
Gender (boy) 1.88 0.26–3.50 0.02
Caffeine (days) −0.29 −0.54–−0.01 0.04
Tubular reabsorption of P Total intake of Ca (mmol/kg/day) 3.10 0.160–6.04 0.04
Total intake of P (mmol/kg/day) −6.21 −8.78–−3.65 0.00
Enteral intake of P (%) −0.09 −0.15–−0.03 0.01
Gestational age (weeks) 3.05 1.92–4.17 0.00
Gender (boy) −4.60 −9.22–0.01 0.05
Cesarean section (yes) −5.12 −9.95–−0.29 0.04
Sepsis (yes) −6.78 −12.72–−0.85 0.03
Furosemide (days) 4.75 −0.53–10.03 0.07
Alkaline Phosphatase Total intake of Ca (mmol/kg/day) −44.94 −69.51–−20.37 0.00
Total intake of P (mmol/kg/day) 23.64 4.14–43.14 0.02
Enteral intake of Ca (%) 2.07 1.69–2.45 0.00
Intake of protein (grams/kg/day) 30.54 14.08–47.01 0.00
Gestational age (weeks) −20.71 −30.37–−11.05 0.00
Postnatal steroids (days) −23.86 −44.29–−3.43 0.02
Urine Ca/Crea ratio Total intake of Ca (mmol/kg/day) 0.138 −0.292–0.568 0.53
Total intake of P (mmol/kg/day) 0.139 −0.204–0.481 0.43
Enteral intake of Ca (%) −0.023 −0.029–−0.016 0.00
Intake of protein (grams/kg/day) 0.497 0.206–0.787 0.01
Sepsis (yes) 0.584 0.003–1.166 0.05
Urine P/Crea ratio Total intake of Ca (mmol/kg/day) −1.10 −2.51–0.31 0.12
Total intake of P (mmol/kg/day) 4.01 2.97–5.05 0.00
Enteral intake of P (%) 0.06 0.04–0.08 0.00
Intake of protein (grams/kg/day) −0.81 −1.76–0.14 0.10
Gestational age (weeks) −0.94 −1.32–−0.55 0.00
Gender (boy) 2.31 0.72–3.89 0.01
Sepsis (yes) 1.72 −0.24–3.68 0.09
Caffeine (days) −0.30 −0.56–−0.03 0.03
sCa: serum calcium (mmol/L); uCa: urine calcium (mmol/L); sP: serum phosphorus (mmol/L);
uP: urine phosphorus (mmol/L); TrP: tubular reabsorption of phosphorus (%); ALP: Alkaline phosphatase (U/L);
uCa/Crea ratio: urine calcium/creatinin ratio (mmol/mmol); uP/Crea ratio: urine phosphorus/creatinine ratio
(mmol/mmol); 95% CI: 95% confidence interval; Co-variables initially included: daily nutritional intake of
calcium, phosphorus, and protein, the enteral amount of calcium and phosphorus intake, caesarian section,
multiple births, birth weight, gestational age, gender, necrotizing enterocolitis, sepsis, caffeine, furosemide,
steroids and sedation.
4. Discussion
In this observational study of initially three randomized groups providing different nutritional
intake to VLBW infants during the first 10 days of life, we found no differences between groups
Low and High concerning the biochemical parameters of Ca-P homeostasis. However, the mixed
model analysis showed that the intake of calcium was associated with increased urinary calcium
excretion and tubular reabsorption of phosphorus and a decrease in the ALP, while the nutritional
intake of phosphorus was associated with a decreased sCa and an increase in sP, uP and uP/creat ratio.
The nutritional intake of calcium and phosphorus affected the TrP and ALP in opposite directions.
Protein intake was greatly associated with a decrease in sP, uP and an increase in ALP, sCa, and uCa,
while, in addition, gestational age and male gender affected especially the phosphorus metabolism.
VLBW infants belong to one of the most vulnerable patient groups for whom adequate postnatal
nutritional intake has life-long consequences [41]. Therefore, intervention studies with different
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nutritional intakes could be seen as unethical in the light of the right of optimal treatment for every
patient. On the other hand, in clinical practice a great variation in clinical guidelines has been reported,
often based on rather low evidence [42]. While fortification of human milk is generally seen as necessary
nowadays, there is also concern about possible risks of introducing cow-milk based products too
early [43,44]. According to our local protocol, fortification is introduced early and additional mineral
supplementation is provided based on laboratory results. The intention is to optimize postnatal growth
and bone mineralization but the efficacy of our protocol has not been proven. The combination of the
Early Nutrition Study and the Early Supplementation Study provided the opportunity to evaluate two
different nutritional concepts within the range of nutritional guidelines and therefore within the ethical
limits. On the other hand, all infants participating in the ESS, independent of group allocation, received
the standard treatment according to the local practice, which frequently led to additional parenteral
supplementation of nutrients in case of electrolyte disturbances or impaired growth. This practice may
have ameliorated the differences between the groups and therefore affected the results. By reallocating
infants from group ENS B to either group Low or High and excluding infants with intermediate
intake from further analysis, we tried to maximize the differences in nutritional intake between the
two remaining groups. The reallocation of infants did not change the baseline patient characteristics.
The detailed analysis of nutritional intake showed that additional supplementation was not different
between the groups and differences in intake were mainly based on enteral nutrition.
Even though the two groups had a maximum difference in nutritional intake, the comparison of
daily concentrations of the biochemical parameters showed no differences between groups High and
Low, probably by leveling out inter-individual differences on group level. In contrast, the linear mixed
model analysis took into account both intra- and inter-individual fluctuations, and thereby enabled us
to specify effects of various co-variables.
Despite an increasing intake of phosphorus, sP remained below our target concentration during
the first week. Recently, a randomized trial, evaluating nutritional support according to current
recommendations in VLBW infants, observed hypophosphatemia in relation to high protein intake [45].
Jamin et al. observed electrolyte disturbances, especially hypophosphatemia and hypokalemia, in
low-birth weight piglets with a high protein diet [46]. Hypophosphatemia is the hallmark of the
refeeding syndrome and a well-known complication in relation to parenteral nutrition of malnourished
patients [47–49]. Bonsante et al. proposed the concept of Placental Incompletely Restored Feeding
(PI-Refeeding) syndrome for electrolyte disturbances found in VLBW infants [50]. This syndrome is
said to be caused by an imbalanced nutritional intake of amino acids and phosphorus. Amino acids and
energy are needed to maintain an anabolic state of the cell, while phosphorus is necessary for a number
of cellular functions, energy homeostasis as well as for bone mineralization. Phosphorus in blood will
preferably be transferred to the cell regardless of bone mineral status. A higher intake of amino acids
will enhance the need for phosphorus in growing cells, and in case of low concentrations of phosphorus
in blood it will be released from bone. Simultaneously with the release of phosphorus, calcium will also
be released from the bone because of an unfavorable Ca/P ratio and will consecutively be excreted in
urine if the sP concentrations are too low. Our results are in agreement with this concept. According to
the mixed model analyses, we found that an increasing amount of protein was associated with an
increase in the sCa, uCa, ALP and uCa/Creat ratio, whereas it was associated with a decrease in sP,
uP and the uP/Creat ratio. Remarkably, in our study, an increase in a sP concentration of 0.13 mmol/L
occurred per 1 mmol/kg intake of phosphorus and a decrease of −0.13 mmol/L per 1 gram/kg protein
intake, meaning that 1 gram/kg of protein intake should be accompanied by 1 mmol/kg of phosphorus
in nutrition of VLBW infants to maintain adequate sP concentrations.
The role of ALP in bone mineralization is controversial, but an increase is usually associated
with poor bone mineralization [30,51]. According to our results, an increasing intake of protein was
associated with an increase in ALP. Again, following the above mentioned mechanisms higher protein
intake enhanced the cellular need of phosphorus and thereby decreased the sP concentration and
the availability of phosphorus for bone mineralization, leading to activation of ALP. We also found
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that an increased ALP was associated with increasing phosphorus intake, while one would expect
lowering of ALP. An explanation for this phenomenon could be a relatively insufficient intake of
calcium in combination with phosphorus intake, since an increasing calcium intake was associated
with decrease in ALP concentrations. In this study, for both groups, the calcium/phosphorus ratio was
below recommendations, meaning that relatively more phosphorus than calcium was administered.
Gestational age at birth seemed to be an important determinant for the phosphorus metabolism
in our study, meaning that infants with a lower gestational age had a higher renal excretion of
phosphorus, irrespective of nutritional intake. Immaturity of the kidneys at lower gestational age
has been shown to cause impaired tubular reabsorption of phosphorus [15]. Renal losses of minerals
may then compromise the effect of nutritional intake on bone mineralization. However, current
recommendations for nutritional intake of calcium and phosphorus usually do not take into account
differences in renal function based on gestational age.
Further, we found that male gender was related to low serum phosphorus concentrations, low
tubular reabsorption and increased renal excretion of phosphorus and uP/creat ratio. We speculate a
retardation in maturation of the renal function in male infants compared to females as is known for the
development of the pulmonary function [52].
All parameters evaluated in this study are regularly used to monitor either electrolyte homeostasis
or bone mineralization. Practices among units vary greatly, measurements may be performed at later
age and greater intervals and not standardized or in combination, leading to inconsistent results and
handling. An explanation for the inconsistency in results of other studies could be the underestimation
of the effects of inter-relationships between various co-variates. In our opinion, these associations
can only be discovered with standardized repeated measurements taking into account other clinical
factors. To our knowledge, this is the first study evaluating changes in biochemical parameters of the
calcium-phosphorus homeostasis based on standardized repeated measurements and daily changes in
nutritional intake in a mixed model linear regression analysis including also clinical factors.
Our data show that standardized repeated measurements of blood and urine samples can provide
useful information with regard to the Ca-P homeostasis. This does not result in a clear advice for
nutritional intake. Nevertheless, this study is a first step and its importance lies in the description
and quantification of changes in a more “physiological way” that will further enable us to develop
new guidelines to improve bone mineral status in preterm infants. Notwithstanding, we confirmed
the relationship between the intake of protein and phosphorus, and demonstrated the effect of renal
immaturity and gender. Thus, a second step could be, to relate the current results to bone mineralization
and provide recommendations for nutritional intake and a third step to develop a concept of target
values for biochemical parameter so that these can be used to monitor nutritional intake to achieve
optimal bone mineralization in daily practice.
This study had several limitations. The mixed model analysis assumes that the effects of the
different variables are linear which has not been proven yet. In addition, the biochemical parameters
may have been influenced by factors that were not taken into account in our analysis. Daily sampling
of biochemical parameter would have been optimal, but this was judged unethical regarding the
amount of blood volume needed. Nevertheless, measurements were performed in a standardized
manner and therefore provided a good reflection of changes in blood and urine concentrations for
the complete study period. Further, in comparison to other studies, both groups had relatively high
daily intakes. This may partly explain the small variations in biochemical parameters. This study
only investigated the biochemical parameters during the first 14 days of life. Maturational changes in
renal function may alter the results; however, repeated measurements will indicate these changes and
thereby can be used as guide for optimal supplementation of minerals.
5. Conclusions
In conclusion, standardized repeated measurements showed that biochemical parameters of
Ca-P homeostasis seemed to be affected by nutritional intake of calcium and phosphorus as well
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as protein, while immaturity of kidneys was related to an increase in urinary excretion of minerals
irrespective of nutritional intake. Further studies are needed to define target values to stabilize
electrolyte balances and improve bone mineralization taking into account nutritional intake and
gestational age of the patient.
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Appendix A
Table A1. Standard parenteral nutritional intake.
Day 1 Day 2 Day 3 Day 4
Fluid mL/kg/day 80 100 125 150
CH grams/kg/day 8 9.6 11.7 13.8
AA grams/kg/day 0.75 1.5 2.25 3
Lipids grams/kg/day 1 2 3 3
EQ Kcal/kg/day 44 62 82 94
Calcium mmol/kg/day 0.75 1.5 2.25 3.00
Phosphorus mmol/kg/day 0.48 0.96 1.44 1.92
Parenteral nutritional intake based on standardized parenteral solutions [35,53]. For infants below 1000 grams,
amino acids were additionally added according to current recommendations [12]. Amino acid solution:
Primene (Baxter, the Netherlands); Lipid emulsion including vitamins: Clinoleic (20%; Baxter, The Netherlands)
or SMOFlipid 20% (Fresenius Kabi; The Netherlands); CH: carbohydrates, AA: amino acids, EQ: energy quotient.
Table A2. Cohort characteristics of all patients included in the Early Supplementation Study.
Characteristics Group ENS A (n = 40) Group ENS B (n = 32) Group C (n = 37)
GA, weeks; med (IQR) 28.2 (25.7–30.1) 28.3 (26.5–30.7) 27.9 (26.1–29.7)
Birth weight, grams; med (IQR) 967 (753–1245) 1012 (847–1199) 1006 (771–1220)
SGA; n (%) 9 (23) 8 (25) 6 (16)
Male; n (%) 21 (53) 20 (63) 18 (49)
Singletons; n (%) 25 (63) 24 (74) 25 (68)
Antenatal Steroids compl.; n (%) 36 (90) 31 (97) 31 (86)
Cesarean section; n (%) 19 (48) 20 (63) 25 (68)
Apgar score (5 min); med (IQR) 7.5 (6.3–9.0) 8.0 (7.0–9.0) 7.0 (7.0–8.0)
Apgar score (5 min) <7; n (%) 10 (25) 5 (16) 8 (22)
Mortality; n (%) 6 (15) 3 (9) 7 (19)
Morbidity
IRDS 24 (60) 19 (59) 23 (62)
Days of MV; med (IQR) 1.5 (0.0–4.8) 1.0 (0.0–4.0) 1.0 (0.0–7.0)
Days of N-CPAP; med (IQR) 18.0 (6.5–38.8) 28.0 (7.0–40.8) 16.0 (6.0–36.5)
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Table A2. Cont.
Characteristics Group ENS A (n = 40) Group ENS B (n = 32) Group C (n = 37)
CLD; n (%) 12 (30) 14 (44) 10 (27)
PDA; n (%) 20 (50) 20 (63) 21 (57)
Ductal ligation; n (%) 4 (10) 2 (6.3) 1 (3)
IVH grade ≤ 2; n (%) 15 (38) 5 (16) 5 (14)
IVH grade ≥ 3; n (%) 2 (5) 7 (21) 4 (11)
Sepsis; n (%) 13 (33) 10 (32) 14 (38)
NEC; n (%) 4 (10) 5 (16) 3 (8)
Bell stage 2; n 2 3 1
Bell stage 3; n 2 2 2
Laparotomy; n 2 1 2
ROP; n (%) 4 (10) 1 (3) 5 (14)
ROP grade ≥ 3 1 0 1
Medication
Caffeine; n (%) 38 (95) 30 (94) 33 (90)
Furosemide; n (%) 11 (28) 10 (31) 7 (19)
Diuretics (maintenance); n (%) 3 (8) 0 3 (8)
Corticosteroids; n (%) 1 (3) 2 (6) 4 (11)
Sedation; n (%) 13 (33) 11 (34) 15 (41)
Nutritional characteristics
Days of PN; med (IQR) 10.0 (8.0–13.0) 10.5 (9.0–14.8) 10.5 (8.3–21.0)
120 mL/kg enteral, day; med (IQR) 9.0 (7.0–12.5) 9.0 (8.0–13.0) 9.0 (7.2–14.8)
150 mL/kg enteral, day; med (IQR) 12.0 (9.0–17.0) 11.0 (10.0–17.0) 12.0 (10.0–20.0)
Start day of BMF; med (IQR) 11.0 (11.0–12.7) 12.0 (11.0–14.0) 6.0 (4.0–8.0)
ENS A: donor milk in addition to mother’s own milk (MOM) and no supplements with enteral feeding
until Day 10; ENS B: preterm formula in addition to MOM and no supplements with enteral feeding until
Day 10; Group C: preterm formula in addition to MOM and fortifier if intake ≥50 mL/day; med: median;
IQR: inter quartile range; GA: gestational age; SGA: small for gestational age according to Fenton et al. [54];
IRDS: infant respiratory distress syndrome; MV: mechanical ventilation; N-CPAP: nasal continuous positive
airway pressure; CLD: chronic lung disease defined as oxygen dependency at 36 weeks gestational age;
PDA: patent ductus arteriosus with need for treatment; IVH: intra-ventricular hemorrhage; Sepsis: >72 h
postnatally and positive blood culture; NEC: necrotizing enterocolitis with staging according to Bell [36];
ROP: retinopathy of prematurity; sedation: morfine and/or midazolam >24 h; PN: parenteral nutrition;
BMF: breast milk fortifier.
Table A3. Nutritional intake of calcium and phosphorus by route of administration.
Nutritional Intake (mmol/kg/Week) Low (n = 40) Median (IQR) High (n = 30) Median (IQR) p-Value
Ca (total) W1 10.7 (9.9–12.0) 13.1 (11.1–14.6) 0.00
Ca (total) W2 16.4 (12.9–17.7) 21.7 (15.3–24.4) 0.00
Ca (enteral) W1 1.7 (1.1–2.2) 3.3 (1.1–5.7) 0.00
Ca (enteral) W2 10.8 (6.2–16.0) 17.5 (2.3–22.8) 0.07
Ca (enteral suppl) W1 0.0 (0.0–0.0) 0.0 (0.0–0.0) 1.0
Ca (enteral suppl) W2 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.22
Ca (PN) W1 9.4 (8.0–10.2) 9.8 (7.9–11.5) 0.34
Ca (PN) W2 3.1 (0.7–7.9) 5.1 ( 1.9–10.9) 0.14
Ca (PNsuppl) W1 0.0 (0.0–0.0) 0.0 (0.0–0.0) 1.0
Ca (PNsuppl) W2 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.74
P (total) W1 10.8 (9.2–12.4) 12.3 (11.1–14.2) 0.00
P (total) W2 16.4 (12.9–19.6) 18.9 (16.0–22.1) 0.02
P (enteral) W1 1.0 (0.6–1.4) 2.1 (0.7–3.9) 0.00
P (enteral) W2 8.1 (5.0–12.0) 10.4 (1.7–17.2) 0.08
P (enteral suppl) W1 0.0 (0.0–0.0) 0.0 (0.0–0.9) 0.03
P (enteral suppl) W2 0.0 (0.0–0.0) 0.0 (0.0–1.4) 0.33
P (PN) W1 7.5 (6.4–8.2) 7.8 (6.3–9.2) 0.34
P (PN) W2 2.5 (0.6–6.3) 4.1 (1.5–8.7) 0.14
P (PN suppl) W1 2.4 (0.5–3.8) 1.8 (0.0–2.7) 0.16
P (PN suppl) W2 2.3 (0.0–4.2) 0.7 (0.0–4.3) 0.30
Low: no enteral supplementation of human milk before Day 11; High: standard protocol: enteral
supplementation of human milk if intake was ≥50 mL/day; IQR: inter quartile range; Ca: calcium;
P: phosphorus; total: som of all nutritional intake; enteral: enteral intake including standard fortification;
enteral suppl: additional enteral supplementation; PN: parenteral intake; PN suppl: additional parenteral
supplementation; W1: week 1; W2: week 2.
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Abstract: Very low birth weight (VLBW) preterm infants are vulnerable to growth restriction
after discharge due to cumulative protein and energy deficits during their hospital stay and
early post-discharge period. The current study evaluated the effectiveness of the preterm infant,
post-discharge nutrition (PIN) program to reduce post-discharge growth restriction in Thai VLBW
preterm infants. A prospective, non-randomized interventional cohort study was undertaken to
assess the growth of 22 VLBW preterm infants who received the PIN program and compared them
with 22 VLBW preterm infants who received conventional nutrition services. Infant’s growth was
recorded monthly until the infants reached six months’ corrected age (6-moCA). Intervention infants
had significantly greater body weights (p = 0.013) and head circumferences (p = 0.009). Also, a greater
proportion of the intervention group recovered their weight to the standard weight at 4-moCA
(p = 0.027) and at 6-moCA (p = 0.007) and their head circumference to the standard head circumference
at 6-moCA (p = 0.004) compared to their historical comparison counterparts. Enlistment in the PIN
program thus resulted in significantly reduced post-discharge growth restriction in VLBW preterm
infants. Further research on longer term effects of the program on infant’s growth and development
is warranted.
Keywords: very low birth weight preterm infant; growth restriction; post-discharge; nutrition program
1. Introduction
Very low birth weight (VLBW) preterm infants are those born before 37 weeks gestation weighing
less than 1500 g, and they comprise between 4% and 8% of neonatal live-births [1,2]. Survival of these
small infants has significantly improved mainly due to the advancement of medical intervention in
neonatal intensive care units (NICU) [2,3]. However, the extra-uterine growth restriction (EUGR),
defined as a decrease in z-score greater than two standard deviations (SD) between birth to discharge [4],
is common in the preterm population [5]. A recent cohort study estimated that a prevalence of being
small for gestational age (SGA) among VLBW infants (birth weight 750–1500 g) born between 2005
and 2012 to be 44.4%–58.8% at discharge [6]. This may be caused by several health problems such
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as need for respiratory support, unstable glucose levels, early sepsis, risk of necrotizing enterocolitis
and feeding intolerance during NICU stay. These concerns impact highly on the prescribed feeding
regimen and result in unrecovered early protein and energy deficits accumulated during hospital
admission [7]. Moreover, post-discharge growth restriction also usually occurs in these infants at
28%–40% until 18–22 months corrected age (moCA) [8]. These poor postnatal growths are potentially
associated with developmental delay [8], obesity and related complications, such as cardiovascular
disease, type II diabetes mellitus and hypertension during adulthood [4,8,9].
In order to compensate for these nutritional deficits and improve the EUGR, the initiation of
aggressive parenteral nutrition (PN) in the first week of life and fortified human milk (HM) to this
population has been suggested during their hospital stay [10–12]. Furthermore, enriching HM or
formula is widely recommended to decrease post-discharge growth restriction and accelerate catch-up
growth [10,13]. However, the HM feeding rate in preterm infants usually declines after discharge [14].
Enriched-nutrient formula (EF) is therefore supplemented to provide adequate intakes of energy and
nutrients to meet the infant’s needs [15–17].
In 2012, a preliminary study was performed at Buddhasothorn Hospital, Chachoengsao, Thailand.
It investigated the nutritional care services and growth outcomes in 85 VLBW preterm infants at
pre- and post-discharge. The findings revealed that the HM feeding rate was decreased from 87% at
discharge to 7% at 6-moCA. After discharge, these infants received unfortified HM and/or standard
term formula (TF). Moreover, 85% of VLBW preterm infants were below the standard growth at
discharge and 43% remained as below the standard growth at 6-moCA.
In order to reduce post-discharge growth restriction in this population, the preterm infant,
post-discharge nutrition (PIN) program was developed and implemented at Buddhasothorn hospital
in early 2014. Based on recent recommendations [10,15,18], it focuses on providing an EF in addition
to fortified HM with regular monitoring after discharge to ensure infant nutritional intakes. The aim
of the present study was to compare growth outcomes in VLBW preterm infants who enlist in the PIN
program with those who received conventional nutrition services.
2. Materials and Methods
A prospective non-randomized interventional cohort study was conducted at Buddhasothorn
Hospital, located in Chachoengsao province, Thailand. The present study was approved by the
Institutional Review Boards of the Faculty of Public Health, Mahidol University (COA. No. MUPH
2014-002), Buddhasothorn Hospital (COA. No.EC-CA 007/2556) and Chachoengsao provincial health
office (COA. No. PH_CCO_REC 003/56). The current study used the subgroup of the study that
registered as a clinical trial with the Thai clinical trials registration number of TCTR20160211001.
2.1. Participants
A total of 22 VLBW preterm infants who were admitted and discharged from the NICU between
March 2014 and February 2015 and given the PIN program were invited to participate in the current
study. Detailed verbal and written explanations were given to parents of VLBW preterm infants
and informed written consent was obtained from the parents of each participant. These infants were
compared with records of 22 VLBW preterm infants who were born and discharged from the NICU
between January 2012 and December 2013. The intervention group was enlisted in the PIN program
after discharge to 6-moCA whereas; the comparison group received a conventional nutrition service at
post-discharge for the same period of time.
A sample size of 22 preterm infants for each group was determined based on a previous study
using a power of 80% and a significance level of 5% to detect a program effect of an increase of 5%
on the body weight with favorable outcomes at 6-moCA [19]. Inclusion criteria of the study include:
(1) birth at ≤34 weeks gestation; (2) birth weight ranged between 750 and 1499 g; (3) no use of any
medical feeding tube at discharge; and (4) residence in Chachoengsao. On the other hand, infants were
excluded if they had: (1) severe respiratory problems; (2) serious congenital anomalies; (3) more than or
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equal to grade III periventricular or intraventricular hemorrhage; (4) surgical necrotizing enterocolitis;
(5) gastrointestinal perforation; (6) severe retinopathy of prematurity; (7) severe birth asphyxia [6,19];
and also if (8) the mothers cannot communicate with researchers.
2.2. Recruitment Process of the Participants
Figure 1 describes the recruitment process of 22 VLBW preterm infants for both intervention
and comparison group. The infants born in the comparison period were randomly assigned to the













 43 VLBW infants 
(15 w ith birth weight < 1000 g) 
   26 VLBW infants 
 in the intervention group  
(7 infants w ith bi rth weight < 1000 g) 
 17 VLBW infants were excluded 
- 1 severe birth asphyxia 
- 1 severe chronic lung disease 
- 1 serious congenital anomalies 
- 13 did not live in Chachoengsao  
   after discharge 
- 1 was refused to participate by his 
   mother due to inconvenience for  
   home visits  
 4 VLBW infants were discontinued 
the PIN  program since they did not 
come to receive prescribed fortified 
human milk / EF at the follow -up 
cl inic visit  
 Random sampling, strati fied for sex 
and birth weight   
 17 VLBW infants were excluded 
- 6 severe birth asphyxia 
- 3 severe chronic lung disease 
- 2 serious congenital  anomalies 
- 2 intraventricular hemorrhage 
   grade III 
- 2 retinopathy of prematurity  
   grade III 
- 1 necrotizing enterocolitis 
- 1 gastrointestinal perforation 
       M onthly home visit in the first  
4 weeks after discharge and  
follow-up clinic visit from discharge 
to 6-moCA  
 The PIN  program, monthly 
home visits in the fi rst 16 weeks 
and a follow-up clinic visi t from 
discharge to 6-moCA  
22 infants in the intervention group 
at 6-moCA 
Intervention group Comparison group
 Study period after  PIN program 
implementation  
(March 2014 to February 2015) 
 Comparison period before PIN  program 
implementation  
(January 2012 to December 2013) 
 85 VLBW infants 
(25 with birth weight < 1000 g) 
   22 VLBW infants in the intervention 
group (5 with birth weight < 1000 g) 
    Subgroups for sex and birth weight 
3 male infants w ith birth weight < 1000 g 
2 female infants w ith birth weight < 1000 g 
9 male infants w ith birth weight 1000-1499 g 
8 female infants w ith birth weight 1000-1499 g 
   22 VLBW infants in the comparison 
group (6 with birth weight < 1000 g) 
    Subgroups for sex and birth weight 
3 male infants w ith birth weight < 1000 g 
3 female infants w ith birth w eight < 1000 g 
8 male infants w ith birth weight 1000-1499 g 
8 female infants w ith birth w eight 1000-1499 g 
68 VLBW infants  
in the comparison group 
(19 infants with birth weight < 1000 g) 
22 infants in the comparison group 
at 6-moCA 
Figure 1. Recruitment process of participants. VLBW = very low birth weight, PIN = preterm infant
post-discharge nutrition, EF = enriched-nutrient formula, g = gram, moCA = months corrected age.
2.3. Nutritional Strategies Conducted for Both Groups during Hospital Admission
Until their discharge from hospital, both groups received parenteral and enteral nutrition.
Infants in both groups received individualized PN formulation in the first few weeks of life. When the
infant’s clinical status was improved, trophic oral feeding was introduced until the full feedings of at
least 120–150 mL/kg/day were achieved [20]. All preterm infants mainly received their mother’s own
milk. Mothers were instructed by NICU nurses to assess volume intake of breast milk by test-weighing
procedure [21] before discharge. In order to increase energy density from 20 to 24 or 27 kcal/oz
during NICU stay as recommended by recent studies [22–24], infants were given fortified HM that
was prepared by adding preterm formula (PF) into expressed HM (calculated by definite formula)
once their volume of feeding reached 100 mL/kg/day [20,25].
2.4. The PIN Program Conducted for the Intervention Group
The PIN program is a post-discharge nutritional plan of feeding fortified HM and/or EF for VLBW
preterm infants from discharge to 6-moCA. It is based on a commentary by the European Society
for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) committee on nutrition [22]
and a nutrition care practice guideline developed by the Oregon Pediatric Nutrition Practice Group
(OPNPG) [15]. The program was developed based on outcomes from focused group discussions of
a multi-disciplinary team in the hospital. Four experts—including two pediatricians, one neonatologist,
and one nurse—reviewed and approved the program. It was implemented as a routine nutritional
service at Buddhasothorn hospital since January 2014. The program also includes education on mothers
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prior to their discharge such as benefits of breastfeeding to preterm infants [26], essential knowledge for
lactating mothers [27,28], preparation method of fortified HM, feeding practices [29,30], and personal
hygiene for their infant care after hospital discharge [29,30]. The contents of the education program
were based on previous studies that recommended the importance of these variables [31,32].
2.4.1. Enriched Milk Intake
The fortified HM suggested in the program was prepared by adding a given calibrated spoon
(0.42 g, contains 2.1 kcal) of a powdered preterm formula (PF) (Pre-Nan Abott, Bangkok, Thailand)
per oz (30 cc) of expressed HM to prepare milk with energy density of 22 kcal/oz. All intervention
infants received fortified HM at discharge. If its volume was less than 50% of daily total volume intake,
EF (Enfalac catch up care, Mead Johnson, Bangkok, Thailand) was supplemented to meet the infant
needs with a goal of energy including 85–120 kcal/kg/day and 1.5–2.5 g/kg/day of protein according
to their corrected age [10,15,22].
Specific written instructions on the fortification of HM and reconstitution of EF powder as well
as containers for the preparation and storage of reconstituted milk were provided to each parent.
In addition, the written instructions were repeated verbally and parental understanding was confirmed
by research personnel. Dietary intake records were given to parents at discharge to assess actual milk
and complementary food intake of infants. At the follow-up clinic, the mothers or caregivers were
asked for more detailed information of their records. Volume of fortified expressed HM, EF, and other
fluid intakes were determined by measuring in oz according to the label on the milk bottle.
2.4.2. Introduction of Semi-Solid Foods
The introduction of semi-solid foods was commenced if: (1) they reached 4–6 months after birth;
(2) body weight was not less than 5 kg; (3) they had no extrusion reflex; (4) they had well controlled
neck and chair sitting posture; (5) they developed an ability to receive spoon feeding; and (6) they
developed an ability to show desire or refusal of food [33–36]. Type and formula of semi-solid foods
recommended in the PIN program was based on guidelines of complementary foods for Thai infant
and toddlers by Thai Ministry of Public Health [36]. In the PIN program, Thai foods such as a pulp of
Thai rice, pumpkin, egg yolk, some kinds of Thai vegetable, such as Coccinia grandis (dtam-leung)
were recommended to the infants from 6 to 9 months after birth. In addition, half a teaspoon of
vegetable oil per 250 g of semisolid foods was added to prevent fat soluble vitamin deficiencies [36].
2.4.3. Biochemical Blood Tests and Nutrient Supplementation
Biochemical blood profiles were also assessed monthly as a high-risk follow-up clinic. One mL of
blood sample was taken at blood drawing unit from all infants and hematocrit (Hct), calcium (Ca),
phosphorus (P), alkaline phosphatase (ALP), and blood urea nitrogen (BUN) were examined in order
to monitor iron deficiency anemia [37], bone health [38], and nutritional status, including sufficiency
of protein. All analyses were conducted at the laboratory unit in the hospital. However, the historical
group did not conduct a regular biochemical blood tests after discharge at the follow-up clinic visit.
As a result, with an exception of Hct, a nutritional status of historical group was unable to be compared
with the intervention group during 1- to 6-moCA and therefore did not include in the results of the
current study. Moreover, monthly home visits were performed to monitor HM fortification procedure
and infant feeding practices [19].
All infants received 2 mg/kg/day of iron at discharge. When abnormal levels of biochemical
markers were identified, special nutrient supplementations were prescribed by a pediatrician at
a follow-up clinic as these follows:
• Hct < 35%: Increase dose of ferrous sulfate/fumarate solution from 2 to 4–5 mg/kg/day [17,37].
• Total Ca < 8.0 mg/dL: Supplement calcium suspension 100–140 mg/kg/day [15,17]
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• Phosphorus < 5.5 mg/day and/or ALP > 450 IU/L: Supplement phosphate solution
60–90 mg/kg/day [15,17]
• BUN > 20 mg/dL: Consider substitution with unfortified HM and/or standard term formula
(TF) [10].
The infants also received 0.5 mL/day of multivitamin drop (MVD) (1 mL of MVD—composed of
2000 international unit (IU) of vitamin A, 400 IU of vitamin D and other water soluble vitamins)—until
infants received total daily milk intake of >32 oz (1000 mL) [15]. However, non-fortified HM and/or
TF was substituted when infants cannot tolerate with fortified HM and/or EF, or had an excessive rate
of weight gain, and also showed Ca, P, and BUN above their normal levels [10].
Estimated volume of breastfeeding was derived by test weighing procedure [21]. Energy and
selected nutrients intakes (protein, vitamin A and D, calcium, phosphorus, zinc, and iron), at 2-, 4-,
and 6-moCA were estimated using HM composition values from literatures [39,40] manufacturer label
claims for PF, EF and TF, drug label of MVD and ferrous fumarate drop, commercial complementary
feeding formula and complementary foods composition recommended by the Thai Ministry of Public
Health [36].
A nutritionist explained to the mothers/caregiver about the procedure of recording actual amount
of all milk feeding, complementary food intake, and nutrient supplementation before infant discharge
and also re-checked their practices monthly at the follow-up clinic visit. These records were kept by
mothers/caregivers at home and by a nutritionist during home visit and at a follow-up clinic visit.
2.5. The Conventional Nutrition Services Conducted for the Comparison Group
Prior to their infant discharge, parents in the comparison group received general education such
as latching technique and observations of feeding intolerance without specific nutritional education.
After discharge, infants received unfortified HM and/or TF. They were provided with 2–5 mg/kg/day
of ferrous fumarate solution and 0.5–1 mL/day of MVD according to a decision of the in-charge
pediatrician at a follow-up clinic. Hematocrit was also tested for all infants at every clinic visits; while
the other chemical blood tests, including Ca, P, ALP and BUN were performed at some visits according
to pediatricians’ decisions.
Enteral intake data of the comparison group was also obtained from dietary intake recorded by
mothers/caregivers and nutritional records by a nutritionist at a follow-up clinic as performed in
the intervention group. Differences of the nutritional activities between the groups are described in
Table 1.
Table 1. Comparisons of activities in the preterm infant post-discharge nutrition (PIN) program and
conventional nutrition services.
The PIN Program Activities Conventional Nutrition Activities
I. Pre-discharge activities
Giving formal nutritional education to
parents/caregivers
No formal nutritional education for
parents/caregivers
II. Post-discharge activities
Giving enriched-nutrient HM and/or EF to the
infants from discharge to 6-moCA
Giving unfortified HM and/or TF from discharge to
infant weaning
Using revised biochemical blood tests and
nutrition supplements protocol
Using biochemical blood tests according to decisions
by in-charge pediatricians
Using revised criteria to start and recommended
types of semi-solid foods to preterm infants
Suggestions mainly about time to start semi-solid
foods at six months after birth without other specific
criteria to start semi-solid foods
Monthly home visit until preterm infants
reached 6-moCA Home visit only one time after hospital discharge
moCA = months corrected age; HM = human milk; EF = enriched-nutrient formula; TF = term formula.
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2.6. Differences in Milk Formula between the Groups
The energy and nutrients values of fortified HM and EF used in the intervention group and
unfortified HM [39,40] and TF used in the comparison group are shown in Table 2. Brands of TF formula
were derived from nutritional records at a follow-up clinic in the historical group. Composition of TF
is obtained from the average amount of ingredients from four commercial brands of TF in Thailand
(S-26, Dumex Hi-Q, Lactogen and Enfalac A+) which contains equal energy density and protein per
100 mL, but are slightly different for the remaining nutrients.
The energy density of fortified HM and reconstituted formula of EF is 21.8 and 22.5 kcal/oz;
while those of unfortified HM and TF is 19.7 and 20.1 kcal/oz, respectively. Fortified HM contains
higher protein than unfortified HM and TF by 12.5% and 22.5%, respectively, but the remaining
nutrients are equal to or less than TF. EF also contains higher protein, calcium, phosphorus, vitamin D
and zinc by 42.9%, 79.2%, 70.6%, 33.8%, and 20.0%, respectively, and >100% of vitamin A and iron
compared to those in TF.
Table 2. Composition of energy and selected nutrients in fortified human milk (HM) and
enriched-nutrient formula (EF) in the intervention group versus unfortified HM and term formula (TF)
in the comparison group.
Composition
Intervention Group Comparison Group
Fortified HM EF Unfortified HM TF
Energy (kcal) 72.60 75.00 65.60 67.00
Protein (g) 1.80 2.10 1.60 1.47
Vitamin A (IU) 122.40 343.30 72.00 160.83
Vitamin D (IU) 20.50 63.00 12.00 47.07
Calcium (mg) 38.03 82.00 29.00 45.77
Phosphorus (mg) 19.03 48.00 14.00 28.13
Zinc (mg) 0.63 0.72 0.53 0.60
Iron (mg) 0.25 1.37 0.13 0.63
HM = human milk, Fortified HM = expressed HM + preterm formula (PF: as a human milk fortifier),
EF = enriched formula, TF = term formula, Milk composition is per 100 mL as provided by the literature
and manufacturer, EF and TF were available cow milk protein-based formula.
The differences of feeding type and nutrient supplementation between the groups are summarized
in Table 3.
Table 3. Comparisons of feeding type and nutrient supplementations for preterm infants after discharge
between the intervention and comparison group.
Intervention Group Comparison Group
I. Feeding type
1.1 Milk intake at discharge
to 6-moCA
Fortified HM and/or EF with energy
density of 22 kcal/oz
Unfortified HM and/or TF with
energy density of 20 kcal/oz
1.2 Semi-solid foods
Recommended formula based on
complementary food guideline for infants
and toddlers by Thai MOPH
Commercial formula and/or any
formula based on caregivers’ decision
II. Nutrient supplementations
2.1 At discharge
Iron 2 mg/kg/day, increase to 4–5 mg/kg/dayif Hct < 35% 2–5 mg/kg/day *
MVD 0.5 mL/day until infants had total dailymilk intake of >32 oz 0.5–1 mL/kg/day *
Calcium suspension 100–140 mg/kg/day if total Ca < 8.0 mg/dL 90–120 mg/kg/day *
Phosphate solution 60–90 mg/kg/day if P < 5.5 mg/dayand/or ALP > 450 IU/L 60–90 mg/kg/day *
* refers to dose of nutrient supplementation based on pediatricians’ decisions, HM = human milk, EF = enriched
formula, TF = term formula, moCA = months corrected age, MOPH = Ministry of Public Health, Hct = hematocrit,
MVD = multivitamin drop, Ca = calcium, dL = deciliter, P = phosphorus, ALP = alkaline phosphatase.
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2.7. Growth Assessments Conducted with Both Groups
Body weight, length and head circumference of infants in both groups were measured monthly,
using revised anthropometric protocol for newborn by the same staff at the follow-up clinic.
The hospital staff who perform growth measurement was trained and validated their measuring
techniques every three months by the supervisor who is an expert in infant growth measurement.
A digital balance (MS 2400; two decimals, maximum load 20 kg, maximum length measured 80 cm)
was used for both weight and length measurements and a tape measure (Hochestmass 1.9 × 150 mm)
was used for a head circumference measurement.
All data of the infants in the comparison group were recorded from patient charts during
hospitalization and out-patient profiles at a follow-up clinic as secondary data until infants reached
6-moCA. Infant growth status was assessed by the Fenton [41] and WHO growth charts [42,43].
2.8. Statistical Analysis
Differences in energy and nutrient intakes between the groups were assessed by the Mann-Whitney
U test. Comparisons of anthropometric variables between the two groups from 1- to 6-moCA were
examined using multivariate of covariance (MANOVA) repeated measures. Mixed model analysis
was used to adjust multiple measurements of each infant. The categorical data were compared using
chi-squared test. Data analyses were conducted using PASW SPSS statistics (version 18.0, SPSS Inc.,
Chicago, IL, USA). All statistical analyses were examined with a significance level of 0.05.
3. Results
3.1. Baseline Characteristics of the Participants
Descriptive characteristics of infants were shown in Table 4. There were no statistically significant
differences in baseline characteristics between the groups.





(n = 22) p-Value
Sex, n (%) Male, 13 (59.0) Male, 11 (50.0) 0.763
GA at birth, week ± day 29 ± 12 day 30 ± 14 day 0.501
Twin, n (%) 3 (13.6) 6 (27.3) 0.457
Growth status at birth
Birth weight, g 1192 ± 202 1151 ± 208 0.502
Length, cm 39.1 ± 2.6 38.4 ± 3.7 0.525
Head circumference, cm 26.1 ± 1.8 26.4 ± 1.9 0.626
SGA at birth
Body weight, n (%) 1 (4.5) 2 (9.1) 1.000
Length, n (%) 1 (4.5) 1 (4.5) 1.000
Head circumference, n (%) 2 (9.1) 2 (9.1) 1.000
SGA at discharge
Body weight, n (%) 19 (86.4) 20 (90.9) 1.000
Length, n (%) 10 (45.5) 14 (63.6) 0.364
Head circumference, n (%) 15 (68.2) 12 (54.5) 0.453
PMA at discharge, week ± day 37 ± 12 day 38 ± 20 day 0.199
LOS, days 52 ± 12 53 ± 17 0.895
Feeding type at discharge, n (%)
Breast milk feeding 18 (81.8) 17 (77.3) 1.000
Mixed feeding 3 (13.6) 4 (18.2) 1.000
Standard formula 1 (4.5) 2 (9.1) 1.000
Growth status at term (40 weeks)
Body weight, g 2631 ± 538 2426 ± 531 0.145
Length, cm 47.7 ± 2.7 46.9 ± 2.9 0.318
Head circumference, cm 33.1 ± 1.6 32.2 ± 2.3 0.470
Maternal age (years) 22.5 ± 4.8 25.3 ± 5.5 0.087
n = number of infant; GA = gestational Age; SGA = small of gestational age; PMA = postmenstrual age;
LOS = length of hospital stay. Data are expressed as mean ± SD. The differences between the groups were
determined by chi-squared test.
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3.2. Human Milk Feeding and Introduction of Semi-Solid Foods
The volume of HM consumed (mL/kg/day) and proportion of HM volume per total volume
of all milk feeds per day (%) among infants in the intervention group was greater than those of
the comparison group (p < 0.05) at 6-moCA, but not 2-and 4-moCA. However, the total duration of
HM feeding did not differ significantly between two groups. The length of time from birth to the
introduction of semi-solids was also not significantly different (Table 5).
Table 5. Comparisons of exclusively human milk feeding, feeding duration and a timing of introducing
semisolid foods between the groups.
Intervention Group (n = 22)
Median (Q1–Q3)
Comparison Group (n = 22)
Median (Q1–Q3)
p-Value
Exclusively of HM feeding
2-moCA
HM intake, mL/kg/day 40.37 (5.51–111.14) 61.20 (3.05–139.55) 0.234
Proportion of HM volume per 35.50 (10.17–79.17) 48.50 (20.21–120.21) 0.381
Total volume of milk feeds per day, %
4-moCA
HM intake, mL/kg/day 24.67 (13.34–61.55) 27.45 (10.00–57.80) 0.761
Proportion of HM volume per 22.82 (15.09–61.09) 21.86 (16.33–56.33) 0.859
Total volume of milk feeds per day, %
6-moCA
HM intake, mL/kg/day 11.73 (3.16–13.51) 3.05 (1.12–11.43) 0.044 *
Proportion of HM volume per 11.82 (4.43–16.43) 2.27 (0.56–7.94) 0.041 *
Total volume of milk feeds per day, %
Total HM feeding duration, weeks after birth 16.00 (10.00–26.00) 18.00 (12.00–24.00) 0.427
Time at introduction of semisolid foods,
weeks after birth 20.00 (17.00–23.00) 21.00 (19.00–24.00) 0.625
n = number of infant, Q1 = the first quartile, Q3 = the third quartile, HM = human milk. moCA = months
corrected age. Total HM feeding duration refers to duration of exclusively HM feeding and/or mixed feeding
(HM feedings plus formula feedings). Differences between groups were assessed by Mann-Whitney U test.
* refers to statistically significant differences.
3.3. Nutritional Intake
Table 6 shows differences in daily energy and nutrient intakes of both groups. The intervention
group showed greater energy and nutrient intakes except in zinc and iron compared to the comparison
group at 2-, 4- and 6-moCA. It was also found that a median iron intake in both groups were slightly
greater than the daily recommendation for healthy term infants.










2-moCA 91.08 (89.27–93.46) 88.40 (85.85–91.74) 0.014 85–120
4-moCA 86.39 (82.15–88.22) 76.67 (72.65–78.16) 0.001
6-moCA 82.07 (80.11–88.63) 69.22 (66.49–71.98) <0.001
Protein, g/kg
2-moCA 2.87 (2.44–3.30) 2.21 (1.95–2.69) 0.024 1.5–2.5
4-moCA 2.48 (2.01–2.89) 2.07 (1.73–2.17) 0.037
6-moCA 1.85 (1.67–2.25) 1.53 (1.39–1.63) <0.001
Vitamin A, IU/kg
2-moCA 555.66 (294.81–779.81) 219.66 (165.33–357.06) 0.004 320–700
4-moCA 476.99 (301.20–665.91) 209.63 (185.04–238.95) <0.001
6-moCA 389.03 (227.10–521.58) 202.24 (191.11–221.02) 0.035
Vitamin D, IU/kg
2-moCA 107.98 (45.14–145.78) 50.00 (36.09–71.00) 0.007 60–160
4-moCA 91.19 (55.00–125.30) 42.72 (32.06–47.84) <0.001
6-moCA 73.23 (40.22–96.57) 40.78 (38.40–44.72) <0.001
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2-moCA 85.80 (63.95–88.95) 68.24 (63.17–69.86) <0.001 60–120
4-moCA 94.64 (78.61–100.08) 54.20 (51.76–57.94) <0.001
6-moCA 66.01 (49.04–69.60) 48.75 (45.77–49.87) 0.016
Phosphorus, mg/kg
2-moCA 40.43 (31.31–59.31) 33.13 (30.00–36.92) <0.001 35–60
4-moCA 71.31 (66.32–77.83) 32.29 (30.14–34.73) <0.001
6-moCA 44.35 (35.08–48.81) 30.30 (29.66–34.33) 0.018
Zinc, mg/kg
2-moCA 0.78 (0.70–0.84) 0.74 (0.70–0.78) 0.226 0.5–1
4-moCA 0.72 (0.64–0.79) 0.71 0.69–0.75) 0.451
6-moCA 0.67 (0.59–0.72) 0.64 (0.59–0.69) 0.572
Iron, mg/kg
2-moCA 4.95 (4.30–5.72) 4.37 (3.99–5.16) 0.080 2–4
4-moCA 5.02 (3.64–5.47) 5.30 (4.16–5.49) 0.411
6-moCA 4.73 (3.17–5.58) 4.51 (2.68–5.41) 0.231
Q1 = the first quartile, Q3 = the third quartile, PIs = preterm infants, RDA = recommended dietary allowance,
the upper limit is for PIs 37–40 weeks GA, the lower limit is for term infants at six months of age, no = number,
moCA = months corrected age, IU = international unit.
3.4. Infant Growth Outcomes
Compared to the comparison group, the intervention group showed significantly greater body
weight (p = 0.013) at 4- and 6-moCA and head circumference (p = 0.009) at 6-moCA (Figure 2).
However, no significant difference in length and weight gain velocity were observed between two
groups at any time point of age. Furthermore, a greater proportion of the intervention group reached
body weight greater than −2SD (Z score) at 4-moCA (81.8% vs. 45.5%, p = 0.027) and 6-moCA (90.9%
vs. 50.0%, p = 0.007) compared with their comparison counterpart. In addition, the intervention group
reached head circumference greater than −2SD (Z score) at 6-moCA (95.5% vs. 54.5%, p = 0.004)
compared to the comparison group (Table 7). On the other hand, no differences were observed for
length. Also, there was no over-standard growth or growth with higher +2SD (Z score) for body
weight, length, and head circumference in both groups. Moreover, there was no correlation between
HM feeding duration and any growth outcomes.
Figure 2. Anthropometric measurement of body weight, (a) and head circumference, (b) of the
intervention and comparison group (n = 22). Data are reported as unadjusted mean ± SD. * denote
a significant difference between groups at a specific time point with intervention greater than the
comparison group (body weight at 4-moCA, p = 0.001, and 6-moCA, p < 0.001; head circumference at
6-moCA, p < 0.001).
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(n = 22) p-Value
2-moCA, higher−2SD (Z score) in
Body weight 14 (63.6) 9 (40.9) 0.227
Length 15 (68.2) 8 (36.4) 0.069
Head circumference 17 (77.3) 10 (45.5) 0.062
4-moCA, higher−2SD (Z score) in
Body weight 18 (81.8) 10 (45.5) 0.027 *
Length, n (%) 17 (77.3) 10 (45.5) 0.062
Head circumference, n (%) 18 (81.8) 11 (50.0) 0.055
6-moCA, higher−2SD (Z score) in
Body weight 20 (90.9) 11 (50.0) 0.007 *
Length 17 (77.3) 11 (50.0) 0.116
Head circumference 21 (95.5) 12 (54.5) 0.004 *
moCA = months corrected age, −2SD (Z score) = −2SD line in Z score growth chart for newborn by World
Health Organization. Data are expressed as number of cases (percentage). The difference between intervention
and comparison group was determined by chi-square test. * refers to statistical significance.
4. Discussion
The current study found an increase in the proportion of infants who were underweight
(after adjustment for gestational age) in both groups; 4.5% at birth and 86.3% at discharge for the
intervention group and 9.1% at birth and 86.9% at discharge for the comparison group. The results may
indicate that early protein and energy deficits were not recovered during hospital admission regardless
of the groups. Our findings were consistent with previous studies [4,8,9,44,45] and the present study
suggested a difficulty of preventing SGA among VLBW preterm infants during hospital admission.
The present study showed differences in anthropometric variables of fortified HM and/or EF
fed versus HM alone and/or TF fed VLBW preterm infants from discharge to 6-moCA. The results
indicated that the intervention group had significantly greater weight at 4- and 6-moCA and head
circumference at 6-moCA compared to the comparison group. These results indicated the usefulness
of the PIN program to compensate for energy and nutritional deficits which VLBW preterm infants
experienced during their hospital stay and better recovery using fortified HM and/or EF. While there
are controversies in beneficial effects of both fortified HM and enriched formula on growth parameters
in preterm infants at post-discharge [7,18,46], the results from the current study were consistent with
other studies that observed better recovery in infants who received energy and nutrient-enriched HM
or formula at early hospital discharge [47–50].
In addition, the results showed significant differences in a proportion of infants reaching standard
weight at 4- and 6-moCA, and head circumference at 6-moCA while no difference was observed
at 2-moCA. This result showed that the PIN program may be effective in shortening the period of
post-discharge growth restriction by 4-moCA without rapid acute effects. Casey, et al. [45] reported
that achieving optimal catch-up growth during a post-natal period, especially by six months after term,
will significantly result in better neurodevelopmental outcomes from 18 months to 6 years compared
with those who achieved catch-up growth later. Considering suggestion by Casey, et al. [45], the PIN
program that provides adequate nutrition to preterm infants during such a critical period may have
beneficial impact on both short- and long-term health in this particular population.
Consistently, the nutrient intakes of infants with fortified HM and EF during study period
were greater and more consistent with current dietary recommendations [15,23] than infants with
unfortified HM and/or TF. These findings may attribute to the effect of enriching HM and formula
to increase energy and protein intake. In addition, MVD, Ca, and P supplementation prescribed
at a follow-up clinic according to the study protocol resulted in significantly higher intake of these
nutrients. However, iron and zinc intakes did not differ between groups. This may be because of
132
Nutrients 2016, 8, 820
a similarity in iron and zinc supplementation practices in both groups. The results also showed a
greater volume of human milk and the proportion of feed volume in the intervention group at 6-moCA.
However, based on the obtained results, we interpreted the results as due to higher consumption of
energy and protein that contained in enriched HM rather than increased volume.
While the PIN program included an education for mothers about benefits of breastfeeding before
infant discharge, the present study did not show improvement in feeding duration between the groups
and, in fact, was shorter than a previous study that reported a proportion and duration of exclusive HM
feeding [20]. The results may indicate insufficient and inadequate lactation support of the PIN program
to overcome problems that mothers experienced at post-discharge. Although the PIN program made
more frequent home visits compared to the conventional service, the content including educational
tools delivered prior to discharge and at each home visit should be adjusted as well as increasing
involvement of lactation experts and frequencies of both on-site and distant counseling opportunities.
In addition, the current study may indicate a presence of additional issues that prevent mothers from
continuing HM feeding after discharge. As a result, further research may be warranted to evaluate
factors that influence mothers to continue feeding HM to their child.
Study Limitations
Limitations of the current study included using the historical comparison group which contributed
to slightly to differences in composition of TF formula intake. In addition, some data deviations might
occur, such as an estimation of breast milk volume intake in some breastfed infants due to inadequate
skill of test-weighing procedure in some mothers. Next, the currently applied inclusion and exclusion
criteria also limited the extrapolation of the observations as documented in this cohort to all cases.
Furthermore, except Hct, we cannot compare the nutritional status of biochemical blood test from 1- to
6-moCA. The main reason is that for the historical group, there were no regular biochemical blood
tests after discharge at the follow-up clinic visit in the previous routine practice. The small sample size
limits the interpretation and generalization of these results. Further studies are recommended in this
area. Lastly, we use non-randomization to evaluate the program, resulting from a limitation of number
of participants in a research setting.
5. Conclusions
Enlistment in a PIN program with enriched HM and formula feeding from hospital discharge to
6-moCA resulted in significantly reduced post-discharge growth restrictions for VLBW preterm babies
compared to those who received unfortified HM and TF in conventional practices. Regular monitoring
is needed to educate mothers or caregivers not to under- or overfeed their infants. Further lactation
support and developed maternal education programs are needed to encourage continued HM feeding
after discharge. Further studies are warranted with concurrent comparison groups and a longer
follow-up period to analyze infant growth, neurodevelopment, and body composition.
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Abstract: We previously compared infant outcomes between a powdered human milk fortifier
(P-HMF) vs. acidified liquid HMF (AL-HMF). A non-acidified liquid HMF (NAL-HMF) is now
commercially available. The purpose of this study is to compare growth and outcomes of premature
infants receiving P-HMF, AL-HMF or NAL-HMF. An Institutional Review Board (IRB) approved
retrospective chart review compared infant outcomes (born < 2000 g) who received one of three
HMF. Growth, enteral nutrition, laboratory and demographic data were compared. 120 infants were
included (P-HMF = 46, AL-HMF = 23, NAL-HMF = 51). AL-HMF infants grew slower in g/day
(median 23.66 vs. P-HMF 31.27, NAL-HMF 31.74 (p < 0.05)) and in g/kg/day, median 10.59 vs.
15.37, 14.03 (p < 0.0001). AL-HMF vs. NAL-HMF infants were smaller at 36 weeks gestational
age (median 2046 vs. 2404 g, p < 0.05). However AL-HMF infants received more daily calories
(p = 0.21) and protein (p < 0.0001), mean 129 cal/kg, 4.2 g protein/kg vs. P-HMF 117 cal/kg, 3.7 g
protein/kg , NAL-HMF 120 cal/kg, 4.0 g protein/kg. AL-HMF infants exhibited lower carbon dioxide
levels after day of life 14 and 30 (p < 0.0001, p = 0.0038). Three AL-HMF infants (13%) developed
necrotizing enterocolitis (NEC) vs. no infants in the remaining groups (p = 0.0056). A NAL-HMF is
the most optimal choice for premature human milk-fed infants in a high acuity neonatal intensive
care unit (NICU).
Keywords: human milk; fortifier; premature infant; enteral nutrition; growth; acidosis;
necrotizing enterocolitis
1. Introduction
Premature infants have significantly increased nutrient needs compared to those born at term [1].
Nutrition-related goals for these infants must aim at promoting similar nutrient provision and growth
as that achieved in utero. Providing human milk remains a preferable nutrient source over customized
premature infant formulas, but alone remains inadequate to meet the high nutritional needs for
rapid growth and development. Long term provision of unfortified human milk has been linked to
suboptimal growth, poor bone mineralization, and multiple nutrient deficiencies of vitamins, minerals,
and trace elements [1]. As a result, human milk fortifiers (HMF) are used to significantly enhance
calorie, protein, vitamin, and mineral intake of the human milk fed premature infant.
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Enteral macronutrient recommendations for premature infants vary according to size.
The American Academy of Pediatrics on nutrition suggests 130–150 calories/kilogram (kg) and 3.8–4.4
g protein/kg/day for infants weighing <1000 g, and 110–130 calories/kg and 3.4–4.2 g protein/kg/day
for infants weighing between 1000 and 1500 g [2]. Protein is highly emphasized as high adequate
provision has been correlated with improved growth and neurodevelopment [3–6]. To achieve enteral
protein goals, powdered or liquid protein modulars may be added alongside HMF to optimize
overall nutrition.
Human milk fortifiers are available in many different compositions, specifically varying in protein
type, protein amount, and form (powder vs. liquid). However if available, the Food and Drug
Administration strongly recommends the use of liquid products over powder in the neonatal intensive
care unit (NICU) setting in an effort to reduce contamination and infection risk [7]. Our unit originally
used a powdered HMF, but transitioned to liquid form when they became commercially available.
Previously, we published a study comparing two HMF used in our unit, one being a powder (P-HMF)
and one being an acidified liquid (AL-HMF) [8]. Our results demonstrated that the acidified product,
though sterile, caused more metabolic acidosis and poor growth in our population of premature
infants. Infants receiving the AL-HMF also had a higher incidence of necrotizing enterocolitis (NEC),
though we were not powered to find this. Our unit has now transitioned to using a non-acidified
liquid fortifier (NAL-HMF). The purpose of this study is compare growth and clinical outcomes of
infants receiving this new HMF to the previous two fortifier groups.
2. Patients and Methods
2.1. Participants and Data Collection
The institutional review board at the University of Nebraska Medical Center (Omaha, NE, USA)
approved this study. Data was retrospectively collected from inpatient electronic medical records of all
infants admitted to the NICU between August 2012 and July 2014 if they met the following criteria;
birth weight (BW) < 2000 g, received at least 25% of enteral feedings as fortified human milk (with the
NAL-HMF) during their NICU stay, and remained in the NICU at least 14 days. Exclusion criteria
included infants with congenital abnormalities or conditions that inhibited growth, such as Trisomy
13. No infants were excluded based on clinical acuity, intrauterine growth restriction, APGAR score,
or ventilator requirements.
Data on the P-HMF and AL-HMF groups was previously collected for infants admitted to the
NICU between October 2009 and July 2011. The AL-HMF group contained a lower number of included
infants due to this HMF being used for a limited time period. Six investigators familiar with the
electronic medical record obtained all data for the NAL-HMF group in a similar manner as the original
groups. Data was reviewed closely for accuracy and corrected if an electronic error occurred. Available
data on each infant was included in the analysis and is displayed in the tables.
2.2. Demographics and Clinical Outcomes
Demographic information was collected for all infants including gender, gestational age at birth
and discharge, and day of life (DOL) at discharge. Additional clinical outcomes were collected as
available including presence of bronchopulmonary dysplasia (BPD) defined as oxygen requirement
at 36 weeks estimated gestational age (EGA), retinopathy of prematurity (ROP) Stage 2 or greater,
Grade 3 or 4 intraventricular hemorrhage (IVH), NEC, and death. Treatment requirements were also
analyzed including need for intraventricular shunt, ROP procedure, and Dexamethasone use.
2.3. Growth and Nutrition
Infants were weighed daily on a gram (g) scale, and length and head circumference measurements
(cm = centimeters) were taken weekly using a measuring tape by nursing staff. Percentile rankings from
the Fenton growth chart were electronically plotted for each documented measurement. Weight, length,
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and head circumference measurements were recorded for infants at birth and 36 weeks EGA if still
hospitalized. An EGA of 36 weeks was empirically selected as an equivalent point of analysis for
growth prior to discharge.
Enteral feeding data collected included DOL enteral feedings were initiated and DOL full enteral
feedings were reached. Full enteral feedings was defined as the infant receiving at least 140 milliliters
(mL)/kilogram (kg)/day of fortified enteral feedings and no parenteral nutrition. Average calorie
and protein intake measured in per kg/day was analyzed for infants who received at least 50% of
their feedings as fortified human milk during NICU stay. Intake was analyzed from the start of full
feedings until the HMF was discontinued or the infant received <50% of feedings as fortified milk.
Growth as measured in g/day and g/kg/day was calculated for infants during the time of reaching
full enteral feedings until they received <50% of feedings as fortified milk. Maximum caloric density of
feedings was recorded for each infant. Number of days on caloric densities higher than the standard 24
calories/ounce was collected for infants requiring more to maintain growth chart percentiles for weight.
Nutrient provision was captured by an electronic medical system (Intuacare), which contained protein
references based on the caloric density of specified formulas or fortified human milk. Nursing staff
recorded daily intake (in mL) of specified feedings, and daily calorie and protein per kilogram was
electronically calculated using the daily recorded weight. The electronic system also calculated the
percentage of human milk vs. infant formula received according to nursing documentation.
2.4. Comparison and Use of Human Milk Fortifiers
Comparison of ingredients and key HMF nutrients are listed in Table 1 according to online
nutritional references [9–11].
Table 1. Comparison of primary nutrients and ingredients of the powdered, acidified liquid, and
non-acidified liquid HMF.
24-Calorie-Per-Ounce Fortified Human Milk [9–11]
Per 100 mL P-HMF AL-HMF NAL-HMF
Protein (g) 2.35 g 3.2 g 2.34 g
Iron (mg) 0.46 mg 1.85 mg 0.46
Calcium (mg) 138 mg 141 mg 138
Phosphorus (mg) 78 mg 78 mg 77
Vitamin D (IU) 119 IU 200 IU 118
pH — 4.7 —
Osmolality








water, whey protein isolate hydrolysate
(milk), medium chain triglycerides
(MCT oil), vegetable oil (soy and high
oleic sunflower oils)




– Information not available. P-HMF, powdered human milk fortifier; AL-HMF, acidified liquid HMF; NAL-HMF,
non-acidified liquid HMF.
Enteral feeding are initiated in this NICU as soon as able following birth, within the first one
to three days of life using maternal breast milk (MBM) as available or donor human milk (from the
Milk Bank of Austin, Texas) at 20 mL/kg/day. Trophic feedings are continued for three to five days
at the discretion of the attending neonatologist. Feedings are then advanced by 20 mL/kg/day and
HMF is added when enteral volumes feedings reach 80–100 mL/kg. A protein modular is also added
once caloric densities reach 24 calories/ounce to optimize protein intake to approximately 4 g/kg/day.
The calories provided from the protein modular are accounted for in the calorie-per-ounce estimates.
The P-HMF group received a powdered protein modular and the NAL-HMF group received a liquid
protein modular. No additional protein modular was provided to infants receiving the AL-HMF
due to higher protein content of the fortifier. All infants are transitioned off of donor human milk to
24 calorie/ounce high protein (3.5 g protein per 100 calories) premature infant formula at 14 days
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of life if a supplement to MBM is needed. We did not analyze differences in donor human milk use
between groups because it is only used for a short period after birth and is provided to all infants
in a similar manner. There were no other nutrition practice changes during the periods of different
fortifier use. Our unit follows a written feeding protocol, so nutrition is managed closely and remains
consistent among providers.
2.5. Laboratory Measurements
Lowest carbon dioxide (CO2) lab values were collected after DOL 14 and 30 for all infants,
if available. Values were not collected prior to eliminate values reflective of parenteral nutrition
support and unfortified enteral feedings. Maximum blood urea nitrogen (BUN) while on full enteral
feedings was additionally collected.
2.6. Data Analysis
The Kruskal Wallis test was used to compare continuous data between the three HMF groups.
If the overall p-value was significant, indicating a significant difference between at least two of the
three groups, the Dunn’s post hoc test for three pair wise comparisons (i.e., Group 1 vs. 2, Group 1
vs. 3, Group 2 vs. 3) was performed. Associations of categorical variables were assessed with the
Fisher’s exact test. Time to weaning off oxygen distributions were estimated using the method of
Kaplan and Meier and were compared using the log-rank test. A p-value < 0.05 was considered
statistically significant.
To assess the difference in growth patterns between infants, a mixed effects model was used.
We included random slopes and intercepts for each subject to capture individual growth pattern as
well as fixed effects for group and day and a group day interaction term. A significant interacting
of day and group indicated differing growth patterns based on group. Growth Velocity (GV) was
calculated using the following equation [12]:
GV “ r1000 ˆ lnpWn{W1qs{pDn ´ D1q (1)
Where Wn refers to the weight on the last evaluated day; W1 refers to the first weight; Dn refers to
the last day of the time period evaluated and; D1 refers to the first day of the time period evaluated.
3. Results
There were 46 infants in the P-HMF, 23 in the AL-HMF, and 51 in the NAL-HMF groups.
There were no significant differences in gender (p = 0.6) or baseline characteristics as shown in Table 2.
Clinical outcomes are displayed in Table 3. Laboratory, growth, and nutrition data are displayed in
Table 4.
Table 2. Baseline characteristics of subjects by group.
Variable P-HMF (Group 1) AL-HMF (Group 2) NAL-HMF (Group 3) Overall p-Value
n Median n Median n Median
EGA at Birth 46 29.15 22 31.00 51 29.60 0.15
Birth Weight (g) 46 1305 22 1481 51 1340 0.21
Weight at 36 Weeks EGA (g) 44 2179 18 2046 50 2404 0.0092Group 2 vs. 3 p < 0.05
Birth Length (cm) 46 39 22 41 51 39 0.14
Length at 36 Weeks EGA (cm) 42 44.5 18 43.5 47 44 0.38
Birth HC (cm) 46 27 22 27.75 51 27.5 0.53
HC at 36 Weeks EGA (cm) 42 32.5 18 31.75 47 32.2 0.55
EGA = Estimated Gestational Age; HC = Head Circumference.
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(Group 3) n = 51 Overall p-Value
n (%) n (%) n (%)
NEC 0 3 (13%) 0 0.0056
ROP 16 (35%) 3 (13%) 4 (8%) 0.0030Group 1 vs. 3, p = 0.006
ROP Procedure 3 (7%) 2 (9%) 1 (2%) 0.24
IVH (Grade 3 or 4) 3 (7%) 1 (5%) 4 (8%) 1.00
Intraventricular Shunt 0 0 0 N/A
Dexamethasone Treatment 9 (20%) 1 (5%) 7 (14%) 0.29
Death 0 0 1 (2%) 1.00
BPD 10/40 (25%) 4/18 (22%) 16/49 (33%) 0.65









n Median n Median n Median
Mean Daily Calorie Provision (per kg) 42 117 18 129 48 120 0.21
Mean Daily Protein Provision (g/kg) 42 3.7 18 4.2 48 4.0
0.0001
Group 1 vs. 2 and
Group 2 vs. 3, p <0.05
Day of Life Feedings Started 46 1 22 1 51 1 0.0019Group 1 vs. 3 p < 0.05
Day of Life Full Feedings Achieved 46 12 22 10 51 9 0.0007Group 1vs. 3 p < 0.05
Growth on HMF (g/day) 45 31.27 21 23.66 49 31.74
0.0001
Group 1 vs. 2 and
Group 2 vs. 3, p < 0.05
Growth on HMF (g/kg/day) 45 15.37 21 10.59 49 14.03
<0.0001
Group 1 vs. 2 and
Group 2 vs. 3, p < 0.05
BUN Maximum on Full Feedings 33 17 17 19 47 16 0.43
CO2 Minimum after DOL 14 33 23 17 19 32 27
<0.0001
Group 1 vs. 3 and
Group 2 vs. 3, 0.05
CO2 Minimum after DOL 30 23 25 9 20 18 25.5
0.0038
Group 1 vs. 2 and
Group 2 vs. 3, p < 0.05
3.1. Clinical Outcomes
All laboratory data analyzed for this study was collected for clinical purposes. Median lowest
C02 levels while on full enteral feedings were significantly lower in the AL-HMF group compared to
the other two groups after both DOL 14 and DOL 30 (p < 0.0001, p = 0.0038). Maximum BUN levels on
full enteral feedings were similar among all groups and were not statistically significant.
The incidence of NEC was significantly higher in the AL-HMF group compared to the P-HMF
and NAL-HMF groups (13% vs. 0% and 0%, p = 0.0056), though we were not powered to evaluate
this variable. Incidence of ROP was significantly higher among the P-HMF than the NAL-HMF group
(35% vs. 8%, p = 0.003). There were no differences in rates of BPD or IVH (Grade 3 or 4) among
all groups.
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3.2. Enteral Growth and Nutrition
Growth, as measured in both g/day and g/kg/day, was statistically significant between groups.
More specifically, infants in the AL-HMF group grew slower than infants in the P-HMF and NAL-HMF
groups. Median growth in g/day from start of full enteral feedings until 36 weeks EGA was 23.66,
compared to 31.27 in the P-HMF and 31.74 in the NA-LHMF group (p = 0.0001). Median growth in
g/kg/day was 10.59 in the AL-HMF group, compared to 15.37 and 14.03 respectively (p < 0.0001).
Infants in the AL-HMF group were smaller at 36 weeks EGA compared to the NAL-HMF group
(median 2046 g vs. 2404 g, p = 0.0092), though there were no differences in length or head circumference.
There were no differences in Dexamethasone use among groups (p = 0.15) that may account for reduced
growth. Infants in the NAL-HMF group started enteral feedings and achieved full enteral feedings
faster than the P-HMF group (p = 0.0019, p = 0.0007), but these infants achieved similar growth.
Among infants receiving >50% of their feedings during NICU stay as fortified human milk ,
infants in the AL-HMF group received more protein at mean 4.2 g/kg/day compared to 3.7 and
4.0 g/kg/day in the P-HMF and NAL-HMF groups (p < 0.0001). These infants also received a higher
mean calorie intake at 129 calories/kg, compared to 117 and 120 calories/kg, respectively, though this
was not significant (p = 0.21).
There were no differences in maximum caloric density of enteral feedings (p = 0.6) or the number
of days on feedings >24 calories/ounce (p = 0.21). Noted however, is that 48% of infants in the AL-HMF
group received enteral feedings >24 calorie/ounce compared to 26% in the P-HMF group and 35% in
the NAL-HMF group.
4. Discussion
Our previous research analyzing the P-HMF and AL-HMF suggested the P-HMF was the more
optimal choice in promoting best clinical outcomes [8]. Now comparing data among all three fortifier
groups, the NAL-HMF appears to be the most successful fortifier for use in a high acuity NICU
population. Despite achieving adequate similar growth, the NAL-HMF is more desirable than the
P-HMF due to its composition as a sterile liquid. When compared to the AL-HMF, the NAL-HMF
promoted greater growth and was not associated with metabolic acidosis or NEC.
4.1. Growth and Enteral Nutrition
Appropriate growth was best achieved among the NAL-HMF and P-HMF groups when
comparing both g/day and g/kg/day weight gain. Infants receiving the NAL-HMF attained the
highest weight among all three groups at 36 weeks EGA, demonstrating most significance when
compared to the AL-HMF group (median 2046 g vs. 2404 g, p < 0.0092). In further comparison of this,
the median length and head circumference for both the acidified and non-acidified liquid group at this
point plotted between the 25%–30% on the Fenton growth chart. By comparison of median weights
at 36 weeks, the NAL-HMF group plotted around the 18% and the AL-HMF group plotted at the
5th. This demonstrates that infants receiving the NAL-HMF were able to achieve a more proportional
weight-for-length ratio. Though we did not directly assess infant acuity level between groups, we do
not suspect this to be a significant factor for decreased growth given the AL-HMF group having similar
baseline characteristics as the other groups.
As growth remains a high priority, infants with suboptimal growth were fed enteral feedings
with caloric densities >24 calories/ounce. Suboptimal growth was determined by clinical evaluation
when an infant was unable to maintain growth percentiles for weight. Despite decreased growth,
more infants in the AL-HMF (48%) group required increased caloric density of feedings compared
to the P-HMF (26%) and NAL-HMF (35%) groups, p = 0.6. The AL-HMF group also received higher
mean calorie intake compared to the other two groups. Had no infants been advanced to increased
caloric densities, it is likely that the discrepancy of growth between the AL-HMF and the remaining
two groups would have been of even greater significance. It may be theorized that additional enteral
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additives and higher caloric densities contributed to a higher incidence of NEC in the AL-HMF group.
However, our previously low recorded rate of NEC at 3% is reflective of similar fortification practices to
achieve desired growth [13]. Despite individual theories for these NEC occurrences, we must address
why the additional additives were required in the first place to achieve adequate growth.
In additional to increased calories, infants in the AL-HMF group also received a higher mean
protein intake compared to the other groups. Higher protein provisions have been linked to improved
growth, yet these infants exhibited poor weight gain. We hypothesize that the acidification of the
AL-HMF may be the explanatory factor in this conundrum. A study by Erickson et al. concluded that
acidifying human milk resulted in 14% decrease in protein and a 56% decrease in lipase activity [14].
This may result in partial fat malabsorption and resulting poor energy intake. A recent study by
Cibulskis and Armbrecht comparing infants receiving an acidified vs. powdered HMF did not
report significant growth differences in weight, length, or head circumference between birth and
discharge [15]. However, growth measured in g/day while on the HMF approached significance
as infants receiving the acidified HMF grew slower (22.3 vs. 19.2 g/day, p = 0.08). In comparison,
Moya et al. reported no discrepancies in weight gain when comparing infants ď1250 g receiving either
an acidified or powdered HMF, and further reported that infants receiving the acidified HMF had
improved linear growth [16]. Limitations of this study, however, include that protein modulars were
used infrequently among infants, so baseline protein provisions were higher in the acidified HMF
group. This study also excluded infants with low APGAR scores and higher respiratory requirements
so may not be applicable to the most fragile infants.
4.2. NEC
The only infants who developed NEC received the AL-HMF. Though not statistically powered to
find NEC, the results raise concern from a clinical standpoint. Our feeding practices have remained
consistent outside of which HMF was used, and we have documented low baseline rates of NEC
on these feeding practices [13]. Feeding initiation and advancement remained fairly consistent
across all three groups. While infants in the NAL-HMF group achieved full feedings more quickly,
none developed NEC. Formula was utilized equally in all groups when MBM was limited and donor
human milk was weaned.
The primary differences in enteral feedings between all fortifier groups are the acidity, high
protein, and high iron content of the AL-HMF. Theoretically, infants receiving the AL-HMF had a
reduced risk for cross-contamination due to the HMF composition as a sterile liquid and because
additional enteral substrates (protein modular, iron) were not required. These infants also received
lower osmolality feedings at baseline, and furthermore as additional supplements were not required
due to the high iron and protein in the AL-HMF. A study by Chan suggests that a high iron-containing
HMF compared to a low iron-containing HMF negates the antimicrobial effects of human milk against
the growth of E. coli, Staphylococcus, Enterobacter, and Streptococcus [17]. Erickson et al. also noted a
reduced white cell count by 76% in human milk acidified to a pH of 4.5, questioning if this decreases
an infant’s host defense [14]. The AL-HMF used in our study acidifies milk similarly to a pH of 4.7.
We must consider if the protective effects of human milk were compromised in infants receiving the
AL-HMF, making them more susceptible to infections. A limitation to this theory is that we did not
analyze the incidence of sepsis between groups. As the cause of these NEC occurrences remains
unknown, we can neither confirm nor exclude use of the AL-HMF as a primary contributor.
4.3. Acidosis
There was a higher incidence of metabolic acidosis in the AL-HMF group compared to the other
two groups. As discussed in our previous study, premature infants are at risk for developing metabolic
acidosis secondary to immature renal and metabolic processes [8]. There were no significant differences
in baseline characteristics such as birth weight or gestational age to suggest any of the three groups
included infants that were smaller or born more prematurely, and therefore more obviously susceptible
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to acidosis. We do not suspect protein provision as a contributor to acidosis. While infants receiving
the AL-HMF received higher daily protein (p < 0.001), mean values remained within the reference
ranges for very low birth weight infants of 3.4–4.4 g protein/kg/day [2]. BUN levels also remained
similar among groups.
While the P-HMF and NAL-HMF do not have defined pH values as shown in Table 1, we suspect
they have limited effects on the final pH of fortified milk, unlike the AL-HMF. Considering a similar
baseline of other characteristics, we again hypothesize that the acidification of the AL-HMF contributed
to this metabolic imbalance. Our results are concurrent with Cibulskis and Armbrecht who reported a
higher incidence of metabolic acidosis (54% vs. 10%) in infants <32 weeks EGA or <1500 g receiving
an acidified vs. powdered HMF [15]. Moya et al. also reported a lower pH at day of life 14 (p = 0.004)
and lower carbon dioxide levels at both day of life 14 (p < 0.001) and 30 (p = 0.021) in infants ď1250 g
receiving an acidified HMF [16].
Development of metabolic acidosis may also contribute to altered weight gain and poor nutritional
consequences. A small study by Rochow et al. reported lower weight gain (median 9 vs. 21 g/kg/day,
p < 0.01) in infants <34 weeks EGA who developed metabolic acidosis compared to those who remained
unaffected [18]. It was also reported that infants who developed metabolic acidosis had a lower bone
density at discharge. Likewise, an early study by Kalhoff et al. analyzed urinary excretion of minerals
in premature infants, concluding that a higher amount of calcium and phosphorus is excreted during
metabolic acidosis [19]. Resultantly, we suggest using a NAL-HMF to provide appropriate growth,
without increasing risk for metabolic acidosis and suboptimal nutrient accretion.
4.4. Strengths and Limitations
This study is the first to quantify nutrition and growth outcomes of three HMF in a Level IIIc
NICU. We did not exclude infants based on acuity, such as presence of IVH, need for high ventilatory
settings, or low APGAR scores. Our high inclusion is more reflective of a standard NICU population,
and therefore provides genuine outcomes for both high and moderate acuity infants. This is both
relevant and applicable to current NICU settings. Nutrition is managed closely and consistently in our
unit, and our current nutrition practices have been published demonstrating excellent growth and low
baseline rates of NEC [13]. Additionally unique to our study is the use of protein modulars to provide
infants similar protein provisions at baseline (approximately 4 g protein/kg/day when receiving
120 calories/kg/day), and reducing this as a significant confounding factor across fortifier groups.
Limitations of this study include that it is retrospective, and there is a limited number of subjects
in the AL-HMF group due to its short term use. Additionally included is our reliance on electronic
documentation for data collection, as we cannot quantify unrecorded or misrecorded data. However,
the system does allow for review of daily entered data for each subject if needed. Evaluation of head
circumference and length measurements may vary among nursing staff due to differences in measuring
tape placement. Additionally, growth measurements were unavailable for infants discharged prior
to 36 weeks EGA. Growth at 36 weeks EGA may also be partially reflective of formula use if MBM
was no longer available. However, it may also provide indication of early growth failure while on
MBM if growth percentiles are low or fall drastically from those at birth. The calculated provision for
calories and protein in fortified human milk were estimated according to manufacturer information
for each HMF. These may only serve as general estimates for our comparisons as the composition of
human milk varies continuously. While standard NICU practices remain consistent, feedings may be
advanced differently based on each infant’s clinical status. Length of trophic feedings may also impact
the day of life to achieving full enteral feedings. As in our previous study of the original two fortifiers,
NEC was statistically significant despite our limited power to find this.
5. Conclusions
The NAL-HMF is an appropriate choice for use in a high level NICU. Caution should be taken
when using an acidified HMF due to its potential effects on growth, tolerance, and metabolic acidosis.
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Abstract: Human breast milk (BM) protein composition may be impacted by lactation stage
or factors related to geographical location. The present study aimed at assessing the temporal
changes of BM major proteins over lactation stages and the impact of mode of delivery on immune
factors, in a large cohort of urban mothers in China. 450 BM samples, collected in three Chinese
cities, covering 8 months of lactation were analyzed for α-lactalbumin, lactoferrin, serum albumin,
total caseins, immunoglobulins (IgA, IgM and IgG) and transforming growth factor (TGF) β1 and β2
content by microfluidic chip- or ELISA-based quantitative methods. Concentrations and changes
over lactation were aligned with previous reports. α-lactalbumin, lactoferrin, IgA, IgM and TGF-β1
contents followed similar variations characterized by highest concentrations in early lactation that
rapidly decreased before remaining stable up to end of lactation. TGF-β2 content displayed same
early dynamics before increasing again. Total caseins followed a different pattern, showing initial
increase before decreasing back to starting values. Serum albumin and IgG levels appeared stable
throughout lactation. In conclusion, BM content in major proteins of urban mothers in China was
comparable with previous studies carried out in other parts of the world and C-section delivery had
only very limited impact on BM immune factors.
Keywords: breast milk; proteins; immune factors; Chinese mothers; CAESAREAN-section
1. Introduction
Evolution has shaped human breast milk (BM) composition to protect the infant against disease(s)
and to supply their nutritional needs [1]. BM proteins are one of the major contributors to this dual role
in early infancy. BM proteins are the primary source of amino acids required for body protein building
and can facilitate nutrient digestion as well as increase their bioavailability. BM proteins can also act as
immunologically active molecules able to confer passive protection against pathogens, to stimulate the
infant’s antimicrobial defences or to modulate the infant immune maturation and responses [2–4].
More than 2500 distinct protein sequences have been identified in BM [5]. The most abundant
BM proteins include lactoferrin, α-lactalbumin, serum albumin and the β- and κ-casein fractions,
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collectively representing about 85% of total BM proteins [6]. Multiple biological activities have been
proposed for lactoferrin, and possibly the best documented effect in the infants is protection against
gastrointestinal infections [7]. Similarly, a multimeric α-lactalbumin-lipid complex (HAMLET) found in
BM has potent pro-apoptotic effects on bacterial [8] and tumoral cells, while sparing healthy eukaryotic
cells [9]. By contrast, serum albumin and caseins likely have a predominantly nutritional role as
opposed to lactoferrin, and these proteins appear to be readily digested by the infant gastrointestinal
proteases. Nevertheless, some biological activities have been proposed for the peptides produced
during the digestion of these proteins [10]. For example, antibacterial activity has been found upon
gastric digestion of β-casein in infants [11].
Immune factors are also important BM components, representing up to 10% of total proteins.
Immunoglobulins (Ig) and members of the transforming growth factor (TGF)-β family are the most
studied key partners of the immunological activity found in colostrum, transitional and mature
milk, ensuring transfer of passive immunity from mother to offspring [12], as well as supporting the
onset of gut homeostasis in the neonate [13–17]. IgA, or more precisely secretory IgA, is the major
isotype found in BM, followed then by IgM and IgG. Its dynamic of secretion over lactation period
has been investigated in several studies, showing high content in colostrum, followed by a rapid
diminution during transition milk to then remain stable in mature milk [18,19]. The TGF-β family
constitutes the most abundant cytokines of BM and consists of three isoforms, of which TGF-β2
predominates, followed by TGF-β1 [20]. Data on the changes of the secretion over lactation period of
these two cytokines are more limited than for Igs, but tend to show overall similar patterns [21].
Infants born by Caesarean section (C-section) suffer from an associated increased risk of
development later in life of immune-related diseases [22–24]. These alterations are commonly attributed
to altered microbiota colonization patterns in those infants due to the absence of the initial inoculation
of maternal vaginal and faecal microbiota [22]. However, potential impact of delivery mode on
BM-related immune parameters may also be an important contributing factor. Indeed, data available
from several studies indicate a delayed onset of lactation following C-section [25,26] preventing the
new-born to gain prompt access to beneficial components of BM. In contrast, little is known about
the impact of C-section delivery on BM composition and in particular on the milk immune factors.
Current data from studies focusing on immunoglobulin content in colostrum samples do not allow
us to draw a clear conclusion on a potential impact of the mode of delivery on the presence of these
antibodies in the BM [4,27]. To our knowledge, no data are currently available on the effect of C-section
delivery on major BM immune factors throughout transitional and mature milk.
Hence, the main objective of the present work was to assess the specific temporal changes of major
proteins’ content in BM across different stages of lactation, with a secondary interest in exploring the
impact of the mode of delivery on BM immune factors. This work was performed in China, a country
presenting one of the highest rates of C-section birth in the world [28], and is part of the larger Maternal
Infant Nutrition Growth (MING) initiative, conducted in a large cohort of urban Chinese mothers [29].
2. Materials and Methods
2.1. Subjects
This study was part of MING, a cross-sectional study designed to investigate the dietary
and nutritional status of pregnant women, lactating mothers, infants and young children up to
three years of age living in urban areas of China. In addition, the BM composition of Chinese
lactating mothers was characterized for major proteins and immune factors. The study was conducted
between October 2011 and February 2012. A multi-stage BM sampling from lactating mothers in
three cities (Beijing, Suzhou and Guangzhou) was performed for BM characterization. In each city,
two hospitals with maternal and child care units were selected and, at each site, mothers at lactation
period 0–240 days were randomly selected based on child registration information. Subjects included
in the period 0–5 days were recruited at the hospital whereas the other subjects were requested by
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phone to join the study; if participation was dismissed a replacement was made. Response rate was
52%. Recruitment and BM sampling, as well as baseline data collection, were done on separate days.
A stratified BM sampling of 540 lactating mothers in six lactation periods of 0–4, 5–11 and
12–30 days, and 1–2, 2–4 and 4–8 months were obtained in MING study. Nevertheless, only 450 BM
samples were analysed in the present study, as the 0–4 days stage could not be included due to the
limited volume of BM collected during this period.
2.2. Inclusion and Exclusion Criteria
Eligibility criteria included women between 18 and 45 years of age with singleton pregnancy,
apparently healthy, full-term infant and exclusively breastfeeding at least until 4 months post-partum.
Exclusion criteria included gestational diabetes, hypertension, cardiac diseases, acute communicable
diseases and postpartum depression. Lactating women who had nipple or lacteal gland diseases,
who had been receiving hormonal therapy during the three months preceding recruitment, or who
had insufficient skills to understand study questionnaires were also excluded.
2.3. Ethical and Legal Considerations
The study was conducted according to the guidelines in the Declaration of Helsinki. All of
the procedures involving human subjects were approved by the Medical Ethics Research Board of
Peking University (No. IRB00001052-11042, 15-11-2011). Written informed consent was obtained
from all subjects participating in the study. The study was also registered in ClinicalTrials.gov with
identifier NCT01971671.
2.4. Data Collection
All mothers completed a general questionnaire including socio-economic and lifestyle aspects.
Self-reported weight during pre-pregnancy and at delivery, number of gestational weeks at delivery,
and delivery method were also recorded. Additionally, a physical examination evaluated basic
anthropometric parameters (height, weight, mid-arm circumference) blood pressure and haemoglobin.
Data collection was done through face-to-face interviews, on the day of BM sample collection.
In addition, date of birth and gender information of the infant was collected after the data collection
since the data was not included in the initial questionnaires. Subjects were contacted by phone and
were asked to clarify these two aspects retrospectively.
2.5. Sample Characteristics
BM sampling was standardized for all subjects and an electric pump (Horigen HNR/X-2108ZB,
Xinhe Electrical Apparatuses Co., Ltd., Beijing, China) was used to sample the BM. Samples were
collected at the second feeding in the morning (9–11 a.m.) to avoid circadian influence on the outcomes.
Single full breast was emptied and an aliquot of 40 mL BM for each time point was secured for
characterization purposes. The rest of the BM was returned to the mother for feeding to the infant.
Each sample was distributed in 5 mL freezing tubes, labelled with subject number, stored at −80 ◦C
and then shipped to the Nestlé Research Centre (Lausanne, Switzerland) for analyses within 6 months
of collection.
2.6. Milk Sample Processing before Analyses
Frozen BM samples were skimmed by thawing to 4 ◦C, high speed centrifugation (2500× g for
10 min at 4 ◦C) and collection of the liquid fraction below the lipid phase. Each skimmed BM sample
was then aliquoted in separate microtubes (Eppendorf AG, Hamburg, Germany) and frozen again
until use. This aliquoting approach was put in place to avoid thawing-freezing cycles between the
different analytical runs for the BM immune factors of interest as one aliquot was then dedicated to
each analysis.
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2.7. Measurement of Major Breast Milk Proteins
The following major BM proteins were measured in all 450 BM samples: α-lactalbumin,
serum albumin, lactoferrin and all caseins. Due to the large number of samples, a classical approach
using, for example, gel electrophoresis or HPLC separation did not provide sufficient throughput
and speed. Therefore, an innovative microfluidic chip based quantitative method was specifically
implemented and validated for BM protein analysis. The method was established on a LabChip GX-II
instrument (Perkin Elmer, Waltham, MA, USA) allowing high-throughput analysis in a 96-well format.
The principle of this technique is based on traditional SDS-PAGE protein separation but the whole
procedure (separation, staining and detection) is integrated and fully automated in a microfluidic
system. Results are provided in digital format (no gel staining or scanning, etc.). The general approach
of this method was described previously [30] for bovine milk protein analysis and needed some slight
adaptations for the BM sample analysis as described below.
2.7.1. Sample Preparation
BM sample preparation was performed according to the LabChip (Perkin Elmer,
Waltham, MA, USA) protocol. A simple 5-fold dilution of BM with water (Merck Lichrosolv quality)
was found to be sufficient prior to protein denaturation and derivatization steps. In contrast to the
immune factor analysis by ELISA, BM defatting was not required for the LabChip analysis thus
avoiding potential protein losses. All sample preparation and processing steps were performed in
96-well format using electronic multichannel pipettes (Eppendorf Xplorer, Eppendorf AG, Hamburg,
Germany). The HT Protein Express protein chip and reagent kit (Perkin Elmer, Waltham, MA, USA)
was used for all analyses and highest purity reagents were required for all buffer preparations. Pure
human milk proteins (α-lactalbumin, serum albumin, lactoferrin from Sigma, St. Louis, MO, USA)
and bovine milk proteins (α-, β- and κ-casein from Sigma, as human proteins not available) were used
as standards to generate individual calibration curves for each protein. The purity of each standard
protein, according to the certificate of analysis, was used to calculate the true concentration of the
protein standard in solution. Reported limit of detection of the LabChip system is 5 ng/μL according
to the manufacturer. Calibration concentrations of the individual protein standards ranged from
25 to 750 ng/μL for serum albumin, from 50 to 1500 ng/μL for α-lactalbumin and lactoferrin, and from
100 to 3000 ng/μL for caseins. Note that as the individual casein proteins could not be fully resolved
on the LabChip system, all casein peaks were integrated as one peak and thus one value for total
casein concentration in BM was obtained (sum of α-, β- and κ-casein). In order to monitor system
performance, a quality control sample (pooled BM from Lee Biosolutions Inc., Maryland Heights,
MO, USA) was analyzed every 20th sample. All samples were analyzed in triplicates using a volume
of 25 μL of BM.
2.7.2. Method Validation
The method was validated for the determination of the four different proteins in human milk.
For each protein (α-, β- and κ-caseins measured as total casein) the linear response of the LabChip
detector was checked over the concentration range expected to be present in human milk samples.
Each protein was analyzed at 8 different levels in triplicate. A quadratic regression was performed and
linearity was assessed from the r2 and the plot of residuals.
To determine the trueness and precision of the method a milk sample was selected and spiked with
the protein standards at 3 levels (the levels were adapted for each protein to cover the concentration
range expected in milk). The non-spiked sample and the spiked samples were analyzed in duplicate
on 6 different days. The spike experiments were used to determine recoveries, data from the duplicate
analyses were used to determine repeatability (r) and data from the between day analyses were used
to determine intermediate reproducibility (iR).
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2.8. Measurement of Selected Breast Milk Immune Factors
Concentrations of IgA, IgG, IgM, TGF-β1 and TGF-β2 in BM samples were measured using
selected commercial ELISA quantification kits that were specifically validated for their usage in milk
matrix background. In more detail, IgA and IgG contents of BM were measured with Human IgA
and IgG ELISA Kits from Bethyl Laboratories Inc., USA (Montgomery, TX, USA) (catalogue numbers
E80-102 and E80-104, respectively), following manufacturer instructions and with milk samples tested
at 1:20,000 and 1:1000 dilutions, respectively. Kit performance with such dilution factors were for IgA
and IgG, respectively: average intra-plate repeatability 5% and 4.5%; average inter-plate repeatability
10.1% and 7.2%; average recovery 87% and 98%. IgM content was measured with the Human IgM
Ready-SET-Go from Affimetrix eBioscience, USA (Santa Clara, CA, USA) (catalogue number 88-50620)
following manufacturer instructions and with milk samples tested at 1:300 dilution. Kit performance
with this dilution factor was: average intra-plate repeatability 3.8%; average inter-plate repeatability
4%; average recovery 90%. Finally, TGF-β1 and TGF-β2 contents were measured with Quantikine
ELISA Human TGF-β1 and TGF-β2 Immunoassay Kits from R&D Systems, USA (Minneapolis, MN,
USA) (catalogue numbers DB100B and DB250, respectively), following manufacturer instructions and
with milk samples tested respectively at 1:5 and 1:4 dilutions on the top of the already 1:1.4 dilution
of the original samples linked to the acidification and pH neutralization steps mandatory to activate
latent TFG-βs from BM samples to their measured immune-reactive forms. Kit performance with such
dilution factors were for TGF-β1 and TGF-β2 respectively: average intra-plate repeatability 4% and
9.3%; average inter-plate repeatability 6.1% and 10.8%; average recovery 84% and 92%.
2.9. Data Analysis
A multiple linear regression was applied to analyze the effect of lactation stage on the levels of the
individual proteins. This model was adjusted for the effects of maternal age and BMI, infant gender,
mode of delivery and geographical location.
A multiple regression model to explain the protein and immune parameter concentration was
applied. The distribution of the residuals were checked via Box-Cox transformation method and a
logarithmic transformation seemed to be adequate for all immune parameters. The following model
was used:
log (concentration) = timeframe + sex + delivery + city + mother′s age + mother′s BMI + ε
The above model was the general model that was used to test for the effect of stage of lactation
(timeframe) on immune parameter concentration taking in to consideration other variables such as
gender, mode of delivery (natural vs. C-section) and geographic location (city). The term ε refers to a
residual error (observed value–predicted value). With this model, contrast estimates were calculated
comparing the successive timeframes (5–11 days vs. 12–30 days, 12–30 days vs. 1–2 months, etc.) to
observe at which timeframes there were significant changes in nutrient concentration.
The same stage of lactation model was used in the subgroup of mothers delivering by C-section
and also for natural delivery. In this case the model become simpler:
log (concentration) = timeframe + sex + city + mother′s age + mother′s BMI + ε
A similar model was used to assess the impact of mode of delivery with the difference of taking
into account the interaction effect of time with the variable in question. The following model was used
so that a comparison of the delivery modes can be made for each timeframe:
log (concentration) = timeframe×delivery + sex + city + mother′s age + mother′s BMI + ε
The same methods were used for the proteins, but a normality assumption is made and therefore
no logarithmic transformation was performed on the 4 protein nutrients.
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3. Results
3.1. Subject Characteristics
In this cross-sectional study, nine different proteins were quantified in 450 BM samples collected at
different stages from early to late lactation (8 months) in apparently healthy Chinese women from three
different cities (i.e., Beijing, Guangzhou, and Suzhou). Figure 1 displays the recruitment flowchart
from eligibility to sample analysis.
Figure 1. Study flow chart of subject recruitment.
Subject demographics and anthropometry are described in Table 1. Maternal age, weight,
body mass index (BMI) and mode of delivery were significantly different among the lactation
stage cohorts. No other significant differences were observed in maternal and infant characteristics
analysed. Note that the significant differences were taken into consideration for the analyses of protein
contents at the different lactation stages as the statistical model was adjusted for these potential
confounding factors.
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Table 1. Maternal and infant characteristics (adapted from [31]).
Study Population
5–11 Days 12–30 Days 1–2 Months 2–4 Months 4–8 Months
(n = 90) (n = 90) (n = 90) (n = 90) (n = 90)
Mother
Age (years), Mean (SD) 27 (4) 27 (3) 28 (4) 27 (4) 26 (4)
Height (cm), Mean (SD) 160 (4) 160 (5) 161 (5) 161 (5) 159 (5)
Weight (kg), Mean (SD) 60.7 (8.7) 60.8 (7.9) 61.9 (8.9) 58.4 (8.3) 56.2 (8.1)
BMI (kg/m2), Mean (SD) 23.7 (3.3) 23.7 (2.8) 23.9 (3.1) 22.5 (2.9) 22.2 (3.1)
Gestational weight gain (kg), Mean (SD) 16.7 (7.4) 16.2 (6.0) 15.9 (5.7) 15.9 (5.9) 14.9 (7.6)
Postpartum weight loss (kg), Mean (SD) 9.1 (6.1) 8.6 (5.3) 9.8 (4.0) 10.0 (6.2) 10.6 (5.9)
Caesarean delivery, N (%) 39 (42) 43 (48) 53 (59) 35 (39) 35 (38)
Infant
Males, N (%) 51 (57) 48 (53) 48 (53) 54 (60) 43 (48)
Gestational age at birth (weeks), Mean (SD) 39.3 (1.2) 39.2 (1.3) 39.2 (1.6) 39.4 (1.3) 39.5 (1.5)
3.2. Major Breast Milk Proteins
3.2.1. Analytical Method Performance
Each protein was quantified using an individual calibration curve (quadratic fitting, all R2 > 0.99,
LabChip GX-II software, v4.1, 2015), based on a dilution series of pure standard proteins. Figure 2A
depicts a typical electropherogram trace of a BM sample measured with the LabChip GX II system.
A calibration curve for α-lactalbumin is shown in Figure 2B which demonstrates the small variation
of replicate measurements. Based on a simple 5-fold dilution of the BM samples, limit of detection
was 50 ng/μL for α-lactalbumin and serum albumin, 100 ng/μL for caseins and 130 ng/μL for
lactoferrin, respectively.
Figure 2. (A) Human breast milk protein separation on the LabChip GX II system. The electropherogram
overlay depicts individual standard milk proteins (red) and a typical human breast milk sample trace
(blue); (B) Calibration curve for α-lactalbumin (in duplicates, 50–1500 ng/μL, R2 0.9996).
The method was fully validated. Recoveries of proteins, determined using spiking experiments
(three spiking levels, analyzed in duplicate on six different days), were between 91.8% and 116.5%.
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Relative repeatability (r%) for all proteins was <9.2% and relative intermediate reproducibility (iR%)
was <26%. Measurement uncertainty was estimated using the simplified approach based on existing
validation data proposed by Barwick [32]. The standard uncertainty (u) was determined at 11 ng/μL
with relative standard uncertainty (u%) of 0.5%. Expanded uncertainty (U) was 19 ng/μL with relative
expanded uncertainty (U%) of 1%.
3.2.2. Analysis of Major Breast Milk Proteins
The concentration of α-lactalbumin decreased from 3.27 to 2.28 g/L over the investigated lactation
period (Table 2). With the exception of the two first stages, all subsequent stages showed a significant
decrease (p < 0.003) in α-lactalbumin content, over time until eight months.
Table 2. Protein content of human breast milk from the different lactation stages (see also Figure S1).
Proteins
5–11 Days 12–30 Days 1–2 Months 2–4 Months 4–8 Months
(n = 90) (n = 90) (n = 90) (n = 90) (n = 90)
Major breast milk proteins
α-lactalbumin (g/L), Median (IQR) 3.27 (0.60) 3.16 (0.55) 2.84 a (0.55) 2.53 a (0.47) 2.28 a (0.63)
Lactoferrin (g/L), Median (IQR) 3.30 (2.11) 1.86 a (0.89) 1.24 a (0.53) 1.15 (0.46) 1.17 (0.47)
Serum albumin (g/L), Median (IQR) 0.48 (0.14) 0.48 (0.14) 0.42 (0.09) 0.44 (0.10) 0.42 (0.08)
Total caseins (g/L), Median (IQR) 5.84 (3.17) 6.57 a (2.15) 6.24 (2.25) 5.79 a (1.69) 5.60 (1.73)
Immune factors
IgA (mg/L), Median (IQR) 1148 (1022) 615 a (494) 553 a (232) 557 (312) 564 (337)
IgM (mg/L), Median (IQR) 117 (168) 47 a (47) 35 a (31) 35 (29) 25 a (25)
IgG (mg/L), Median (IQR) 22 (13) 23 (12) 20 (14) 24 (15) 23 (14)
TGF-β1 (ng/L), Median (IQR) 1258 (1305) 685 a (482) 600 (356) 598 (379) 659 (410)
TGF-β2 (ng/L), Median (IQR) 5286 (10,444) 2322 a (3100) 1877 a (1890) 1920 a (2112) 2311 b (2868)
a p < 0.05 vs. previous stage; b p < 0.05 vs. previous 1–2 months stage.
The concentration of lactoferrin also decreased over full lactation period, from 3.30 to 1.17 g/L
(Table 2). This decrease was constant during lactation until 1–2 months, with significant differences
(p < 0.000) in lactoferrin content between the first three investigated stages, and then stabilizing until
the eighth months.
The concentration of serum albumin during the lactation period ranged from 0.48 to 0.42 g/L
(Table 2) and did not show any significant differences between stages.
The concentration of caseins during the lactation period followed a different pattern than the
other proteins, showing a significant transient increase from 5.84 g/L at stage 1 to 6.57 g/L in Stage 2
and 6.24 g/L in Stage 3 before returning to starting values in later stages (Table 2).
3.3. Breast Milk Immune Factors
IgA and IgM contents reflected the temporal change pattern of most of the major BM proteins
with significantly higher contents in early milk before rapidly decreasing over time, reaching a basal
plateau after 1 month of infant’s age (Table 2). IgG concentration did not follow the same pattern as it
appeared stable throughout lactation (Table 2).
TGF-β1 and TGF-β2 BM contents proved to be also significantly higher in the very early milk
(5–11 days period, Table 2). Then, while TGF-β1 concentration remained stable up to the end of the
covered lactation period, TGF-β2 content continued to significantly decrease in the 1–2 months stage
before significantly increasing again later back to 12–30 days levels.
Regarding impact of mode of delivery on immune factor contents in BM, even if occasional
statistical significant differences or trends could be observed (see Figures 3 and 4), C-section delivery
did not appear to consistently impact BM concentrations in immune factor.
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Figure 3. Comparison of (A) IgA; (B) IgM and (C) IgG immunoglobulin contents in breast milk from
mothers delivering their infant either vaginally (Natural) or by Caesarean section for each lactation
period of this study. Box plot represent medians with 25th and 75th percentile, min-max range and
outliers. Statistical significance was set at p < 0.05 and significant p-values are indicated in the graphs.
Figure 4. Comparison of (A) TGF-β1 and (B) TGF-β2 contents in breast milk from mothers delivering
their infant either vaginally (Natural) or by Caesarean section for each lactation period of this study.
Box plot represent medians with 25th and 75th percentile, min-max range and outliers. Statistical
significance was set at p < 0.05 and significant p-values are indicated in the graphs.
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4. Discussion
4.1. Major Breast Milk Proteins
Various separation techniques and approaches have been exploited to identify and quantify milk
proteins. Traditionally, chromatographic or electrophoretic methods have been used to profile major
BM proteins [33–35] whereas immuno-based approaches, i.e., ELISA or antibody arrays, were the
method of choice for quantitative analysis of individual proteins [36–38]. More recently, targeted
LC-MS techniques have been developed to separate and quantify specific milk proteins [39]. The low
throughput nature of these methodologies is often the limiting factor for application to larger numbers
of samples. In order to address the challenge to precisely quantify major BM proteins in a large number
of individual samples, as in the case of the present study, an innovative microfluidic chip-based method
was specifically implemented, validated and applied in a high-throughput approach.
Despite a small limitation in the quantification of individual caseins, we believe that the minimal
sample preparation and the 96-well sample format ideally combines speed and robustness of the
analysis process and thus paves the way for a new technological standard for the measurement
of α-lactalbumin, lactoferrin, serum albumin and total caseins in future studies addressing BM
protein composition.
α-lactalbumin was the most abundant whey protein in the Chinese mother’s BM samples (Table 2),
in agreement with previous data in the literature [19]. Even though its content decreased significantly
over the first two months, it remained high in all lactation stages. The high levels of this protein in BM
are likely key for the nutrition of the breast-fed infant. Contrary to other BM proteins, α-lactalbumin
appears to be fully hydrolysed and absorbed in the infant intestine, thus to be a good source of
nitrogen and indispensable amino acids [40]. This protein contributes as well to the balanced amino
acid composition of BM and, in particular, to its high levels of tryptophan, which ultimately allows
BM to cover the infant’s amino acid requirements with limited amounts of protein [41]. High levels of
tryptophan in this protein would be also associated with its protective effects against epileptic seizures
in animal models [42]. Besides its nutritional role, the α-lactalbumin HAMLET complex found in BM
has anti-tumoral [9] and bactericidal effects [8]. Furthermore, α-lactalbumin bears bioactive peptide
sequences (e.g., mineral chelator or anti-microbial peptides) that may be released and transiently exert
their activity (e.g., increased mineral absorption or prevention of infection) in the infant intestine. In line
with this, Kelleher et al. [43] observed increased mineral absorption and Bruck et al. [44] inhibition of
E. coli-induced diarrhoea in infant monkeys fed a formula supplemented with bovine α-lactalbumin.
The second most abundant whey protein in our samples was lactoferrin (Table 2) for which the
observed concentration values and gradual decrease along lactation were similar to those previously
reported [19,45]. The bioavailability of lactoferrin, thus its nutritional relevance as a source of amino
acids and nitrogen to the infant, is not known. However, it has been found intact in infant faeces
and resistant to digestion in an in vitro digestion model, which suggest that the nutritional role of
lactoferrin may need reconsideration and further studies [40]. In contrast, multiple biological activities
have been proposed for this protein [40] including infant protection against gastrointestinal infection
and sepsis [7].
It is noteworthy that temporal changes trends of α-lactalbumin and lactoferrin along lactation
are fully aligned with that of the total proteins measured in the same BM samples as previously
reported [29].
Due to the complexity of the casein composition in BM and limitations in mass resolution of the
new analytical method used in this study, caseins were not quantified individually but as total caseins
(combining α-, β- and κ-casein concentrations, Table 2). This novel analytical approach, however, was
potentially susceptible to introducing some bias in comparison to the more classical acid-precipitation
based methodology. Interestingly, our results demonstrated that this was not the case as the increase
of casein concentration at the beginning of lactation followed by a slight decrease at the later period
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was closely aligned with a previous report [46]. These results support the theory that casein and whey
protein synthesis and/or secretion is regulated by different mechanisms in the mammary gland [47].
In contrast to the other major whey proteins, serum albumin concentration stayed mostly constant
across the lactation stages. Comparison with literature data showed similar concentrations in our
samples [19]. It is noteworthy that, contrary to other BM proteins that are synthesized by the mammary
gland, serum albumin is transferred from the maternal blood [2]. To our knowledge, no specific
biological activities have been attributed to this protein. It certainly contributes to the nutrition of the
infant as it appears to be highly digestible [2].
4.2. Breast Milk Immune Factors
BM contents of immune factors at the different lactation stages (Table 2) were also in agreement
with the previously published ranges [18,48–51], as well as with our own previous findings
(unpublished data), indicating that BM from Chinese mothers does not differ from worldwide
references in these bioactive components.
IgA and IgM BM contents were significantly high in early milk before rapidly decreasing over
time, reaching a basal plateau after 1 month of infant’s age, while IgG content was stable throughout
lactation. These differences in production pattern between IgG and both other immunoglobulins
resides in the fact that IgA and IgM are actively secreted in BM through the poly-immunoglobulin
receptor expressed by mammary gland epithelial cells [12] while IgG is more passively appearing in BM
through transudation from the systemic circulation, as already mentioned above for serum albumin.
While TGF-β1 contents of BM followed the same temporal changes that the majority of
investigated proteins as previously described [21], variation of TGF-β2 concentration appeared to be
slightly different, also with a strong decrease until the 1–2 months lactation stage but followed by an
increase, reaching at 8 months the level observed in the second half of the first month of lactation
(Table 2). Such type of fluctuating pattern of TGF-β2 BM content has already been observed in a
previous study [49], however, to a smaller extent and at different time points. Whether this evolution
of TGF-β2 has a physiological role for the infants remains to be determined. Indeed, studies mainly
focusing on TFG-β1 and 2 demonstrated that milk-borne TGF-βs regulate inflammation [13],
stimulation of IgA isotype switching in B cells [52], maintenance of intestinal epithelium barrier
function [14], induction of oral tolerance [15], and consequently help to prevent allergic diseases [53,54].
It is noteworthy that C-section delivery did not appear to consistently impact BM content in the
major immune factors measured in the present study. The high number of mothers participating in
our study together with the high rate of C-section delivery thus allows increasing knowledge on the
previously described limited impact of the mode of delivery on major immune BM proteins [4,27],
while extending at the same time the former observations on colostrum to transitional and mature
milk. Moreover, our data also tend to indicate that the increased risk of immune-related diseases
associated with C-section delivery may not be associated with any alterations of major BM immune
factors’ composition. However, we cannot rule out a potential effect of the mode of delivery on the
immune factor composition of the colostrum as our earliest milk samples were collected 5–11 days
after delivery. In addition, the impact of delayed onset of lactation following C-section [25,26] on later
infant health was not assessed in the present study and would deserve deeper investigation in order to
further consolidate the above hypothesis.
The cross-sectional nature of our study limits the conclusions related to the stage-driven changes,
which would have been best assessed by a longitudinal design. However, our statistical model
adjusted for the maternal and infant baseline factors known or suspected to impact on milk nutrient
composition [55]. Our results are also reinforced by the fact that they were remarkably consistent with
those previously published.
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5. Conclusions
This multi-centric cross-sectional study covering 8 months of lactation for 450 Chinese mothers
demonstrated that their BM content in major proteins was comparable with previous studies carried
out in other parts of the world, highlighting that key protein components of BM are conserved
across geographic localization. Moreover, this study is to our knowledge the first one to address
the effect of C-section delivery on major BM immune factors throughout transitional and mature
milk, actually showing that C-section delivery had very limited impact on the maternal-to-offspring
transmission of active immune competence.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/8/8/504/s1,
Figure S1: Comparison of major milk protein content for (A) α-lactalbumin; (B) lactoferrin; (C) serum albumin
and (D) total casein for each lactation period. Box plot represent medians (n = 90 per lactation period) with 25th
and 75th percentile, min-max range and outliers. Statistical significance was set at p < 0.05 and significant p-values
are indicated in the graphs.
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Abstract: Human breast milk (BM) amino acid (AA) composition may be impacted by lactation stage
or factors related to geographical location. The present cross-sectional study is aimed at assessing the
temporal changes of BMAA over lactation stages in a large cohort of urban mothers in China.
Four hundred fifty BM samples, collected in three Chinese cities covering eight months
of lactation were analyzed for free (FAA) and total (TAA) AA by o-phthalaldehyde/
fluorenylmethylchloroformate (OPA/FMOC) derivatization. Concentrations and changes over
lactation were aligned with previous reports. Both the sum and the individual TAA values
significantly decreased during the first periods of lactation and then generally leveled off. Leucine
and methionine were respectively the most and the least abundant indispensable amino acids across
all the lactation stages, whereas glutamic acid + glutamine (Glx) was the most and cystine the least
abundant dispensable AA. The contribution of FAA to TAA levels was less than 2%, except for free
Glx, which was the most abundant FAA. In conclusion, the AA composition of the milk from our
cohort of urban Chinese mothers was comparable to previous studies conducted in other parts of the
world, suggesting that this is an evolutionary conserved trait largely independent of geographical,
ethnic, or dietary factors.
Keywords: breast milk; amino acids; lactation period; cross-sectional study
1. Introduction
Evolution has shaped the composition of breast milk to ensure optimal development of healthy
term offspring. However, breast milk composition is not constant and appears to be affected by
multiple factors, including lactation stage, mothers’ genetic background and diet, gestational age at
delivery, or geographical location [1].
Breast milk protein is a key nutrient supporting body growth and organ development
during the first few months of life by providing nitrogen and indispensable amino acids (IAA)
required for body protein building and by stimulating the secretion of growth-promoting hormones
(i.e., insulin, insulin-like growth factor (1-IGF1)). Potent insulinotropic amino acids such as the
branched chain amino acids—Leucine, Lysine, and Threonine—can be particularly important in
this context. However, emerging evidence suggests that the relatively low levels of protein and
insulinotropic amino acids in breast milk may be protective against the development of metabolic
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disorders later in infant life [2]. Because body weight, body composition, growth rate, and volume
of milk intake are known to change with an infant’s age [3,4], infant requirements in terms of both
protein and individual amino acid composition also varies along the different stages of lactation [3].
Most amino acids in breast milk are found as constituents of protein chains, but there is also
a certain amount of free amino acids (FAA), which usually account for less than 10% of the total
amino acid (TAA) levels [5,6]. Although still poorly explored, emerging evidence suggests specific
physiological roles of the FAA fraction, such as appetite control [7]. Many studies have analyzed the
TAA content in human milk, but they often characterize a limited number of samples, do not account
for the important lactation-stage associated changes, or both. The number of studies on FAA is even
more limited. In their systematic review of breast milk amino acid composition studies from different
continents, Zhang et al. [8] report geographical differences in the content of some TAA and FAA,
although data from some regions of the world is relatively limited. In particular, studies looking at
breast milk protein quality in China are scarce, with only two small studies reporting on the average
TAA composition of one to six months [9] and 7–180 days [10] postpartum milk. To our knowledge,
no data on TAA and FAA content in milk from Chinese mothers along lactation is available to date.
The objective of this cross-sectional study was to assess the temporal changes of FAA and TAA in
milk secreted during the different stages of lactation in a large cohort of Chinese mothers from three
different cities in urban China.
2. Materials and Methods
2.1. Subjects
This study was part of the Maternal, Infant and Nutrition Growth study (MING), a cross-sectional
study designed to investigate the dietary and nutritional status of pregnant women, lactating mothers,
and young children aged from birth up to three years living in urban areas of China [11]. In addition,
the human milk composition of the lactating mothers was characterized. The study was conducted
between October 2011 and February 2012. A multi-stage milk sampling from lactating mothers in
three cities (Beijing, Suzhou, and Guangzhou) was performed for breast milk characterization. In each
city, two hospitals with maternal and child care units were randomly selected; at each site, mothers at
lactation periods from 0 to 240 days were randomly selected based on child registration information.
Subjects included in the 0–5-day period were recruited at the hospital, whereas the other subjects
were invited by telephone to join the study; if participation was dismissed, a replacement was found.
Response rate was 52%. Recruitment, milk collection, and baseline data collection were completed on
separate days.
Stratified milk sampling of 540 lactating mothers in six lactation periods of 0 to 4, 5 to 11, and 12 to
30 days, and 1–2, 2–4, and 4–8 months, was obtained in the MING study. Nevertheless, only 450 milk
samples were analyzed in the amino acid study, as the 0- to 4-day stage could not be included due to
the limited volume of milk collected during this period.
Eligibility criteria included women between 18 and 45 years of age giving birth to a single, healthy,
full-term infant and exclusively breastfeeding until at least 4 months after birth. Exclusion criteria
included gestational diabetes, hypertension, cardiac diseases, acute communicable diseases,
and postpartum depression. Lactating women who had nipple or lacteal gland diseases, who had been
receiving hormonal therapy during the three months preceding recruitment, or who had insufficient
skills to understand study questionnaires were also excluded.
The study was conducted according to the guidelines in the Declaration of Helsinki. All of
the procedures involving human subjects were approved by the Medical Ethics Research Board of
Peking University (No. IRB00001052-11042). Written informed consent was obtained from all subjects
participating in the study. The study was registered at ClinicalTrials.gov (NCT01971671)
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2.2. Data Collection
All subjects responded to a general questionnaire including socio-economic and lifestyle aspects
of the mother. The self-reported weight at delivery, the number of gestational weeks at delivery,
and the delivery method were also recorded. Additionally, a physical examination (height, weight,
mid-arm circumference, blood pressure, and hemoglobin levels) was also carried out.
Data collection was done through face-to-face interviews on the day of milk sample collection.
The infant’s date of birth and gender information was collected retrospectively by phone interview.
2.3. Sample Collection
Breast milk sampling was standardized for all subjects and performed with an electric pump
(Horigen HNR/X-2108ZB, Xinhe Electrical Apparatuses Co., Ltd., Beijing, China). Samples were
collected at the second feeding in the morning (9–11 a.m.) to avoid circadian influence on the outcomes.
Single full breast was emptied, and an aliquot of 40 mL was secured for characterization purposes.
The rest of the milk was returned to the mother for infant feeding. One-milliliter aliquots of each
sample were transported on dry ice to a laboratory and stored at −80 ◦C until further analysis.
2.4. Amino Acid Analysis
All samples were analyzed by Eurofins Technology Service (Suzhou) Co. Ltd., Suzhou, China.
TAA content was determined according to a validated o-phthalaldehyde/
fluorenylmethylchloroformate (OPA/FMOC) derivatization procedure described by Blankenship et al. [12].
Briefly, protein-bound amino acids were converted to the free state by acid hydrolysis in 6 M of
hydrochloric acid at 110 ◦C for 22 h with a phenol antioxidant in the absence of oxygen.
The digests were derivatized with ortho-phthalaldehyde (OPA), mecaptopropionic acid (MCP),
and 9-fluorenylmethyl chloroformate (FMOC-Cl) under alkaline conditions prior to injection.
Separation and quantification of the amino acid derivatives were performed by high-performance
liquid chromatography HPLC with a UV/diode array and fluorescence detection. The limit
of detection (LOD) was 1 mg/100 g and the limit of quantification (LOQ) was 5 mg/100 g.
Average repeatability was 12%, and reproducibility between duplicate determinations was 18% for
the 18 measured amino acids with recoveries ranging from 64.9% to 129.6%.
FAA content was determined according to the same OPA/FMOC method, but without the acid
hydrolysis step. All samples were analyzed in duplicate.
2.5. Statistical Analysis
Multiple linear regression was applied to analyze the effect of the lactation period on the levels
of TAA and FAA. This model was adjusted for the effects of maternal age and body mass index
(BMI), infant gender, mode of delivery, and geographical location. Comparisons were made regarding
each subsequent lactation period (5–11 days vs. 12–30 days, 12–30 days vs. 1–2 months, 1–2 months vs.
2–4 months, and 2–4 months vs. 4–8 months) by calculating contrast estimates produced by the model.
For the socio-demographic and anthropometric data, analysis of variance was applied for the
continuous variable in question and the lactation period in order to check if there was at least 1 period
that was different than the others. For factor variables, an independence test was performed in order
to detect differences in distribution among the different period.




In this cross-sectional study, TAA and FAA were quantified in 450 breast milk samples collected
at different stages from early to late lactation in healthy urban Chinese women. The recruitment
flowchart from eligibility to sample analysis is illustrated in Figure 1.
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Figure 1. Study flow chart.
Subject demographics and anthropometry are described in Table 1. Maternal age, weight, BMI,
and mode of delivery were significantly different among the lactation stage cohorts. No other significant
differences were observed in maternal and infant characteristics analyzed.
Table 1. Maternal and infant characteristics.
Lactation Period
5–11 Days 12–30 Days 1–2 Months 2–4 Months 4–8 Months
p Value
(n = 90) (n = 90) (n = 90) (n = 90) (n = 90)
MOTHER
Age (years), Mean (SD) 27 (4) 27 (3) 28 (4) 27 (4) 26 (4) 0.005
Height (cm), Mean (SD) 160 (4) 160 (5) 161 (5) 161 (5) 159 (5) 0.102
Weight (kg), Mean (SD) 60.7 (8.7) 60.8 (7.9) 61.9 (8.9) 58.4 (8.3) 56.2 (8.1) <0.001
BMI (kg/m2), Mean (SD) 23.7 (3.2) 23.7 (3.0) 23.9 (3.1) 22.5 (2.9) 22.2 (3.1) <0.001
Gestational weight gain (kg), Mean (SD) 16.7 (7.4) 16.2 (6.0) 15.9 (5.7) 15.9 (5.9) 14.9 (7.6) 0.419
Postpartum weight loss (kg), Mean (SD) 9.1 (6.1) 8.6 (5.3) 9.8 (4.0) 10.0 (6.2) 10.6 (5.9) 0.119
Non-Smoker, n (%) 90 (100) 89 (99) 90 (100) 86 (98) 89 (100) 0.176
Cesarean delivery, n (%) 39 (42) 43 (48) 53 (59) 35 (39) 35 (38) 0.004
Household income (RMB/month)
<2000 RMB, n (%) 20 (22) 17 (19) 24 (27) 26 (29) 31 (34)
2000–4000 RMB, n (%) 37 (41) 45 (50) 41 (46) 40 (44) 41 (46)
>4000 RMB, n (%) 30 (33) 22 (24) 23 (26) 22 (24) 18 (20)
Unknown, n (%) 1 (1) 6 (7) 2 (2) 0 (0) 0 (0) 0.206
INFANT
Males, n (%) 51 (57) 48 (53) 48 (53) 54 (60) 43 (48) 0.865
Gestational age at birth (weeks), Mean
(SD) 39.3 (1.2) 39.2 (1.3) 39.2 (1.6) 39.4 (1.3) 39.5 (1.5) 0.684
3.2. Total Amino Acids
The levels of TAA were compared across different lactation stages after adjusting for maternal
age and BMI as well as for mode of delivery, infant gender, and geographical location.
The sum of TAA in milk samples significantly decreased with increasing lactation stage until
the 2–4-month milk, which did not differ significantly from that at 4–8 months (Figure 2A). Median
values ranged between 1608 mg/100 g and 1053 mg/100 g in the 5–11-day and the 2–4-month
samples, respectively.
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Figure 2. Box plot of the log-transformed sum of total (TAA, (A)) and of free (FAA, (B)) amino acids
in milk from the different lactation periods. n = 90 milk samples per lactation period. Statistically
significant differences between two periods were set at p < 0.05.
Concentrations of total IAA are reported in Table 2. Leucine and methionine were respectively
the most and the least abundant IAA in our sample set across all the lactation stages. The levels of
all IAA were highest in the early milk samples and then decreased with increasing lactation period
until 2–4 months. Some differences of lower magnitude were still perceived between the two latest
lactation stages; in particular, the levels of Leucine, lysine, and methionine were higher and the levels
of histidine and phenylalanine were lower in 2–4-month than in 4–8-month milk.
Table 2. Total amino acid content (mg/100 g) of milk from the different lactation periods.
Lactation Period
5–11 Days 12–30 Days 1–2 Months 2–4 Months 4–8 Months
IAA †
Histidine 51.2 (19.9) 44.5 § (14.1) 36.5 § (12.6) 34.9 § (7.2) 25.0 § (6.8)
Isoleucine 81.0 (23.4) 71.6 § (15.4) 64.6 § (16.8) 54.0 § (11.6) 53.8 (10.7)
Leucine 153.7 (63.2) 133.7 § (35.1) 130.3 (33.5) 108.1 § (24.9) 122.6 § (38.8)
Lysine 112.0 (31.0) 93.8 § (23.1) 78.8 § (18.9) 63.4 § (13.1) 67.9 § (13.1)
Methionine 21.8 (11.7) 16.7 § (6.6) 13.0 § (9.0) 9.2 § (6.1) 11.8 § (7.1)
Phenylalanine 64.4 (35.9) 52.4 § (18.3) 40.4 § (13.6) 37.6 § (10.8) 28.4 § (9.0)
Threonine 85.1 (28.1) 66.9 § (14.6) 58.0 § (13.3) 50.0 § (8.7) 48.6 (11.3)
Valine 97.9 (34.3) 81.1 § (16.7) 72.1 § (21.0) 59.7 § (16.0) 60.9 (12.7)
DAA †
Alanine 70.9 (23.0) 55.9 § (14.3) 45.9 § (15.7) 38.7 § (10.9) 38.6 (9.1)
Arginine 106.5 (36.6) 90.8 § (22.8) 77.0 § (24.5) 64.6 § (21.3) 65.3 (16.7)
Asx ‡ 132.9 (84.1) 115.5 § (54.4) 106.9 (40.0) 97.2 (56.8) 83.8 § (24.6)
Cystine 25.4 (12.5) 17.7 § (6.3) 12.5 § (5.2) 12.3 (3.4) 9.9 § (5.5)
Glx ‡ 248.1 (193.7) 220.1 § (92.4) 216.3 (59.3) 188.6 (105.2) 182.8 § (30.8)
Glycine 46.3 (15.2) 34.5 § (9.7) 27.6 § (10.5) 23.6 § (7.0) 23.5 (6.8)
Proline 140.2 (42.4) 117.7 § (26.5) 110.6 § (25.4) 95.3 § (20.9) 94.5 (17.2)
Serine 77.8 (27.0) 59.0 § (14.1) 47.9 § (9.8) 42.9 § (8.1) 41.7 (8.0)
Tyrosine 72.5 (30.4) 57.7 § (14.1) 44.1 § (19.5) 41.4 (13.9) 37.1 § (10.3)
SUM 1608.3 (589.5) 1296.5 § (368.4) 1188.1 § (341.7) 1053.2 § (291.9) 992.4 (175.9)
† IAA = indispensable amino acids; DAA = dispensable amino acid; ‡ Asx = sum of aspartic acid + asparagine;
Glx = sum of glutamic acid + glutamine. Medians (inter-quartile ranges) of n = 90 samples per lactation period
are shown. A median with a “§” superscript is significantly different from the median of the previous lactation
period (p < 0.05).
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Regarding dispensable amino acids (DAA) (Table 2) Glx (sum of glutamic acid + glutamine) was
the most and cystine the least abundant amino acids. Again, the highest concentration for all DAA
was recorded in the earliest milk (i.e., 5–11 days), and a subsequent decrease was observed in most
DAA across the intermediate time points until reaching similar levels at the two latest lactation stages.
In contrast, stable levels were observed for Glx and Asx (sum of aspartic acid + asparagine) between
the 12–30-day and 2–4-month milk. A further decrease occurred in the 4–8-month samples.
3.3. Free Amino Acids
The levels of FAA were compared across the different lactation stages after adjusting for maternal
age and BMI as well as for mode of delivery, infant gender, and geographical location.
In contrast to TAA, the sum of the individual FAA content was lower in the first compared with
the latest lactation stages, with median values ranging between 20.1 mg/100 g of milk at 5–11 days
and 29.0 mg/100 g of milk at 2–4 months (Figure 2B).
Concentrations of the individual FAA are reported in Table 3. Glx was the most abundant in
FAA across the data set, and its concentration was higher in mature milk than in early-stage milk.
In the latest lactation stages, it contributed up to more than 70% of the FAA mass. Similarly to Glx,
levels of alanine, cystine, glycine, and serine were lowest in the early-stage milk. Opposite changes
were observed in free IAA, of which highest concentrations were generally found in early-stage
samples. The only exception was threonine, which remained stable across the lactation periods.
Table 3. Free AA content (mg/100 g) of milk from the different lactation periods.
Lactation Period
5–11 Days 12–30 Days 1–2 Months 2–4 Months 4–8 Months
IAA †
Histidine 0.29 (0.21) 0.42 § (0.23) 0.33 § (0.15) 0.33 (0.19) 0.28 (0.10)
Isoleucine 0.17 (0.11) 0.19 (0.13) 0.13 § (0.10) 0.13 (0.07) 0.15 § (0.07)
Leucine 0.33 (0.20) 0.4 (0.2) 0.34 § (0.14) 0.33 (0.14) 0.34 (0.15)
Lysine 0.61 (0.51) 0.56 § (0.28) 0.46 § (0.20) 0.42 § (0.23) 0.54 § (0.28)
Methionine 0.11 (0.07) 0.13 (0.13) 0.10 § (0.07) 0.07 § (0.06) 0.12 § (0.05)
Phenylalanine 0.31 (0.17) 0.40 (0.17) 0.32 § (0.17) 0.33 (0.17) 0.30 (0.12)
Threonine 0.69 (0.38) 0.69 (0.36) 0.70 (0.36) 0.78 (0.34) 0.85 (0.38)
Valine 0.58 (0.27) 0.70 § (0.30) 0.61 § (0.21) 0.59 (0.21) 0.59 (0.18)
DAA †
Alanine 1.26 (0.81) 1.75 § (0.79) 2.07 § (0.67) 1.93 (0.68) 1.85 (0.46)
Arginine 0.46 (0.49) 0.42 § (0.28) 0.25 § (0.22) 0.25 (0.19) 0.25 (0.13)
Asx ‡ 0.47 (0.36) 0.52 (0.30) 0.54 (0.35) 0.55 (0.38) 0.58 (0.40)
Cystine 0.32 (0.13) 0.49 § (0.21) 0.46 (0.17) 0.49 (0.21) 0.50 (0.15)
Glx ‡ 10.89 (9.89) 15.09 § (8.74) 18.03 § (7.17) 20.22 § (7.28) 19.36 (8.07)
Glycine 0.51 (0.29) 0.62 § (0.23) 0.68 § (0.25) 0.64 (0.28) 0.76 § (0.28)
Proline 0.56 (0.33) 0.40 § (0.28) 0.54 (0.29) 0.40 (0.31) 0.45 § (0.44)
Serine 0.72 (0.43) 0.85 § (0.36) 0.91 § (0.40) 1.11 § (0.63) 1.11 (0.43)
Taurine 2.26 (2.65) 1.91 (1.78) 1.94 (1.31) 1.87 (1.42) 2.03 (1.12)
Tyrosine 0.38 (0.26) 0.40 (0.20) 0.28 § (0.17) 0.25 (0.14) 0.28 § (0.13)
SUM 20.1 (12.5) 25.5 § (10.4) 27.4 § (8.0) 29.0 (9.7) 28.6 (10.7)
† IAA = indispensable amino acids; DAA = dispensable amino acid; ‡ Asx = sum of aspartic acid + asparagine;
Glx = sum of glutamic acid + glutamine. Medians (inter-quartile ranges) of n = 90 samples per lactation period
are shown. A median with a “§” superscript is significantly different from the median of the previous lactation
period (p < 0.05).
The contribution of FAA to TAA levels was less than 2% for most amino acids studied.
A major exception was free Glx, which, on average, contributed to around 8% of the total Glx
concentration. The ratio of free to total Glx gradually increased across the increasing lactation stages,
from less than 5% at 5–11 days up to more than 10% at 4–8 months.
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Of note is that compared with the TAA (Table 2) inter-individual variability in FAA values was
very high (Table 3).
4. Discussion
Amino acids are an essential component in infant nutrition, and their levels in breast milk
are believed to be optimal to support healthy growth during the first months of life. Because of this,
the amino acid intake from human milk is considered to match infant requirements, and the breast milk
amino acid content is used to estimate the protein quality and quantity in breast milk substitutes [3].
Therefore, a reliable evaluation of the amino acid composition in breast milk is important.
The concentration of the sum of TAA—a good proxy of the true protein content—at the different
lactation stages was, in our samples, remarkably similar to that reported in transitional, mature,
and late milk in a recent systematic review of studies from Africa, Asia, Europe, and North America [8].
A limitation in our study, however, is the lack of colostrum samples. This said, although colostrum
is important for the protection of the neonate, the amount of amino acids provided by the colostrum
protein is likely limited due to the low secreted volumes as well as to the relatively low digestibility
of the major colostrum proteins [13]. Similar to the results reported in the systematic review by
Zhang et al. [8], the sum of TAA was greater in the early stage of lactation, slowly declining in
concentration as lactation progressed, reaching generally stable levels after 2–4 months. These changes
are consistent with the protein content results of the MING study reported elsewhere [11] and with the
well-known evolution of the protein content in breast milk, i.e., high during the early lactation stages,
and sharply decreasing during the transitional milk period to level off in mature milk [13]. It has been
proposed that these changes in the amino acid content of the milk match the infant requirements for
growth, which is fast during the neonatal period sharply decreasing during the first months of life [14].
Declining protein concentrations may also prevent amino acid overfeeding as milk volume intake
per unit body weight increases along lactation [3,4]. Of note, protein concentration in human milk is
remarkably low compared with that from most other mammals. Low protein intake during infancy is
believed to protect the individual against obesity and metabolic disease later in life, possibly related to
optimal appetite and hormonal programming [15].
The levels of individual TAA’s in the different lactation stages of the MING cohort were also close
to those reported by Zhang et al. [8]. The only amino acid showing a consistently lower value in our
samples was cystine. However, cystine is known to be particularly sensitive to the acid treatment used
for protein hydrolysis in our samples [16], and the cystine levels that we report here may underestimate
the real values.
Globally, the individual TAA levels showed similar temporal patterns as the sum of TAA.
However, whereas a strong decrease between early, transitional, and mature milk was observed
for some amino acids such as methionine, cystine, and glycine, this drop was less substantial for
Glx levels, which were comparable in transitional and mature milk. This observation is consistent
with the fact that besides the variations in protein content, changes in the quality of the protein occur
along lactation. Specifically, a significant decline in the concentration of the sulfur amino acid-rich and
glycine-rich whey proteins but stable levels of the Glx-rich casein were found in our milk samples [17]
and are usually reported [18], resulting in a whey to casein ratio that increases throughout lactation [13]
and, as observed in our samples, in an evolving amino acid profile.
As expected from previous reports [6], the contribution of FAA to the TAA mass was less than 3%
in all lactation periods. Because of this, the contribution of the FAA to the nutritional requirements of the
infant is expected to be low. The physiological importance of FAA for infants is not yet well understood.
It has been proposed that FAA are more rapidly absorbed, leading to accelerated appearance in the
systemic circulation and thus reaching the peripheral organs faster than the protein-bound amino
acids [6,8]. However, to our knowledge, the absorption kinetics of free and protein-bound amino acids
in breast milk has never been compared, and the physiological relevance of a potentially faster delivery
to the peripheral tissue of the small FAA load delivered by milk remains speculative.
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Free Glx was very abundant in our samples, contributing to around 70% of the FAA mass and
reaching up to 10% of the total Glx levels in the later lactation periods. Similar observations have also
previously been reported where both glutamic acid and glutamine were shown to be the most abundant
FAA in human milk throughout the first trimester of lactation [19]. Specifically, the authors of [19]
reported a 2.5- and 20-fold increase in glutamic acid and glutamine FAA concentrations, respectively,
with progressing lactation. It should be noted that, similar to our findings, these FAAs represented
more than 50% of total FAAs at three months [19]. Total Glx was also the most concentrated TAA in
our samples, suggesting an important role of this amino acid on the mammary gland metabolism,
on infant nutrition, or both, despite the fact that glutamic acid and glutamine are considered DAA
that can be synthesized by the body [20]. More specifically, the transamination of glutamic acid
by the mucosal intestinal cells yields alanine, which enters the gluconeogenic pathway. In addition,
both glutamic acid and glutamine from the lumen act as major energy substrates for the intestinal
cells [21,22]. In the neonatal pig for instance, the gastrointestinal tract uses dietary glutamine and
glutamate as its key respiratory fuel. In humans, trials with very low birth weight infants and critically
ill adult patients highlight the central role of glutamic acid and glutamine in protecting intestinal
growth and integrity [23–25], therefore suggesting glutamic acid and glutamine as important molecules
in milk for the immature infant gut. More recent results from Ventura et al. [7] also suggest a role of
Glutamate on the satiety status of the lactating infant.
Similar to Glx, free alanine, cystine, glycine, and serine also increased along the lactation periods
in our samples. Intriguingly, similar findings were reported in the systematic review by Zhang et al. [8],
indicating a consistent pattern in stage-associated changes independent of ethnic or geographic factors.
This consistency is outstanding in light of the important inter-individual FAA variability in our study,
the inter-study variability observed in the report by Zhang et al., and even the intra-individual changes
reported by others in transitional and mature breast milk [26]. However, the physiological significance
of the concentration rise of these DAA through lactation is not clear. Furthermore, understanding
the physiological relevance of the increased inter-individual variability observed in FAA needs to
be elucidated.
An important limitation in our study is that our analytical method did not permit to quantify
the concentration of tryptophan. Yet the IAA tryptophan is usually the limiting amino acid in infant
formula; thus, its concentration in breast milk is often used to estimate the protein quality and to adjust
the level of the protein in the formula. Another limitation is the cross-sectional nature of the study that
weakens the conclusions related to the stage-driven changes, which would have been best assessed by
a longitudinal design. However, our statistical model adjusted for the maternal and infant baseline
factors that were known or suspected to impact milk nutrient composition [1], including maternal
weight and mode of delivery, which differed between the lactation period cohorts. Our results are also
reinforced by the fact that they were remarkably consistent with those previously published.
5. Conclusions
In conclusion, the amino acid composition of the milk from our cohort of urban Chinese mothers
was comparable to human milk data from previously reported studies carried out in other parts of
the world, suggesting that amino acid composition in breast milk is an evolutionary conserved trait
largely independent of geographical, ethnical, or dietary factors.
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Abstract: (1) Background: Late preterm infants account for the majority of preterm births and are
at risk of altered body composition. Because body composition modulates later health outcomes
and human milk is recommended as the normal method for infant feeding, we sought to investigate
whether human milk feeding in early life can modulate body composition development in late
preterm infants; (2) Methods: Neonatal, anthropometric and feeding data of 284 late preterm
infants were collected. Body composition was evaluated at term-corrected age by air displacement
plethysmography. The effect of human milk feeding on fat-free mass and fat mass content was
evaluated using multiple linear regression analysis; (3) Results: Human milk was fed to 68% of
the infants. According to multiple regression analysis, being fed any human milk at discharge
and at term-corrected and being fed exclusively human milk at term-corrected age were positively
associated with fat-free mass content(β = −47.9, 95% confidence interval (CI) = −95.7; −0.18; p = 0.049;
β = −89.6, 95% CI = −131.5; −47.7; p < 0.0001; β = −104.1, 95% CI = −151.4; −56.7, p < 0.0001);
(4) Conclusion: Human milk feeding appears to be associated with fat-free mass deposition in late
preterm infants. Healthcare professionals should direct efforts toward promoting and supporting
breastfeeding in these vulnerable infants.
Keywords: human milk; late preterm infants; body composition
1. Introduction
Late preterm birth, defined as a birth that occurs between 34 0/7 and 36 6/7 weeks of gestation,
accounts for the majority of all preterm births [1]. Late preterm infants show increased mortality and
morbidity compared with full-term newborn infants [2]. It has been reported that the first months
of the postnatal life of late preterm infants are characterized by rapid postnatal catch-up growth,
and as a result, at term-corrected age, late preterm infants achieve a weight either comparable to or
higher than full-term newborns [3,4]. Evidence indicates that early body composition development
in these infants is accompanied by a major deposition of fat mass so that, at term-corrected age,
increased adiposity irrespective of the percentile at birth has been found. Unlike very preterm infants,
however, late preterm infants appear not to develop a fat-free mass deficit [4].
It has long been recognized that early life represents a critical time window in terms of metabolic
programming [5]. Indeed, increased adiposity early on may contribute to negative health outcomes
later [6], whereas fat-free mass accretion has been positively associated with faster brain processing [7].
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Considering the key role played by body composition development in modulating later health
outcomes [6], identification of the determinants of body composition may help in tailoring nutritional
interventions in infancy. Mode of feeding in early life has been reported to affect body composition
development [8]. Human milk is recommended as the normal and unequalled method for feeding
both preterm and term infants [9].
While some authors have investigated the determinants of body composition, including human
milk feeding, in very preterm infants at the time of hospital discharge [10,11], there is a paucity of
data on early determinants of body composition in late preterm infants who are recognized to be
undergoing a critical period of development [12]. Huang et al. [8] have conducted a systematic review
and meta-analysis, including infants born before completion of the 37th week of gestational age, to
investigate whether body composition at term-corrected age differs between breastfed and formula-fed
infants. However, late preterm infants were relatively underrepresented in the investigation. The aim
of the present study was to investigate whether human milk consumption in early life could modulate
body composition development at term-corrected age in late preterm infants.
2. Materials and Methods
2.1. Design and Setting
We conducted an observational cohort study. Approval was obtained from the institutional review
board of Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore
Policlinico (code number 506_2015, date of approval: 22 May 2015) and written informed consent from
the infants’ parents.
2.2. Sample
All consecutive newborns admitted to the authors’ institution between July 2015 and May
2016 were screened for eligibility. The inclusion criteria were gestational age from 34 0/7 to 36 6/7,
Caucasian parentage and clinical stability at term-corrected age. The exclusion criteria were presence
of congenital disease; chromosomal abnormalities; cardiac, brain, renal, endocrine, gastrointestinal or
infectious disease; respiratory distress syndrome, defined as the need for any respiratory support for
longer than seven days; and pre-pregnancy maternal body mass index >30.
2.3. Nutritional Practices
Infants were fed on demand. Mothers were encouraged either to breastfeed their infant or express
their milk according to their infant’s clinical condition. According to our internal nutritional procedure,
human milk was not fortified [13]. When human milk was unavailable or insufficient, formula feeding
was started. Infants born at 34 weeks gestational age and infants born small for gestational age
(SGA) at 35–36 weeks gestational age were fed a post-discharge formula (range of protein content:
2–2.4 g/100 mL; range of energy content: 73–82 kcal/100 mL) up to the maximum corrected age
of 40 weeks. Late preterm infants, born adequate for gestational age (AGA), at 35–36 weeks of
gestational age, were fed a regular-term formula (range of protein content: 1.3–1.7 g/100 mL; range of
energy content: 66–68 kcal/100 mL).
2.4. Data Collection
Infants were enrolled at birth. At enrolment, basic subject characteristics such as gestational age at
birth, anthropometrics parameters at birth and at discharge (weight, length and head circumference),
gender, being a twin, and being adequate for gestational age or small for gestational age were recorded
prospectively. Gestational age was based on the last menstrual period and first trimester ultrasonogram.
Term-corrected age was calculated from the chronologic age, that is the time elapsed after birth,
reduced by the number of weeks the infant was born before the expected date of delivery, that is,
40 weeks of gestation [14]. Infants with birth weight in the <10th or ≥10th percentile for gestational
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age, based on Fenton’s growth chart [15], were, respectively, classified as having weight that was
SGA or AGA. The feeding status at discharge (any human milk, including exclusively human milk or
exclusively formula) and length of hospital stay were also collected. Specifically, infants fed any extent of
human milk, irrespective of the quantity or the exclusivity, were categorized as fed any human milk [9].
After discharge, the parents were asked to report in a diary the mode of feeding from discharge up to
term-corrected age (40 weeks ± 2 days).
2.5. Growth and Body Composition Assessment
Anthropometric measurements were assessed at birth, at discharge and at term-corrected age
(40 weeks ± 2 days). Body weight, length and head circumference were measured according to
standard procedures [16]. The weight of each baby was measured on an electronic scale accurate to 0.1 g
(PEA POD Infant Body Composition System; Cosmed, Concord, CA, USA). Body length was measured
to the nearest 1 mm on a Harpenden neonatometer (Holtain, Crymych, UK). Head circumference was
measured to the nearest 1 mm using non-stretch measuring tape. All measurements were assessed
by trained medical staff of the author’s institution. The late preterm infants’ growth (weight, length
and head circumference) z-scores were then calculated using the z-score calculator provided by the
University of Calgary, Calgary, Alberta, Canada [17]. Body composition was assessed at term-corrected
age using an air-displacement plethysmograph (PEA POD Infant Body Composition System; COSMED,
Concord, CA, USA). A detailed description of the PEA POD’s physical design, operating principles,
validation, and measurement procedures is provided elsewhere [18,19]. Briefly, the PEA POD assesses
fat mass and fat-free mass by direct measurements of body mass and volume and the application
of a classic densitometric model where percentage of body fat is calculated using body density and
pre-determined fat and fat-free mass density values. Body fat was defined as body weight minus
fat-free mass. A constant fat mass density value of 0.9007 g/mL [20,21] is used. Fat-free mass density
values are calculated as the sum of the contribution of the various components in the fat-free mass
compartment. Age- and sex-specific fat-free mass density values extrapolated from data by Fomon et
al. are used [22].
2.6. Statistical Analysis
All descriptive data are expressed as the mean ± SD or n (%). The associations between
neonatal characteristics (anthropometric measurements at birth and at term-corrected age, feeding
status at discharge and at term-corrected age), fat mass and fat-free mass content at term-corrected
age were assessed using univariate linear regression analysis. Multiple linear regression models,
including variables that resulted to be significant at univariate analysis, were used to identify
the determinants of fat mass and fat free mass content at term-corrected age. In order to avoid
collinearity, with regard to anthropometric parameters, we included only weight at term-corrected age
as independent variable since it was most closely correlated with fat-free mass and fat mass content at
term-corrected age in the univariate analysis. Weight was expressed as z-scores, in order to take into
account gestational age. All statistical analyses were performed using SPSS (SPSS, version 12; SPSS,
Chicago, IL, USA) and Stata (StataCorp. 2013, Stata Statistical Software: Release 13. StataCorp LP,
College Station, TX, USA).
3. Results
A total of 284 late preterm infants were enrolled. The flow chart of the study is reported in
Figure 1. The mean hospital stay was 8.9 ± 5.05 days. The mean postmenstrual age at discharge was
36.6 ± 0.8 weeks. The mean chronological age at term-corrected age was 33.1 ± 3.6 days.
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Figure 1. Flow chart of the study.
The basic characteristics of the subjects at birth are shown in Table 1.
Table 1. Basic subject characteristics at birth.
Late Preterm Infants (n = 284) Males (n = 147) Females (n = 137)
Gestational age (weeks) 35.3 ± 0.8 35.2 ± 0.9 35.4 ± 0.7
Birth weight (g) 2413 ± 387 2427 ± 404 2397 ± 369
Length (cm) 45.3 ± 2.4 45.3 ± 2.6 45.3 ± 2.2
Head circumference (cm) 31.9 ± 1.4 31.9 ± 1.6 31.9 ± 1.2
Weight z-scores −0.23 ± 0.87 −0.27 ± 0.8 −0.28 ± 0.8
Length z-scores −0.33 ± 0.91 −0.31 ± 0.9 −0.28 ± 0.8
Head circumference z-scores −0.09 ± 0.88 −0.06 ± 0.9 −0.01 ± 0.8
Small for gestational age n (%) 42 (15) 18 (12) 24 (18)
Twins n (%) 119 (42) 50 (34) 69 (50)
Data are presented as the mean (SD) or n (%).
Mode of feeding, anthropometric parameters and body composition in the enrolled late preterm
infants at discharge and at term-corrected age are reported in Tables 2 and 3, respectively.
In the univariate analysis, anthropometric parameters at birth and at term-corrected age,
gestational age, being male and being fed human milk at discharge and at term-corrected age were all
positively associated with fat-free mass content at term-corrected age, whereas being born small for
gestational age and being a twin were negatively associated. With regard to fat mass, anthropometric
parameters at birth and at term-corrected age and being exclusively fed human milk at discharge
were positively associated with fat mass content at term-corrected age, whereas being born small for
gestational age was negatively associated (Table 4).
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Table 2. Mode of feeding and anthropometric parameters of the enrolled late preterm infants
at discharge.
Late Preterm Infants (n = 284) Males (n = 147) Females (n = 137)
Exclusive human milk n (%) 97 (34) 53 (36) 44 (32)
Exclusive formula n (%) 91 (32) 35 (24) 56 (41)
Any human milk n (%) 193 (68) 112 (77) 81 (59)
Weight (g) 2270 ± 497 2317 ± 442 2200 ± 428
Length (cm) 45.1 ± 2.7 45.1 ± 3.4 45.1 ± 2.2
Head circumference (cm) 31.9 ± 1.4 31.9 ± 1.5 31.8 ± 1.1
Weight z-scores −0.92 ± 0.8 −0.95 ± 0.8 −0.94 ± 0.8
Length z-scores −0.70 ± 0.9 −0.85 ± 1.0 −0.53 ± 0.8
Head circumference z-scores −0.38 ± 0.7 −0.51 ± 0.8 −0.30 ± 0.7
Table 3. Mode of feeding, anthropometric parameters and body composition of the enrolled late
preterm infants at term-corrected age.
Late Preterm Infants (n = 284) Males (n = 147) Females (n = 137)
Exclusive human milk n (%) 88 (31) 54 (37) 34 (25)
Exclusive formula n (%) 134 (47) 68 (46) 66 (48)
Any human milk n (%) 150 (53) 79 (54) 71 (52)
Weight (g) 3396 ± 504 3380 ± 526 3240 ± 521
Length (cm) 49.4 ± 2.3 49.7 ± 2.5 49.1 ± 2.2
Head circumference (cm) 35.1 ± 1.6 35.3 ± 2.0 34.7 ± 1.3
Weight z-scores −0.31 ± 1.1 −0.38 ± 1.1 −0.23 ± 1.0
Length z-scores −0.56 ± 1.0 −0.59 ± 1.1 −0.53 ± 0.9
Head circumference z-scores 0.14 ± 0.9 0.25 ± 0.9 −0.02 ± 0.9
Fat mass % 14.7 ± 4.7 14.2 ± 4.5 15.3 ± 4.9
Fat free mass % 85.2 ± 4.8 85.8 ± 4.6 84.7 ± 4.9
Fat mass (g) 510 ± 2.1 493.8 ± 204 527.6 ± 219
Fat free mass (g) 2878 ± 392 2934.2 ± 408 2817.1 ± 366
Table 4. Univariate linear regression analysis for associations of infant characteristics, anthropometric
parameters and mode of feeding with fat-free mass and fat mass at term-corrected age.
Parameters
Fat-Free Mass at Term-Corrected Age
(g)
Fat Mass at Term-Corrected Age (g)
β 95% Confidence Interval p β 95% Confidence Interval p
Gestational age (weeks) 64.5 8.1; 120.9 0.025 −5.7 −36.5; 25.0 0.713
Being male (yes vs. no) 117.0 26.1; 207.8 0.012 −33.8 −83.2; 15.7 0.180
Being small for gestational age (no vs. yes) −401.9 −522.3; −281.5 <0.0001 −128.5 −196.8; 60.3 <0.0001
Weight z-score at birth 280.9 238.1; 323.7 <0.0001 92.5 65.4; 119.6 <0.0001
Length z-score at birth 175.0 129; 220.9 <0.0001 60.8 34.5; 87.1 <0.0001
Head circumference z-score at birth 156.4 107.3; 205.4 <0.0001 57.5 29.9; 85.0 <0.0001
Weight z-score at term-corrected age 307.1 283.9; 330.2 <0.0001 140.3 124.1; 156.6 <0.0001
Length z-score at term-corrected age 246.4 212.4; 280.4 <0.0001 103.6 82.7; 124.4 <0.0001
Head circumference z-score at term-corrected age 232.5 191.3; 273.6 <0.0001 87.5 62.8; 112.1 <0.0001
Being twin (no vs. yes) −187.6 −289.6; −85.6 <0.0001 −32.8 −89.8; 24.8 0.256
Being exclusively human milk fed vs. exclusively formula fed at discharge −333 −483.6; −183.5 <0.0001 −99.1 −179.1; −19.1 0.016
Being fed any human milk vs. exclusively formula fed at discharge −223 −337.9; −109.0 <0.0001 −43.6 −110.0; 22.9 0.197
Being exclusively human milk fed vs. exclusively formula fed at term-corrected age −226 −344.6; 109.1 <0.0001 17.8 −48.1; 83.8 0.594
Being fed any human milk vs. exclusively formula fed at term-corrected age −227 −327.8; −126.2 <0.0001 −7.8 −65.0; 49.4 0.788
At multiple regression analysis, when including mode of feeding at discharge, being male,
weight z-score at term-corrected age and being fed any human milk at discharge were positively
associated with fat-free mass content at term-corrected age (Tables 5 and 6).
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Table 5. Multiple linear regression analysis for associations of gender, weight z-score at term-corrected
age, being a twin and being exclusively fed human milk at discharge with fat-free mass at term-corrected
age (R2 = 0.88, p < 0.0001).
Model
Fat-Free Mass Content at Term-Corrected Age (g)
β 95% Confidence Interval p
Intercept 3008.4 2898.5; 3118.3 <0.0001
Male (yes vs. no) 80.6 20.6; 140.6 0.009
Being a twin (no vs. yes) −7.9 −73.4; 57.6 0.8
Weight z-score at term-corrected age 361.2 327.9; 394.6 <0.0001
Mode of feeding at discharge (being exclusively
human milk fed vs. being exclusively formula fed) −39.6 −102.4; 23.2 0.214
Table 6. Multiple linear regression analysis for associations of gender, weight z-score at term-corrected
age, being a twin and being fed any human milk at discharge with fat-free mass at term-corrected age
(R2 = 0.85, p < 0.0001).
Model
Fat-Free Mass Content at Term-Corrected Age (g)
β 95% Confidence Interval p
Intercept 3037.2 2961.2; 3113.1 <0.0001
Male (yes vs. no) 68.0 24.2; 111.7 0.002
Being a twin (no vs. yes) −38.7 −82.3; 4.7 0.08
Weight z-score at term-corrected age 347.7 325.2; 370.2 <0.0001
Mode of feeding at discharge (being fed any
human milk vs. being exclusively formula fed) −47.9 −95.7; −0.18 0.049
With regard to fat mass content, the weight z-score at term-corrected age was positively associated
with its content at term-corrected age, whereas the mode of feeding was not significantly associated
(Table 7).
Table 7. Multiple linear regression analysis for associations of weight z-score at term-corrected age,
and being exclusively human milk fed at discharge with fat mass at term-corrected age (R2 = 0.63,
p < 0.0001).
Model
Fat Mass Content at Term-Corrected Age (g)
β 95% Confidence Interval p
Intercept 517.7 430.8; 604.5 <0.0001
Weight z-score at term-corrected age 164.9 137.8; 192.0 <0.0001
Mode of feeding at discharge
(being exclusively human milk fed vs.
being exclusively formula fed)
27.2 −27.0; 81.5 0.321
In the multiple regression analysis, when including the mode of feeding at term-corrected age,
being male, the weight z-score at term-corrected age and being fed either exclusively or any human
milk at term-corrected age were positively associated with fat-free mass content at term-corrected age
(Tables 8 and 9).
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Table 8. Multiple linear regression analysis for associations of gender, weight z-score at term-corrected
age, being a twin and being fed exclusively human milk at term-corrected age with fat-free mass at
term-corrected age (R2 = 0.88, p < 0.0001).
Model
Fat-Free Mass Content at Term-Corrected Age (g)
β 95% Confidence Interval p
Intercept 3098.2 3018.1; 3178.3 <0.0001
Male (yes vs. no) 84.3 41.1; 127.4 <0.0001
Being a twin (no vs. yes) 23.4 −23.6; 70.4 0.32
Weight z-score at term-corrected age 355.0 332.8; 377.2 <0.0001
Mode of feeding at term-corrected age
(being exclusively human milk fed vs.
being exclusively formula fed)
−104.1 −151.4; −56.7 <0.0001
Table 9. Multiple linear regression analysis for associations of gender, weight z-score at term-corrected
age, being a twin and being fed any human milk at term-corrected age with fat-free mass at
term-corrected age (R2 = 0.86, p < 0.0001).
Model
Fat-Free Mass Content at Term-Corrected Age (g)
β 95% Confidence Interval p
Intercept 3088.1 3023.3; 3152.9 <0.0001
Male (yes vs. no) 75.0 34.8; 115.2 <0.0001
Being a twin (no vs. yes) 1.5 −41.2; 44.2 0.94
Weight z-score at term-corrected age 354.5 333.7; 375.3 <0.0001
Mode of feeding at term-corrected age
(being fed any human milk vs. being
exclusively formula fed)
−89.6 −131.5; −47.7 <0.0001
4. Discussion
The findings of this study indicate that the consumption of human milk is associated with
fat-free mass deposition in late preterm infants. It must be taken into account that the strength of this
relationship appears to become stronger towards the achievement of term-corrected age, suggesting a
potential cumulative effect of human milk consumption on body composition development.
Fat-free mass content has been recognized to positively modulate central nervous system
development because greater fat-free mass gains during the hospital stay have been associated with
improved cognitive and motor scores at one year of corrected age in very-low-birth-weight infants [23].
In addition, higher fat-free mass content in former preterm infants at four months of corrected age was
found to be associated with shorter brain speed processing [7]. On the other hand, the consumption of
human milk at term-corrected age was found to be negatively associated with fat mass deposition.
Considering that late preterm infants are at risk for developing increased adiposity at term-corrected
age [3,4], which in turn could represent a risk factor for developing metabolic syndrome later in life,
it could be speculated that human milk exerts a potentially protective effect in late preterm infants
against obesity risk.
The present results are consistent with previous data published in the literature. Larcade et al. [11]
reported that the number of days very preterm infants were fed human milk during their hospital stay
positively correlated with fat-free mass content at discharge. Accordingly, Huang et al. [8] conducted a
meta-analysis investigating the effect of breastfeeding and formula feeding on the body composition
of 642 preterm infants (<37 weeks of gestational age). The authors found significantly lower fat
mass in breastfed infants in comparison to formula-fed infants (mean difference 0.24; 95% CI 0.17,
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0.31 kg) at term-corrected age. These results differ from those reported by Gale et al. [24] who found
significantly higher fat mass content in healthy, full-term, breastfed infants at three to four months
of age in comparison to formula-fed infants. However, it must be taken into account that preterm
infants, including those born between 34 and 36 weeks of gestation, still need to complete their
organ development and present a lack of both fat-free mass and fat mass at birth because premature
birth interrupts the physiologic development of body composition [25]. Furthermore, it has been
demonstrated that the early postnatal growth of late preterm infants is characterized by a major
deposition of fat mass so that at term-corrected age, late preterm infants show a higher fat mass content
than term infants [3,4]. Hence, the promotion of fat-free mass accretion by consumption of human
milk may represent a physiological compensatory mechanism aimed at recovering body composition,
promoting neurodevelopment and protecting preterm infants from potential unbalanced nutritional
intake provided by infant formulas.
In the present study, not surprisingly, weight z-scores at birth and at term-corrected age
were positively associated with fat-free mass at term-corrected age. Indeed, the fat-free mass
compartment accounts for the majority of the weight [25]. In addition, the finding that weight z-scores
at term-corrected age are positively associated with fat mass content at term-corrected age can be
explained by the fact that the early postnatal growth of late preterm infants is characterized by a major
deposition of fat mass [4]. Consistently with previous data reported in the literature [26], being male
was positively associated with fat-free mass content at term-corrected age.
While this study is of clinical interest, it presents some limitations. First of all, the data collected
in the present study refer to late preterm infants not affected by comorbidities, so that their effect on
body composition development has not been assessed. Furthermore, body composition was evaluated
only at one time point, and as a result, the effect of human milk feeding over time has not been
investigated. The main strength of the paper is represented by the fact that body composition data
have been collected from a large number of late preterm infants.
5. Conclusions
The findings from this study indicate that human milk feeding appears to be associated with
early fat-free mass deposition in late preterm infants. On the basis of the present results, health care
professionals should direct efforts toward promoting and supporting breastfeeding in these vulnerable
infants. Future research is desirable to explore the effect of comorbidities and the persistence of the
effect of human milk consumption on body composition development in late preterm infants.
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Abstract: Fatty acids (FA), phospholipids (PL), and gangliosides (GD) play a central role in infant
growth, immune and inflammatory responses. The aim of this study was to determine FA, PL, and GD
compositional changes in human milk (HM) during lactation in a large group of Chinese lactating
mothers (540 volunteers) residing in Beijing, Guangzhou, and Suzhou. HM samples were collected
after full expression from one breast and while the baby was fed on the other breast. FA were assessed
by direct methylation followed by gas chromatography (GC) analysis. PL and GD were extracted
using chloroform and methanol. A methodology employing liquid chromatography coupled with
an evaporative light scattering detector (ELSD) and with time of flight (TOF) mass spectrometry was
used to quantify PL and GD classes in HM, respectively. Saturated FA (SFA), mono-unsaturated
FA (MUFA), and PL content decreased during lactation, while polyunsaturated FA (PUFA) and GD
content increased. Among different cities, over the lactation time, HM from Beijing showed the
highest SFA content, HM from Guangzhou the highest MUFA content and HM from Suzhou the
highest n-3PUFA content. The highest total PL and GD contents were observed in HM from Suzhou.
In order to investigate the influence of the diet on maternal milk composition, a careful analyses of
dietary habits of these population needs to be performed in the future.
Keywords: FA; phospholipids; gangliosides; breast milk; chromatography
1. Introduction
Human milk (HM) is considered the optimal form of nourishment for infants during the
first six months of life [1] and among its macronutrients, the lipid fraction is crucial, representing
approximately 50% of the energy supplied to the newborn infant [2]. Lipids (2%–5%) occur in milk in
the form of fat globules mainly composed of triacylglycerols (TAG) (~98% of total lipids) surrounded by
a structural membrane composed of phospholipids (PL) (0.8%), cholesterol (0.5%), enzymes, proteins,
glycosphingolipids (e.g., gangliosides (GD)), and glycoproteins [3,4].
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The majority of fatty acids (FA), approximately 98%, are esterified to a glycerol backbone to
form TAG and about 0.2%–2% is found in molecules, such as cholesterol, PL, and GD. In HM,
saturated FA (SFA) content ranges from 20% to 70% of total FA, mono-unsaturated FA (MUFA)
from 23% to 55%, polyunsaturated FA (PUFA) from 6% to 36%, and long chain polyunsaturated
FA (LCPUFA) from 0.3% to 8%. Among PUFA, linoleic (LA, 18:2n-6) and alpha linolenic acids
(ALA, 18:3n-3) are essential because they are not synthesized in the human body and they are precursors
of arachidonic (ARA, 20:4n-6) and docosahexaenoic (DHA, 22:6n-3) FA that are associated with normal
brain development, especially in early life [5].
PL are mainly distributed into five classes: phosphatydylinositol (PtdIns),
phosphatydylethanolamine (PtdEtn), phosphatydylserine (PtdSer), phosphatidylcholine (PtdCho),
and sphingomyelin (CerPCho). Ptdlns, PtdEtn, PtdSer, and PtdCho consist of a glycerol esterified with
FA in the sn-1 and sn-2 positions. A phosphate residue with different organic groups (inositol, serine,
ethanolamine, or choline) is present in the sn-3 position. CerPCho consists of a sphingoid base
backbone to which an amide-linked long-chain FA can be attached, leading to the ceramides
(N-acyl-sphingoid bases) [6]. In the case of CerPCho the primary hydroxyl group of the sphingoid
base is linked to phosphorylcholine. Therefore, PL are a source of FA and choline, the precursors of the
neurotransmitter acetylcholine, which acts by regulating the transduction signal and serves as a source
of methyl groups in intermediate metabolism, being considered essential for optimum development of
the brain [7,8].
GD are glycosphingolipids formed by a hydrophobic ceramide and a hydrophilic oligosaccharide
chain. This chain may contain N-acetylneuraminic acid (sialic acid) or, less commonly,
N-glycoloylneuraminic acid (Neu5Gc), where a glycol group is bound to the C5 amino group.
It has been reported that sialic acid is involved in many biological and pathological phenomena,
either recognizing or masking the recognition of several ligands, such as selectins or pathogens [9].
Recently, Gurnida et al. [10] concluded that nutritional supplementation with a milk lipid preparation
rich in GD appears to have beneficial effects on cognitive development in healthy infants aged
0–6 months.
Traditionally, lactation has been viewed in three stages: colostrum (day 1–5 postpartum),
transitional milk (day 6–15 postpartum), and mature milk (after day 15 postpartum). It has been
showed that FA, PL, and GD content in HM change during lactation stages [4,11–19] and factors, such as
maternal diet. may influence HM short chain FA [20,21], PUFA composition [22–24], and gangliosides
content [25].
The objective of this study was to determine, for the first time, the FA, PL, and GD content in
HM of Chinese mothers, follow its temporal change along lactation, and evaluate if the geographical
region within China would affect HM lipid composition. This study is part of the larger initiative:
the Maternal Infant Nutrition Growth (MING) study [26].
2. Materials and Methods
2.1. Subjects
This study was part of MING, a cross-sectional study designed to investigate the dietary and
nutritional status of pregnant women, lactating mothers, and young children aged from birth up to
three years living in urban areas of China [26]. In addition, the HM composition of Chinese lactating
mothers was characterized. The study was conducted between October 2011 and February 2012.
A multi-stage milk sampling from lactating mothers in three cities (Beijing, Suzhou, and Guangzhou)
was performed for breast milk characterization. In each city, two hospitals with maternal and child care
units were selected and, at each site, mothers at lactation period 0–240 days were randomly selected
based on eligibility criteria. Subjects included in the period 0–5 days were recruited at the hospital,
whereas the other subjects were requested by phone to join the study; if participation was dismissed
a replacement was made. The response rate was 52%. Recruitment and milk, as well as baseline
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data collection, were done in separate days. A stratified milk sampling of 540 lactating mothers in
six lactation periods of 0–4, 5–11, and 12–30 days, and 1–2, 2–4, and 4–8 months was obtained in the
MING study.
2.2. Inclusion and Exclusion Criteria
Eligibility criteria included women between 18–45 years of age giving birth to a single, healthy,
full-term infant and exclusive breastfeeding at least until four months of age. Exclusion criteria
included gestational diabetes, hypertension, cardiac diseases, acute communicable diseases,
and postpartum depression. Lactating women who had nipple or lacteal gland diseases, who had been
receiving hormonal therapy during the three months preceding recruitment, or who had insufficient
skills to understand study questionnaires were also excluded.
2.3. Ethical and Legal Considerations
The study was conducted according to the guidelines in the Declaration of Helsinki. All of
the procedures involving human subjects were approved by the Medical Ethics Research Board
of Peking University (No. IRB00001052-11042). Written informed consent was obtained from all
subjects participating in the study. The study was also registered in ClinicalTrials.gov with the number
identifier NCT01971671.
2.4. Data Collection
All subjects responded to a general questionnaire including socio-economic and lifestyle aspects
of the mother. Self-reported weight at delivery, number of gestational weeks at delivery, and delivery
method were also recorded. Additionally, a physical examination evaluated basic anthropometric
parameters (height, weight, mid-arm circumference) blood pressure, and hemoglobin. Data collection
was done through face-to-face interviews the day of HM sample collection. In addition, the date of
birth and gender information of the baby was collected after the data collection, since the data was
not included in the initial questionnaires. Subjects were contacted by phone and were asked to clarify
these two aspects retrospectively.
2.5. HM Sampling
Breast milk sampling was standardized for all subjects and an electric pump
(Horigen HNR/X-2108ZB, Xinhe Electrical Apparatuses Co., Ltd., Beijing, China) was used
to sample the milk. Samples were collected at the second feeding in the morning (9:00–11:00 a.m.) to
avoid circadian influence on the outcomes. A single full breast was emptied and aliquots of 10 mL
for colostrum and 40 mL for the remaining time points was secured for characterization purposes.
The rest of the milk was returned to the mother for feeding to the infant. Each sample was distributed
in freezing tubes, labelled with subject number, and stored at −80 ◦C until analysis. Figure 1 shows
the study flowchart for the subjects’ recruitment.
2.6. Analytical Methods
2.6.1. FA Quantification
FA profile was determined by preparing the methyl esters of FA (FAMEs). A direct
transesterification of HM was performed with methanolic chloridric acid solution, as described by
Cruz-Hernandez et al. [27]. Briefly, into a 10 mL screw cap glass test tube, milk (250 μL) was added
and mixed with 300 μL of internal standard FAME 11:0 solution (3 mg/mL) and 300 μL of internal
standard TAG 13:0 solution (3 mg/mL). After addition of 2 mL of methanol, 2 mL of methanolic
chloridric acid (3 N), and 1 mL of hexane, the tubes were heated at 100 ◦C for 90 min. To stop the
reaction 2 mL of water were added and after centrifugation (1200× g for 5 min) the upper phase
(hexane) was transferred into gas chromatography vials. The analysis of FAMEs was performed by GC
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using a CP-Sil 88 capillary column (100 m, 0.25 mm i.d. 0.25 μm film thickness) and their identification















Did not meet criteria (n:85)
Declined to participate
(n:196)
Figure 1. Study flowchart for subject recruitment.
2.6.2. Phospholipid Quantification
PL were quantified as previously described by Giuffrida et al. [28]. Briefly, 250 mg of maternal
milk was mixed with 250 mg of water and 9.5 mL of chloroform/methanol (2/1 v/v). After addition
of 10 μL of phosphatydilglycerol internal standard solution (5 mg/mL), the sample solution was
put into an ultrasonic bath at 40 ◦C for 15 min. After centrifugation (1000 relative centrifugal force
(RCF), for 10 min), the sample solution was filtered through 0.2 μm PTFE filters; the filtrate was
mixed with 2 mL of potassium chloride solution (8.8 g/L) and centrifuged (1000 RCF for 10 min).
The organic phases were evaporated to dryness and the residual lipids were redissolved in 150 μL of
chloroform/methanol (9/1 v/v), filtered through 4 mm polyvinylidene fluoride (PVDF) membrane
filters analyzed by high performance liquid chromatography coupled with evaporative light scattering
detector (HPLC-ELSD). PL classes were separated by normal-phase HPLC using 2 Nucleosil 50-5,
250 × 3 mm, 5 μm (Macherey-Nagel, Easton, PA, USA) equipped with pre-column Nucleosil 50-5,
8 × 3 mm, 5 μm (Macherey-Nagel, Easton, PA, USA). All chromatography was performed at 55 ◦C.
Solvent A contained ammonium formiate 3 g/L and solvent B of acetonitrile/methanol (100/3 v/v).
Gradient conditions for PL analysis were as follows: time = 0 min 1% solvent A; time = 19 min 30%
solvent A; time = 21 min 30% solvent A; time = 24 min 1% solvent A; with a flow rate 1 mL/min.
Injection volume was 0.01 mL. The best signal and resolution was achieved at the following ELSD
conditions: evap. = 90 ◦C; neb = 40 ◦C, flow rate of N2 = 1 L/min.
2.6.3. Gangliosides Quantification
GD were quantified as previously described by Giuffrida et al. [2]. Briefly, HM (0.2 mL) was
dissolved in water (1 mL) and mixed with 4 mL methanol/chloroform (2/1). After centrifugation
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(3000× g, for 10 min), the upper liquid phase was quantitatively transferred into a 15 mL centrifuge
tube. The residue was mixed with water (1 mL), 2 mL of methanol/chloroform (2/1), shaken, put
into an ultrasonic bath at 25 ◦C for 10 min, centrifuged (3000× g, for 10 min), and upper liquid
phases polled together; the volume was adjusted to 12 mL with methanol 60% and pH to 9.2 by
adding Na2HPO4 30 mmol/L (0.2 mL). The extract solution was loaded on an Oasis HLB VAC RC
SPE cartridges (30 mg, 15 mL, Waters) previously conditioned with methanol (2 mL) and methanol
60% (2 mL). The sample was passed through the cartridge at maximum flow rate 2–3 mL /min.
The sorbent was washed with 2 mL of methanol 60% and dried by vacuum suction for a few seconds;
the analyte was eluted with methanol (2 mL). Solvent was evaporated to dryness under a nitrogen
flow at 30 ◦C and the residual lipids were re-dissolved in 0.2 mL of methanol 70% and analysed
by liquid chromatography (LC) coupled with quadrupole time of flight (QTOF), using an Aquity
BEH C18 column (1.7 μm; 150 × 2.1 mm i.d.; Waters). All chromatography was performed at 50 ◦C.
Solvent A was composed of water/methanol/ammonium acetate (1 mmol/L) (90/10/0.1 v/v/v) and
solvent B of methanol/ammonium acetate (1 mmol/L) (100/0.1 v/v). Gradient conditions were as
follows: time = 0 min 10% solvent A; time = 0.2 min 10% solvent A; time = 8.2 min 5% solvent A;
time = 12.2 min 5% solvent A; time = 12.4 min 0% solvent A; time = 18.4 min 0% solvent A;
time = 18.6 min 10% solvent A; time = 21 min 10% solvent A. Flow rate was 0.2 mL/min. Injection
volume was 0.01 mL for GD3 and 0.005 mL for GM3. The mass spectrometer was equipped with an
electrospray ionization (ESI) ion source. The ESI mass spectra were recorded in the negative ion mode
under the following conditions: ion spray voltage (IS) −4000 V, temperature of the source 400 ◦C,
declustering potential (DP) −40 V, ion source gases one and two at 40 and 35 psi, respectively, curtain
gas at 15 psi, collision energy −40 V. GD3 and GM3, were monitored by transitions of the precursor
ions to the m/z 290. Quantification was performed by the standard addition method.
3. Results
3.1. Demographics and Anthropometrics of Study Subjects
In the current study we analyzed HM from 539 mothers (Figure 1), collected in a cross-sectional
design over eight months postpartum. Milk obtained for analyses was a single, whole breast milk
sample to have a comprehensive view on nutrient content. The details of the demographics and
anthropometrics of the study subjects are outlined in Table 1. Groups of mothers, which delivered
either a male or a female infant, were comparable for their age and anthropometric and demographic
characteristics. Gestational age at birth (average 39 weeks) were also comparable between groups.
The details of demographics and anthropometrics of the study subjects for the time period 0–4 days
are not available.
Table 1. Maternal descriptive characteristics.
5–11 Days 12–30 Days 1–2 Months 2–4 Months 4–8 Months
(n = 90) (n = 90) (n = 90) (n = 90) (n = 90)
Mother
Age (years), Mean ± SD 27 ± 4 27 ± 3 28 ± 4 27 ± 4 26 ± 4
Natural delivery 27 ± 4 27 ± 3 28 ± 5 26 ± 4 26 ± 4
Caesarean delivery 28 ± 3 27 ± 4 29 ± 4 28 ± 4 27 ± 4
Height (cm), Mean ± SD 160 ± 4 160 ± 5 161 ± 5 161 ± 5 159 ± 5
Weight (kg), Mean ± SD 60.7 ± 8.7 60.8 ± 7.9 61.9 ± 8.9 58.4 ± 8.3 56.2 ± 8.1
BMI (kg/m2), Mean ± SD 23.7 ± 3.3 23.7 ± 2.8 23.9 ± 3.1 22.5 ± 2.9 22.2 ± 3.1
Gestational weight gain(kg), Mean ± SD 16.7 ± 7.4 16.2 ± 6.0 15.9 ± 5.7 15.9 ± 5.9 14.9 ± 7.6
Postpartum weight loss (kg), Mean ± SD 9.1 ± 6.1 8.6 ± 5.3 9.8 ± 4.0 10.0 ± 6.2 10.6 ± 5.9
Gestational age at birth (weeks), Mean ± SD 39.3 ± 1.2 39.2± 1.3 39.2 ± 1.6 39.4 ± 1.3 39.5 ± 1.5
SD: standard deviation.
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3.2. FA
FA were determined by gas chromatography coupled with flame ionization detector (GC-FID),
as previously described by Cruz-Hernandez et al. [27] and the results are listed in Table 2.
In our study total SFA content increased significantly from colostrum (35.7% of total FA) to
transitional milk (38.9% of total FA) and decreased in mature milk (36.2% of total FA), with palmitic
acid (16:0) being the most abundant FA and decreasing significantly (p < 0.05) from 23.2% in colostrum
to 19.8% of total FA in mature milk (Table 2). Stearic acid (18:0) content was constant along the lactation
period, i.e., colostrum, transitional, and mature milk, at about 5% of total FA, and medium-chain (MC)
FA (10:0–14:0) content was low in colostrum (6.8% of total FA) compared to transitional (13.1% of
total FA), and mature milk (11.0% of total FA) (Table 2). Arachidic (20:0) and lignoceric acids (24:0)
were constant along the lactation time at about 0.2 and 0.1% of total FA, respectively. No significant
differences (p > 0.05) on total SFA content were observed among cities in colostrum, and transitional
milk (Table 2). SFA content was significant lower (p < 0.05) in mature milk from Suzhou (34.5% of
total FA). Palmitic (22.5%, 19.4%, and 18.5% of total FA in colostrum, transitional, and mature milk,
respectively) and stearic (4.9%, 4.5%, and 4.8% of total FA in colostrum, transitional and mature milk,
respectively) FA also showed the lowest content in mature milk from Suzhou.
In the total population the MUFA content of HM decreased from 40.7% in colostrum to 36.9%
of total FA in mature milk, with oleic acid (18:1n-9) being the most abundant FA and decreasing
along the lactation time from 34.2% in colostrum to 31.9% of total FA in transitional and mature
milk. Other MUFA (i.e., 17:1n-7, 20:1n-9, 22:1n-9. and 24:1n-9) also decreased over the lactation
period (Table 2). The highest level of total MUFA content was found in colostrum (43.1% of total
FA), transitional (39.3% of total FA), and mature milk (38.3% of total FA) from Guangzhou (Table 2).
The lowest level of total MUFA content was found in colostrum (38.4% of total FA), transitional
(34.7% of total FA), and mature milk (34.3% of total FA) from Beijing (Table 2). HM samples obtained
from mothers in Guangzhou contained the highest level of Oleic acid whereas milk obtained from
mothers in Beijing contained the lowest level, respectively: colostrum (37.1% vs. 32.6% of total FA),
transitional (34.0% vs. 30.3% of total FA), and mature milk (33.4% vs. 30.1% of total FA).
In the total population, total PUFA n-6 increased from 21.7% in colostrum to 24.1% of total FA in
mature milk with linoleic acid (18:2n-6) being the most abundant FA and increasing along the lactation
time from 18.9% in colostrum to 22.8% of total FA in mature milk. ARA (20:4n-6) content decreased
from 0.9% to 0.5% of total FA from colostrum to mature milk. Beijing and Suzhou showed higher total
PUFAn-6 content in colostrum (23.3% and 22.8% of total FA, respectively), transitional (22.5% and
22.9% of total FA, respectively), and mature milk (26.6% and 25.3% of total FA, respectively) than
Guangzhou (Table 2).
Total PUFA n-3 in HM from total population slightly increased from 1.4% in colostrum to 1.9% of
total FA in mature milk with linolenic acid (18:3n-3) being the most abundant and increasing along
the lactation time from 0.9% in colostrum to 1.5% of total FA in mature milk. DHA (22:6n-3) slightly
decreased over lactation period from 0.5% in colostrum to 0.3% of total FA in mature milk, and EPA
(20:5n-3) was present in a small amount (<0.1% of total FA in colostrum, transitional, and mature milk).
The highest level of total PUFA n-3 content was found in colostrum (1.8% of total FA), transitional (2.1%
of total FA), and mature milk (2.4% of total FA) from Suzhou (Table 2), which, as a consequence,
showed the lowest n-6 to n-3 ratio (12.7% in colostrum, 10.9%in transitional milk, and 10.5% of total FA
in mature milk).
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3.3. Phospholipids
PL classes were determined by LC-ELSD, as previously described by Giuffrida et al. [28] and the
results are listed in Table 3.
We did not measure minor constituents, such as lysophosphatidylcholine, which may contribute
only to small amounts of the infant’s diet.
From the total population, total PL content in HM decreased along the lactation period from 33.0 in
colostrum to 24.2 mg/100 mL in mature milk, being significant lower (p < 0.05) in mature milk (Table 3).
PtdCho was the most abundant PL in HM (from 12.0 mg/100 mL in colostrum to 8.2 mg/100 mL in
mature milk) followed by CerPCho (from 9.1 mg/100 mL in colostrum to 7.2 mg/100 mL in mature milk),
PtdEtn (from 8.5 mg/100 mL in colostrum to 6.4 mg/100 mL in mature milk), PtdIns (from 1.8 mg/100 mL
in colostrum to 1.5 mg/100 mL in mature milk), and PtdSer (from 1.5 mg/100 mL to 1.0 mg/100 mL in
mature milk). The PL class distribution was similar in colostrum, transitional, and mature milk (Figure 2).
Among the cities, PtdCho content did not show significant difference (p > 0.05) (Table 3);
however, when considering the mature milk data at different lactation stages (Figure 3), PtdCho content
was significant higher at 2–4 months in Suzhou (9.0 mg/100 mL) when compared to Beijing
(7.1 mg/100 mL) and Guangzhou (6.4 mg/100 mL). CerPCho content was significant higher
(p < 0.05) in colostrum (10.9 mg/100 mL) of lactating mothers from Beijing and in transitional milk
(8.5 mg/100 mL) of lactating mothers from Suzhou (Table 3); when considering the different lactation
stages of mature milk (Figure 3), Beijing showed significantly higher content (12.9 mg/100 mL)
at 12–30 days and Suzhou at 1–2 months (10.9 mg/100 mL). PtdEtn content was significant lower
(p < 0.05) in colostrum (7.6 mg/100 mL) and mature milk (5.3 mg/100 mL) of lactating mother
from Beijing and significant higher (p < 0.05) in colostrum (12.6 mg/100 mL) and transitional milk
(10.8 mg/100 mL) of lactating mothers from Suzhou (Table 3); when considering the mature of the
milk data at different lactation stages (Figure 3) Suzhou showed the highest contents of PtdEtn at
1–2 months (8.6 mg/100 mL). PtdIns content was significant low (p < 0.05) in mature milk
(1.2 mg/100 mL) of lactating mothers from Beijing and significant higher (p < 0.05) in colostrum
(2.3 mg/100 mL), transitional (2.4 mg/100 mL), and mature milk (1.7 mg/100 mL) of lactating
mothers from Suzhou (Table 3); within mature milk (Figure 3) Suzhou showed the highest content of
PtdIns (2.0 mg/100 mL) at 1–2 months. PtdSer content was significant higher (p < 0.05) in colostrum
(1.8 mg/100 mL) of lactating mothers from Beijing and significantly different (p < 0.05) in transitional
(1.3 mg/100mL) and mature milk (1.2 mg/100 mL) of lactating mothers from Suzhou (Table 3).
Within mature milk (Figure 3) Beijing showed the highest PtdSer content (1.7 mg/100 mL) at 12–30 days
and Suzhou at 1–2 months (1.5 mg/100 mL, respectively). Finally, Suzhou showed significant higher
(p < 0.05) PL content in colostrum (38.9 mg/100 mL), transitional milk (34.9 mg/100 mL), and mature milk
(26.0 mg/100 mL), and Beijing showed the lowest content in mature milk (22.3 mg/100 mL) (Table 3).
3.4. Gangliosides
Gangliosides were determined by LC-MS/MS as described by Giuffrida et al. [29] and the results
are listed in Table 4.
From the total population, the amount of GD changed during the lactation period (Table 4),
with GM3 significantly increasing (p < 0.05) from 3.8 mg/mL in colostrum to 10.1 mg/L in mature milk
and GD3 significantly decreasing (p < 0.05) from 4.1 mg/mL in colostrum to 1.0 mg/mL in mature milk.
Total gangliosides increased significantly (p < 0.05) from 8.0 mg/L in colostrum to 11.0 mg/L in mature
milk (Table 4). However, variability was high and total ganglioside content ranged from 1.66–28.44 mg/L
in colostrum, 2.77–22.04 mg/L in transitional milk, and between 0.90–36.88 mg/L in mature milk;
GM3 contents ranged between 0.63–13.03 mg/L in colostrum, 1.01–17.71 mg/L in transitional milk,
3.45–25.97 mg/L at 1–2 months, 3.45–25.97 mg/L at 2–4 months, and between 5.17–34.41 mg/L
at 4–8 months; GD3 contents ranged between 0.55–18.04 mg/L in colostrum, 0.06–15.52 mg/L in
transitional milk, 0.15–4.93 mg/L at 1–2 months, 0.06–5.0 mg/L at 2–4 months, and between 0.05 and
6.77 mg/L at 4–8 months. The GM3/GD3 ratio also increased over the lactation period, to 0.9 in
colostrum and 10.1 in mature milk, consistent with the variation of GM3 and GD3 described above.
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Figure 2. Change in phospholipid (PL) classes distribution in colostrum, transitional and mature milk.
Figure 3. PL contents at different lactation stages, i.e., 12–30 days, 1–2 months, 2–4 months,
and 4–8 months postpartum are shown in the total population and cities. TP stands for total population.
* indicates significant difference (p < 0.05) among cities within the lactation stage.
Among the different cities, GM3 content was comparable (p > 0.05) in colostrum; GM3 highest
content (p < 0.05) in transitional milk (7.7 mg/L) was observed in HM of lactating mothers from
Guangzhou and in mature milk in lactating mothers from Guangzhou and Suzhou, at 10.5 and 10.8 mg/L,
respectively (Table 4). Within mature milk (Figure 4) Beijing, Guangzhou, and Suzhou showed the highest
GM3 content at 4–8 months (11.0 ± 3.9, 12.3 ± 5.5, and 15.6 ± 6.1 mg/L, respectively). The highest content
(p < 0.05) of GD3 was observed in colostrum of lactating mothers from Suzhou (8.6 mg/L); GD3 content
was comparable (p > 0.05) in transitional milk among the different cities and between Guangzhou and
Suzhou in mature HM (Table 4). However, when considering mature milk at different lactation stages
(Figure 4), Beijing, Guangzhou, and Suzhou showed the highest GD3 content at 12–30 days (0.9 ± 1.3,
1.1 ± 1.1, and 1.5 ± 2.2 mg/L, respectively). Suzhou showed the highest content (p < 0.05) of total GD in
colostrum and mature milk (12.6 and 11.9 mg/L, respectively), the highest content (p < 0.05) of total GD
in transitional milk was observed in Guangzhou (10.7 mg/L) (Table 4).
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Figure 4. GM3 and GD3 contents at different mature milk lactation stages, i.e., 12–30 days, 1–2 months,
2–4 months, and 4–8 months postpartum are shown in total population (TP) and cities. * stands for
significant difference (p < 0.05) at 4–8 months between Beijing and Suzhou for GM3, at 12–30 days
between Beijing and Suzhou, and at 2–4 months and at 4–8 months between Guangzhou and Suzhou
for GD3.
4. Discussion
This study measured the FA, PL, and GD content and the profile of 539 HM samples from Beijing,
Guangzhou, and Suzhou.
4.1. FA
Results from the total population (Table 2) showed a total SFA content of 35.7% ± 3.9% in
colostrum, of 38.9% ± 4.1% in transitional milk, and of 36.2% ± 4.7% in mature milk. Chinese studies
have reported SFA level in colostrum ranging from 36.8% to 41.3% [30,31], in transitional milk from
35.2% to 42.6% [31,32] and in mature milk from 35.1% to 41.1% [30–34], in agreement with our results.
When considering other populations (e.g., Caucasian, American) the SFA level in colostrum was
42.3%–43.7% [35–37], in transitional milk it ranged from 43.1% to 45.2% [36,37] and, in mature milk,
from 37.4% to 57.1% [34–38], therefore, Chinese populations seem to show lower amount of total SFA
in colostrum, transitional and mature milk when compared to other populations.
In this study, main SFA, lauric (12:0), myristic (14:0), palmitic (16:0), and stearic (18:0) acid
contents were 2.6% ± 1.6%, 3.8% ± 1.7%, 23.2% ± 1.9%, and 5.2% ± 1.0% of total FA, respectively,
in colostrum (Table 2); 6.1% ± 2.3%, 5.5% ± 2.2%, 20.5% ± 2.3%, and 5.0% ± 0.8% of total FA
in transitional milk (Table 2); and 5.2% ± 1.9%, 4.2% ± 1.7%, 19.8% ± 2.6%, and 5.1% ± 1.1% of
total FA, respectively, in mature milk (Table 2). Among the Chinese population, lauric, myristic,
palmitic, and stearic acids ranged between 3.0%–4.9%, 5.2%–5.3%, 20.1%–23.3%, and 6.0%–7.0% of total
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FA, respectively, in colostrum [30,31]; between 4.2%–6.5%, 3.8%–6.4%, 19.7%–23.3%, and 5.4%–8.1%
of total FA, respectively, in transitional milk [31,32]; and finally between 3.8%–6.3%, 3.4%–6.5%,
17.3%–22.3%, and 5.0%–8.0% of total FA, respectively, in mature milk [30–34]. When considering
other populations, lauric, myristic, palmitic, and stearic acids ranged between 1.2%–4.5%, 4.8%–7.3%,
24.0%–27.3%, and 5.5%–7.1% of total FA, respectively, in colostrum [35–37]; between 5.2%–6.5%,
6.5%–7.7%, 22.2%–22.6%, and 5.7%–7.4% of total FA, respectively, in transitional milk [36,37];
and finally between 3.7%–6.1%, 4.9%–7.0%, 18.7%–23.0%, and 4.8%–7.6% of total FA, respectively,
in mature milk [34–38]. Philippian population showed high lauric (13.82%) and myristic (12.12%) FA
contents [34] and it was reported [20,21] that 10:0, 12:0, and 14:0 FA content increases when lactating
women consumed high-carbohydrate diets, whereas the secretion of the 18-carbon chain unsaturated
FA, which are derived from the diet, decreased. High contents of lauric (10.2%) and myristic FA
(9.1%) have been also reported in the milk of women from Nigeria [4] as a typical response to
a high-carbohydrate diet.
Results from the total population (Table 2) showed total MUFA content of 40.7% ± 3.8% in
colostrum, of 37.7% ± 4.3% in transitional milk, and of 36.9% ± 4.1% in mature milk. Chinese studies
have reported MUFA levels in colostrum ranging from 34.7% [30] to 43.1% [31], in transitional milk
from 30.8% to 42.9% [31,32], and in mature milk from 28.5% to 45.6% [30–34], in agreement with
our results.
When considering other population, MUFA levels in colostrum ranged between 32.1%–44.4% of
total FA [35–37], in transitional milk it was 35.1% of total FA [37], and in mature milk ranged from
30.3%–44.4% of total FA [34,35,37,38], therefore, Chinese populations seem to show comparable MUFA
content in colostrum, transitional and mature milk to other populations.
Among MUFA, oleic acid was the most abundant FA and its content ranged from 34.4% in
colostrum to 31.9% in transitional and mature milk. In the Chinese population oleic acid ranged from
28.4%–36.3% of total FA in colostrum [30,31]; from 25.9%–36.5% of total FA in transitional milk [31,32],
and from 24.9%–38.1% in mature milk [30–34], and in other populations from 28.4%–40.1%, from
27.7%–32.1%, and from 21.9%–40.5% of total FA in colostrum [35–37], transitional [36,37], and mature
milk [34–38], respectively.
Results from the total population (Table 2) showed total n-6 and n-3 PUFA content of 21.7 ± 3.6
and 1.4% ± 0.5% in colostrum, respectively, of 21.6 ± 3.8 and 1.9% ± 0.7% in transitional milk,
and of 24.1 ± 5.0 and 1.9% ± 0.9% of total FA in mature milk. Chinese studies have reported PUFA
levels in colostrum ranging from 14.8%–22.5% for n-6PUFA and from 2.9%–3.9% for n-3PUFA [30,31],
in transitional milk from 13.7%–27.6% for n-6PUFA and from 2.5%–5.1% for n-3PUFA [31,32],
and in mature milk from 14.1%–27.8% for n-6PUFA and from 2.6%–6.8% for n-3PUFA [30–34],
therefore, the values are in agreement with the n-6PUFA results of this study, but higher for n-3PUFA.
When considering other populations, PUFA levels in colostrum ranged between 11.2%–14.0% for
n-6PUFA and from 1.9%–3.5% of total FA for n-3PUFA [35–37], in transitional milk from 12.3%–14.1%
for n-6PUFA and from 1.5%–3.3% of total FA for n-3PUFA [36,37], and in mature milk from 9.5%–20.3%
for n-6PUFA and from 1.3%–3.2% of total FA for n-3PUFA [34–38]. Therefore, the Chinese populations
seem to show higher contents of total n-6 PUFA when compared to other populations.
Among PUFA, LA (18:2n-6), and ALA (18:3n-3), considered essential FA because humans lack
the enzymes required for their biosynthesis, were the most abundant FA we observed in colostrum,
mature and transitional milk (18.9% ± 3.6%, 19.7% ± 3.8%, and 22.8% ± 4.9% of total FA for LA,
respectively and for 0.9% ± 0.4%, 1.4% ± 0.6%, and 1.5% ± 0.9% of total FA for ALA, respectively).
In the Chinese population, LA and ALA ranged from 10.3%–19.2% and from 0.9%–1.3% of total
FA, respectively, in colostrum [30–32]; from 9.8%–23.3% and from 0.9%–2.2% of total FA, respectively,
in transitional milk [31,32]; and from 10.9%–23.7% and from 0.9%–3.0% of total FA, respectively,
in mature milk [30–34], in agreement with our findings.
In other populations, LA and ALA ranged from 8.6%–11.9% and from 0.7%–1.1% of total FA,
respectively, in colostrum [35–37]; from 10.3%–12.5% and from 0.8%–1.3% of total FA, respectively,
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in transitional milk [36,37]; and from 7.9%–17.8% and from 0.4%–1.4% of total FA, respectively,
in mature milk [34–38].
Finally, in our study, DHA contents for the total population ranged from 0.3%, in mature milk,
to 0.5% in colostrum and transitional milk, therefore, lower than the DHA content reported for Chinese
marine populations in colostrum (1.5%) [30], transitional (0.6%) [31], and mature milk (0.5%–2.8%) [30,33].
The ratio ARA/DHA (1.8–2.2) was comparable to average worldwide ratio of about 1.5 [22].
Among different cities, over lactation time, HM from Beijing showed slightly higher SFA content
(Table 2), Guangzhou the highest MUFA content (Table 2), and Suzhou the highest n-3PUFA content
(Table 2).
It is known that the type of fat/oil in the maternal diet influences the FA composition
of breast milk. Francois et al. [22] showed that the consumption of six different dietary fats,
each providing a specific FA, caused an acute response in HM FA composition, especially within
24 h, and that the response remained significantly elevated for 1–3 days after consumption of dietary
fat. Therefore, difference observed in HM FA composition may reflect variation in maternal diet [33].
However, a careful analyses of dietary habits of Guangzhou, Beijing, and Suzhou needs to be
performed for correlating to HM composition.
4.2. Phospholipids
Several studies have recognized the importance of PL for infant growth [39–41]. At the same time,
PL are involved in immunity and inflammatory responses [42], and in neuronal signaling [43].
PL content in HM significantly (p < 0.005) decreased along the lactation period from 33.0 in colostrum
to 24.2 mg/100 mL in mature milk, in agreement with previous studies performed elsewhere [12,44].
The PL class distribution was similar in colostrum, transitional and mature milk (Figure 2).
PL as emulsifiers are essential for the solubilization of dietary fats and as a consequence for their
digestion and absorption. In this regard, the higher content of PL in colostrum and transitional HM
compared to mature milk might explain the good fat absorption from HM by the newborn, despite
poor pancreatic secretion, as suggested by Harzer et al. [11]. A decrease in PL content in HM along the
lactation stage might occur because the diameter of the milk fat globule membrane increases [11,45],
decreasing the PL/TAG ratio [7,8].
Our study showed that PtdCho was the most abundant PL in HM (Figure 2), followed by CerPCho
and PtdEtn, and PtdIns and PtdSer, in agreement with previous studies [3,11,12,44,46]. PtdCho and
CerPCho are important sources of choline considered as an essential nutrient for infants. Choline is
a precursory amino alcohol of the neurotransmitter acetylcholine, it acts by regulating the transduction
signal, and serves as a source of methyl groups in intermediate metabolism, being considered
essential for optimum development of the brain [7,8]. In addition, CerPCho can reduce cholesterol
absorption between 20.4%–85.5%, depending on the ingested dose (0.1% and 5.0%, respectively) [47],
being possibly involved in cholesterol regulation programming.
The amount of total PL in colostrum (33.0 ± 13.2 mg/100 mL), transitional (28.5 ± 14.4 mg/100 mL),
and mature milk (24.2 ± 11.4 mg/100 mL), was comparable to the values reported by Bitman et al. [44]
(35, 31, and 27 mg/100 mL, respectively), Thakkar et al. [48] (20.8–24.2 mg/100 mL in mature milk),
and Garcia et al. [49] (15.3–47.4 mg/100 mL in mature milk); higher than the values reported by
Sala-Vila et al. [12] (13.5, 14.0, and 9.8 mg/100 mL, respectively), Lopez et al. [50] (13.5 mg/100 mL in
mature milk) and Zou et al. [51] (16.8, 22.3, and 19.2 mg/100 mL, respectively).
In the total population PtdCho contents in colostrum, transitional, and mature milk were
12.0 ± 5.8, 10.1 ± 5.5, and 8.2 ± 5.0 mg/100 mL, respectively, comparable to values reported in
literature, 4.3–11.2, 5.7–9.4, and 2.0–11.2 mg/100 mL, respectively [44,48–56].
CerPCho contents in colostrum, transitional, and mature milk were 9.1 ± 4.0, 7.3 ± 4.1,
and 7.2 ± 4.0 mg/100 mL, respectively, comparable to values reported in the literature of 5.3–11.0,
9.0–11.6, and 3.1–13.5 mg/100 mL, respectively [44,48–57].
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PtdEtn contents in colostrum, transitional, and mature milk were 8.5 ± 5.2, 8.2 ± 5.3,
and 6.4 ± 3.4 mg/100 mL, respectively, higher than values reported in the literature for colostrum
and transitional milk 1.4–6.4 and 1.5–5.6 mg/100 mL, respectively [44,51], and comparable to values
reported for mature milk of 0.2–8.1 mg/100 mL [3,11,12,44,48,49,51,52].
PtdIns and PtdSer contents in colostrum (1.8 ± 0.7 and 1.5 ± 1.6 mg/100 mL, respectively),
transitional (1.8 ± 1.0 and 1.1 ± 0.8 mg/100mL, respectively), and mature milk (1.5 ± 0.7 and
1.0 ± 1.1 mg/100 mL, respectively) were comparable to values reported in previous studies for
PtdIns, 1.4–3.3, 1.5–2.2, and 0.2–2.2 mg/100 mL, respectively, and for PtdSer, 2.1–3.6, 1.5–2.2,
and 0.8–4.5 mg/100 mL [44,48–51,53].
Among the different cities, Suzhou showed the highest total PL and PtdEtn levels in colostrum,
transitional, and mature milk (Table 3). Dietary sources of PtdEtn may be lecithin from rapeseed oil,
whose consumption may explain also the higher content of ALA in HM from Suzhou. However, a careful
analyses of dietary habits of this region needs to be performed for correlating to HM composition.
It is well known [58] that lipid and liposoluble nutrients content increases towards the latter
part of a feeding session, a phenomenon that has been corroborated by biochemical analyses of
total milk fat in fore-milk, and hind-milk [59,60]. Therefore, in order to assure sample homogeneity
in our study all efforts have been made to collect fully-expressed milk. Among the cited studies,
only Bitman et al., Thakkar et al., Holmes et al., and Fischer et al. [44,48,54,56] refer to full breast milk
samples, Sala-Vila et al. [12] to fore-milk, and no detailed sampling procedure is described in the other
studies. Analysis performed in fore-milk and hind-milk rather than fully-expressed milk could explain
the discrepancy among results.
4.3. Gangliosides
GD are widely distributed in almost all human tissues, with the highest amount found in neural
tissue and extra-neural organs, such the lung, spleen, and gut. It has been reported that during the
first stages of life, dietary GD may have an important role in preventing infections [61] and in cognitive
development functions [10,62].
Our data confirmed, as previously reported [14,16,17,29,63,64], that the amount of GD changes
during the lactation period, with GD3 decreasing and GM3 increasing over the lactation period.
Rueda et al. [15] postulated that a high concentration of GD3 in early milk may reflect its biological
role in the development of organs, such as the intestine, as was observed in our study in all cities.
The increase in GM3 in mature milk has been associated with signal transduction, cell adhesion,
and growth factor receptors, leading to the development of the immune and central nervous
systems [14,17,61]. In the studied population, the sum of GM3 and GD3 increased from 8.0 mg/L
in colostrum to 11.0 mg/L in mature milk, as previously published [29]. It has been reported [64] that
the sum of GM3 and GD3 can range from as low as 2 mg/L to as high as 25 mg/L, depending on
breast milk sampling, population demographics, diet, and analytical methodologies. In this study,
total ganglioside content ranged from 1.66–28.44 mg/L in colostrum, 2.77–22.04 mg/L in transitional
milk, and between 0.90–36.88 mg/L in mature milk, covering total GD contents previous reported,
i.e., 2.8–59.7 mg/L in colostrum [14,15,17,18,29,63,65], 0.9–30.7 mg/L in transitional [14,15,17,18,63,65],
and 1.6–68.6 mg/L in mature milk [14,15,17,18,29,48,63,65,66]. When considering average values,
in colostrum and transitional milk, GM3 content (3.8 and 5.5 mg/L, respectively) was lower than the one
reported by Ma et al. [63] (6.5–7.1 and 8.3–9.6 mg/L, respectively). Within mature milk, at 1–2 months
GM3 content (9.08 mg/L) was comparable to the one reported by Ma et al. [63,64] (8.3–11.3 mg/L) and
higher than the content reported by Thakkar et al. [48] (2.3–2.9 mg/L); after 3–8 months GM3 content
(10.46–12.92 mg/L) was lower than what reported by Ma et al. [63,64] (17.4–21.4 mg/L) and higher
than the content reported by Thakkar et al. [48] (3.9 mg/L). However, when considering minimum and
maximum values, GM3 contents (0.63–13.03, 1.01–17.71, and 0.8–34.41 mg/L, in colostrum, transitional,
and mature milk, respectively) were comparable with GM3 contents previously reported [48,63,64].
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As for GM3, when considering average values, in colostrum and transitional milk, GD3 content
(4.1 and 3.0 mg/L, respectively) was lower than the one reported by Ma et al. [63] (20 and 10 mg/L,
respectively). Within mature milk, at 1–2 months GD3 content (0.87 mg/L) was lower than the one
reported by Ma et al. [63,64] (4.6–7.0 mg/L) and by Thakkar et al. [48] (1.9–2.3 mg/L); after 3–8 months
GD3 content (0.25–0.50 mg/L) was lower than that reported by Ma et al. [63,64] (1.5–2.7 mg/L) and
by Thakkar et al. [48] (1.7 mg/L). However, when considering minimum and maximum values,
GD3 contents (0.6–18.0, 0.1–15.5, and 0.1–9.3 mg/L, in colostrum, transitional, and mature milk,
respectively) were comparable with GD3 contents previously reported [48,63,64]. Among the cities
Suzhou showed the highest GM3 and GD3 contents (Table 4) in colostrum and mature milk.
Ma et al. [64] suggested that the ganglioside concentrations in HM at any time point may be
influenced by the mother's dietary intake of gangliosides or their precursors. It was demonstrated [67]
that GD3 and GM3 are transferred across the human placenta using an ex vivo model of
dually-perfused isolated human placental lobules, suggesting that they are available to the developing
fetus. Therefore, a careful analysis of dietary habits in this region needs to be performed for correlating
to HM GD composition.
5. Conclusions
In this study, FA, PL, and GD contents and compositions of HM from lactating women living in
Suzhou, Guangzhou, and Beijing were evaluated.
HM was collected over a period of eight months, allowing the observation of lipid compositional
changes during lactation.
SFA, MUFA, and PL content decreased during lactation, PUFA and GD content increased.
Among different cities, over lactation time, HM from Beijing showed the highest SFA content, HM from
Guangzhou showed the highest MUFA content, and HM from Suzhou showed the highest n-3PUFA
content. The highest total PL and GD contents were observed in HM from Suzhou. In order to
investigate the influence of the diet on maternal milk composition, a careful analysis of dietary habits
of these population needs to be performed in future work.
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Abstract: Human milk is the optimal food for human infants, including infants born prematurely.
In the event that a mother of a hospitalized infant cannot provide breast milk, donor milk is considered
an acceptable alternative. It is known that the macronutrient composition of donor milk is different than
human milk, with variable fat content and protein content. However, much less is known about the
micronutrient content of donor milk, including nutritional antioxidants. Samples of breast milk from 12
mothers of infants hospitalized in the Newborn Intensive Care Unit until were collected and analyzed
for concentrations of nutritional antioxidants, including α-carotene, β-carotene, β-cryptoxanthin,
lycopene, lutein + zeaxanthin, retinol, and α-tocopherol. Additionally, a homogenized sample
of donor milk available from a commercial milk bank and samples of infant formulas were
also analyzed. Concentrations of nutritional antioxidants were measured using high-performance
liquid chromatography. Compared to breast milk collected from mothers of hospitalized infants,
commercially available donor milk had 18%–53% of the nutritional antioxidant content of maternal
breast milk. As donor milk is becoming a common nutritional intervention for the high risk preterm
infant, the nutritional antioxidant status of donor milk–fed premature infants and outcomes related to
oxidative stress may merit further investigation.
Keywords: antioxidants; breast milk; infant feeding; infant formula; breast milk substitutes; human milk
1. Introduction
Human milk is the optimal food for infants, including infants born prematurely. In the event
that a mother of a hospitalized infant cannot provide breast milk, donor milk is often considered an
acceptable or even ideal alternative to the mother’s own milk. It is known that the macronutrient
composition of donor milk is different from human milk, with variable fat content and protein content
lower than that of mature milk [1–4]. However, much less is known about the micronutrient content of
donor milk, including nutritional antioxidants.
There is increasing evidence that links early exposure to oxidative stress with potentially lifelong
consequences. The premature infant is especially susceptible to damage from oxidative stress for
two reasons: (1) adequate concentrations of antioxidants may be absent at birth; (2) the ability to
increase synthesis of antioxidants is impaired. This can lead to an increased risk for the development
of oxidative stress–induced diseases such as bronchopulmonary dysplasia (BPD), retinopathy of
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prematurity (ROP), necrotizing enterocolitis (NEC), and periventricular leukomalacia (PVL) [5,6].
Therefore, it is critical in premature infants to ensure an adequate supply of dietary antioxidants.
The objective of this analysis was to compare the nutritional antioxidant profile of different types of
feedings for premature infants, including samples of maternal breast milk collected during neonatal
hospitalization and pasteurized pooled donor milk.
2. Materials and Methods
A total of 12 breast milk samples from women with singleton infants who were admitted to
the Neonatal Intensive Care Unit were collected for analysis. These samples were obtained as a
subset of subjects (n = 30) who were enrolled in a study of nutritional antioxidant status of Newborn
Intensive Care Unit (NICU) hospitalized infants who had excess breast milk available after clinical
use. Institutional Review Board approval was obtained prior to collection of any samples. The median
gestational age was 37.1 weeks, with a range 30.3–42.0 weeks. A 2.0 mL sample was collected
from each participant in a sterile plastic tube, protected from heat and light, and stored at −80 ◦F
freezers until they were analyzed. In addition, a single 2 mL aliquot of the commercially available,
pooled donor milk sample was collected for analysis, and single 2 mL samples of the commercially
available preterm infant formula, transitional infant formula, and term infant formula used in
the study unit were collected. All formulas were from a single manufacturer (Abbott Nutrition®).
Analysis of samples was performed at the Biomarker Research Institute at the Harvard School of
Public Health. Measurements of lutein + zeaxanthin, β-cryptoxanthin, trans-lycopene, cis-lycopene,
total lycopene, α-carotene, trans-β-carotene, cis-β-carotene, total-β-carotene, retinol, α-tocopherol
and γ-tocopherol were obtained. Concentrations in plasma samples were measured as described
by El-Sohemy et al [7]. Plasma samples (250 μL) were mixed with 250 mL ethanol containing 10 μg
rac-tocopherol/mL (Tocol) as an internal standard, extracted with 4 mL hexane, evaporated to dryness
under nitrogen, and reconstituted in 100 mL ethanol-dioxane (1:1, by vol) and 150 mL acetonitrile.
Samples are quantitated by high-performance liquid chromatography (HPLC) on a Restek Ultra
C18 150 mm × 4.6 mm column with a 3 μm particle size encased in a column oven (Hitachi L-2350,
Hitachi, San Jose, CA, USA) to prevent temperature fluctuations, and equipped with a trident guard
cartridge system (Restek, Corp., Bellefonte, PA, USA). A mixture of acetonitrile, tetrahydrofuran,
methanol, and a 1% ammonium acetate solution (68:22:7:3) was used as the mobile phase at a flow rate
of 1.1 mL/min, with a Hitachi L-2130 pump in isocratic mode, a Hitachi L-2455 diode array detector
(300 nm and 445 nm), and a Hitachi L-2200 auto-sampler with water-chilled tray. The Hitachi System
Manager software (D-2000 Elite, Version 3.0) was used for peak integration and data acquisition.
Because lutein and zeaxanthin co-elute on the chromatogram, the two are grouped and provided as
lutein + zeaxanthin. Internal quality control was monitored with four control samples analyzed within
each run. These samples consisted of two identical high-level plasmas and two identical low-level
plasmas. Comparison of data from these samples allowed for within-run and between-run variation
estimates. In addition, external quality control was monitored by participation in the standardization
program for carotenoid analysis from the National Institute of Standards and Technology U.S.A.
Descriptive statistics included means and standard deviations. A one sample t-test was used to
compare the mean value from the 12 maternal breast milk (MBM) to the known value of the donor or
infant formulas values p < 0.05 was considered statistically significant.
3. Results
The results for the concentrations of α-carotene, total β-carotenes, β-cryptoxanthin, total lycopenes,
lutein + zeaxanthin, retinol, α-tocopherol, and γ-tocopherol for each of the feeding types are shown in
Table 1.
When the concentrations of carotenoids between the 12 breast milk samples and the pooled
donor milk sample were compared, the donor milk sample was descriptively lower in all carotenoids.
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A statistically significant difference was found between concentrations of total lycopene (p = 0.006).
A comparison of levels of carotenoids breast milk vs. donor milk is shown in Figure 1.
Table 1. Nutrition antioxidant content of infant feedings.
Nutritional Antioxidant
(μg/L)
Premature Formula Transitional Formula Term Standard Formula
Breast Milk Mean (SD)
N = 12 Donor Milk
α-carotene 0.51 1.40 0.5 7.7 (14.5) 3.6
β-carotene 71.1 63.9 25.0 49.1 (75.5) 13.7
β-cryptoxanthin 0.9 0.9 0.48 21.7 (40.0) 3.8
Lycopene 1.5 5.8 79.8 66.1 (55.9) 11.9
Lutein + zeaxanthin 65.5 56.9 58.4 40.1 (42.5) 21.4
Retinol 3086.2 911.8 571.2 401.6 (516.3) 185.8
α-tocopherol 20,109.1 13,360.2 8520.0 5880.8 (4971.7) 1381.9
γ-tocopherol 6787.1 6561.6 4204.0 1207.1 (668.4) 622.8
Figure 1. The concentrations of α-carotene, β-carotene, lycopene, and lutein + zeaxanthin in maternal
breast milk vs. donor milk samples. Lycopene was statistically significant (p = 0.006).
Samples of the transitional formula and premature formula were also significantly lower in
lycopene when compared to breast milk (p = 0.003 and 0.002, respectively) (see Table 1).
When concentrations of tocopherols between the 12 breast milk samples and the pooled donor
milk sample were compared, a statistically significant difference was found between concentrations
of both α- and γ-tocopherols (p = 0.009 and 0.01, respectively). A comparison of concentrations of
tocopherols in breast milk vs. donor milk is shown in Figure 2.
Figure 2. The concentrations of α-tocopherol and γ-tocopherol in maternal breast milk vs. donor
milk samples. All values were significantly different (p = 0.009 and 0.01 for α-tocopherol and
γ-tocopherol, respectively).
Samples of the transitional formula and premature formula were significantly higher in
α-tocopherol when compared to breast milk (p = 0.003 and 0.002) and all infant formulas were
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significantly higher in γ-tocopherol when compared to breast milk (p < 0.0001 for term, transitional,
and premature formulas) (see Table 1).
4. Discussion
Donor milk is considered to be an effective alternative source of nutrition when the mother’s
own milk is not available, and preterm infants are the primary recipients. Donor milk is obtained
from healthy, lactating mothers who consent to donate their surplus which is collected, processed,
and stored by specialized centers such as human milk banks. Donor milk is pasteurized to reduce
microbial growth and ensure its safety for consumption. The most common pasteurization procedure
is Holder pasteurization, in which milk is exposed to a temperature of approximately 62.5 ◦C (144.5 ◦F)
for at least 30 min [8]. Pasteurization is necessary to inactivate most viral and bacterial compounds,
but can affect the nutrition and immunological properties of breast milk. While it has been shown
that pasteurized mother’s milk retains some of the beneficial and protective effects [1,4,9] there does
appear to be an impact on the antioxidant capacity of donor milk [10,11]. Significant decreases in the
anti-oxidant compounds malondialdehye and glutathione have been found after pasteurization [12].
The pasteurization of human milk has also been shown to result in significant losses of vitamin D,
with reductions of 10%–20% [13].
Preterm infants are born relatively deficient in antioxidant defenses, with increased oxidant
stress [5]. Many events, such as infection, mechanical ventilation, intravenous nutrition, and blood
transfusions result in oxidative stress. Oxidative stress is associated with serious conditions in
the newborn, such as bronchopulmonary dysplasia (BPD), respiratory distress, retinopathy of
prematurity (ROP), and necrotizing enterocolitis (NEC), as well as an increased risk of infection [6].
Ensuring adequate nutritional antioxidant status may provide protective benefits to infants at an
increased risk of developing these conditions or may positively impact an infant’s recovery from
these complications.
Studies have shown that there are significant differences in the antioxidant capacity of different
types of infant feeding. One study has shown that the total antioxidant capacity in the breast milk of
mothers who deliver prematurely is higher than the breast milk of mothers who deliver at term [14],
while another study has found them to be equal [15]. However, both have superior antioxidant capacity
when compared to formula [15,16]. Breast-fed and formula-fed infants show significant differences in
plasma antioxidant nutrient concentrations [17]. The mother’s diet also affects the antioxidant capacity
of human milk. An increased consumption of dairy products, fruits and vegetables, cereals and nuts
has been shown to increase the total antioxidant capacity of the breastmilk [16].
Major nutritional antioxidants include α- and β-carotenes, lutein + zeaxanthin, lycopene,
and α-tocopherol. Humans cannot synthesize these compounds and thus they must be provided
exogenously through dietary intake. Carotene levels in colostrum have been shown to be five times
higher than in mature breast milk [17]. Similarly, breast-fed premature infants have been shown to
have higher serum carotenoids than formula-fed premature infants [18]. In one study, carotenoid
supplementation was associated with a blunted increase in C-reactive protein (CRP) concentrations
from one to 40 weeks post-menstrual age, whereas CRP levels rose in controls [19]. The association
of a lower CRP with higher carotenoid consumption likely reflects carotenoid antioxidant and
immunomodulatory properties. In populations of children with acute infections, a significant inverse
correlation was shown between serum CRP and carotene concentrations [20]. Plasma β-carotene
concentrations have indeed been found to be lower in infants with bronchopulmonary dysplasia [21],
which may result in a reduction of their antioxidant protection. Our study does report that β-carotene
concentrations in donor milk were less than one-third of those in fresh breast milk, and our p-value of
0.13, which approaches statistical significance, may be more likely due to the limited power of our
study. This may indicate that further investigation into carotenoid anti-inflammatory effects in sick,
preterm infants is warranted.
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It is thought that lutein + zeaxanthin influence the maturation of cells in the macular region
of the retina [22] and protect against stress and oxidation in the retinal pigment epithelium [23].
Vishwanathan et al. determined that the mean concentration of lutein was significantly greater than
the other carotenoids in brain tissue samples of infants who died within the first 18 months of life [22].
Preterm infants also had significantly lower concentrations of lutein + zeaxanthin compared to term
infants in most of the brain regions [22]. These findings, in addition to previous research, help support
the role lutein + zeaxanthin plays in visual and cognitive development. Breast-fed infants have
been shown to have higher serum lutein levels than formula-fed infants, possibly due to increased
bioavailability of the compound in breast milk, and a dose-dependent relationship exists between
lutein in the diet and lutein in the serum [24]. It was calculated that four times more lutein is needed in
infant formula than in human milk to achieve similar serum lutein concentrations among breast-fed
and formula-fed infants [24]. In a recent pilot randomized controlled trial in healthy newborns,
lutein administration proved effective in increasing the levels of biological antioxidant potential
by decreasing the total hydroperoxides as markers of oxidative stress [25]. In another study by
Mazoni et al., the effect of lutein + zeaxanthin on prevention of BPD appears relevant, although not
statistically significant (p = 0.07) [26]. Lutein supplementation also has been shown to result in greater
rod photoreceptor sensitivity responses when compared to controls [19]. A pilot study showed a
potential antioxidant effect of lutein in the neonatal period [25]; however, another study showed that
lutein supplementation did not enhance the biological antioxidant capacity [27], although this second
study did not achieve a statistically significant difference in the serum lutein concentrations between
the placebo and intervention group. A positive association was seen between plasma lutein levels
and total antioxidant status (r = 0.13, p = 0.02) [27]. Our study finds that concentrations of lutein +
zeaxanthin were approximately half of the concentrations found in maternal breast milk. Both donor
milk and maternal breast milk had lower lutein + zeaxanthin concentrations when compared to the
infant formulas tested; however, given the study that demonstrated possible improved bioavailability
from breast milk [24], it cannot be assumed that the formula-fed infants would have higher serum
concentrations. Additionally, it is important to note that not all formula manufacturers provide
supplemental lutein in preterm formula, and therefore infant intake may vary widely based on
formula selection.
Vitamin E is an antioxidant that protects cell membranes against free radicals [28].
Although vitamin E deficiency is thought to be rare in healthy adults, it is much more common
in premature infants [29]. Vitamin E occurs naturally in several different isoforms, including α- and
γ-tocopherol. These isoforms differ by one methyl group and are not interconvertible in human
metabolism [30]. As a result, increased intakes of α- or γ-tocopherol will cause a rise in serum
concentrations of that specific tocopherol [31,32]. Importantly, serum and tissue levels of vitamin E
isoforms correlate [33], meaning the dietary intake of tocopherols has the potential to influence
biological mechanisms.
One change in infant nutrition that has occurred in the last several decades is the increase in the
γ-tocopherol isoform in the diet of infants. This is primarily due to in the use of soy oils, which are
extremely high in γ-tocopherol, as the primary lipid component in infant formulas [34]. While human
breast milk has been shown to contain some γ-tocopherol, previous studies have shown the content of
γ-tocopherol in infant formula to be up to seven times higher than that in human milk [35]. Our findings
concur with this report, demonstrating γ-tocopherol levels in our formula samples to be 3.5–5.6 times
higher than in maternal breast milk samples. This level of γ-tocopherol in infant formula does not
appear to provide similar protection from lipid peroxidation as human milk [36]. Serum levels of
γ-tocopherol in infants have been shown to increase during the first week of life [37], presumably from
dietary sources [35]. Recently, our understanding of these tocopherols isoforms has expanded as new
evidence indicates that vitamin E isoforms have different roles in influencing inflammation. In contrast
to the anti-inflammatory properties of the α-tocopherol isoform, the γ-tocopherol isoform has been
shown to increase cytokine production (i.e., IL-2) and demonstrate pro-inflammatory properties [38–42].
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Importantly, serum γ-tocopherol isoforms at as little as 10% of the concentration of α-tocopherol
have been shown to ablate the anti-inflammatory benefit of alpha-tocopherol [41]. With regard to
α-tocopherol, long-term supplementation (six months minimum and up to 24 months) has been shown
to positively impact mental development, particularly intelligence quocient (IQ), in school-age children
who were extremely low-birth-weight infants (ELBW) [43], raising the possibility that α-tocopherol
might be a functional molecule in a developing brain. Although some NICU infants receive donor milk
for only a limited amount of time, other institutions use donor milk as a primary source of nutrition
throughout NICU hospitalization; our finding that α-tocopherol levels in donor milk samples were
significantly decreased when compared to breast milk may make consideration of vitamin E status
important in these infants.
Donor milk still has unique advantages compared to formula and continues to represent
an important alternative if maternal milk is not available, specifically with regard to necrotizing
enterocolitis [44]. In a Cochrane systematic review and meta-analysis, Quigley et al. demonstrated
both benefits and risks associated with the use of donor milk. Importantly, there was a higher incidence
of NEC among infants with birth weights <2500 g and in those fed formula versus those fed donor
milk (relative risk of 2.5 (95% CI, 1.2, 5.1) [44]. Because NEC is the most common gastrointestinal
emergency among very-low-birth-weight (VLBW) infants, its prevention is a powerful argument in
favor of donor milk as an alternative supplement to formula when the mother’s own milk is not
available. The Quigley et al. review and meta-analysis, however, concluded that infants fed donor
milk experienced slower weight (p < 0.0001), length (p < 0.0003) and head circumference (p < 0.0001)
gains than those fed formula [44]. These risks associated with donor milk are of significant concern
because VLBW infants are born with impoverished nutrient reserves, and are subject to metabolic
stresses that further elevate nutritional requirements [45]. Nutrient deficits and sub-optimal growth
have significant long-term neurodevelopmental consequences [46,47]. Quigley et al. point out that
all but one of the randomized controlled trials examined in their meta-analysis were >25 years old,
when smaller VLBW infants did not survive, and these studies also may not be reflective of current
practice [44]. In a more recent study conducted in 2012–2014, The Early Nutrition Study Randomized
Clinical Trial found no difference in infections, necrotizing enterocolitis, or mortality during the
first 60 days of life in 373 infants fed pasteurized donor milk or preterm formula for supplemental
feedings [48]. Another study 2014 of 201 ELBW infants found no difference in NEC or infection rates
between infants receiving human milk (including donor milk) and infants receiving formula; however,
the duration of mechanical ventilation was significantly higher among formula-fed infants (24 vs. 60 h,
p = 0.016) in the group exposed to formula [48].
Our analysis has several limitations. First, the antioxidant capacity of breast milk includes many
other compounds than the ones highlighted in this study, including uric acid, enzymes, and lipids.
However, the antioxidants targeted in this study are modifiable by maternal diet, which may allow for
interventions targeted at increasing the antioxidant potential of human milk. Additionally, we did
not have the serum levels of donor milk–fed infants to compare to infants receiving maternal breast
milk to compare the impact of decreased intake. Additionally, our statistical power was limited by
low numbers of analyzed breast milk, a precious commodity to a premature neonate. The median
gestational age of 37 weeks in our cohort includes preterm breast milk samples, and the donor milk
samples are from a commercial pooled supply. Future studies evaluating the serum nutritional
antioxidant status of infants receiving the mother’s own milk, donor milk, and infant formulas will
expand our knowledge in this area.
5. Conclusions
As donor milk is becoming a common nutritional intervention for the high risk preterm infant,
the nutritional antioxidant status of donor milk–fed premature infants and outcomes related to
oxidative stress may merit further investigation.
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Abstract: Breast-fed infants may depend solely on an adequate supply of iodine in breast milk for the
synthesis of thyroid hormones which are essential for optimal growth and cognitive development.
This is the first study to measure breast milk iodine concentration (BMIC) among lactating women in
Western Australian (n = 55). Breast milk samples were collected between 2014 and 2015 at a mean
(±SD) of 38.5 (±5.5) days post-partum. The samples were analysed to determine median BMIC
and the percentage of samples with a BMIC < 100 μg/L, a level considered adequate for breast-fed
infants. The influence of (a) iodine-containing supplements and iodised salt use and (b) consumption
of key iodine-containing foods on BMIC was also examined. The median (p25, p75) BMIC was 167
(99, 248) μg/L and 26% of samples had a BMIC < 100 μg/L. Overall, BMIC tended to be higher with
iodine-containing supplement usage (ratio 1.33, 95% confidence interval (CI) (1.04, 1.70), p = 0.030),
cow’s milk consumption (ratio 1.66, 95% CI (1.23, 2.23), p = 0.002) and lower for Caucasians (ratio 0.61,
95% CI (0.45, 0.83), p = 0.002), and those with secondary school only education (ratio 0.66, 95% CI
(0.46, 0.96), p = 0.030). For most women, BMIC was adequate to meet the iodine requirements of their
breast-fed infants. However, some women may require the use of iodine-containing supplements or
iodised salt to increase BMIC to adequate levels for optimal infant nutrition.
Keywords: iodine; breast milk; supplementation; iodine status
1. Introduction
Iodine, an essential nutrient, is required by humans for the synthesis of thyroid hormones which
are vital for normal growth and development [1,2]. A regular and adequate supply of iodine is
particularly important during the critical period for brain and central nervous system development,
namely, from the second trimester of pregnancy to 3 years of age [1]. Iodine deficiency during this
time results in a spectrum of adverse effects known as iodine deficiency disorders, with the most
severe outcomes, irreversible mental impairment and cretinism, resulting from severe iodine deficiency
during pregnancy. In infants, iodine deficiency leading to inadequate thyroid activity results in delayed
growth and physical development, and impaired cognitive function [1,2].
During intrauterine life, iodine is transferred from the mother to the fetus [3]. This results in a
pool of iodine stored in the fetal thyroid gland, with the size of the pool strongly reflecting maternal
dietary iodine intake. However, even under conditions of maternal iodine sufficiency, this fetal iodine
pool is small and turns over rapidly after birth to partly support the iodine demand of newborns [4].
Infants, however, rely solely on dietary sources to meet their iodine needs. Breast-fed infants are
particularly vulnerable to iodine deficiency as they may be completely dependent on the iodine
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concentration of breast milk for their intake of iodine [5]. Consequently, maternal iodine requirements
are increased during breastfeeding to provide sufficient amounts for the mother and to also meet the
iodine demands of the developing infant, via breast milk. Given that 40%–45% of the iodine ingested
by the mother appears in breast milk [6], a maternal iodine intake during breastfeeding of 190 μg/day
(Australian Estimated Average Requirement (EAR)) would provide just under the Australian Adequate
Intake (AI) of 90 μg/day for infants aged 0–6 months [7]. This is achieved by a physiological response
during breastfeeding whereby iodine is strongly concentrated by the lactating mammary gland due
to the increased expression of the sodium iodide symporter, the main iodine transporter in lactating
breast cells [8]. This results in human milk having an iodine concentration 20–50 times higher than
that of plasma [4].
Breast milk iodine concentration (BMIC) is influenced by, and may be an indicator of, maternal
iodine status during breastfeeding [4,5,8–11]. BMIC is also influenced by other factors including recent
maternal iodine intake [12] and duration of lactation [5]. While no reference ranges for the adequate
iodine concentration of breast milk have been specified, values above 75 μg/L have been suggested to
indicate sufficient maternal iodine intake [4]. An iodine balance study of full-term infants found that a
positive iodine balance is only achieved when iodine intake is 15 μg/kg per day, which equates to a
BMIC of 100–200 μg/L [8].
A wide range of median or mean BMIC values has been reported in several reviews conducted in
areas of varying iodine sufficiency [4,8,10]. BMIC typically ranges from <50 μg/L in iodine-deficient
areas [5] to 100–150 μg/L in areas of iodine sufficiency [4] and as high as 150–180 μg/L in areas of
good iodine supply [8,10]. A BMIC < 100 μg/L has been identified in studies from France, Germany,
Belgium, Sweden, Spain, Italy, Denmark, Thailand and Zaire while studies from Iran, China, USA
and some parts of Europe have identified above this level [4]. A recent study in Nepal identified
a median BMIC of 250 μg/L, and the estimated iodine intake of the infants involved (0–6 months)
was 200 μg/day [13]. WHO’s recommended maximum iodine intake for infants <2 years old is
180 μg/day [14], therefore some infants in this area may be consuming excessive iodine intakes
through breast milk [13]. This can result in subclinical hypothyroidism and permanently affect their
neurodevelopment [15].
In recent decades, Australia has been regarded as a country with mild iodine deficiency.
Two initiatives introduced in response to the re-emergence of this public health issue are the mandatory
fortification of all bread (except organic) with iodised salt in 2009 [16] and the 2010 National Health
and Medical Research Council recommendation that all pregnant and breastfeeding women take a
daily supplement containing 150 μg of iodine [17]. Despite this recommendation, only two studies
have examined the iodine content of breast milk in Australia to assess either iodine provision to
breastfed infants or maternal iodine status. The first was a small (n = 50) cross-sectional study of
breastfeeding women in Sydney, conducted more than a decade ago and prior to mandatory iodine
fortification. This study identified a median BMIC of 84 μg/L [18], indicating inadequate maternal
iodine intake based on the adequate cut-off of 100 μg/L. The second larger and more recent study
compared the BMIC of lactating women in South Australia pre- (n = 291) and post- (n = 653) mandatory
fortification. The median BMIC of samples from both periods were indicative of adequate breast milk
iodine levels, however, BMIC was significantly higher in the post-fortification samples compared with
the pre-fortification samples (187 vs. 103 μg/L; p < 0.05) [19].
To date, there is no information regarding BMIC for lactating mothers in Western Australia (WA),
nor for iodine status of WA breastfeeding women. WA has long been considered an iodine-sufficient
area of Australia, based on measures of iodine status in studies involving school-children and
adults [20,21]. However, this outcome may not reflect the iodine status in breastfeeding women,
who have substantially greater requirements for iodine [1]. In the present study we examined BMIC in
breastfeeding women in a local cohort to determine adequacy of iodine provision to breastfed infants.
We also investigated the influence of iodine-containing supplements and iodised salt use, as well as
the consumption of key iodine-containing foods, on this biomarker of iodine status.
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2. Materials and Methods
2.1. Subjects and Design
Participants were recruited in 2013–2014 as part of the Perth Iodine and Pregnancy Study II
(PIPS II) via advertising (flyer in private women’s ultrasound practices n = 15 and newspaper, radio
and websites n = 7), in-person by study coordinator (public maternity hospital antenatal clinics n = 21
and pathology centre n = 3) and word of mouth (n = 8). At the time of recruitment, women were aged
18 years and over and were in the first or second trimester of pregnancy (gestation range 5–22 weeks).
Other inclusion criteria were no history of thyroid disease, not currently taking thyroid medication,
having a singleton birth and not currently breastfeeding but with the intention to breastfeed their
baby. Women were excluded from the study if English was not the main language spoken at home.
The study was approved by the Curtin University (Approval No. HR 47/2013; 15 April 2013) and
Women and Newborn Health Service Human Research Ethics Committees (Approval No. 2014075EW;
4 August 2014) and informed written consent was obtained from each participant.
Breast milk samples were collected between February 2014 and August 2015. Participants were
mailed vials for sampling together with instructions to provide (duplicate) 5 mL nonfasted breast milk
samples at home at the start of a single morning feed (preferably between 0900 and 1200 h) when
their baby was aged 4–6 weeks. Women were asked to record baby’s age and time of day of sampling.
Participants were also asked to provide information on current medication use, daily use of dietary
supplements, daily intake (yes/no) of any amount of six key iodine-containing foods (cow’s milk,
cheese, ice cream, yoghurt, bread/bread products, eggs), use of iodised salt (yes/no) and whether
or not they smoke cigarettes. Sociodemographic characteristics of the women, namely parity, age,
postcode, ethnicity, household income and education, had been collected previously.
2.2. Laboratory Procedures
Breast milk samples were stored at −20 ◦C from time of sampling until collection and then
at −80 ◦C until analysis. After thawing, milk samples were homogenized before analysis by
inductively coupled plasma mass spectrometry (ICPMS) in an accredited commercial laboratory
(PathWest Laboratory Medicine WA, Nedlands, Australia). ICPMS is considered the gold standard to
determine iodine concentration in complex sample matrices such as breast milk [9,22]. An optimised
ICPMS method for breast milk has been published recently [22] and was adapted for this study.
In brief, sonicated breast milk samples were diluted in mild alkali solution, ionized with inductively
coupled plasma and the ions separated and quantified in a Perkin Elmer NexION 300 ICP-MS mass
spectrometer (PerkinElmer Inc., Waltham, MA, USA).
2.3. Statistical Analysis
Distributions of BMIC were skewed and descriptive statistics reported as medians and 25th,
75th percentile. The proportion of women with BMIC < 100 μg/L, the suggested cut-off for providing
an adequate iodine supply to breast-fed infants, was also determined. Statistical analyses of BMIC
were carried out on the log base 10 scale to better approximate normality. Multiple regression analyses
were used to assess associations of BMIC with: (a) use of iodine supplements and iodised salt; (b) daily
consumption of six key iodine-containing foods (yes/no); and (c) all studied factors simultaneously.
Associations of cohort characteristics with use of iodised salt or iodine supplements were assessed via
logistic regressions. Data were analysed using IBM SPSS version 20 (IBM Corporation, Tokyo, Japan)
and TIBCO Spotfire S+ version 8.2 (TIBCO Software Inc., Boston, MA, USA). A 5% level of significance
was chosen.
3. Results
Sociodemographic characteristics of the 55 study participants are shown in Table 1. The mean
age (±standard deviation (SD)) of the study women was 31.4 (±4.7) years. This is consistent with
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the average age of women who gave birth in WA in 2013 of 29.8 years [23]. The majority of women
were pregnant for the first time (52.7%), were tertiary educated (72.3%), had a total household income
of >$AUS100K (67.3%) and were Caucasian (80.0%). Compared with available Western Australian
data from the Australian Bureau of Statistics Census 2011, our cohort included an over representation
of women with a higher reported education level and higher household incomes [24]. All women
provided breast milk samples, however one woman was excluded as she reported being a smoker,
thus leaving 54 women for breast milk analysis. Breast milk samples were collected at 28–56 days
postpartum with a mean (±SD) of 38.5 (±5.5) days. All samples were provided in the morning between
0600 h and 1200 h. The median (p25, p75) BMIC was 167 (99, 248) μg/L indicating adequate maternal
iodine intake for the group. However, 26% of women had BMIC less than the suggested cut-off level
for adequacy of 100 μg/L (see Figure 1).






Secondary school 7 12.7
Trade or technical 3 5.5
Diploma 5 9.1
Professional 2 3.6
Bachelor degree 22 40.0









1 Tertiary educated includes Professional, Bachelor degree and Postgraduate university.
Figure 1. Percentage distribution of breast milk iodine concentration (BMIC) (μg/L).
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Thirty-one women (57.4%) reported the daily use of an iodine-containing supplement, some of
which contained less than the amount recommended (i.e., 150 μg). Use of iodised salt and
iodine-containing supplements were independently associated with increases of similar magnitudes
in BMIC (ratio 1.37, 95% CI (1.05, 1.80), p = 0.025 and ratio 1.37, 95% CI (1.04, 1.79), p = 0.029,
respectively—see Table 2). There was no significant difference (p = 0.96) between the median
BMIC values for the use of either iodised salt or iodine-containing supplements without the other.
Among all cohort characteristics jointly considered only low household income (<$AUS50K) remained
significantly (negatively) associated with iodine supplement usage (1/8 vs. 30/46, p = 0.010 Fisher test).
Exactly half of the women reported using iodised salt, with usage higher among non-Caucasians
(10/11 vs. 17/43, p = 0.005).
Table 2. Effect of iodine supplement and iodised salt use on BMIC.
n Median BMIC (μg/L)
Yes supplement + Yes salt 15 272 **
Yes supplement + No salt 16 151 *
No supplement + Yes salt 12 156 *
No supplement + No salt 11 98 **
Overall p = 0.028; * There was no difference between the ‘Yes supplement + No salt’ and ‘No Supplement +
Yes salt’ groups (p = 0.960); ** There was a significant difference between the ‘Yes supplement + Yes salt’ and
‘No supplement + No salt’ groups (p = 0.003).
For the six key iodine-containing foods, the majority of women reported daily consumption
of bread/bread products (79.6%) and cow’s milk (77.8%) and with just less than half of women
(46.3%) reporting daily intake of cheese. Furthermore, about a third of women (37.0%) reported daily
consumption of yoghurt, around a quarter (27.8%) ate eggs daily and 5.6% of women said they ate
ice cream each day. However, only daily cow’s milk intake was significantly associated with higher
BMIC values after adjusting for the other foods or on its own (ratio 1.44, 95% CI (1.01, 2.06), p = 0.49
and ratio 1.44, 95% CI (1.03, 2.01), p = 0.040, respectively). None of the other foods were significant,
jointly or marginally, in influencing BMIC values. Furthermore, cow’s milk remained the only food
positively associated with BMIC after adjustment for iodine-containing supplements and iodised salt
use (ratio 1.50, 95% CI (1.10, 2.04), p = 0.013). Overall in the joint model, BMIC tended to be higher
with iodine-containing supplement usage and cow’s milk consumption and lower for Caucasians and
those with secondary school only education (see Table 3).
Table 3. Significant joint explanatory variables for BMIC *.
Variable Ratio ** (95% CI) p-Value
Caucasian ethnicity 0.61 (0.45, 0.83) 0.002
School only education 0.66 (0.46, 0.96) 0.030
Iodine supplement use 1.33 (1.04, 1.70) 0.030
Cow’s milk consumption 1.66 (1.23, 2.23) 0.002
* Analyses carried out on the log BMIC scale with non-significant terms (sociodemographic and dietary factors)
removed by backwards elimination; ** Exponentiated coefficient from the joint model for log (BMIC) predicts the
ratio of BMIC for the listed category relative to those not in the category, given fixed values of the other variables.
4. Discussion
This is the first study to report BMIC values for breastfeeding women in Western Australia.
The median BMIC value of women would provide an adequate iodine supply for breastfed infants.
However, BMIC levels were below the suggested adequate cut-off (100 μg/L) for 26% of women,
indicating some infants may be at risk for iodine deficiency, especially if exclusively breast-fed as is
recommended. These findings are consistent with results for the post-fortification cohort of the recent
South Australian study. However, compared to our study, the proportion of women with BMIC below
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the adequate cut-off level was considerably lower in the study by Huynh et al. (26% vs. 13%) [19].
The one participant who reported being a smoker in the present study was excluded from breast
milk analysis as the chemical thiocyanate found in cigarettes competitively inhibits the sodium iodide
transporter in the lactating breast and impairs iodine transport into breast milk [25], thereby distorting
BMIC values.
Despite the NHMRC recommendation for all breastfeeding women to use a daily 150 μg iodine
supplement, only about half of the women (54%) in the present study reported behaviour consistent
with this (an additional two women reported use of a daily iodine supplement containing less than
the recommended iodine amount). In a recent study of breastfeeding women conducted in regional
New South Wales (n = 60), iodine-containing supplements were being taken by 45% of women,
although frequency of use and iodine content were not documented [26]. These results suggest a
low level of awareness and/or compliance amongst Australian breastfeeding women regarding the
national iodine supplement recommendations. In contrast, 90% of South Australian women in the
post-fortification cohort reported use of supplements containing any iodine [19], although again
details of frequency of use and iodine content were not documented. Furthermore, given the low
use of iodine-containing supplements in low income cases compared to higher income participants
(12.5% vs. 65.2%, respectively) in the present study, perhaps the availability of government subsidized
iodine supplements is warranted in Australia, as is the case in New Zealand. Interestingly, in the
Perth Infant Feeding Study Mark II conducted in 2002–2003 prior to the supplement recommendation,
no breastfeeding women reported taking iodine supplements [27].
In addition, 50% of women in the present study reported using iodised salt. This is similar to the
45% of lactating women using iodised salt in the regional New South Wales study by Charlton et al. [26].
In the present study, use of iodised salt was significantly higher among non-Caucasians (p = 0.013),
possibly explaining why BMIC tended to be higher in non-Caucasian mothers compared with
Caucasian mothers (p = 0.002). This later finding is consistent with the results of the South Australian
study by Huynh et al. [19].
As shown in Table 2, use of both iodine-containing supplements and iodised salt together resulted
in the highest median BMIC value (272 μg/L). The use of either iodine-containing supplements
or iodised salt had similar positive effects on median BMIC values, suggesting both methods are
equally effective in improving the iodine content of breast milk. Our results are consistent with other
recent studies that have examined the effect of supplementation and/or iodised salt use on breast
milk iodine content [28,29]. The lowest median BMIC was recorded for those women using neither
iodine-containing supplements nor iodised salt. This median BMIC value of 98 μg/L is borderline for
inadequate BMIC using the cut-off of 100 μg/L. This suggests that for women in our study, food sources
alone may not provide the amounts of iodine required during breastfeeding to meet maternal and
infant needs. Furthermore, given breast milk samples in the present study were provided in the early
post-partum period and BMIC of iodine-deficient lactating women has been shown to decrease in
the first 6 months postpartum [5], the use of some form of iodine supplementation by these women
is important.
Of the six key iodine-containing foods examined in the study, only daily cow’s milk consumption
was significantly associated with higher BMIC values, independent of other foods and supplement
and iodised salt use. Some cow’s milk was consumed daily by more than three-quarters of women in
the study. Despite quantity not being examined in the present study, this suggests the importance of
cow’s milk consumption in terms of iodine intake for breastfeeding women. Interestingly, milk and
dairy foods were the highest contributors to iodine intake in the study by Charlton et al. which used a
self-administered validated iodine-specific food frequency questionnaire to assess dietary iodine intake
of Australian breastfeeding women [26]. Conversely, daily consumption of bread/bread products
was not associated with higher BMIC values, despite the fact that a very high proportion of women
reported consumption of these foods daily and their known fortification with iodine. This finding
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therefore questions the impact of the bread fortification initiative for lactating women in relation
to BMIC.
There are some limitations to the interpretation of our study findings. Firstly, the impact of time
of supplement intake, iodised salt use and consumption of key iodine-containing foods relative to
breast milk sampling were not examined. Leung et al. [12] reported a rise in BMIC following acute oral
ingestion of 600 μg potassium iodide, with peak levels at 6 h post-ingestion, and concluded that recent
maternal iodine intake would influence the interpretation of BMIC values. Furthermore, as BMIC
values fluctuate throughout the day, single breast milk samples provide an imprecise measurement of
daily iodine output or maternal iodine sufficiency [30]. In addition, actual compliance with reported
supplement use, use of iodised salt or intake of foods examined in the 24-h prior to breast milk
sampling could not be confirmed with participants. Finally, while the study included a cross-section of
breastfeeding women from both public and private health care systems, the sample size is relatively
small and all women who participated (bar one) lived in the Perth metropolitan area, so generalisability
of results to the wider breastfeeding population is made with qualifications.
5. Conclusions
Despite these limitations, for the majority of women in the present study, BMIC was adequate
to meet the iodine requirement of their breast-fed infants. However, the study also indicates that
some breast-fed infants may be at risk of iodine deficiency, which could potentially be reduced by
the maternal use of iodine-containing supplements and/or iodised salt. Further studies of women
representing the social and regional diversity of the population will be needed to confirm our findings.
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Abstract: Cytokines and growth factors in colostrum and mature milk may play an important
role in infant immune maturation, and may vary significantly between populations. We aimed
to examine associations between environmental and maternal factors, and human milk (HM)
cytokine and growth factor levels. We recruited 398 pregnant/lactating women in the United
Kingdom, Russia, and Italy. Participants underwent skin prick testing, questionnaire interview,
and colostrum and mature milk sampling. HM cytokine and growth factor levels were quantified
by electro-chemiluminescence. We found significant geographical variation in growth factor levels,
but no evidence of variation between sites in cytokine detectability. There was an inverse correlation
between time of milk sampling and growth factor levels in colostrum for Hepatocyte Growth Factor
(HGF) and TGFβ1 and TGFβ3, but not TGFβ2, and levels were significantly higher in colostrum
than mature milk for all growth factors. The kinetics of decline were different for each growth factor.
Cytokines were present at much lower levels than growth factors, and the decline over time was less
consistent. HM growth factors and cytokine levels vary between populations for unknown reasons.
Levels of HM mediators decline at different rates postpartum, and these findings suggest specific
biological roles for HM growth factors and cytokines in early postnatal development.
Keywords: colostrum; human milk; immune modulators; immunologically active molecules;
cytokines; growth factors; environmental influence
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1. Introduction
Human milk (HM) is usually the first source of nutrition for a newborn, and an important factor
assisting infants in the first months of life, not only as a nutrition source but also as a manner of
adapting infants to their extra-uterine environment. Breastfeeding is known to have positive short- and
long-term effects on child health, although its influence on allergy development is still debatable [1].
There have been few attempts to investigate relationships between maternal and environmental factors
and immune active profiles of HM. Data from a variety of studies suggest that factors such as country
of maternal origin, diet, exercise, and exposure to smoke or farming environment in early life may
influence colostrum and HM constituents [2–22].
It has been shown that Hepatocyte Growth Factor (HGF) is known to regulate vascular endothelial
growth factor (VEGF) production from endothelial cells [23] and complements VEGF biological activity
in the infant gut [24]. HGF levels in maternal serum change throughout pregnancy, peaking at
30 to 40 weeks of gestation and then decreasing upon delivery [25]. As levels of HGF are 20 to 30 times
higher in colostrum than in maternal serum [26] it is reasonable to propose that HGF is actively
excreted into HM in order to support infant’s gut immunity maturation and growth.
Inverse relationships between the risk of atopic diseases, associated with T-helper lymphocyte
type 2 (TH2) immune response, and indicators of early-life exposure to infections, such as high birth
order or sibship size, early attendance at day care, and early exposure to pets or other animals are
well described [27]. The “hygiene hypothesis” remains one of the most popular current hypotheses
on early-life exposures and allergy risk [28]. It has been suggested that farming environment [6],
higher bacterial exposure [7], or maternal country of origin [5] may have significant impacts on HM
immune composition, and such effects on HM composition may be an important pathway through
which early variations in microbial exposures influence risk of allergy development.
Our study aimed to prospectively investigate the relationship between maternal and
environmental factors and levels of HGF, Transforming Growth Factor beta (TGFβ)1,2,3 and
detectability of TH1 and TH2 cytokines using colostrum and HM samples collected from birth cohorts
in three regions; the UK, eastern Europe, and continental Europe.
2. Materials and Methods
2.1. Study Setting, Eligibility Criteria, and Ethics
The investigations and sample collection have been conducted following ethical approval
by Ethics committee in three countries participating in the study: West London Rec 3 (UK)
(Ref. number 10/H0706/32) and all paperwork has been completed according to the hospital R&D
Joint Research Office (UK) (JROSM0072) policy; Ethical Committee of the Azienda Ospedaliera di
Verona (Italy) (approval No. 1288), and Moscow Institute of Paediatrics and Child Health of Ministry
of Health of Russian Federation (Russia) (approval No. 1-MS/11). All women provided written
informed consent.
Women were enrolled at antenatal and postnatal units of three participating centres—St. Mary’s
Hospital, London, UK; Maternity Hospital No. 1, Moscow, Russia; G.B. Rossi Hospital, Verona, Italy.
Inclusion criteria for the study were: healthy term infants and their mothers intending to breastfeed
and willing to comply with the study procedures.
Exclusion criteria were: maternal immunosuppressive treatment during lactation, or severe
illness; infants with a major birth defect, admitted to neonatal intensive care, other severe illness, born
prematurely (<37 weeks gestation), or with low birth weight (<2nd centile).
2.2. Medical Records and Interview
Following enrolment, participants underwent allergy skin prick testing (SPT) and answered
a 10 min interview-based questionnaire regarding their medical history. Exposure variables recorded
were selected based on a detailed review of known determinants of HM composition [29].
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Information collected from the recruited women included parity; age; mode of delivery; details of
residence environment, such as mould presence at home, regular contact with animals and/or pets at
home; exposure to tobacco smoke (smoker or living in household with smoker or self-reported passive
smoker); any reports of infections during pregnancy. We also obtained information on maternal dietary
preferences—fish, fresh fruit, and probiotic intake. Participant medical records were reviewed by study
personnel to extract relevant health information which was not available from questionnaires, prior to
breast milk analysis. SPT was undertaken using the following solutions: Histamine 1% Positive Control,
Glycerol Negative Control, House Dust Mite (Dermatophagoides pteronyssinus), Cat (Felix domesticus),
Grass Pollen, Birch pollen, Peanut, Hazelnut, Egg (all from Stallergenes, SA 92160 Anthony, France),
and Cow’s milk (ALK-Abello, Hǿrsholm, Denmark). SPT was performed by standard technique using
1 mm lancets (ALK-Abello, Hǿrsholm, Denmark), and were read at 15 min. Allergic sensitization was
defined as a wheal ≥3 mm to at least one allergen, in the context of a wheal ≥3 mm to histamine and
no wheal to the negative control.
2.3. Human Milk Sampling
Participants were given sterile tubes to collect their own colostrum (once in the first 6 days
of life) and mature HM (once at 4–6 weeks postpartum). Local site investigators and participating
mothers were asked to collect colostrum or milk at the first morning breastfeed, by manual expression
(colostrum) or collecting the drip (mature milk) from the contra-lateral breast during feeding [15].
Colostrum samples were frozen at −50 ◦C to −80 ◦C within 12 h of collection. HM samples were
collected at home, stored in the fridge for not longer than 4 h, and transported to participating units by
study staff, and frozen at 50 ◦C to −80 ◦C within 12 h of collection. It has been previously demonstrated
that storage for 6 months at either −20 ◦C or −80 ◦C did not influence the concentration of immune
active factors in human milk [30]. After thawing, samples were centrifuged at 1500× g for 15 min
at 4 ◦C. The lipid layer was removed with a pipette and aqueous fraction was analysed for immune
modulators [31]. All milk samples were transported to London at −70 ◦C where the samples were
stored at −80 ◦C until analysis.
2.4. Electro-Chemiluminescence
We used electro-chemiluminescence to measure immune mediators in colostrum and breast milk
samples for Th1 and Th2 cytokines, HGF, and TGFβ1-3 (MesoScale Discovery, Rockville, MD, USA).
Laboratory experiments were run according to manufacturer’s protocol, using an eight-point standard
curve. No dilution was used for Th1 and Th2 cytokines and HGF, and 1:2 dilution for TGFβ assays,
following pilot experiments which showed that TGFβ2 levels in undiluted milk samples were often
greater than the upper limit of detection. Assays were run in duplicate, and mediator levels were
excluded where the CV was >25%—Median (IQR) levels and assay detection limits for each immune
mediator studied are shown in Table A1.
2.5. Protein Analysis
We used turbidimetry to assess total protein concentration in colostrum samples (Abbott Architect
Analyser C8000, Abbott, Abbott Park, IL, USA). For turbidimetry colostrum, proteins were denatured
by benzethonium chloride, then measured at 404 nm. Pilot experiments determined that a 1:30 onboard
dilution was needed to bring the colostrum protein concentration to within the linear measurement
range of the Architect Analyser (3–60 g/L). Prior to protein analysis samples were thawed and
centrifuged at 3000× g for 15 min at 4 ◦C. Next, 300 μL of supernatant were carefully transferred to the
tubes and loaded into the Architect device for the analysis.
2.6. Statistical Analysis
Maternal factors and levels/detection of cytokines and growth factors were summarized using
standard descriptive statistics. As outcome variables were not normally distributed, non-parametric
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tests such as the Mann–Whitney U-test, were used to compare independent observations of different
populations for unadjusted analyses. All growth factors have been presented as a continuous variable
(pg/mL), whilst data on cytokines were transformed into a binary variable (detectable versus
undetectable). Since concentration of growth factors and cytokines were assayed twice
(in both colostrum and breast milk) for many participants, we used a mixed-effect regression model to
account for the absence of independence between those two measures and to evaluate a broad range
of variables. Continuous data with non-parametric distribution were log-transformed for inclusion in
regression models.
Model selection was based on major approaches such as Akaike and Bayesian information
criteria. Difference between groups effects (maternal and environmental factors) as well as within
subject effects were evaluated using multilevel mixed-effect regression model. Factors and covariates
included in the models were: parity, maternal sensitisation, maternal age, site of collection, mode of
delivery—vaginal birth/caesarean section, mould presence at home, pets at home or regular contact;
exposure to tobacco smoke (i.e., maternal active smoking or living in household with smoker or
self-reported passive smoker) at recruitment; at least one self-reported maternal infection during
pregnancy; maternal diet—fish intake at least once per week versus less often; daily fresh fruit versus
less often; daily probiotic versus none/less often.
As models were used for the statistical analysis, the sample size reduced slightly, due to incomplete
data for one or more variables included in the multivariate model in 56 individuals. This explains
discrepancy in colostrum numbers. Reduced numbers were included in analysis of human milk
samples, due to missing samples. Milk samples were missing due to cessation of breastfeeding before
this time, due to mother’s not supplying a sample within the four to six week time window for
sampling, and due to loss to follow up/not contactable women.
Outcomes assessed were levels of HGF, TGFβ1, TGFβ2, TGFβ3, and cytokine detectability.
Relationship between corrected growth factor levels and time (measured as HGF/Protein,
TGFβ1/Protein, TGFβ2/Protein, and TGFβ3/Protein in pg/g) was assessed using the Spearman
rank correlation coefficient. Results were considered significant when p-values were reported at a level
less than 0.05. Bonferroni correction was used in mixed models analyses to control for false discovery.
3. Results
3.1. Study Population
Total of 481 mothers were recruited into the study from June 2011 to March 2012 from the
birth centres and antenatal and postnatal units of secondary and tertiary hospitals from three
countries, located in Northern Europe, Eastern Europe, and the Mediterranean area. Of 481 women,
398 (UK n = 101, Russia n = 221, Italy n = 76) provided samples and were included in this
study. The 83 mothers unwilling or unable to provide colostrum samples postnatally were not
evaluated further.
Demographic data of the participants is presented in Table 1. Significant differences between
groups were seen for most variables recorded. Maternal age (highest in Italy), maternal allergic
sensitization (highest in UK), rate of Caesarean section (highest in UK), tobacco smoke exposure
(highest in Russia), antenatal infections (highest in Italy), and time of colostrum collection (earlier in
Russia than other sites) all differed significantly. There was also weak evidence for differences in parity
and birth weight across centres). Infant sex did not significantly differ across sites.
3.2. Association between Collection Time and Colostrum/Breast Milk Composition
Among the environmental and maternal factors analysed we found time of milk sample collection
postpartum to have the most significant influence on growth factor levels, and a mixed effect on
cytokine detectability. A significant decline over time in colostrum was seen for HGF, TGFβ1 and
TGFβ3, IL2, IL5, IL10, and IFNγ. No significant influence but similar trends were seen for most of the
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other mediators (Table 2 and Figure 1). Differences between colostrum and mature milk showed similar
findings for growth factors, which were all statistically significant. For cytokine detectability in breast
milk versus colostrum, findings were mixed and not entirely consistent with the changes seen over
time in colostrum. IL10 was more commonly detected in colostrum than in HM, but IL4 and IFNγ were
more commonly detected in HM, despite no change or a decline in detectability over time in colostrum
samples. Other cytokines showed no significant difference between colostrum and HM (Table 2).
Table 1. Characteristics of study participants.
UK Russia Italy p-Value (Three Countries)
Maternal allergic sensitisation * 35/94 (37) 22/156 (14) 9/40 (23) <0.01 a
Maternal Age (years) 32.8 (4.78) 29.8 (4.45) 37.4 (5.38) <0.01 b
Vaginal Delivery 70/101 (69) 188/219 (86) 62/76 (82) <0.01 a
Male sex 54/101 (53) 118/216 (55) 41/76 (54) 0.98 a
Birth Weight (grams) 3527 (535.37) 3526 (438.97) 3328 (476.95) 0.05 b
Primiparous women 55/100 (55) 93/216 (43) 29/75 (39) 0.06 a
Household tobacco smoke exposure 30/99 (30) 135/218 (62) 25/76 (33) <0.01 a
Antenatal Infections † 16/100 (16) 61/211 (29) 29/76 (38) <0.01 a
Time of colostrum collection (hours) 58.61 (33.2) 50.03 (14.34) 57.84 (26.52) <0.01 b
a Pearson χ2 test has been used; b ANOVA test has been used. Data shown are (n/(%)) for binary variables,
and (mean (S.D.)) for continuous variables; * Defined as skin prick test wheal ≥3 mm to at least one of
a panel of common allergens; † Antenatal infection is defined as at least one self-reported maternal infection
during pregnancy.




Paired Differences between HM and Colostrum of
Colostrum and Breast Milk Composition
Change over Time β p-Value Difference between
Colostrum and HM over Time
β p-Value
HGF Lower −0.01 <0.001 ** Higher in colostrum −1.35 <0.001 **
TGFβ1 Lower −0.003 0.01 * Higher in colostrum −0.93 <0.001 **
TGFβ2 No change −0.003 0.12 Higher in colostrum −1.12 <0.001 **
TGFβ3 Lower −0.01 <0.001 ** Higher in colostrum −2.03 <0.001 **
IL2 Lower −0.02 0.02 * No difference 0.32 0.30
IL4 No change −0.01 0.22 Higher in HM 0.72 0.04 *
IL5 Lower −0.03 <0.001 ** No difference −0.54 0.09
IL10 Lower −0.02 <0.001 ** Higher in colostrum −1.66 <0.001 **
IFNγ Lower −0.01 0.04 * Higher in HM 1.20 <0.001 **
IL12 No change −0.01 0.12 No difference −0.11 0.73
IL13 No change −0.01 0.09 No difference 0.09 0.72
Data shown are concentration (pg/mL) for growth factors, and detectable versus not detectable for cytokines.
A multilevel mixed-effect regression model was used for all analyses, which were adjusted to the following
factors: Parity, Maternal Atopy, Maternal age, Site of collection, Mode of delivery, Mould presence at home, Pets
at home or regular contact; Exposure to tobacco smoke; At least one self-reported maternal infection during
pregnancy; Maternal diet. HM, human milk; HGF, Hepatocyte Growth Factor. * p value < 0.05; ** p value < 0.01.
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Figure 1. Unadjusted growth factors concentration (pg/mL) in colostrum and breast milk across all
sites (overall) and at each site of collection (London, Moscow, and Verona). ** p value < 0.01.
3.3. Association between Collection Site and Colostrum/Breast Milk Composition
3.3.1. Growth Factors
We found a significant influence of country of residence on some growth factor concentrations
(Table 3 and Figure 2). TGFβ2 and TGFβ3 showed consistent findings in colostrum and HM
samples—levels of both factors were higher in UK and lower in Italy, with intermediate levels in
Russian women. HGF was lowest in the colostrum, but not HM, of mothers in Italy (mean log HGF
7.38, SE 0.12 in Italy; 7.98 (0.11) UK; 7.99 (0.10) Russia). TGFβ1 did not show consistent differences
between sites in colostrum and HM analyses, with higher levels in UK colostrum samples compared
with Italy (mean log TGFβ1 6.80 (0.07) in the UK; 6.53 (0.08) Italy); and high levels in Russian HM
samples (6.36 (0.08)) compared with Italy (5.86 (0.11)) or the UK (5.96 (0.11)). We evaluated a number of
other maternal factors for association with growth factor concentrations, and found weak evidence of
an association between fish consumption less than once a week and higher levels of TGFβ1 (mean log
TGFβ1 6.72 (0.06) for less than once a week; 6.57 (0.05) for more than once a week); and primiparity
with higher levels of HGF in colostrum (7.87 (0.08) for primiparous; 7.69 (0.08) for multiparous) and
HM (6.92 (0.11) for primiparous; 6.75 (0.11) for multiparous).
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Table 3. Concentration (pg/mL) of growth factors in colostrum and breast milk and exposures
associated with the levels.
Median (IQR) pg/mL Important Growth Factor Level Difference between the Groups
Colostrum
HGF 2055.31 (964–6239)
UK and Russia higher than in Italy p < 0.001
Primipara higher than Multipara p = 0.05
TGFβ1 731.534 (505–1142)
UK higher than Italy p = 0.01
Fish consumption Less than once
a week higher than At least once a week p = 0.04
TGFβ2 42,209.88 (23,847–98,597) UK higher than Russia and Italy p < 0.05
TGFβ3 1535.081 (847–3395) UK higher than Russia higher than Italy p < 0.05
Breast Milk
HGF 784.041 (508–1189) Primiparous higher than Multigravida p = 0.05
TGFβ1 493.514 (375–653) Russia higher than UK and Italy p < 0.05
TGFβ2 14,040.62 (10,080–27,262) UK higher than Russia and Italy p < 0.05
TGFβ3 279.41 (183–395) UK higher than Russia higher than Italy p < 0.05
A multilevel mixed-effect regression model was used for all analyses, which was adjusted using Bonferroni
correction, to the following factors: Parity, Maternal Atopy, Maternal age, Site (Country) of collection, Mode of
delivery—labour versus no labour, Mould presence at home, Pets at home or regular contact; Exposure to
tobacco smoke (i.e., smoker or living in household with smoker or self-reported passive smoker) at recruitment;
At least one self-reported maternal infection during pregnancy; Maternal diet—fish intake at least once per
week versus less often; daily fresh fruit versus less often; daily probiotic versus none/less often.
Figure 2. Association between site of collection and growth factor concentrations in colostrum
and breast milk. Data shown are mean (bold line) and 95% CI (shaded area) for log transformed
concentrations of HGF (a); TGFβ1 (b); TGFβ2 (c); and TGFβ3 (d) in the UK (red), Russia (blue),
and Italy (green). A multilevel mixed-effect regression model was used for all analyses which were
adjusted to the following factors: Parity, Maternal Atopy, Maternal age, Site (Country) of collection,
Mode of delivery, Mould presence at home, Pets at home or regular contact; Exposure to tobacco smoke,
at recruitment; At least one self-reported maternal infection during pregnancy; Maternal diet.
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3.3.2. Cytokines
Women reporting infections during pregnancy had detectable levels of IL5 less often in comparison
to mothers reporting no antenatal infections (Table 4). Smoking, type of delivery, and antenatal
infections were not related to detection of cytokines in HM or colostrum.






IL2 49/342 (14%) 38/190 (20%) NA
IL4 35/342 (10%) 30/190 (16%) NA
IL5 77/342 (23%) 27/190 (14%) Antenatal infectionsOR 0.49 (95% CI 0.25–0.98)
IL10 225/342 (66%) 69/190 (36%) NA
IFNγ 66/342 (19%) 92/190 (48%) NA
IL12 63/342 (18%) 31/190 (16%) NA
IL13 86/342 (25%) 58/190 (31%) NA
NA—no association. A multilevel mixed-effect regression model was used for all analyses which were adjusted
to the following factors: Parity, Maternal Atopy, Maternal age, Site (Country) of collection, Mode of delivery,
Mould presence at home, Pets at home or regular contact; Exposure to tobacco smoke, at recruitment; At least
one self-reported maternal infection during pregnancy; Maternal diet.
3.3.3. Protein and Sodium in Colostrum
Protein in human colostrum declines over time (r = −0.42; p < 0.001) with all growth factor
levels demonstrating a significant and marked decline over time, although the slope of decline varied
between growth factors. When corrected for protein, the correlation between growth factor levels and
time of collection was inconsistent between factors, with a significant decline seen for HGF/Protein,
an increase over time seen for TGFβ1/Protein and TGFβ2/Protein, and no change over time seen for
TGFβ3/Protein. The relationship between time of colostrum collection and growth factor or growth
factor/Protein level for the four growth factors measured is shown in Table A2 and Figure 3.
Figure 3. Effect of correcting growth factor concentrations for total protein level on the relationship
between concentration and time. Data show nonlinear curves for unadjusted concentrations (pg/mL)
of HGF (blue), TGFβ1 (orange), TGFβ2 (green), and TGFβ3 (pink) in colostrum in relation to time of
sampling. Correlations were explored using raw data (a); and the ratio of growth factor concentration
to protein concentration in the same sample (b). Trends in absolute and relative growth factors
concentration in colostrum change over time. All correlation coefficients were statistically significant
apart from the TGFβ3/Protein ratio in Figure 3b.
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4. Discussion
In this large prospective cohort study, we have confirmed earlier findings of significant differences
in milk composition between sites, but were not able to explain these differences through maternal
or environmental factors. We identified important differences between mediators in kinetics of
decline postpartum and these data suggest specific mechanisms controlling HM immune composition,
and support important biological roles for HM immune factors in the developing infant.
Data from a variety of studies suggest that colostrum and HM constituents may be influenced
by the country of origin and a number of environmental conditions which may differ significantly
from one location to another [3–7,32], but the cause of this difference is still unclear. Our data suggest
that HGF levels were lower in the colostrum/milk of Italian mothers and TGFβ2 and TGFβ3 were
higher in colostrum/milk of UK mothers with the same significant difference for colostral TGFβ1
(Figure 2). Amoudruz showed that Mali women have higher levels of TGF-β1 in comparison with
women born in Sweden [5]. Peroni reported higher HM TGF-β1 in a farming compared with urban
environment [6]. Tomicic found Estonian mothers have lower HM TGFβ2 than Swedish mothers [7]
which the authors suggested may be due to differences in microbial exposure. Orivuori et al. assessed
HM samples collected in four countries of continental Europe and Finland and showed TGFβ1 levels
to be highest in Finland and sIgA lowest in Germany [32]. We explored a number of maternal and
demographic variables including markers of microbial load such as maternal report of probiotic, pet,
and mould exposure, but we were not able to confirm these previous findings.
At present, we do not possess strong evidence of maternal allergic status influences on qualitative
and quantitative immunological constituents in HM. We did not find any relationship between the
levels of growth factors and/or detectability of cytokines and maternal allergy; this is in agreement
with data from other studies which found no obvious trend in HM composition of allergic mothers
compared to non-allergic [32–34].
Our data show some evidence for higher levels of HGF and TGFβ3 in the colostrum of
primiparous women. Data from some studies suggest that parity does not influence HM composition.
This borderline trend can be seen in some (but not all [3,35]) other studies [4,36,37], suggesting that
higher levels of certain immune active markers can be found in the HM of primiparous mothers,
which may be an additional mechanism to explain decreased allergy risk with an increase of birth order.
We found some evidence that fish intake during pregnancy can influence HM composition [3]—we
found higher colostrum TGFβ1 in women eating fish less than once a week. This adds to a confusing
picture, with Urwin reporting TGF-β1 levels to be highest in the colostrum of women residing in the
river and lake region of China [3], well known for high fish consumption and Hawkes not finding any
relationship between fish oil intervention and TGFβ1 levels [38]. Thus, the reasons behind differences
in the HM immunological profile between countries remain unclear. Further work should consider
genetic and gene/environment influences, as well as detailed dietary assessments, in addition to the
factors evaluated in this study. Data from So-Yeon Lee and co-authors show that breastfeeding was
found to be associated with a reduced risk of allergic sensitisation in children with CT/CC geno-type,
suggesting gene-environment interaction between the CD14C-159T polymorphism and breastfeeding
in relation to aeroallergen sensitisation [39].
It is well established that colostrum is particularly rich in immunologically active molecules and
that levels of immunological factors are lower in mature HM [6,12,40,41]. Although our study did
not involve HM collection in the same individuals over multiple timepoints, the sample size was
large enough to identify a strong relationship between time of sampling postpartum and growth
factor levels. We observed a strong relationship between growth factor levels and time postpartum
both within colostrum, and between colostrum and mature milk samples, which was independent
of geographical location. Although the difference between colostrum and mature milk composition
is well established in the literature [6,12,40,41], our finding of a rapid decline in growth factor levels
(HGF, TGFβ1, TGFβ3) and evidence for reduced detectability of cytokines (IL2, IL5, IL10, IFNγ) in
colostrum with time postpartum has not been consistently demonstrated by others. Soto-Ramirez et al.
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found none of the immune markers to correlate with the time of milk collection in a study conducted
in the USA [42]; this may be partially explained by a wide range in collection times (week one to eight)
and absence of colostral samples. In a study done in China with a narrower range of collection times,
levels of TGF-β1 and TGF-β2 decreased significantly over time [3]. Studies which do not adequately
account for variations in sampling time may explain some of the inconsistency of HM composition
and its determinants in the literature [29].
Dilution could be a potential explanation of the growth factor decline over time. During the first
week of life the infant’s volume requirements are low. Later levels of the immune active molecules
decrease as the volume and nutritional requirements of the infant increase. Immune active constituents
of colostrum and breast milk represent a minor component but one of the most biologically active
parts of HM total protein. In this study, we attempted to adjust for dilutional effects by correcting
growth factor colostrum levels for total protein level in the same sample. Correction for colostrum total
protein failed to consistently remove the relationship between factor level and time postpartum, and
highlighted significant variation between factors in the kinetics of decline. This implies active transport
of these growth factors using varied mechanisms specific to each factor. If we assume biological
relevance, then these results suggest that infants need relatively higher amounts of TGFβ1 and TGFβ2
for longer than that of TGFβ3 or HGF. TGFβ3 is significantly different from TGFβ1 and TGFβ2 in
its detailed tertiary structure of the active domain despite homology in amino acid sequence [43].
There is some evidence [43] that TGFβ3 may also have distinct functions to other TGFβ isoforms.
TGFβ3 is up-regulated by milk stasis, and induces apoptosis in mammary gland epithelium during
involution, in contrast to TGFβ1 and TGFβ2 [44]. The biological relevance of HM TGFβ is illustrated
by the observed direct correlation between the levels of TGFβ in human milk and infant serum IgA [45].
As the infant’s immune response matures there is likely to be less need for an extrinsic supply of
immune stimulants.
The main limitations of our study are first that we did not assess maternal diet using a food
frequency questionnaire, did not collect detailed information on the strain of probiotics and/or fish oil
supplements used, and did not evaluate maternal genotype as a potentially important determinant or
modulator of HM composition. This means that while we were able to explore our primary focus of
maternal and demographic factors influence on HM composition, we were not able to reliably identify
reasons for the difference in HM composition identified between sites. Second, we sampled single
colostrum and HM specimens from each subject. Our findings regarding the kinetics of growth factor
decline in colostrum and HM need to be explored further in prospective studies with longitudinal
sampling at multiple timepoints within the same participants. Third, we only made preliminary
attempts to adjust for the effect of time or milk maturity on compositional analysis. Since time
postpartum may be a surrogate for milk/breast maturity, we aimed to identify a ‘correction factor’ that
might reflect milk maturity. We did not find evidence that any growth factor concentration was related
to HM protein concentration, but further work is needed to identify markers of HM maturity in order
to control for this in compositional analysis of colostrum. Maternal body mass index (BMI) data has
not been assessed due to a difficulty in one of the participating countries. Finally, due to logistical,
funding, and sample size constraints our analysis covers only a small number of growth factors and
cytokines, so may not be generalisable to all immune factors in HM.
5. Conclusions
In this large international cohort study of HM composition, we have found an important influence
of time after birth on colostrum composition, which must be adjusted for in any further research.
Despite adjusting for this and other factors, we identified unexplained and significant variation in
HM immune composition between geographically distant populations. Overall, our data suggest that
levels of human milk mediators decline at different rates post-partum, and this may suggest that these
factors are likely to have specific biological roles in early postnatal development. An important aim
of future research should be to optimize the analysis of HM composition, accounting for maturity of
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milk, and aim to better understand the biological roles and consequences for the developing infant of
variations in HM immune composition.
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Appendix A
Table A1. Lower limit of detection values (pg/mL) for cytokines and growth factors analysis and
overall locations median concentrations for all immune active molecules (values below LLOD for all
cytokines have been transformed into 1/2 of LLOD).
Immune Active Molecule Median Lower Limit of Detection Median (IQR) Colostrum Median (IQR) HM
IFN-γ 3.49 1.23 (0.51–3.49) 3.49 (1.54–7.8)
IL2 2.06 0.6 (0.29–1.47) 0.98 (0.23–2.06)
IL4 1.83 1.83 (0.24–1.83) 1.83 (0.50–1.83)
IL5 2.89 1.44 (0.57–2.85) 1.57 (0.33–2.89)
IL10 1.50 2.67 (1.01–9.04) 1.5 (0.74–2.66)
IL12 3.50 1.85 (0.34–3.5) 2.13 (0.32–3.5)
IL13 4.60 4.6 (1.85–4.69) 4.6 (3.52–6.76)
HGF 73.00 2055.31 (964–6239) 784.041 (508–1189)
TGFβ1 8.73 731.534 (505–1142) 493.514 (375–653)
TGFβ2 265.00 42,209.88 (23,847–98,597) 14,040.62 (10,080–27,262)
TGFβ3 8.37 1535.081 (847–3395) 279.41 (183–395)
Standard curve ranges: IFN-γ, IL2, IL4, IL5, IL10, IL12, IL13 0—2500 pg/mL; HGF, TGFβ1, TGFβ2 0—100.000;
TGFβ3 0—50.000. All values presented in pg/mL.
Table A2. Absolute and relative decline of growth factors over time.
Growth Factor Concentration
(pg/mL)/Time of Collection
Raw Concentration (pg/mL) Growth Factor/Protein Ratio
HGF r = −0.39, p < 0.001 ↓ r = −0.19, p = 0.003 ↓
TGFβ1 r = −0.21, p < 0.001 ↓ r = 0.25, p < 0.001 ↑
TGFβ2 r = −0.16, p = 0.01 ↓ r = 0.20, p = 0.004 ↑
TGFβ3 r = −0.35, p < 0.001 ↓ r = −0.06, p = 0.34 ↓
↑—Positive correlation with time of collection; ↓—Negative correlation with time of collection.
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Abstract: Human milk (HM) contains a plethora of metabolic hormones, including leptin, which is
thought to participate in the regulation of the appetite of the developing infant. Leptin in HM
is derived from a combination of de novo mammary synthesis and transfer from the maternal
serum. Moreover, leptin is partially lipophilic and is also present in HM cells. However, leptin has
predominately been measured in skim HM, which contains neither fat nor cells. We optimised
an enzyme-linked immunosorbent assay for leptin measurement in both whole and skim HM
and compared leptin levels between both HM preparations collected from 61 lactating mothers.
Whole HM leptin ranged from 0.2 to 1.47 ng/mL, whilst skim HM leptin ranged from
0.19 to 0.9 ng/mL. Whole HM contained, on average, 0.24 ± 0.01 ng/mL more leptin than skim HM
(p < 0.0001, n = 287). No association was found between whole HM leptin and fat content (p = 0.17,
n = 287), supporting a cellular contribution to HM leptin. No difference was found between pre- and
post-feed samples (whole HM: p = 0.29, skim HM: p = 0.89). These findings highlight the importance
of optimising HM leptin measurement and assaying it in whole HM to accurately examine the amount
of leptin received by the infant during breastfeeding.
Keywords: leptin; human milk; whole human milk; skim human milk; appetite; obesity
1. Introduction
Human milk (HM) is a heterogeneous fluid composed of a combination of macro- and
micro-nutrients, cells, and a plethora of biomolecules that provide the necessary elements to sustain
infant growth, protection and development [1–3]. The developmental effects of breastfeeding extend
to the programming of various organs and systems of the newborn, including that of appetite
regulation [4]. This early developmental programming results in a reduction in obesity and other
metabolic diseases not only in the short-term, but also in adulthood [5–9]. The complex system
of breastfeeding-mediated appetite regulation is attributable to various factors associated with the
practice of breastfeeding, such as feeding on demand, but also potentially to a host of appetite
regulatory molecules present in HM [4]. These include whey and casein proteins, HM oligosaccharides,
and recently discovered in HM appetite regulatory hormones, including the well-documented
adipokine leptin, adiponectin, and many others [10–14].
Amongst these appetite molecules, leptin is the most widely studied, being primarily known for
promoting satiety and energy expenditure in adults through binding to the full length leptin receptor
(ObRb) expressed on the arcuate nucleus of the hypothalamus [15]. In addition, leptin stimulates
cell proliferation, regulates blood pressure, and is also involved in the T-cell immune response,
thus displaying pleiotropic roles [16,17]. White adipose tissue is one of the main sources of serum
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leptin, secreting leptin proportionally to the number of white adipocytes present in the body [18].
Further, gastric chief cells, the placenta, and the mammary epithelium also synthesise and secrete
leptin in adults [19–22].
In infants, HM is believed to be a major source of leptin early in life, with the endogenous
leptin-synthesising mechanisms being still immature [23]. Leptin in HM has been hypothesised
to be involved both in the short-term control of appetite and in developmental programming of
appetite and energy-signalling pathways, promoting efficient energy control and storage throughout
life [9,24]. Leptin administered during the first 14 days of life has been shown to act as a neurotrophic
agent, promoting neural growth from the arcuate nucleus of the hypothalamus to additional appetite
control centres located in the central nervous system [25]. HM leptin may provide short-term appetite
control in the infant also by up-regulating circulating melanocortins, potent anorexigenic agents
that promote satiety [26]. Leptin in HM is sourced both endogenously from the mammary gland
and from the maternal serum, following secretion from white adipocytes and gastric chief cells
into the bloodstream [9]. In the lactating mammary gland, serum-derived leptin combines with
locally-synthesised leptin by the mammary epithelium to yield the total leptin content of HM [22].
Leptin in HM has been predominately measured in skim HM, which does not contain the
cellular and fat components of HM [26–28]. Considering that the leptin peptide is capable of
lipophilic interactions [29,30], it is plausible it may associate with the fat globule in whole HM.
Moreover, HM cells, which are predominantly of epithelial origin in mature HM of healthy
mother/infant dyads [1,31], are also thought to contribute to the leptin concentration of whole HM [22].
Few previous studies have measured leptin in whole HM using a radioimmuno-assay (RIA) [21,32].
However, RIA is not considered appropriate for measuring leptin in a lipid-rich medium such as whole
HM due to interference of triglycerides with the binding of radioactive-labelled antigens to antibodies,
which compromises the sensitivity of the assay [33,34]. Given the lack of an optimised assay to detect
leptin in whole HM and the absence of reliable comparisons of leptin levels between whole and skim
HM, we developed an enzyme-linked immunosorbent assay (ELISA) as a more appropriate means
of measuring leptin in HM, with two antibodies assisting in immobilising the leptin antigen, and
compared the leptin concentration between pre- and post-feed samples, as well as whole and skim HM.
2. Materials and Methods
2.1. Study Participants
All procedures involving the recruitment of lactating mothers and HM sample collection and
analyses were approved by, and conducted in accordance with, the guidelines of the Human Research
Ethics Committee of The University of Western Australia (ethics approval number RA/4/1/4253).
All mothers provided informed written consent in the form of a secure online questionnaire that was
administered and securely stored by The University of Western Australia. A single sample of whole
HM expressed by a mother in her first month of lactation was used for optimisation of the leptin assay.
Following assay optimisation, 61 lactating mothers (38 Caucasian, 23 non-Caucasian) with a mean
maternal age of 33.6 ± 4.39 years, of full-term healthy infants were recruited to assess leptin differences
between whole and skim HM (Table 1). HM samples (~5 mL) were obtained at approximately 1100 h
aseptically, as previously described by Hassiotou et al. [35], from each breast before and after the
infant fed from a single breast session either by using a Medela Symphony (Medela AG, Baar, Zug,
Switzerland) breast pump or by hand expression. Samples were stored at −20 ◦C prior to analysis.
Samples were collected at the second, fifth, ninth, and 12th months of lactation (Table 1).
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Table 1. Maternal and infant anthropometric and demographic characteristics (n = 61). Values are
mean ± SD (range). Table includes mothers who provided samples for multiple months.
Stage of Lactation (Month) 2 5 9 12
Maternal age (years) 32.9 ± 4.21 (28–40) 33.4 ± 4.27 (24–40) 34.0 ± 4.57 (25–43) 34.1 ± 4.35 (26–44)
Maternal BMI 27.1 ± 7.15 (20.1–38.5) 23.5 ± 4.46 (18.0–35.2) 24.0 ± 5.15 (18.7–37.2) 24.8 ± 5.6 (18.2–34.6)
Parity 2.10 ± 0.75 (1–4) 2.13 ± 0.85 (1–4) 1.96 ± 0.94 (1–4) 2.05 ± 0.98 (1–4)
Infant sex (Male/Female) 12/9 16/16 17/13 12/12
Infant birth weight (kg) 3.58 ± 0.64 (2.66–4.23) 3.49 ± 0.45 (2.66–4.46) 3.49 ± 0.46 (2.82–4.46) 3.59 ± 0.46 (2.80–4.46)
Infant body length (cm) 57.6 ± 2.17 (54.2–61.3) 64.5 ± 2.09 (61.5–69.5) 70.9 ± 2.11 (68.0–74.5) 73.9 ± 2.38 (71.5–78.5)
BMI: body mass index.
2.2. Measurement of Leptin in Whole and Skim Human Milk by an Enzyme-Linked Immunosorbent
Assay (ELISA)
Whole HM samples were thawed at room temperature, vortexed for 10 s and aliquoted
(2 × 750 μL) into 1.5 mL microfuge tubes (Sarstedt, Numbrecht, Germany). One whole HM aliquot was
centrifuged (05PR-22 Refrigerated Centrifuge, Hitachi, Tokyo, Japan) at 1500× g for 10 min at 4 ◦C and
the resultant skim HM portion was aspirated. Both skim and whole HM aliquots were sonicated on ice
at 100 Hz for three cycles of 5 s pulses, with a 20 s rest interval using an ultrasonic processor VCX130
(Sonics and Material, Newton, CT, USA). Eleven dilutions ranging from 1 to 50-fold were prepared
from both milk preparations using 1% bovine serum albumin (BSA; Sigma-Aldrich, Castle Hill, NSW,
Australia) in phosphate-buffered saline (PBS; Gibco Life Technologies, Paisley, Scotland).
Leptin concentration for each dilution was measured using the Human Leptin ELISA DuoSet
(R&D Systems, Minneapolis, MN, USA). Capture antibody (4 ng/mL, diluted with PBS, pH 7.4)
was pipetted (100 μL per well) to coat the bottom of the wells of flat bottom 96-well microtiter
plates (Flow Laboratories, McLean, VA, USA). Plates were sealed and incubated overnight at
room temperature. Wells were washed three times with PBS/Tween wash buffer (0.05% Tween
20; (Bio-Rad Laboratories, Gladesville, NSW, Australia) in PBS, pH 7.4), dispensed at 400 μL per well,
using a plate washer (Immunowash 1575, Bio-Rad Laboratories, Hercules, CA, USA). Washed plates
were inverted and blotted against absorbent paper to ensure no remaining solution was present inside
the wells. Blocking buffer (1% w/v BSA in PBS, pH 7.4) was added (300 μL per well) to block non-specific
binding sites. Plates were sealed and incubated for one hour at room temperature. Blocking buffer
was washed according to the wash procedure described earlier. Diluted samples and standards
(0–0.9 ng/mL) were added (100 μL per well) in duplicates and plates were sealed and incubated
for 2 h at room temperature. Unbound components from samples and standards were washed,
and biotinylated detection antibody (4 ng/mL, diluted in 1% w/v BSA in PBS, pH 7.4) was added
(100 μL per well). Plates were sealed and incubated for 2 h at room temperature. Unbound detection
antibody was washed, and streptavidin-horseradish peroxidase (HRP; R&D Systems, Minneapolis,
MN, USA) (50 ng/mL in PBS, pH 7.4) was added (100 μL per well), and plates were sealed, wrapped
in aluminium foil to avoid exposure to direct light, and incubated for 20 min at room temperature.
Streptavidin-HRP was washed and substrate colour reagent (1:1 mixture of 12 mL/vial hydrogen
peroxide and 4 mL/vial enhanced luminol, R&D Systems, Minneapolis, MN, USA) was added (100 μL
per well). Plates were sealed and wrapped in aluminium foil and were incubated for 20 min at room
temperature. Sulphuric acid (1 M, R&D Systems, Minneapolis, MN, USA) stop solution was added
(50 μL per well) and absorbance was read at 450 nm by a plate spectrophotometer (Enspire Multimode
Plate Reader, Waltham, MA, USA). Standard curves and leptin concentrations were calculated using
linear regression (Figures 1 and 2).
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y = 0.7333x + 0.036 
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Figure 1. Standard curve for the leptin enzyme-linked immunoassay (ELISA) for whole and skim
human milk. Standards were selected according to previous literature investigating levels of leptin in



















Figure 2. Leptin concentration for whole and skim human milk for each dilution tested. Values are
mean ± SEM (n = 100 diluted human milk preparations). Leptin levels in whole and skim human milk
are shown by black and white bars, respectively.
Recovery assays to discern the optimal dilution factor for leptin detection were conducted on
dilutions reporting leptin concentrations within the range of the protein standards used (Table 2).
Following optimisation of the dilution factor, leptin concentration in matched whole and skim
HM samples from the study population was measured. All whole and skim HM samples were
prepared according to the same centrifugation and sonication protocol used in the assay optimisation.
Recovery of a known amount of the leptin protein when added to samples was 97.7% ± 9.7% (n = 10)
(Table 2), with the leptin kit reporting an intra-assay variability of <5% and an inter-assay variability of
<7.2%.
Table 2. Recovery percentages for each dilution factor for skim and whole human milk
leptin measurement.
Dilution Factor Skim Human Milk Leptin (%) Whole Human Milk Leptin (%)
1 61.5 ± 2.09 17.1 ± 2.9
2 179.0 ± 0.82 14.0 ± 2.7
5 96.3 ± 1.2 14.0 ± 1.4
10 71.3 ± 1.6 97.1 ± 9.1
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2.3. Measurement of Fat Content in Human Milk
The total fat content of HM samples was measured using the creamatocrit method [37,38].
Samples were placed in micro-haematocrit tubes, plugged with sealant and centrifuged at 12,000× g
for ten min in a micro-haematocrit centrifuge (Hermle Z230H Labortechnik, Wehingen, Germany).
The resultant milk column was placed on the creamatocrit analyser (Creamatocrit Plus, Medela Inc.,
McHenry, IL, USA) and the length of the fat layer and the total milk column was measured, from which
the total fat content was calculated. It has been shown that Creamatocrit measurements strongly
correlate with the biochemical spectroscopic esterified fatty acid assay [38–40].
2.4. Statistical Analyses
Statistical analyses were performed using Microsoft Excel 2013 (Microsoft Corporation,
Redmond, WA, USA) and R 2.9.10 (R Core Team, Vienna, Austria) [41] for Windows 10, with the
additional R package “nlme” (R Core Team, Vienna, Austria) used for linear mixed effects
modelling [42]. Student’s paired t-tests were conducted to assess leptin differences between matched
skim and whole HM samples in the entire study population. Differences between whole and skim
HM leptin concentrations were subsequently analysed within each month of breastfeeding, also using
matched Student’s t-test.
Linear mixed effects modelling was used to examine any associations between HM fat content
and whole HM leptin concentration. Responses were modelled with and without controlling for
the volume of milk that had been removed from the breast during the collection of the HM sample.
To discern the significant random effects to use for each statistical model analysing the association
between HM fat content and whole HM leptin concentration, three separate models were devised;
one linear model with no random effects and two linear mixed effects models with the following
random effects: the effect of general inter-individual variation present in the study population, and the
effect of the stage of lactation in addition to inter-individual variation. Analysis of variance (ANOVA)
tests were then used to compare each model with the same fixed effects, namely fat content and
fat content when controlled for volume of milk removed from the breast. The final model for the
association between whole HM leptin concentration and fat content accounted for inter-individual
variation and the stage of lactation as random effects when volume removed was not controlled for
in the model. Similarly, when volume of milk removed from the breast was controlled for in the
linear mixed effects models, inter-individual variation and stage of lactation were also considered as
significant random variables to include in the analysis of associations between fat content and whole
HM leptin concentration.
Similarly, the association between leptin concentration in whole HM samples and the
corresponding fat content was also analysed within each month of lactation. Given that the volume
of HM removed during feeding was only collected for 74 samples out of the entire study population,
the liner mixed effects models used for intra-month analysis did not control for volume of milk
removed from the breast. As with the analysis between the association of leptin levels in whole
HM samples and fat content for the entire population, for each month, three statistical models were
devised; one linear model with no random effects, and two linear mixed effects models with the
following random variables included: the effect of inter-individual variation present in the study
population and the effect of the stage of lactation in addition to inter-individual variation. Analysis of
variance (ANOVA) was then used to compare each model within each month. For each month
of breastfeeding, the only significant random effect found was general inter-individual variation.
p < 0.05 was considered statistically significant. All values presented are mean ± standard deviation
(SD), unless stated otherwise. All R2 values were generated from the linear regression line of best
fit equations.
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3. Results
3.1. Participants
The demographic characteristics of mothers and infants in the study population are shown in
Table 2. All infants (n = 61) were born at term, healthy, and were growing appropriately for their
age according to the World Health Organisation’s (WHO) growth charts for exclusively-breastfed
infants [43,44]. Mean maternal body mass index (BMI) was highest at 27.1 ± 7.15 kg/m2 during the
second month of lactation and lowest during the fifth month of lactation at 23.5 ± 4.46 kg/m2 (Table 1).
Compared to the second month of lactation, maternal BMI decreased by 2.30 ± 1.55 kg/m2 over the
first 12 months of breastfeeding (p < 0.01).
3.2. Leptin Optimisation
Measurement of leptin in whole and skim HM was optimised using an ELISA-based assay.
One- to 20-fold dilutions for both skim and whole HM yielded leptin concentrations within the
standard range of the assay (0–0.9 ng/mL), whilst dilutions above 20-fold reported values Redmond
outside of the upper protein standard used (Figure 2). Mean leptin concentrations for 15-fold
(whole HM: 0.8 ± 0.07 ng/mL, skim HM: 0.75 ± 0.09 ng/mL) and 20-fold (whole HM:
0.9 ± 0.11 ng/mL, skim HM: 0.9 ± 0.09 ng/mL) dilutions were close to the highest protein standard,
thus further consideration was not given to these dilution factors (Figure 2). Ten-fold dilution of whole
HM yielded the best recovery rates (97.7% ± 9.7%) (Table 2). Five-fold-diluted skim HM recovered
96.3% ± 1.2% of leptin (Table 2). Therefore, subsequent samples were diluted by 10-fold and five-fold
with the diluent reagent for whole and skim HM samples, respectively, given these dilution factors
recovered the highest percentage of leptin protein when the assay was performed for whole and
skim HM.
3.3. Whole and Skim Human Milk Leptin
Leptin levels measured using the optimised assay were compared between whole and skim HM
obtained during different stages of lactation from 61 lactating mothers. Whole HM leptin levels ranged
from 0.2–1.47 ng/mL, whilst a 0.19–0.9 ng/mL range was obtained for skim HM leptin (Figure 3).
Whole HM leptin was 0.24 ± 0.01 ng/mL higher than skim HM leptin across all samples (p < 0.0001,
n = 287) (Figure 3). Leptin levels were also higher in whole HM compared to skim HM within each
month of lactation (Table 3). Matched pre-feed whole HM samples contained 0.24 ± 0.07 ng/mL
more leptin than pre-feed skim preparations (p < 0.01, n = 157), with 0.25 ng/mL ± 0.05 ng/mL more
leptin measured in post-feed whole HM samples compared to paired skim post-feed aliquots (p < 0.01,
n = 137).
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Figure 3. Comparison between whole and skim human milk (HM) leptin concentration (n = 287).
*** Indicates significant difference between matched whole and skim human milk leptin values
(p < 0.001).
No association was observed between whole and skim HM leptin (p = 0.55, n = 287) (Figure 4a).
HM fat content was not related to leptin concentration in whole HM when the volume of milk removed
from the breast during sample collection was not accounted for (p = 0.52, n = 283) (Figure 4b) or
accounted for (p = 0.24, n = 74) in the analysis. Further, no association between leptin levels in whole
HM samples and fat content were found within each stage of lactation (Table 4).








2 0.50 ± 0.16 0.32 ± 0.16 p < 0.0001
5 0.48 ± 0.16 0.26 ± 0.07 p < 0.0001
9 0.56 ± 0.11 0.22 ± 0.03 p < 0.0001
12 0.54 ± 0.14 0.21 ± 0.02 p < 0.0001
* p-values indicate significant differences between whole and skim human milk leptin concentrations at given
time points.
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(a) (b)
Figure 4. (a) Association between skim and whole human milk (HM) leptin (n = 287). No association
was detected between skim and whole HM leptin levels in matched samples (R2 = 0.001, p = 0.552);
(b) no association was detected between fat content and leptin concentration in whole HM (R2 = 0.0004,
p = 0.17, n = 284). The solid black line is the line of best fit.
Table 4. Association between leptin levels in whole human milk and fat content at each stage
of lactation.
Month of Lactation N (Samples) R2 p-Value *
2 66 0.0013 0.782
5 72 0.018 0.686
9 83 0.069 0.577
12 66 0.153 0.889
* p-values indicate absence of associations between whole human milk leptin concentrations and fat
concentrations at given time points.
No differences between pre- and post-feed whole (p = 0.29, n = 74) and skim (p = 0.89, n = 74)
leptin levels were detected after accounting for the volume of milk consumed by the infant during
the session (Figure 5). Post-feed samples contained 36.2 ± 2.82 g/L more fat compared to matched
pre-feed samples (p < 0.01, n = 74).
(a) (b)
Figure 5. After accounting for the volume of milk consumed by the infant during the session, no
differences in pre- and post-feed (a) whole and (b) skim human milk (HM) leptin values were detected
in the study population.
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4. Discussion
This study has shown that whole HM contains significantly higher levels of leptin compared to
skim HM and that sampling either before or after a breastfeed does not influence this level.
Leptin has been previously shown to be present in HM and has been hypothesised to participate
in the short- and long-term regulation of appetite in the breastfed infant [9,45]. In addition, HM leptin
may be involved in other functions in the breastfed infant given its known pleiotropic properties,
and in mammary development [46,47]. Although many studies have previously measured leptin in
HM, optimisation of the methodology has not been well documented and most studies have focused on
the levels of leptin in skim HM. However, leptin has been proposed to have lipophilic properties [29]
and is also synthesised by mammary epithelial cells [22], which comprise the majority of cells in
mature HM from healthy mother/infant dyads [1,48,49]. It is, therefore, conceivable that leptin in
HM is associated with the fat and/or cells, which are not present in its skim fraction, suggesting that
previous measurements of skim HM leptin have underestimated the concentration of leptin in HM.
In this study, we performed a comparison of leptin levels between whole and skim HM and optimised
an ELISA assay to accurately measure it in both HM preparations.
Leptin levels were found to be, on average, two-fold higher in whole HM compared to skim
HM (Figure 3, Table 3). There are limited studies that have compared whole and skim HM leptin
levels and they utilized RIA based methodologies. While results of our study are in agreement with
two previous studies that found higher levels of leptin in whole than skim HM, the actual values
are different. Houseknecht et al. [32] reported whole HM leptin levels (10.1 ± 2.6 ng/mL, n = 23)
that were approximately seven times higher than in skim HM (1.5 ± 0.87 ng/mL, n = 23) and, on
average, 20 times higher than levels found in this study (Figure 3). Moreover, Smith-Kirwin et al. [21]
reported 56-fold higher leptin levels in whole HM (73.2 ± 39.0 ng/mL, n = 8) compared to skim HM
(approximately 1.3 ng/mL), and a 130-fold higher mean whole HM leptin concentration compared to
the present study. For skim HM both studies observed leptin levels 1.5–2.5 times greater than those
found here [21]. The higher absolute leptin levels measured in these studies may be attributable to
the analysis. Both studies used the RIA technique, which is not as reliable as ELISA in measuring
leptin levels in whole HM due to its known inaccuracies of immune-reactive antibodies binding to
the epitopes of antigens suspended in a lipid-rich medium, such as whole HM, or of interference
of iron and emulsifiers with the assay [33,34]. In addition, differences in the technique optimisation
between the two previous studies are apparent, as the whole HM leptin level in one study is seven
times greater than the other. Both commercially available RIA and ELISA kits are originally designed
to measure leptin in serum, not in HM; therefore, optimisation is critical. On the other hand, our results
are comparable to leptin levels in many other studies that measured it in skim HM using ELISA,
or whole and skim HM using RIA. ELISA in skim HM detected similar leptin levels
(from 0.30 ± 0.04 ng/mL at 1 month to 0.10 ± 0.02 ng/mL at 12 months, n = 72) in a study
by Bronsky et al. [50], (0.28 ± 0.38 ng/mL, n = 651) in a study by Weyermann et al. [27],
and (0.16 ± 0.04 ng/mL, n = 28) in a study by Miralles et al. [26]. RIA in skim HM also detected close
leptin levels: (0.18 ± 0.15 ng/mL, n = 23) in a study by Schuster et al. [28] and (1.00 ± 0.80 ng/mL,
n = 13) in a study by Schueler et al. [51]. RIA results in whole HM (1.34 ± 0.14, n = 24) in a study by
Bielicki et al. [52] were also comparable to our whole HM leptin levels.
Whilst it has been hypothesised that leptin may be associated with fat globules present in whole
HM due to its lipophilic nature [21,29] this was not borne out in this study (Figure 4b,
tab:nutrients-08-00711-t004) despite analysing pre- and post-feeding milk samples with a wide range
of fat content of 11.0–128.8 g/L. The lack of an association between HM fat content and whole HM
leptin levels suggests that fat may not have a strong contribution to HM leptin levels compared
to the cellular fraction of HM. Lactocytes, myoepithelial cells, and stem cells present in HM have
been previously shown to express the leptin gene [22]. Additionally, flow cytometric analysis of
HM cells has revealed that the majority of lactocytes and stem cells contain the leptin protein [22].
Given that lactocytes are the dominant cell type in mature whole HM when both the mother and
infant are healthy [1,48,49,53,54], it is likely that lactocytes contribute significantly to HM leptin levels.
Indeed, the cellular fraction of HM can constitute a significant portion of milk, comparable to its skim
240
Nutrients 2016, 8, 711
and fat fractions [1,31]. This warrants investigation to further discern the cellular contribution to
leptin levels in whole HM, and emphasises the need to assay whole HM for leptin and, potentially,
for other appetite hormones, to obtain accurate measurements of the levels of these hormones in HM.
Importantly, the procedures of whole HM preparation for such measurements must enable complete
lysis of the milk cells for accurate results. This is also very important during sample preparation for
whole HM ELISA, achieved in the present study by sonication.
Higher leptin levels in whole HM compared to the skim fraction indicate that infants ingest a larger
dose of leptin than that calculated from skim HM. Whilst HM cells likely contribute to the increased
leptin level in whole HM the bioavailability of this source is unknown. However, we speculate that the
process of digestion would release leptin proteins from HM cells. It is also possible that these cells are
absorbed through the stomach mucosa after ingestion and enter the circulation, as has been confirmed
with HM leukocytes and stem cells [35,55].
The lack of an association between whole HM leptin and milk fat content may be also attributable
to the biochemical properties of the leptin peptide. Although paradoxical to the notion that leptin
is synthesised by white adipocytes which exhibit a lipophilic nature, leptin may also consist of
hydrophilic regions, enabling it to primarily interact with aqueous fluids. The specific hydrophilic
regions exhibited on the leptin peptide are hypothesised to be conserved cysteine residues tethered to
disulphide bridges [29,56], which may form polar bonds with water molecules, given sulphide’s strong
electronegativity properties [57]. Leptin crystallization studies could further confirm its hydrophilic
properties [56], providing insight into the lack of an association between the leptin protein and the fat
component of whole HM.
Upon analysis, we also found no difference between the concentration of whole HM leptin in
pre- and post-feed samples, indicating the small samples taken either pre- or post-feed provide the
same levels of leptin despite differences in fat content. To measure the cellular contribution of leptin in
HM, it may be possible to acquire larger pre- and post-feed sample volumes and examine the number
of cells in the sample. Hassiotou et al. [1] has shown that cell content increases post-feed, as does fat,
when larger sample volumes were attained or the breast was well drained of milk.
5. Conclusions
We describe the first standardised and optimised ELISA assay for the measurement of leptin in
both skim and whole HM, demonstrating higher concentrations of leptin in whole HM preparations
compared to skim HM samples. Further, we provide evidence supporting the lack of an association
between the fat component of HM and its leptin content, suggesting a contribution of HM cells,
which merits further investigation. Accurate analysis of whole HM leptin will assist in clarifying the
biological role of this milk component for the breastfed infant, improving our understanding of early
developmental programming of appetite and its implications for obesity prevention later in life.
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Abstract: Human milk is the ideal nutrition source for healthy infants during the first six months of
life and a detailed characterisation of the composition of milk from mothers that deliver prematurely
(<37 weeks gestation), and of how human milk changes during lactation, would benefit our
understanding of the nutritional requirements of premature infants. Individual milk samples from
mothers delivering prematurely and at term were collected. The human milk metabolome, established
by nuclear magnetic resonance (NMR) spectroscopy, was influenced by gestational and lactation age.
Metabolite profiling identified that levels of valine, leucine, betaine, and creatinine were increased in
colostrum from term mothers compared with mature milk, while those of glutamate, caprylate, and
caprate were increased in mature term milk compared with colostrum. Levels of oligosaccharides,
citrate, and creatinine were increased in pre-term colostrum, while those of caprylate, caprate,
valine, leucine, glutamate, and pantothenate increased with time postpartum. There were differences
between pre-term and full-term milk in the levels of carnitine, caprylate, caprate, pantothenate, urea,
lactose, oligosaccharides, citrate, phosphocholine, choline, and formate. These findings suggest that
the metabolome of pre-term milk changes within 5–7 weeks postpartum to resemble that of term
milk, independent of time of gestation at pre-mature delivery.
Keywords: pre-term; infant; nutrition; human milk; metabolites; NMR; metabolomics
1. Introduction
Human milk (HM) is the recognised gold standard for feeding new-born full-term healthy infants.
HM is a unique food source that contains all the exacting amounts of required nutrients to support the
growth and development of term infants during the first six months of life. The health benefits of HM
have been well documented [1]. Current data suggest that the quantity of HM consumed by healthy
term infants is on average 0.778 kg human milk/day, with males consuming 0.056 kg/day more than
females. Human milk consumption rises rapidly during the first month postpartum to ~0.6 kg/day
and increases to ~0.82 kg/day in 3–4 month old infants [2].
Human milk is also regarded as particularly important for feeding pre-mature infants. There are
many health benefits related to providing a pre-term infant with HM, including improvements in
digestion, nutrient absorption, gastrointestinal function, and neurodevelopment of the infant [3,4].
In addition, an exclusive HM diet has been associated with lower rates of necrotizing enterocolitis,
a potentially fatal gastrointestinal complication, in premature infants [5]. Human milk oligosaccharides
(HMO) are known to affect the gut microbiota and it has been speculated that HMOs could account for
the lower observed incidences of necrotizing enterocolitis [6].
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Mother’s milk is inadequate for rapidly growing pre-term neonates, which can be ascribed to
a higher protein and energy requirement of pre-term neonates, particularly those of low birth weight
and <28 weeks gestation, leading to insufficient weight gain and nutrition deficits [7,8]. For extremely
pre-term and very low birth weight infants, the fortification of HM using commercial fortifiers is often
recommended in order to supply the neonate with the nutrients required to support its rapid rate of
growth. Studies have shown that the addition of HM fortifier can improve weight, length, and head
circumference growth, in addition to bone mineralization and neurological outcomes [9–13].
It is known that the composition of pre-term milk differs from that of milk of full-term mothers,
with higher reported levels of total protein, fat, carbohydrate and energy in pre-term milk [14].
Differences in the proteome of the two types of milk have also been reported [15]. Generally, studies
have focused on the macronutrient content of pre-term and term HM without consideration of
micronutrients such as biologically significant metabolites [14].
Previous work on milk metabolomes has predominantly considered bovine milk [16–20] and
human milk [21–28]. Recently, a multi-analytical platform study identified 710 metabolites in human
milk by using a combination of MS- and NMR-based analytical techniques [21]. Moreover, a recent
study identified subtle differences between some milk metabolites during the first month of
lactation [27]. However, the changes in pre-term and full-term human milk metabolomes over a
full lactation time course have not yet been reported in detail.
In this study, we report how gestational age affects the low-molecular-weight metabolome of HM
from mothers of pre-term and term infants over range of stages of lactation. The milk metabolomes
were compared using proton nuclear magnetic resonance spectroscopy (1H NMR)-based metabolomics
from milk samples from mothers at different gestational ages. Longitudinal samples were also
examined to analyse how pre-term milk develops with time postpartum compared with term milk.
2. Materials and Methods
2.1. Ethical Approval
Ethical approval for this study was granted by The Clinical Research Ethics Committee of the
Cork Teaching Hospitals, Cork, Ireland (clinical number reference ECM 4(s) 06/08/13).
2.2. Samples and Sample Collection
2.2.1. Pre-term Samples
Multiple frozen (´20 ˝C) longitudinal pre-term HM samples were collected from 15 individual
mothers of pre-term infants (Table 1). The HM samples were collected from the freezers of the neonatal
intensive care unit of Cork University Maternity Hospital (Wilton, Co. Cork, Ireland). Each bottle
of HM was dated allowing for an accurate calculation of the gestational age of the infant when the
milk was expressed. The HM samples from each individual mother were pooled according to ‘day
postpartum’ up to 14 days and according to ‘week postpartum’ after this, creating n = 62 pre-term
HM samples. For one donor (Pre-1), information on number of days postpartum was unavailable and
accordingly samples from this donor were removed from multivariate models using gestational age or
days postpartum for modelling or visualization purposes.
2.2.2. Full-term Samples
Frozen (´20 ˝C) HM samples (n = 30) were obtained from The Western Trust Milk Bank,
Irvinestown, Co. Fermanagh, Ireland (Table 2). The HM samples were from 30 individual mothers
of healthy full-term infants who donated milk with consent for use for research purposes. The
mothers expressed milk in a domestic setting and stored milk at ´20 ˝C before shipping to The
Western Trust Milk Bank, Ireland. HM was pasteurised and microbiologically screened before being
frozen and shipped to University College Cork where it was stored at ´20 ˝C. Milk samples were
246
Nutrients 2016, 8, 304
categorized according to the length of time postpartum; colostrum (<5 days postpartum; n = 5),
transitional (6 days–2 weeks postpartum; n = 4), mature (>2 weeks, n = 21).
Table 1. Sample information from mothers of pre-term infants.
Sample Id Secretor Status Gestation Infant Weight, Grams Age of Mother, Years Gravida 1 Para 2 Number of Samples Postpartum Span 3
Pre 01 Se+ – – – – – 4 –
Pre 02 Se+ 38 weeks 3210 35 2 2 4 7–11 weeks
Pre 03 Se+ 28 weeks 1190 33 1 1 9 4–12 days
Pre 04 Se+ 31 weeks 1830 36 3 3 5 1–5 weeks
Pre 05 Se+ 30 weeks 1340 29 1 1 7 4 days–7 weeks
Pre 06 Se+ 32 weeks + 2 days 2340 42 2 2 1 8 days
Pre 07 Se´ 24 weeks + 4 days 540 33 1 1 4 1–4 days
Pre 08 Se´ 31 weeks 1680 35 2 2 2 5–14 weeks
Pre 09 Se+ 35 weeks + 6 days 2410 33 1 1 3 2–5 weeks
Pre 10 Se+ 35 weeks + 2 days 3100 26 1 1 2 4–5 days
Pre 11 Se+ 33 weeks + 4 days 1800 29 6 5 2 4–6 days
Pre 12 Se+ 35 weeks + 4 days 3260 45 4 3 + 2 4 2 9–10 days
Pre 13 Se+ 26 weeks 650 40 – – 15 6 days–8 weeks
Pre 14 Se´ 28 weeks + 3 days – – – – 1 13 weeks
Pre 15 Se+ 32 weeks – – – – 1 9 weeks
1 Number of pregnancies, including the current pregnancy; 2 number of times the mother has given birth; 3
time range indicates days postpartum of first and last samples from that donor; 4 indicates twin pregnancy.
2.3. NMR Spectroscopy
NMR spectroscopy was essentially performed as described earlier [29]. Briefly, the samples
skimmed by centrifugation at 4000 g for 15 min and removal of the top fat layer before filtering
to remove residual lipids and protein using Amicon Ultra 0.5 mL 10 kDa (Millipore, Billerica, MA,
USA) spin filters at 10,000 g for 30 min at 4 ˝C. A filtered sample (500 μL) was mixed with 100 μL
D2O containing 0.025% 3-(trimethylsilyl) propionic-2,2,3,3-d4 acid, sodium salt (TSP; Sigma-Aldrich,
St. Louis, MO, USA) as an internal chemical shift reference. 1H NMR spectroscopy was performed
at 298 K on a Bruker Avance III 600 spectrometer, operating at a 1H frequency of 600.13 MHz,
and equipped with a 5-mm 1H TXI probe (Bruker BioSpin, Rheinstetten, Germany). The sample
sequence was randomized prior to acquisition and standard one-dimensional spectra were acquired
using a single 90˝ pulse experiment with a relaxation delay of 5 s. Water suppression was achieved
by irradiating the water peak during the relaxation delay, and a total of 64 scans were collected into
32,768 data points spanning a spectral width of 12.15 ppm. All 1H spectra were initially referenced
to the TSP signal at 0 ppm. Prior to Fourier transformation, the data were multiplied by a 0.3 Hz
line-broadening function. The proton NMR spectra were phase and baseline corrected manually using
Topspin 3.2 (Bruker Biospin, Rheinstetten, Germany). NMR signals were assigned in accordance
with existing literature [20,21,25,29], 2D NMR spectroscopy, Chenomx NMR Suite 8.1.2 (Chenomx Inc,
Edmonton, AB, Canada) and the Human Metabolome Database [30].
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Table 2. Sample information from mothers of term infants.
Sample ID Secretor status Time postpartum Group
Term 01 Se+ <5 days Colostrum
Term 02 Se+ <5 days Colostrum
Term 03 Se+ <5 days Colostrum
Term 04 Se+ <5 days Colostrum
Term 05 Se+ <5 days Colostrum
Term 06 Se+ 2 weeks Transitional
Term 07 Se+ 2 weeks Transitional
Term 08 Se´ 6 days Transitional
Term 09 Se´ 2 weeks Transitional
Term 10 Se´ 15 weeks Mature
Term 11 Se´ 9 weeks Mature
Term 12 Se+ 15 weeks Mature
Term 13 Se´ 11 weeks Mature
Term 14 Se´ 15 weeks Mature
Term 15 Se´ 11 weeks Mature
Term 16 Se+ 16 weeks Mature
Term 17 Se´ 9 weeks Mature
Term 18 Se+ 19 weeks Mature
Term 19 Se+ 24 weeks Mature
Term 20 Se+ 11 weeks Mature
Term 21 Se+ 7–10 weeks Mature
Term 22 Se+ 13 weeks Mature
Term 23 Se+ 13 weeks Mature
Term 24 Se+ 14 weeks Mature
Term 25 Se+ 5 weeks Mature
Term 26 Se+ 27 weeks Mature
Term 27 Se´ 33 weeks Mature
Term 28 Se´ 27 weeks Mature
Term 29 Se+ 29 weeks Mature
Term 30 Se+ 33 weeks Mature
2.4. Secretor Status
Maternal secretor status was determined as previously described [25]. In brief the absence
or presence of 2-FL was used to determine secretor status quantified by NMR spectroscopy
(2-FL corresponds to NMR signal at δ 5.32 ppm). Milk from mothers classified as non-secretors
did not have any detectable levels of 2-FL, whereas milk from mothers classified as secretors did
contain 2-FL.
2.5. Multivariate Data and Statistical Analyses
NMR spectra of milk samples were aligned using Icoshift by co-shifting of the whole spectra
according to the anomeric lactose proton at 5.23 ppm [31]. The proton NMR spectra were subdivided
into 0.01 ppm bins, reducing each spectrum into 957 separate variables in the regions 10.00–5.00 and
4.72–0.5 ppm. Principal component analysis (PCA) and orthogonal partial least squares discriminant
analysis (OPLS-DA) were performed in order to identify differences in the metabolite profiles. The data
was mean-centred and Pareto-scaled prior to analysis. The OPLS-DA model was cross-validated
using segmentation with seven splits. Covariance was investigated by analysis of OPLS-DA
regression coefficients back-transformed to original data and colour coded by the loading weights [32].
The multivariate data analysis was performed using SIMCA-P + 13 (Umetrics AB, Umeå, Sweden).
Alignment by Icoshift, binning, and analysis of OPLS-DA plots were performed in MATLAB 7.13 using
in-house developed scripts (MathWorks Inc., Natick, MA, USA). Univariate statistical significance
was evaluated by Student’s t-test using the Statistics Toolbox in MATLAB 7.13 (MathWorks Inc.,
Natick, MA, USA).
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3. Results
HM samples (n = 92) were collected from 45 individual mothers with different gestational ages at
delivery, ranging from 24.6–35.8 weeks in the case of pre-term samples and more than 37 weeks for
full-term samples (Tables 1 and 2). For pre-mature deliveries, infant birth weight ranged from 540 g
to 3260 g. Age of the mothers of pre-term infants ranged from 26–45 years, and all had at least one
previous pregnancy longer than 24 weeks gestation (Table 1).
The median spectrum of all 92 milk samples is shown in Figure 1. Each signal corresponds to
proton resonances in milk metabolites according to assignments in Table 3. Differences in fucosylated
human milk oligosaccharides (HMO) have previously been described to depend on maternal secretor
status [33]. Accordingly, secretor status of the mothers was determined by examining the specific
patterns of fucosylated oligosaccharides (Figure 1B) [25]. Thirteen mothers were found to be
non-secretors, accounting for 28.9% of the mothers included in the study (Tables 1 and 2).
The collected milk samples were analysed for changes during lactation following both full-term
(Figure 2) and pre-term (Figure 3) delivery. Figure 2 shows a scores plot of principal component (PC) 2
and PC3 from a principal component analysis (PCA) model of full-term milk samples. The samples are
grouped into colostrum, transitional, and mature groups and coloured according to days postpartum.
The scores plot shows the distinct groupings of the milk samples, and indicates a gradual change in the
milk metabolome as the milk develops from colostrum towards mature milk (Figure 2). In addition,
no detectable differences were observed between mature milk samples in the intervals before 26 weeks
and after 26 weeks (Figure 2). There was an apparent difference in milk metabolites depending on
secretor status in term milk samples, as the milk samples were separated into secretor or non-secretor
groups along PC2 (Figure 2).
Figure 1. Median 1H NMR spectrum of 92 human milk samples. (A) Aliphatic region 4.6–0 ppm
(B) Human milk oligosaccharides in 5.45–5.00 ppm region; and (C) aromatic region 9.7–5.5 ppm region.
For peak assignments refer to Table 3.
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0.85 CH3 29 Methanol 3.37 CH3
1.53 CH2 30 Lactose 3.23, 3.5–4.0 Multiple
2 Caprate
0.85 CH3 31 Gluconate 4.05 CH
1.53 CH2 32 Galactose 4.57 CH
3 Butyrate
0.88 CH3 33 Fuc α1,4 GlcNAc 5.03 CH-1
1.55 β-CH2 34 Fuc α1,3 GlcNAc 5.19 CH-1
2.16 α-CH2
35 LNDFH II
5.03 Fuc (α1-4) CH-1
4 Pantothenate 0.91 CH3 5.38 Fuc (α1-3) αGlc CH-1
5 Leucine 0.94 CH3 5.43 Fuc (α1-3) βGlc CH-1
6 Valine
0.98 γ-CH3 36 LNDFH I
5.16 Fuc (α1-2) CH-1
1.03 γ’-CH3 5.03 Fuc (α1-4) CH-1
7 3-BHBA
1.18 CH3 37 LNFP III
5.11 Fuc (α1-3) GlcNAc CH-1




5.29 Fuc (α1-2) CH-1
1.23–1.29 CH3-6 5.4 Fuc (α1-3) αGlc CH-1
9 Lactate 1.32 CH3 5.46 Fuc (α1-3) βGlc CH-1
10 Alanine 1.47 CH3 39 LNFP I 5.32 Fuc (α1-2) CH-1
11 6’-SL 1.73 CH3 40 2’FL 5.32 Fuc (α1-2) CH-1
12 3’-SL 1.78 CH3 41 3’FL
5.39 Fuc (α1-3) αGlc CH-1
13 Acetate 1.91 CH3 5.44 Fuc (α1-3) βGlc CH-1
14 GlcNAc 2.04 CH3 42 LNFP V
5.39 Fuc(α1-3)αGlc CH-1
15 Sialic acid 2.06 CH3 5.44 Fuc (α1-3) βGlc CH-1
16 Glutamate
2.12 β-CH2 43 Urea 5.76 NH2
2.33 γ-CH2 44 Fumarate 6.51 CH = CH
17 Methionine 2.13 CH3 45 Tyrosine
6.9 CH-3,5
18 Glutamine
2.11 β-CH2 7.2 CH-2,6
2.46 γ-CH2 46 Methylhistidine
7.06 CH-4
19 Citrate




20 Dimethylamine 2.72 2 CH3 7.37 CH-4
21 2-oxogluturate 2.99 CH2 7.42 CH-3,5
22 Creatinine 3.02 CH3
48 Hippurate
7.54 CH-2,6
23 Creatine 3.03 CH3 7.63 CH-4
24 Malonate 3.12 CH2 7.82 CH-3,5





4.16 CH2 6.13 CH-10
27 Carnitine




28 Betaine 3.24 3 CH3 5.91 CH-10
7.87 CH-11
Abbreviations: 3-BHBA, 3-betahydroxybutyrate; FL, fucosyllactose; Fuc, Fucose; GlcNAc, N-acetylglucosamine;
LDFT, lactodifucotetraose; LNDFH, lacto-N-difucohexaose, LNFP, lacto-N-fucopentaose; SL, sialyllactose.
Several milk metabolites were found to be present in significantly different concentration in
colostrum, transitional, and mature milk. Fucosylated oligosaccharides, and also components of
oligosaccharides (Fucose, N-acetylneuraminic acid, N-acetylglucosamine), were found at the highest
levels in colostrum, and levels decreased in mature milk samples (Figure 2B). Moreover, levels of
valine, leucine, pantothenate, citric acid, lactic acid, betaine, and creatinine were higher in colostrum
and transitional milk compared with mature HM, and levels of glutamate, butyrate, caprylate,
and caprate were higher in mature HM compared with colostrum and transitional milk. The level
of β-hydroxybutyrate was found to be independent of milk maturity in full-term HM (Figure 2B).
Milk from non-secretor mothers did not contain oligosaccharides with α1-2 fucosylated structures
(Figure 2B); however, the level of 3’ fucosyllactose (3’-FL) was increased in non-secretor mothers
compared with secretor mothers.
Similarly, the pre-term milk samples were also examined for an effect of stage of lactation
on the milk metabolome. The scores plot of a two component PCA model of milk samples from
pre-term mothers is shown in Figure 3, in which samples are coloured according to number of days
postpartum. The scores and loadings plots clearly show the changes in milk metabolome occurring
over time in pre-term milk. Levels of fucosyl moieties, N-acetylneuraminic acid, N-acetylglucosamine,
3’-sialyllactose, 6’-sialyllactose, 2’-fucosyllactose, citric acid, choline, and creatinine decreased with time
postpartum (Figure 3B), while levels of 3-FL, lacto-N-difucohexaose I (LNDFH I), butyrate, caprylate,
caprate, lactic acid, valine, leucine, alanine, glutamate, and pantothenate increased with time
postpartum (Figure 3B). Only two mothers, who donated seven milk samples in total, were identified
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as non-secretors (Table 1). Thus, it was not possible to identify differences in the PCA model for
pre-term samples on the basis of secretor status.
Figure 2. (A) Principal component analysis scores plot of full-term milk samples from 30 mothers (n = 30));
samples are coloured according to days postpartum; Colostrum (dots), transitional (squares), and mature
(triangles); the circle denotes samples from non-secretor mothers, while remaining samples are from
secretor mothers; and (B) corresponding loading line plots. For peak assignments refer to Table 3.
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Figure 3. (A) Principal component analysis scores plot of pre-term milk samples from 15 mothers
(n = 58), coloured according to number of days postpartum; and (B) corresponding loading line plot.
For peak assignments refer to Table 3.
As some of the same time-related changes were apparent in both pre-term and full-term milk
samples, the difference between the pre-term and full-term milk metabolomes of similar days
postpartum was investigated. Citrate (P = 0.00057), lactose (P = 0.0039), and phosphocholine (P = 0.049
were found to be present in significantly higher levels in pre-term milk samples compared with
full-term milk samples (Figure 4). Citrate level is known to decrease with time postpartum [28],
while lactose is the major milk metabolite identified by NMR spectroscopy [20].
Thus, in the following analysis, NMR resonances originating from lactose were removed in order
to increase the weight of other metabolites in the multivariate models. A PCA of pre-term and full-term
milk samples (n = 88) was generated using two principal components which, together, explained 80.8%
of the total variance described by the PCA model (Figure 5). From the PCA model, it is apparent that
the milk metabolite profile from mothers of pre-term infants older than 5–7 weeks resembles that of
full-term milk, as they are positioned in close proximity to the full-term milk samples, independent of
time of gestation at delivery (Figure 5).
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Figure 4. Box plots showing the distributions of 2-fucosyllactose, 3-fucosyllactose, choline, citrate,
glutamate, lactose, phosphocholine, and valine concentrations in pre-term (PT) and full-term (FT)
milk. Pre-term milk samples <14 days postpartum and full-term colostrum, transitional, and mature
>26 weeks were excluded from the analysis in order to compare milk with a similar range of days
postpartum. Horizontal lines indicate medians; coloured boxes specify interquartile ranges and dashed
lines the ranges without outliers. The open circles indicate outliers (falls in-between 1.5ˆ and 3ˆ the
interquartile range). *** = P < 0.001, ** = P < 0.01, * = P < 0.05; the comparisons were made using
two-tailed Student’s t-test.
Figure 5. Principal component analysis scores plot of mature milk samples from pre-term
(squares, n = 58) and full-term (circles, n = 30) mothers. Pre-term milk samples are coloured according
to days postpartum.
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OPLS-DA was also performed on the pre-term and full-term milk samples (Figure 6). Full-term and
pre-term colostrum and transitional milk were excluded from the analysis, due to there being too few
samples of these, and to be able to compare milk samples with similar days postpartum. The OPLS-DA
model shows that significant differences exist between the metabolite profiles of pre-term and full-term
milk (Figure 6B). In full-term milk, carnitine, caprylate, caprate, pantothenate, beta-hydroxybutyrate,
and urea were found to be present in higher levels compared with pre-term milk, while lactose (Figure 4),
Fucosyl moieties, N-acetylneuraminic acid, N-acetylglucosamine, 3’-sialyllactose, 6’-sialyllactose,
lacto-N-difucohexaose I (LNDFH I), glutamate, citric acid, phosphocholine, choline, and formic acid
were found in higher levels in pre-term milk (Figure 6).
Figure 6. (A) Orthogonal partial least squares discriminant analysis of pre-term (n = 20, days
postpartum range 3–14 weeks) and full-term (n = 21, days postpartum range 3–26 weeks) milk.
Full-term colostrum, transitional, and pre-term milk <2 weeks postpartum have been excluded.
Cross-validation, Q2: 0.70; (B) corresponding OPLS-DA coefficients plot. Each variable has been
coloured according to the OPLS-DA loadings (correlation between NMR variables and pre-term/
full-term classes); for peak assignments refer to Table 3.
4. Discussion
Pre-mature birth is considered to have long-lasting adverse effects on health, and it has been
proposed that the introduction of metabolomics technologies may facilitate better understanding
of these effects [34]. The exact causes of preterm delivery are not clear, but often associated with
inflammation [35]. In the present study, causes of the preterm delivery were not known. In this study,
differences in metabolomic profiles of HM were associated with gestational age. Previous studies
have shown many health benefits of breast-feeding pre-term infants. However, mother’s milk may not
always be adequate for pre-term infants with high nutrition density requirements, which can lead to
insufficient weight gain and nutrition deficits. To date, only a few metabolomics studies have been
performed on pre-term human milk in the first few weeks of lactation [27]. To our knowledge, this is
the first study to comprehensively characterize and compare the pre-term and full-term human milk
metabolome over a lactation time-course (up to 14 weeks postpartum). Milk metabolomics may be
used in a clinical setting [23], in order to establish the milk metabolome for infant nutrition in cases
where the optimal nutrition is a key advantage as in pre-term infants. Milk metabolomics studies
in cows’ milk have previously shown an ability to yield information about the health status of the
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cow [29,36]. It can likewise be hypothesized that the milk metabolome of lactating mothers can give
information that can be used in a clinical setting.
Previous studies have shown that several factors influence the variability in the milk metabolome.
The epithelial cells in the mammary gland are accountable for the milk production, and these cells
are ultimately responsible for converting most precursors into milk components, but many other cell
types are also involved in milk production [37]. Development of the mammary epithelial cells during
pregnancy has been shown to influence transport pathways in the mammary gland responsible for
different protein profiles of milk [38]. Moreover, insulin has been shown to be actively transported into
milk and maternal diabetes affect milk insulin levels [39]. Maternal factors such as diet, lifestyle and
phenotype have been shown to influence the milk composition [26]. Moreover, secretor status is also
important for the biosynthesis of milk oligosaccharides [26]. The presence of α1,2 fucosyltransferase
gene (FUT2) is important for the milk oligosaccharides since non-secretors, which lack the FUT2 gene,
are unable to biosynthesize HMOs with a fucose bound to a N-acetylglucosamine via a glycosidic α1,2
linkage. Non-secretor status occurs in approximately 20% of most human populations [40,41]. In the
present study, non-secretor status, identified by increased level of 3-FL, was found in 28.9 % of milk
donors. Gestational age and the stage of lactation are also known to influence the milk proteins [14],
lipids [42], and lactose [43]. Preliminary HM metabolomic studies have shown a difference between
the metabolite profiles of pre-term and full-term HM [22,24]. Additionally, the metabolite extraction
procedure in sample preparation prior to NMR spectroscopy has shown to influence the milk metabolite
levels. In a recent paper, a sample preparation method using ultrafiltration as employed in the present
study, was found to be superior compared with methanol/chloroform extraction in terms of separating
small molecules from proteins and lipids [28]. Levels of HMO and its components are known to
decrease with time [44]. A specific HMO, lacto-N-tetraose, has also been shown to be elevated
in pre-term milk [45]. Interestingly, specific HMOs, LNDFH I, 3’-sialyllactose, and 6’-sialyllactose,
and common components of HMO, including fucose, N-acetylglucosamine, and N-acetylneuraminic
acid were identified to be present in higher concentrations in pre-term milk. HMOs have previously
been shown to prevent necrotizing enterocolitis in neonatal rats [6], which may be linked to alterations
in the microbiota of the infant’s gut [46]. Thus, the elevated amounts of HMOs in pre-term milk may
be a factor in the observed association of lower rates of necrotizing enterocolitis in premature infants
fed HM [5].
Most of the free amino acids in HM steadily decrease in level as the milk matures [42].
However, the pre-term milk amino acid composition has not been well characterized throughout
the course of lactation [47–49]. Glutamate is known to increase with lactation time [47] and this was
also found in both pre-term and full-term milk in the present study. Valine and leucine, two essential
amino acids, were found at the highest concentration in full-term colostrum and decreased with time
postpartum, in agreement with other human milk metabolomics studies [27]. In contrast, increases in
valine and leucine levels were observed in pre-term milk with time post-partum, which is in contrast
to the pattern observed in full-term milk and that previously reported for pre-term milk [48,49].
Short- and medium-chain fatty acids (SMCFA; butyrate, caprylate, and caprate) were found in
higher concentrations in full-term milk compared with pre-term milk. Moreover, the levels of SMCFA
increased with time postpartum, as previously reported [50]. Choline is of high nutritional value, as it
is abundant in cell membranes and acts as a precursor for the important messenger acetylcholine,
and infants require high amounts of choline in order to sustain their rapid growth. Phosphocholine
was found in higher levels in pre-term milk than in full-term milk, which is in agreement with previous
reports on phosphocholine [51]. In contrast, pre-term milk has previously been shown to contain lesser
amounts of choline [51], which is contradictory to findings in the present study.
In this study, it was shown that, after 5–7 weeks the metabolite profiles of pre-term milk resembled
that of full-term milk, independently of gestational age. For extremely early pre-term infants born
at a gestational age of, e.g., 24 weeks, these findings suggest that mother’s milk becomes equivalent
to mature milk for term infants by the time the infant reaches ~29 weeks post-menstrual age. This is
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a significant finding concerning a period in which the infant still requires advanced nutritional support
to maintain its growth and long-term developmental requirements. Clinical metabolomics could
potentially be advantageous to determine when milk metabolites levels become inadequate due to
maturation of milk, if causal relationships between milk metabolites and infant growth parameters can
be established. Previous studies have shown that protein concentration remains at higher levels in
pre-term human milk even after 8 weeks of lactation [13]; however, we believe this to be the first study
to document the changes in the metabolomics profile of pre-term human milk as it evolves to resemble
that of full-term milk, and to show that this occurs independent of gestational age at delivery.
In conclusion, specific differences in milk metabolites exist between milk from mothers delivering
pre-maturely and at term. Moreover, milk metabolite composition is associated with gestational age and
the metabolome of pre-term milk changes within 5–7 weeks postpartum to resemble that of full-term
milk, independent of time of gestation at delivery. However, as this study did not systematically
collect samples from a cohort of mothers in a longitudinal design, further studies of this kind are
recommended to more fully understand the significance of the changes reported herein.
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Abstract: Background: There is scant information about whether, after a high-risk pregnancy,
breast milk provides enough vitamins for assuring satisfactory bodily reserves in newborns.
Objective: To comparatively evaluate, in women with high-risk and normal pregnancy, the concentration
of retinol and α-tocopherol in breast milk. Methods: This cross-sectional, analytical study was evaluated
with reverse-phase high-performance liquid chromatography (HPLC). Informed consent was signed
by 95 mothers with a high-risk pregnancy and 32 mothers with a normal pregnancy. From the
mothers with a high-risk pregnancy were obtained: 23 samples of colostrum, 24 of transitional milk,
and 48 of mature milk. From the normal pregnancy group, 32 mature milk samples were collected.
Pregestational Body Mass Index (BMI) and the gestational weight gain were noted. Models of logistic
regression were constructed to identify the variables related to a low concentration of either retinol or
α-tocopherol in breast milk. Results: The concentration of retinol and α-tocopherol in mature milk was
60 (interquartile range (IQR), 41–90) and 276 (103–450) μg/dL, respectively, for the high-risk pregnancy
group, and 76 (65–91) and 673 (454–866) μg/dL, respectively, for the normal pregnancy group (p = 0.001).
The concentration of retinol and α-tocopherol was similar in the subgroups of mothers with different
disorders during gestation. A clear correlation was found between a greater pregestational weight and a
lower concentration of retinol (Rho = –0.280, p = 0.006), and between α-tocopherol and retinol in all cases
(Rho = 0.463, p = 0.001). Among women having a high-risk pregnancy, those delivering prematurely
rather than carrying their pregnancy to term had a reduced concentration of retinol (54 (37–78) vs.
70 (49–106) μg/dL; p = 0.002) and a tendency to a lower concentration of α-tocopherol in breast milk
(185 (75–410) vs. 339 (160–500) μg/dL; p = 0.053). Compared to mothers with a normal pregnancy,
those with a high-risk pregnancy (whether carried to term or ending in preterm delivery) exhibited a
reduced concentration of retinol in mature milk (p = 0.003), as well as a tendency to a lower concentration
of α-tocopherol (p = 0.054). Conclusion: Even though the women in the high-risk pregnancy group
showed a deficiency of vitamins A and E in their breast milk, the unique biological benefits of this
milk justify the promotion of breast feeding as the optimal method of nourishing neonates and infants.
In these cases, it should be recommended that the woman increase her consumption of certain nutrients
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during pregnancy. Additionally, after childbirth mothers should consider the use of supplements to
produce milk of adequate quality and thus meet the needs of the baby and prevent any deficiency
in micronutrients.
Keywords: breast milk; liposoluble vitamins; high-performance liquid chromatography;
pregestational obesity
1. Introduction
Approximately 22% of all pregnancies are high-risk in Mexico each year [1]. One of the risk factors
for complications during pregnancy is being overweight, leading to a higher prevalence of gestational
diabetes, hypertension, pre-eclampsia, asthma, and thromboembolic disease [2]. Around 60% of
Mexican women in reproductive age are overweight [3]. Additionally, excessive weight gain during
pregnancy also increases the risk of adverse outcomes for both mother and child [4], and a high
percentage of Mexican women gain more weight than recommended [5].
Similarly, gestational diabetes is a risk factor for the increased incidence today of teratogenicity,
which has been observed more frequently in fetuses of diabetic versus healthy mothers.
These malformations are the result of tissue injury caused by the activity of free radicals [6].
Natural antioxidants reduce the adverse effects of these radicals, since they can capture and neutralize
reactive oxygen species, thus preventing lipid peroxidation. This neutralization is essential, especially
in situations where oxidative stress is elevated, such as gestational diabetes and preeclampsia [7].
One of the essential natural antioxidants is vitamin E, which comprises a group of eight fat-soluble
compounds that are classified as α-, β-, γ-, and δ-tocopherol or tocotrienol. Of these, α-tocopherol is
the most active compound [8].
The variation of glycaemia during pregnancy leads to serious complications for the mother-child
binomial [7,8]. Although there is currently little evidence of the association between the concentration
of retinol and diabetes in pregnant women [9], this disease makes such women more prone to a
marginal or poor biochemical status of vitamin A [9]. In addition to potentiating the complications
caused by diabetes in pregnant women, low levels of vitamin A leave their children vulnerable to
developing a deficiency of the same [10,11].
An adequate nutritional status during the first 2–3 years of life is necessary for subsequent health
and well-being. Deficient development cannot be reversed after passing this critical window [12].
In this sense, a study in Egypt stressed that vitamin E is a key micronutrient for development, with its
deficiency leading to a delay in growth [13]. The authors also noted that 78.2% of children showing a
delay in their growth were deficient in vitamin E, having plasma concentrations of α-tocopherol at
7.7 mmol/L versus 14.1 mmol/L for the group of control children [13]. Fares et al. [14] revealed that
deficiencies of vitamins A, E, and D were very common among infants with very low birth weight in
Tunisia, and were associated with preeclampsia. However, the risk of preeclampsia did not diminish
after the administration of vitamin C and E in a series of studies in Western countries [15,16].
The results of administering vitamin E supplements have been variable. One reason is that the
appropriate status of α-tocopherol during pregnancy has not yet been defined. Moreover, in the
various global reports on the usefulness of vitamin E supplements during pregnancy, the plasma
concentration of α-tocopherol is often not even determined. In situations where a low concentration of
α-tocopherol was documented, the administration of supplements of vitamin E has proven beneficial.
In a Hungarian population, for instance, supplementation of vitamin E in women was associated with
a decreased incidence of premature babies [17]. The establishment of a clear criteria for adequate levels
of vitamin E deserves further investigation.
It is also known that placental transfer of vitamins A and E during pregnancy is limited and
that the reserve of these micronutrients in the newborn is low, especially in the case of premature
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babies. Consequently, exclusive breastfeeding is the only way to meet their nutritional needs [8].
Since exposure to hyperoxia at birth increases the risk of free radical formation [18], it is essential that
the mother provide the infant a sufficient supply of vitamin E through breastfeeding.
Due to the importance of vitamins A and E for the mother and child, the aim of the present study
was to determine the concentration of retinol and α-tocopherol in the breast milk of mothers after
undergoing a high-risk versus normal pregnancy, as well as after giving birth preterm versus carrying
their pregnancy to term. Associations were examined between low levels of vitamins A and E in breast
milk and maternal characteristics.
2. Material and Methods
2.1. Study Design and Population
A cross-sectional and analytical study was conducted to determine the presence of retinol and
α-tocopherol in the breast milk of 95 mothers with a high-risk pregnancy (and whose newborns
were confined in the neonatal intensive care unit during the first and second month after birth) and
32 mothers with a normal pregnancy and healthy newborns. The study took place from January 2013
to October 2016. It was conducted at the Instituto Nacional de Perinatología (National Institute of
Perinatology) and the School of Medicine, National Polytechnic Institute, in Mexico City.
The sample size was calculated with a 95% confidence interval, utilizing information from
previous reports that estimated the mean content of vitamin A in breast milk [19]. After the mothers
had agreed to participate and signed informed consent, they were asked to fill out a survey to provide
data about their obstetrical background.
The manner of sampling mothers was not probabilistic or based on consecutive cases. Inclusion
criteria were that the women lived in the metropolitan area of Mexico City, agreed to provide all data
requested through a survey (maternal age, sociodemographic characteristics, medical and obstetrical
history, course of current pregnancy and term, mode of delivery, pregnancy-related complications,
weight, and complications of the neonates), were breastfeeding their newborns/infants and secreting
breast milk in adequate quantities, were 18–45 years old, and were not taking medications or
vitamin/multivitamin supplements. All participating mothers had been eating customary Mexican
food during pregnancy and none had adopted special diets.
The 127 mothers that participated in the study were recruited by the nutrition team of the
National Perinatology Institute (all women in this unit who consented were included). In the high-risk
pregnancy group, all the newborns and some of the women were hospitalized. Contrarily, in the
normal pregnancy group, none of the infants were hospitalized. Among the 95 mothers with a high-risk
pregnancy, 48 delivered preterm and 47 carried their pregnancy to term. All 32 mothers with a history
of normal pregnancy carried their pregnancy to term.
Preterm childbirth was defined as a gestation lasting less than 37 weeks. A normal pregnancy
was defined as the lack of complications or disorders before and/or during gestation. When there
were pregnancy-related complications, illnesses, or events that represented a health risk, the situation
was considered high risk. Especially important was any appearance of the woman or an increase
in complications that could have caused maternal/perinatal morbidity/mortality. The following
conditions were examined for any possible association with low levels of retinol or α-tocopherol:
(i) multiple gestation (involving twins, triplets, etc.), which increases the risk of infants being born
prematurely (before 37 weeks of pregnancy); (ii) pregnancy with triplets or quadruplets, which implies
a greater the probability of delivery by cesarean section; (iii) pregnancy after age 30 and/or after
taking fertility drugs (both related to multiple births); and (iv) gestational diabetes, preeclampsia
or eclampsia.
Preeclampsia, a syndrome marked by a sudden rise in the blood pressure of a pregnant woman
after the 20th week of pregnancy, can affect the kidneys, liver, and brain. When left untreated,
the condition may result in long term health problems or be fatal for the mother and/or the
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fetus. Eclampsia is a more severe form of preeclampsia, marked by anemia, seizures, and coma
in the mother (implying an increased risk for a first-time pregnancy in women over 35 years of
age). Preeclampsia and gestational diabetes were based on the criteria of the American College of
Obstetricians and Gynecologists [20,21].
2.2. Milk Sampling
Samples of breast milk were aseptically obtained from the mothers, either at home or in the
hospital, during the morning (08:00–10:00) and after 8–10 h of fasting. The first sample of breast milk
from mothers with a history of high-risk pregnancy was obtained in the hospital during the 48 h
immediately after birth. These samples were considered as colostrum. Transitional milk was obtained
from these same mothers at eight days postpartum. Mature milk samples were obtained from both
groups of women between the first and second month postpartum. Breast milk was delivered by
mothers to the hospital milk bank with the high-risk pregnancy group, because the newborns were in
the Neonatal Intensive Care. This milk was deposited in sterile polypropylene bottles and stored at
4 ◦C or colder. The women with a history of normal pregnancy delivered their sample of breast milk to
the nutritionist when they brought their healthy child to the hospital. From each recipient, an aliquot
of 15 mL was filled without leaving any air pockets (to avoid oxygenation). This aliquot was taken
from a full breast sample, previously homogenized. Each aliquot was protected from ultraviolet light
with aluminum foil and placed in refrigeration at –20 ◦C.
2.3. Type of Milk
From the high-risk pregnancy group, 23 of the breast milk samples obtained were considered as
colostrum, 24 transitional milk, and 48 mature milk. From the normal pregnancy group, 32 mature milk
samples were obtained. Colostrum is considered as the breast milk from delivery to approximately five
days postpartum, transitional milk from day 6–15 postpartum, and mature milk from day 15 onwards.
2.4. Laboratory Methods
The procedure for determining the concentration of vitamins A and E (as retinol and α-tocopherol)
was based on high-performance liquid chromatography (HPLC) in the reverse phase. The internal
standard was all-trans-retinyl-acetate (800-Across-01. Software Total Chrome, version 6.3.2.0646,
Whippany, NJ, USA). This determination was carried out on all of the breast milk samples from the
127 participating mothers.
Retinol and α-tocopherol levels were determined in breast milk by using a binary HPLC pump
(Flexar model, Perkin-Elmer, Naperville, IL, USA) with an injector (loop size 100 μL, Flexar model),
a sensitive UV7 detector (Flexar model, Norwalk, CT, USA), a three-column microbondapak rp-18
Pecosphere C-18 of 3 μm and 33.46 mm (Perkin-Elmer), and an acrodisc CR-13 mm syringe filter with
a 0.2 μm PTFE (polytetrafluoroethylene) membrane (Teflon).
After the extraction, vitamins A and E were isolated from the samples of breast milk. First the
matrix was saponified, followed by extraction of the analytes of interest. The esters of retinal were
hydrolyzed to retinol by saponification. To 15 mL of breast milk was added 24 mL of potassium
hydroxide in a solution of 16% methanol (weight per volume). This alkaline mixture was heated
to 75 ◦C and maintained at that temperature for 30 min, then cooled for 5 min. For the extraction
of the vitamins, 16 mL of petroleum ether was added in a separatory funnel, and then the solution
was stirred and left to stand for 30 min. The aqueous phase was drained and disposed of three times.
The etheric dissolution was washed with deionized water to eliminate the alkaline excess, reaching
pH 7 (measured with pH paper). The solvent was recovered in Falcon tubes of 50 mL, to be evaporated
in a steam bath at 70 ◦C. The residue was dissolved with 2 mL of ethanol, then filtered with acrodisk
CR 13 mm syringe filters with a 0.2 μm PTFE membrane. An injection volume was taken from this
solution for the chromatography with 50 μL, which was run for 10 min. To obtain the target of the
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reactives, a process of saponification and extraction was carried out in the absence of breast milk.
All samples were processed in duplicate and each replicate was injected twice [22].
Microbondapak columns with a UV/visible detector were utilized to establish the conditions
for the chromatographic system, with methanol/water (96:4) for the mobile phase and a wavelength
of 325 nm for retinol and 290 nm for α-tocopherol. The analytic parameters for linearity were
R2 = 0.9955 for retinol and R2 = 0.9808 for α-tocopherol, while the detection and quantification
limits were 1.1 μg/dL and 2.7 μg/dL for retinol and 0.9 μg/dL and 2.3 μg/dL for α-tocopherol.
Regarding accuracy, relative standard deviation (RSD) was 4.5% for the same day and RSD 4.8%
between days for retinol, and 4.9% for the same day and 4.1% between days for α-tocopherol. The
recovery was 85.8 ± 7.8% μg/dL for retinol and 98 ± 1.9% μg/dL for α-tocopherol. Once validated,
the method was applied to the quantification of retinol and α-tocopherol in samples of breast milk [23].
2.5. Evaluating Maternal Body Mass Index (BMI) and Morbidity in Mothers and Newborns/Infants
The pregestational weight and height of the mother was obtained from the clinical history.
The BMI was calculated considering ≤18.49 kg/m2 as underweight, 18.50–24.99 kg/m2 as normal,
25–29.9 kg/m2 as overweight and ≥30 kg/m2 as obese. The evaluation of the gestational weight was
based on both the pregestational BMI and the tables of the Institute of Medicine (IOM, Washington,
DC, USA). The increase in gestational weight was calculated by subtracting the pregestational weight
from the maximum gestational weight, and the result was classified as adequate or below/above the
recommended level, according to the guidelines of the IOM [24]. The absence or presence of morbidity
in mothers and newborns/infants was determined by reviewing the corresponding clinical history.
3. Statistical Analysis
For clinical data, anthropometric and sociodemographic characteristics of the mothers and
newborns were reported as the mean ± Standard Deviation (SD) and the median with an interquartile
range (IQR) of p25–p75. Due to the nature of the variables, a parametric analysis was performed with
the Student’s t-test and a non-parametric analysis with the Mann-Whitney U test and the Kruskal-Wallis
test. Additionally, frequency and percentages for categorical variables were analyzed with the
Pearson’s X2 test. For qualitative variables, such as marital status, occupation, level of education,
and pregnancy outcome, frequency measurements were calculated. For numerical variables, including
the age of the mother and pregestational weight and height, measurements of central tendency and
dispersion were utilized. With the Kruskal-Wallis test, analysis was made of the difference between the
concentration of retinol and α-tocopherol between groups and in relation to the pregestational BMI of
the mother. For the concentration of the vitamins and the outcome of the pregnancy, the Mann-Whitney
U test was employed. We used the median value for women with high-risk or normal pregnancy as a
comparison group. The two values used in the logistic regression model were considered risk variables
when they were below these medians. A statistical significance was considered at p < 0.05. Data entry
and analysis were performed with the statistical program SPSS version 20 for Windows (SPSS Inc.,
Chicago, IL, USA).
4. Ethical Aspects
Data gathering and analysis was confidential, taking such ethical questions as autonomy and
security into account. The guidelines of the Helsinki Declaration were followed. The project protocol
was approved by the Scientific and Ethics Committee of our institution. All women participating in
this study were given medical attention at the highest level of medical specialties in a health center in
Mexico City (with ethical approval code number 212250-49501).
5. Results
Of the 95 mothers with a high-risk pregnancy and 32 with a normal pregnancy, the median age
was 28 years (IQR = 20–34 years), cohabitation was the most common marital status, and homemaker
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was the most common occupation. Regarding educational level, nearly 90% had finished middle
school. Concerning obstetric background, 44% of the participants were primigravida, 98% of the births
took place by caesarean section, and the average weight of the neonates was 1686 g (Table 1).
Table 1. Clinical, anthropometric and sociodemographic characteristics of the mothers and newborns
(n = 127).
Clinical and Anthropometric Characteristics
High-risk pregnancy n = 95 Normal pregnancy n = 32
Mean ± SD p
Age (years) a 28 ± 5 27 ± 8 0.456
Pregestational weight (kg) a 62.2 ± 10 59.9 ± 10 0.253
Maximum gestational weight (kg) a 70.4 ± 13 67 ± 13 0.239
Height (cm) a 156 ± 6 156 ± 5 0.632
Pregestational BMI a 25.5 ± 4 24.5 ± 3 0.176
Number of prenatal check-ups a 4 ± 2 4 ± 0.5 0.211
Gynecological age (years) a 15 ± 8 16.5 ± 5 0.890
Menarche (age in years) a 12 ± 2 12 ± 1 0.878
Weight of the newborn (g) a 1686 ± 843 2167 ± 689 0.004
Length of the newborn (cm) a 40 ± 5 48.2 ± 5 0.006
Sociodemographic characteristics b Frequency (%)
Marital status
Single 23 (24) 4 (13)
0.556Married 35 (37) 11 (34)
Cohabitation 37 (39) 17 (53)
Occupation
0.883Homemaker 73 (77) 24 (75)
Working outside the home 22 (23) 8 (25)
Level of education
0.823
Primary or less 10 (11) 2 (6)
Middle school 40 (42) 14 (44)
High school 33 (35) 13 (41)
Professional 12 (12) 3 (9)
Socioeconomic level
0.983Lower to lower-middle class 95 (100) 31 (96)
Data expressed as the a mean ± standard deviation—Student’s t; b frequency (%)—Pearson’s X2.
There were differences between the two groups of mothers (normal versus high-risk pregnancy)
in relation to the concentration of retinol and α-tocopherol in mature breast milk (Figures 1 and 2),
as well as in neonate weight and length. Concerning anthropometric characteristics, women with
a high-risk pregnancy had an average pregestational BMI of 25.5 kg/m2 and those with a normal
pregnancy 24.5 kg/km2, while the average gestational weight gain was 8.2 kg for both groups (Table 1).
For the women with a high-risk pregnancy, the most common disorder or condition related to risk
was preeclampsia (40/95), followed by anemia (29/95), advanced maternal age (14/95), and gestational
diabetes (12/95). The complications of the neonates born of these women were preterm birth or low
birth weight (62/95), infant respiratory distress syndrome or gastroschisis (18/95), and lesions related
to the birth canal (6/95). The rest showed no complications (9/95).
When comparing the distinct subgroups of women with different disorders during
gestation, there were similar concentrations of retinol and α-tocopherol in breast milk (Table 2).
However, the concentration of retinol and α-tocopherol in breast milk was lower in women that gave
preterm birth compared to those who carried their pregnancy to term. Considering the women with a
high-risk pregnancy, the concentration of retinol was higher in the mature milk of women with normal
pregestational weight, while no significant difference was found in the concentration of α-tocopherol
among those having adequate gestational weight gain.
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Women with normal pregestational BMI had a higher concentration of retinol compared to those
who were overweight or obese (see Table 2). The Spearman correlation revealed that the greater
the pregestational weight (relative to normal), the lower the concentration of retinol (Rho = −0.280,
p = 0.006). Moreover, there was a correlation between α-tocopherol and retinol (Rho = 0.463, p = 0.001).
Compared to women with a normal pregnancy, the mature breast milk of those with a
high-risk pregnancy who delivered at full term showed a similar concentration of retinol but a lower
concentration of α-tocopherol. Compared to the mature milk of women with a normal pregnancy,
in contrast, the breast milk of those with a high-risk pregnancy who delivered preterm had a reduced
concentration of retinol and α-tocopherol in the diverse types of milk (colostrum, transition milk, and
mature milk) (Figures 1 and 2).
Figure 1. Box plot distribution of the concentration of retinol (A) and α-tocopherol (B) in breast milk,
comparing the women with a full-term, high-risk pregnancy to those with a normal pregnancy. For the
high-risk pregnancy, the distinct types of breast milk are shown (colostrum, transition milk, and mature
milk). * p; Mann-Whitney U. The bottom and top of the box represent the first and third quartiles (IQR),
and the band inside the box the median. The ends of the whiskers denote the lowest and highest values
still within 1.5 IQR. Outlier values are not displayed. NP, normal pregnancy.
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Figure 2. Box plot distribution of the concentration of retinol (A) and α-tocopherol (B) in breast milk,
comparing women with a preterm, high-risk pregnancy to those with a normal pregnancy. For the
high-risk pregnancy, the distinct types of breast milk (colostrum, transition milk and mature milk) are
shown. * p; Mann-Whitney U. The bottom and top of the box represent the first and third quartiles
(IQR), and the band inside the box the median. The ends of the whiskers denote the lowest and highest
values still within 1.5 IQR. Outlier values are not displayed. NP, normal pregnancy.
When the logistic regression model included variables that corresponded to a high-risk pregnancy,
it was observed that in all cases the concentration of both vitamin precursors was lower with high-risk
versus normal pregnancy. However, no particular risk factors were associated with these lower
concentrations. Hence, the following model was performed.
For the regression model, we utilized the median values for concentrations of retinol below
60 μg/dL and for α-tocopherol below 276 μg/dL in the group high-risk pregnancy, while using
these values below 76 and 673 μg/dL for retinol and α-tocopherol, respectively, in the group with
a history of normal pregnancy. For the high-risk pregnancy group, the variables associated with
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a low concentration of retinol in breast milk were preterm childbirth and pregestational overweight or
obesity. For the normal pregnancy group, only pregestational overweight or obesity was significant.
Meanwhile, for all the women (whether having a high-risk pregnancy or a history of normal pregnancy),
a significant risk of a low concentration of α-tocopherol was correlated with preterm childbirth and
a tendency was associated with preeclampsia (Table 3).
Table 3. Variables associated with low concentrations of retinol and α-tocopherol in mothers that
underwent a high-risk pregnancy (n = 95).
Maternal variables
The Median Concentration in Mature
Milk of Mothers Who Underwent
a High-Risk Pregnancy
The Median Concentration in Mature
Milk of Mothers Who Experienced
a Normal Pregnancy
OR CI 95% p * OR CI 95% p *
Retinol concentration (≤60 μg/dL) (≤76 μg/dL)
Preterm childbirth 2.618 1.111–6.169 0.028 2.112 0.858–5.856 0.112
Preeclampsia 1.512 0.429–5.450 0.512 0.992 0.992–1.138 0.102
Gestational diabetes 0.879 0.277–3.122 0.575 0.272 0.023–3.249 0.273
Anemia 0.877 0.281–3.629 0.258 0.955 0.906–1.006 0.331
Maternal age: under 19 or over 29 years 0.818 0.364–1.838 0.390 2.189 0.858–5.586 0.101
Pregestational overweight or obesity 1.179 1.822–2692 0.039 3.563 1.422–8.927 0.007
α-tocopherol concentration (≤276 μg/dL) a (≤673 μg/dL) b
Preterm childbirth 2.243 0.985–5.111 0.039 2.091 1.689–2.588 0.038
Preeclampsia 1.304 0.567–3.001 0.532 1.063 0.992–1.138 0.051
Gestational diabetes 0.892 0.228–3.483 0.869 0.289 0.023–2.951 0.336
Anemia 0.914 0.252–3.319 0.892 0.955 0.906–1.006 0.331
Maternal age: under 19 or over 29 years 1.879 0.459–2.484 0.879 0.402 0.035–4.591 0.441
Pregestational overweight or obesity 1.056 0.447–2.494 0.870 0.772 0.064–9.302 0.838
CI 95%: 95% confidence interval. OR: odds ratio. Low concentrations of retinol and α-tocopherol: value below
the median in mothers after a high-risk pregnancy and those with a history of a normal pregnancy. * p Value in
logistic regression model.
Regarding the different types of breast milk (Table 4), the concentration of both α-tocopherol and
retinol were lower among women who gave preterm childbirth. A positive correlation existed in all
cases between the concentration of retinol and that of α-tocopherol in the different types of milk, with
Rho values of 0.325 for colostrum, 0.375 for transition milk, and 0.300 for mature milk (p ≤ 0.001).
Table 4. Concentration of retinol and α-tocopherol in relation to the type of breast milk.
Pregnancy Length
Colostrum Transition Mature
Retinol, median (IQR), μg/dL
Preterm (n = 48) 36 (32–63) 60 (39–81) 43 (36–66)
Full term (n = 47) 49 (39–86) 73 (49–115) 52 (37–72)
p a 0.010 0.020 0.032
α-tocopherol, median (IQR), μg/dL
Preterm (n = 48) 405 (109–676) 233 (90–372) 175 (59–465)
Full term (n = 47) 654 (205–2313) 676 (174–1884) 285 (55–477)
p a 0.004 0.001 0.012
Data expressed as the median (IQR). a Mann Whitney U; IQR, interquartile range.
There was a reduced level of retinol and α-tocopherol in mothers giving preterm birth
or having low birth-weight neonates compared to those that carried their pregnancy to term.
However, the concentration of retinol (p = 0.244) and α-tocopherol (p = 0.090) did not show a significant
difference in relation to complications of the newborn. Likewise, no significant difference existed for
the concentration of retinol (p = 0.243) or α-tocopherol (p = 0.897) in regard to the history of pregnancies.
When comparing women with preterm delivery to those who carried their pregnancy to term,
the concentration of retinol was 54 (IQR; 37–78) vs. 70 (IQR; 49–106) μg/dL (p = 0.002), while that
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of α-tocopherol was 155 (IQR; 74–410) vs. 445 (IQR; 160–500) μg/dL (p = 0.053). On the other hand,
compared to women with a high-risk pregnancy, those with a normal pregnancy had a higher level of
both vitamin precursors in mature milk.
6. Discussion
There was an association between a lower concentration of retinol and α-tocopherol in mature
breast milk and two risk factors: pregestational overweight or obesity and preterm delivery.
This significance was established with the original statistical analysis and confirmed by the logistic
regression model. No significant difference in the concentration of retinol or α-tocopherol was found
in relation to either of the morbidities existing among women in the high-risk pregnancy group.
Although no direct association was detected between preeclampsia and lower levels of these vitamin
precursors, this morbidity is related to overweight and obesity, a condition that, in turn, may cause
preterm delivery.
6.1. Concentration of Retinol and α-Tocopherol
Considering that breast milk is the only source of nutrition for newborns, it is important to
determine whether the content of vitamins A and E are adequate, especially when the neonate is
premature or of very low weight [25,26]. In the majority of reports, the concentration of α-tocopherol
in the colostrum of women is two to three times higher than that detected presently in Mexican women
after a high-risk pregnancy. For the women with a normal evolutive pregnancy, some of the current
results are similar to those described for women from Bangladesh and Poland [27,28].
Concerning retinol, for the group of mothers in this study with a history of normal pregnancy
and having a normal delivery, the average concentration of this vitamin precursor is close to that
commonly reported. In contrast, the women in the present study with a high-risk pregnancy had,
on the average, about half the concentration of retinol previously found for women with a normal
pregnancy, and a third of this concentration in the cases of preterm childbirth. These values are close
to those observed in a group of women in Bangladesh [27,29,30].
The similarities in the concentration of these two vitamins between Mexico and Bangladesh [27]
may be due to the characteristics of the particular populations under study. That is, the women in
both studies had a low socioeconomic status and poor health indicators, which makes them more
prone to the development of nutritional deficiencies. Although the nutrient concentrations found in
the women are low, Ahmed et al. demonstrated that this amount is sufficient to satisfy the nutritional
needs of infants.
In relation to transitional milk, the concentration of retinol and α-tocopherol described in diverse
populations [31–35] is higher than that evidenced in the present study after a high-risk pregnancy.
Kodentsova and Vrzhesinskaya reported a mean concentration for each of these vitamin precursors
in Russian women that was very similar to the present high-risk pregnancy group. This similarity
is likely due to the fact that approximately 50% of Russian women who participated in the study
experienced a preterm pregnancy [36].
Regarding mature milk in the current contribution, the mean concentration of α-tocopherol and
retinol for both groups of women (with a normal pregnancy and high-risk pregnancy) is very similar
to most reports on these micronutrients. However, for women who, herein, had a high-risk pregnancy,
the median concentration of α-tocopherol was higher than that detected in Polish women [37–43] and in
a group of adolescent mothers in Brazil [44]. In another study by Tokusoglu et al. [45], the concentration
of α-tocopherol in the mature milk of Turkish women was similar to that commonly observed in
colostrum. Quiles et al. [26] found higher than average values for mature milk in Spain, but this was
based on only 15 women. The small sample size likely influenced the results.
The level of α-tocopherol and retinol in breast milk is normally greater in colostrum and thereafter
exhibits a downward trend during the different stages of lactation. In this study, the women with
a high-risk pregnancy showed this downward trend. We compared the average concentration of
270
Nutrients 2017, 9, 14
α-tocopherol previously reported for different groups of women, mostly with a normal evolutive
pregnancy, to that found presently for women with a high-risk pregnancy. This concentration was
herein found to be 2–3 times lower in colostrum, approximately two times lower in transitional milk,
and very similar in mature milk [31,32,46–48].
Although an inverse correlation has been reported between the concentration of retinol and
α-tocopherol in colostrum [49], the current results evidence a positive correlation between these
two vitamins, which implies the existence of suboptimal concentrations. This manifests the need for
supplementation [50] to prevent deficiencies in any given population.
6.2. Preterm Childbirth
For women in the present study with preterm birth, the median concentration of 405 (IQR; 109–676)
μg/dL of α-tocopherol in colostrum was lower than that detected in the colostrum of some other
groups of women having the same gestational age. For example, there were 1450 μg/dL in a group of
German women [51], 1292.1–1722.8 μg/dL in Spanish women [26], and 1222 ± 772 μg/dL in Tunisian
women [14]. Nevertheless, the current findings coincide with the concentration of α-tocopherol in
the colostrum of women in other studies that gave preterm birth, such as the 250 μg/dL detected in
Canadian women [52] and the 260.0 ± 30.0 μg/dL for Russian women [31]. In the case of retinol in
the colostrum of women having given preterm birth, the median value of 36 (32–63) μg/dL observed
herein is lower than the 57.5 ± 50.1 μg/dL described by Fares et al. [14]. This suggests the need to
focus on reinforcing vitamin levels in women with preterm births and their neonates.
The hypothesis that the concentration of vitamin E depends on gestational age is still very
controversial [49,53]. Nonetheless, this idea is supported by the current findings. Similar results
were reported for a group of Spanish women by Quiles et al. [26], who found significantly higher
concentrations of vitamin E at all stages of lactation in women who had carried their pregnancy to
term compared to those giving preterm birth.
Compared to the women that carried their pregnancy to term in the present study, those that
gave preterm birth had lower concentrations of retinol and α-tocopherol. The greatest deficiency was
detected for the latter vitamin precursor. These results coincide with the findings of Souza et al. [54].
To compensate for this deficiency, supplementation of these vitamins should be provided during
pregnancy (especially when involving high-risk) and breastfeeding. Unlike the current results,
a Brazilian study reported variable concentrations of α-tocopherol, without any difference between
women giving premature birth and those carrying their pregnancy to term. It has been postulated
that the concentration of this vitamin is associated with birth weight more than prematurity [53].
However, this idea was not corroborated presently, evidencing multifactorial causes for the deficiency
of this vitamin.
The current findings emphasize the fact that the neonate of a preterm birth requires special
care, such as optimal nutrition. Not only does the prematurity of birth imply low reserves of
vitamins A and E, but also the poor nutritional status of the mother indicates a limited transfer of the
same through the placenta. For these reasons, liposoluble vitamins (e.g., retinol and α-tocopherol)
should be assimilated by women with high-risk pregnancies [55] to avoid complications such as a
delay in intrauterine growth or in neurodevelopment. A deficiency of these vitamins can even induce
miscarriage [29].
Furthermore, it is recommended that preterm neonates immediately begin enteral feeding with
breast milk and, if possible, vitamin supplementation [55]. Indeed, clinical assays have been conducted
in which pregnant women were given a supplement of RRR α-tocopherol acetate, resulting in a
significantly elevated concentration of this vitamin in transition milk and mature milk, as well as in
the mothers themselves who gave preterm birth [50].
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6.3. Does the BMI Affect the Concentrations of Retinol and α-Tocopherol?
The current results reveal that the higher the pregestational BMI (relative to normal) and the
greater the gap between the real and recommended gestational weight gain, the lower the concentration
of retinol tends to be. In this sense, the simple fact of having a high BMI is a risk factor for increased
production of proinflammatory cytokines, a problem that can be counteracted if women are protected
by adequate concentrations of two antioxidant substances, retinol and α-tocopherol. Perhaps it was
the deficiency of retinol and α-tocopherol that, in large part, caused the relatively high frequency of
preeclampsia among the women presently studied, considering that this deficiency (as well as others)
can lead to greater oxidative stress [37] which, in turn, when coupled with other factors, tends to
trigger this disorder [56,57].
A negative correlation was observed herein between pregestational BMI and the concentration
of retinol and α-tocopherol. Like any population with overweight and obesity, pregnant women
lack antioxidants and are exposed to cytokines that can harm their health and that of their offspring,
thus affecting fetal programming and the first 1000 days of life [58–60].
The results suggest that the present participants showed no association between gestational
diabetes (or other morbidities correlated with pregnancy) and low concentrations of retinol and
α-tocopherol in breast milk, in agreement with another report that found no such association [11].
Since breast milk is the only source of these vitamins, however, there may be a greater risk, especially in
the case that the newborn is premature or suffers from complications that increase oxidative stress.
The current results, like the vast majority of studies on liposoluble vitamins in breast milk [61–63],
evidence a wide range in the concentration of vitamins A and E (especially vitamin E) among
participants. This variation could be related to differences in lifestyle, in the consumption of nutrients
and/or enrichment of food, and in the use of vitamin and food supplements. Some methodological
factors, such as the day and time of collecting samples or the time elapsed since the last breastfeeding
and the last meal, could contribute to this variability. Additionally, differences in methods of analysis
also represent an important factor of variation. Finally, the methods employed for hydrolysis and
extraction of an organic matrix of vitamins can affect the concentration of the same in breast milk [62].
Nourishing an infant with milk from his or her own mother results in better growth and
nutritional status (including the level of vitamins A and E) than that observed in infants fed formula.
Moreover, breast milk composition may be affected by obstetric characteristics, such as a premature
delivery. In the present study, the composition of retinol and α-tocopherol in breast milk was negatively
affected by premature birth and pregestational overweight and obesity. Furthermore, the concentration
of these vitamin precursors was lower in the breast milk of women that had undergone a high-risk
pregnancy compared to those having had a normal pregnancy.
Studies that explore the association between neonatal/maternal characteristics and the
concentration of retinol and α-tocopherol in breast milk are important for determining the subgroups
of newborns at risk for a vitamin A and E deficiency. This information should lead to strategies
(e.g., vitamin supplementation) to target the subgroups at risk. Moreover, this approach can broaden
the understanding of the influence of maternal factors such as gestational age on the adaptation
capacity of mechanisms for transferring retinol and α-tocopherol to the mammary gland.
Certain elements of this study could be considered as limitations, including the lack of an
evaluation of the nutritional state and diet of the participants. Another limitation is that a determination
of fat in breast milk samples was not made. However, in other populations a high negative correlation
has been shown between the concentration of serum cholesterol, the BMI, and the level of tocopherol
and retinol. In addition, it must be kept in mind that all of the women participating in this study were
of a low socioeconomic level, meaning that the results obtained cannot be generalized to all Mexican
women during the period of breastfeeding.
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7. Conclusions
Since the nutritional needs of a woman are sharply increased during pregnancy, it can be a
challenge to meet these needs if careful attention is not paid to an adequate consumption of nutrients.
Any inadequate dietary alteration can affect the health of the mother-fetus binomial. Deficiencies in
micronutrients are related to gestational diabetes, preeclampsia, eclampsia, delayed intrauterine
growth, low birth weight of the neonate, premature separation of the placenta, premature childbirth,
spontaneous abortion, and congenital anomalies. Moreover, maternal nutrition determines the quality
of breast milk. The concentration of vitamins A and E in breast milk depend on the concentration of
the same in the mother. Hence, a maternal deficiency translates into the same problem for the neonate.
Even though the women in the high-risk pregnancy group showed a deficiency of
vitamins A and E in their breast milk, the unique biological benefits of this milk justify the promotion
of breast feeding as the optimal method of nourishing neonates. In these cases, it should be
recommended that the woman increase her consumption of certain nutrients during pregnancy.
Additionally, after childbirth, she should consider the use of supplements to produce milk of adequate
quality and, thus, meet the needs of the baby and prevent a deficiency of micronutrients.
When the concentration of vitamins A and E are low in the breast milk of mothers after a
high-risk pregnancy, we also recommend supplements for a child who receives nutrition exclusively
from the mother. This supplementation should begin during the first days of life and continue
until the infant initiates a complementary diet. Some studies have demonstrated that a deficiency
in vitamins A and E in newborns, above all those with premature birth, increases the frequency of
cases of bronchopulmonary dysplasia, intraventricular hemorrhage, periventricular leukomalacia,
retinopathy, and necrotizing enterocolitis. Currently, there is not enough information to evaluate the
possible benefits or adverse effects of supplementation during pregnancy.
In the current study, maternal overweight and obesity, as well as preterm birth, were associated
with a low concentration of vitamins A and E in breast milk. It is necessary to determine whether
the level of physical activity and the individual metabolism influence the quantity of food that each
woman needs to achieve an optimal nutritional state and an adequate production of milk. The length
and intensity of lactation also significantly affects the nutritional needs of the mother, although this is
rarely considered.
Finally, during the period of breast feeding both the mother and child are at risk for a deficiency
of vitamins A and E, especially in developing countries like Mexico and, thus, represent a public
health problem. Moreover, if the concentration of vitamins A and E are low in the mother, the child is
susceptible to suffering a like deficiency.
This study improves the knowledge about the content of vitamins A and E in breast milk from
mothers after a high-risk pregnancy. Future research could include other nutrients that are also
important for the development of the breast-fed child, as well as evaluate the nutritional intake of
women during a high-risk pregnancy.
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Krzykowski, G.; Martysiak-Żurowska, D.; Kamińska, B. Longitudinal study of vitamins A, E and lipid
oxidative damage in human milk throughout lactation. Early Hum. Dev. 2012, 88, 421–424. [CrossRef]
[PubMed]
29. De Lira, L.Q.; Ribeiro, P.P.; Grilo, E.C.; Lima, M.S.; Dimenstein, R. Alpha-tocopherol level in serum and
colostrum of breastfeeding women and association with maternal variables. Rev. Bras. Ginecol. Obstet. 2012,
34, 362–368. (In Portuguese) [PubMed]
30. Shi, Y.D.; Sun, G.Q.; Zhang, Z.G.; Deng, X.; Kang, X.H.; Liu, Z.D.; Ma, Y.; Sheng, Q.H. The chemical
composition of human milk from Inner Mongolia of China. Food Chem. 2011, 127, 1193–1198. [CrossRef]
[PubMed]
31. Martysiak-Zurowska, D.; Szlagatys-Sidorkiewicz, A.; Zagierski, C. Concentrations of alpha- and
gamma-tocopherols in human breast milk during the first months of lactation and in infant formulas.
Matern. Child Nutr. 2013, 9, 473–482. [CrossRef] [PubMed]
32. Garcia, L.R.; Ribeiro, K.D.; Araújo, K.F.; Azevedo, G.M.; Pires, J.F.; Batista, S.D.; Dimenstein, R. Níveis de
alfa-tocoferol no soro e leite maternos de puérperas atendidas em maternidade pública de Natal. Rio Grande
do Norte Rev. Bras. Saude. Matern. Infant. 2009, 9, 423–428. [CrossRef]
33. Sakurai, T.; Furukawa, M.; Asha, M.; Kanno, T.; Kojima, T.; Yonekubo, A. Fat-soluble and water-soluble
vitamin contents of breast milk from Japanese women. J. Nutr. Sci. Vitaminol. 2005, 5, 239–247. [CrossRef]
34. Engle-Stone, R.; Haskell, M.J.; Nankap, M.; Ndjebayi, A.O.; Brown, K.H. Breast milk retinol and plasma
retinol-binding protein concentrations provide similar estimates of vitamin A deficiency prevalence and
identify similar risk groups among women in Cameroon but breast milk retinol underestimates the
prevalence of deficiency among young children. J. Nutr. 2014, 144, 209–217. [PubMed]
35. Tanumihardjo, S.A.; Russell, R.M.; Stephensen, C.B.; Gannon, B.M.; Craft, N.E.; Haskell, M.J.; Lietz, G.;
Schulze, K.; Raiten, D.J. Biomarkers of nutrition for development (BOND)-vitamin A Review. J. Nutr. 2016,
146, 1816S–1848S. [CrossRef] [PubMed]
36. Kodentsova, V.M.; Vrzhesinskaya, O.A. Evaluation of the vitamin status in nursing women by vitamin
content in breast milk. Bull. Exp. Biol. Med. 2006, 141, 323–327. [CrossRef] [PubMed]
275
Nutrients 2017, 9, 14
37. Kamao, M.; Tsugawa, N.; Suahra, Y.; Okano, T. Determination of fat-soluble vitamins in human plasma,
breast milk, and food samples: Application in nutrition survey for establishment of “Dietary Reference
Intakes for Japanese”. J. Health Sci. 2007, 53, 257–262. [CrossRef]
38. Tijerina-Sáenz, A.; Innis, S.M.; Kitts, D.D. Antioxidant capacity of human milk and its association with
vitamins A and E and fatty acid composition. Acta Paediatr. 2009, 98, 1793–1798. [CrossRef] [PubMed]
39. Antonakou, A.; Chiou, A.; Andrikopoulos, N.K.; Bakoula, C.; Matalas, A.L. Breast milk tocopherol content
during the first six months in exclusively breastfeeding Greek women. Eur. J. Nutr. 2011, 50, 195–202.
[CrossRef] [PubMed]
40. Szlagatys-Sidorkiewicz, A.; Zagierski, M.; Luczak, G.; Macur, K.; Baczek, T.; Kaminska, B. Maternal smoking
does not influence vitamin A and E concentrations in mature breastmilk. Breastfeed. Med. 2012, 7, 285–289.
[CrossRef] [PubMed]
41. Wallingford, J.; Underwood, B. Vitamin A deficiency in pregnancy, lactation and the nursing child.
In Vitamin A deficiency and Its Control; Bauernfeind, J., Ed.; Academic Press: Orlando, FL, USA, 1986;
pp. 101–152.
42. Agne-Djigo, A.; Idohou-Dossou, N.; Kwadjode, K.M.; Tanumihardjo, S.A.; Wade, S. High prevalence of
vitamin A deficiency is detected by the modified relative dose-response test in six-month-old Senegalese
breast-fed infants. J. Nutr. 2012, 142, 1991–1996. [CrossRef] [PubMed]
43. Tyndall, J.A.; Okoye, V.; Elumelu, F.; Dahiru, A.; Pariya, H.B. Vitamin A and iron deficiency in pregnant
women, lactating mothers and their infants in Adamawa State, Nigeria: A prospective cohort study. Am. J.
Food Nutr. 2012, 2, 14–20. [CrossRef]
44. Azeredo, V.B.; Trugo, N.M. Retinol, carotenoids, and tocopherols in the milk of lactating adolescents and
relationships with plasma concentrations. Nutrition 2008, 24, 133–139. [CrossRef] [PubMed]
45. Tokusoglu, O.; Tansug, N.; Aksit, S.; Dinc, G.; Kasirga, E.; Ozcan, C. Retinol and α-tocopherol concentrations
in breast milk of Turkish lactating mothers under different socio-economic status. Int. J. Food Sci. Nutr. 2008,
59, 166–174. [CrossRef] [PubMed]
46. Debier, C. Vitamin E during pre- and postnatal periods. Vitam. Horm. 2007, 76, 357–373. [PubMed]
47. Sziklai-László, I.; Majchrzak, D.; Elmadfa, I.; Cser, M.A. Selenium and vitamin E concentrations in human
milk and formula milk from Hungary. J. Radioanalytical Nuclear Chem. 2009, 279, 585–590. [CrossRef]
48. Fujita, M.; Shell-Ducan, B.; Ndemwa, P.; Brindle, E.; Lo, Y.J.; Kombe, Y.; O’Connor, K. Vitamin A Dynamics
in breastmilk and liver stores: A life history perspective. Am. J. Hum. Biol. 2011, 23, 664–673. [CrossRef]
[PubMed]
49. De Lira, L.Q.; Lima, M.S.; de Medeiros, J.M.; da Silva, I.F.; Dimenstein, R. Correlation of vitamin A nutritional
status on alpha-tocopherol in the colostrum of lactating women. Matern. Child Nutr. 2013, 9, 31–40. [CrossRef]
[PubMed]
50. Pires Medeiros, J.F.; Ribeiro, K.D.; Lima, M.S.; das Neves, R.A.; Lima, A.C.; Dantas, R.C.; da Silva, A.B.;
Dimenstein, R. α-tocopherol in breast milk of women with preterm delivery after a single postpartum oral
dose of vitamin E. Br. J. Nutr. 2016, 115, 1424–1430. [CrossRef] [PubMed]
51. Haug, M.; Laubach, C.; Burke, M.; Harzer, G. Vitamin E in human from mothers of preterm and term infants.
J. Pediatr. Gastroenterol. Nutr. 1987, 6, 605–609. [CrossRef] [PubMed]
52. Bishara, R.; Dunn, M.S.; Merko, S.E.; Darling, P. Nutrient composition of hindmilk produced by mothers of
very low mothers of very low birth weight infants born at less than 28 weeks gestation. J. Hum. Lact. 2008,
24, 159–167. [CrossRef] [PubMed]
53. Grilo, E.C.; Lira, L.Q.; Dimenstein, R.; Ribeiro, K.D. Influence of prematurity and birth weight on the
concentration of α-tocopherol in colostrum milk. Rev. Paul. Pediatr. 2013, 31, 473–479. [CrossRef] [PubMed]
54. Souza, G.; Dolinsky, M.; Matos, A.; Chagas, C.; Ramalho, A. Vitamin A concentration in human milk and its
relationship with liver reserve formation and compliance with the recommended daily intake of vitamin
A in preterm and full term infants in exclusive breastfeeding. Arch. Gynecol. Obstet. 2015, 291, 319–325.
[CrossRef] [PubMed]
55. Ho, M.Y.; Yen, Y.H. Trend of nutritional support in preterm infants. Pediatr. Neonatol. 2016, 57, 365–370.
[CrossRef] [PubMed]
56. Shamim, A.A.; Schulze, K.; Merrill, R.D.; Kabir, A.; Christian, P.; Shaikh, S.; Wu, L.; Ali, H.; Labrique, A.B.;
Mehra, S.; et al. First-trimester plasma tocopherols are associated with risk of miscarriage in rural Bangladesh.
Am. J. Clin. Nutr. 2015, 101, 294–301. [CrossRef] [PubMed]
276
Nutrients 2017, 9, 14
57. Cohen, J.M.; Kramer, M.S.; Platt, R.W.; Basso, O.; Evans, R.W.; Kahn, S.R. The association between maternal
antioxidant levels in midpregnancy and preeclampsia. Am. J. Obstet. Gynecol. 2015, 213, 695.e1–695.e13.
[CrossRef] [PubMed]
58. Wei, X.; Peng, R.; Cao, J.; Kang, Y.; Qu, P.; Liu, Y.; Xiao, X.; Li, T. Serum vitamin A status is associated with
obesity and the metabolic syndrome among school-age children in Chongqing, China. Asia Pac. J. Clin. Nutr.
2016, 25, 563–570. [PubMed]
59. Hrolfsdottir, L.; Schalkwijk, C.G.; Birgisdottir, B.E.; Gunnarsdottir, I.; Maslova, E.; Granström, C.; Strøm, M.;
Olsen, S.F.; Halldorsson, T.I. Maternal diet, gestational weight gain, and inflammatory markers during
pregnancy. Obesity (Silver Spring) 2016, 24, 2133–2139. [CrossRef] [PubMed]
60. McCurdy, C.E.; Schenk, S.; Hetrick, B.; Houck, J.; Drew, B.G.; Kaye, S.; Lashbrook, M.; Bergman, B.C.;
Takahashi, D.L.; Dean, T.A.; et al. Maternal obesity reduces oxidative capacity in fetal skeletal muscle of
Japanese macaques. JCI Insight 2016, 1, e86612. [CrossRef] [PubMed]
61. Lima, M.S.R.; Dimenstein, R.; Ribeiro, K.D.S. Vitamin E concentration in human milk and associated factors:
A literature review. J. Pediatr. (Rio J.) 2014, 90, 440–448. [CrossRef] [PubMed]
62. Fares, S.; Sethom, M.M.; Kacem, S.; Ksibi, I.; Feki, M.; Jebnoun, S.; Kaabachi, N. Retinol and alpha-tocopherol
in the colostrum of lactating Tunisian women delivering prematurely: Associations with maternal
characteristics. Pediatr. Neonatol. 2016, 57, 120–126. [CrossRef] [PubMed]
63. Debier, C.; Pottier, J.; Goffe, C.H.; Larondelle, Y. Present knowledge and unexpected behaviors of vitamins A
and E in colostrum and milk. Liviest. Prod. Sci. 2005, 98, 135–147. [CrossRef]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Breastmilk Production in the First 4 Weeks after Birth
of Term Infants
Jacqueline C. Kent *, Hazel Gardner and Donna T. Geddes
School of Chemistry and Biochemistry, The University of Western Australia, Crawley 6009, Australia;
Hazel.Gardner@uwa.edu.au (H.G.); Donna.Geddes@uwa.edu.au (D.T.G.)
* Correspondence: Jacqueline.Kent@uwa.edu.au; Tel.: +61-8-6488-1208
Received: 30 September 2016; Accepted: 21 November 2016; Published: 25 November 2016
Abstract: Breastmilk provides the ideal nutrition for the infant, and exclusive breastfeeding is
recommended for the first 6 months. Adequate milk production by the mother is therefore critical,
and early milk production has been shown to significantly affect milk production during established
lactation. Previous studies indicate that milk production should reach the lower limit of normal for
established lactation (440 mL per day) by day 11 after birth. We have used test-weighing of term
infants before and after each breastfeed over 24 h to measure milk production in the first 4 weeks of
lactation in mothers with and without perceived breastfeeding problems to provide information on
how often milk production is inadequate. Between days 11 and 13, two-thirds of the mothers had
a milk production of less than 440 mL per day, and between days 14 and 28, nearly one-third of the
mothers had a milk production of less than 440 mL per day. The high frequency of inadequate milk
production in early lactation and the consequence of suboptimal milk production in later lactation
if left untreated suggest that objective measurement of milk production can identify mothers and
infants at risk and support early intervention by a lactation specialist.
Keywords: breastfeeding; milk production; insufficient milk
1. Introduction
There is a sound evidence base for the health advantages of breastfeeding for infants and their
mothers, and a dose-response relationship has been demonstrated [1]. As such, any breastfeeding
should be encouraged and full breastfeeding achieved if possible. Milk production and adequacy at
6 weeks after birth, for mothers of both healthy breastfeeding term infants and non-nursing preterm
infants, have been shown to have a significant relationship with milk production 4–6 days after
birth [2,3]. Hill et al. therefore suggest that interventions that promote an adequate milk supply
by the first week postpartum are critical [2]. These include skin-to-skin contact and milk removal
(breastfeeding or expressing) within an hour of birth and frequent milk removal during the first 24 h
after birth. Early initiation of lactation, particularly breastfeeding or expressing within an hour of
birth, has been shown to lead to a higher rate of breastfeeding beyond 6 weeks for term infants [4].
Skin-to-skin contact between mother and infant for the first hour after birth results in earlier effective
breastfeeding [5] and an increased likelihood of breastfeeding 1–4 months after birth than when the
infant was swaddled in blankets [6]. There is also a positive effect of the number of breastfeeds in the
first 24 h on milk production on days 3 and 5 after birth [7]. It is important, therefore, to know if milk
production is adequate during early lactation. The lower limit of normal daily milk production for
established lactation has been calculated to be 440 g [8]. During the first week of lactation, on day 5,
daily milk transfer during breastfeeding is 415 ± 123 g (combined data from a total of 305 breastfeeding
mothers [7,9–14]). For mothers who were exclusively expressing breastmilk, one study of mothers
of term infants measured a milk production of 973 ± 176 g per day on day 5 [15]. There is limited
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data on milk production during the second week after birth, but data from 10 mothers showed a daily
milk transfer of 653 ± 154 g with a slightly higher milk yield of 668 ± 163 g due to some mothers
occasionally pumping their breastmilk [11]. Hill et al. reported a lower milk production of 556 ± 187 g,
but some of those mothers were supplementing [3]. Taken together, published data indicate that 92%
of term mothers produce at least 440 g per day by 2 weeks of lactation.
It has been reported that 58% of term mothers experience problems with breastfeeding, including
a perception of insufficient milk supply, in the first 2 weeks and this is associated with a lack of
confidence in breastfeeding [16]. A perception of insufficient milk supply is given as a reason for the
introduction of supplementary infant formula [17,18]. If breastmilk supply is actually inadequate
supplementary feeds are necessary. If supplementary feeds are given instead of breastfeeds they
could have a negative impact on milk supply. Measurement of milk production using in-home 24-h
test-weighing is being used increasingly by lactation consultants and general practitioners as a clinical
tool to either reassure mothers that their breastfeeding patterns and milk production are normal,
or to guide advice to increase or decrease milk production or breastmilk transfer [19]. We aim to use
24-h milk profiles during the establishment of lactation to try to verify that full milk production
is achieved by 2 weeks of lactation in mothers without perceived breastfeeding problems and,
in a vulnerable population, how frequently milk supply is not adequate indicating that intervention
would be appropriate.
2. Materials and Methods
A convenience sample of mothers within 4 weeks after the birth of a singleton, term infant
(≥37 weeks gestational age at delivery, birth weight ≥2500 g) who were fully or partially
breastfeeding [20] were invited to participate between June 2009 and April 2016. We recruited
mothers under the care of general practitioners or lactation consultants for perceived breastfeeding
problems, and volunteers for studies undertaken by the research group (e.g., Prime et al. [21]) who
were without perceived breastfeeding problems. Demographics were recorded and the participants
were loaned accurate digital scales (BabyWeigh™, Medela Inc., McHenry, IL, USA, resolution 2 g,
accuracy ± 0.034%) to measure their milk profile. This involved the participants test-weighing their
infants in their own homes [22] before and after each breastfeed or supplementary feed and recording
amounts of breastmilk expressed. All measurements of breastfeed amounts and milk production
are measured in grams but expressed in mL because the density of milk is 1.03 g·mL−1. Data were
recorded either on paper or entered on a password-protected website accessed by invitation only.
Breastfeeding parameters were calculated: the total amount of milk transferred from the mother to the
infant while breastfeeding (total breastfeeding transfer), the amount of breastmilk expressed during the
24-h period (total breastmilk expressed), the total amount of milk produced by both breasts in the 24-h
period (total breastmilk production = total breastfeeding transfer + total breastmilk expressed), and the
total infant milk intake (total breastfeeding transfer plus expressed breastmilk and/or supplementary
formula). The duration of each feed was taken from the time of weighing before to the time of weighing
after the feeding.
Analysis used R version 3.2.1 GUI Snow Leopard (The R Foundation for Statistical Computing,
Vienna, Austria) [23] with the base package and the library nlme [24] for linear mixed effects models.
Summary statistics are presented as mean ± SD where the Shapiro-Wilk test indicated normality,
or median (interquartile range) otherwise. Groups were compared on demographic and milk intake
variables using two-tailed independent samples Student’s t-test where the Shapiro-Wilk test indicated
normality, and Kruskal-Wallis rank sum test otherwise. Linear mixed effects analyses of the relationship
between demographic and milk intake variables and total milk production were carried out with
random effects of different intercepts for each mother. Differences were considered to be significant
where p < 0.05.
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All participants supplied written, informed consent to participate in the studies, which were
approved by the Human Research Ethics Committee at The University of Western Australia
(RA/4/1/4103) and Women and Newborn Health Service (1746/ew).
3. Results
Sixty-two percent of participants who agreed to participate completed 24-h milk profiles between
6 and 28 days after birth. There were 13 participants without perceived breastfeeding problems
(6 female infants, all Caucasian, 4 primiparous, 12 vaginal delivery) and 103 participants with perceived
breastfeeding problems (50 female infants). Complete demographics were available for 48 participants
(43 Caucasian, 32 primiparous, 28 vaginal delivery). Seventy-six of these provided information
regarding their breastfeeding problems. The most common was a perception of insufficient milk
supply (59 participants), but pain (11 participants) and positioning and attachment (10 participants)
were also mentioned. Seventy-five of the participants with perceived breastfeeding problems were
supplementing their infants with expressed breastmilk and/or infant formula, 45 using expressed
breastmilk alone, 25 using infant formula and expressed breastmilk, and 5 participants used formula
but no expressed breastmilk. The characteristics of the participants are presented in Table 1.






Birth weight (g) 3498 (293) 3450 (3206, 3739) 0.051
Gestational age at delivery (weeks+days) 39+2 (1+3) 39+6 (38+7, 40+3) 0.025
Feed frequency (breasts) 12 (3) 12 (4) 0.50
Average feed duration (min) 17 (5) 15 (13, 21) 0.052
Average feed amount (mL) 63 (27) 30 (20, 45) <0.001
Total breastfeeding transfer (mL·day−1) 693 (174) 399 (211) <0.001
Total breastmilk expressed (mL·day−1) 160 (n = 1) 168 (78, 272) (n = 68)
Supplementary infant formula (mL·day−1) 0 135 (80, 272) (n = 72)
Total infant milk intake (mL·day−1) 699 (168) 567 (164) 0.007
Data are presented as mean (SD) or median (IQR). Comparisons between measures for participants with
and without perceived breastfeeding problems were made using Student’s t-test where the Shapiro-Wilk test
indicated normality, and Kruskal-Wallis rank sum test otherwise.
There were no significant differences between the groups for birth weight, frequency of
breastfeeds, duration of breastfeeds, or total breastmilk production, but there were significant
differences between the two groups for gestational age at delivery, average feed amount,
total breastfeeding transfer, and total infant milk intake. Those with perceived breastfeeding problems
who were supplementing with infant formula had a significantly lower average feed amount and total
breastfeeding transfer (p < 0.001).
There were no significant relationships between infant age, birth weight, gestational age at
delivery or average feed duration on total breastfeeding transfer (p > 0.13), but there were significant
relationships between average feed duration and average feed amount (R2 = 0.08, p = 0.003),
feed frequency and average feed amount (R2 = 0.10, p = 0.010), feed frequency and total breastfeeding
transfer (R2 = 0.05, p = 0.018), and average feed amount and total breastfeeding transfer (R2 = 0.62,
p < 0.001).
All measurements of total milk production are shown in Figure 1. Twenty-nine measurements
were made between 6 and 13 days of lactation. For those with perceived breastfeeding problems the
total breastmilk production of 14 was ≥440 mL and 12 was <440 mL. Of the participants without
perceived breastfeeding problems two had a total breastmilk production of 624 and 678 mL, and one
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who had a total breastmilk production of 338 mL at 1.4 weeks was an experienced breastfeeding
mother (parity 4) who subsequently produced 722 mL at 5.1 weeks.
Eighty-seven measurements were made between 14 and 28 days of lactation. For the 77 of those
with perceived breastfeeding problems, the total breastmilk production of 53 was ≥440 mL, and for 24
was <440 mL. All 10 participants without perceived breastfeeding problems had a total breastmilk
production of ≥ 440 mL.
Figure 1. Total milk production of mothers with (circles) and without (crosses) perceived
breastfeeding problems. The dotted lines indicate the mean ± SD of milk production derived from
the literature [7,9–14,25]. The horizontal grey line indicates the lower limit of normal for established
lactation [8].
4. Discussion
The current data from all but one of the participants who did not have any perceived breastfeeding
problems support the findings of limited published data suggesting that full milk production is
normally reached by the second week of lactation. Even for mothers with perceived breastfeeding
problems, over half were producing more than 440 mL per day in the first 13 days after birth.
It is normal for infants to lose weight after birth, and a recent study has demonstrated that the time
of the nadir of weight occurs 52.3 h after birth with a loss of 218 g and a weight ratio (weight divided
by birth weight) of 0.933 [26]. Compared with infants who were breastfed less than 7 times a day
in the first 24 h after birth, infants who were breastfed 7 or more times received significantly more
breastmilk, had a maximum weight loss that was 1% lower (5.8% compared with 6.8%), started to
regain weight 19 h earlier, and had more than regained their birth weight by 7 days after birth [9].
Although there was no statistically significant difference in the feed frequency between those with and
without breastfeeding problems, we observed that 11 of the participants with perceived breastfeeding
problems had a feed frequency of <7, a mean total breastfeeding transfer of 195 mL, and a mean total
breastmilk production of 344 mL. It is possible that this low production is a result of early infrequent
breastfeeding. We suggest that if fully breastfed infants have not regained their birth weight by 7 days
after birth the mother’s milk profile should be measured during the second week. If it is shown to be
low (<440 mL) then early remedial action could be taken, which could include correction of positioning
and attachment, increase in feeding frequency, and use of galactogogues. If an ample milk supply is
demonstrated the infant should be assessed.
There were small effects of average feed duration and frequency on average feed amount, and
a small effect of feed frequency on total breastfeeding transfer. However, the frequency and duration of
breastfeeds for this population was very close to the average for mothers of exclusively breastfed infants
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between 4 and 26 weeks of lactation [17]. The most significant factor affecting total breastfeeding
transfer was the average feed amount. This suggests that, while infants should be fed often and
feed times should not be unnecessarily restricted, the major contributor to low total breastfeeding
transfer is the amount of milk transferred during each breastfeed. About two-thirds of the mothers
with perceived breastfeeding problems were already expressing breastmilk, suggesting that milk
was possibly available but the infant was unable to remove sufficient milk during breastfeeding.
The attention of the lactation specialist on good positioning and attachment and investigation of
other possible reasons for poor milk transfer is reinforced by these data. The one participant who
had a low measured milk production at 1.4 weeks gave only one extra breastfeed but doubled the
amount transferred during each breastfeed and more than doubled her milk production by 5 weeks,
illustrating that milk production can be increased during the early weeks as the infant becomes more
effective at breastfeeding.
5. Study Limitations
Investigation of breastmilk production of mothers with and without breastfeeding problems
in early lactation would benefit from a more detailed history of the initiation of lactation from
the time of birth, including time of first breastfeed, skin-to-skin care, assessment of attachment,
frequency of breastfeeds, and frequent measurements of the infants’ weights in the first week after
birth. Measurement of 24-h milk profiles at 7 and 14 days after birth would allow identification of the
factors that are most important in optimizing breastfeeding milk transfer. Weighing an infant before
and after every feeding for 24 h can be demanding, so while this technique is very useful, it is not
appropriate for all lactating mothers.
6. Conclusions
The high frequency of inadequate milk production in early lactation and the consequence of
suboptimal milk production in later lactation if left untreated underline the importance of early
identification of mothers and infants at risk. Measurement of milk profile during the second week of
lactation provides an objective measure of breastfeeding milk transfer and total breastmilk production.
These measures, considered with the infant’s weight changes, can provide an indication that early
intervention by a lactation specialist to improve milk production is warranted.
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Abstract: Human milk (HM) components influence infant feeding patterns and nutrient intake, yet
it is unclear how they influence gastric emptying (GE), a key component of appetite regulation.
This study analyzed GE of a single breastfeed, HM appetite hormones/macronutrients and
demographics/anthropometrics/body composition of term fully breastfed infants (n = 41, 2 and/or
5 mo). Stomach volumes (SV) were calculated from pre-/post-feed ultrasound scans, then repeatedly
until the next feed. Feed volume (FV) was measured by the test-weigh method. HM samples were
analyzed for adiponectin, leptin, fat, lactose, total carbohydrate, lysozyme, and total/whey/casein
protein. Linear regression/mixed effect models were used to determine associations between GE/feed
variables and HM components/infant anthropometrics/adiposity. Higher FVs were associated with
faster (−0.07 [−0.10, −0.03], p < 0.001) GE rate, higher post-feed SVs (0.82 [0.53, 1.12], p < 0.001),
and longer GE times (0.24 [0.03, 0.46], p = 0.033). Higher whey protein concentration was associated
with higher post-feed SVs (4.99 [0.84, 9.13], p = 0.023). Longer GE time was associated with higher
adiponectin concentration (2.29 [0.92, 3.66], p = 0.002) and dose (0.02 [0.01, 0.03], p = 0.005), and lower
casein:whey ratio (−65.89 [−107.13, −2.66], p = 0.003). FV and HM composition influence GE and
breastfeeding patterns in term breastfed infants.
Keywords: human milk; term breastfed infants; gastric emptying; feeding frequency; ultrasound;
stomach volumes; appetite hormones; macronutrients; feed volume; anthropometrics; body composition
1. Introduction
Breastfeeding and its longer duration are associated with reduced risks of developing obesity
and other chronic non-communicable diseases later in life [1,2]. This unique protection could be
the result of many mechanisms associated with both nutritive and non-nutritive components of
human milk (HM) [3] as well as breastfeeding patterns and behaviour [4,5]. It has been shown
that HM has the pleiotropic role, providing immune and anti-inflammatory protection [6,7] and
endocrine, developmental, neural, and psychological benefits [2]. Non-nutritive HM components
such as hormones, growth factors, neuropeptides, and anti-inflammatory and immune-modulating
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agents influence the growth, development, and function of the gastrointestinal (GI) tract during early
infancy [8], while some micronutrients act as nutritional antioxidants, improving GI functions [9];
however, there is much to be learned about the spectrum of HM programming agents, how their
patterns change throughout lactation period, and their short-term effect on the gastric emptying (GE)
rate of the breastfed infants.
GE is a process by which ingested food is mechanically and chemically partially broken down and
delivered to the duodenum at a controlled rate for further digestion and absorption [10,11]. While well
studied in the preterm population [12–14], in healthy term fully breastfed infants the GE rate and its
relationship with breastfeeding patterns are not fully understood.
GE rate and patterns are known to depend on the nature and macronutrient composition of
the ingested meal. HM or formula in the infant stomach separates into two phases, a liquid phase
consisting of water, whey proteins, lactose, etc., and a semi-solid phase consisting of curd formed
by casein and lipids. The semi-solid phase typically empties more slowly than the liquid phase.
Different proportions of these phases in part explain the difference between GE patterns of formula-fed
and breastfed infants—linear and curvilinear, respectively [12,15].
HM has a unique composition, including nutrients, growth factors, immune factors, and hormones.
Despite numerous investigations into the different effects of HM and formula, few components,
including major macronutrients, have been studied in connection with the GE of breasted term infants.
Fatty acids profiles are not associated with GE rate in preterm infants [16], while in term infants
more rapid GE has been attributed to the fat and protein components of feeds with similar lactose
concentration and osmolality [17].
Both osmolality and carbohydrate content are known to influence the rate of GE in adults [18],
but in infants results are dependent on the type of carbohydrate [19,20].
Proteins from different HM fractions such as whey and casein are resistant to proteolysis in the
infant stomach [21] and the protein content of a food has also been shown to influence appetite and
its regulation [22]. Infant formula generally empties more slowly than HM in term infants; further,
formulas with different casein:whey protein ratio exhibit different GE rates, with casein-predominant
formulas emptying slower than whey-predominant formulas [23]. Thus the casein:whey ratio of HM
could play an important role in controlling GE in the breastfed infant.
HM lysozyme, also present in whey in a relatively high concentration, catalyzes the hydrolysis
of specific bonds in Gram-negative bacteria cell walls and plays multiple roles in digestive strategy,
such as controlling the microbiome in the stomach and speeding up the digestion of microbial protein,
which may affect gastric motility and GE rate [24,25].
The satiety hormone leptin and the appetite-stimulating hormone adiponectin are also present
in HM. Although not transferred to the infant circulation in direct manner, levels of HM leptin and
adiponectin from HM have been found to correlate with levels of these hormones in infant serum [26,27]
and are known to affect both appetite control and infant body composition (BC) [28,29], but are yet to be
investigated in relation to GE in the term infant. In animal models (rat, mouse), injection of leptin into
the fourth ventricle has been shown to delay GE [30] and oral administration reduced food intake [31].
Leptin in HM is by far the most studied appetite hormone, but predominantly in skim milk [32].
Leptin measured in skim HM was not associated with time between feeds [33,34] or GE [34] in term
breastfed infants, emphasizing the need for studies including whole milk leptin, where the levels of
leptin are shown to be higher [32]. Adiponectin has the highest concentration of any appetite hormone
in HM. It is present in a biologically active form that is resistant to digestion [35]. In the animal model
adiponectin inhibits tension-sensitive gastric vagal afferent mechanosensitivity, modulating satiety
signals in both lean and obese animals, while simultaneously increasing the mechanosensitivity of
mucosal gastric vagal afferent in the obesity-induced model [36]. In humans, elevated serum levels
of adiponectin are associated with more rapid GE in diabetic patients [37]. It is not known whether
adiponectin levels impact GE in the infant and this warrants further investigation.
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The volume of milk taken at a single feed varies greatly both within and between infants [38].
This may be affected by HM composition, with greater breastfeeding frequency associated with lower
total 24-h protein intakes and higher lactose concentrations [39]. This suggests that the variations
in HM components between mothers may potentially influence GE rate and time, and therefore
feeding patterns.
This study investigated the effects of HM appetite hormones (whole milk adiponectin and
leptin, skim milk leptin) and macronutrients (fat, total carbohydrates, lactose, oligosaccharides, total
protein, casein and whey protein, lysozyme) on feeding frequency and GE. Further exploration of
infant demographics, anthropometrics, and BC was carried out to determine relationships with infant
feeding and GE.
2. Materials and Methods
2.1. Participants
Lactating mothers and their infants (n = 27) were recruited predominantly through the Australian
Breastfeeding Association. Inclusion criteria were: healthy singletons, gestational age ≥ 37 weeks,
fully breastfed on demand at the point of measurement. Exclusion criteria were: infant health issues
requiring medication that could potentially influence GE rate (e.g., reflux), indications of low maternal
milk production or infant growth issues. All mothers provided written informed consent to participate
in the study, which was approved by the University of Western Australia, Human Research Ethics
Committee (RA/1/4253) and registered with the Australian New Zealand Clinical Trials Registry
(ACTRN12616000368437).
2.2. Study Design
Participants arrived at our laboratory at King Edward Memorial Hospital for Women
(Subiaco, Perth, WA, Australia) in the morning (09:30–11:30 a.m.) to avoid circadian influence on the
outcomes, and stayed for two consecutive breastfeeding sessions. Before the first feed (F1) infants were
weighed and had ultrasound stomach volumes recorded (pre-feed residual, R1). Mothers expressed a
pre-feed sample (fore-milk) of milk from the feeding breast/breasts and then breastfed their infants
as usual. Immediately after F1, infant stomach volumes images and infant weights were taken, and
mothers expressed a post-feed (hind-milk) milk sample. Subsequent scans of the stomach were
scheduled at 15–20 min intervals (although attending infants’ needs caused some variation) until the
infant cued for the next feed (F2), when a final stomach volume immediately before F2 was measured
(pre-feed residual, R2).
To assess infant BC bioimpedance spectroscopy measurements were taken pre-feed,
unless impractical—then they were taken post-feed [40]. Ultrasound skinfold, length, and head
circumference measurements were taken post-feed. This combination of two methods for measuring
infant BC was used to ensure safe, non-invasive and accurate assessment and to avoid the inherent
limitations of a singular technique [41]. Clothing was removed for the measurements except for a dry
diaper and a singlet.
2.3. Feeding Frequency
Mothers were asked how frequently their infant feeds, and the self-reported typical time between
the feeds (e.g., every three hours) during the week prior to the study session was taken as a proxy
measure of feeding frequency.
2.4. Feed Volume Measurement
The volume of milk transferred from a breast/breasts by the infant was determined by weighing
the infant immediately before and after the breastfeed using electronic scales (±2.0 g, Medela Electronic
Baby Weigh Scales, Medela Inc., McHenry, IL, USA). Milk intake (g) was calculated by deducting the
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initial weight from the final weight of the infant [42] and was converted to mL (feed volume; FV) using
HM density of 1.03 g/mL [43].
2.5. Stomach Measurements with Ultrasound
The infant’s stomach was scanned using the Aplio XG (Toshiba, Tokyo, Japan) machine, with a
high-resolution PVT-674BT (6MHz) transducer and Parker ultrasonic gel (Fairfield, NJ, USA). Three to
nine (median [IQR]: 5 [5; 6]) serial measurements of infant stomachs were taken 3 to 62 min apart
(16 ± 10). Scans were performed with the infant in the semi-supine position according to the method
validated in preterm infants [44]. Briefly, the sagittal and transverse planes of the stomach were used
to measure the longitudinal (L), anterior-posterior (AP) and transverse (T) diameters directly from
images on the ultrasound screen using electronic calipers (Figure 1). One experienced sonographer
with good intra- and interrater reliability [44] performed all of the measurements. Gastric volume (mL)
was calculated from the above measured diameters using following equation for an ellipsoidal body:
Stomach volume (mL) = L (mm) × AP (mm) × T (mm) × 0.52. (1)
Figure 1. Measurements of infant’s stomach with ultrasound. Ultrasound images of infant’s
stomach: (a) transverse view with anterior-posterior (AP) and transverse (T) diameter measurements;
(b) longitudinal view with longitudinal (L) diameter (maximum length) measurement. Stomach volume
(mL) = longitudinal diameter (mm)× anterior-posterior diameter (mm) × transverse diameter (mm)× 0.52.
2.6. Milk Sample Collection
Mothers hand-expressed or pumped small (1–2 mL) pre- and post-feed milk samples into separate
5-mL polypropylene plastic vials (Disposable Products, Adelaide, SA, Australia). Fat concentration
was measured (below) and samples were frozen at −20 ◦C for further biochemical analysis.
2.7. Biochemical Analysis
2.7.1. Fat Content
Percentage fat was measured in pre- and post-feed samples immediately after sample collection
with the creamatocrit method [45] using the Creamatocrit Plus device (Medela Inc., McHenry, IL, USA).
Fat concentration of the pre- and post-feed milk samples (g/L) was calculated from the cream content
of the milk samples, based on the equation [46]:
Fat (g/L) = 3.56 + (5.917 × cream percentage). (2)
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Fat concentration in the volume consumed by the infant was further calculated [47]:
Fat (g/L) = 0.53 × Fat pre-feed + 0.47 × Fat post-feed. (3)
2.7.2. Sample Preparation
Prior to further analysis, all samples were thawed for two hours at room temperature (RT)
and aliquoted into 1.5-mL tubes (Sarstedt, Numbrecht, Germany). Components’ concentrations
were determined in both pre- and post-feed samples in case of adiponectin, skim and whole
milk leptin, fat, and lactose, and in pooled samples in case of total protein, casein, whey protein,
total carbohydrates, and lysozyme. Concentrations of pre- and post-feed samples were averaged to
arrive at the concentration used for statistical analyses. Whole milk was used for measuring whole
milk adiponectin and leptin concentration. Milk samples were defatted (by centrifugation at RT in a
Beckman Microfuge 11 (Aberdon Enterprise Inc., Elk Grove Village, IL, USA) at 10,000× g for 10 min
and removing the fat layer by clipping it off with the top of the tube [48]) for analysis of skim milk
leptin, total protein, lysozyme, lactose, and total carbohydrates concentrations. The standard assays
were adapted for and carried out using a JANUS workstation (PerkinElmer, Inc., Waltham, MA, USA)
and measured on EnSpire (PerkinElmer, Inc., Waltham, MA, USA).
2.7.3. Leptin
Leptin concentration in HM was measured using the R & D Systems Human Leptin enzyme
linked immunosorbent assay (ELISA) DuoSet kit (Minneapolis, MN, USA) optimized to measure leptin
in sonicated skim HM, as previously described by Cannon et al. [33] and further modified to measure
leptin in skim and whole HM milk as described by Kugananthan et al. [32]. Recovery of leptin was
97.7% ± 9.7% (n = 10) with a detection limit of 0.05 ng/mL and an inter-assay CV of <7.2%.
2.7.4. Adiponectin
Adiponectin concentration in whole milk was measured using the Biovendor Human Adiponectin
Sandwich ELISA kit (Life Technologies, Asheville, NC, USA). Adiponectin recovery was 96.2% ± 3.2%
(n = 10) with a detection limit of 1 ng/mL and an inter-assay CV of <2.5%.
2.7.5. Protein
Casein and whey proteins were separated by the method fully described by Kunz and
Lonnerdal [49], and Khan et al. [50]. Protein concentrations (total protein of skim HM, casein and
whey proteins) were measured using the Bradford Protein Assay adapted from Mitoulas et al. [51].
Recovery of protein was 100.6% ± 5.2% (n = 5) with a detection limit of 0.031 g/L and an inter-assay
CV of 7.8% (n = 18). Casein:whey ratio was calculated as follows:
Casein:whey ratio = casein concentration/whey protein concentration. (4)
2.7.6. Lysozyme
Lysozyme concentration was determined using a modified turbidimetric assay [52]. Hen egg
white lysozyme (EC 3.2.1.17, Sigma, St. Louis, MA, USA) standards (range 0.00075–0.0125 g/L) and
skim milk samples were diluted 10-fold with 0.1 M of Na2HPO4/1.1 mM of citric acid (pH 5.8) buffer.
Twenty-five microliters of standards or diluted skim milk samples were placed into the wells of
a plate (Greiner Bio-One, Frickenhausen, Germany), 175 μL of Micrococcus lysodeiltikus suspension
(0.075% w/v, ATCC No. 4698, Sigma, St. Louis, MA, USA) was added into each well and plate
was incubated at RT for 1 h. The absorbance was measured at 450 nm. Recovery of lysozyme was
97.0% ± 5.0% (n = 8) with a detection limit of 0.007 g/L and an inter-assay CV of 13.0% (n = 8).
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2.7.7. Carbohydrates
Defatted milk was deproteinized with trichloroacetic acid [53] before dehydration by sulphuric
acid [54]. This technique reliably estimates concentrations and carbon content for monosaccharides,
disaccharides, and polysaccharides. Total carbohydrates were analyzed by UV-spectrophotometry.
Recovery of total carbohydrates was 101.4% ± 2.1% (n = 7) with a detection limit of 0.007 g/L and an
inter-assay CV of 3.3% (n = 7).
Lactose concentration was measured using the enzymatic spectrophotometric method of Kuhn
and Lowenstein [55], adapted from Mitoulas et al. [51], with recovery of 98.2% ± 4.1% (n = 10),
detection limit of 30 mM and inter-assay CV of 3.5%.
The human milk oligosaccharides (HMO) concentration (g) was calculated by deducting
concentration of lactose (g) from concentration of total carbohydrates (g). The glucose and galactose
were not measured or accounted for as their concentrations in HM are small and comparable or less
than the assays errors [56].
2.8. Hormone and Macronutrient Dose
Doses were defined as the amount of hormone/macronutrient ingested during a breastfeed
and calculated as average of the pre- and post-feed HM component concentration, multiplied by
the corresponding FV. When an infant fed from both breasts at the breastfeeding session,
hormone/macronutrient doses from these individual breastfeeds were calculated separately and
added together.
2.9. Infants’ Anthropometrics and Body Composition
2.9.1. Anthropometric Measurements
Infants’ weight was determined by weighing before breastfeeding using Medela Electronic Baby
Weigh Scales (±2.0 g; Medela Inc., McHenry, IL, USA). Clothing was removed except for a dry diaper
and a singlet. Infant crown-heel length was measured once to the nearest 0.1 cm using non-stretch tape
and headpiece and footpiece, both applied perpendicular to the hard surface. Infant head circumference
was measured with non-stretch tape. Infant BMI was calculated according to the following formula:
BMI = Body weight (kg)/(Height (m))2. (5)
2.9.2. Body Composition with Bioelectrical Impedance Spectroscopy
Infants’ whole body bioimpedance were measured using the Impedimed SFB7 bioelectrical
impedance analyzer (ImpediMed, Brisbane, Queensland, Australia) applying an adult protocol
(wrist to ankle) according to the manufacturer’s instructions and analyzed with settings customized
for each infant according to Lingwood et al. [57] and Gridneva et al. [41]. Values of resistance (ohm) at
frequency of 50 kHz (R50) were determined from the curve of best fit, averaged for analysis purposes
and used in the Lingwood et al. age matched (3 and 4.5 mo infants) equations for fat-free mass (FFM)
of 2 and 5 mo infants respectively [57]:
FFM 3 mo = 1.458 + 0.498 × W − 0.197 × S + 0.067 × L2/R50 (6)
FM 4.5 mo = 2.203 + 0.334 × W − 0.361 × S + 0.185 × L2/R50, (7)
where L is body length (cm), R50 is resistance (Ω), S is sex (male = 1, female = 2) and W is infant
weight (kg).
%FM was calculated as follows:
%FM = 100(Weight (kg) − FFM (kg))/Weight (kg). (8)
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2.9.3. Body Composition with Ultrasound Skinfold Measurements
Infant ultrasound skinfold measurements were carried out using the Aplio XG (Toshiba, Tokyo,
Japan) ultrasound machine, PLT-1204BX 14-8 MHz transducer and sterile water-based Parker ultrasonic
gel (Fairfield, NJ, USA). Single ultrasound scans of four anatomical sites (biceps, subscapular, suprailiac,
and triceps) were performed on the left side of the body with minimal compression. Skinfold thickness
(skin thickness and the skin–fat interface to fat–muscle interface distance) was measured directly from
images on the screen using electronic calipers. One experienced sonographer (DG) with good intra-
and interrater reliability [44] performed all of the measurements.
The doubled ultrasound skinfold thickness was used in Brook body density (d) age-matched
(3–18 mo) equations [58] developed for skinfolds measured with calipers:
Male d = 1.1690 − 0.0788 × log (∑SFT) (9)
Female d = 1.2063 − 0.0999 × log (∑SFT), (10)
where d is infant body density (kg/L) and ∑SFT is a sum of four skinfolds (mm).
Predicted body density was converted to %FM using the Lohman equation [59]:
%FM = 100 × (5.28/d − 4.89), (11)
where d is the infant body density (kg/L).
2.10. Statistical Analysis
Statistical analysis was performed in R 2.9.0 [60] for Mac OSX using additional packages nlme [61];
lattice [62], lattice extra [63], and car [64]; MASS [65], sfsmisc [66] and multcomp [67] for mixed effects
modeling, data representation, robust regression, and multiple comparisons of means, respectively.
Descriptive statistics are reported as mean ± standard deviation (SD) (range) or median (IQR) unless
otherwise stated; model parameters are presented as estimate ± standard error (SE), and, where
appropriate, an approximate 95% confidence interval (95% CI).
Measurements missing due to insufficient sample volume: skim milk leptin, whole milk
leptin, adiponectin, total protein, whey and casein protein, lactose and total carbohydrate (n = 3);
lysozyme (n = 5). Measurements of fat (n = 14) were missing as a result of either insufficient sample
volumes or absence of separate feed volumes from breasts where both breast were offered during one
feed. Also missing were feeding frequency as reported by mothers (n = 6), measurements of length,
head circumference, infant BMI, %FM measured with bioelectrical spectroscopy (n = 4) and %FM
measured with ultrasound skinfolds (n = 5).
GE time was determined as the time from the start of F1 to the start of F2 and included the time
between two feeds and feed duration. Feed duration was included as up to 80% of HM consumed by
term healthy breastfed infants in the first 4–5 min [68]. GE during breastfeeding was defined as the
volume of milk to have left the stomach, calculated as the difference between the immediate post-feed
stomach volumes and the sum of R1 and FV.
Due to the lack of term infant gastric-emptying studies focusing on stomach volume, no power
calculation/sample size determination could be performed for this study. A goal of 20 infants at
each two and five months was selected with the expectation that this would be sufficient to show
overall patterns. When available, infants were included in both subsets to allow for investigation of
longitudinal patterns. Linear mixed effects models allow us to treat the individual feeds as separate,
without having to assume independence, when there may be correlations between feeds within infants.
Influences on GE rate were analyzed by first fitting a time curve to the sequential post-feed
stomach volumes using linear mixed effects models; as curves differed significantly within and
between infants (p < 0.001), random time curves were fitted to feeds within infants. Time terms
(linear, square root) were selected as per the fractional polynomial method of [69]; this model also
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considered possible confounding effects of FV (median-centred) and feed duration (median-centred).
Interaction terms involving the time curve indicated changes in the GE rate; main effects indicated
overall effects on post-feed stomach volumes but not the GE rate. The addition of one term to this base
model was used to investigate associations with (a) concentrations/doses of hormones/macronutrients;
(b) infant characteristics/anthropometrics/BC; (c) R1. Whether the overall effect of HM component
concentrations differs by feed volume was investigated by including interactions between FV and
concentration measures. Models using the selected technique did not converge for fat concentration,
lysozyme concentration, or lysozyme dose. Omitting the random effect of feed within infant provided
converging models, but no evidence of an association with fat or lysozyme was seen. Given the
complexity of linear mixed effects models used to analyze GE rate, no further adjustments were
performed and p < 0.05 was considered to be statistically significant.
Associations between pre-feed residual stomach volumes, FV, immediate post-feed stomach
volumes, feed duration, feeding frequency and both hormone and macronutrient concentrations
and doses, and infant anthropometrics/BC parameters were tested using robust linear regression.
Mixed effects models were considered, but were not significantly better (p > 0.1) Robust linear
regression (rlm) was chosen so as to address heteroscedasticity in the data and points with high leverage
in the majority of the predictors; MM-estimation (M-estimation with Tukey’s biweight, initialized by
a specific S-estimator) accounting for appropriate covariates was used [65]. Approximate p-values
were determined using the Wald test. Multivariate models accounting for FV were used for testing the
relationship with FV-dependent predictor (fat dose and concentration).
Possible age differences in HM components, infant characteristics, and GE/breastfeeding
parameters were analyzed with either linear mixed effects models or robust linear regression models;
model type was determined using likelihood ratio tests. Linear mixed effects models were used to
analyze relationships of GE during feed time with HM components and infant characteristics. R1, FV
and feed duration were not associated with stomach volume reduction during the feed time, therefore
univariate models were run. Multivariate linear mixed effects models accounting for R1, FV and feed
duration were used in analysis of relationships of immediate post-feed stomach volumes with HM
components and infant characteristics.
Owing to the large number of comparisons, a false discovery rate adjustment [70] was performed
on associated subgroupings of results with one or more p-values < 0.05. p-values were considered
to be significant at <0.011 for GE time, <0.031 for feeding frequency, <0.038 for R2, and <0.008 for
associations between HM components’ concentrations.
3. Results
3.1. Participants
Characteristics of the 27 participants (2 months (n = 20; longitudinal: 7 females, 7 males;
cross-sectional: 2 females, 4 males); 5 months (n = 21; longitudinal: 7 females, 7 males; cross-sectional:
6 females); overall n = 41 feeds) are described in Table 1. At the study session, infants fed from one
(n = 23) or both (n = 18) breasts.
3.2. Influence of Infant Age
Infant anthropometrics and %FM measured with bioimpedance spectroscopy significantly differed
by infant age (p < 0.001), while breastfeeding and GE parameters did not change significantly (p > 0.067)
(Table 1).
Lower whey protein concentration (5.51 ± 0.96 g/L 5 mo vs. 6.41 ± 1.39 g/L 2 mo, p = 0.034)
and subsequently a higher casein:whey ratio (0.32 ± 0.14 5 mo vs. 0.22 ± 0.07 2 mo, p = 0.035) were
observed at 5 months. All other measured appetite hormones and macronutrient concentrations did
not differ significantly by infant age (p > 0.053).
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3.3. Analyzed Human Milk Components
Appetite hormones and macronutrient concentrations and doses per feed are presented in Table 2.
Higher skim milk leptin concentrations were associated with lower whole milk leptin concentrations
(−0.25 [−0.34, −0.16], p < 0.001) and higher protein concentrations were associated with higher whey
protein concentrations (0.68 [0.41, 0.95], p < 0.001). Higher HMO concentrations were associated with
higher total carbohydrates concentrations (p < 0.001) and lower lactose concentrations (p < 0.001).
Table 1. Participant characteristics expressed as mean ± SD and range.
Characteristics
2 mo a 5 mo b Total c
Mean ± SD Range Mean ± SD Range Mean ± SD Range
Infant characteristics
Infant age (weeks) 9 ± 1 6–10 22 ± 1 18–23 16 ± 7 6–23
Infant length (cm) 57 ± 2 53–61 65 ± 2 *** 62–69 61 ± 4 53–69
Infant weight (kg) 5.3 ± 0.8 4.2–6.3 7.2 ± 1.0 *** 5.8–9.5 6.3 ± 1.3 4.2–9.5
Infant BMI 15.9 ± 1.3 13.9–18.1 17.6 ± 1.7 *** 14.9–20.4 16.7 ± 1.7 13.9–20.4
HC (cm) 39 ± 1 37–42 43 ± 2 *** 40–46 41 ± 2 37–46
Fat Mass with BIS (%) 21.4 ± 3.6 11.1–27.1 28.9 ± 3.2 *** 21.7–35.8 25.3 ± 5.0 11.1–35.8
Fat Mass with US (%) 24.2 ± 3.6 17.5–30.5 26.6 ± 3.6 20.8–35.9 25.5 ± 3.8 17.5–35.9
BF/GE characteristics
Feed volume (mL) 86 ± 34 35–140 85 ± 33 36–180 86 ± 33 35–180
SV after feed 1 (mL) 87 ± 36 32–141 93 ± 41 22–189 90 ± 38 22–189
Feed duration (min) 28 ± 14 11–72 20 ± 8 6–37 24 ± 12 6–72
SV reduction (mL) d 5 ± 21 (−42)–33 4 ± 26 (−57)–56 4 ± 24 (−57)–56
GE time (min) e 94 ± 29 44–153 88 ± 18 50–140 91 ± 24 44–140
Residual 1 (mL) 6 ± 12 0–50 11 ± 19 0–62 9 ± 16 0–62
Residual 2 (mL) 20 ± 20 0–81 15 ± 15 0–55 18 ± 18 0–81
Feeding frequency (h) f 2.3 ± 0.7 1.0–4.0 2.7 ± 0.8 1.5–4.0 2.5 ± 0.7 1.0–4.0
Data are mean ± SD and ranges. a n = 20; b n = 21. c n = 41 feeds. d Stomach volume reduction during feed
time is calculated as the difference between the sum of residual 1 and feed volume and the immediate stomach
volume after Feed 1 . e GE time is the time from the start of Feed 1 to the start of Feed 2 (time between
feeds plus feed duration). f Feeding frequency self-reported by mothers as to how often infant feeds
(e.g., every three hours). *** Indicates significant differences (p < 0.001) between two- and five-month-old
infants. Abbreviations: BF—breastfeeding; BIS—bioimpedance spectroscopy; GE—gastric emptying; HC—head
circumference; SV—stomach volume; US—ultrasound.
Table 2. Concentrations and doses of measured HM hormones and macronutrients.
Components
Concentration Dose Per Feed
Mean ± SD Range Mean ± SD Range
Adiponectin (ng/mL, ng) 10.02 ± 4.08 6.18–22.58 868.62 ± 491.32 238.60–2536.91
WM leptin (ng/mL, ng) 0.51 ± 0.18 0.23–1.10 44.80 ± 24.30 10.15–115.03
SM leptin (ng/mL, ng) 0.28 ± 0.12 0.20–0.84 24.8 ± 15.0 6.91–73.00
Total protein (g/L, g) 11.29 ± 2.56 7.60–24.16 0.99 ± 0.39 0.35–2.29
Casein (g/L, g) 1.54 ± 0.53 0.69–3.45 0.14 ± 0.07 0.04–0.29
Whey protein (g/L, g) 5.97 ± 1.26 3.82–9.08 0.52 ± 0.19 0.17–0.95
Casein:whey ratio 0.27 ± 0.11 0.10–0.73 n/a a n/a a
Lysozyme (g/L, g) 0.14 ± 0.12 0.05–0.48 0.01 ± 0.01 0.003–0.030
TCH (g/L, g) 82.72 ± 7.89 67.08–97.49 7.28 ± 2.62 3.28–15.18
Lactose (g/L, g) 65.84 ± 5.14 53.49–77.94 5.86 ± 2.22 2.19–12.06
HMO (g/L, g) 16.88 ± 9.89 (−10.86) b–35.77 1.42 ± 0.94 (−1.09) b–3.78
Fat (g/L, g) 42.74 ± 12.10 17.42–66.79 3.57 ± 1.45 0.64–6.40
Data are mean ± SD and ranges, n = 41 feeds. a Casein:whey ratios for doses are the same as for concentrations.
b Negative values are seen for human milk oligosaccharides (HMO) when lactose measurements are higher
than total carbohydrates. Abbreviations: SM—skim milk; TCH—total carbohydrates; WM—whole milk.
3.4. Gastric Emptying Rate
The overall decreasing curvilinear pattern of GE (linear: 0.04 [−0.17, 0.24], p = 0.72; square root:
−10.5 [−12.7, −8.2], p < 0.001) is shown in Figure 2. Higher FVs were associated with faster
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(−0.07 [−0.10, −0.03], p < 0.001) GE rate (Figure 3) and higher overall post-feed stomach volumes
(0.82 [0.53, 1.12], p < 0.001). No association was seen between feed duration and post-feed stomach
volume (−0.25 [−0.68, 0.18], p = 0.23).

















Figure 2. Overall curvilinear pattern of gastric emptying (n = 41 feeds). The lines represent the overall
pattern of changes in stomach volume as measured by ultrasound imaging. Bold line represents local
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Figure 3. Gastric emptying of individual feeds in term breastfed infants (n = 41 feeds). Feeds are
grouped by milk intake (MI) to illustrate the effect of the feed volumes; approximately equal numbers
are included in each panel. Data points represent stomach volumes calculated from ultrasound images;
connecting lines link measurements from the same feed. Bold line represents local regression smoother
(LOESS, span = 0.9).
Immediate post-feed stomach volumes were not associated with R1 (p = 0.91).
After accounting for time post-feed, FV, and feed duration, as per the above model, larger R1
volumes (0.55 [0.24, 0.86], p = 0.003) and higher whey protein concentrations (4.99 [0.84, 9.13], p = 0.023)
were associated with larger post-feed stomach volumes, while the casein:whey ratio (2.2 ± 0.88,
p = 0.030) and lactose concentration (−0.04 ± 0.02, p = 0.037) modified the GE curve depending on
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FV. Higher casein:whey ratios at lower FVs were associated with faster GE, and at higher FVs with
slower GE, while higher lactose concentrations at lower FVs were associated with slower GE, and at
higher FVs with faster GE. No other associations with post-feed stomach volumes or changes to the
GE curves were found (Table 3).
Table 3. HM components and infant characteristics and their associations with feed variables and
gastric emptying.
Predictors
Feed Volume a Gastric Emptying Time a Post-Feed Stomach Volumes b
Estimate ± SE
(95% CI)
p-Value Estimate ± SE
(95% CI)




Adiponectin (ng/mL) 1 ± 1.3 (−36.6,134.5) 0.44
2.3 ± 0.7
(0.9, 3.7) 0.002


































































Whole milk leptin (ng) n/a n/a −0.1 ± 0.2(−0.4, 0.2) 0.44
−0.2 ± 0.2
(−0.5, 0.2) 0.28
Skim milk leptin (ng) n/a n/a −0.2 ± 0.2(−0.7, 0.3) 0.38
0.4 ± 0.2
(−0.1, 0.8) 0.086
Total protein (g) n/a n/a −25.9 ± 12.4(−50.2, −1.7) 0.040
15 ± 13.1
(−13.7, 43.7) 0.27
Whey protein (g) n/a n/a 47.6 ± 18.7(10.8, 84.3) 0.015
50.6 ± 24.3
(−2.8, 104) 0.061
Casein (g) n/a n/a −119 ± 53.3(−223.4, −14.6) 0.030
0.4 ± 47.6
(−104.2, 105.1) 0.99
Lysozyme (g) n/a n/a −276.2 ± 370.7(−1002.9, 450.4) 0.46
395.5 ± 258.3
(−114.7, 905.6) 0.13
Total carbohydrates (g) n/a n/a −4.1 ± 1.8(−7.6, −0.5) 0.030
−4.6 ± 3
(−11.2, 2.1) 0.16
Lactose (g) n/a n/a −5.8 ± 2.7(−11.1, −0.6) 0.037
−3.1 ± 5.4
(−15.1, 8.9) 0.58
HMO (g) n/a n/a −3.1 ± 3.1(−9.2, 3) 0.32
−3.2 ± 2.7
(−9.1, 2.8) 0.27
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Table 3. Cont.
Predictors
Feed Volume a Gastric Emptying Time a Post-Feed Stomach Volumes b
Estimate ± SE
(95% CI)
p-Value Estimate ± SE
(95% CI)















Infant length (cm) −0.03 ± 1.3(−2.6, 2.6) 0.98






























Data are parameter estimate ± SE and 95% CI, n = 41 feeds. a Effects of predictors taken from univariate
regression models; b Effects of predictors taken from linear mixed effects models that accounted for
postprandial time, feed volume and feed duration. c After the false discovery rate adjustment the
p-values were considered to be significant at <0.011 for GE time (bold font); d n/a—dosage is dependent
on feed volume. Abbreviations: BIS—bioimpedance spectroscopy; HMO—human milk oligosaccharides;
US—ultrasound skinfolds.
3.5. Feed Volume, Feed Duration, and Gastric Emptying during Breastfeeding
Higher FVs were associated with higher stomach volumes measured immediately post-feed
(0.79 [0.51, 1.07], p < 0.001) and longer GE times (0.24 [0.03, 0.46], p = 0.033). FV was not associated
with either concentrations of measured HM components or infant’s characteristics/anthropometrics/BC
(Table 3).
Feed duration was not associated with FV (0.06 [−0.03, 0.15], p = 0.20) or R1 volume
(0.01 [−0.17, 0.19], p = 0.91).
After accounting for R1 (1.07 [0.47, 1.7], p = 0.002), FV (1.00 [0.71, 1.3], p < 0.001) and feed
duration (−0.30 [−0.96, 0.36], p = 0.34), immediate post-feed stomach volumes were not associated
with either measured HM components (p > 0.068) or infant’s demographics/anthropometrics/BC
(p > 0.46). Stomach volume reduction during breastfeeding was not associated with either measured
HM components (p > 0.11); infant’s demographics/anthropometrics/BC (p > 0.48); R1, FV or feed
duration (p > 0.34).
3.6. Gastric Emptying Time
The GE time was not associated with feed duration (0.35 [−0.29, 0.98], p = 0.28), but was
negatively associated with R2 (−0.63 [−1.05, −0.21], p = 0.005) after accounting for FV (p < 0.001).
Longer GE times were associated with higher adiponectin concentration (2.3 [0.9, 3.7], p = 0.002)
and dose (0.02 [0.01, 0.03], p = 0.005), and lower casein:whey ratio (−65.9 [−107.1, −24.7], p = 0.003).
No associations with infant characteristics were seen (Table 3).
3.7. Pre-Feed Residuals
Infants cued for F1 and F2 with different residual volumes (R1 and R2) present in their
stomachs (Table 1). Larger FVs were associated with smaller R1 volumes (p = 0.002), with each
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−0.92 [−1.47, −0.37] mL of R1 volume resulting in extra mL of FV. Larger R2 volumes were associated
with larger FVs (p = 0.006), each additional mL of FV resulting in 0.21 [0.07, 0.35] mL greater R2.
There was no association between R2 and R1 in univariate model (0.11 [−0.19, 0.42], p = 0.46).
After accounting for FV and GE time (p < 0.001 for both) larger R2 volumes were associated with larger
R1 volumes (0.36 [0.11, 0.60], p = 0.005).
After accounting for FV, R2 was not associated with any concentration of HM components
(p ≥ 0.038 after adjusting for multiple comparisons).
3.8. Feeding Frequency
A longer time between the feeds was seen when infants were longer, heavier, and had higher
%FM measured with BIS (Table 4) in univariate models. The associations for length and weight were
not significant after accounting for the other (p > 0.38); the association for %FM measured with BIS
was not significant after accounting for infant length (p = 0.095).
Table 4. Associations between infant feeding frequency and HM components and infant characteristics.
Predictors
Feeding Frequency (h) a
Estimate ± SE (95% CI) b p-Value
Concentrations
Adiponectin (ng/mL) −0.001 ± 0.03 (−0.06, 0.06) 0.96
Whole milk leptin (ng/mL) −1.1 ± 0.7 (−2.5, 0.3) 0.13
Skim milk leptin (ng/mL) 0.8 ± 1.6 (−2.3, 4) 0.60
Total protein (g/L) −0.05 ± 0.05 (−0.15, 0.04) 0.28
Whey protein (g/L) −0.1 ± 0.1 (−0.3, 0.1) 0.42
Casein (g/L) 0.04 ± 0.2 (−0.4, 0.5) 0.86
Casein:whey protein ratio 0.4 ± 1.1 (−1.7, 2.5) 0.68
Lysozyme (g/L) −0.4 ± 1.1 (−2.5, 1.7) 0.71
Total carbohydrates (g/L) 0.01 ± 0.02 (−0.03, 0.04) 0.73
Lactose (g/L) −0.05 ± 0.02 (−0.1, −0.01) 0.031
HMO (g/L) 0.01 ± 0.02 (−0.03, 0.04) 0.73
Fat (g/L) −0.02 ± 0.01 (−0.04, 0.01) 0.19
Doses
Adiponectin (ng/mL) 0.0002 ± 0.0003 (−0.0004, 0.0008) 0.50
Whole milk leptin (ng/mL) −0.002 ± 0.01 (−0.01, 0.01) 0.80
Skim milk leptin (ng/mL) 0.01 ± 0.01 (−0.01, 0.03) 0.59
Total protein (g/L) 0.1 ± 0.3 (−0.5, 0.8) 0.67
Whey protein (g/L) 0.1 ± 0.7 (−1.3, 1.5) 0.89
Casein (g/L) 2.1 ± 2 (−1.7, 5.9) 0.27
Lysozyme (g/L) −5.7 ± 17.2 (−39.4, 27.9) 0.73
Total carbohydrates (g/L) 0.1 ± 0.1 (0, 0.2) 0.22
Lactose (g/L) 0.04 ± 0.06 (−0.08, 0.17) 0.49
HMO (g/L) 0.3 ± 0.1 (0, 0.5) 0.051
Fat (g/L) −0.2 ± 0.1 (−0.5, 0) 0.085
Demographics
Infant sex (Male) −0.2 ± 0.3 (−0.7, 0.4) 0.53
Infant age (months) 0.2 ± 0.1 (0, 0.3) 0.078
Anthropometrics
Infant length (cm) 0.1 ± 0.03 (0.04, 0.15) 0.004 c
Infant weight (kg) 0.2 ± 0.1 (0.1, 0.4) 0.010
Head circumference (cm) 0.1 ± 0.1 (0, 0.2) 0.23
Infant BMI 0.13 ± 0.1 (0, 0.3) 0.10
Body composition
% fat mass with US 0.07 ± 0.03 (0, 0.13) 0.040
% fat mass with BIS 0.08 ± 0.02 (0.03, 0.12) 0.002
Data are parameter estimate ± SE and 95% CI, n = 41 feeds. a Feeding frequency self-reported by mothers
as to how often infant feeds (e.g., every three hours). b Effects of predictors are results of univariate
regression model. c After the false discovery rate adjustment the p-values were considered to be significant
at <0.031 (highlighted). Abbreviations: BIS—bioimpedance spectroscopy; HMO—human milk oligosaccharides;
US—ultrasound skinfolds.
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4. Discussion
Our research shows that HM components, such as adiponectin, whey protein, casein: whey ratios,
lactose, total carbohydrates, and oligosaccharides are associated with gastric emptying and
breastfeeding patterns of breastfed infants. GE is a mechanism involved in satiety, therefore milk
components influencing GE have the potential to affect infant milk intake and therefore growth and
development in early life and subsequently health later in life.
Given the assumption that HM composition potentially influences GE [14,71], in term infants we
expected the appetite hormones to be associated with infant GE rate such that high concentrations
and/or doses of leptin would result in slower GE [30], whereas adiponectin might induce faster GE [37]
consistent with both animal and human models. However, neither the concentrations nor doses of
these hormones were related to GE rate. Previously skim milk leptin was not found to be associated
with either GE rate or GE time [33,34], which we have confirmed with this larger study cohort.
It was speculated that whole milk leptin, which is known to be of higher concentration, might be the
reason for the negative finding [32]. While our measures of whole milk leptin were typically higher,
there is an opinion that values of this magnitude are unlikely to contribute considerably to infant
serum levels [72] so only the local pathways would be engaged in GE regulation. As such we were
unable to find a relationship between whole milk leptin and GE. This is in contrast to animal studies
showing reduced GE [30] or food intake [31] after injection or oral administration of leptin, respectively.
However, it is possible that the long-term energy expenditure regulatory effect of leptin [73] may mask
its short-term satiety effect on GE. Alternatively, if levels of leptin are contributing significantly to
serum levels, there is a possibility that the number of receptors in the stomach of the young infant
is low. Further, short-term satiety signaling through hypothalamic neurons is not fully mature, both
of which would allow the infant to maintain a high physiological drive to feed to ensure adequate
growth [28,73]. Gender differences in infant serum leptin levels associated with adiposity [74] have
also been speculated to play a role in gastric response to HM leptin, although we did not find any
relationships between infant sex/adiposity and both GE rate and GE time.
In contrast to leptin, we found that increased levels and doses of adiponectin were associated
with longer GE times. This finding may partially explain the growth-regulating effect of adiponectin in
infants in the first six months of life [29], when high HM adiponectin concentration is associated
with lower infant weight and adiposity. Further adiponectin is 20-fold higher in concentration
compared to leptin and is therefore likely to have greater biological significance [75]. The lack of
association between adiponectin and GE rate is in agreement with studies of rats that showed that
gastric epithelium and glands are populated with adiponectin receptors, which downregulate gastric
motility [36,76]. Conversely, the findings are in contrast to studies of type 2 diabetic adults, in which
elevated levels of adiponectin were associated with faster GE [37]. Further, other HM hormones such
as ghrelin, cholecystokinin, and insulin may counteract or interact synergistically with leptin [77,78]
and/or adiponectin.
Our study examined an extensive array of macronutrients beyond fat, total protein and lactose.
Consistent with the findings of Cannon et al. [34] there were no associations with fat and total protein
and either GE rate or GE time. Studies in dogs indicate that all three major macronutrients activate
the ileal brake, resulting in reduction of GE; limited human studies support the findings for fat and
carbohydrates while associations with protein are not so straightforward [79,80]. We were unable to
find associations between the HM fat content and GE consistent with findings of Khan et al. [39] and
Kent et al. [38] regarding the feeding frequency. This may be because lipids initiate the ileal brake when
they reach the ileum via hydrolysis of triacylglycerol into fatty acids, thereby producing a delay in GE
in humans [79]. Further analysis of HM fatty acids may shed more light on GE in breastfed infants.
However, we have found that higher whey protein concentrations are associated with larger
post-feed stomach volumes, although we did not see any interaction with time, so no effect on
GE rate was detected. This contradicts the results of studies of GE conducted on breastfed and
formula-fed infants or studies of formula with different casein:whey ratio [15,81] in which a fast or
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slow GE rate was explained by concentrations of whey protein or casein, respectively. Previous studies,
however, could not adequately analyze the effect of the whey protein concentration in conjunction
with volume, as they only reported gastric half-emptying time, restricted monitoring time, and/or
controlled infants’ volume intakes. The whey fraction of HM is highly soluble in the gastric juices
and rapidly empties from the stomach compared to other proteins such as casein. Whey isolate,
however, was associated with a lower gastric inhibitory polypeptide (GIP) response in adults, consistent
with decreased rate of GE [82]. It may very well be that whey protein speeds up the initial stage of GE
(probably during the breastfeeding time), but once it activates jejunal or ileal brakes the overall GE
is reduced.
While lactose is related to GE rate, it is affected by FV; at the middle range FVs (71–108 mL) lactose
has no relationship with GE, whereas at lower FVs higher lactose concentrations are associated with
slower GE, and at higher FVs with faster GE. These results are consistent with Khan et al. [39],
who reported an association of higher lactose concentration with increased feeding frequency.
These findings could be an important addition to the evaluation of the digestive and metabolic
effect of lower breastfeeding frequency and larger FVs, common in Western countries, contrary to the
lactation practices in traditional societies [83].
In terms of casein:whey ratios the effect is opposite to that of lactose where at lower FVs higher
casein:whey ratios are associated with faster GE, and at higher FVs with slower GE, which may explain
the contradictory findings for casein associations with GE rate in previous studies [14,23]. Cows’ milk
casein was found to activate the ileal brake in adults, resulting in reduced food intake, although its
effect on GE was not significant [84]. The finding of smaller volumes resulting in more rapid GE rate
might be explained by the time casein spends in the acidic environment of the stomach. While soluble
whey proteins rapidly enter the small intestine mostly intact, casein transit is delayed due to the curd
formation. When it exits the stomach it is mainly in the form of degraded peptides [85]. If the FVs are
small some casein may exit intact, thereby speeding up GE, while if the FVs are large, casein curdles
and degrades to the opioid peptides that slow down GE [86]. However, this mechanism does not
explain why higher casein:whey ratios of HM were associated with shorter GE time, which could be
due to the smaller amounts of whey protein reaching the small intestine and having less effect on
jejunal or ileal brakes [80]. Our finding that higher whey protein concentrations are associated with
larger post-feed stomach volumes further supports this possible explanation.
Further, k-casein has been shown to inhibit the binding of Helicobacter pylori to human mucosa
in vitro [87]. Helicobacter pylori are Gram-negative bacteria present in the stomach, and are known
to downregulate levels of ghrelin and leptin in the stomach [88], which may significantly affect GE.
The protective action of HM k-casein is reinforced by lysozyme, one of the major whey proteins.
While we have not seen any significant associations between lysozyme and GE, lysozyme contributes
to the control of the GI bacterial population [89], and could be upregulated to control the bacterial
population in the GI tract [90] and increase digestion of microbial protein [24], all of which could
potentially influence GE. In a clinical study of preterm infants, lysozyme added to donor HM or
formula was associated with increased body weight, normalization of the stool, and improved feed
tolerance [91]. While all of this suggests that lysozyme could potentially have an effect on GE in certain
circumstances, given that we have studied a healthy population the magnitude of the effect could
be insignificant.
GE during feed administration has been previously documented in preterm infants. In this study,
an average of 20% of feed volume is emptied from the stomach during breastfeeding compared with
10% in preterm [92]. This is probably due to a more mature GI tract in term infants and the effect of
both larger FVs and present pre-feed residuals, which were associated with faster GE rate, but not to
the longer feed duration time in term infants or milk composition as no associations were found.
While we speculated that milk composition might regulate the milk intake of the infant and/or
the residual volume in the stomach prior to cueing for the next feed, we were unable to show
this. Rather, FV is more strongly associated with GE rate than variations in milk composition.
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Gastric mechanosensation is an important factor in the regulation of satiation during food intake.
Indeed, gastric distention is an important determinant of GE [93], and volume-related suppression
of GE rate has been reported in animal models [94]. The observed volume-related acceleration of
GE with larger FVs emptying more quickly in term breastfed infants is consistent with our previous
findings [34]. The biggest effect of volume was seen after the feed and as the post-prandial period
progressed the magnitude of this effect decreased (Figure 2). This may also explain the variability in the
time between each feed for an infant over a 24-h period [33,38]. Feeding frequency decreases between
one and three months of lactation, while milk intake during each breastfeeding session increases,
with both parameters remaining constant up to six months [95]. This is attributed to the fact that
as infants mature they become able to consume larger FVs [38], resulting in a longer time between
feeds. Also, larger FVs are generally consumed at night or in the early morning when the frequency
of feeding declines [33,38]. This decline in feeding frequency also coincides with higher nocturnal
concentrations of leptin and fat, and lower concentrations of lactose in HM [33], although relationships
between both feeding frequency and FV and these components’ concentrations are yet to be evaluated.
The recommendations for breastfeeding are to feed on demand. Interestingly, we found that
the majority of infants cued for a feed when milk was still present in the stomach, albeit in variable
volumes (Table 1). This suggests that the reduction of gastric distension, which regulates hunger
sensations, plays a greater role in signaling time to feed [96]. Further, it may be beneficial to the
developing infant to have the gastric mucosa exposed to HM anti-inflammatory components such as
lysozyme or immunomodulatory agents and growth factors, all of which contribute to the maturation
of the GI tract [8]. Thus it may be detrimental to prescribe decreasing the frequency of feeding in
breastfed infants or expect the infant stomach to be empty in order to feed again [97].
Furthermore, interesting associations were observed between infant milk intake and volumes
remaining in the stomach prior to the first and second feed. Smaller residual volumes prior to the first
feed were associated with greater milk intakes, and greater milk intakes were associated with larger
volumes in the stomach prior to feeding again. This suggests that breastfed infants may appear to be
consuming HM volumes in a variable pattern, but due to varying residuals may actually be feeding to
a predetermined stomach volume, which is also supported by the positive relationship between both
pre-feed residuals (R1, R2). In fasting adults ghrelin was found to increase and spontaneously decrease
at the time points of the customary meals [98], supporting the involvement of the brain in GI tract
regulation. Further studies monitoring two or more consecutive feeds or even 24-h GE measurements
and analyses of ghrelin in HM would clarify this finding.
In healthy adults post-lag GE and colonic transfer is reported to be faster in men than in
women [99]. In this study infant sex, age, anthropometrics, and BC were not associated with GE
and breastfeeding parameters, with the exception of feeding frequency. Feeding frequency decreases
in the first three months of lactation and then remains stable until six months [95,100]. The absence
of a significant association between feeding frequency and age, together with associations with
anthropometric and body composition parameters, illustrates that feeding frequency is dictated by the
growth and development of an infant rather than the infant age. These findings further underline the
need for breastfeeding on demand, with the frequency linked to individual infant growth rates rather
than scheduled feeding, which could exert a detrimental effect on infant growth.
While the monitoring of a single feed limits the analysis possibilities, examination of multiple
feeds requires the study to be carried out in the mother’s home for long periods of time. The sample
size is not a limitation of the study, as although no associations between milk composition and GE
rate were detected, we were able to clearly show a relationship between FV and GE rate as well as
associations between milk composition and other GE parameters.
5. Conclusions
Human milk appetite hormones and macronutrients and feed volume affect gastric emptying
and feeding patterns in term breastfed infants. Adiponectin, whey protein, and casein:whey ratio are
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associated with GE, while the effects of casein:whey ratios and lactose concentrations on GE vary with
feed volume. Larger feed volumes result in a faster GE rate. Thus, milk composition and feed volume
play an important role in appetite regulation via gastric function.
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Abstract: Gestational diabetes increases the risk of a range of adverse perinatal outcomes, including
breastfeeding failure, but the best cut-off point for gestational diabetes is unknown. The purpose of
this study was to evaluate the association between mild gestational glucose tolerance impairment
and the early cessation of exclusive breastfeeding (EBF). This is an observational study of 768 women
with full term pregnancies that were screened for gestational diabetes at 24–28 weeks gestation.
Subjects were divided into two groups: those with a normal 1-h glucose challenge test and those with
an elevated 1-h glucose challenge test but still did not qualify for gestational diabetes. We constructed
multivariable logistic regression models using data from 616 women with normal gestational glucose
tolerance and 152 women with an isolated positive 1-h glucose challenge test. The risk of early
exclusive breastfeeding cessation was found to increase in women with mildly impaired glucose
tolerance during pregnancy (adjusted OR, 1.65; 95% CI: 1.11, 2.45). Risks of early EBF cessation
were also independently associated with the amount of neonatal weight loss and admission to
the neonatal ward. Instead, parity was associated with a decreased risk for shorter EBF duration.
Insulin resistance—even in the absence of gestational diabetes mellitus—may be an impeding factor
for EBF.
Keywords: breastfeeding; gestational diabetes; neonate; glucose tolerance test; prediabetes;
insulin resistance; pregnancy outcomes
1. Introduction
The role of maternal metabolic health on early lactation success is only recently gaining
recognition. A wide range of entangled factors may contribute to reduced milk supply. We know that
gestational diabetes predisposes women to both perinatal depression and undesired weaning [1–3].
Several authors have reported that glucose homeostasis during pregnancy may affect breast
development [4] and could correlate with breastfeeding outcomes [5,6]. Insulin resistance may act at
the lactocyte level [7]. Pregnant women at risk of metabolic syndrome are prone to delayed onset of
lactogenesis stage II (DLII) [8]—a risk factor for early breastfeeding cessation [9]. In recent years, it
has been shown that most of the time, variation in onset of lactogenesis stage II (LII) is predicted by
1-h post-glucose challenge (1-hOGTT) at 26 weeks of gestation [8]. This finding is in line with current
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data suggesting that the correlation between any degree of glucose tolerance impairment and adverse
offspring outcome follows a continuous pattern, and that even mild degrees of hyperglycemia may be
associated with complications [10].
Taken together, these data suggest that suboptimal maternal glucose tolerance may be a key
factor in the establishment of breastfeeding. Despite the rising prevalence of gestational prediabetes,
studies on neonatal outcomes of this condition are still scarce. To shed some light on this issue, we
conducted a secondary analysis and evaluated the following research question: is there an association
between mild gestational hyperglycemia and the early cessation of exclusive breastfeeding (EBF)?
2. Experimental Section
2.1. Enrollment
We enrolled a population-based sample of mother–infant dyads attending a general care pediatric
clinic in a middle-class neighborhood in Majorca, Spain. The enrollment phase lasted from January
2007 to December 2012. We invited all mothers who attempted breastfeeding to participate in “a study
on infant feeding” upon their first well-child visit. The study was approved by the Institutional Review
Boards of the Health Authority of the Balearic Islands, and participants consent was obtained prior to
their inclusion in the study.
2.2. Selection Criteria and Data Collection
This analysis was conducted in the context of an ongoing observational study of breastfeeding
natural history. The study protocol has previously been described in detail [11,12]. In brief, the study
was conducted as a review of medical records from a Pediatric Office where approximately 120 babies
are enrolled every year. Prenatal inclusion criteria were: (1) the routinely administered 24 to 28-week
gestation 1-hOGTT, and (2) mothers had to be free of gestational diabetes (GDM). Post-birth inclusion
criteria were (3) delivery at term (37 weeks of gestation), and (4) the mother initiated breastfeeding
as planned. We extracted additional data on patient characteristics and on infant feeding from the
prenatal and pediatric medical records. From the pediatric record, information on infant feeding was
collected at discharge from the hospital and at the scheduled well-baby visits. Information about
the duration of EBF was obtained from pediatric records, information previously collected from
mother’s report of how the baby was being fed at the time of well-baby visits at 2 weeks, and at
2, 4, 6, and 9 months of age. Duration of EBF was defined as the last notation in the record when
the infant was fed only breast milk. According to the WHO, exclusive breastfeeding means that the
infant receives only breast milk. No other solids are given, with the exception of vitamins, minerals,
or medicines. Of the eligible mother–infant dyads, 768 had information available for all key variables,
and were therefore included in the analyses presented here.
2.3. Glucose Challenge Test
According to the recommendations of the American College of Obstetrics and Gynecology
(ACOG) [13], standard practice in our setting involves universal screening for GDM in all pregnant
women at 24–28 weeks’ gestation by a nonfasting 1-h 50 g glucose challenge test. Patients testing
positive for the 1-hOGTT (1-h plasma glucose 7.8 mmol/L) were asked to return for a 3-h 100 g oral
glucose tolerance test (3-hOGTT).
Categorization. Based on 1-hOGTT and 3-hOGTT, subjects were stratified into the following three
glucose tolerance groups:
(i) Normal glucose tolerance (NGT), defined by normal 1-hOGTT results (1-h plasma
glucose < 7.8 mmol/L);
(ii) Mild impairment of glucose tolerance (MIGT), defined by a single abnormal value greater than
or equal to 7.8 mmol/L, but less than 10.6 mmol/L;
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(iii) GDM, requires at least two of the following on the 3-hOGTT: fasting glucose 5.8 mmol/L,
1-h glucose 10.6 mmol/L, 2-h glucose 9.2 mmol/L, or 3-h glucose 8.1 mmol/L.
2.4. Data Analysis
Our outcome measure was discontinuation of EBF. Dichotomization: this variable has been split at
the median to form short and normal breastfeeding duration groups. Our primary predictor was MIGT
in pregnancy. Patients were allocated to the NGT group or to the MIGT group. Data were analyzed
using the IBM-SPSS (V22.0) Package (IBM Corp., Armonk, NY, USA). First, we examined distributions
and summary measures for each variable. Table 1 shows, for each study group, continuous
variables as median followed by range, while categorical variables are presented as proportions.
Univariate differences across the groups were assessed using Mann–Whitney test for continuous
variables, and either chi square or Fisher’s exact test for categorical variables. Multiple regression
analysis was used to identify perinatal factors that independently predicted a short duration of EBF.
Covariates considered included parity, glucose tolerance status in pregnancy, delivery type, birth
weight, admission to the neonatal ward, and neonatal weight loss at discharge. A series of models
were constructed using these covariates. The final models included main effects significant at p < 0.05.
Table 1. Patient characteristics.
Variable
NGT: 1-h Plasma
Glucose < 7.8 mmol/L
(N = 616)
MIGT: 10.6 mmol/L > 1-hOGTT









Mother’s age (years) 33 (20–45) 33 (25–42) 0.064
Gestational weight gain 12 (1–39) 12 (4–27) 0.84






Birth weight 3272 (1995–4800) 3395 (2050–4390) 0.018
Birth height 49.5 (33–54) 50 (45.5–53.5) 0.13
Birth head circumference 34.5 (31–37) 34.5 (31–37.5) 0.74
Percent of loss of birth weight to
discharge 6 (−0.32–0.21) 7 (−7–13) 0.41




Table 1 shows the demographic and perinatal characteristics of the 768 study participants stratified
into our two predefined glucose tolerance categories in pregnancy: NGT (n = 616) and MIGT (n = 152).
Around eighty percent (80.2%) of subjects tested in the normal range for glucose tolerance. This was
a predominantly middle-class cohort from a general pediatric clinic where most participants had
private health insurance. There were no significant differences between the groups with respect to
most baseline characteristics, but birth weight was lowest in the NGT group (p = 0.018), and birth
height was lower in the NGT group than in the MIGT group—though this difference did not reach
statistical significance (p = 0.13).
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3.2. EBF Outcome: Univariate Analysis
Table 2 shows that, upon univariate analysis, the rate of EBF adverse outcomes was significantly
higher in the MIGT than in the NGT group (58% vs. 48%; p = 0.03). In fact, in the MIGT cohort,
median duration of EBF was 56 days (1–300), while in the NGT cohort, it was significantly longer:
100 days (1–360) (p = 0.045). Other significant findings for decreased EBF duration included parity,
gender of the newborn infant, neonatal weight loss at discharge, and admission to the neonatal ward.




Equal or Later than Day 100
(N = 384) p
MIGT 58% 42%
0.03 *NGT 48% 52%
Gender:
0.001 **Male 214 (54%) 169 (43%)
Female 179 (45%) 225 (57%)
Parity:
<0.001 ***1 271(72%) 214 (57%)
>1 107 (28%) 159 (28%)
Mother’s age (years) 33 (18–42) 33 (21–45) 0.92
Gestational weight gain 12 (1–30) 12 (4–39) 0.05
Weeks of gestation 40 (37–42) 40 (37–42) 0.27
Delivery type:
0.38
Eutocic 184 (50%) 207 (57%)
Instrumental 61 (17%) 55 (15%)
C-section 119 (33%) 110 (30%)
Birth weight 3252(1995–4390) 3330 (2310–4800) 0.02 *
Birth height 49.5 (33–54) 50 (45.5–54) 0.32
Birth head circumference 34.5 (31–37) 34.5 (31–37.5) 0.36
Percent of loss of birth weight to discharge 7 (−7–21) 6 (−32–20) <0.001 ***
Abbreviations: mild impairment of glucose tolerance (MIGT); normal glucose tolerance (NGT). * p < 0.05;
** p < 0.01; *** p < 0.001.
3.3. EBF Outcome: Multivariate Analysis
We reanalyzed the association between MIGT and EBF outcome after adjustment for significant
univariate variables (Table 3). EBF duration—as a dichotomous variable (<100 days)—was
independently associated with the MIGT group (OR: 1.65; CI: 1.11–2.45). In addition, neonatal
weight loss at discharge and admission to the neonatal ward were identified as significant risk factors
for short EBF duration in the multivariable model. Instead, parity was associated with a decreased risk
for shorter EBF duration.
Table 3. Multivariate analysis of factors independently associated with reduction in exclusive
breastfeeding duration.
AOR (95% CI) p
Mildly impaired glucose tolerance 1.65 (1.11–2.45) 0.01
Early neonatal weight loss 1.73 (1.26–2.36) 0.001
Admission to neonatal ward 3.32 (1.04–10.60) 0.04
Parity 0.57 (0.41–0.79) 0.001
Abbreviations: AOR, adjusted odds ratio.
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4. Discussion
In this report, we aimed to determine whether an abnormal 1-hOGTT is independently associated
with adverse EBF outcomes despite a normal subsequent 3-hOGTT. We have shown that MIGT during
pregnancy predicts a shortened breastfeeding duration. To our knowledge, there is only one other
study on the lactational implications of mild gestational hyperglycemia. Interestingly, it shows that
testing positive in the 1-hOGTT is the main contributing factor to a delay or failure in the onset of LII [9],
and specifically, that DLII is a clinical indicator of women at risk of early postpartum breastfeeding
cessation. Three groups have evaluated the effect of DLII on breastfeeding outcomes. Chapman et al.
showed that among women planning to breastfeed ≥6 months, women without DLII were more likely
to continue breastfeeding [14]. In the analyses by Hruschka and colleagues, immediate postpartum
supplementation was associated with DLII [15]. Finally, data from over 2400 mothers showed that
DLII was associated with the cessation of any and exclusive breastfeeding at 4-weeks postpartum [9].
Since O’Sullivan first described gestational glucose intolerance, progressively lower thresholds
have been proposed for the diagnosis and treatment of GDM. New data have demonstrated that the risk
of adverse outcomes increases, even among women with sub-threshold results in fasting and post-load
glucose screening [16]. Furthermore, it was recently reported that pregnant women with an isolated
abnormal glucose value at 1-hOGTT carry a severe metabolic perturbation, characterized by markedly
reduced beta-cell function; their metabolic phenotype resembles that of GDM, and may be associated
with the same adverse outcomes as GDM [17]. The Hyperglycemia and Adverse Pregnancy Outcome
(HAPO) study showed associations between increasing levels of fasting, 1-h, and 2-h plasma glucose
obtained on oral glucose-tolerance testing and each of the adverse perinatal outcomes examined: birth
weight above the 90th percentile and cordblood serum C-peptide level above the 90th percentile,
premature delivery, shoulder dystocia or birth injury, intensive neonatal care, hyperbilirubinemia,
and preeclampsia [18]. The effects of GDM on short-term breastfeeding outcomes have been clearly
documented, unlike the effects of MIGT. Yet, women with a history of GDM face challenges with EBF
in the critical period for setting up breastfeeding success. A recent systematic review of ten original
papers from 1989 to 2013 on the effect of GDM on LII onset shows that all studies consistently identified
that LII occurred later among gestationally diabetic mothers than in non-diabetic mothers [19]. LII is
characterized by changes in breastmilk components—in particular, a decrease in breastmilk sodium.
Conversely, the presence of GDM increases the risk of an elevated breastmilk sodium level on
day three postpartum [20]. A case–control study revealed that women diagnosed with low milk
supply were significantly more likely to have had GDM compared with women with other lactation
outcomes [21]. Poorer sucking patterns have been found among newborn infants of mothers with
GDM [22]. A cross-sectional analysis including 2038 women found that the adjusted odds of EBF at
hospital discharge were lower among women with GDM compared to women without GDM [23].
Overt GDM is associated with significantly increased risks of adverse breastfeeding outcomes.
Whereas, until recently, women with an abnormal 1-hOGTT (with normal 3h-OGTT) were regarded as
a false positive result, emerging data suggest that current diagnostic criteria for GDM are too restrictive,
and that lesser degrees of hyperglycemia also increase offspring risks [10]. Despite the associated
adverse pregnancy outcomes, no international consensus exists that identifies a cut-off value for the
definition of GDM. Current criteria of the International Association of Diabetes and Pregnancy Study
Groups (IADPSG) are lower than the ACOG 2013 thresholds (fasting glucose 5.1 versus 5.8 mmol/L,
or 1-h glucose 10.0 versus 10.6 mmol/L). It has been reported that applying the IADPSG criteria to
the population would increase the rate of GDM from 7.3% to 10.3% [24]. A 2013 National Institutes of
Health (NIH) panel states that there are clear benefits to the standardization of international diagnostic
criteria. Nevertheless, the panel is concerned with the adoption of new criteria that would increase the
prevalence of GDM (and the corresponding costs and interventions), without clear demonstration of
improvements in health outcomes [25]. Therefore, new tools—such as Capula’s index—continue to be
developed to improve the accuracy and cost-effectiveness of this screening [26].
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A brief literature review shows that it is well established that insulin resistance is a strong predictor
of short breastfeeding duration, but the underlying causal contributors remained unclear until very
recently. Over the last years, insulin-sensitive gene expression has been shown to be upregulated
during the lactation cycle, and insulin is now considered to play a direct role in lactation [27].
The established dogma has been that women are never physiologically unable to lactate, but
rather that low milk supply is a mistaken belief on their part. Thus, most interventions have focused
on improving breastfeeding education. However, emerging clinical research suggests an important
association between suboptimal glucose tolerance and lactation difficulty. Our findings add to the
evidence that a woman’s metabolic complications adversely affect her lactation outcomes. 1-hOGTT
may be a useful clinical indicator to identify women at risk of early postpartum breastfeeding cessation.
These results have clinical implications, underlining that breastfeeding support of women with
abnormal glucose tolerance should be individualized. Given the current insulin resistance epidemic,
caregivers face the challenge of meeting the growing need for clinical guidance of women with both
metabolic disturbances and low milk supply. Further translational research is needed to successfully
implement interventions that will enable more women to avoid undesired breastfeeding cessation.
These analyses have several limitations. First, this is a secondary analysis. Second, the nature
of these data did not allow for evaluation of the contribution of interactions between conditions
previously reported (e.g., gestational weight gain and maternal obesity, neonatal weight loss
and DLII). Third, our significant findings may be inauthentic due to unmeasured confounding.
A factor that influences a woman’s ability to breastfeed is the presence of personal or professional
support. Other mother-centered factors include social barriers, work-related barriers, or a dislike
of breastfeeding. We do not have data on all maternal factors that may affect milk production and
composition. Finally, our assessment of metabolic dysregulation was done prenatally. We do not know
to what extent maternal metabolic status in the early postpartum is affected.
Strengths of this study include the consistency with existing literature and the prospective design
to collect breastfeeding duration and exclusivity data. The study does not rely on later recall of
breastfeeding outcomes. Although the study populations and availability of pertinent confounders
differed, the current study confirms that 1-hOGTT represents an important metabolic perturbation in
pregnancy, characterized not only by increased risk for adverse pregnancy outcomes, but also by early
breastfeeding dysfunction. It is becoming clear that long glucose challenge tests are not superior to
short glucose challenge tests in the assessment of prenatal glucose tolerance.
Finally, we clearly identified several additional independent risk factors for early breastfeeding
cessation (e.g., neonatal weight loss, admission to the neonatal ward, and parity).
5. Conclusions
In summary, women who test positive for 1-hOGTT may be less able to sustain EBF at 100 days.
These findings suggest that 1-hOGTT may already identify a high-risk population of mothers in need
of interventions to increase breast milk production.
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Abbreviations
The following abbreviations are used in this manuscript:
1-hOGTT 1-h post-glucose challenge
3-hOGTT 3-h glucose tolerance test
ACOG American College of Obstetricians and Gynecologists
DLII delayed onset of lactogenesis stage II
EBF exclusive breastfeeding
GDM gestational diabetes
IADPSG International Association of Diabetes and Pregnancy Study Groups
LII lactogenesis stage II
MIGT mild impairment of glucose tolerance
NGT normal glucose tolerance
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Abstract: The calcium supplementation status during the postpartum period among Chinese lactating
women is still unclear. The objective of this study is to utilize data from two population-based
prospective cohort studies to examine the calcium supplementation status and to identify whether
breastfeeding is associated with increased calcium supplementation among Chinese mothers
after child birth. Information from 1540 mothers on breastfeeding and calcium supplementation
measured at discharge, 1, 3, and 6 months postpartum were extracted to evaluate the association
between breastfeeding and calcium supplementation postpartum. A generalized linear mixed
model was applied to each study initially to account for the inherent correlation among repeated
measurements, adjusting for socio-demographic, obstetric factors and calcium supplementation
during pregnancy. In addition, breastfeeding status measured at different follow-up time points
was treated as a time dependent variable in the longitudinal analysis. Furthermore, the effect sizes
of the two cohort studies were pooled using fixed effect model. Based on the two cohort studies,
the pooled likelihood of taking calcium supplementation postpartum among breastfeeding mothers
was 4.02 times (95% confidence interval (2.30, 7.03)) higher than that of their non-breastfeeding
counterparts. Dietary supplementation intervention programs targeting different subgroups should
be promoted in Chinese women, given currently a wide shortage of dietary calcium intake and
calcium supplementation postpartum.
Keywords: calcium supplementation; breastfeeding; postpartum; infant; nutrients; generalized linear
mixed model; time dependent variable; pooled analysis; China
1. Introduction
The mineral accretion rate of a neonate reaches about 30–40 mg/kg per day, while calcium
transfer between mothers and infants is on average 210 mg per day [1–3]. For babies who are breastfed
exclusively through the first 6 months, the amount of mineral demand from the mothers is four times
greater than that during 9 months of pregnancy [4]. The calcium requirement of mothers during
lactation has been the subject of much discussion [5–7]. In 2011, the Institute of Medicine published
the calcium dietary reference intakes by life stage, in which Estimated Average Requirement (EAR) of
calcium for pregnant and lactating adult women is recommended as 800 mg [8].
Compared to western countries, the lower consumption of dairy products in China results
in that most of Chinese residents have calcium intake lower than the adequate intake (AI) [9–11].
In a prospective cohort study of women’s health from Shanghai, the median intake of calcium was
485 mg/day, 60% of calcium from plant sources, and only 20% from milk, which was lower than
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the age group specific AI (800 mg/day for 18–49 years group and 1000 mg/day for over 50 years
group) [11,12]. Only 6.25% of perimenopausal women reached the standard of calcium intake in
Changsha [13]. The average intake of calcium of Beijing elderly was 505 mg/day, which was about one
half of the recommended adequate intake for the elderly [14]. In the National Nutrition and Health
Survey of 2002, fewer than 5% reached the adequate intake levels of calcium for all age groups and
the prevalence of calcium supplementation during pregnancy was 41.4% [15,16]. Besides cultural
preferences, the lower consumption of dairy products in China is attributed to the high rate of lactose
intolerance, which is around 80% to 95% [17,18].
The Chinese National Health and Family Planning Commission recommends that pregnant
women should have a dietary calcium intake of 1000 mg per day from the second trimester and
increase to 1200 mg per day from the third trimester until the end of lactation [19]. However, low dietary
calcium intake in lactating women has been reported in different regions of China, as shown in Table 1.
This suggests that calcium supplementation for lactating women is an important public health issue to
mothers in China based on the current evidence about the benefits of calcium intake during lactation
on reducing maternal bone loss [20–23].
Table 1. Dietary calcium intake of lactating women in different regions of China.
Study Location Study Design Study Period
Average Daily Dietary
Calcium Intake (Postpartum)
Guangzhou [24] Prospective cohort 2002 786.45 mg (12 weeks)
Hunan [25] Cross-sectional 2011–2012 426 mg
Beijing, Suzhou &
Guangzhou [26] Cross-sectional 2011–2012
401.4 mg (0–1 month)
585.3 mg (1–2 months)
591.2 mg (2–4 months)
649.0 mg (4–8 months)
Fujian [27] Prospective cohort 2012
428 mg (2 days)
454 mg (7 days)
595 mg (30 days)
544 mg (90 days)
Shanghai [28] Prospective cohort 2014–2015
749.3 mg (1–3 days)
781.1 mg (7–9 days)
762.3 mg (14–17 days)
768.4 mg (25–27 days)
678.5 mg (39–41 days)
The calcium supplementation status during postpartum period among Chinese lactating women is
still unclear. The objective of the present study is to utilize data from two population-based prospective
cohort studies to examine the calcium supplementation status and to identify whether breastfeeding is
associated with increased calcium supplementation among Chinese mothers after child birth.
2. Materials and Methods
2.1. Study Participants
Two prospective cohort studies were conducted in an urban area, Chengdu (capital city) and a
rural area, Jiangyou (county-level city), Sichuan Province, China between 2010 and 2012. Mothers who
gave birth to a healthy singleton infant were invited to participate before discharge. These two studies
used the same methodology based on same questionnaires, which had been used in Australia and
China [29–31] previously, to interview all consented women face-to-face at discharge, and followed
up the participants at one, three and six months postpartum by telephone interviews. The baseline
interview collected detailed information on mothers and newborns, including socio-demographic,
obstetric characteristics and dietary supplements during pregnancy. The follow-up interviews
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collected detailed information on lactation patterns and durations and dietary supplements during the
postpartum period. The World Health Organization (WHO) standard definition of any breastfeeding
was used in these two studies; ‘Any breastfeeding’ is defined as the infant has received breast milk
(direct from the breast or expressed) with or without other drink, formula or other infant food [32].
2.2. Ethical Approval
The two cohort studies were approved by the Human Research Ethics Committee of Curtin
University, Perth, Western Australia (approval numbers: HR169/2009 and HR168/2009, respectively).
The present study was also approved by the Human Research Ethics Committee of Curtin University
(approval number: RDHS-101-15). The data used in this study were de-identified.
2.3. Statistical Analysis
The outcome of the present study is maternal calcium supplementation status (yes or no)
measured longitudinally during three different postpartum periods (from discharge to 1 month,
from 1 month to 3 months, and from 3 months to 6 months, respectively) at three follow-up
time points (namely, 1 month, 3 months and 6 months postpartum). The main variable of
interest, any breastfeeding status, was measured longitudinally at three different postpartum
time points (discharge, 1 month and 3 months postpartum). Descriptive statistics of mothers’
socio-demographic status, obstetric characteristics, calcium supplementation during pregnancy and
the three postpartum periods, and any breastfeeding status at the three postpartum time points were
obtained and reported. Chi-square test was conducted to compare the calcium supplementation
rates between breastfeeding group and non-breastfeeding group at the different follow-up time
points. Generalized linear mixed model (GLMM) was used to examine the effect of breastfeeding
on calcium supplementation postpartum taking into account inherent correlations among repeated
measurements. Furthermore, the breastfeeding status was included as a time-dependent variable in
the longitudinal analysis. Random intercept model without covariates (Model I) was run initially
to test random intercept effect, and then any breastfeeding status at the different time points and
an indicator variable of measurement times were added into the above Model I to be a Model II.
Furthermore, subject level socio-demographic covariates such as household annual income, maternal
age and maternal education were then added into and adjusted in the Model II to formulate a Model III.
Finally, obstetric characteristics such as parity, gravidity, infant gender, infant birth weight and infant
gestational week, together with calcium supplementation during pregnancy, were further adjusted in
the Model III to become the final Model IV. The above regression analysis was carried out for data
set extracted from each cohort study separately, and the results of Model II and final Model IV were
reported. In addition, a pooled effect size was calculated using a fixed effect model given that the
heterogeneity between the two studies was tested being statistically nonsignificant. All statistical
analyses were performed by using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).
3. Results
3.1. Characteristics of Participants
For each cohort, mothers’ baseline socio-demographic status, obstetric characteristics and calcium
supplementation during pregnancy are presented in Table 2. In the Jiangyou study, 695 mothers were
interviewed at baseline, and 648 and 620 mothers remained in the study at 1 month and 3 months
postpartum, respectively. Any breastfeeding rate dropped slightly from 93.53% at discharge to 91.05%
at 1 month postpartum then continuously to 83.71% at 3 months postpartum. In the other cohort
conducted in Chengdu, 845 mothers were interviewed at baseline and 760 mothers were followed up
until six months postpartum. Any breastfeeding rate declined from 93.02% at discharge to 87.89% at
1 month postpartum then substantially to 73.42% at 3 months postpartum.
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BF Non-BF BF Non-BF
Number of participants 650 (93.5) 45 (6.5) 786 (93.0) 59 (7.0)
Household annual income (Chinese yuan)
<2000 186 (31.0) 9 (23.1) 1 (0.2) 0 (0.0)
2000–5000 309 (51.4) 23 (59.0) 155 (23.5) 12 (24.0)
>5000 106 (17.6) 7 (17.9) 503 (76.3) 38 (76.0)
Maternal age (years)
<25 373 (57.4) 26 (57.8) 156 (19.9) 5 (8.5)
25–29 163 (25.1) 13 (28.9) 372 (47.3) 28 (47.5)
>29 114 (17.5) 6 (13.3) 258 (32.8) 26 (44.0)
Maternal education
Secondary school or lower 355 (54.6) 25 (55.6) 90 (11.5) 11 (18.6)
Senior school 215 (33.1) 18 (40.0) 165 (21.0) 11 (18.6)
University or higher 80 (12.3) 2 (4.4) 531 (67.5) 37 (62.8)
Parity
Primiparous 518 (79.7) 37 (82.2) 700 (89.1) 51 (86.4)
Multiparous 132 (20.3) 8 (17.8) 86 (10.9) 8 (13.6)
Gravidity
Primigravida 249 (38.3) 18 (40.0) 430 (54.7) 26 (44.1)
Multigravida 401 (61.7) 27 (60.0) 356 (45.3) 33 (55.9)
Infant gender
Male 328 (50.5) 26 (57.8) 412 (52.4) 34 (57.6)
Female 322 (49.5) 19 (42.2) 374 (47.6) 25 (42.4)
Infant birth weight (g)
<2500 10 (1.5) 2 (4.4) 13 (1.7) 0 (0.0)
≥2500 640 (98.5) 43 (95.6) 773 (98.3) 59 (100.0)
Infant gestational week
<37 8 (1.2) 3 (6.8) 9 (1.2) 2 (3.4)
≥37 640 (98.8) 41 (93.2) 777 (98.8) 57 (96.6)
Calcium supplementation during pregnancy
Yes 410 (63.1) 25 (55.6) 627 (79.8) 47 (79.7)
No 240 (36.9) 20 (44.4) 159 (20.2) 12 (20.3)
Data are presented as n (%); BF: any breastfeeding; Non-BF: non-breastfeeding.
3.2. Calcium Supplementation Status during Postpartum Period
Overall, among mothers in the Jiangyou cohort, an inverted U shape of calcium supplementation
rates at three different postpartum periods was observed, which corresponded to 13.4%, 19.4%
and 17.7%, respectively. While in the Chengdu cohort, a constant decline trend was recorded with
22.5%, 22.2% and 12.0% reported at the three postpartum periods. When considering separately for
breastfeeding and non-breastfeeding groups, as shown in Figures 1 and 2, the calcium supplementation
rate in the breastfeeding group was statistically significantly higher than that in the non-breastfeeding
group for all the different postpartum periods, except between discharge and 1 month in the Jiangyou
cohort (p = 0.36). In the Jiangyou cohort, calcium supplementation rates ranged from 13.7% to 21.2% for
breastfeeding mothers, and ranged from 1.7% to 8.9% for non-breastfeeding mothers. In the Chengdu
cohort, calcium supplementation rates reduced from around 23% in the first 3 months postpartum to
14.5% between 3 months and 6 months in breastfeeding mothers, and ranged from 5.0% to 14.1% in
non-breastfeeding mothers.
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Figure 1. Calcium supplementation postpartum in Jiangyou.
Figure 2. Calcium supplementation postpartum in Chengdu.
3.3. The Association between Breastfeeding and Calcium Supplementation Postpartum
In Model I (without any covariates) for both cohorts, subject random effect was found to be
statistically significant. Hence, both the primary variables of interest (i.e., breastfeeding status and the
indicator variable of measurement times) were subsequently added into the Model I for examining the
association between breastfeeding and calcium supplementation postpartum. As shown in Table 3,
the likelihood of calcium supplementation in breastfeeding mothers were 5.85 times (95% confidence
interval (CI) (2.50, 13.72)) and 2.88 times (95% CI (1.50, 5.54)) higher of that in non-breastfeeding
mothers in Jiangyou and Chengdu, respectively. After adjusting for socio-demographic and obstetric
factors as well as calcium supplementation during pregnancy, the odds ratios (ORs) and its 95% CI
had changed appreciably to 6.95 and (2.68, 18.04) in the Jiangyou study, and 3.03 and (1.52, 6.02) in
the Chengdu study, respectively. The heterogeneity between these two studies was not significant
(I2 = 0.479, p = 0.17) statistically, therefore a fixed effect model was used to pool the ORs of the two
studies. The pooled analysis of these two cohort studies revealed that calcium supplementation
postpartum was significantly positively associated with breastfeeding with an adjusted OR = 4.02 with
a 95% CI of (2.30, 7.03).
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Table 3. Association between breastfeeding status and calcium supplementation postpartum.
Variable
Model II Model IV
Crude ORs (95% CI) Adjusted ORs (95% CI)
Jiangyou Cohort
Measurement times *
At discharge (ref) 1 1
1 month 1.72 (1.24, 2.38) 1.90 (1.33, 2.70)
3 months 1.57 (1.12, 2.20) 1.69 (1.18, 2.44)
Breastfeeding status *
Non-breastfeeding (ref) 1 1
Any breastfeeding 5.85 (2.50, 13.72) 6.95 (2.68, 18.04)
Chengdu Cohort
Measurement times *
At discharge (ref) 1 1
1 month 1.02 (0.74, 1.43) 1.02 (0.72, 1.45)
3 months 0.31 (0.21, 0.46) 0.30 (0.20, 0.45)
Breastfeeding status *
Non-breastfeeding (ref) 1 1
Any breastfeeding 2.88 (1.50, 5.54) 3.03 (1.52, 6.02)
Pooled effect size of two studies
Non-breastfeeding (ref) - 1
Any breastfeeding - 4.02 (2.30, 7.03)
Crude ORs (obtained from Model II): Model included breastfeeding status and the indicator variable of
measurement times; Adjusted ORs (obtained from the final Model IV): Model adjusted for socio-demographics
variables (household annual income, maternal age and maternal education); obstetric factors (parity, gravidity,
infant gender, infant birth weight and infant gestational week); and calcium supplementation during pregnancy;
* p < 0.05; ref: reference category.
4. Discussion
To our knowledge, the present study is the first population-based study that determines the
longitudinal trend of calcium supplementation by Chinese women from discharge to 6 months
postpartum and the effect of breastfeeding on calcium supplementation. A relatively low level
of calcium supplementation (less than 23%) was observed throughout the postpartum period in
either breastfeeding mothers or non-breastfeeding mothers. The pooled effect size after adjusting
for socio-demographics variables (household annual income, maternal age and maternal education);
obstetric factors (parity, gravidity, infant gender, infant birth weight and infant gestational week);
and calcium supplementation during pregnancy reveals that mothers who breastfed their babies were
4.02 times more likely to take calcium supplements compared to their non-breastfeeding counterparts
during postpartum. The present result is consistent with previous findings that breastfeeding mothers
consumed more calcium than non-breastfeeding counterparts [33–35]. One reason leading to the higher
calcium supplementation in breastfeeding mothers may be the general belief that adequate calcium
intake is beneficial to breast milk production, and mothers’ special attention to infants’ calcium intake
under the context of wide shortage of calcium intake for Chinese women, in spite of recent evidence
demonstrating that calcium supplementation in lactation has no significant effect on increasing calcium
content in breast milk [36–38]. The other reason might be mothers’ perception of the beneficial effect of
calcium supplementation on maternal bone loss during lactating. Some studies found little benefits
of calcium supplementation on maternal bone loss during lactating [36,39,40], whereas other studies
carried out in the U.S. and Brazil suggested that higher calcium intake during early lactation could
minimize the bone loss for the mothers who had daily calcium intake less than 500 mg [20,21].
Further investigation on the factors contributing to difference of calcium supplementation between
breastfeeding mothers and non-breastfeeding mothers as well as the effect of calcium supplementation
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on reducing maternal bone loss during lactation or enhancing maternal skeleton remodeling and
remineralization after weaning of breastfeeding is recommended.
Given the habitually lower calcium dietary intake and relatively high lactose intolerance rate in
the general Chinese population [12,15,17], calcium supplementation plays an important role on bone
health, especially for exclusive breastfeeding women who provide around 300 mg of calcium per day
to their babies via breast milk which accompany maternal bone calcium turnover [41].
This study had several strengths. We utilized data from two cohort studies to investigate the
longitudinal trends of calcium supplementation at three different postpartum time points (i.e., 1 month,
3 months and 6 months postpartum) and conducted random effect regression modelling accounting
for inherent dependency between the repeated measurements. Moreover, since the breastfeeding
status was measured longitudinally as well in two cohorts, it was treated as a time-dependent
variable in the analysis to account for possible feedback effects between the breastfeeding status
and calcium supplementation at different times. In addition, our pooled analysis based on the two
individual studies yielded the combined effect size with a larger sample size and higher statistical
power. Moreover, calcium supplementation during pregnancy was adjusted in the modelling to
control for the consequent effect of calcium intake during pregnancy on calcium supplementation
during lactation.
A caveat of this study was that both cohort studies were carried out in Sichuan Province,
which may limit the results being able to generalize to other regions of China. Sichuan Basin has special
geographic characteristics, where the number of cloudy or rainy days is substantially larger than that in
other regions in China, which may lead to a relatively lower level of vitamin D synthesis and calcium
deficiency consequently [42]. However, to the best of our knowledge, no data were available currently
on calcium supplementation during postpartum in other regions of China for comparison purpose.
5. Conclusions
In conclusion, calcium supplementation during postpartum in Sichuan is variable at different
times postpartum with a relatively low level (less than 23%). Although breastfeeding has a substantive
effect on calcium supplementation postpartum, dietary supplementation intervention programs and
health education targeting different subgroups (e.g., breastfeeding mothers and bottle feeding mothers)
should be promoted in Chinese women, given currently a wide shortage of dietary calcium intake and
calcium supplementation during postpartum.
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Abstract: Breastfeeding is recommended beyond 12 months of age, but little is known about the
contribution of breastmilk and infant formula to the nutritional intake of toddlers as they transition
to a family diet in the second year of life. This study is a cross-sectional analysis of data collected
from a birth cohort study in Adelaide, Australia. Dietary intake data were collected when children
were approximately 1 year of age by an interviewer-administered multi-pass 24 h recall and a
mother-completed 2 days food diary. Children were categorized according to their milk feeding
method, i.e., breastmilk, infant formula, combination or other, and their nutrient intakes compared
with recommended nutrient reference values. Complete data were available for 832 children, of which
714 had plausible energy intakes. Breastmilk and formula made a substantial contribution to the
nutrient intake of those toddlers, contributing 28% and 34% of total energy, and 16% and 26%
of protein intake, respectively when not drunk in combination. In general, Australian toddlers
transitioning to the family diet consumed nutritionally adequate diets, although almost one quarter
of all children and half of breastfed children with plausible intakes had iron intakes below the
estimated average requirement, placing them at risk of iron deficiency.
Keywords: nutritional adequacy; diet; toddler; breastmilk; formula; iron
1. Introduction
Breastfeeding is recommended beyond 12 months of age [1–3], but relatively little is known about
the contribution of breastmilk and infant formula to the nutritional intake of toddlers as they transition
to a family diet in the second year of life. Similarly, little is known about the nutritional content and
adequacy of the diets of Australian children under the age of 2 years. While the Australian National
Infant Feeding Survey studied this age group, its focus was on breastfeeding and age of introduction
of complementary foods and it did not investigate what and how much children in this age group
ate [4]. On the other hand, the 2011–2012 Australian National Nutrition and Physical Activity Survey
(NNPAS) [5] and the 2007 Australian National Children’s Nutritional and Physical Activity Survey
(NCNPAS) [6] only studied the diets of children aged 2 years and older. What data are available on the
diets of Australian infants and toddlers aged less than 2 years come from a number of single-center or
state-based studies of infants and toddlers of varying ages [7–12]. Relatively little is known about the
diets of children as they enter their second year of life [9] and much of what we know about the diets
of this age group comes from international studies [13–15].
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The objectives of this paper were therefore to (1) estimate the usual intake of a cohort of Australian
toddlers and to evaluate their diets relative to the Nutrient Reference Values (NRVs) for Australia and
New Zealand [16]; (2) identify the contribution that breastmilk and formula make to the nutrient intake
of toddlers; and (3) investigate the relationship between milk feeding method and nutrient adequacy.
2. Materials and Methods
2.1. Design
This study is a cross-sectional analysis of dietary data collected as part of the Study of Mothers’
and Infants’ Life Events Affecting Health (SMILE), a population-based longitudinal birth cohort
study [17]. This study has recruited and is following a cohort of socioeconomically-diverse South
Australian newborns from birth and into their third year of life. The primary health outcomes of this
study are two related conditions: dental caries and obesity/overweight of young children.
2.2. Setting and Recruitment
In total, 2147 mothers and 2181 newborns, including 34 pairs of twins, were recruited from the
three major maternity hospitals in Adelaide, Australia from July 2013 until August 2014. All new
mothers who were sufficiently competent in English to be able to understand the description and
instructions of the study were invited to participate. Those mothers who indicated their intention to
move out of the greater Adelaide area within a year were excluded.
Mothers were recruited, usually within 48 h of giving birth, from the postnatal wards of the
participating hospitals. Those agreeing to participate in the study were invited to complete a baseline
questionnaire designed to collect mother and family-related information including socio-demographic
details such as age, income, education, occupation and postcode. Further details of sample size and
recruitment procedures have been reported elsewhere [17].
2.3. Ethical Considerations
The study was approved by the Southern Adelaide Clinical Human Research Ethics Committee
(HREC/50.13, approval date: 28 February 2013) and the South Australian Women and Children Health
Network (HREC/13/WCHN/69, approval date: 7 August 2013), and received clinical governance
clearance from the three participating maternity hospitals. Signed informed consent was obtained
from mothers who were advised that their participation was voluntary and that they could withdraw
at any time without prejudice.
2.4. Collection and Handling of Dietary Data
Once their child had reached 12 months of age, mothers of the 1919 infants remaining in the
study were mailed a food diary and a cover letter explaining that a member of the research team
would telephone them to collect a 24 h dietary recall (24 HDR) of their child’s intake and explain
how to complete the food diary. The 24 HDR was conducted via a telephone interview by a trained
dietitian using the five-step multi-pass method [18]. At the end of the 24 HDR interview mothers were
allocated two days in the following week to record their child’s food intake in the food diary. The days
allocated ensured that, together with the 24 HDR, three nonconsecutive days (2 week days and one
weekend day) of dietary intake over a 10-day period were recorded. The food diary booklet contained
instructions for recording their child’s intake and included a detailed example of a one-day food record,
as well as photos of food portion sizes and examples of household measures (cups, bowls and spoons),
to help mothers estimate amounts consumed when completing both the 24 HDR and the food diary.
The dietary data were entered into FoodWorks® version 8 (Xyris Software) and analyzed using the
AUSNUT 2011–2013 food composition database [19]. Foods consumed by children but not included
in the AUSNUT database were added utilizing nutrient information gathered from the nutrition
information panels of product labels and manufacturer websites. The 24 HDR and the two-day food
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diary were entered together as a food record by a team of four nutritionists. For quality management
purposes, standardization training was conducted and data were entered following a detailed data
entry protocol. Cross-checking between the 24 HDR and food diary was conducted for data clarification
purposes—for example, where a type of bread (e.g., wholegrain) had been collected as part of the
24 HDR but not recorded by the mother in the food diary.
Breastmilk intake was estimated using the method employed for this age group in the UK 2011
Diet and Nutrition Survey of Infants and Young Children (DNSIYC) [14]. Breastfeeds were recorded
in minutes and the amount of milk consumed was calculated as 10 g/min to a maximum of 100 g
per feed, as the contribution to nutrient intake after 10 min of breastfeeding is considered minimal in
this age group [20]. If within 30 min of the start of the previous feed a second breastfeed was started,
it was not considered a new feed, and the breastfeeding time was added to the previous feed to a
maximum of 10 min [14]. If the child was breastfed for less than two minutes, this was not considered
long enough to contribute to their nutrient intake and was not included [14].
Children were grouped initially into four categories of milk feeding method on the basis of
whether or not they had consumed breastmilk and/or formula on one or more days. Formulas included
infant formula, defined as suitable for children up to 12 months, and toddler formula. The ‘breastmilk
group’ included toddlers who had received breastmilk but no formula. The ‘formula group’ included
toddlers who had received infant or toddler formula but no breastmilk. The ‘combination group’
included toddlers who had received both breastmilk and infant or toddler formula. Children in these
first three groups may also have consumed (usually in small amounts) animal milk or animal milk
substitutes in addition to breastmilk and/or formula. Children in the ‘other’ group had consumed
neither breastmilk nor infant or toddler formula.
2.5. Statistical Analysis
Once entered into FoodWorks® version 8 (Xyris Software, High Gate Hill, Qld, Australia),
data were downloaded into an Access database (Microsoft Office, 2013) and imported into SPSS version
22 (IBM SPSS Statistics for Windows, Armonk, NY, USA) for statistical analysis. Descriptive statistics
were run to identify outliers and improbable intakes of weight of food, energy and macronutrients, and
data were checked and cleaned appropriately. As the child’s current weight was unknown, a plausible
energy intake was estimated for each child using a sex specific estimated energy requirement (EER) for
a reference child of the participant’s age [16]. The child’s date of birth and the date when the 24 HDR
was completed was used to calculate their age. The degree of under and over-reporting was assessed
by calculating the ratio of reported energy intake to the EER for each child. Children were deemed to
have an implausible intake if they had an average daily energy intake below 0.54 or above 1.46 for
their age and sex specific reference EER [7].
Descriptive statistics, including mean values and standard deviations as well as 25th and 75th
percentiles, were derived for children with plausible intakes for nutrient intakes averaged across the
three days. The data were then transformed to determine the proportion of children with inadequate
and excessive intakes compared with the NRVs for children aged 1–3 years [16]. Inadequate intakes
were considered to be any value below the Estimated Average Requirement (EAR) and excessive
intakes were considered to be any value above the Upper Limit of intake (UL), where relevant.
The mean intake of energy, macronutrients and those micronutrients for which more than
10% of the total sample had inadequate or excessive intakes were reported for each milk feeding
group. A one-way ANOVA with a post hoc Bonferonni test was used to determine any significant
between-group differences in mean intake of each nutrient. The percentage contribution of breastmilk
and formula to total intake of energy and nutrients was determined for each group. Due to the
small numbers of children with inadequate intakes in some groups, those children who received any
formula whether in combination with breastmilk or not were collapsed into a single group for further
analysis. The proportion of children with inadequate or excessive intakes in each of these three milk
feeding group was then determined. Multivariate binary logistic regression, adjusting for maternal
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age, education and infant sex, was employed to determine the relationship of milk feeding group and
inadequate or excessive intakes of nutrients. A p-value of < 0.05 was considered to be statistically
significant for all analyses.
3. Results
Of the 1919 children who were mailed a food diary, 1165 had a completed 24 HDR interview
(61% response rate) and 844 had returned food diaries (44% response rate). Usable, complete 3 day
records were available for 832 children (43%). The participant flow chart is presented in Figure A1.
3.1. Participant Characteristics
Mothers who provided baseline data but did not provide complete dietary data at 12 months were
younger (p < 0.001), less educated (p < 0.001), more socially disadvantaged (p < 0.001) and more likely
to have been born outside of Australia (p < 0.001). However, due to the deliberate over-recruitment
of disadvantaged women into the SMILE study [17], women who provided complete dietary data
were generally representative of the socioeconomic profile reported by the Pregnancy Outcome Unit
for South Australian for births in 2013 with regards to parity and country of birth, but our sample
consisted of fewer younger (<25 years) and overweight or obese mothers [21] (Table S1).
The mean age of participant children was 13.1 ± 0.8 months and 54.7% were boys. In total,
118 children had implausible energy intakes (3 under-reporters and 115 over-reporters) and
those 714 children with plausible energy intakes represent the analysis population in this study.
The characteristics of mother-child dyads with and without plausible dietary data are presented in
Table 1. There was no significant association between over-reporting and any of the maternal or child
characteristics investigated, with the exception of milk feeding method.
Table 1. Characteristics of mother–child dyads with complete dietary data and of the subsets with
plausible and implausible energy intake.
Total Plausible Implausible
(n = 832) (n = 714) (n = 118)
Maternal characteristics n % n % n % p a
Maternal age at birth (years)
<25 74 8.9 62 8.7 12 10.3 0.583
25–29 259 31.2 227 31.9 32 27.4
≥30 496 59.8 423 59.4 73 62.4
Maternal education completed
School/vocational 358 43.4 310 43.7 48 41.0 0.585
Some university and above 468 56.7 399 56.3 69 59.0
IRSAD score b
Deciles 1–2 120 14.5 104 14.7 16 13.7 0.941
Deciles 3–4 175 21.2 147 20.7 28 23.9
Deciles 5–6 172 20.8 147 20.7 25 21.4
Deciles 7–8 161 19.5 140 19.7 21 17.9
Deciles 9–10 198 24.0 171 24.1 27 23.1
Mother’s country of birth
Australia and N. Zealand 613 74.1 519 73.1 94 80.3 0.061
Asia—other 57 6.9 35 4.8 5 1.7
India 50 6.0 47 6.6 3 2.6
China 36 4.4 34 3.2 2 6.8
UK 31 3.7 23 7.3 8 4.3
Other 40 4.8 35 4.7 5 4.3
Maternal BMI c (kg/m2)
<25 476 60.6 413 60.8 63 58.9 0.217
25–29.99 170 21.6 151 22.2 19 17.8
>30 140 17.8 115 16.9 25 23.4
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Table 1. Cont.
Total Plausible Implausible
(n = 832) (n = 714) (n = 118)
Parity
Primiparous 388 48.2 336 48.7 52 45.2 0.489
Multiparous 417 51.8 354 51.3 63 54.8
Child characteristics
Child age (mean SD) 13.1 0.8 13.1 0.8 13.0 0.7 0.660 d
Infant sex
Boy 455 54.7 395 55.3 60 50.8 0.366
Girl 377 45.3 319 44.7 58 49.2
Milk feeding method
Breastmilk 219 26.3 201 28.3 18 15.3 <0.001
Breastmilk and formula 68 8.2 59 8.3 9 7.6
Infant formula 314 37.7 275 38.5 39 33.1
Other 231 27.8 179 25.1 52 44.1
a Chi Square p value; b Index of Relative Socio-Economic Advantage and Disadvantage (IRSAD) where decile
1 = most disadvantaged and decile 10 = most advantaged; c Body Mass Index; d Independent t-test.
3.2. Nutrient Intake of Children
3.2.1. Comparison of Nutrient Intakes with Nutrient Reference Values
Overall, children had adequate daily intakes of energy, protein and micronutrients, with a few
notable exceptions (Table 2). Roughly one in ten children had intakes below the EAR for vitamin C
(14.0%), thiamin (14.4%) and calcium (12.6%), while just over two out of ten (22.5%) had intakes below
the EAR for iron (Figure 1). Conversely, 18.2% and 14.1% had intakes which exceeded the UL for
sodium and zinc (Figure 2), respectively. Dietary fibre intake was generally low in this group.
Figure 1. Frequency of intake of iron (n = 714) showing estimated average requirement (EAR = 4 mg)
and upper limit of intake (UL = 20 mg).
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Figure 2. Frequency of intake of zinc (n = 714) showing estimated average requirement (EAR = 2.5 mg)
and upper limit of intake (UL = 7 mg).
Table 2. Nutrient intakes of children a (mean age 13.1 months) and comparison with selected Nutrient
Reference Values for children aged 1–3 years.
Average Intake/Day Mean SD 25 75 EAR <EAR% UL >UL%
Total mass (kg) 1179 393 993 1322
Energy (kJ) 3803 714 3297 4378
Protein (g) 36 11 28 44 12.0 0.0
Total carbohydrate (g) 107 23 89 123
Sugar (g) 63 17 51 73
Total fat (g) 36 9 29 42
Saturated fat (g) 16.5 5.1 12.8 20.1
Polyunsaturated fat (g) 4.2 1.6 3.1 5.0
Monounsaturated fat (g) 12.3 3.4 10.0 14.3
Dietary fibre (g) 9.6 4.0 6.7 11.8
Water (g) 1013 386 809 1100
Sodium (mg) 725 324 487 916 1000 18.2
Potassium (mg) 1467 433 1171 1745
Calcium (mg) 650 235 481 812 360 12.6 2500 0.0
Phosphorous (mg) 736 229 573 888 380 6.3 3000 0.0
Magnesium (mg) 137 38 110 164 65 2.0
Iron (mg) 7.1 4.0 4.2 9.0 4 22.5 20 1.5
Zinc (mg) 5.4 1.5 4.4 6.4 2.5 2.2 7 14.1
Vitamin A RE b (μg) 726 492 487 851 210 0.4 NA c
Thiamin (mg) 0.8 0.5 0.5 1.0 0.4 14.4
Riboflavin (mg) 1.4 0.6 1.0 1.8 0.4 2.1
Niacin equivalents (mg) 16.6 5.5 12.8 19.8 5 0.0 NA d
Folate (μg) 321 130 226 404 120 3.1 NA d
Vitamin C (mg) 61 46 36 80 25 14.0
NA—not applicable. a Children with plausible energy intakes; b Retinol equivalents; c Upper limit refers to
vitamin A from retinol; d Upper limit refers to intake from supplements.
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3.2.2. Comparison of Nutrient Intakes by Milk Feeding Method
The majority of all 832 children were still receiving breastmilk (n = 334, 36%) and/or formula
(n = 374, 53%); only 26 children (4%) were consuming toddler formula. Of those with plausible
energy intakes, 260 children (36%) were consuming breastmilk and 334 children (47%) were consuming
formula. Children were categorized according to whether or not they consumed breastmilk and/or
formula and the mean intakes of energy, macronutrients and those micronutrient for which more than
10% of children had inadequate or excessive intakes were compared (Table 3). There were a number
of significant between-group differences for all nutrients but in general children who did not drink
either breastmilk and/or formula had significantly higher intakes of energy, protein, sodium, calcium
and a lower intake of vitamin C than the other groups. There was no significant difference in the
mean protein and energy intakes of those children in the breastmilk group compared with those in
the formula group, although formula made a greater contribution to the total protein (26% vs. 16%)
and energy intake (34% vs. 28%) of children than did breastmilk. Those children who drank only
breastmilk had significantly lower intakes of zinc than all other groups, while those children who
drank only formula had significantly higher intakes of calcium than those children who consumed
breastmilk either with or without formula, and significantly higher intakes of zinc and iron than all
other groups. Formula contributed 31% and 50% of the total iron intake in those who drank formula
with or without breastmilk, respectively.
3.3. Relationship of Milk Feeding Method and Adequacy of Selected Nutrients
Due to the small number of children with inadequate intakes in some groups, those children who
received any formula, whether in combination with breastmilk or not, were collapsed into a single
group. Those children who were in the breastmilk-only group were significantly more likely than
the other milk feeding groups to have intakes of calcium, iron, and thiamin below the EAR (Table 4).
Children who drank neither breastmilk nor formula were almost 10 times more likely (AOR 9.64, 95%
CI 5.27–17.62) than the breastmilk-only group to have intakes of vitamin C below the EAR, but children
who drank formula were less likely (AOR 0.23, 95% CI 0.09–0.59) to have inadequate vitamin C intakes.
Almost half (48.8%) of the children in the breastmilk-only group had iron intakes below the EAR while
children who consumed formula were less likely (AOR 0.04, 95% CI 0.02–0.07) to have inadequate iron
intakes than those who drank breastmilk. Conversely, children in the breastmilk-only group were less
likely than all other groups to have intakes of zinc above the UL and less likely than the group that
drank neither breastmilk nor formula to have sodium intakes above the UL.
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4. Discussion
In this study we have described the diets of a cohort of Australian toddlers aged approximately
1 year, an age by which they should have transitioned predominantly to family foods. More than one
half and one third of children continued to consume formula or breastmilk, respectively. These ‘milks’
contributed up to roughly one third of their total energy intake and one quarter of their protein intake
when consumed either alone or in combination. A relatively high prevalence of formula feeding
(32%) has been reported in another Australian cohort of slightly older toddlers (12–16 months) [9]
and 38% of children aged 12–18 months in the UK-based DNSIYC were receiving formula of some
kind [14]. The higher prevalence of formula use in our study can be attributed to the younger age of
this birth cohort, which had a mean age of 13.1 months at the time that dietary intake was assessed.
The Australian Infant Feeding Guidelines (AIFG) encourage the continuation of breastfeeding beyond
the first year of life, and while it is recommended that cow’s milk not be given as a main drink to
infants under the age of 12 months, this restriction is lifted once children enter their second year of life.
Furthermore, the AIFG specifically state that “special complementary foods or milks for toddlers are
not required for healthy children” [1] (p. 89).
It is unclear why contemporary Australian mothers continue to feed their children formula
beyond 12 months of age. However, the advertising of toddler formulas has become increasingly
prevalent [22] since Australia became a signatory to the International Code of Marketing of Breastmilk
Substitutes (WHA 34.22 1981) which prohibits the advertising of infant formulas. With both products
sharing common visual packaging elements such as colour, shape, typeface and logo, toddler milk
advertisements appear to function as de facto infant formula advertisements with most women not
being able distinguish between toddler and infant formulas and referring to both as ‘formula’ [23,24].
While most toddlers in this study were still consuming ‘infant’ versions of formula the advertising of
toddler formula may have promulgated the perception amongst mothers that formulas of any kind
are beneficial to the health of toddlers and are essential to meet the needs of developing toddlers that
cannot be met by cow’s milk and family foods.
In general, toddlers in this study consumed diets that either met or exceeded their nutritional
requirements, with relatively small numbers failing to meet the EAR for any nutrient. A notable
exception was our finding that roughly one in five toddlers consumed diets below the EAR of 4 mg/day
for iron [16] which placed them at risk of iron deficiency. This is consistent with the findings of a recent
Australian study of slightly older toddlers (mean age: 19.6 months) which reported a similar mean iron
intake of 6.6 mg/day and that 18.6% of toddlers had inadequate iron intakes [8]. Comparison with
international studies is difficult due to differences in the nutrient recommendations between countries
and methodological differences in the way in which dietary data are collected. Nevertheless, just over
one in 10 (13%) of UK children aged 12–18 months had iron intakes below the Lower Recommended
Nutrient Intake (LRNI) of 3.7 mg/day [25]. When this slightly lower cut point was applied to our
data, 17.8% of the SMILE cohort had intakes below the UK LRNI for iron. In comparison, less than
1% of toddlers aged 12 to 23 months in the US Feeding Infants and Toddlers Survey (FITS) reportedly
consumed diets below the EAR for iron, which for the USA is set lower, at 3 mg/day for this age
group [13]. Nevertheless, when the USA cut-off point was used, 8.3% of the SMILE cohort had an
average daily iron intake below this level, which remains appreciably higher than that reported in
the FITS.
Children in this study who consumed formula, either with or without breastmilk, were unlikely
to have inadequate iron intakes. Conn et al. reported a significant difference in the average daily
iron intake of breastfed and non-breastfed infants in a younger cohort of children aged 9 months
(6.3 mg/day vs. 11.9 mg/day, p < 0.001) [7]. Infant formulas are required by law to be fortified with
iron, and in our study toddlers consuming formula either in combination with breastmilk or alone
received one third to one half of their iron from formula, respectively. On the other hand, while the
iron in breastmilk is highly absorbable, the overall levels are low [26] and breastmilk contributed only
3% of the total iron intake in those who were breastfed and not consuming formula. The Euro-Growth
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study investigated the determinants of iron status in 12-month-old infants and reported that the most
important factor positively associated with iron status was the duration of feeding of iron-fortified
formula [27].
Foods that children transition to are often poor sources of iron or they may consume low amounts
of those foods which are rich in iron [9]. For instance, Byrne et al. reported that the median intake of
meat and alternatives amongst a group of Australian toddlers aged 12–16 months was 56 g/day and
one quarter had intakes of 28 g/day or less, which is well below the recommended daily intake for
this age group of a single 65 g serve of this food group [28]. A low intake of this food group, which
is the primary source of iron in the diets of toddlers, is likely to be more of an issue for breastfed
toddlers than those who continue to consume appreciable amounts of either infant or toddler formula.
Almost one half of children who were breastfed and not consuming formula and one third of children
who were not consuming either formula or breastmilk had iron intakes below the EAR, compared with
less than 5% of children consuming formula.
While roughly one in ten of all children had calcium and thiamin intakes below the EAR,
almost one third of children who were breastfed without receiving formula failed to meet the EAR
for both these nutrients. Children from the other milk feeding groups were significantly less likely
than those in the breastfed only group to fail to meet the EAR for calcium and thiamin. As with iron,
formula contributed a larger proportion of the overall intake of both calcium (50%) and thiamin (36%)
in the formula only group than did breastmilk (28% and 11%, respectively) in the breastmilk-only
group. This finding is partly explained by the fact that the formula group consumed on average more
formula (443 g) than the breastmilk group consumed breastmilk (352 g), and that formula is typically
fortified with vitamins and minerals at levels which exceed the highly variable levels of these nutrients
found in breastmilk.
The primary limitations of this study are that usual intake of nutrients was estimated by summing
and averaging the three days of intake, though this method does not adjust for the day-to-day
variability in intake within individuals, which can be achieved with the use of specialist software that
was not available to the researchers [29]. Nevertheless, this method is likely to provide more reliable
estimates of usual nutrient intake than estimates derived from a single 24 h recall. While less than half
of the mothers returned complete dietary data on the intake of their child, the deliberate oversampling
of participants from disadvantaged groups means that the sample of women and children in this study
are generally representative of the population from which they were drawn.
5. Conclusions
This is one of the first studies to report the contribution of breastmilk and formula to the diets
of Australian children as they transition to family foods at the beginning of their second year of
life. While the majority of children had intakes which met or exceeded their nutrient requirements,
those children who consumed breastmilk only as their milk feed were at greater risk of having
intakes below the EAR for iron, calcium and thiamin. This finding should, however, be interpreted
with caution and women should continue to be encouraged to breastfeed their children beyond
12 months of age. However, it is possible that breastfeeding mothers may have a misplaced faith in the
nutritional superiority of breastmilk over formula and cow’s milk as they transition to the family meal.
All mothers, regardless of the milk they feed their child, must be educated and encouraged to feed
their infant a varied and high-quality diet with adequate serves of the core food groups. In particular,
health professionals should advise mothers of the importance of incorporating iron- and calcium-rich
complementary foods into their child’s diets, both of which are important nutrients required for
adequate growth and development of toddlers.
Supplementary Materials: The following is available online at http://www.mdpi.com/2072-6643/8/8/501/s1:
Table S1 Comparison of characteristics of participants and non-participants and South Australian pregnancy
outcome data for 2013.
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Abstract: Background: The 2010 World Health Organisation (WHO) Infant and Young Child Feeding
(IYCF) indicators are useful for monitoring feeding practices. Methods: A total sample of 300 subjects
aged 6 to 23 months was recruited from urban suburbs of Kuala Lumpur and Putrajaya. Compliance with
each IYCF indicator was computed according to WHO recommendations. Dietary intake based on
two-day weighed food records was obtained from a sub-group (N = 119) of the total sample. The mean
adequacy ratio (MAR) value was computed as an overall measure of dietary intake adequacy.
Contributions of core IYCF indicators to MAR were determined by multinomial logistic regression.
Results: Generally, the subjects showed high compliance for (i) timely introduction of complementary
foods at 6 to 8 months (97.9%); (ii) minimum meal frequency among non-breastfed children aged
6 to 23 months (95.2%); (iii) consumption of iron-rich foods at 6 to 23 months (92.3%); and minimum
dietary diversity (78.0%). While relatively high proportions achieved the recommended intake levels
for protein (87.4%) and iron (71.4%), lower proportions attained the recommendations for calcium
(56.3%) and energy (56.3%). The intake of micronutrients was generally poor. The minimum dietary
diversity had the greatest contribution to MAR (95% CI: 3.09, 39.87) (p = 0.000) among the core IYCF
indicators. Conclusion: Malaysian urban infants and toddlers showed moderate to high compliance
with WHO IYCF indicators. The robustness of the analytical approach in this study in quantifying
contributions of IYCF indicators to MAR should be further investigated.
Keywords: infant and young child feeding; dietary adequacy; core complementary feeding indicators;
micronutrients; dietary diversity
1. Introduction
Culture- and age-appropriate infant and young child feeding (IYCF) practices are well recognized as
imperative for child health and survival. In 2008, the World Health Organization (WHO) recommended
a set of population-level breastfeeding practices and food-related aspects of child feeding practices
appropriate for children aged 6 to 23 months [1]. The questionnaire comprises eight core indicators and
seven optional indicators of feeding practices, and offers the advantage of inter-country comparisons of
IYCF practices.
In examining indicators of infant and young child feeding practices using data from Demographic
and Health Surveys (DHS) of 46 countries between 2002 and 2008, Lutter et al. [2] reported that: (i) few
infants and young children benefited from optimal complementary feeding practices; and (ii) less than
one-third and only 21% of children aged 6 to 23 months met the minimum criteria for dietary diversity
and received a minimum acceptable diet, respectively. Based on India’s National Family Health Survey
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(2005–2006), involving over 18,000 children aged zero to 23.9 months, Menon et al. [3] reported overall
poor status of IYCF practices, especially indicators for complementary feeding, with 16% and 9%
complying with minimum dietary diversity and minimum acceptable diet, respectively. A similar
finding was reported by Marriot et al. [4], in assessing the WHO IYCF indicators of 14 low-income countries
in Africa and Asia. The mean minimum dietary diversity adherence was found low, ranging from 11.3%
for ages 6 to 11 months to 25.1% among those aged 18–23 months. The low prevalence of dietary diversity
was reflected in poor compliance with minimum acceptable diet which was only 7.7% for infants 6 to
11 months of age and 16.3% for those aged 18–23 months. These recent reviews indicate room for
improvement in young child feeding practices in low- to middle-income countries.
The International Life Sciences Institute of Southeast Asia region (ILSI SEA) Expert Panel on
Infant and Young Child Nutrition, at its meeting in 2012, highlighted the importance for the region to
undertake country-specific assessment of the IYCF indicators in association with measured dietary
intakes and nutritional status of infants and young children [5]. In this respect, Cambodia, Indonesia,
Philippines and Vietnam have periodic updates on IYCF practices, as reported by Demographic and
Health Surveys (DHS) and/or Multiple Indicator Cluster Surveys (MICS) for these countries.
Malaysia is not covered by either the DHS or MICs, and relies instead on its National Health
and Morbidity Surveys (NHMS) for IYCF data, such as the Third NHMS undertaken in 2006 [6] and
the just-completed 2016 NHMS. There are concerns for inadequate feeding practices in Malaysia
in view of recent findings of rather high prevalence of stunting and underweight among young
children. Stunting among urban children nationwide was reported at 23.9% in ages 0.5–0.9 years [7],
and underweight was reported at 19.6% among children aged 0–4 years [8]. Over-reliance on milk,
leading to a lack of dietary diversity, was reported among Malaysian urban children aged one to three
years [9]. Hence, this study was undertaken to assess the quality of young child feeding practices and
dietary intake adequacy in a sample of infants and toddlers.
2. Methodology
This cross-sectional study was undertaken with the following objectives:
2.1. Objectives
1. To estimate the prevalence of compliance with the WHO IYCF indicators in a total sample of
300 infants and toddlers aged 6.0–23.9 months;
2. To determine dietary intake using a two-day weighed food records of a sub-group of infants and
toddlers (N = 119), matched for age and sex with the total sample, with dietary intake adequacy
computed as the mean adequacy ratio (MAR);
3. To determine the contributions of the WHO core complementary feeding indicators to the MAR
values of the sub-group of subjects.
2.2. Subjects
The inclusion criteria for the selection of the study subjects were:
• Infants and children aged 6.0 to 23.9 months
• Malay ethnicity
• Families residing in the urban suburbs of Kuala Lumpur and Putrajaya
• Subjects attending licensed child care centers (registered with the Social Welfare Department
of the Ministry of Women, Family and Community Development (Licensed child care centers
are obliged to adhere to government regulations including caregiver to child ratio, standards of
hygiene and menu guidelines.))
• Consent of the child care center management and parents/caregivers
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The exclusion criteria were:
• Mentally or physically disabled infants and children
• Ill at the time of data collection
• Having dietary restrictions
The rationale for including only Malay infants and children of families from urban areas is to
minimize the influence of cultural and socio-economic factors on feeding practices of infants and
toddlers. Malay is the predominant ethnicity of the Malaysian population.
2.3. Total Sample Size for Determining Compliance with IYCF Indicators
The total sample size was estimated according to the guidelines of the WHO “Indicators for
assessing infant and young child feeding practices [1] (Part 2 Measurements). Based on assuming
an indicator estimate of 50% and a 95% confidence interval, a minimum number of 225 infants and
young children aged 6.0–23.9 months was recommended. It was decided to have a total sample size
of 300 subjects in case of dropouts and incomplete questionnaires. Data collection was carried out
in 2013–2014.
A list of the licensed child care centers was compiled from various sources including the
Association of Registered Care Providers of Selangor and the Ministry of Health Nutrition Division.
The child care centers were contacted through emails and phone calls. Out of approximately 100 centers,
about one-fifth gave permission for the conduct of this study. Using the snow-ball approach in going
from one center to the next, approximately 100 infants and children who met the inclusion criteria
were recruited for each of these age groups: 6.0–11.9 months, 12.0–17.9 months and 18.0–23.9 months,
with almost an equal proportion of males and females in each age group. As the participants were
recruited by convenience sampling, they are not deemed as representative of urban Malay toddlers.
The WHO IYCF indicators questionnaire was translated to the Malay language and pretested
before use on five Malay mothers. This is to improve the language, technical contents and length of
time used for the interview. Calculation for compliance with each IYCF indicator was in accordance
with the formula recommended by WHO [1] (Part 2 Measurements).
2.4. Sub-Group of Toddlers for Two-Day Weighed Food Records and Compliance with Core Complementary Feeding
Only a sub-group of subjects was included for the two-day weighed food records part of the study,
given that weighing of food intake was time-consuming. The sub-group of subjects was matched for
age and sex to the total sample. In this way, the sub-sample comprised approximately 40 subjects in
each of the three age groups of 6.0–11.9 months, 12.0–17.9 months and 18.0–23.9 months, making a total
of 120 subjects. This age disaggregation is in accordance with the recommendation for studying the
core complementary feeding indicators [1]. Each of the age groups consisted of approximately an equal
proportion of male and female subjects. At the end, 119 subjects were included as one questionnaire
was found to be incomplete.
Trained research assistants with at least a bachelor-level qualification in nutrition or dietetics
carried out the weighing of food intake for two days when the child was in the center from about 7 a.m.
until 5 p.m., Monday to Friday. All foods consumed were weighed for two consecutive weekdays but
not on a weekend, as the day care centers are closed during the weekends.
For solid or semi-solid foods, the research assistants prepared a duplicate plate of the food items
that were given to the child. The individual items were weighed using a kitchen scale that has a weight
capacity of 2 kg and a weight graduation of 1 gm (TANITA-KD160WH). The amounts not consumed
by the child were deducted from the total amounts weighed. The research assistants checked for
ingredients used in preparing the food items by asking the center manager or person who prepared
the foods or beverages.
For recording food and beverages consumed by children who were fed individually by the center
helpers, the research assistants first identified the ingredients used in preparing the food or beverage,
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and then estimated the amounts of the food/beverage consumed by the child, based on the serving
spoon or cup. As the entire procedure of observation, weighing and calculation for each child was
time-consuming, a research assistant could complete the procedure for only three to four subjects a day,
on average.
Parents/caregivers were instructed to record foods and beverages, in terms of description and
quantity, taken by their child from the time he/she was picked up from the child care center until the
following morning when the child was brought back to the center. The research assistants checked the
forms and sought clarifications from parents/care givers, particularly for the quantities and types of
constituents in the food or beverage consumed at home or outside.
3. Statistical Analyses
Compliance with the IYCF indicators was reported in percentage. Dietary intake was computed
in terms of percentage of meeting the Malaysian dietary recommendations (Recommended Nutrient
Intakes (RNIs) [10]. The mean adequacy ratio (MAR) was used as an overall measure of dietary
adequacy. Several studies have reported MAR values to be positively associated with other indexes of
dietary quality [4,11]. In order to compute MAR, one has to calculate first the nutrient adequacy ratio
(NAR), which is defined as the ratio of a subject’s nutrient intake to the recommended nutrient intake
(RNI) of the assessed nutrient, appropriate for the age and sex of the subject.
NAR = Actual nutrient intake (per day)/Recommended nutrient intake (RNI) (1)
The value for MAR is calculated as the total of all the NARs divided by the total expressed as
a percentage. MAR has a range from 0% to 100% with 100% as the ideal [12].
MAR = ∑ NARs/Total number of nutrients (2)
For computing MAR, each of the NARs was truncated as 1, so that a high intake of one nutrient
could not compensate for the low intake of another nutrient, as originally conceived by Malden et al. [13]
and cited by Vieux et al. [14].
Multinomial logistic regression was used to assess the odds of compliance with the core
complementary feeding indicators as the nominal independent variable, and MAR values as the
dependent variable. All analyses were performed with SPSS version 22.0 (SPSS Inc., Chicago, IL, USA).
A level of <0.05 was set for statistical significance.
Ethics Approval and Consent
The study proposal was approved by the Joint Committee on Research and Ethics of the International
Medical University, Kuala Lumpur, Malaysia on 23 September 2013. (Project ID No. IMU R 123/2013).
The Study Information Sheet and Written Consent Form in the Malay and English language were
also approved by the IMU ethics committee. The Study Information Sheet comprised the following
information: What is the purpose of this research? Why you are invited to this research? What is
involved in this research? Is there any danger? How does this research help me? Contact persons for
further information. After we had explained the information to the parents, one of them signed the
Written Consent Form allowing their child to participate in the study.
4. Results
4.1. Total Sample Compliance with IYCF Indicators (N = 300)
The total sample size of 300 children consisted of 105 subjects aged 6.0–11.9 months, 87 aged
12.0–17.9 months, and 98 aged 18.0–23.9 months, with about an equal proportion of male and female
subjects in each age group. These children were from young families with mothers having an average
age of 30.9 ± 0.3 years, and with 1.4 ± 0.1 of children aged three years or less per family, on average.
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Out of the WHO set of 15 IYCF indicators, data was collected for 12 indicators only, as the
other three indicators referred to feeding practices for infants aged from zero to under 6 months,
whereas these study subjects were aged 6.0–23.9 months. The subjects showed high compliance for
several of the assessed indicators, namely (i) Children ever breastfed (99.3%); (ii) Timely introduction
of complementary foods at 6–8 months (97.9%); (iii) Minimum meal frequency among non-breastfed
children aged 6–23 months (95.2%); and (iv) Consumption of iron-rich foods at 6–23 months (92.3%)
(Table 1). In contrast, the other indicators were achieved by relatively lower proportions of the
subjects, and these include indicators related to breastfeeding beyond 6 months of age: (i) Continued
breastfeeding at 2 years (38.3%); (ii) Continued breastfeeding at 1 year (57.1%); and (iii) Age-appropriate
breastfeeding among children aged 6–23 months receiving breast milk as well as solids in the previous
day (55.9%).
The minimum acceptable diet indicator was also found to have relatively low compliance among
the non-breastfed children (39.5%) and breastfed children (50.6%). The minimum acceptable diet
indicator combines compliance with the minimum dietary diversity and minimum meal frequency
indicators. Actually, the subjects showed quite high compliance with meeting the latter two indicators
separately, which is 78% for minimum dietary diversity, and 95.2% and 69.3% for minimum meal
frequency among non-breastfed and breastfed children, respectively. However, in computing the
minimum acceptable diet indicator for non-breastfed subjects, the formula includes the criteria of
receiving two milk feeds, in addition to meeting the criteria for dietary diversity and meal frequency;
moreover, the dairy group is excluded when calculating dietary diversity to avoid “double counting” [1]
(WHO Part 2 Measurements). Consequently, the acceptable diet formula becomes more stringent to
attain, resulting in a relatively lower prevalence of compliance among the non-breastfed.
Table 1. Compliance (%) with WHO IYCF indicators [1] (WHO, 2010) by total sample (N = 300).
Core Indicators % (N) *
1. Early initiation of breastfeeding
Proportion of children born in the last 24 months who were put to the breast
within one hour of birth 76.3 (300)
2. Exclusive breastfeeding under 6 months -
3. Continued breastfeeding at 1 year
Proportion of children aged 12–15 months who are fed breast milk during
the previous day 57.1 (56)
4. Timely introduction of solid, semi-solid or soft foods
Proportion of infants aged 6–8 months who receive solid, semi-solid or soft
foods during the previous day 97.9 (47)
5. Minimum dietary diversity
Proportion of children aged 6–23 months who received foods from 4 or more
food groups during the previous day 78.0 (300)
6. Minimum meal frequency
Breastfed children: Proportion of breastfed children aged 6–23 months who
received solid, semi-solid, or soft foods the minimum number of times or
more during the previous day 69.3 (163)
Non-breastfed children: Proportion of children aged 6–23 months who received
solid, semi-solid or soft foods or milk feeds the minimum number of times or
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Table 1. Cont.
7. Minimum acceptable diet
Breastfed children: Proportion of children aged 6–23 months who had at least
a minimum dietary diversity and the minimum meal frequency during the
previous day
50.6 (166)
Non-breastfed children: Proportion of children aged 6–23 months who received
at least 2 milk feedings and had at least the minimum dietary diversity and the
minimum meal frequency during the previous day
39.5 (129)
Total: 45.8 (295)
8. Consumption of iron-rich or iron-fortified foods
Proportion of children aged 6–23 months who receive an iron-rich food or
iron-fortified food that is specially designed for infants and young children,
or that is fortified in the home during the previous day
92.3 (298)
Optional Indicators
9. Children ever breastfed
Proportion of children born in the last 24 months who were ever breastfed 99.3 (300)
10. Continued breastfeeding at 2 years
Proportion of children aged 20–23 months who received breast milk
during the previous day 38.3 (47)
11. Age-appropriate breastfeeding -
Proportion of children aged 6–23 months who received breast milk,
as well as solid, semi-solid or soft foods during the previous day 55.9 (161)
12. Predominant breastfeeding under 6 months (0–5.9 months) -
13. Duration of breastfeeding (0–5.9 months) -
14. Bottle feeding
Proportion of children aged 0–23 months who are fed with a bottle during the
previous day 80.4 (296) **
15. Milk feeding frequency for non-breastfed children
Proportion of non-breastfed children 6–23 months of age who received at least
2 milk feedings during the previous day 91.3 (127)
* Number of eligible subjects; ** Age studied 6.0–23.9 months.
4.2. Compliance with Core Complementary Feeding Indicators by Sub-Group (N = 119)
Compliance with four of the five core indicators for complementary feeding was investigated
among the sub-group of subjects, as only a small number (N = 13) of subjects (aged 6 to 8 months) was
eligible for computing the indicator on “Timely introduction of solids“, which was hence excluded.
The sub-group showed generally high compliance with the core complementary feeding indicators
(Table 2). There was high compliance with (i) Timely introduction of solid, semi-solid or soft foods
(92.3%); (ii) Consumption of iron-rich foods (92.4%); (iii) Minimum meal frequency among both
breastfed and non-breastfed children aged 6–23 months (91.7% and 85.5%, respectively); as well as
(iv) Minimum dietary diversity (83.2%). A low prevalence for the minimum acceptable diet indicator
for non-breastfed (34.6%) and breastfed (68.8%) infants was recorded for the sub-group.
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Table 2. Compliance (%) with WHO core complementary feeding indicators by sub-group (N = 119).
* Core Complementary Feeding Indicators Compliance% (N)







Consumption of iron-rich or iron-fortified foods 92.4 (119)
* Timely introduction of solid, semi-solid or soft foods indicator was excluded owing to the small number of
subjects who were eligible (N = 13 aged 6 to 8 months).
4.3. Dietary Intake Adequacy of Sub-Group (N = 119)
Based on the two-day weighed food intake, dietary intake adequacy was computed and described
as meeting the Malaysian recommendations for energy and nutrient intake (RNI) [10]. The nutrient
adequacy ratio (NAR) value exceeded 1.0 for energy, protein, calcium and iron, indicating that their
intakes achieved more than 100% of the recommended levels (RNIs) (Table 3). Mean iron and protein
intake were double the RNI recommendation levels, while those for energy and calcium exceeded 100%.
The likely dietary sources for these nutrients were animal food including milk, chicken meat, fish and
eggs. As for the NAR values for the rest of the nutrients, they ranged from 0.50 for vitamin A to 0.84 for
zinc, denoting intake of these nutrients met 50% to 84% of the RNIs, respectively. Relatively high
proportions of the subjects achieved the RNI for protein (87.4%) and iron (71.4%), while just over half
managed to do so for calcium (56.3%) and energy (56.3%). The proportions of the subjects meeting the
rest of the micronutrients were low and these include vitamin A, thiamin, vitamin C niacin, riboflavin
and zinc. This finding suggests that the subjects were not consuming sufficient vegetables, fruits,
legumes and whole grains.
Table 3. Energy and nutrient intake adequacy (N = 119).
Dietary Intake †
Percentage of the Recommended
Nutrient Intake (RNI) Achieved % ± SD
a Nutrient Adequacy Ratio
(NAR) Value Mean ± SE
energy 110.7 ± 49.2 1.14 ± 0.05
protein 202.8 ± 101.9 2.07 ± 0.10
calcium 127.5 ± 92.6 1.32 ± 0.10
iron b 216.7 ± 181.2 2.44 ± 0.21
zinc 75.7 ± 70.2 0.84 ± 0.10
thiamin 47.6 ± 34.6 0.55 ± 0.06
riboflavin 76.0 ± 51.5 0.82 ± 0.06
niacin 66.5 ± 53.5 0.77 ± 0.07
vitamin C 41.5 ± 39.7 0.57 ± 0.07
vitamin A 42.2 ± 39.6 0.50 ± 0.06
c Mean adequacy ratio (MAR) 0.67 ± 0.02
† based on two-day weighed food record; a NAR for a given nutrient is the ratio of a subject’s nutrient intake to
the recommended nutrient intake of the assessed nutrient, appropriate for the age and sex of the subject; b based
on 15% bioavailability; c Mean adequacy ratio (MAR) was calculated as the total of all the NARs (∑ NAR for
energy and nine nutrients) divided by the total, expressed as a percentage.
For this study, it was arbitrarily decided to compute NAR for energy and nutrients taken by the
subjects that met at least 40% of the Malaysian RNIs. Hence, NAR was determined for energy and
the following nine nutrients: protein, calcium, iron, zinc, vitamin A, vitamin C, thiamin, riboflavin
and niacin. The value for MAR was then calculated as ∑ NARs divided by the total (10 in this case)
expressed as a percentage.
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Overall, the mean adequacy ratio (MAR) value computed was 0.67, indicating that the dietary
intake of the subjects met, on average, 67% of the combined RNIs for energy and the nine nutrients
under consideration in this study.
4.4. Contributions of Core Complementary Feeding Indicators to Dietary Intake Adequacy (N = 119)
Multinomial logistic regression was used to determine the contributions of the four WHO core
complementary feeding indicators as the independent variables to dietary intake adequacy based
on MAR values as the dependent variables. Since MAR = 0.67 was generated from the weighed
dietary intake in this study, MAR > 0.6 was selected for comparison with MAR ≤ 0.5. Among the
core complementary feeding indicators, minimum dietary diversity contributed highest to dietary
intake adequacy (OR 11.10; 95% CI: 3.09, 39.87) (p = 0.000) (Table 4). The other core complementary
feeding indicators showed lower odds of contributing to intake adequacy for the same MAR values.
The minimum dietary diversity indicator also showed the highest odds of leading to dietary intake
adequacy (OR 5.49; 95% CI: 1.35, 22.22) (p = 0.017) with MAR set at a lower level of (0.5 < MAR ≤ 0.6)
that is, overall dietary adequacy between 50.1% and 60% (Table 4). Hence, these results suggest that,
for this sample of Malaysian urban toddlers, compliance with minimum dietary diversity is of key
importance towards attaining dietary intake adequacy.
Table 4. Contributions of WHO core complementary feeding indicators to dietary intake adequacy
(N = 119) †.
Dietary Intake Adequacy
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Above results generated using multinomial logistic regression whereby the reference category is MAR ≤ 0.5;
† Dietary adequacy defined as meeting the combined RNIs for energy and nine nutrients (protein, calcium,
iron, zinc, vitamin A, vitamin C, thiamin, riboflavin and niacin); NAR = 10 Nutrient adequacy ratio (NAR) for
a given nutrient is the ratio of a subject’s intake to the current recommended nutrient intake of the assessed
nutrient, appropriate for the age and sex of the subject. Mean adequacy ratio (MAR) is the total of all the NARs
(∑ NAR for energy and nine nutrients) divided by the 10, expressed as a percentage; 0.5 < a MAR ≤ 0.6: meeting
between 50.1% to 60.0% of the combined RNIs for the 10 NARs; b MAR > 0.6: meeting more than 60% of the
combined RNIs for the 10 NARs.
5. Discussion
In a sample of urban Malaysian infants and toddlers aged 6 to 23 months, this study highlighted
(i) moderate rates of continued breastfeeding beyond 6 months of age; (ii) high proportions of
compliance with timely introduction of complementary foods and receiving iron-rich foods; and
(iii) moderate to low proportions met the acceptable diet indicator (minimum dietary diversity and
minimum meal frequency). Achieving the indicator on acceptable diet is important as it reflects
compliance with both the qualitative and quantitative aspects of complementary feeding. Studies have
well documented the significant relationships between attaining a minimum acceptable diet and child
nutritional status. In assessing the WHO IYCF indicators of 14 low-income countries in Africa and
Asia, Marriot et al. [4] found children consuming a minimum acceptable diet had a significantly lower
overall probability of being underweight and stunted. Based on India’s National Family Health Survey
(2005–2006), involving over 18,000 children aged zero to 23.9 months, Menon et al. [3] showed the
acceptable diet indicator as a strong predictor of stunting and underweight.
Dietary intake adequacy in terms of MARs was shown to be influenced most by the minimum
dietary diversity indicator. This finding is in line with growing global evidence of the usefulness
of dietary diversity in predicting dietary quality, including micronutrient intake adequacy among
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infants and young children [12,15–17]. In evaluating cross-country patterns based on DHS data,
Jones et al. [18] reported that achieving minimum dietary diversity reduced the odds of stunting
among children in India, Bangladesh and Zambia. Data from the 2007 Bangladesh Demographic and
Health Survey of 1508 children aged 6 to 23 months also showed that those who achieved minimum
dietary diversity had a significantly higher height for their age [19]. Nguyen et al. [20] reported
a strong positive association between maternal and child dietary diversity in Bangladesh, Vietnam and
Ethiopia, and hence advocated the measurement of both maternal and child dietary diversity. A low
dietary diversity score was significantly associated with poor nutritional status of indigenous children
in Malaysia [21]. A lack of dietary diversity is often reported in low-income populations as their
diets are predominantly based on starchy staples, as animal food sources are costly and may not be
readily available.
Countries are encouraged to conduct periodic surveys using the WHO IYCF indicators to
enable comparing trends of breastfeeding and complementary feeding practices within countries
and among countries, as well as for identifying populations at risk and evaluating the impacts of
interventions [18]. Countries in Southeast Asia generally showed higher compliance with timely
introduction of complementary foods than that for dietary diversity, meal frequency and acceptable
diet (Table 5). These findings suggest that complementary foods are provided in a timely manner,
but the diets tend to lack variety and frequency as recommended. Hence, owing to low achievements
of dietary diversity and meal frequency, compliance with a minimum acceptable diet is generally low
in the region.
Table 5. Comparison of WHO IYCF practices among countries in Southeast Asia *.












Timely introduction of complementary foods 82 91.0 89 90.7 97.9
Minimum dietary diversity 48.0 58.2 78.7 76.9 78.0
Minimum meal frequency
breastfed
Non-breastfed 74.0 61.4 80.7 69.3
Total 68.0 78.7 48.2 90.5 95.2
Minimum acceptable diet
breastfed 32.0 34.2 68.2 62.4 50.6
Non-breastfed 26.0 43.0 40.5 54.5 39.5
Consumption of iron-rich/iron-fortified foods 75.8 67.5 78.3 92.3
* Cambodia, Indonesia, Philippines and Vietnam covered by Demographic and Health Surveys (DHS) or
Multiple Indicators Cluster Surveys (MICS) [22–25]; ** N = 300.
Limitations of Study
The relatively small sample size and the homogeneous subjects preclude generalizing the results to
other socio-economic and ethnic population groups of Malaysia. As a cross-section study, interpretation
of causality of the data is restricted. The accuracy of the results is also limited by the methods of data
collection, particularly relying on weighing of foods and food intake recording by parents/caregivers.
There may be bias in the selection of subjects using the convenient snow-ball approach. The dietary
results obtained should not be extended to children who do not attend licensed day care centers where
the menus are based on the recommendations of the Ministry of Health.
6. Conclusions
Continued efforts remain essential for improving feeding practices to ensure adequate and quality
complementary feeding in Malaysia and the region. This study provides an analytic approach at
examining the contributions of core complementary feeding indicators to dietary intake adequacy.
This approach should be validated with larger subject samples from different socio-economic statuses
to verify its usefulness at different population levels.
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Abstract: Little is known about the dietary patterns of Asian infants in the first year of life, nor of
their associations with maternal socio-demographic factors. Based on the Growing Up in Singapore
towards healthy Outcomes (GUSTO) mother-offspring cohort, cross-sectional dietary patterns were
derived by factor analysis using 24-h recalls and food diaries of infants at 6-, 9- and 12-months of age.
Dietary pattern trajectories were modeled by mapping similar dietary patterns across each age using
multilevel mixed models. Associations with maternal socio-demographic variables, collected through
questionnaires during pregnancy, were assessed using general linear models. In n = 486 infants, four
dietary pattern trajectories were established from 6- to 12-months. Predominantly breastmilk: mainly
breastmilk and less formula milk, Guidelines: rice porridge, vegetables, fruits and low-fat fish and
meat, Easy-to-prepare foods: infant cereals, juices, cakes and biscuits and Noodles (in soup) and seafood:
noodle and common accompaniments. In adjusted models, higher maternal education attainment
was correlated with higher start scores on Predominantly breastmilk, but lowest education attainment
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increased its adherence over time. Older mothers had higher start scores on Easy-to-prepare foods,
but younger mothers had increased adherence over time. Chinese mothers had higher start scores
on Predominantly breastmilk but greater adherence to Guidelines over time, while Indian mothers had
higher start scores on Easy-to-prepare foods but greater adherence to Predominantly breastmilk with time
(p < 0.05 for all). Changes in trajectories over time were small. Hence, dietary patterns established
during weaning are strongly influenced by maternal socio-demographic factors and remain stable
over the first year of life.
Keywords: infant dietary patterns; dietary pattern trajectories; first year of life; Asian; factor analysis;
multilevel mixed models
1. Introduction
Tracking of eating habits through childhood and into adulthood has been observed in different
populations [1–4], demonstrating the value of healthful dietary patterns early in life in setting the
foundation for life-long eating habits [5]. Thus, besides ensuring an adequate supply of key nutrients
and calories to achieve optimal growth, development and health during infancy, the establishment of
healthful dietary patterns is also critical.
The importance of healthful dietary patterns during infancy is further supported by recent studies
demonstrating associations in infant dietary patterns with growth [6–8] and cognitive outcomes [9,10].
For example, Health conscious and Family foods dietary patterns, comprising mainly family table foods,
at 9-months of age have been related to lower body mass index (BMI) at the same time point [8],
while Discretionary dietary pattern trajectories, comprising finger foods that are convenient to prepare,
from 6 to 24-months appeared have been associated with lower IQ in adolescence [11]. Most of these
studies, however, have examined infancy dietary patterns in Caucasian populations and less is known
about dietary patterns in Asian infants.
The influence of maternal socio-demographic factors in shaping infancy dietary patterns is widely
recognized. Dietary patterns that adhere to infant feeding guidelines are often adopted by mothers
with higher educational levels [6,7,12–17], lower BMI [12–14], higher household income [7,14,15] and
who are multiparous [8,12,14,17,18]. In contrast, unhealthy infant dietary patterns [19] are associated
with younger mothers [6,12,13,15–19] and mothers who smoke [6,14,15,17]. The majority of these have
been conducted in Caucasian populations [6,8,12–18,20] with the exception of one study in Japan [18]
and another in a multi-ethnic population in America [7]. While it is well established that dietary
patterns differ markedly between Asian and Caucasian adults [21,22], the extent to which dietary
patterns in Asian infants differ from their Caucasian counterparts and whether maternal predictors of
those patterns differ in an Asian infant population remains unexplored.
Weaning represents a transition period during which the diet undergoes rapid changes from
milk-based to solid foods, increasing in variety to resemble an adult-like diet. Yet, most studies have
limited their scope to a single time-point [7,8,12,17] and may not have adequately accounted for the
transitory nature of weaning diets. The concept of modeling dietary patterns longitudinally across time
points into dietary trajectories has recently been developed by Smithers et al. [11] to address this issue,
but no study to date have explored predictors of infant dietary pattern trajectories using this model.
In this study, we aim to better understand the dietary patterns of Asian infants by
longitudinally examining the dietary pattern trajectories of infants participating in a multi-ethnic Asian
mother-offspring cohort study from 6- to 12-months of age. We also examined potential maternal
socio-demographic predictors of these dietary pattern trajectories during this period.
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2. Subjects and Methods
Our study is based on the Growing Up in Singapore Towards healthy Outcomes (GUSTO)
cohort [23]. Between June 2009 and September 2010, pregnant women 18–50 years of age were recruited
from Singapore’s two major public maternity units: National University Hospital (NUH) and KK
Women’s and Children’s Hospital (KKH). In brief, the participants were Singapore citizens or
permanent residents with the intention to deliver in one of the above-named hospitals, reside in
Singapore for the next 5 years, spouses were of the same race, and both parents had a homogenous
parental background of Chinese, Malay, or Indian ethnicity. The exclusion criteria included receipt of
chemotherapy treatment or psychotropic drugs or the presence of serious medical conditions such as
type-1 diabetes mellitus. The study received ethical approval from the institutional review boards of
the respective hospitals involved. Written consent was obtained from all participants.
2.1. Maternal and Infant Characteristics
Socio-demographic characteristics such as maternal age, ethnicity, marital and employment
status, housing, monthly household income and education level were obtained from the participants
during the first clinic visit upon recruitment (<14 weeks gestation). At 26–28 weeks of gestation,
self-reported information on pre-pregnancy BMI, tobacco smoking and alcohol consumption were
collected. Details on infant gender and birth order were obtained from birth delivery reports.
2.2. Infant Dietary Assessment
Mothers were sent 3-day food diaries to record dietary intakes of their children prior to their
postnatal clinic visits at 6-, 9- and 12-months and the diaries were collected at the visits. Instructions
and further information on food recording were indicated in the diaries. Mothers who did not complete
the food diaries were interviewed by trained personnel at the clinic visits, where a 24-h recall was
conducted using the 5-stage, multiple-pass interviewing technique [24]. A set of food pictures and
household measurements were provided in the food diaries and during the 24-h recalls to aid in the
description of portion size consumed. For the dietary analyses, data from 24-h recalls and 1-day record
from the food diaries were used to increase the sample size of the study. Breastmilk consumption
via direct breastfeeding was estimated as 780 mL for 6 month-old infants and 600 mL for 9- and
12-month-old infants, based on methods described by Ponza et al. [25]. For expressed breastmilk,
consumption was quantified according to exact volumes recorded by mothers.
2.3. Identifying Dietary Patterns
Food items from the 24-h recalls (n = 295, 322, 249 at 6, 9 and 12 months, respectively) or 1-day
record (chosen by a randomized order) from the food diaries (n = 191, 164, 237 at 6, 9 and 12 months,
respectively) were grouped into pre-defined food groups. Food groups with low intakes among the
infants (n < 3) were further combined based on similarity in culinary usage and nutrient profile [26,27].
A total of 493, 894 and 1137 food items were identified and subsequently grouped into 34, 44 and
61 food groups at 6, 9 and 12 months of age, respectively. Dietary patterns at each time point were
extracted by exploratory factor analysis (EFA) using the principal factor method in SPSS version
22.0 (IBM) [28,29] (see Supplementary Materials). EFA solutions were assessed for the magnitude of
loadings of food groups, and each pattern was named based on loadings of ě˘0.30 [9,12,13,15,16].
A dietary pattern score, standardized to a mean of zero and standard deviation of one, was calculated
for each subject as a function of the contribution (“loading”) that each food made to the pattern.
Four dietary patterns were extracted at month-6 and -9 and five dietary patterns at month-12.
2.4. Construction of Dietary Pattern Trajectories
Using multi-level mixed models in Stata version 13.0 (Stata Corporation, College Station,
Texas, TX, USA), dietary trajectories were empirically constructed by mapping the dietary patterns extracted
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by EFA at 6-, 9- and 12-months. This procedure accounts for the repeated measures of dietary pattern
scores of each subject. The dietary patterns across the three time-points were examined for their similarity
in the types of foods and their loadings to ascertain their suitability to be modeled as trajectories. The
mapping of each pattern to a trajectory was based on similar key constituent foods (with high loadings)
found in the dietary patterns across the three time-points and this correspondingly determined the name
of each trajectory [11]. The model generates estimates of intercepts and slopes. The intercept reflects the
trajectory score at the start point of each trajectory (6-months of age), while the slope denotes the rate of
change in trajectory scores over time. Details have been previously described by Smithers et al. [11].
2.5. Statistical Analysis
Of the 1247 women recruited, 486 singleton subjects with complete birth measurements and dietary
records at 6-, 9- and 12-months were included in the final subgroup (illustrated in Supplementary
Materials Figure S1). Pearson’s chi-square tests and independent sample t-tests were used to compare
the characteristics of mothers included in this analysis and those with missing dietary records.
Pearson’s correlation coefficients were used to assess the correlation between dietary scores derived
from 1-day record of the food diaries with the average of the other 2-day records in the subset of
mothers who completed the food diaries at the 3 time-points. General linear models were performed
to study the associations between dietary trajectory estimates and maternal socio-demographic
factors (maternal age, education, ethnicity, employment, BMI at 26-weeks gestation, pre-pregnancy
smoking and alcohol status, monthly household income, cohabitation status, parity and infant
sex). Socio-demographic factors were stratified into categorical variables and imputations were
performed on missing data using the mode. These models were adjusted for potential covariates as
described above.
All statistical analyses were performed using the statistical software package SPSS version 22.0
(IBM Corp, New York, NY, USA). A 2-tailed p-value of <0.05 was considered to be statistically significant.
3. Results
Maternal and infant characteristics of participants with complete dietary records from 6- to
12-months (n = 486) were similar to those without complete dietary records (n = 438) (Supplementary
Materials Table S1). Nonetheless, mothers who provided complete dietary records were more likely to
live together with their spouses and had higher monthly household income compared with those who
did not provide complete dietary records.
3.1. Dietary Pattern Trajectories
Four dietary pattern trajectories were observed from 6- to 12-months and were labeled
Predominantly breastmilk, Guidelines, Easy-to-prepare foods and Noodles (in soup) and seafood (Figure 1).
The Predominantly breastmilk trajectory was characterized by breastmilk feeding that exceeded formula
milk, the addition of fresh fruits at 9-months, and bean curd (tofu), high-fat ethnic breads and starchy
vegetables at 12-months. The Guidelines trajectory followed recommended weaning guidelines [30]
and was characterized by rice porridge, low-fat fish and meat, a variety of vegetables and fresh fruits
as core foods items throughout the 6–12-month period. This trajectory was also characterized by lower
intakes of infant cereal at 9- and 12-months.
The Easy-to-prepare foods trajectory consisted of foods that require little preparation (infant cereals,
juices, cakes and biscuits, as well as adult table foods such as white rice, green vegetables) at 6-months
and progressed to easy-to-prepare foods such as breads, spreads, biscuit and confectionaries at
12-months. The Noodles (in soup) and seafood trajectory was pre-dominantly noodle-based and consisted
of common accompaniments such as eggs, seafood products, dried preserved fruits and bean curd
(tofu) found in noodle soup meals. An additional dietary pattern emerged at 12-months of age but did
not fall into any of the dietary trajectories: the Pulses and grains pattern. This pattern was distinguished
by high intakes of nuts and seeds, grains, legumes and lentils and high energy-dense confectionaries.
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A complete list of food items and their loading scores for each dietary pattern and trajectory is provided
in the supplementary file (Supplementary Materials Tables S2–S4). Examples of foods consumed in
each item are also provided in Supplementary Materials Table S5. Dietary patterns scores derived
from 1-day record of the food diaries were found to be significantly correlated with the other 2-days of
the same diaries (correlation coefficient ranged from 0.43 to 0.82) for all dietary patterns and all time
points except for the Easy-to-prepare foods dietary pattern at 9-months (correlation coefficient = 0.123)
(Supplementary Materials Tables S6).
Rice porridge 
Yellow, orange, red vegetables 
Fish (Low fat) 
Pork, beef, lamb (Low fat) 













Yellow, orange, red vegetables 
Fish (Low fat) 
Infant cerealsa 
Broccoli, cauliflower 








Fish (Low fat) 
Pork, beef, lamb (Low fat) 
Soya bean drink 
Starchy vegetables and gourds 











Infant formula milks 
0.89 
-0.85 







Infant formula milks 
Beancurds (Tofu) 
Starchy vegetables and gourds 













White rice (Plain) 
Green leafy vegetables 
Infant biscuits 












High fat spreadsc 







Cakes, biscuits, local snacks 
Clear soup 
White rice (Plain) 
Malted drinks 















Seafood products, dried anchovies 
Eggs 
Dried preserved fruits 













Noodles (In soup) 












Month 6 Month 9 Month 12 
Figure 1. Mapping of dietary patterns at age 6, 9 and 12 months to trajectories. Only foods with
loadings ě˘0.30 are shown in the figure. A full list of food items and their loadings are provided in
Supplementary Materials. a Includes rice, wheat and oat baby cereals; b Includes white and whole
wheat breads, breads with fillings or toppings, and baked ethnic breads; c Includes butter, ghee, peanut
butter and margarine; d Added to drinks and cereals.
3.2. Characteristics of Study Population with Trajectory Estimates
The dietary pattern trajectory estimates of 486 infants summarized with respect to their maternal and
infant characteristics are shown in Supplementary Materials Tables S7 and S8. Ranges of intercepts and
slopes are listed in the Supplementary Materials. In general, the slopes were small relative to the intercepts.
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3.3. Associations with Trajectory Intercepts
The fully adjusted associations between the intercepts and maternal socio-demographic
characteristics are shown in Table 1. Higher Predominantly breastmilk trajectory start scores for
infants at 6 months were significantly associated with higher maternal education, higher income,
Chinese ethnicity, not working outside the home and having more than one child at home.
Higher Guidelines trajectory intercepts at 6 months were associated with post-secondary education.
Male infants had higher Easy-to-prepare foods trajectory intercepts at 6 months, while their mothers
were more likely to be older (>34 years old) and of Indian ethnicity. No significant maternal factors
were associated with the Noodles (in soup) and seafood trajectory.
3.4. Associations with Trajectory Slopes
The fully adjusted associations between maternal socio-demographic characteristics and rates
of change in dietary trajectory scores (slopes) over the period of 6 to 12-months are shown in Table 2.
Mothers of Indian ethnicity, of lower education qualification and primiparous had higher positive
slopes for the Predominantly breastmilk trajectory. Chinese infants had higher positive slopes for the
Guidelines trajectory than Malay or Indian infants. Infants with higher slopes for the Easy-to-prepare
foods trajectory had younger mothers. Chinese infants had higher slopes for the Noodles (in soup) and
seafood trajectory.
The Pulses and grain dietary pattern emerged only at 12-months of age and was associated with
Indian ethnicity and mothers with post-secondary education (Supplementary Materials Table S9).
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4. Discussion
Using multi-level modeling, we integrated food intakes at 6-, 9- and 12-months of age and identified
four well-defined dietary patterns and their trajectories over that time period. A key observation was that
the rates of change (slopes) of the trajectory scores were much smaller than the differences in the start
scores (intercepts) in groups defined by maternal socio-demographic characteristics. This suggests that
the maternal characteristics that predict dietary patterns at 6-months of age also largely determine the
adherence to the same dietary patterns trajectories for the first year of life. To our knowledge, this is
the first study to examine these dietary patterns and associations in an Asian population.
4.1. Dietary Patterns
In our study, the Predominantly breastmilk pattern resembles the “breastfeeding” pattern and
“longer breastfeeding, late contemporary food introduction and use of home-made foods” reported
in the ALSPAC [12] and EDEN studies [8,13], respectively. This pattern was characterized by higher
intake of breastmilk and lower intake of formula milk and was accompanied by intakes of fruits
and vegetables. The Guidelines pattern in our study corresponds to the healthy/prudent eating
pattern [7,8,14–17,20] and was characterized by higher intakes of fruits, vegetables, whole grains,
poultry and fish. While continued breastfeeding is encouraged during complementary feeding
(6–12 months of age), the emphasis in current guidelines for this period is to offer infants a variety of
food groups, rather than the type of milk taken [31,32]. The Easy-to-prepare foods pattern corresponds to
an unhealthy eating pattern characterized by intakes of sugary desserts, high-fat foods and refined
grains [6,15,17,18]. Lastly, the Noodles (in soup) and seafood pattern, which has not been observed in
other studies, appears to reflect Asian adult eating patterns. It resembles the “use of adults’ foods” in
the EDEN study [8,13].
4.2. Associations between Maternal Factors and Trajectory Intercepts
The trajectory intercept values obtained from the mixed models represents the start point of each
dietary pattern trajectory (at 6-months of age). To our knowledge, only three cohort studies to date
have reported results for infant dietary patterns at 6-months of age [7,12,17]. Similar to the ALSPAC
study [12], higher start scores of our Predominantly breastmilk trajectory at 6-months was associated
with higher maternal education attainment. The IFPS II study reported that a higher “formula”
dietary pattern (reverse of breastmilk) at 6-months of age was negatively associated with maternal
education [7]. The relationship we observed with household income is not surprising, as income is
closely linked to educational attainment. Its effect on breastfeeding status tends to attenuate when
adjusted for education attainment [33,34]. The relationship we observed between higher start scores
on the Predominantly breastmilk trajectory and unemployment is supported by evidence from studies
showing that women working part-time or unemployed are more likely than their counterparts
to breastfeed [35–37]. In Singapore, working mothers are entitled to 16 weeks of government-paid
maternity leave or 12 weeks of maternity leave depending on citizenship, marriage status and duration of
employment, but can choose to consume leave non-consecutively [38]. This may in part explain the lower
start scores at 6 months on the Predominantly breastmilk trajectory for employed mothers when they return
to work. Similarly, we found higher educational attainment to be associated with higher start scores of the
Guidelines trajectory. Mothers with higher education are probably more aware of recommended practices
and guidelines for weaning diets. A similar finding was also observed in the IFPS II study [7].
Maternal ethnicity was strongly associated with the start scores of our diet trajectories.
Chinese mothers tended to start their infants on the Predominantly breastmilk pattern, while Indian
ethnicity was associated with the Easy-to-prepare foods pattern. Ethnic differences in dietary patterns
has also been observed in the American population, where White and African-American mothers
scored higher on “guidelines” and “easy-to-prepare foods” patterns compared to their Hispanic
counterparts [7], suggesting the importance of culture on diet and weaning practices.
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We observed that higher start scores on the Easy-to-prepare foods trajectory were also associated
with older mothers. In contrast, previous findings suggest that younger mothers tend to provide
their children with more convenient foods, perhaps owing to time constraints [39]. Differences in
childcare practices among different populations may explain these contrasting findings. For example,
young Singaporean couples tend to live with their parents and leave their infants under the
grandparents’ supervision. Those infants are more likely to be fed traditional, home-prepared weaning
meals than ready-to-eat meals.
No key maternal determinant emerged in the full model analyses for the Noodles (in soup) and
seafood trajectory, suggesting it may be less influenced by cultural or socioeconomic factors.
4.3. Associations between Maternal Factors and Trajectory Slopes
The trajectory slopes represent the rate of change of each dietary pattern trajectory between 6- and
12-months. The means and standard deviations of the trajectory slopes were small (<0.05 ˘ 0.10)
compared to the intercepts (<0.51 ˘ 1.04), suggesting that infants tend to maintain their dietary patterns
over time. The range of the slopes we observed is similar to that reported by Smithers et al [11].
Mothers with lowest educational attainment and primiparous had higher slopes for the
Predominantly breastmilk trajectory, suggesting a greater adherence to this pattern over time. This may
not be ideal as the World Health Organization (WHO) recommends that solid foods be introduced
shortly after 6-months of age [31] to ensure that infants obtain adequate micronutrients that breastmilk
may not supply in sufficient quantity [30,40]. In addition, the variety of food and food textures
provided to infants are believed to facilitate the development of oral motor skills and taste preferences
and thereby help build a foundation for healthy eating habits [31,32,41].
Mothers in the youngest age group (18–29) tended to have greater adherence to the Easy-to-prepare
foods trajectory with time, possibly owing to limited knowledge and experience with infant nutrition [39].
Maternal ethnicity continues to be a prevailing determinant of the slope of the dietary pattern
trajectories. We observed that while Indian mothers have greater adherence to the Predominantly
breastmilk trajectory over time, Chinese mothers adhere more to the Guidelines and Noodles (in soup) and
seafood trajectories over time, reflecting a transition to an increasing pattern of table and adult foods.
We also observed a Pulses and grain dietary pattern emerging at 12-months, particularly in Indian
mothers of higher education status.
4.4. Strengths and Limitations
Our study captures the important time points of an infant’s weaning diet and fills an important
data gap on early feeding patterns. The modeling of dietary pattern trajectories has enabled us to
take a longitudinal approach to assessing the overall diet. Compared to conventional cross-sectional
analyses, this technique allows us to observe the introduction of new foods through time and the
dietary transition during the weaning period. Furthermore, the representation of dietary pattern scores
as intercepts and slopes has enabled us to explore the extent to which changes in diet over time are
influenced by socio-demographic variables. While the trajectory intercepts signify the cross-sectional
dietary pattern scores at 6-months of age, the slopes illuminate the dynamic changes in dietary patterns
over time, which cannot be observed in the cross-sectional studies.
Limitations of our study also merit comment. First, single 24-h recalls or 1-day dietary
records may not be a good representative of an infant’s usual diet due to day-to-day variation
in intakes. However, we have demonstrated high correlation of dietary pattern scores across
the 3-days of the food diaries, reflecting good reproducibility of the single day dietary records.
Second, GUSTO participants were not randomly sampled from the general population, with deliberate
over-sampling of Malay and Indian mothers, and were recruited from two maternity hospitals in
Singapore. However, these recruitment sites are the two largest maternity hospitals in Singapore and
consist of both private and subsidized patients.
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5. Conclusions
We examined trajectories of four distinct dietary patterns across three time points between 6- and
12-months. The trajectories were largely determined at the start points (intercepts), and changes
over time (slopes) were small. This suggests the importance of establishing the “right” diet at the
start of complementary feeding, as dietary changes are more difficult once habits are established.
By understanding the key maternal socio-demographic factors that influence dietary patterns during
complementary feeding, health professionals and policy-makers can provide more targeted and
culturally-appropriate support and advice for mothers and their infants.
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Abstract: The aim of the present paper was to describe food and nutrient intake among 12-month-old
Norwegian-Somali and Norwegian-Iraqi infants, with a focus on iron and vitamin D intake.
A cross-sectional survey was conducted from August 2013 through September 2014. Eighty-nine
mothers/infants of Somali origin and 77 mothers/infants of Iraqi origin residing in Eastern Norway
participated in the study. Data were collected using two 24-h multiple-pass recalls. Forty percent of
the Norwegian-Somali infants and 47% of the Norwegian-Iraqi infants were breastfed at 12 months
of age (p = 0.414). Median energy percentages (E%) from protein, fat and carbohydrates were within
the recommended intake ranges, except the level of saturated fats (12–13 E%). Median intakes of
almost all micronutrients were above the recommended daily intakes. Most of the infants consumed
iron-enriched products (81%) and received vitamin D supplements (84%). The median intakes of iron
and vitamin D were significantly higher among infants receiving iron-enriched products and vitamin
D supplements compared to infants not receiving such products (p < 0.001). The findings indicate
that the food and nutrient intake of this group of infants in general seems to be in accordance with
Norwegian dietary recommendations. Foods rich in iron and vitamin D supplements were important
sources of the infants’ intake of iron and vitamin D and should continue to be promoted.
Keywords: food; nutrient intake; infants; immigrants; Norway
1. Introduction
The first two years of a child’s life are particularly important as this is a period of rapid growth
when nutritional needs are high [1,2]. Knowledge about infants’ and toddlers’ food and nutrient
intake is therefore important to evaluate their diet and identify potential challenges. In Norway,
national dietary surveys of infants and toddlers have been performed at the ages of 6, 12 and
24 months [3–5]. Due to methodological issues, infants and toddlers of immigrant mothers were
excluded from these surveys, and separate surveys for these children have been called for by the
Norwegian Directorate of Health [6].
Consequently, compared to infants of Norwegian-born parents, less is known about the food
and nutrient intake of infants of immigrant parents in Norway. However, some previous smaller
studies of Norwegian immigrant children have shown some potential nutrition challenges, such as
high prevalence of iron and vitamin D deficiencies and a relatively high added sugar intake [7–9].
It has further been suggested that immigrant children may be introduced to cow’s milk at a younger
age than ethnic Norwegian children, although inconsistent trends have been observed [9]. As cow’s
milk contains very little iron, consumption >500 mL/day has been associated with reduced iron stores
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in young children [10,11]. However, intake of fortified foods seems to improve iron status in late
infancy [12].
To address the paucity of data on food and nutrient intake and infant feeding practices
among Norwegian children with immigrant backgrounds, the InnBaKost study was initiated in
2012. Information on breastfeeding and complementary feeding practices among 6-month-old
Norwegian-Somali and Norwegian-Iraqi infants was recently published [13]. The present paper
aimed to describe and compare food and nutrient intake among 12-month-old Norwegian-Somali and
Norwegian-Iraqi infants, with a focus on iron and vitamin D intake.
2. Materials and Methods
2.1. Subjects and Design
A cross-sectional survey was carried out from August 2013−September 2014. Mothers born
in Somalia or Iraq and living in Oslo, Akershus or Buskerud were eligible for inclusion.
These two immigrant groups were chosen, as they are the two non-Western immigrant groups in
Norway with the highest number of births per year [14]. Children on a special diet due to serious illness
were excluded. If the mother had twins or triplets, only one child was included by random selection.
Mothers who participated in the InnBaKost survey of 6-month-old infants [13] were contacted
again when their children turned 12 months old. These mothers had not received any information
about the results in the 6-months survey or dietary counselling which could influence dietary habits at
the infants’ 12 months of age. In the 6-month survey, 107 Norwegian-Somali mothers and infants and
80 Norwegian-Iraqi mothers and infants participated [13]. Of these, 70 Norwegian-Somali infants and
61 Norwegian-Iraqi infants participated in the 12-month follow-up survey. Seven of the Somali-born
mothers and eight of the Iraqi-born mothers declined to participate further, while 30 Somali-born
mothers and 11 Iraqi-born mothers could not be reached. Along with the mothers/infants participating
in the 6-month survey, 19 additional Somali-born mothers and 16 additional Iraqi-born mothers
were recruited. The additional mothers were recruited through lists obtained from the National
Population Register. Mothers who were not reached from these lists in the 6-month survey were
approached again when the infants were 12 months. A total sample of 89 Norwegian-Somali infants
and 77 Norwegian-Iraqi infants were included for the present analysis.
To collect data on the food intake of the 12-month-old infants, two 24-h multiple-pass recalls were
conducted face-to-face as closely as possible to the child’s 12-month birthday. Eight trained female
fieldworkers speaking the relevant language performed the interviews in Somali, Arabic, Kurdish or
Norwegian. A total of 8% (n = 13) only completed one single 24-h recall. For mothers who were unable
to meet in person, the interview was conducted over the telephone. Of all the participants, 3% (n = 5)
had both interviews conducted over the telephone, while 4% (n = 7) had one of the two interviews
conducted over the telephone. The interviews were conducted at a time and place chosen by individual
mothers. The average time between the two 24-h recalls was 2 weeks. For 7% of the participants,
there were more than 4 weeks between the two interviews. Approximately 78% of all the dietary
recalls were collected for intakes on weekdays and 22% were collected for intakes on weekends among
Norwegian-Somali infants, and the numbers were 83% and 17%, respectively, for Norwegian-Iraqi
infants. In both groups, over 85% of the recall days were reported as representative of the usual daily
dietary intake of the child. Each mother who completed the two 24-h recalls received a voucher for a
baby shop worth approximately US $25.
The Regional Committees for Medical and Health Research Ethics (2012/957) approved the study,
and informed consent was obtained from all the participating mothers.
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2.2. 24-h Multiple-Pass Recall Method
The 24-h multiple-pass recall method was used to collect data on the 12-month-old
Norwegian-Somali and Norwegian-Iraqi infants. The method was first developed and pilot tested on
12 Somali-born and Iraqi-born mothers from January to June 2013 [15].
Briefly, in this dietary recall method, the mothers were to be interviewed twice about the exact
food and beverage intake of their children during the preceding 24 h. A 24-h period was defined
as from the time the child woke up the previous day until the time the child woke up the day of
the interview.
The dietary recall was divided into three passes. In the first pass, the mothers were asked to
report everything that their children had consumed the previous day, including during the night.
Each breastfeeding occurrence was also to be reported. In the second pass, mothers were asked to
provide additional detailed information about each item of food and drink consumed by the children.
This included type of product, brand names, cooking methods, amounts and leftovers. For homemade
dishes, the mothers were asked for the recipes, and the list of ingredients was recorded. The third
pass was a review of the recall, and the mothers were given the opportunity to provide any additional
information regarding the children’s food and drink consumption. During the last pass, the field
workers were also instructed to prompt for information about foods and drinks not mentioned that
were considered to be easy to forget, such as snacks, fruits, water, juices and supplements, which the
field workers read from a list.
Two photographic booklets previously used in Norwegian national dietary surveys, were
utilized during the interviews as an aid to estimate portion sizes. The Spedkost booklet [4] containing
17 colour photograph series of infant portion sizes of selected foods and drinks was mostly employed.
The Norkost booklet [16] containing a series of adult portion sizes was mainly used to estimate portion
sizes of different kinds of bread.
A picture library containing 405 pictures divided into 19 folders on an iPad was used to help
identify the types of foods/drinks/products given to the children. The development of the picture
library has been described in more detail elsewhere [15].
2.3. Questionnaire and Background Characteristics
A questionnaire with 19 questions on five topics was used to collect additional information
about the infants. The questions related to breastfeeding (whether the infant was breastfed, and if
so, the frequency of breastfeeding), the age of introduction to various foods and drinks, whether the
infant had any allergies/intolerances, the use of dietary supplements and arenas for receiving infant
nutrition information.
In Norway, healthcare personnel routinely measure the length and weight of children during
regular check-ups at children’s health clinics, including at 12 months of age. Participating mothers
were asked to bring their infant’s health cards to the interview in order to record these data.
Other background characteristics, such as infants’ gender, mothers’ age, mothers’ age when they
immigrated to Norway, number of children, parental education levels and fathers’ origins, were
already provided from the 6-month survey. The same questions were asked of newly recruited
mothers. All mothers were also asked to provide information on current work status and person/place
in charge of day-care for the infants. When possible, other persons in charge of the day-care of the
infant during the recall days were consulted on the infants’ dietary intake during those hours.
2.4. Food Intake and Nutrient Calculations
Information from the 24-h recalls was manually coded by nutritionists. All foods and beverages
consumed by each child were converted into grams of edible portions. For recipes, a modified version
of the summing method was applied to calculate the intake of each ingredient [17]. A breast milk intake
of 124 mL per feed or an intake of 497 mL for children whose mothers reported to have breastfed their
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children four times or more was used, as described by Grewal et al. [15]. The daily nutrient intakes
(averaged over the two days) were computed using a food database and a dietary calculation system
(KBS, version 7.2, database AE-10) developed at the Department of Nutrition, University of Oslo,
Oslo, Norway. The food database used is mainly based on the official Norwegian food composition
table but is also continuously supplemented with data on new food items and nutrient content.
Relevant food products missing from KBS were added, and the nutrient content was based on the
nutrient content listed on the products’ nutritional label. Nutrients from dietary supplements and
from fortified foods consumed during the recall days were included in the calculated nutrient intake.
The calculated average daily nutrient intake from the two recalls was compared to the recommended
intake ranges for macronutrients and recommended daily intakes (RI) for micronutrients [18].
2.5. Statistical Analysis
Data from the questionnaire and background characteristics were manually entered into the
statistical software package IBM SPSS Statistics version 22.0. Data about the food and nutrient intakes
estimated from KBS were transferred to SPSS. All data were further processed and analysed in SPSS.
Energy intake information acquired during the telephone interviews (n = 12) did not differ from those
who completed two face-to-face 24-h recalls and were therefore included in the analyses. Mothers who
only completed one 24-h recall were also included.
The weight and length of the children were converted into Z-scores for weight-for-age,
height-for-age and weight-for-height according to 2006 WHO child growth standards [19] using
WHO Anthro (version 3.2.2, January 2011, Geneva, Switzerland) and macros. Cow’s milk and yoghurt
were categorized as ‘dairy products’ in the analysis. Infant formula and infant cereals were categorized
as ‘iron-enriched products’.
Iron intake was compared between infants receiving and not receiving dairy products and between
infants receiving and not receiving iron-enriched products. The intake of dairy products and the intake
of iron-enriched products were tested by different background characteristics. The intake of vitamin
D was compared between infants receiving and not receiving vitamin D supplements. The intake of
vitamin D supplements was tested by different background characteristics. The data did not adhere to
a normal distribution, and continuous variables are presented as median and 25th and 75th percentiles
(P25–P75) and were tested using a Mann-Whitney U test. Categorical variables were tested using a
Chi-square test.
3. Results
Selected characteristics of the infants and their parents are presented in Table 1. The Norwegian-Somali
infants had significantly higher Z-scores for height-for-age (1.4 vs. 0.6, p = 0.001) but not for
weight-for-height (0.7 vs. 0.2, p = 0.087) compared to the Norwegian-Iraqi infants. The Somali-born
mothers were younger (29 years vs. 32 years, p = 0.026), had lived in Norway for a longer period of
time (10 years vs. 7 years, p = 0.012) and a higher percentage were working at the time of interviewing
(27% vs. 13%, p = 0.026) compared to the Iraqi-born mothers. A higher proportion of the Iraqi-born
mothers had higher education compared to the Somali-born mothers (64% vs. 38%, p = 0.001).
3.1. Breastfeeding
At 12 months of age, 40% of the Norwegian-Somali infants and 47% of the Norwegian-Iraqi
infants were breastfed (p = 0.414). The median breastfeeding frequency among those breastfeeding
was 4.5 times a day in both groups.
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3.2. Food Intake
Data from the 24-h recalls on daily intakes of various types of foods and drinks among all
infants are presented in Table 2. Percentages of and intake among consumers are presented in Table 3.
Norwegian-Somali infants had significantly higher median daily intakes of commercial infant cereals,
commercial fruit purees, fish/fish products, yoghurt and cow’s milk compared to the Norwegian-Iraqi
infants (Table 2). Norwegian-Iraqi infants, on the other hand, had significantly higher daily intakes of
refined flour bread, cake, meat and meat products, eggs, fruits and berries, added sugar, tea and water
than Norwegian-Somali infants (Table 2).
Commercial infant cereals and fruit purees, potatoes and fish/fish products were consumed by a
significantly higher proportion of Norwegian-Somali infants compared to Norwegian-Iraqi infants,
while bread, grain products, cake, meat, eggs, fruit/berries and tea were more commonly consumed
by Norwegian-Iraqi infants (Table 3).
3.3. Energy and Nutrient Intake
The average energy and nutrient intake from the 24-h recalls are shown in Table 4. The median
energy intake among Norwegian-Somali infants was 3791 kJ compared to 4122 kJ among
Norwegian-Iraqi infants (p = 0.059). The median energy percentages (E%) from protein, fat and
carbohydrates were within the recommended intake ranges in both groups; however, the intake of
saturated fats was above the recommended upper level of 10 E%. The intake of added sugar, on the
other hand, was below 5 E% in both groups.
The main sources of saturated fat intake in the total diet of the Norwegian-Somali infants were
cow’s milk (which contributed with 22%), breast milk (22%), commercial infant cereals (9%) and cheese
(8%) (data not shown). The main sources of saturated fats among the Norwegian-Iraqi infants were
breast milk (23%), meat and meat products (11%), cow’s milk (9%) and cheese (9%). Yoghurt was
the main source of the added sugar intake among both the Norwegian-Somali and Norwegian-Iraqi
infants (38% vs. 23%).
The median intake of all micronutrients, except iron and niacin in both groups and zinc among
Norwegian-Somali infants were above the RI.
3.4. Factors Associated with Iron Intake
The main sources of dietary iron were commercial infant cereals (which contributed with 51%
among Norwegian-Somali vs. 34% among Norwegian-Iraqi infants), iron supplements (13% vs. 9%),
infant formula (10% vs. 19%) and bread and other grain products (10% vs. 8%). During the recall days,
6% of the Norwegian-Somali infants and 8% of the Norwegian-Iraqi infants received supplements
containing iron (p = 0.574, data not shown). Table 5 shows the percentage of the infants receiving dairy
products and iron-enriched products and also median intakes of iron among infants receiving dairy
products and iron-enriched products. There were no significant differences between the two groups
regarding the proportion who had received dairy products, whether it concerned any dairy products or
more than 500 g dairy products per day. A higher proportion of Norwegian-Somali infants had received
iron-enriched products compared to Norwegian-Iraqi infants (88% vs. 73%, respectively; p = 0.015).
Intakes of iron did not differ significantly between infants receiving dairy products compared to infants
not receiving dairy products. However, the median intake of iron was significantly higher among
infants receiving iron-enriched products (8.1 mg/day) compared to infants not receiving iron-enriched
products (3.7 mg/day; p < 0.001). Neither intake of dairy products nor intake of iron-enriched products
differed significantly between genders, according to mothers’ ages, number of years lived in Norway,
education level, current work status or number of children.
367












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Nutrients 2016, 8, 602
3.5. Factors Associated with Vitamin D Intake
Vitamin D supplements comprised more than half of the vitamin D intake in both groups
(61% among Norwegian-Somali infants vs. 52% among Norwegian-Iraqi infants). Other sources
of vitamin D were commercial infant cereals (19% in both groups), infant formula (7% vs. 17%) and fish
and fish products (6% vs. 3%) among Norwegian-Somali and Norwegian-Iraqi infants, respectively.
During the recall days, a total of 84% of the infants had received vitamin D supplements. Significantly
more among the Norwegian-Somali infants compared to the Norwegian-Iraqi infants had received
vitamin D supplements during the recall days (94% vs. 71%, respectively; p < 0.001) The median
(P25–P75) intake of vitamin D among those receiving vitamin D supplements was 14.5 (10.8–18.1)
μg/day compared to 4.1 (1.5–7.6) μg/day among those not receiving vitamin D supplements (p < 0.001).
The intake of vitamin D supplements did not differ significantly between genders, according to mothers’
ages, number of years lived in Norway, education level, current work status or number of children.
4. Discussion
The present paper describes the food and nutrient intake in a group of 12-month-old Norwegian
infants of mothers who immigrated to Norway from Somalia and Iraq. The findings indicate that the
nutrient intake in this group of infants in general seems to be in accordance with Norwegian dietary
recommendations, with the possible exception of certain micronutrients. The intake of added sugar
was low, whereas the median intake of saturated fats exceeded the recommendations.
4.1. Breastfeeding
In this group of infants with immigrant backgrounds, 40% of the Norwegian-Somali infants and
47% of the Norwegian-Iraqi infants were breastfed at 12 months of age, with a median frequency
of 4.5 times a day. This is quite similar to the 46% found to be breastfed in the Norwegian national
dietary survey of infants at 12 months of age who had an average breastfeeding frequency of 3.5 times
a day [4]. Breastfeeding patterns have been shown to vary between ethnic subgroups in a society,
but also to depend on country of residence [20–22]. Data from a nationally representative population
based cohort study from Ireland [21] and the National Survey of Children’s Health in the US [22]
reported higher breastfeeding initiation and longer duration among immigrant mothers compared
to the native mothers. However, the breastfeeding prevalence in Ireland and the US were in general
lower than what is common in Norway and other Scandinavian countries [23]. This may explain the
opposite findings and the greater differences between immigrant and native mothers compared to
our findings.
4.2. Food Intake
Commercial infant cereals, bread, potatoes and vegetables, fruit and berries, meat/meat products
and fish/fish products were the most commonly consumed foods among the Norwegian-Somali
and Norwegian-Iraqi infants. These foods were also consumed by a high proportion of infants in
the Norwegian national dietary survey [4]. Commercial infant dinners were consumed by a higher
proportion of infants in the national dietary survey compared to infants in the present survey [4].
Homemade dinners were also more common than commercial infant dinners at 6 months of age among
Norwegian-Somali and Norwegian-Iraqi infants [13]. The lower use of commercial infant dinners
among the children with immigrant background may be due, as reported in a study of Somali mothers
in the US, to concerns about the lack of freshness of commercially produced baby foods and also the
practice of feeding children the same foods as adults [24].
One important consideration when comparing these results is that the Norwegian national dietary
survey used a semi-quantitative food frequency questionnaire (FFQ) to assess the infants’ dietary intake
at 12 months of age [4], while the present study used repeated 24-h recalls due to limited knowledge
about Norwegian-Somali and Norwegian-Iraqi infants’ diets. Thus, any comparison between the
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two studies should be undertaken with caution because the results from the national dietary survey
represent the infants’ intake over a longer period of time.
4.3. Energy and Nutrient Intake
The energy intake among both Norwegian-Somali and Norwegian-Iraqi infants was lower than
the mean intake of 5100 kJ reported in the national dietary survey, which only reported the energy
and nutrient intake of non-breastfed infants [4]. The average daily energy requirement for boys and
girls at 12 months of age is 337 kJ/kg and 333 kJ/kg, respectively, according to Nordic nutrition
recommendations [25]. Based on the median weights of the infants in the sample, Norwegian-Somali
infants would have an average daily energy requirement of 3440 kJ and Norwegian-Iraqi infants would
have an average daily energy requirement of 3252 kJ, which is lower than the average energy intake
found in this study. However, the quality of the data on weight and height may have some limitations
as each child health clinic may differ in terms of accuracy in reporting the measurements and the
measurements may have been taken a few weeks before or after the 24-h recalls were performed.
In addition, the weights of several infants were not registered, which may also have affected the
median weights reported in this study. Furthermore, breast milk amounts were only estimated and
this, along with possible misreporting of dietary intakes, may give inaccurate energy intake data.
The median E% of protein, total fat and carbohydrates were all within the recommended intake
ranges [18]. Saturated fat was above the recommended 10 E%. However, one of the major sources of
saturated fats in the diet was breast milk, which is recommended to give to infants until 12 months
of age and beyond [18]. Other main sources of saturated fats was cow’s milk and meat and meat
products. Parents could reduce the infants’ intake of saturated fats by changing high-fat dairy products
with low-fat products as well as using lean cuts of meat. The intake of added sugar was appreciably
lower than the recommended upper level of 10 E%, which is a positive finding. These results are
quite similar to those reported in the national dietary survey, where saturated fats accounted for
12 E% and added sugar only accounted for 4 E%. Previous studies of young children with immigrant
backgrounds in Norway and other countries have suggested that high sugar and sweetened beverage
intake could be prevalent in this group [9,26–28]. However, the studies from Norway were conducted
several years ago, and it could be that the trend of reducing the intake of added sugar, which has been
reflected in the national dietary surveys, is also the case for this group of children. In the national
dietary surveys, the intake of added sugar decreased from 10 E% in 1999 to 4 E% in 2007 due to the
reduced intake of sugary drinks among Norwegian infants and the reduced levels of added sugar
in commercial infant products [4,29]. In addition, a qualitative survey among Somali-born mothers
in Norway revealed that most mothers thought that their infants at 12 months were too young to be
given sugar [30]. However, the older siblings were usually eating candy and the majority of mothers
had sweets available at home at all times, which may indicate that sweets and sugary drinks may be
introduced at a later stage in the child’s life.
4.4. Factors Associated with Iron Intake
Iron deficiency has been reported to be prevalent among both immigrant and non-immigrant
children in Europe [7,31,32], however, some studies have suggested a higher prevalence among
immigrant children [7,32]. The consumption of milk with low iron content and the excessive
consumption of cow’s milk have been reported in the literature to be factors that may cause iron
deficiency [32,33]. On the other hand, iron-enriched products may be a protective factor against
inadequate iron intake [32].
In the present study, we found no significant differences in iron intake among infants who
consumed dairy products compared to those who did not consume dairy products. There were no
significant differences among those who consumed more than 500 g/day of dairy products compared
to those who consumed less. Still, high consumption of cow’s milk is not recommended as it may
inhibit the iron absorption [34]. Higher iron intakes were observed among infants who received
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iron-enriched products compared to those who did not receive these products. This has also been
found among one-year-old children in other studies [12,35]. The majority of infants in the present
study received iron-enriched products; however, the median intake of iron was lower than the RI [18]
and the intake reported in the national dietary survey (12.8 mg/day) [4] for both Norwegian-Somali
and Norwegian-Iraqi infants. The higher intakes of iron among the infants in the national dietary
survey may be explained by a lower consumption of cow’s milk (92 g/day), with only 51% consumers,
and a higher consumption of commercial infant cereals (293 g/day) and infant formula (144 g/day),
with 82% and 40% consumers, respectively [4]. Commercial infant cereals and infant formula were the
two major sources of iron in the diet of the infants in the national dietary survey, followed by bread
and meat/meat products [4].
4.5. Factors Associated with Vitamin D Intake
The intake of vitamin D exceeded the recommended levels for both Norwegian-Somali
and Norwegian-Iraqi infants. Severe vitamin D deficiency has been reported to be prevalent
among 6-week-old infants of immigrant backgrounds in Norway who did not receive vitamin D
supplements [8]. In the present study, vitamin D supplements were given to the majority
of Norwegian-Somali and Norwegian-Iraqi infants, as was seen in the 6-month survey [13].
The proportion was lower among the Norwegian-Iraqi infants. Vitamin D supplements were more
commonly given in this sample compared to the 67% reported in the national dietary survey;
those infants also had lower average intake of vitamin D (6.8 μg/day) [4]. Those not receiving vitamin
D supplements in the present survey were more likely to have much lower intakes of vitamin D than
those receiving vitamin D supplements and also lower intakes than the RI of 10 μg/day [18]. Vitamin D
supplementation has recently been reported by Moffat et al. [36] to be almost similar and high among
both immigrants and Canadian-born mothers, although less so for refugee mothers. According to their
findings, current public education on vitamin D supplementation delivered by nurses and other health
educators seems to be similarly effective for Canadian and immigrant parents [36]. A study by Madar
et al. showed significant improvement in vitamin D status among infants with immigrant backgrounds
in Norway after receiving free vitamin D supply together with tailor-made information handouts [37].
Vitamin D supplements are provided for free to of non-Western immigrant backgrounds at child health
centres in Norway due to concerns about inadequate vitamin D intakes in this group. [38]. The findings
of this study suggest that this information may have reached the majority of the participating mothers.
4.6. Strengths and Limitations of the Study
Two very specific subgroups of the Norwegian population were chosen for the study, which is
an important strength of the survey. According to lists from the National Population Register, the
participating Norwegian-Somali and Norwegian-Iraqi infants accounted for approximately 19% and
27%, respectively, of all Norwegian-Somali and Norwegian-Iraqi infants who turned 12 months old
during the recruitment period in the three Norwegian counties included. Recruitment challenges are
widely reported in studies among immigrant populations [39], and was also observed in the present
study. The advantage was the use of bilingual field workers, which enabled the recruitment of mothers
with limited Norwegian language skills. A possible limitation is the relatively large number of mothers
lost to follow-up at 12 months, although new mothers were recruited. However, a comparison of
background characteristics from the 6-month survey [13] and a description of the two immigrant groups
by Statistics Norway [40] suggest that the mothers are to some extent representative of Somali-born
and Iraqi-born mothers in these three counties in Norway.
In general, the dietary assessment of infants can be complicated by the fact that dietary habits
change rapidly in infancy. A review by Burrows et al. has indicated that weighed food records may
provide the best dietary estimates for younger children from 0.5 to 4 years old [41]. However, the 24-h
multiple-pass recall is less time consuming and is reportedly used more frequently among immigrant
populations, along with FFQs [39,42]. The recalls were mainly performed face-to-face, which may be a
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benefit as potential misunderstandings can be easily clarified in a personal interview. On the other
hand, the presence of a field worker may cause a perception of authority on the part of the mothers,
which could lead to social desirability response bias [43].
Although the macronutrient composition may reflect the true dietary practices of the
two immigrant groups, reporting errors such as underreporting or overreporting may contribute
to apparently low or high intakes of certain foods [41]. For infants in particular, not all foods served
are necessarily consumed as some is wasted. Furthermore, the mothers may share the responsibility
for their children with other adults (e.g., partners, grandparents and day-care), and it may be more
difficult for the mothers to assess children’s intake during the hours they were not present [44].
In addition, biochemical indicators of iron and vitamin D status were not measured in the present
study, which is necessary in order to assess the infants’ iron and vitamin D status.
5. Conclusions
The findings of this study indicate that the food and nutrient intake of Norwegian-Somali
and Norwegian-Iraqi infants in general seems to be in accordance with the Norwegian dietary
recommendations. The intake of dairy products was generally higher among Norwegian-Somali
infants compared to Norwegian-Iraqi infants, but dairy product intake did not seem to affect iron
intake. Iron-enriched products and vitamin D supplements were important sources of the infants’ iron
and vitamin D intake. Vitamin D supplements and foods rich in iron should continue to be promoted.
Infants with immigrant backgrounds are excluded from the Norwegian national dietary surveys, and
the present study contributes with information about food and nutrient intake among two of these
groups living in Norway. More research to investigate infant feeding practices among immigrant
groups in Norway is needed.
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Abstract: The diet of young children is an important determinant of long-term health effects, such as
overweight and obesity. We analyzed two-day food consumption records from 1526 young children
(10–48 months old) attending 199 daycare centers across The Netherlands. Data were observed and
recorded in diaries by caregivers at the day nursery and by parents at home on days that the children
attended the daycare center. According to national and European reference values, the children
had an adequate nutrient intake with exception of low intakes of total fat, n-3 fatty acids from fish
and possibly iron. Intakes of energy and protein were substantially higher than recommended
and part of the population exceeded the tolerable upper intake levels for sodium, zinc and retinol.
Consumption of fruit, fats, fish, and fluids was substantially less than recommended. The children
used mostly (semi-)skimmed milk products and non-refined bread and cereals, as recommended.
Two thirds of the consumed beverages, however, contained sugar and contributed substantially to
energy intake. In young children, low intakes of n-3 fatty acids and iron are a potential matter of
concern, as are the high intakes of energy, protein, sugared beverages, and milk, since these may
increase the risk of becoming overweight.
Keywords: young children; nutrition; dietary habits; childcare
1. Introduction
Proper nutrition of young children promotes optimal growth and development. The right amount
of energy and nutrients also reduces the risk for developing overweight and obesity, dental caries,
and gastrointestinal problems like constipation and diarrhea. In addition, there is some evidence that
diet quality and especially breakfast consumption is related to cognitive functioning and academic
performance of children [1,2]. Unfavorable dietary habits may have long-term implications, especially
since childhood overweight tends to track into adulthood [3] and overweight and obesity are major
risk factors for cardiovascular disease, type 2 diabetes mellitus, and cancer [4]. Early childhood is a
critical period for prevention of diet-related disease later in life; dietary habits tend to be established at
an early age and are maintained throughout later life [5].
In The Netherlands, about 40% of children until four years of age attend childcare [6].
Childcare providers are in a unique position to educate parents about healthy eating, to encourage
children to eat healthy, and to provide a healthy environment for children to eat, grow and develop.
In the current study, food consumption was registered in a large population of young children
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(10–48 months old) attending day care across The Netherlands. Intakes of energy, macro- and
micronutrients and on consumption of a complete set of food groups (e.g., bread, milk products,
sweetened beverages) were established and compared with current recommendations. Some of the
results have been published previously [7,8]; however, these were based on a smaller sample and only
comprised a small selection of macronutrients and a few food groups.
2. Materials and Methods
2.1. Study Population
Details on the recruitment methods were previously published [7]. In brief, 199 childcare centers
located across the Netherlands, were recruited between 2011 and 2014 to participate in the study,
which was originally offered to all childcare centers in The Netherlands by Nutricia Nederland BV,
Zoetermeer, The Netherlands, as a service to support their nutrition policy. Children between the age
of 10 and 48 months who were attending the nursery for at least two days per week could participate
in the study. The manager of the childcare center invited the children’s parents to participate in the
study and obtained written and signed informed consent from them. The study has been conducted in
accordance with the Declaration of Helsinki and complied with national and EU data protection laws
(Directive 95/46/EC). According to Dutch law, approval by a medical-ethical committee is exempted
for this type of observational research.
2.2. Dietary Intake Assessment
Details on the assessment methods were previously published [7,8]. In brief, at the childcare
center, food and beverage consumption was recorded on a structured poster by the carers for all
children participating in the study during two days. Dutch children attending a childcare center
usually eat breakfast and the main (hot) meal at home and lunch and a morning and afternoon snack at
the childcare center. Few childcare centers serve a hot meal during lunchtime or in the evening. For the
food and beverages consumed at home, a parent completed a structured diary at the same two days.
Berdien van Wezel Dieticians (The Hague, The Netherlands), were responsible for data collection.
Trained dieticians instructed carers and parents, supervised the recording and were responsible for
coding and computer entry of the consumption data using the FoodFigures system [9].
2.3. Data Processing
A raw data set containing, for each child, records with food codes and a quantity (g or mL),
eating occasion (e.g., breakfast), day and location (home or childcare center) per food code was
exported from the FoodFigures system. Data checking and calculation of nutrient intake and food
group consumption was performed using a software application in SAS [10,11] specifically developed
for processing of dietary data [12]. The Dutch food composition database (NEVO), edition 2013,
was used for calculation of nutrient intake [13]. In this edition of the NEVO database, dietary fiber
is considered an energy-contributing nutrient (2 kcal/g fiber). A few food codes were derived from
the NEVO database of 2011 or from an additional food composition database. Data were checked
for inconsistencies and completeness of the records, i.e., two days, both at the childcare center and at
home, should be present for each child. Potential outliers at the high and the low end of the quantity
of consumed foods were listed and checked in the original diaries and posters. After correction of the
database, a final check on potential outliers of the calculated nutrient intake was performed.
2.4. Data Analysis
Mean daily energy and nutrient intake was calculated for all children and for each age group
(i.e., 10 and 11 months old and 1, 2 and 3 years old, which included children ě12–<24 months, ě24–<36
months, and ě36–<48 months, respectively). As (energy-adjusted) nutrient intake differed very little
between boys and girls, their results are not separately presented. We used the “Statistical Program to
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Assess Dietary Exposure” (SPADE) to transform the nutrient intake from the two days into a theoretical
“usual” intake distribution of the population [14]. For all nutrients, we used the SPADE model for
daily intakes, except for n-3 fish fatty acids and folic acid for which the module for episodical intakes
was used and docosahexaenoic acid, for which no model was found that fitted the required criteria.
We followed the European Food Safety Authority’s (EFSA) guidance [15] to compare the usual intake
distribution with dietary reference values (specifically, Adequate Intake and Tolerable Upper Intake
Levels (TUIL)) as established by the Health Council of The Netherlands (HCN) [16–18] and, if relevant,
more recent ones from the EFSA [19]. For this comparison, we assumed that the usual intake based
on the two weekdays that the children attended the childcare center is representative for their true
usual intake.
Furthermore, individual foods were divided into food groups to calculate the mean daily
consumption of each food group. We defined several food group classifications. The first, a classic one,
was based on type of food (e.g., meat, meat products, and poultry; bread; fruit). We used a second
one, based on the food based dietary guidelines (“Schijf van Vijf”) published by The Netherlands
Nutrition Centre (NNC) [20], to compare mean daily consumption of the relevant food groups with
the recommendations that apply to children from 1 to 3 years old. Finally, we subdivided the foods
grouped according to the NNC classification in preferable or neutral foods and foods that should be
eaten by exception only [21]. Preferable foods contribute positively to a diet preventive for chronic
diseases, whereas “by exception” foods contribute negatively to such a diet. Classification of foods is
based on their content of saturated fat, trans fat, sodium, dietary fiber and added sugar. For example,
full-fat milk products (as opposed to skimmed milk) are classified as by-exception food, just as milk
products and beverages with added sugar. The contribution of these food groups to the intake of
selected nutrients was also calculated. Furthermore, we simulated the effect of replacing liquid cow’s
milk by formula among exclusive cow’s milk users on usual iron and protein intake. In this simulation,
liquid cow’s milk was replaced by young children’s formula (with a nutrient composition according to
Nutrilon, Zoetermeer, The Netherlands, a brand from the Nutricia company).
3. Results
3.1. Study Population
Table 1 presents the characteristics of the study population (n = 1526). Body weight and height
are not presented, as they were not considered sufficiently accurate and comprised a high proportion
of missing values.
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10–11 months old 31 2.0
1 year old 411 26.9
2 years old 497 32.6
3 years old 410 26.9
Missing 177 11.6
Zip-code based socioeconomic





Number of days per week
that the child attended
childcare center
2 days 939 61.5
3 days 348 22.8
4 days 68 4.5
5 days 16 1.1
Missing 155 10.2




Between 19 and 67 (mean 41) food records were available per child. A food record comprises
the consumption of a given quantity of a given food or beverage at a given occasion (e.g., breakfast).
14 children were breastfed (11 of whom were 12 months or younger).
3.2. Nutrient Intake
Table 2 displays the average daily intake of macronutrients (mean and standard deviation), both
in absolute amount as in energy density. Boys had a higher mean energy intake than girls (5483 kJ
versus 5271 kJ). All gender differences in intake of macronutrients were attributable to the higher
energy intake by boys. However, the intake relative to energy was very similar for boys and girls
(see supplementary materials Table S1). The absolute intakes of micronutrients (Table 2) were also
somewhat higher for boys than for girls (see supplementary materials Table S1). According to their
parents, 92% of the children had received a vitamin D supplement on at least one of the two study days.
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Table 2. Mean daily nutrient intake by children attending childcare by age (mean of 2 days).
Total Group









Nutrient Unit Mean SD Mean SD Mean SD Mean SD Mean SD
Energy kJ 5383 958 4241 795 4954 822 5424 872 5841 923
Protein g 45 9 32 8 43 9 45 8 48 10
en% 14.1 2.2 12.6 2.2 14.6 2.4 13.9 2.0 13.9 2.1
Carbohydrates g 174 34 136 27 159 30 177 32 189 33
en% 54.4 5.1 54.2 5.9 54 5.3 54.8 5.0 54.5 4.8
Mono- and disaccharides g 100 25 79 18 91 24 102 24 108 26
en% 31.2 5.7 31.4 5.5 30.7 6.1 31.7 5.3 31.1 5.7
Polysaccharides g 75 16 58 15 69 14 75 15 81 16
en% 23.4 3.4 23.1 3.6 23.6 3.6 23.3 3.1 23.4 3.3
Fat g 42 11 34 10 38 10 42 10 45 11
en% 29.1 4.6 30.4 5.5 28.7 4.8 28.9 4.5 29.3 4.3
Saturated fatty acids g 14.8 3.8 12.6 4.7 13.5 3.4 14.8 3.7 16.1 3.8
en% 10.4 1.8 11.2 2.8 10.3 1.9 10.3 1.8 10.4 1.7
Monounsaturated fatty acids g 14.4 4.5 11.7 4.3 12.9 4.2 14.4 4.5 15.8 4.4
en% 10.0 2.3 10.4 3.0 9.8 2.4 9.9 2.3 10.2 2.2
Polyunsaturated fatty
acids (PUFA) g 8.6 3.2 6.7 2.3 8.0 3.1 8.6 3.0 9.4 3.4
en% 6.0 1.8 5.9 1.5 6.1 1.9 5.9 1.7 6.0 1.7
n-3 PUFA g 1.0 0.4 0.9 0.3 1.0 0.3 1.0 0.4 1.1 0.4
en% 0.7 0.2 0.8 0.2 0.7 0.2 0.7 0.2 0.7 0.2
ALA (C18:3 (n-3) cis) g 1.0 0.3 0.8 0.3 0.9 0.3 1.0 0.3 1.0 0.4
en% 0.7 0.2 0.7 0.2 0.7 0.2 0.7 0.2 0.7 0.2
EPA (C20:5 (n-3) cis) g 0.01 0.03 0.02 0.03 0.02 0.03 0.01 0.02 0.01 0.03
en% 0 0 0 0 0 0 0 0 0 0
DHA (C22:6 (n-3) cis) g 0.02 0.04 0.02 0.04 0.02 0.05 0.02 0.04 0.02 0.04
en% 0 0 0 0 0 0 0 0 0 0
n-6 PUFA g 7.3 2.8 5.4 2.0 6.8 2.7 7.3 2.6 8.0 3.0
en% 5.1 1.6 4.8 1.4 5.1 1.7 5.0 1.5 5.1 1.5
Linoleic acid (C18:2 (n-6) cis) g 7.3 2.8 5.4 2.0 6.7 2.7 7.2 2.6 7.9 3.0
en% 5.0 1.6 4.8 1.4 5.1 1.7 5.0 1.5 5.1 1.5
Trans-unsaturated fatty acids g 0.4 0.2 0.3 0.2 0.4 0.2 0.4 0.2 0.5 0.2
en% 0.3 0.1 0.2 0.1 0.3 0.1 0.3 0.1 0.3 0.1
Cholesterol mg 76.1 38.0 45.9 45.9 69.2 37.2 77.4 38.6 84.4 38.2
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Nutrient Unit Mean SD Mean SD Mean SD Mean SD Mean SD
Dietary fiber g 12.6 2.7 12.4 2.6 12.4 2.7 12.5 2.6 13.1 2.7
g/MJ 2.4 0.4 3.0 0.5 2.5 0.5 2.3 0.4 2.3 0.4
Water g 1045 248 885 219 988 240 1047 231 1133 245
Sodium mg 1273 359 790 266 1117 301 1317 340 1420 341
Potassium mg 1923 405 1435 420 1864 391 1934 377 2010 402
Phosphorus mg 943 199 715 190 907 189 941 186 997 206
Magnesium mg 181 38 134 29 172 36 181 34 194 40
Iron mg 6.3 2.0 8.4 2.5 6.5 2.4 6.0 1.7 6.1 1.7
Calcium mg 735 186 684 200 734 177 720 177 745 202
Copper mg 0.61 0.15 0.59 0.13 0.58 0.14 0.60 0.14 0.66 0.15
Selenium μg 22 6 21 6 21 6 22 6 24 6
Zinc mg 6.0 1.4 6.0 1.4 6.0 1.4 5.9 1.4 6.1 1.5
Iodine μg 120 30 118 22 117 31 119 30 124 31
Vitamin A (RAE) μg 846 568 753 448 746 483 834 568 902 626
Retinol μg 731 560 648 434 636 479 712 558 787 618
Thiamin (Vitamin B1) mg 0.58 0.17 0.60 0.20 0.58 0.17 0.57 0.17 0.57 0.17
Riboflavin (Vitamin B2) mg 1.13 0.29 0.97 0.24 1.09 0.27 1.12 0.29 1.17 0.31
Niacin mg 7.7 2.5 6.4 2.6 7.4 2.4 7.7 2.5 8.1 2.6
Vitamin B6 mg 0.80 0.27 0.69 0.28 0.79 0.25 0.81 0.28 0.82 0.28
Folate (DFE) μg 156 47 177 49 162 47 154 50 154 46
Vitamin B12 μg 2.95 1.06 1.95 0.79 2.73 0.90 2.94 1.00 3.18 1.19
Vitamin C mg 93 35 105 29 94 35 92 35 92 35
Vitamin D μg 3.7 2.8 8.4 3.7 4.7 3.5 3.2 2.1 2.8 1.8
Vitamin E mg 6.8 2.8 8.0 2.9 6.8 3.0 6.6 2.7 7.0 2.7
1 The total number of children does not equal the sum of those in the age groups, due to missing data on
age. en%: energy percent, i.e., the energy that the nutrient contributes to the total energy intake of a person,
expressed as percentage; ALA: alpha-linolenic acid; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid;
RAE: retinol activity equivalents; DFE: dietary folate equivalents; SD: standard deviation
Comparing the transformed usual intake distribution with dietary reference values the following
results were found. The intake of most of the assessed macro- and micronutrients was found to be
adequate (see supplementary materials Table S2). Exceptions were encountered for:
‚ Energy: Mean daily intake, both for boys (5.5 MJ) and girls (5.3 MJ), was higher than the
requirement established by the HCN (5 MJ for boys, 4.5 MJ for girls between 1 and 3 years
old [16] and much higher than the intake considered adequate according to EFSA (3.3–4.9 MJ for
boys, 3.0–4.6 MJ for girls [19]).
‚ Protein: Median usual intake (45 g, 14 energy percent) was approximately three times higher than
the Adequate Intake of 5 energy percent [16] or the Population Reference Intake of 11–13 g [19].
Among the children below 1 year, 26% exceeded the TUIL of 15 energy percent for this age.
If, among the children that used exclusively cow’s milk, liquid cow’s milk would be substituted
by formula, median usual protein intake would decrease from 14.2 to 12.3 energy percent.
‚ Fat: Intake was relatively low (29 energy percent). The mean usual intake was within the
recommended range (25–40 energy percent) according the HCN recommendation [16], although
11% of the population had an intake below 25 energy percent. The mean intake was lower than
the more recent EFSA recommendation (35–40 energy percent for children under 4 years [19]).
Less than 5% of the children achieved a usual fat intake of 35 energy percent. No children below
the age of 1 year achieved a usual fat intake of 40 energy percent, as recommended by the HCN
and EFSA.
‚ Dietary fiber: With a mean of 12.7 g or 2.3 g/MJ, the usual intake of the children of 1 year and
older was below the intake considered as adequate by the HCN (2.8 g/MJ [17]) and not achieved
by 92% of them. However, new reference intakes for young children established by EFSA are
lower (10 g [19]). These were achieved by the large majority of the children.
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‚ n-3 fatty acids from fish, i.e., eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA):
the mean daily intake of DHA by children below 2 years and of EPA + DHA by children above
2 years was far below the intake considered adequate by the HCN or EFSA.
‚ Iron: The median usual iron intake of 6.0 mg was lower than the Adequate Intake of 8 mg/day [18]
and also lower than the Population Reference Intake of 7 mg/day established by EFSA [22].
This implies that iron intake was possibly inadequate. Children receiving formula, most of them
in combination with cow’s milk, had a median usual intake of 6.8 mg iron, whereas exclusive
cow’s milk users had a median usual intake of 5.6 mg. If, in the latter group, liquid cow’s milk
products would be replaced by formula, median usual iron intake would increase to 8.5 mg.
‚ Sodium: The percentage of children with a usual sodium intake of more than 1200 mg,
i.e., the upper limit established by the NNC for young children above 1 year, increased with age
from 47% to 81%, whereas the usual intake of all children below 1 year exceeded the upper limit
of 400 mg [23].
‚ Zinc: The median usual intake of 5.9 mg was adequate. However, 17% of the children exceeded
the TUIL of 7 mg/day.
‚ Retinol: 30% of the children exceeded the TUIL of 800 mg retinol. The percentage increased from
27% in the youngest age group to 33% in the oldest age group. Liverwurst spread, popular among
young children, appeared to be responsible for the excess intake.
3.3. Food Consumption
Almost all children (98%) had eaten a breakfast on both days, contributing to 20% of the daily
energy intake. Only 12 out of 1526 (<1%) children did not have breakfast on any of the days.
Table 3 shows the mean daily consumption of food groups, classified according to type of food,
across all age groups. Consumption of potatoes, vegetables, fruits, cereals, and cheese was similar
across all age groups. In contrast, consumption of bread and, in accordance, fat spreads doubled over
age, just as cakes and biscuits, and meat. Consumption of milk products increased slightly over age,
with exception of the much lower consumption (176 g) by children under 1 year. However, this was
compensated by the high consumption (411 mL) of follow-on formulae among the youngest age group,
87% of which used formula. Mean consumption of formulae (follow-on or young-child formulae)
decreased from 111 mL among the 1-years old (41% users) to 15 mL among the 3-years old (7%
users). Consumption of mixed dishes, including baby and young-child meals in jars, also substantially
decreased over age. Mean fish consumption was rather low, and did not change with age. We
calculated from the food records that the children ate fish once per 10 days on average.
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Table 3. Mean daily consumption of food groups (g) by children attending childcare by age (mean of
2 days).
Total Group









Food Group Mean SD Mean SD Mean SD Mean SD Mean SD
Potatoes 29 27 25 25 31 28 28 27 28 26
Vegetables 58 39 48 45 60 41 58 39 61 38
Fruit 128 59 129 66 127 58 129 59 130 61
Legumes 1 7 1 4 2 9 1 6 1 6
Bread 100 35 57 29 86 33 103 33 114 33
Cereals (including rice and pasta) 29 29 21 26 30 30 28 28 30 28
Cakes and biscuits 13 12 6 8 11 10 14 12 16 13
Nuts, seeds, savory snacks 1 5 0 0 1 3 1 5 2 6
Milk and milk products 358 158 176 217 333 162 363 143 383 147
Follow-on and young children’s formula 63 135 411 226 111 162 35 87 15 61
Cheese 14 11 14 10 15 11 14 11 15 12
Eggs 3 8 1 4 2 7 3 8 3 8
Fish 5 12 2 7 5 12 5 12 6 13
Meat, meat products, poultry 44 25 24 23 40 24 44 22 49 26
Soy and vegetarian products 8 49 0 2 8 54 8 47 10 55
Savory spreads 4 6 0 0 3 6 4 6 4 7
Mixed dishes 20 45 52 78 28 53 15 39 14 35
Soups 10 33 0 1 6 23 12 37 13 39
Sugar, confectionary, sweet spreads 18 13 6 7 13 10 20 12 23 14
Fat spreads, oils, savory sauces 24 11 11 8 20 10 24 11 27 12
Non-alcoholic beverages
(excluding milk products) 427 222 182 145 367 204 446 209 508 220
1 The total number of children does not equal the sum of those in the age groups, due to missing data on age;
SD: standard deviation.
3.4. Consumption According to Food-Based Dietary Guidelines
Figure 1 displays the consumption of food groups by children from 1 year, classified according
to the food-based dietary guidelines. Figure 1 shows for each defined food group the percentage
of children with a consumption quantity (g or mL) below and above the recommended daily
consumption. The majority of children did not comply with the recommendations for fruit and
cooking fats. Around 40% of the children did not comply with the recommendations for vegetables,
potatoes (including rice and pasta), cheese, meat (including poultry, fish and eggs) and beverages
(including liquid milk products). Children who ate a hot meal at the childcare center ate more
vegetables: Only 30% of them did not comply with the recommendation. A large majority of
children complied with the recommendations for bread (including breakfast cereals), fat spreads
and milk products.
The food groups were also subdivided into preferable or neutral foods and foods that should be
eaten by exception only. Table 4 shows the mean consumption of each food group. More than half of
the foods from the potatoes group were eaten as by-exception type. This was due to the consumption
of white rice and refined pasta (instead of brown rice and wholemeal pasta). In contrast, bread
and breakfast cereals were almost always eaten as wholemeal or “brown” type. Cheese was mostly
eaten as full-fat type and therefore classified as by-exception type. Milk products were mostly (79%)
consumed as preferable or neutral type, i.e., (semi-)skimmed, non-sweetened milk. Two thirds of
the meat group was eaten as by-exception type, mostly because of the saturated fat content of the
meat or the salt content of processed meats. Fats and oils, in contrast, were predominantly of the
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preferable (less-saturated fat) type. Sixty-two percent of the beverages were drunk as by-exception
type, mostly because they contained sugars. This percentage is even higher as part of the water (in the
preferable group) was used to mix it with fruit juice concentrate or syrup. Thirty-seven percent of
the total foods (in g) consumed by the children were by-exception foods (35% at home and 40% at
the childcare center). The higher consumption of by-exception foods at childcare centers was mainly
attributable to by-exception beverages (see supplementary materials Figure S1).
Figure 1. Percentage of children from 1 year old with a daily consumption (g) below, above or in within
the range of the recommendation.
Table 4 also lists the contribution of the food groups to mean intake of selected nutrients.
Bread, milk products and sweetened beverages were important contributors to energy intake.
Milk products contributed most to protein intake, followed by bread and the meat group.
Sweetened beverages were by far the largest contributors to intake of sugars, at a distance followed by
milk products (contributes mainly lactose), fruit, and sugar and sweet spreads. Bread and potatoes
were the main contributors to polysaccharides. Milk products, meats, and fats and oils contributed
mostly to intake of fat and saturated fatty acids. However, almost half of the intake of polyunsaturated
fatty acids originated from fats and oils. Dietary fiber came mainly from bread and breakfast cereals,
followed by vegetables and fruit. Bread was also responsible for one third of the daily sodium intake
(which excluded salt added at cooking and at the table), followed by processed meats, cheese and milk
products. Fruit, followed at a distance by sweetened beverages (including fruit syrups and juices) and
vegetables and milk, contributed most to vitamin C intake.
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4. Discussion
This study showed that Dutch children aged 10 to 48 months, at the days they attended
childcare, appeared to have an adequate nutrient intake according to national and European reference
values with exception of intakes of total fat, n-3 fatty acids from fish and possibly iron which
were all lower than the reference values. Intakes of energy and protein were substantially higher
than recommended and part of the population exceeded the Tolerable Upper Intake Levels for
sodium, zinc and retinol. Consumption of fruit and fats was substantially less than recommended
according to food-based dietary guidelines. So were, to a lesser extent, components of the hot meal
(vegetables, potatoes/rice/pasta, and meat/fish/poultry/eggs) and fluids. The children consumed
milk products and bread mostly as recommended with respect to type (i.e., low fat and high fiber
types, respectively), but milk consumption was on average higher than recommended. A notably high
consumption of sugar-containing beverages contributed substantially to energy intake. Almost all
children ate breakfast and received vitamin D supplements at the recorded days.
Results presented here are from a large dataset, which covers a very large variety of childcare
centers, located across the country. Some limitations should be mentioned. Firstly, the authors were
not involved in the design of the data collection methods, nor in the execution of the data collection.
It was therefore difficult to evaluate the quality of the data. However, based on the documentation
provided and the performed data checks, we assessed the data to be of sufficient quality to merit
publication. Missing data on gender, age, and body weight and height reduced the usefulness of
the data. However, comparing our results with those of the Dutch National Food Consumption
Survey conducted among young children in 2005/2006 in the age categories of 2- and 3-years old
overlapping between the studies, we observed that mean energy intake was very similar between
the surveys (5632 kJ/day versus 5645 kJ/day, respectively). The Dutch National Food Consumption
Survey concluded, based on comparison of energy intake and energy requirement, that underreporting
was not an issue in their survey [24]. We conclude therefore that substantial underreporting is unlikely
in our study either. Secondly, there are considerations with respect to the study population and design.
During the period of data collection (2011–2014) approximately 40% of Dutch children under the age
of 4 attended a childcare center on one or more days per week [6]. Although formal childcare in
the Netherlands is partly subsidized depending on family income, parents (in particular mothers) of
children attending a childcare center had on average a higher family income, were more educated
and worked more hours per week than parents of other children of the same age [25]. The study
population was therefore not representative of the total Dutch population of 10 to 48 months old.
In addition, response rates were not formally monitored. Furthermore, food consumption was only
recorded on days that the children attended the childcare center. Although we assumed—to compare
the children’s usual nutrient intake distribution with dietary reference values—that the recorded days
were representative of a child’s diet, this can be questioned, considering the structure of the day, the
food provider, and possible peer pressure. Nevertheless, the data are valuable in their own right.
They were mostly observed and recorded directly by the food providers, both at home and at the
childcare center. The latter is unusual in food consumption surveys.
As concluded from other studies and countries, reviewed by EFSA [19], intake of n-3 fatty acids,
in particular DHA and EPA, and iron and vitamin D is low among the Dutch young children. The low
dietary intake of vitamin D was largely remedied through the high proportion of children (92%) that
received a vitamin D supplement. Although some practitioners doubt whether such a high percentage
of supplement users is real, communication about the recommendation has improved since 2012.
Intake of n-3 fatty acids was much lower than recommended. Mean DHA intake by children younger
than 2 years is only one fifth of the intake considered as adequate (100 mg/day). Children receiving
formula, fortified with DHA, more or less double their DHA intake. If the children of 2 to 4 years old
would eat 50 g lean fish and 50 g fatty fish such as salmon per week, as recommended by the NNC, they
would easily achieve an adequate intake of DHA and EPA combined. Whether the low n-3 fatty acid
intake has health consequences is uncertain. As for iron, there is evidence that iron deficit at young age
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may interfere with cognitive development [26,27]. However, while the usual iron intake of all children
in this survey is above the Average Requirement of 3 mg/day for 1–3 years old established by the US
Institute of Medicine [28], 25% of the children from 1 year do not achieve the Average Requirement of
5 mg/day recently proposed by EFSA [22]. Recent research in a well-defined, healthy population of
400 young children in The Netherlands has shown that iron deficiency and iron deficiency anemia
was detected in 18.8% and 8.5% of the children, respectively, with a lower iron deficiency prevalence
among children receiving formula and a higher prevalence among children receiving a large amount
(more than 400 mL/day) of cow’s milk after adjustment for age [29]. However, iron intake was not
assessed in this study.
The high intake of energy and protein among young children is also a universal observation
across Europe [19]. They both increase the risk for overweight [30,31]. In particular the 1-year-old are
at risk: they use a lot of milk, mostly cow’s milk and also formula, and have the highest protein intake.
Although no reference value for sugars has been established by the HCN or by EFSA, increasing
evidence shows that in particular sugar-sweetened beverages increase the risk of overweight [32].
We also found that usual intake exceeded the Tolerable Upper Intake Level for zinc (17%) and retinol
(30%). As the Adequate Intake and TUIL for zinc are very close, such an excess is inevitable and is
unlikely to be harmful. The TUIL for retinol intake among young children is based on the relatively
low TUIL for pregnant women owing to its teratogenic effects and adjusted to children. Some excess
intake is therefore not likely to be harmful for young children. Also, vitamin A intoxication has not
been reported in young children in The Netherlands. Excess retinol intake can nevertheless be avoided
if childcare centers and parents restrict the consumption of liverwurst (spread) by their young children,
in accordance with the NNC guideline. Dietary sodium intake—70% of the children exceeded the
TUIL set by the NNC—is difficult to reduce without endangering a balanced diet. Even though the
Dutch bread sector made a major effort to reduce the salt content of bread, bread is a main contributor
to young children’s sodium intake. According to EFSA, however, sodium intake is not a matter of
concern [19].
The results of this survey are in particular informative to nutrition policy and education, both for
childcare organizations as for parents and youth health care providers. They demonstrate that the
young children’s food consumption pattern could be substantially improved by a few changes, such
as a replacement of sugared beverages by water and some reduction of milk products. For example,
milk-based desserts could be replaced by fruit. Childcare centers that serve a hot meal are able to
increase the children’s daily vegetable consumption. All in all, these changes would result in lower
energy and protein intake and higher vegetable and fruit consumption, which may in turn lower the
risk of overweight. Reduction of a high milk consumption should be able to enhance iron absorption
from the diet, as calcium hampers iron absorption. Stimulating fish consumption, both at home
and at day care, is a feasible way to increase intake of n-3 fatty acids. Only if, in specific situations,
a recommended diet is difficult to achieve, replacement of cow’s milk by formula may help to meet
some of the dietary recommendations.
5. Conclusions
Dutch 10 to 48-month-old had, at least on the days they attended childcare, mostly an adequate
nutrient intake. The intake of n-3 fatty acids and of iron however was low, which is in line with
European findings. This seems a matter of concern in young children in this survey and most likely
in all young children in the Netherlands, although more research is needed on their potential health
effects. The high intakes of energy and protein in this population are also a matter of concern as they
may increase the risk of becoming overweight.
Almost all children ate breakfast and received vitamin D supplements. They used mostly
(semi-) skimmed types of milk products and non-refined bread and cereals, as recommended.
However, their relatively high milk consumption and very high consumption of sugared beverages
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are undesirable and the latter should be replaced mostly by water. The relative low consumption of
fruit, vegetables and fish, on the other hand, should be increased.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/8/7/428/s1,
Figure S1: Consumption of foods by 1–3 years old by location, Table S1: Mean daily nutrient intake by children
10–48 months old attending childcare by gender (mean of 2 days), Table S2: Distribution of usual nutrient intake as
calculated with SPADE model for daily intakes and comparison of the distribution with dietary reference values.
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Abstract: Timing and type of complementary food in infancy affect nutritional status and health later
in life. The objective of this paper was to assess complementary feeding practices, looking at timing,
type, and compliance with World Health Organization (WHO) recommendations. Data were obtained
from a birth cohort of 400 infants, enrolled in Trieste (Italy) between July 2007 and July 2008 and
followed up for three years, using a “food introduction timing table”. Five WHO recommendations
standards were used to assess parental compliance and associated factors. Thirty seven percent of
mothers returned the completed “timing table” up until the child was three years of age. Eighty six
percent of infants were already receiving complementary foods at six months. The first food type to be
introduced was fresh fruit (170 days from birth, median). Overall, infants shared a very similar diet,
which was different from the family diet and characterized by delayed introduction of certain food
types. Five percent of parents complied with either all five or only one of the WHO recommendations,
34% with three, and 35% with four. The parents’ partial compliance with WHO recommendations is
probably due to conflicting information received from different sources. This advocates for national
evidence-based guidelines, supported and promoted by health professionals.
Keywords: complementary feeding; compliance with WHO recommendation; timing of introduction
of complementary food; infant nutrition; Italy
1. Introduction
Complementary feeding is a process that, according to World Health Organization (WHO) [1],
should take place between the ages of around six months and two years, this being a crucial period for
child growth, development, and health. Studies conducted in low and high-income countries show
that inadequate nutrition during this period increases the risk of becoming underweight or overweight,
with potentially serious life-long health effects [2–5]. Under- and over-nutrition can coexist in the
same country, regardless of the country’s economic status, and tend to affect the poorest population
groups [6]. The time of introduction of complementary foods, as well as their type, are crucial not only
to ensure that nutritional needs are met in the short term, but also to promote good health later in life
and to prevent overweight and obesity [7–10].
The WHO recommends, as a public health measure, exclusive breastfeeding up to six months
of age, followed by adequate, safe and appropriate complementary foods with breastfeeding
continuing up to two years and beyond [1]. This recommendation has been adopted in many
countries, including Italy [11]. In conflict with the WHO recommendation, the European Society
for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) recommends the introduction
of complementary foods no earlier than 17 and no later than 26 weeks of age [12]. This commentary
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triggered a debate [13], and in 2011 the WHO released a statement reaffirming that exclusive
breastfeeding for six months has several advantages over exclusive breastfeeding for three to four
months, and should be followed by gradual introduction of solid food alongside breastfeeding [14].
WHO also recommends that, between the ages of 6 and 12 months, the infant’s diet should be
progressively integrated into a healthy family diet, without restrictions on the types of food that
are offered. There is no evidence to support the practice of delaying the introduction of potentially
allergenic foods (e.g., tomatoes, fish, eggs), with the exception of the replacement of breast milk or
formula with cow milk, which is not recommended before 12 months of age due to its low content
in iron [15]. This recommendation is shared by ESPGHAN [12]. Finally, WHO warns against the use
of honey in the first 12 months due to the risk of botulism, and recommends that, from six months
onwards, infants should make a gradual transition to eating family foods limiting the consumption
of commercial complementary foods [1,16] as these may delay the infant’s acceptance of the family’s
normal diet [15].
In spite of these recommendations, data on current feeding practices suggest that the introduction
of complementary foods before six months is common in many countries [17,18], including Italy [19,20],
where there are no Ministry of Health guidelines on complementary feeding. The national guidelines
on the protection, promotion, and support of breastfeeding simply state that “after six months, breast
milk, with appropriate complementary feeding, provides an important contribution to the nutrition,
health and development of the child” [11]. What “appropriate complementary feeding” means is not
clearly explained.
The cohort study aimed at investigating the transition from milk to family foods, and
its association with overweight, in a birth cohort of 400 children followed up for 36 months.
The prevalence and duration of breastfeeding, the data on nutrient intake at six month of age and on
the mothers’ socioeconomic status, have already been reported in previous papers [20,21]. The specific
objective of the present research was to assess complementary feeding practices, focusing on timing,
characteristics, and compliance with the WHO recommendations. Considering that there is very
little national data [19,22] describing complementary feeding practices, a better understanding of
parents’ approach to the introduction of complementary foods could support the development of
evidence-based national guidelines on infant feeding.
2. Materials and Methods
Data were obtained from a cohort study conducted at the maternity hospital of Trieste (Institute for
Maternal and Child Health Burlo Garofolo), Italy, between July 2007 and July 2011. A cohort of
400 mother-infant pairs was followed up for three years, using telephone interviews and self-reported
diaries to investigate feeding practices and attitudes of mothers. The study was approved by the
ethics committee of the Institute. The study design, methods, and sampling procedures have already
been reported [21]. In brief, mother-infant pairs were enrolled at birth according to the following
eligibility criteria: birth weight ≥2000 g, no congenital malformation nor severe diseases that required
hospital admission, gestational age of 36 completed weeks or more, and residence in the province
of Trieste. Upon enrolment, mothers were checked for eligibility and asked to give their informed
consent. During the first contact, they were given a feeding diary with instructions on how to record
type and quantity of foods over a 24-h period on three separate non-consecutive days at 3, 6, 9, 12, 18,
24, and 36 months of age of the infant [23,24].
At the same time, mothers were also given a “timing of introduction of food timetable”
(“food timetable”) in which they were asked to record information on the characteristics, preparation
and date of introduction of the first food type for each of 17 set food categories. The food timetable
was handed back to the researchers when the child was 36 months old, together with the last feeding
diary and the data on weight and length/height of the child recorded by the paediatricians at 1, 3, 6, 9,
12, 18, 24 and 36 months, on the occasion of periodic health checks.
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The food timetable was divided into food categories: fresh fruit, vegetables (with a separate
category for tomatoes because of their potential allergenicity), cereals (with a focus on gluten free pasta
and bread), cow milk, milk products, meat, legumes, fish, eggs, cured meats, industrial fruit juice,
tubers, honey, sugar (added to drinks or foods), sweets, creamy porridge, and nuts and seeds. For each
food category, mothers were asked to record the date of the first tasting and the date from which
the food type was fully incorporated in the infant’s diet, if different from the date of the first tasting.
Mothers were also asked to record the method of preparation (e.g., raw or cooked, homogenized or
lyophilized) and the characteristics (e.g., commercial baby food or homemade) of each food item.
WHO recommends appropriate complementary feeding starting from the age of six months,
with continued breastfeeding up to two years and beyond. Appropriate complementary feeding is:
timely, adequate, safe, and properly fed. On the basis of these indications we derived from the WHO
recommendations five standards to assess compliance:
1. introduction at or after 6 months;
2. “minimum dietary diversity”;
3. use of homemade vs. commercial baby food;
4. introduction of cow’s milk at 12 months or more;
5. introduction of honey at 12 months or more.
Recommendation 1 describes the concept of “timeliness”, recommendations 2, 3, and 4 cover
“adequateness”, meaning that food provides sufficient energy, protein, and micronutrients to meet
a growing child’s nutritional needs. “Safety” is represented by recommendation 5. With regards to
“propriety of feeding” the timing questionnaire did not assess either meal frequency or feeding methods.
The second recommendation is based on a slightly modified version of WHO’s “minimum dietary
diversity” indicator, by which infants are defined as “compliant” if their diet incorporates four to seven
different food categories by the age of 12 months. [25]. The seven food groups used by WHO to codify
this indicator are: “grains, roots, and tubers”; “flesh foods (meat and fish)”; “dairy (milk) products”;
“legumes and nuts”; “vitamin-A rich fruits and vegetables”; “other fruits and vegetables”; and “eggs”.
In the present study, “vitamin-A rich fruits and vegetables” were not assessed as an independent group
because Italy is considered to be free from vitamin A deficiency [26]. Instead, we chose to allocate to
fruits and vegetables two separate categories with the aim of evaluating their independent contribution
to the daily diet. Because our timing questionnaire covered a period of three years, we also extracted
an index of “maximum dietary diversity” to determine how many children had introduced all seven
food categories into their diet by the age of 12 months.
For the third recommendation, we analyzed the consumption of homemade vs. commercial
complementary baby food defining the use of the latter as ‘high’ if it covered at least three out
of five food groups (fruit, vegetables, meat, fish, cereals, and milk products) at six months of age.
Almost 38% of infants fell into this category.
Differences between groups were examined with Fisher exact two-tailed test for categorical
variables and with Mann-Whitney rank-sum test for continuous variables.
In order to perform the logistic regression analyses described below, the sample was divided into
two groups based on the timing of the first introduction of complementary food. The cut-off was set
at 21 weeks, which was the median of the distribution curve (Figure 1). The 21 weeks value had the
additional advantage of falling in the middle of the ESPGHAN recommended window (17 to 26 weeks).
This timing distribution was used as dependent variable.
The independent variables reflected the objective of the study to assess compliance with WHO
recommendations both as stand-alone variables and as overall compliance with any three out of
five. The relation between these independent variables and timing was analyzed using stratified and
simultaneous univariate and multivariate logistic regression analyses. The variables included in the
simultaneous models are presented in Supplementary Materials Tables S1–S6.
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The stratified analysis was carried out considering each of the following variables:
mothers’ characteristics, including age (≥34 years), body mass index (BMI) before pregnancy (≥25),
place of birth (Italy vs. other), level of education (degree or higher vs. lower), occupation, whether she
was breastfeeding or had breastfed, if she had allergies or a family history of allergies, if she was or had
been a smoker, and type of professional figure (paediatrician or midwife) who provided counselling
on complementary feeding.
Figure 1. Distribution curve of the timing of first introduction of complementary foods in weeks.
The probability density function was estimated with a non-parametric Kernel density estimation (KDE).
The characteristics of the mothers were selected based on literature data. The information on
which professional figures were providing counselling on complementary feeding was based on the
hypothesis, formulated by the authors but also supported by literature [27,28], that this may influence
mothers’ behavior.
All the analyses were carried out using Stata IC 14.1 (StataCorp LP, College Station, TX, USA).
3. Results
3.1. Population Characteristics
Four hundred mother-infant pairs were enrolled in the study, but only 148 (37%) completed
and returned the food timetable when the child reached 36 months of age. The participation rate
declined during the study: after three months 34% (135/400) of mothers had withdrawn from the study.
This percentage subsequently followed a fluctuating pattern, rising to 59% (235/400) at 6 months and
then dropping to 43% (173/400) and 41% (165/400) at 9 and 12 months, respectively. By the time of
the 24-month interview, the study cohort had reduced by 67% (132/400). The characteristics of the
mothers and infants of the sub-cohort that completed the timing questionnaire are described in Table 1.
No statistically significant differences were observed between the cohort (400) and the sub-cohort
(148), as already reported [16,17]. In brief, 89% of mothers (mean age 33.7 years; Standard Deviation
4.4) had a medium-to-high level of education, 95% declared they were employed before birth and 80%
were in employment at six months after birth. Most infants (90%) were born between 38 and 42 weeks
of gestation and 82% by vaginal delivery. The majority (91%) weighed between 2500 g and 4199 g at
birth, and 79% were between 46 and 52 cm long. The infants’ mean BMI was calculated at three and
six months: 70% and 75% of infants had a BMI that fell within the normal range (between the 15th and
the 85th WHO percentile), 15% and 3% were below the 15th percentile, while 15% and 21% were over
the 85th percentile, respectively.
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Table 1. Characteristics of mothers at enrolment and children at birth.
Cohort Sub-Cohort
Mothers n (%) n (%) p *
Age (years) (n = 399) (n = 148) 0.713
≤29 90 (23) 29 (20)
30–34 160 (40) 59 (40)
≥35 149 (37) 60 (40)
Born in Italy (n = 400) (n = 148) 0.451
Yes 351 (88) 134 (91)
No 49 (12) 14 (9)
Education (n = 348) (n = 147) 0.158
≤Secondary school 59 (17) 16 (11)
Completed high school or equivalent 154 (44) 64 (43)
Bachelor degree or higher 135 (39) 67 (46)
Employment before birth (n = 323) (n = 136) 1.000
Yes 306 (95) 129 (95)
No 17 (5) 7 (5)
Employment at 6 months after birth (n = 218) (n = 147) 0.790
Yes 176 (81) 117 (80)
No 42 (19) 30 (20)
Allergy of mother or of other family member (n = 263) (n = 148) 0.812
Yes 64 (24) 38 (26)
No 199 (76) 110 (74)
Children n (%) n (%) p
Gestational age (weeks) (n = 339) (n = 147) 0.730
36–37 29 (9) 14 (9)
38–42 310 (91) 133 (91)
Infant gender (n = 345) (n = 148) 0.142
male 173 (50) 85 (57)
female 172 (50) 63 (43)
Birth weight (g) (n = 344) (n = 148) 0.552
<2500 3 (1) 2 (1)
2500–4199 324 (94) 136 (92)
≥4200 17 (5) 10 (7)
Birth length (cm) (n = 342) (n = 148) 0.563
<46 5 (1) 2 (1)
46–52.9 283 (83) 117 (79)
≥53 54 (16) 29 (20)
* p-Value is calculated using a two-tailed Fisher Exact test.
3.2. Timing of Complementary Feeding
At six months of age, 73% of infants were still receiving breast milk but, in contrast with WHO
recommendations, only 7% were exclusively breastfed; 40% received formula and breast milk, 27% only
formula and 26% breast milk and complementary food. One infant was given food other than milk
before the age of three months, 7% at three months, 32% at four, 47% at five months. Only 14% of
infants were given their first complementary food at six months or more
The median age of introduction of solid foods was 5.2 months (min 2.8; max 7.2). The
interval between the first tasting and the complete introduction of the different food categories
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ranged from 6 to 32 days. The range was narrower for food groups such as dairy products,
vegetables, and cereals (6, 6, and 7 days, respectively) and wider for honey, sugar, and cow milk
(32, 29, and 22 days, respectively). The timetable of the complete introduction of each food category is
reported in Figure 2.
Figure 2. Timing of introduction of the single food groups in days from birth. The ends of the whiskers
are set at 1.5*IQR above the third quartile (Q3) and 1.5*IQR below the first quartile (Q1). If the Minimum
or Maximum values are outside this range, then they are shown as outliers. IQR = Inter Quartile Range.
In the figure, the cereals/tubers categories and the sweets/desserts categories, which include
sweets and creamy porridge, have been merged for representational purposes. The first food group to
be introduced was fresh fruit (at a median age of 170 days); followed by vegetables (182 days); cereals,
including bread, pasta with gluten, and rice (193 days); milk products (189 days); and meat (197 days).
The last food groups to be introduced were cow milk (362 days), honey (365 days), and nuts and seeds
(484 days). In 80% of the cases, the first type of food to be offered was the apple, followed by vegetable
soup (41%), and baby cereals (41%). The use of gluten-free products (bread, pasta, and desserts) was
low (17% of infants) and the timing of their introduction was similar to that of the products with gluten.
The introduction of pasta with gluten occurred at a median of 234 days, as opposed to 224 days for
gluten-free pasta. The most frequently used commercial baby food types were: milk products (67%),
fish (62%), sweets and desserts (61%), cured meat (52%), cereals (52%), meat (49%), fruit (27%), and
vegetables (3%).
3.3. Compliance with WHO Recommendations
Table 2 shows the percentage of mothers who complied with the WHO recommendations on
complementary feeding. The recommendations to which most mothers adhered were the minimum
diversity diet (96%) and the introduction of honey after 12 months of age (80%), while 62%
of the mothers complied with the recommendation to limit the use of commercial baby foods.
However, the analysis of the “maximum diversity diet” indicated that, by the age 12 months, only 45%
of children had introduced all seven food groups and, in particular, eggs and legumes had been
introduced by 53% and 74% of infants, respectively.
Table 2. Percentage of mothers who followed the WHO recommendations (n = 148).
Items Included in the Score (n)
Introduction of solid foods ≥6 months 14% (21)
Reduced use of commercial baby foods 62% (92)
Introduction of cow’s milk ≥12 months 63% (94)
Introduction of honey ≥12 months 80% (118)
Minimum dietary diversity 96% (142)
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As shown in Figure 3, eight mothers (5%) complied with all five recommendations and eight
(5%) complied with only one, while 34% complied with at least three recommendations. Within this
subgroup, the least frequently adhered to recommendation was the introduction of complementary






























Figure 3. Number of recommendations (0, 1, 2, 3, 4 and 5) followed by mothers and percentage
of compliance.
3.4. Regression Analyses
The stratified analyses showed that only few of the outcomes considered were significantly
associated with selected mothers’ characteristics. The introduction of cow milk after 12 months was
significantly associated with the introduction of the first foods at 21 weeks of age or more if mothers
were not breastfeeding their infants at six months (66%, p = 0.03), did not have a family history of
allergy (80%, p < 0.01), had a BMI (kg/m2) of less than 25 (72%, p = 0.02), and were younger than
35 years old (76%, p = 0.02). The test of homogeneity showed significant differences only between
mothers with or without a history of allergy (p = 0.03).
Compliance with at least three out of five recommendations was significantly associated with
the introduction of the first food at 21 weeks of age or more, if mothers where not breastfeeding their
infants at six months (63%, p = 0.05), did not have a family history of allergy (74%, p = 0.01), had a BMI
(kg/m2) of less than 25 (71%, p = 0.02), and if they had received information on infant feeding from a
midwife (68%, p = 0.03).
The multivariate logistic regression analyses showed no significant associations between the
outcomes and maternal characteristics, probably due to the small size of the sample. The results are
reported in the Supplementary Materials section (Tables S2–S6).
4. Discussion
As already observed in other studies [20,22,29], the timing of the introduction of complementary
foods tends to follow a standard pattern: the infant’s diet includes only few categories of food and
differs substantially from that of the family, with commercial baby foods taking up a considerable
share. Our study shows that the feeding practices of this cohort follow the same pattern and fall short
of the WHO recommendations on breast and complementary feeding. Seventy five percent of mothers
adhered to three or more out of five WHO recommendations on adequate complementary feeding,
but only 5% complied with all five. The lowest rate of compliance related to the recommendation to
introduce complementary foods at six months or more, with 86% of infants receiving complementary
foods before the age of six months. This percentage is higher than the one reported in a recent
study in the Netherlands [14], but close to the data reported in a nutrition survey from the UK [30]
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and in a WHO multicenter study of comparable sample size conducted in different countries [31].
However, comparisons with other studies are difficult because most of them adopt a cut-off of 17
weeks of age for early introduction, as recommended by ESPGHAN [12].
Despite the evidence that, in terms of prevention of allergies, there is no benefit in delaying the
introduction of potentially allergenic foods [15] and that, in fact, early contact with food can induce
tolerance and desensitization [32], the mothers in our cohort deferred the introduction of tomatoes,
eggs, fish, and nuts and seeds, to between 8 (fish) and 16 months of age (nuts and seeds), as shown in
Figure 2. This may have contributed to the lack of “maximum dietary diversity” by 12 months observed
in more than half of the infants in our cohort. Indeed, as noted in a recent national survey [33,34],
in a developed country such as Italy, without nutritional deficiencies and with high availability of
nutrients, the “maximum dietary diversity” index could, and should, be higher.
It has been shown that the process of food learning starts very early and that there is a period in
which new foods are relatively easily accepted [35,36]. Because food preferences developed at an early
age may have long-lasting influence [37], it would be desirable to expose infants to as many tastes as
possible in the first year of life. In her study [38], Cashdan showed that infants introduced to solids
unusually late maintain a reduced diet and food range throughout childhood, perhaps as a result of
the contraction of the sensitive period.
The partial compliance with WHO recommendations observed in our cohort, has already been
reported by others [22,29,39]. Considering that 98% of the mothers in our study declared they received
information on complementary feeding from their paediatrician and that in 62% of the cases, this advice
was followed, the role of health professionals seems to be crucial, despite the lack of a statistically
significant association in our regression analyses.
One of the possible reasons for the lack of correct and consistent information on the timing
and type of complementary feeding is that in Italy there are no specific national Ministry of Health
guidelines incorporating the WHO recommendations. These are therefore unevenly acquired by health
professionals and poorly transferred to parents.
To our knowledge, this is the first study to explore in detail timing of complementary feeding
and compliance with WHO recommendations, and associated factors, in Italy. The study does,
however, have a number of limitations. The main problem is the loss to follow up of enrolled
mother-infant pairs between birth and 36 months of age (37%), which greatly reduced the availability
of complete data and thus the power to detect significant associations by multivariate analyses.
The second major limitation is the complexity of the food timetable which required regular updating
over a long period of time with detailed information regarding newly introduced food types.
Although this tool is designed to provide high quality data, in our case this was at the expense
of the sample size, making it difficult to compare our results with those of other national surveys.
5. Conclusions
Our paper describes the partial compliance with WHO recommendations on complementary
feeding, in northeast Italy. Most of the infants in our cohort were started on complementary foods
before the age of six months. They shared a very similar diet, which was very different from the family
diet and characterized by the delayed introduction of certain food types. Further research will be
needed to clarify the association between compliance with recommendations and socio-economic
variables, in order to identify vulnerable groups in the population, including migrant families.
Taken together, our results suggest that Italy would greatly benefit from national evidence-based
guidelines on infant feeding to support the development of solid public health strategies.
These guidelines should be free from commercial interests, consistently adhered to, and promoted by
all health professionals, especially in the light of the considerable influence their advice seems to have
on parental practices.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/9/1/34/s1.
Table S1: Association between introduction of first foods after 21 weeks and compliance with WHO recommendations
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both as stand-alone variables and as overall compliance with any three out of five and selected variables by bivariate
logistic regression analysis (n = 148), Table S2: Association between introduction of first foods after 21 weeks and
introduction of honey after 12 months adjusted by selected variables by multivariate logistic regression analysis
(n = 130), Table S3: Association between introduction of first foods after 21 weeks and introduction of cow milk after
12 months adjusted by selected variables by multivariate logistic regression analysis (n = 130), Table S4: Association
between introduction of first foods after 21 weeks and less consumption of baby food adjusted by selected variables
by multivariate logistic regression analysis (n = 130), Table S5: Association between introduction of first foods after
21 weeks and minimum dietary diversity recommendation adjusted by selected variables by multivariate logistic
regression analysis (n = 130), Table S6: Association between introduction of first foods after 21 weeks and compliance
with three out of five WHO recommendations adjusted by selected variables by multivariate logistic regression
analysis (n = 130).
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Abstract: The nutritional quality of infant food is an important consideration in the effort to
prevent a further increase in the rate of childhood obesity. We hypothesized that the canning of
composite infant meals would lead to elevated contents of carboxymethyl-lysine (CML) and favor
high glycemic and insulinemic responses compared with milder heat treatment conditions. We have
compared composite infant pasta Bolognese meals that were either conventionally canned (CANPBol),
or prepared by microwave cooking (MWPBol). A meal where the pasta and Bolognese sauce were
separate during microwave cooking (MWP_CANBol) was also included. The infant meals were
tested at breakfast in healthy adults using white wheat bread (WWB) as reference. A standardized
lunch meal was served at 240 min and blood was collected from fasting to 360 min after breakfast.
The 2-h glucose response (iAUC) was lower following the test meals than with WWB. The insulin
response was lower after the MWP_CANBol (´47%, p = 0.0000) but markedly higher after CANPBol
(+40%, p = 0.0019), compared with WWB. A combined measure of the glucose and insulin responses
(ISIcomposite) revealed that MWP_CANBol resulted in 94% better insulin sensitivity than CANPBol.
Additionally, the separate processing of the meal components in MWP_CANBol resulted in 39%
lower CML levels than the CANPBol. It was therefore concluded that intake of commercially canned
composite infant meals leads to reduced postprandial insulin sensitivity and increased exposure to
oxidative stress promoting agents.
Keywords: infant food; glycemia; insulinemia; human; advanced glycation end products;
carboxymethyl-lysine; early protein hypothesis; protein quality; carbohydrate digestibility;
glycemic index
1. Introduction
In the development of infant formulas, weaning food, and composite infant meals, the main aim
has traditionally been to ensure the provision of adequate amounts of essential nutrients. Great interest
has therefore been devoted to the availability of certain nutrients, such as protein and selected minerals.
Two nutritional quality characteristics that are emphasized in food for adults are the availability
of carbohydrates affecting the glycemic response, and the presence of process-induced advanced
glycation end products (AGEs), which affect the biological value of the protein. Carbohydrate-rich
foods with low glycemic impact were recently classified as relevant for the prevention and treatment
of type 2 diabetes, coronary heart disease, and probably obesity [1]. High-glycemic meals have
been associated with the increased activation of inflammatory markers in the postprandial phase [2].
Elevated intakes of AGEs are of interest due to their association with cardiometabolic risk markers
and pathological conditions such as diabetes [3–5]. In the case of powder-based weaning foods,
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considerable and varying amounts of AGEs were recently reported in milk powder, infant formulas,
and gruel [6,7]. Furthermore, high intakes of ultra-processed food products were recently positively
and independently associated with increased prevalence of excess weight gain and obesity in different
age groups in Brazil [8]. It is interesting to note that composite canned meals intended for small
children are subjected to high-temperature treatment. Excessive heat treatment is known to affect
the availability of the carbohydrate component [9], and the homogenization of composite infant
meals prior to canning is likely to further increase the availability of the carbohydrate components
for digestion and absorption [10]. Additionally, homogenization of the meal components could be
expected to boost AGE formation by enhancing the accessibility of the necessary precursors.
Based on the above, we hypothesized that the canning of homogenized composite infant meals
may render carbohydrates and protein rapidly available for digestion and absorption, leading to high
blood glucose and insulin responses. Furthermore, it was hypothesized that the increased availability
of carbohydrates and proteins would result in the formation of higher levels of AGEs than in less
harshly processed composite meals. The objectives of the present work were to establish some of the
nutritional quality characteristics of canned homogenized composite meals intended for infants, and
to compare them with more gently processed alternatives.
2. Methods
Two studies were performed, the first of which involved a commercially canned pasta Bolognese
meal and a canned composite meal with beef and white beans (Study 1). In the second study,
a commercially canned pasta Bolognese meal (purée with some intact soft pieces) was again used
and compared with a similar but microwave heat-treated meal (cracked spaghetti with minced meat
and vegetables). Separately boiled cracked spaghetti served with a commercially canned meat sauce
was also included. White wheat bread (WWB) was used as a reference [11] in both studies to allow
the determination of the glycemic index (GI) and the insulinemic index (II). The GI is defined as the
incremental area under the blood glucose curve (iAUC) following the intake of a test meal, expressed as
a percentage of an equi-carbohydrate reference meal, eaten by the same subject. The II is calculated
similarly, based on the corresponding insulin responses. WWB is a starch-rich product considered
to be a more physiologically relevant reference product than pure glucose, due to its more complex
food matrix. The meal studies were performed in healthy adults to investigate the postprandial effects
on glucose and insulin. In Study 2, non-esterified fatty acids (NEFAs) and triglycerides (TGs) were
also analyzed. N-carboxymethyl-lysine (CML) was used as a marker of AGEs. The CML contents in
some commercially canned composite infant meals and relevant composite frozen meals intended for
adults were included for comparison. All test products were heated to eating temperature prior to the
analysis of CML, determination of rate of in vitro starch hydrolysis, or being served as a test meal.
2.1. General Study Design
Healthy adult volunteers were recruited for the studies. All test subjects gave their informed
consent, and were aware that they could withdraw from the study at any time. The studies were
approved by the Regional Ethical Review Board in Lund (LU 558-01 and 2012/615). The test meals
and the reference meal were served as breakfast in a random order, after overnight fasting. The tests
were performed approximately one week apart and commenced at the same time in the morning.
Subjects were instructed to maintain their regular lifestyle throughout the period of the study. The day
prior to a test they were told to avoid alcohol, excessive physical activity, and food rich in dietary fiber.
On the evening (21.00–22.00) before each test, the subjects were instructed to eat a standardized meal
consisting of white wheat bread with spread and drink of their own choice. However, the subjects
were instructed to have the same evening meal before each test.
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2.2. Study 1
Five men and four women aged 24–41 years, with normal body mass indices (23.1 ˘ 2.7
kg/m2; mean ˘ SD), normal fasting blood glucose (4.4 ˘ 0.05 mmol/L; mean ˘ SEM), and who
were not taking any medication, participated in the study. The test subjects were recruited and
the study performed between October 1999 and February 2000. Test subjects were recruited by
advertising on notice boards around the Lund University (LU) campus, and by contacting former
volunteers. Two commercially available canned composite meals, “canned Meat&Pasta” and “canned
Meat&Beans”, intended for infants aged 12 months, were studied. The meals were microwave heated
according to the manufacturer’s instructions before serving. Both test meals and the reference WWB
meal contained 30 g of potentially available carbohydrates [12]. Both the test meals and the reference
meal were served with 250 mL water and followed by 150 mL coffee or tea. Finger-prick capillary blood
samples were taken repeatedly up to 120 min after ingesting the meal for the analysis of blood glucose
concentrations (glucose oxidase-peroxidase reagent) and serum insulin (Insulin ELISA, Mercodia AB,
Uppsala, Sweden).
Product Characterization
Levels of CML were determined in freeze-dried samples of selected canned composite infant meals
and corresponding frozen ready-to-eat meals intended for adults using gas chromatography mass
spectrometry (GC-MS) according to Birlouez-Aragon [3]. The results are presented in Table 1. The in vitro
rate of starch hydrolysis (hydrolysis index, HI) was analyzed for the meals using the method described
by Granfeldt et al. [13]. Before HI-analysis, samples of the composite meals were rinsed in a strainer
using tap water to obtain the intact pieces of the carbohydrate sources (beans and pasta).
2.3. Study 2
2.3.1. Recipes and Processing Conditions
Canned pasta Bolognese (CANPBol) for infants aged 12 months was bought in the local
supermarket, and two other test meals were prepared in the laboratory. In order to investigate the
possible advantages of minimal processing of a composite meal, an in-pack pasteurization method
was used (MicVac AB, Mölndal, Sweden). The microwave cooked test meal (MWPBol) was based
on a recipe resembling that of the CANPBol meal, and contained: 60 g water, 50 g crushed tomatoes
(ICA, Solna, Sweden), 17 g carrots, 17 g yellow onions, 16 g minced beef, 13 g manually cracked
spaghetti (ICA Italia, Solna, Sweden), 10 g tomato purée (ICA), 10 g celery root, 2 g corn starch
(Maizena, Unilever, Solna, Sweden), 2 g rapeseed oil (ICA), 0.15 g iodized salt (Falksalt, Ab Hanson
& Möhring, Halmstad, Sweden), 0.2 g dry oregano (Santa Maria, Mölndal, Sweden), 0.1 g dry
basil (Santa Maria), and 0.07 g white pepper (Santa Maria). A test meal consisting of separately
microwave-cooked pieces of spaghetti (ICA Italia) and canned Bolognese sauce (Felix Köttfärsås
Original, Orkla Foods, Eslöv, Sweden) was used to study the effect of preparing the meal components
separately (MWP_CANBol). All pasta and canned Bolognese sauce were bought from one batch. In the
case of the MWPBol meal, all dried/canned ingredients and minced beef was bought from one batch,
but vegetables were bought fresh every week. The minced beef was frozen in portions and thawed prior
to the preparation of each serving. Each MWPBol portion was prepared the evening before the test by
combining the minced meat with small pieces of the vegetables, crushed tomatoes, spices, and cracked
spaghetti. After sealing the tray with plastic film, the portion was cooked in a microwave oven for
8 min, chilled on ice and then stored overnight in a refrigerator. Just before serving, MWPBol meal
was reheated in microwave oven for 1.5 min. In the case of the MWP_CANBol meal, cracked spaghetti
was boiled in water for 7.5 min using a similar tray sealed with plastic film in microwave oven and
stored in the refrigerator overnight. In the morning, the pasta was heated separately for 2 min, and the
canned Bolognese sauce was heated separately for 2.5 min, in the microwave oven. The pasta and
Bolognese sauce were then mixed on the plate before serving. Each CANPBol portion was weighed
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on a plate just before serving, and microwave heated for 2.5 min, with breaks for stirring after 1 and
2 min.
2.3.2. Product Characterization
All test and reference meals in Study 2 were standardized so as to contain 35 g available starch,
according to Holm et al. [12]. The CANPBol meal and the canned Bolognese sauce were analyzed as
bought, without preparation. The microwave-cooked spaghetti was re-heated before analysis, and the
starch content converted to dry matter basis. The protein contents in the test meals were determined
using an elemental analyzer (FlashEA 1112, Thermo Fischer Scientific Inc., Waltham, MA, USA). The fat
contents in the commercial products were estimated from the manufacturers’ declarations. In the
case of WWB, estimates of the protein and fat contents were based on a previous analysis of a similar
product [14]. CML was determined using high-pressure liquid chromatography mass spectrometry
(HPLC-MS/MS), with an Accela UHPLC pump with an autoinjector coupled to an LTQ VelosPro
Orbitrap mass spectrometer (Thermo Scientific, Waltham, MA, USA). The MS/MS was run in positive
electrospray ionization ion trap mode, detecting two selected reaction monitoring (SRM) transitions
for CML and two for the internal standard. Xcalibur software (ver. 2.2, Thermo Scientific) was used
for both data acquisition and evaluation. Samples were prepared by hydrolyzing 0.3 g sample for
12 h at 110 ˝C, using 6 M HCl, together with isotope-labelled d4-CML (Larodan Fine Chemicals
AB, Malmö, Sweden) as internal standard. CML was extracted after hydrolysis using solid phase
extraction (TelosneoPCX, Teknolab Sorbent AB, Västra Frölunda, Sweden). All the dried samples
were reconstituted in 0.01% (v/v) nonafluoropentanoic acid (Sigma-Aldrich, Steinheim, Germany)
and centrifuged before analysis. Solid phase extraction, chromatographic parameters, ion source
parameters, and the SRM transitions were the same as described by Tareke et al. [6,7]. CML analyses
were performed on three different days. To check any instrumental inconsistency, duplicates of each
sample were analyzed on one occasion. The portion sizes, macronutrient and energy compositions,
and the CML contents are presented in Table 2.
2.3.3. Subjects
The inclusion criteria were being a healthy, non-smoker with normal weight (body mass index,
BMI, 19–25 kg/m2), aged 18–40 years, with a stable body weight over the previous two months.
Exclusion criteria were being a vegetarian/vegan and/or having food allergies, lactose intolerance,
having any disease or taking any medication that might affect the study, as well as being pregnant
or lactating.
2.3.4. Sample Collection and Protocol
The subjects arrived at the laboratory at 7:45 a.m. after overnight fasting. A peripheral
venous catheter (BD Venflon Dickinson, Helsingborg, Sweden) was inserted into an antecubital
vein. Capillary plasma glucose and venous blood samples were collected, after which the individually
assigned test meal was served, together with 250 g of tap water (time 0). All meals were tolerated and
finished within 10–15 min, except for one test person who needed 20 min to finish eating the CANPBol
meal. Blood samples were taken at 15, 30, 45, 60, 90, 120, 240, 270, 300, 330, and 360 min after the
beginning of the meal. One hundred and thirty-five minutes after the meal, each subject was given
200 g water to be drunk within 15 min. Two hundred and forty-five minutes after the start of the meal,
a standardized lunch, consisting of a ready-to-eat dish of 400 g (2320 kJ) pasta with tomatoes, basil,
and mozzarella cheese (Pasta al Pomodoro, Gooh, Lantmännen, Sweden) was served. The lunch meal
was served with 250 g tap water, and was to be consumed within 20 min.
2.3.5. Blood Analysis
Blood glucose was analyzed in capillary blood (HemoCue®B-glucose, HemoCue AB,
Ängelholm, Sweden). Serum was obtained from venous blood collected in CAT tubes (BD Vacutainer,
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ref. 368492) and left to clot for 60 min before being centrifuged at 3500 rpm for 10 min at 4 ˝C.
Plasma was obtained in EDTA tubes (BD Vacutainer, ref 368274) and put on ice for a maximum of 30 min
until centrifuged at 3500 rpm for 10 min at 4 ˝C. Samples were then aliquoted in Eppendorf tubes and
stored immediately at ´20 ˝C until analysis. Serum insulin and serum TGs were analyzed by a lab at
Skåne University Hospital (Clinical Chemistry, Region Skåne, Sweden), whereas NEFAs were analyzed
at the department using a colorimetric assay (NEFA C, ACS-ACOD method, WAKO Chemicals GmbH,
Neuss, Germany).
3. Statistical Calculations
The least number of subjects required to detect a difference in the GI with a power of 80% at a
level of p < 0.05, is ten [15]. The sample size in Study 1 was nine, and in order to improve the power
of Study 2, twenty-one subjects were included. The iAUCs for glucose and insulin were calculated
using GraphPad Prism (GraphPad Software, San Diego, CA, USA) and the trapezoid model. All areas
below the baseline were excluded from the calculations. The results are expressed as means ˘ SEM.
Differences resulting in p < 0.05 were considered statistically significant.
3.1. Study 1
The 120 min blood glucose and insulin iAUCs were used to determine GI and II, respectively.
The statistical differences were evaluated using the general linear model (ANOVA) followed by Tukey’s
multiple comparisons test using Minitab software (ver. 13, Minitab Inc., State College, PA, USA).
3.2. Study 2
Differences in CML content between the test meals and the reference meal were evaluated with
one-way ANOVA using GraphPad Prism (as described above). The composite insulin sensitivity index
(ISIcomposite), also called the Matsuda index, was calculated for both the test meals and the reference
meal in order to assess the insulin sensitivity.
ISIcomposite = 10,000/
‘
[fasting glucose (mmol/L) ˆ fasting insulin (nmol/L) ˆ glucose iAUC
0–120 min (mmol¨ min/L) ˆ insulin iAUC 0–120 min (nmol¨ min/L)] [16,17].
The effects of the test meals and reference meal on glucose and insulin responses, as well as on
the NEFA and TG levels, were evaluated using the PROC MIXED SAS procedure. The subject was
treated as a random effect and the test meal as a fixed effect. The fixed effect of corresponding baseline
(fasting) values was included as a covariate, and time ˆ meal interactions were tested. All models
were tested for the normality of residuals. To adjust for multiple comparisons of significant effects, the
Tukey–Kramer post hoc significance test was performed. Statistical analyses of metabolic outcomes
were performed using SAS 9.2 (SAS Institute Inc., Cary, NC, USA) and Minitab software (ver. 16).
The data are presented as iAUC values or least-square means (LSMs) ˘ SEM. The data were also tested
for outliers. The fasting level of insulin was found to be an outlier for one subject, and the result was
therefore not included in the insulin analyses. In addition, insulin data were lacking for one subject
30 min after the CANPBol meal and for another 240 min after the MWP_CANBol meal. Due to the
missing values, those two test meals were excluded from the calculations for insulin. Another subject
missed the CANPBol meal, resulting in n = 20 for the CANPBol meal for all blood tests except insulin,
where n = 18.
4. Results
4.1. Study 1
The canned meals intended for infants contained three to four times higher levels of CML
(expressed as mg CML/g protein) than frozen meals with similar ingredients but intended for adults
(Table 1). The HI for canned beans was 44, which was significantly lower (p < 0.05) than the HI of both
the canned pasta (109) and WWB reference (100).
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The glycemic response to canned Meat&Beans (GI = 48 ˘ 11) was significantly lower (p < 0.05)
than that after the reference WWB meal (GI = 100). The GI of canned Meat&Pasta (79 ˘ 12) did
not differ from either of the other two meals. No significant differences were found in the insulin
responses, and the II values were 100, 91 ˘ 13, and 140 ˘ 30 for WWB, canned Meat&Beans, and canned
Meat&Pasta, respectively.
Table 1. N-carboxymethyl-lysine (CML) content in canned and homogenized meals intended for
infants and in frozen ready-to-eat meals intended for adults.




Hash “Pytt i panna”
Canned, homogenized 0.45
Frozen 0.14
Results are presented as the mean of two duplicates.
4.2. Study 2
Twenty-one healthy volunteers (14 men and 7 women) participated in Study 2. All female
subjects were taking birth control medication. The mean BMI was 21.8 ˘ 0.3 kg/m2 and mean
age 24.3 ˘ 0.9 years (˘SEM). All subjects had normal fasting blood glucose levels (5.4 ˘ 0.06 mmol/L).
The recruitment of test subjects and the study were performed from November 2012 to March 2013.
Recruitment was performed by advertising on notice boards at and around the LU campus as well as by
contacting former volunteers. The macronutrient composition and CML content of the various foods
are presented in Table 2. All test and reference meals were similar in content of available carbohydrates
and the protein and fat levels as well as energy contents were within the same range for all composite
test meals. CANPBol and MWPBol contained significantly higher levels of CML compared with
MWP_CANBol. The CML-content of WWB was significantly lower than in all test meals.
Table 2. Portion sizes and contents of macronutrients, energy, and CML in the test meals and reference
meal in Study 2.
Meal Portion g Starch g/Port Protein g/Port Fat 1 g/Port Energy kJ/Port CML 2,3 mg/Port
WWB 83 35 4.9 0.7 704 0.41 ˘ 0.04 a
CANPBol 467 34 13 11.7 1232 9.75 ˘ 0.89 b
MWPBol 479 36 15 11.5 1292 8.98 ˘ 0.13 b
MWP_CANBol of which: 309 35 12 9.3 1143 5.94 ˘ 0.64 c
Canned Bolognese sauce 130 3.3 7.3 8.9 - 5.94 ˘ 0.64 c
Pasta, uncooked 42 30 4.4 0.4 - n.a.
Maize starch (Maizena) 2 1.7 - - - n.a.
1 Estimated from a previous study (WWB) and manufacturers’ declarations (commercial products/ingredients).
WWB, white wheat bread; CANPBol, canned mixed meal; MWP_CANBol, canned Bolognese sauce served
with microwave-cooked spaghetti; MWPBol, microwave-cooked mixed meal; n.a., not analyzed; 2 Values are
presented as mean ˘ SEM, n = 4; 3 Values within the row not sharing a superscript letter are significantly
different, p < 0.05.
4.2.1. Blood Glucose Responses
No differences were observed in fasting glucose levels. There was a significant time ˆ meal
interaction (p < 0.0001) over the 360 min follow-up (Figure 1). Incremental glucose responses (0–120 min)
were significantly lower (31%–63%) following all the test meals than after the WWB meal (Table 3).
Furthermore, the glucose response (iAUC and GI) after the MWP_CANBol meal was significantly lower
than those after the two other test meals, during the same time period. After the standardized lunch
meal (iAUC 240–360) the glucose response following the MWP_CANBol breakfast was significantly
lower compared to WWB and CANPBol. The cumulative glucose response over the entire test period
408
Nutrients 2016, 8, 340
(iAUC 0–360 min) showed that overall glycemia following the MWPBol and MWP_CANBol meals
was lower than following the CANPBol meal and WWB reference meal.
Figure 1. Mean (˘SEM) changes in glucose response after the test meals and reference meal and the
subsequent standardized lunch (Study 2).
Table 3. Glucose and insulin responses 1, together with a measure of insulin sensitivity after the test
meals and the reference meal (Study 2).
WWB 2 CANPBol 2 Δ % MWPBol 2 Δ % MWP_CANBol 2 Δ %
Glucose
GI 0–120 min 100 a 79 ˘ 13 b ´21 61 ˘ 5.4 b ´39 38 ˘ 3.6 c ´62
iAUC 0–45 min 68.4 ˘ 6.13 a 61.8 ˘ 5.30 a ´10 62.0 ˘ 3.40 a ´9 40.6 ˘ 4.31 b ´41
iAUC 0–120 153 ˘ 16.0 a 104 ˘ 13.7 b ´31 84.6 ˘ 10.3 b ´45 57.4 ˘ 7.7 c ´63
iAUC 240–360 148 ˘ 18.5 a 136 ˘ 16.3 a ´8 120 ˘ 12.4 a,b ´19 92.2 ˘ 13.1 b ´38
iAUC 0–360 312 ˘ 30.8 a 240 ˘ 31.9 a,b ´23 245 ˘ 37.9 b ´22 206 ˘ 33.3 b ´34
Insulin
II 0–120 min 100 a 161 ˘ 19 b 61 129 ˘ 15 a,b 29 57 ˘ 5.5 c ´43
iAUC 0–45 min 5.11 ˘ 0.79 a 8.10 ˘ 1.02 b 59 7.15 ˘ 0.88 b 40 4.01 ˘ 0.63 a ´22
iAUC 0–120 11.3 ˘ 1.79 a 15.8 ˘ 2.45 b 40 12.4 ˘ 1.90 a,b 10 5.95 ˘ 0.97 c ´47
iAUC 0–360 26.4 ˘ 3.74 a 32.2 ˘ 4.86 a 22 26.5 ˘ 3.81 a 0.2 20.2 ˘ 2.75 b ´24
ISIcomposite 703 ˘ 82 a 733 ˘ 98 a 4 865 ˘ 72 a 23 1421 ˘ 135 b 102
1 Values are presented as mean ˘ SEM; 2 Values within the same row not sharing superscript letters are
significantly different, p < 0.05. GI, glycemic index; iAUC, incremental area under the curve; II, insulin index;
ISIcomposite, insulin sensitivity index; WWB, white wheat bread; CANPBol, canned mixed meal; MWP_CANBol,
canned Bolognese sauce served with microwave-cooked spaghetti; MWPBol, microwave-cooked mixed meal.
4.2.2. Insulin Response
No differences were observed in fasting insulin levels. There was no significant time ˆ meal
interaction over the 360 min study period (Figure 2). During the first 45 min, the insulin level
was significantly higher following the CANPBol meal (59%) and the MWPBol meal (40%) than the
MWP_CANBol meal and the WWB meal. The incremental insulin responses during the periods
0–120 and 0–360 min were significantly lower after the MWP_CANBol meal than after all other meals.
In addition, the insulin response during 0–120 min was significantly higher following the CANPBol
meal than the WWB reference meal.
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Figure 2. Mean (˘SEM) changes in insulin response after the intake of the test meals and reference
meal, and subsequent standardized lunch (Study 2).
4.2.3. Blood Lipids
No differences were observed in fasting levels of NEFAs or TGs and no significant time ˆ meal
interactions were observed for either of the lipid variables (p < 0.0001). Pairwise comparisons of NEFA
levels at 240 min showed that they were significantly lower after the MWPBol and MWP_CANBol
meals than after the WWB meal (p = 0.0392 and 0.0001, respectively, Figure S1). The overall TG
response was significantly higher after the CANPBol (p = 0.0216) and MWPBol (p = 0.0008) meals than
after the WWB meal (Figure 3). Furthermore, the level of TGs was significantly higher following the
MWPBol meal than after the MWP_CANBol meal (p = 0.0041) over the 360 min.
Figure 3. Mean (˘SEM) changes in triglyceride response after the intake of the test meals and reference
meal, and a subsequent standardized lunch (Study 2).
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5. Discussion
The major finding of this study is that canned composite pasta Bolognese meals, processed
according to a common procedure for infant meals, elicited substantially higher postprandial metabolic
responses in healthy adults than meals intended for adults prepared with conventional cooking
conditions. In fact, the infant CANPBol meal elicited an almost two-fold higher postprandial glucose
and a 2.6 times higher insulin level during the first 2 h, compared with a meal of canned meat sauce
served with gently and separately cooked pasta (MWP_CANBol). When combining the glucose and
insulin data in a composite index, ISIcomposite, the insulin sensitivity was improved by 94% after the
MWP_CANBol meal, compared with the CANPBol meal. The significantly higher insulin response
(+59%) during the first 45 min after the CANPBol meal, compared to the WWB meal, cannot be
explained by the corresponding increase in glucose, since this was reduced by 10% (not statistically
significant). Instead, we suggest that a fraction of the proteins was rendered highly soluble by the
canning process, and may thus exert insulinotrophic effects. Surprisingly, the microwave-cooked
composite meal (MWPBol) also led to a significant increase in early insulin response, but no significant
differences were found in insulin, compared with WWB, over 120 min. The separately processed
meal, MWP_CANBol, resulted in substantially lower glucose (´63%) and insulin (´47%) responses,
compared with WWB. Apparently, the canning of Bolognese sauce per se did not result in an elevated
insulin response, and the reduction in both glucose and insulin is in line with previous findings
regarding pasta meals, where a low glucose peak and a late net increment with an accompanying
lowering of insulin responses have been reported [18]. Holm et al. have previously reported a higher
postprandial glycemic response in healthy adults to canned pasta, compared to cooked pasta [9].
They observed glucose responses that were twice as high after canned then after boiled spaghetti,
and the insulin response was also significantly increased by canning. A suggested mechanism for
the rapid uptake of carbohydrates following the intake of canned pasta was the excessive swelling
of the starch, resulting in a very soft and easily digestible texture. The significantly reduced glucose
response following the canned Meat&Beans in Study 1 is probably the result of some remaining intact
cell structures following homogenization and canning of the composite bean meal [19]. This was
also illustrated by the lower in vitro rate of starch hydrolysis for the bean component in the canned
Meat&Beans meal (HI = 44), than in the canned Meat&Pasta meal (HI = 109) and the WWB reference
meal (HI = 100). It should be noted though, that only the intact beans were included in HI-analysis,
since they stayed in the strainer after washing. The high HI found for canned pasta is in line with the
findings of a previous study indicating that homogenized spaghetti (cooked spaghetti treated for 35 s
in a food processor) had a higher GI (73) than intact spaghetti (60), but was still lower than that for
bread baked using spaghetti ingredients (100) [18]. Taken together, these findings indicate that canning
of pasta disrupts the texture.
The substantial reduction in postprandial glycemic response after the MWP_CANBol meal,
compared to the other meals, is further reflected by the improved glucose tolerance following a
standardized lunch, manifested by a 38% lower glucose response, than after the WWB breakfast.
Another indication of improved insulin sensitivity at the time of lunch (240 min) following the
MWP_CANBol breakfast was the reduced NEFA levels. This is in agreement with other reports
showing that suppressed NEFA levels between meals improves glucose tolerance following a second
meal [20]. The increase in TG levels tended to be higher after the intake of CANPBol than after the
other meals over the first postprandial hour. This may be related to a higher availability of lipids from
this particular canned composite meal.
It has been suggested that the mechanism behind the increased risk of obesity associated with
high protein intakes during infancy may be the protein-associated stimulation of insulin and IGF-1
release [21]. The results of the present study show that insulin stimulation by infant food may be
related not only to the quantity of protein, but possibly also to process-induced changes in protein
availability. In line with this, hydrolyzed protein appears to stimulate insulin release to a higher extent
than intact protein [22].
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The CML content in the MWP_CANBol meal was significantly lower than in the MWPBol meal
(´34%) and the CANPBol meal (´39%). Gentle processing of the composite meal, as in the case of
the MWPBol meal, was, thus, not as effective as expected in terms of reducing CML contents and
no significant difference was found between the CML levels in the MWPBol and CANPBol meals.
These results indicate that it may be more important to separate the protein- and carbohydrate-rich
meal components during processing, than to use gentle heat treatment of a composite meal. The CML
comparison in Study 1 indicates that freezing may be an interesting way forward to allow for both
gentle and separate heat treatment of the different meal components. It is important to note that
the formation of CML renders lysine less available. The fact that lysine is an essential amino
acid is one reason to counteract CML formation during processing of all foods, and especially in
products intended for infants. Additionally, dietary exposure to CML has repeatedly been linked to
impaired metabolism. Consequently, a cross-over study in healthy subjects has shown that exposure to
CML-levels of 5.4 mg CML/day (GC-MS analysis) for one month resulted in lower insulin sensitivity,
lower plasma levels of omega-3 fatty acids, and higher concentrations of blood lipids than after a
low-AGE diet (2.2 mg CML/day) [3]. Similarly, the consumption of a high-AGE diet (24.6 mg CML/day,
LC-MS analysis) for one month led to increased fasting insulin and insulin resistance (HOMA-IR),
compared to a diet low in AGEs (10.7 mg CML/day), in overweight women [23]. The CML content in
one portion of CANPBol was 9.7 mg (LC-MS analysis), and a single meal of canned infant food would
thus provide 0.75 mg CML/kg body weight in 12-month-old infants (assuming a body weight of 13 kg).
This is more than twice the amount of CML ingested in the case of the high-CML diet previously
mentioned where the intake in adults corresponded to 0.35 mg/kg body weight per day [23]. A recent
review of randomized controlled trials has shown that high AGE intakes are associated with increased
levels of TNF-alpha, which is an established biomarker of inflammation in healthy humans [24].
Furthermore, high postprandial glycemia per se, as seen in the current study in the case of CANPBol,
has been associated with low-grade inflammation [2,25]. In summary, the intake of canned infant meals
appears to result in reduced postprandial insulin sensitivity and high intakes of AGE (measured as
CML). The latter is due to favorable conditions for the Maillard reaction, which may result in lower
lysine availability and pro-inflammatory responses.
It should be noted that the sample size in Study 1 was lower than that recommended for GI
determinations, which may partly explain the larger variation in insulin response after the canned
Meat&Pasta meal than after the CANPBol meal. It cannot be excluded that the inclusion of coffee/tea
at both test and reference breakfasts in Study 1 may have influenced the postprandial insulin sensitivity
and it was therefore removed from the study design in Study 2. Although the metabolic responses to
the infant meals were measured in healthy adults, it is reasonable to assume that the differences seen,
depending on the type of processing, would be similar in infants.
6. Conclusions
The findings of this study indicate an urgent need for more research on the metabolic effects
of food products intended for infants and young children. The importance of considering both the
quantity and quality of macronutrients when designing diets for infants was also recently pointed out
by Alvisi et al. [26]. Gentle and separate processing of meal components seems to have a beneficial
impact on human metabolism compared to canning or microwave heated mixed composite meals.
With respect to CML contents, conventional cooking and freezing of meal components appears to be
more beneficial in comparison with canning.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/8/6/340/s1,
Figure S1: Mean (˘SEM) changes in NEFA response after the intake of the test meals and the reference meal
(Study 2).
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Abstract: In many countries, infant cereals are one of the first foods introduced during the
complementary feeding stage. These cereals are usually made with refined cereal flours, even though
several health benefits have been linked to the intake of whole grain cereals. Prior evidence suggests
that food preferences are developed at early stages of life, and may persist in later childhood and
adulthood. Our aim was to test whether an infant cereal with 30% of whole grain was similarly
accepted both by parents and infants in comparison to a similar cereal made from refined flour.
A total of 81 infants between 4 and 24 months old were included in the study. Parent-infant pairs
participated in an 8-day experimental study. Acceptance was rated on hedonic scales (4-points for
infants and 7-points for parents). Other attributes like color, smell, and taste were evaluated by the
parents. Acceptability for infant cereals with whole grain and refined cereals was very similar both
for infants (2.30 ± 0.12 and 2.32 ± 0.11, p = 0.606) and parents (6.1 ± 0.8 and 6.0 ± 0.9, p = 0.494).
Therefore, our findings show that there is an opportunity to introduce whole grain cereals to infants,
including those who are already used to consuming refined infant cereals, thereby accelerating the
exposure of whole grain in early life.
Keywords: acceptability; complementary feeding; infant cereals; whole grain
1. Introduction
Scholars have long established that the complementary feeding stage is very important because
of the continued rapid growth and many changes that affect children’s health and development [1–3].
These changes have a major influence on nutritional status during infancy and the food preferences
during childhood and adulthood [4–6]. For this reason, several authors have strongly recommended
the intake of healthy foods from the very beginning of the complementary feeding stage [7–9].
Weaning practices are significantly influenced by cultural beliefs [10,11]. However, in many
countries, infant cereals are one of the first foods introduced at the beginning of the complementary
period [11–14]. One possible reason stems from their sensorial and digestive properties [15].
For millennia, cereals have been staples for humans and are currently a large part of U.S. Dietary
Guidelines [16]. Cereals are a good source of energy and macronutrients, such as carbohydrates,
proteins and fats, that are needed for growth. Cereals are also an important source of vitamins,
minerals and other essential bioactive compounds necessary for health [17].
Cereals can be consumed as whole grain or refined. Although the definition of whole grain is
currently under discussion, the International American Association of Cereal Chemistry (AACC)
Nutrients 2017, 9, 65 415 www.mdpi.com/journal/nutrients
Nutrients 2017, 9, 65
defined whole grains as “intact, ground, cracked or flaked caryopsis, whose principal anatomical
components—the starchy endosperm, germ, and bran—are present in the same relative proportions
as they exist in the intact caryopsis” [18]. In 2010, the Healthgrain Consortium broadened the AACC
definition of whole grain to include small losses of components—that is, less than 2% of the grain/10%
of the bran. Such losses may occur through processing methods required to ensure the safety and
quality of whole grain and are allowed under the above definition [19].
It should be taken into account that until the 19th century, cereals were consumed as whole grain;
it was only during the Industrial Revolution with the advent of new milling techniques that the bran
and germ were removed from the grain kernel, obtaining refined cereal flours with improved texture
and taste and ultimately leading to longer shelf life [20].
Several organizations and scholars have acknowledged the benefits associated with the
intake of whole grain cereals for adults and children above two years [21–23]. Moreover, the
USDA (US Department of Agriculture) recommends that, during the second semester of life,
infants should be gradually introduced to fiber-containing foods, such as whole grain cereals,
vegetables, and legumes [10]. Although there is no general agreement regarding daily dietary intake
recommendations for whole grain (even for adults) [23,24], these recommendations are important
and should be further studied in infants and young children. As eating habits can be molded during
complementary feeding time, the early introduction and consumption of infant cereals elaborated with
whole grain flour could be desirable [22].
In most countries, commercial infant cereals are made with refined cereal flours
(www.innovadatabase.com). One of the main problems found when whole grain is introduced into
the diet of an adult is the low sensorial acceptability compared to refined cereal-based foods [23,25].
However, prior research reveals that infants and young children have a higher acceptance of new foods
in the complementary feeding period until the age of 18–24 months [26–28]. In this vein, several authors
recommend gradually introducing whole grain products by substituting refined cereals as an effective
way of incorporating whole grain into consumers’ diets [23]. This can be reinforced by the development
of technological processes to improve sensorial properties of whole grain products [29,30].
The present study was designed to determine if the intake of an infant cereal-based product with
30% whole grain was similarly accepted both by parents and their children, compared to the same
infant cereal without whole grain (refined cereals).
2. Materials and Methods
2.1. Infant Cereal Samples
All infant cereals used in this experiment were commercially available products from HERO
ESPAÑA S.A (Murcia, Spain). We selected this brand of multicereals to conduct this study because it
is one of the most widely consumed infant cereals on the Spanish market. One of two infant cereals
contained 30% of whole grain flour, WGC (new recipe), and the other one 100% refined cereal flours,
RC (old recipe). The ingredients for WGC were: hydrolyzed cereal flour (wheat, wheat whole grain,
corn, rice, oat, barley, rye, sorghum and millet), minerals, natural flavor and vitamins where the content
of wheat whole grain flour was 30% of total cereals. The ingredients of RC were: hydrolyzed cereal
flours (wheat, corn, rice, oat, barley, rye, sorghum and millet), minerals, natural flavor and vitamins.
The nutritional composition of the two infant cereals used in this study is described in Table 1.
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Table 1. Nutritional composition of the two infant cereals used in the study.
Mean Value (100 g) WGC RC
Energy (kcal) 380 372
Protein (g) 9.1 8.5
Carbohydrates (g) 78 81.6
Sugars (g) 21 22
Fat (g) 2.3 1.3
Fiber (g) 5.2 3
WGC: Whole Grain Cereal and RC: Refined Cereal.
2.2. Participant Characteristics
There were 81 parents with infants between the ages of 4–24 months recruited through
advertisement on the website of the University of Murcia (Spain), as well as in kindergartens and
parents’ circles. Eligible healthy infants had a gestational age of 37–42 weeks and a birth weight greater
than 2500 g and had been fed with gluten-containing cereals prior to enrolment in the experiment.
Infants that had food allergies, swallowing or digestion problems, or other medical issues that could
influence the ability to eat were excluded. There were an additional 20 pairs excluded because the
parents did not complete the study or did not return the questionnaire (See Supplementary Materials).
Once all parent-infant pairs were recruited, they were assigned to only one group where they received
two packages of infant cereals (WGC and RC). The distribution of samples was counterbalanced to
avoid any possible bias. The study protocol was approved by the Research Ethical Committee of the
University of Murcia. Written informed consent was obtained from both parents of all participating
infants before the inclusion.
2.3. Data Collection
Testing was carried out at home during a period of eight days. For the home-use test, the parents
were responsible for conducting the experiment and collecting the data requested in the questionnaire
(See Supplementary Materials). Prior to testing, the parents received both detailed written and
oral instructions.
2.3.1. Testing
Parents received two coded packs of cereals. During days 1 and 2, infants were accustomed
to the first of the two cereals. On the third day, parents evaluated the acceptance. Over days 4 and
5, infants continued eating the cereal which they used to eat before enrollment in the present study.
On day 6, the same process started with the second infant cereal—familiarization on days 6 and 7 and,
on day 8, evaluation of acceptance. No additional foods or beverages were introduced into the infants’
diet during the study. All samples used in this study were packaged into identical foil bags. Each bag
was marked with a three-digit randomization code. At the moment of feeding, the samples were
counterbalanced and randomized; consequently, a child was fed with one sample on one day and the
other sample on the other day. Each parent fed his/her infant in the habitual place, at a normal pace
until the infant refused the spoon or bottle three consecutive times. Rejection behaviors are typically
turning the head away, closing the mouth firmly, pushing the spoon away, spitting the food out or
becoming upset [14,31]. Before each feeding, it was necessary to ensure that the infant was sufficiently
hungry. In particular, parents were asked not to feed their infants with infant milk, other beverages,
or solid foods for 1 h before the cereal intake [14,32]. Furthermore, testing occurred at approximately
the same time of the day and 30 to 60 min before the infants’ next scheduled feeding, so that variation
of intake was not affected by different levels of hunger or satiation, but rather reflected hedonic
response to the food. Regarding mode of preparation, this depended on the parents’ habits (using
bottle or spoon). Parents performed the sensory evaluation of the same products only after feeding
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their infants to ensure no interference with their infant’s reactions due to non-habitual parent behavior
(product testing) during the feeding (days 3 and 8) [14,32].
2.3.2. Measure of Food Acceptance
Parents were first asked to answer questions about their infants, feeding practices as well as
socio-demographic information, such as gender, age and education (See Supplementary Materials).
Then, parents were asked to score their degree of liking using a 7-point hedonic scale ranging from 1
“dislikes very much” to 7 “likes very much.” This test allowed us to evaluate the acceptability of each
parent for the sample of cereal. Parents’ liking represents one important step to deciding if this type of
cereal would be suitable for their infants. For the assessment of the acceptance by children, we used a
4-point hedonic scale [14,31]. This scale uses the following scores: ”— “ (very negative) if the infant
spit out the food, frowned, pushed the spoon away or stopped eating; “−“ (negative) if the infant ate
a couple of spoonful, grimaced and stopped eating; “+” (positive) if the infant ate some of the food
without a specific reaction; “++” (very positive) if the infant accepted the first spoonful immediately
and displayed signs of content, such as a relaxed face or a smile [14,31].
2.4. Statistical Analyses
Data are expressed as means ± standard error of mean (SEM) for the following variables: age of
introduction of infant cereals and parent’s perception of child’s degree of liking. For variables related
to sensory analysis, data were expressed as mean ± standard deviation (SD). The categorical variables
were expressed as percentage (%).
Descriptive analysis was employed to describe parents’ and infants’ characteristics as well as
all variables related to consumption, mode of preparation, frequency of intake of infant cereals and
sensory analysis. The evaluation of infants’ acceptance, assessed by parents, was converted into
scores of −3, −1, 1 and 3 so that there were equal intervals between adjacent scores throughout the
scale. Taking into account that all variables are not distributed normally (Kolmogorov–Smirnov test),
non-parametric analyses were performed: the Wilcoxon test for paired samples was used to detect
differences in sensorial variables between the two samples of infant cereals; in the case of cereal feeding
practices, variables expressed as percentages as per the Mann–Whitney test were applied in order to
detect difference between both age ranges.
All results with a significance level of p < 0.05 were considered statistically significant.
Statistical analyses of data were performed using the Statistical Package for the Social Sciences (SPSS
version 19.0; Inc., Chicago, IL, USA).
3. Results
3.1. Subject Characteristics and Cereal Feeding Practices
The characteristics of the 81parent-infant pairs are presented in Table 2. The mean age of
introduction of infant cereals was 5.2 (±1.3) months. The type of milk used by parents to prepare the
cereals was in 55.6% of cases as follows: 21.0% “growing-up” milk; 13.5% cow’s milk; 7.4% infant
formula; and 2.5% breast milk (Table 3).
Parents were asked about the cereal feeding mode (bottle and/or spoon) and the number of times
infants were fed per day (Table 3). The cereal feeding mode was distributed as follows: most infants
(70.4%) were taking cereals from a bottle, 16.0% took cereals with a spoon and 13.6% used both bottle
and spoon. There were significant differences in the mode of preparation of infant cereals depending
on the age group (p < 0.05). Cereal bottle feeding was higher in the group of infants between 13 and
24 months of age (80%) as compared to the group of infants below one year. In general, more than 50%
of infants took two servings a day, almost 40% took one serving a day, and the rest between three or
more servings (7.4%) without significant differences between the two age ranges studied (below and
above one year of age) (Table 3).
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Table 2. Characteristics of infants and parents who participated in this study.




















Values expressed as percentage.
Table 3. Cereal feeding practices used for parents to prepare the infant cereals.
Age Range
4–11 Months 12–24 Months Total
Type of Milk Used
Breast milk 6.5 (2) - 2.5 (2)
Infant formula 9.7 (3) 6.0 (3) 7.4 (6)
Follow on formula 77.4 (24) 42 (21) 55.6 (45)
Growing up milk 3.2 (1) 32 (16) 27 (17)
Cow’s milk 3.2 (1) 20 (10) 13.6 (11)
Mode of Cereal Feeding a
Bottle 54.8 (17) 80 (40) 70.4 (57)
Spoon 25.8 (8) 10 (5) 16 (13)
Both 19.4 (4) 10 (5) 13.6 (11)
Frequency of Intake
One serving 48.4 (11) 34 (17) 39.5 (32)
Two serving 41.9 (13) 60 (30) 53.1 (43)
Three or more serving 9.7 (3) 6 (3) 7.4 (6)
Values are expressed as percentage of total infant (number of infants); a Superscript indicates that there is
significant differences between both groups of age and mode of feeding cereals (z = −2.281; p < 0.05).
The average amount of WGC and RC cereals consumed by age group is shown in Figure 1.
In both cases, over 75% of infants consumed the entire serving of the cereals prepared, with no
significant differences between the infant cereals evaluated.
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Figure 1. Infants’ consumption of the serving of infant cereals prepared by parents. WGC: Whole Grain
Cereal; RC: Refined Cereal. Values are expressed as percentage of total infants. (A) represents
the consumption of cereals by infants 4–11 months of age; (B) consumption of cereals by infants
12–24 months of age.
3.2. Parents’ Perception of Infants’ Liking
As shown in Table 4, parents’ rating of their infants’ degree of liking was not statistically
significant between the two infant cereals evaluated (WGC and RC)—neither within the two age groups
(p = 0.317, p = 0.666 for group 4–11 months and group 12–24 months, respectively) nor in the total
sample (n = 81, p = 0.606). Both infant cereals were highly accepted with average scores higher than 2.
Table 4. Parent’s perception of child’s degree of liking (mean ± SEM).
Age WGC (n = 81) RC (n = 81) p-Value
4–11 months 2.35 ± 0.19 2.16 ± 0.18 0.317
12–24 months 2.29 ± 0.16 2.40 ± 0.15 0.666
Total (n = 81) 2.3 ± 0.12 2.32 ± 0.11 0.606
WGC: Whole Grain Cereal; RC: Refined Cereal.
3.3. Parents’ Acceptability of Infant Cereals
There were no significant differences between WGC and RC in any of the attributes, as shown in
Table 5. Parental rating of liking for each attribute did not differ for any infant cereal, indicating that
parents reported the same liking for each sample. In general, the score for each attribute was very
similar between both samples and overall acceptability was rated very high for both cereal products
(6.1 for WGC and 6.0 for RC). In addition, we asked parents why they liked the infant cereals and
which attributes influenced their choices. In both cases, the criteria for their choices were similar;
for example, about 50% of the parents chose the taste as first choice, followed by aroma (20%),
and texture (17%).
Table 5. Sensory evaluation of infant cereals by parents (mean ± SD).
Attributes WGC RC p-Value
Color 6.1 ± 0.9 5.8 ± 1.1 0.090
Aroma 6.3 ± 0.9 6.3 ± 0.8 0.850
Taste 6.2 ± 0.9 6.1 ± 0.9 0.799
Texture 5.9 ± 1.1 6.2 ± 1.1 0.235
Overall acceptability 6.1 ± 0.8 6.0 ± 0.9 0.494
* Values in rows with different superscripts are significantly different (p < 0.05).
4. Discussion
The present study reveals that the addition of whole grain in infant cereals was similarly well
accepted from the sensorial point of view by both parents and their infants as compared to refined
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cereals. Importantly, previous studies have observed that early exposure to foods affects infants’
later taste acceptance patterns and that infants are able to communicate their acceptance by both
quantity of intake and facial expression [32]. In our study, we did not observe any differences in
the facial expression or in the intake, and more than 75% of the infants ate the entire cereal serving
prepared by their parents. Several factors are likely to explain the high acceptability found in whole
grain infant cereals such as the percentage of whole grain used in this study (30%), the milk used
for the reconstitution of the cereal (already accepted by the infants) or technology advances in cereal
processing which improve the sensorial characteristics of whole grain cereals.
The selected amount of whole grain tested in our study was based on the minimal amount of
whole grain with possible beneficial effects. Although there is no defined adequate intake of whole
grain for adults or infants, Ferruzi et al. [15] have suggested that a whole grain food should provide
8 g of whole grain per 30 g serving (27 g/100 g) in order to be defined as a whole grain food which is
nutritionally meaningful.
Interestingly, it has been reported that the main factor of consumer rejection in whole grain-based
products is its bitter taste and rough texture [25,33]. In our study, we did not observe any of these issues.
In fact, parents were reporting similar sensory liking scores in taste and texture and high scores in both
infant cereals. Our results are similar to those found in students by Magalis et al. (2016), who did not
find statistical differences in bitter taste between refined and whole grain products, although sensorial
preferences tended toward some refined cereal products [25]. Other sensorial studies in school children
have also reported a similar degree of acceptability of whole grain versus refined cereal products,
i.e., whole grain products were well accepted [34,35].
Whole grain cereals, as well as vegetables, can be bitter due to their content of polyphenolic
compounds [36]. Similar to findings in our study, Lange et al. (2013) and Mennella et al. (2015)
reported that when the new foods are introduced (vegetables) with other foods already accepted,
the acceptability of new foods was better [14,37]. This effect was related to the reduction of the
unpleasant, bitter or sour notes of the vegetables not only by dilution, but also by the sweetness
of the milk. The sweetness of breast milk has been estimated as equivalent to a 2.12% solution of
sucrose [38]. The sweetness of standard formula milks is similar [39]. Salty and sweet tastes have
the characteristic of blocking or masking unpleasant tastes present in many foods, such as a bitter
taste in vegetables [38,39]. A clinical study of school-aged children has shown that the presence of
diluted solutions of a sweetener (aspartame) along with vegetables increased the liking of vegetables
and decreased the perception of bitter taste [40]. For that reason, we could hypothesize that like in
vegetables, our infant cereals with whole grain were highly accepted due to the fact that they were
reconstituted with infant milk formulas or breast milk previously accepted by the infant. In our study,
whole grain cereals were mainly prepared with milk formula and to a lesser extent with breast milk.
The presence of sweet taste and its acceptance by infants could mask the bitter notes present in the
whole grain cereals, leading the products to be accepted in the same way as the refined product [41,42].
Regarding infant cereal practices, our study shows that the mean age of introduction of cereals
was 5.2 months. In Spain, infant cereals are usually the first food introduced at the beginning of
weaning and therefore the age of introduction in our study was in line with current recommendations
of first introducing products between 4 and 6 months of age [3,43].
The complementary feeding period is a “critical time window” in human development during
which eating behaviors are developed [44]. For this reason, timing, type and ways the foods are
introduced are important feeding practices in the development of acceptance of healthy food as
part of a healthy diet. Cereals play a main role at the beginning of and during the complementary
feeding period. The type of cereals consumed (whole grain or refined) may influence both health and
nutritional status of infants. In adults, it has been shown that significant consumption of whole grain
products is associated with a lower risk of cardiovascular diseases, diabetes, obesity, colon cancer and
gastrointestinal health [36]. A previous meta-analysis concluded that there is a negative correlation
between intake of whole grain and mortality, with a reduction of 7% in risk associated with each
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single serving/day increase in whole grain intake [45]. Due to increasing evidence of health benefits
associated with whole grains, several authors have strongly recommended implementing strategies for
educating consumers to gradually incorporate whole grains into their diets through the substitution
of refined cereals [23]. Although the beneficial effects of whole grains have not been demonstrated
in infants or young children due to the lack of clinical trials in this age range, the development of
healthy dietary habits during early stages of infancy including a diet with whole grain products could
be desirable [22].
Two potential risks of the use of whole grain in infant cereals should be taken in account.
Firstly, as compared to refined rice, whole grain rice has a higher content of inorganic arsenic, which is
concentrated in the bran layers [46,47]. Secondly, in unbalanced diets, excessive fiber content is likely
to have negative effects on mineral bioavailability [48]. In order to avoid these issues, we have used
whole grain wheat in compliance with European infant legislation (Directive 2006/125/CE) [48].
Also, the fiber content of the cereals used in our study was within commercial standard values.
5. Conclusions
This research was conducted as a preliminary study toward a clinical trial designed to evaluate
whole grain effects in infants with ages ranging from 5 to 9 months. Interestingly, we found that
infant cereals with 30% whole grain were very well accepted from a sensory point of view by
infants between 4 to 24 months as well as by their parents. Moreover, there is a lack of studies
showing that refined cereal flours in infants and young children are better from a nutritional point
of view than whole grain infant cereals. Throughout most of human development, whole grain
cereals—not refined cereals—were naturally consumed. Therefore, there might be an opportunity to
(re)introduce whole grain cereals to infants who are accustomed to consuming refined infant cereals,
thereby accelerating the exposure of whole grain in early life. This research represents a first step in
our understanding of sensory acceptability of whole grain infant cereals in infants aged 4 to 24 months.
We encourage future studies to analyze both the acceptability of higher percentages of whole grain
in infant cereal-based products as well as possible imprinting of health effects on infants during the
complementary feeding period.
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Abstract: Iron, calcium, and zinc are important nutrients for the young, developing child. This study
describes the usual intake of iron, calcium, and zinc among US children in the second year of life
using two days of dietary intake data from the National Health and Nutrition Examination Survey
2003–2012. Estimates were calculated using PC-SIDE to account for within and between person
variation. Mean usual iron, calcium, and zinc intakes were 9.5 mg/day, 1046 mg/day, and 7.1 mg/day,
respectively. Over a quarter of children had usual iron intakes less than the Recommended Dietary
Allowance (RDA) (26.1%). Eleven percent of children had usual calcium intakes below the RDA
and over half of children had usual intakes of zinc that exceeded the tolerable upper intake level
(UL). Two percent or less had usual intakes below the Estimated Average Requirement (EAR) for
iron, calcium, and zinc. Our findings suggest that during 2003–2012, one in four children and one
in ten children had usual intakes below the RDA for iron and calcium, respectively. Children who
are not meeting their nutrient requirements could be at increased risk for developing deficiencies
such as iron deficiency or could lead to a shortage in adequate nutrients required for growth and
development. One in every two children is exceeding the UL for zinc, but the interpretation of
these estimates should be done with caution given the limited data on adverse health outcomes.
Continued monitoring of zinc intake and further assessment for the potential of adverse health
outcomes associated with high zinc intakes may be needed.
Keywords: iron; calcium; zinc; young children; usual nutrient intake; NHANES
1. Introduction
Iron, calcium, and zinc are key minerals needed to ensure optimal cognitive development [1,2],
bone health [3], and growth [1]. For young children, the American Academy of Pediatrics (AAP) has
identified iron and zinc as critical nutrients—especially for children who are exclusively breastfed
and are transitioning to the introduction of complementary foods [4]. Although the majority of
children 12–23 months of age have transitioned to solid foods, this time period is still an important
period of physical and cognitive development and adequate nutrient intakes are needed [5].
Iron, calcium, and zinc are needed throughout early childhood. Iron is important for optimal cognitive
development [1]; calcium is critical in the development of bones and teeth and can be especially
important during growth spurts [3], and zinc is important in growth [1]. Ensuring adequate intake of
iron, calcium, and zinc can help reduce the risk of developing severe deficiencies such as iron deficiency
anemia [1,2] or impaired growth, such as rickets [1,3]. Conversely, nutrient intakes exceeding cut points
such as the tolerable upper intake level (UL) could lead to adverse consequences; however, limited data
are available on functional outcomes for young children with regard to higher intake values [1,3].
Nationally representative data on the nutrient intake for this age group as well as the proportions
who are meeting Dietary Reference Intakes, such as the Estimated Average Requirement (EAR),
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the Recommended Dietary Allowance (RDA), and those exceeding the UL, are lacking. Nutrition intake
estimates among this age group can inform clinicians about key nutrient intakes during a critical
growth period, as well as provide a basis for population level estimates that can support efforts,
such as the United States Department of Agriculture (USDA)/Health and Human Services (HHS)
Dietary Guidance Development Project for Birth to 24 Months and Pregnancy (B24/P) [6]. We focus
this analysis on three key minerals needed for growth and development (iron, calcium, and zinc) for
children 12–23 months of age and present the proportion meeting the EAR, RDA, and those exceeding
the UL.
2. Materials and Methods
2.1. National Health and Nutrition Examination Survey
NHANES is an ongoing nationally representative survey of the noninstitutionalized civilian
US population [7]. The survey is conducted using a stratified multistage probability design.
Data from NHANES are released in 2-year cycles. This analysis includes data from 2003 to 2012.
Survey respondents participate in a household interview in which participants are asked a variety
of questions including information on demographics and health-related questions and a physical
examination in which participants undergo a medical exam and participate in a dietary interview.
Analyses reported by race/ethnicity were restricted to non-Hispanic white, non-Hispanic black,
and Mexican American respondents because of the small number of individuals of other racial and
ethnic groups; however, all race/ethnicities are included in analyses not stratified by race/ethnicity.
We limited our analyses to children who were aged 12–23 months at the time of the physical
examination. All participants in NHANES provide written informed consent or by proxy for those
who are under 7 years of age. The National Center for Health Statistics Research Ethics Review Board
provided the following protocol approval numbers for the presented survey years: Protocol #98-12
(NHANES 1999–2004), Protocol #2005-06 (NHANES 2005–2006), Continuation of Protocol #2005-06
(NHANES 2007–2010), and Protocol #2011-17 (NHANES 2011–2012).
2.2. Nutrient Intake
Usual nutrient intake (calories, iron, calcium, and zinc) was estimated using two 24 h dietary
recall questionnaires. The first dietary recall was conducted in-person and the second dietary recall
was conducted 3–10 days later via telephone. Dietary interviews for children less than 6 years of age
were conducted using a proxy (i.e., a parent) who was most familiar with the child’s dietary intake [8].
The USDA Food and Nutrient Database for Dietary Studies was used to determine the nutrient amount
for foods that are reported in NHANES 2003–2012 [9–13]. Total nutrient intake for day one and day
two of the 24 h dietary recall were used in analyses.
2.3. Analytic Sample
There were a total of 1534 children aged 12–23 months at the time of the physical examination
from 2003 to 2012 and were eligible to complete a dietary recall. Children were excluded if they
reported consuming any breast milk on either day one or day two of the dietary interview (n = 94)
because nutrient intakes from breast milk were not available and therefore, total nutrient intake could
not be calculated. Additionally, children who did not have a dietary intake record for day one and day
two, or who had a dietary record that was coded as not reliable, were excluded (n = 318), leaving a
final sample size of 1122 (78% of the eligible sample who did not consume any breast milk).
2.4. Covariates
Information on age, race/ethnicity, and income to poverty ratio were obtained through the
household interview questionnaire. Race/ethnicity was based on respondents’/parental answers to
questions on race and Hispanic origin. The income to poverty ratio, a ratio of family income to poverty
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guidelines, was based on the family’s reported household income. The income to poverty ratio was
split into three categories: (1) income to poverty ratios <1.85; (2) income to poverty ratios between
1.85 and less than 3.5; and (3) income to poverty ratios ě3.5. These income to poverty ratios correspond
to income eligibility cut-offs used in the United States Department of Agriculture Women, Infants,
and Children Program.
2.5. Statistical Analyses
Using data from the two 24-h dietary recalls, the usual intakes of total caloric intake (for reference),
iron, calcium, and zinc for children 12–23 months of age were estimated using software developed by
Iowa State University, PC-SIDE version 1.02 (Iowa State University, Ames, IA, USA) and within-person
variation of nutrient intake were accounted for across days. In addition, the proportion of children
below two specific cut-points, i.e., estimated average requirement (EAR) and recommended dietary
allowance (RDA), and the proportion above the cut-points for tolerable upper intake level (UL) for
each mineral were assessed. The EAR is the average daily nutrient intake estimated to meet the needs
of half the healthy children of this age; whereas, the RDA is the average daily nutrient intake estimated
to meet the needs of nearly all healthy children of this age [14]. The UL is the highest average daily
intake likely to pose no adverse health effects [14]. Usual intakes were adjusted for the intake day of
the week and interview method (in person vs. telephone). Estimates of usual intake and proportions
were calculated by sex, race/ethnicity, and income to poverty ratio. Since usual intakes cannot be
negative, any estimates that were negative (i.e., lower bound for 95% Confidence Interval (CIs)) were
truncated at zero. Additionally, if a cut-point fell on the distribution of intakes such that no individual
was included, these values did not have a standard error; thus, a zero value was given and no 95% CIs
were provided.
SPSS Complex Samples Design version 23.0 (SPSS Inc., Chicago, IL, USA) was used to account
for the survey design and calculate frequencies and Chi-square tests. All analyses were conducted
using 10-year dietary weights calculated from day two dietary weights for the period 2003–2012,
as recommended by the National Center for Health Statistics, Centers for Disease Control and
Prevention [15,16]. For analyses conducted with PC-SIDE, standard errors were calculated using
a set of 150 Jackknife replicate weights calculated using the 10-year dietary weights. T-tests were
calculated to assess differences in mean usual intakes; statistical significance defined as p < 0.05.
3. Results
A total of 1122 children aged 12–23 months of age were included in the analysis. Approximately half
of children were male (52%) (weighted percent). Over half (53.6%) of children were non-Hispanic white,
14.4% were non-Hispanic black, and 17.8% were Mexican American (weighted percent). Among the
analytic sample, 49.3% reported an income to poverty ratio <1.85 (weighted percent).
Among children 12–23 months of age, the mean usual caloric intake was 1264 kcal/day (95% CI:
1225, 1302). Caloric intake did not differ by sex or income to poverty ratio, but non-Hispanic black
children had significantly higher usual caloric intake than either non-Hispanic white children or
Mexican American children (1350 kcal/day, 1267 kcal/day, and 1218 kcal/day, respectively) (p < 0.05).
Mean usual iron intake was 9.5 mg/day (Table 1). Compared to non-Hispanic white and non-Hispanic
black children, Mexican-American children had significantly lower reported mean usual iron intake
(9.6 mg, 10.2 mg, and 8.5 mg, respectively) (p < 0.05). Mean usual calcium intake was 1046 mg/day;
no differences were observed by sex, race/ethnicity, or poverty status. Mean usual zinc intake was
7.1 mg/day; girls had significantly lower zinc intake compared to boys (6.9 mg vs. 7.3 mg, respectively)
(p < 0.05).
Less than 1% of children had usual iron intakes below the EAR (3 mg/day) [1]; however, 26.1% had
usual intakes below the RDA (7 mg/day) [1]. Mexican American children had significantly higher
proportions below the RDA for iron compared to non-Hispanic white and non-Hispanic black children
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(36.4%, 24.3%, and 18.7%, respectively) (p < 0.05). No children had usual iron intakes exceeding the UL
(40 mg/day) [1].
Table 1. Mean usual iron, calcium, and zinc intake for children age 12 to 23 months 1,2 by select
demographic characteristics, NHANES 2003–2012.
Mean (95% Confidence Interval)
Iron (mg) Calcium (mg) Zinc (mg)
Total (n = 1122) 9.5 (9.0, 10.0) 1046 (1002, 1090) 7.1 (6.9, 7.4)
Sex
Male (n = 574) 9.8 (9.1, 10.5) 1050 (992, 1108) 7.3 (7.0, 7.7) a
Female (n = 548) 9.1 (8.5, 9.7) 1041 (985, 1097) 6.9 (6.7, 7.2) b
Race/ethnicity 3
Non-Hispanic white (n = 332) 9.6 (8.9, 10.4)a 1055 (981, 1128) 7.2 (6.8, 7.6)
Non-Hispanic black (n = 261) 10.2 (9.4, 11.1)a 983 (909, 1056) 7.2 (6.6, 7.7)
Mexican American (n = 357) 8.5 (8.0, 9.1) b 1047 (993, 1100) 7.2 (6.8, 7.5)
Poverty status
Income to poverty ratio <1.85 (n = 684) 9.4 (8.8, 9.9) 1020 (973, 1068) 7.2 (6.9, 7.5)
Income to poverty ratio 1.85 to <3.5 (n = 204) 9.2 (8.3, 10.1) 1056 (962, 1149) 7.0 (6.5, 7.5)
Income to poverty ratio ě3.5 (n = 174) 9.8 (8.7, 10.9) 1095 (1011, 1180) 7.1 (6.6, 7.6)
1 Does not include any children who reported consuming breast milk on either day one or day two of the 24-h
dietary recall; 2 age in months at time of exam in Medical Examination Center; 3 race/ethnicity subanalyses are
limited to those individuals who report being either non-Hispanic white, non-Hispanic black, and Mexican
American; values with superscript letters that differ are significantly different, p-value < 0.05; abbreviations:
National Health and Nutrition Examination Survey (NHANES).
Two percent of children 12–23 months had usual calcium intake below the EAR (500 mg/day) [3]
and 11.2% had usual calcium intakes below the RDA (700 mg/day) [3] (Table 2). Non-Hispanic black
children and children with an income to poverty ratio <1.85 had significantly higher proportions below
the RDA for calcium (p < 0.05). There were no children 12–23 months with usual calcium intakes that
exceeded the UL (2500 mg/day) [3].
Less than 1% of children had usual zinc intakes below either the EAR (2.5 mg/day) [1] or the RDA
(3 mg/day) [1]. Over 50% of children had usual zinc intakes that exceeded the UL (7 mg/day) [1];
no differences by sex, race/ethnicity, or income to poverty ratio were observed.
4. Discussion
Our analyses presented nationally representative usual mean intake for children 12–23 months
of age on key minerals needed for healthy growth and development [1,3]. Our findings indicate that
one in four children and one in ten children 12–23 months of age are not consuming enough iron
and calcium to meet current RDA recommendations, respectively. However, one in two children
12–23 months of age are exceeding the UL for zinc.
Our findings, presented here, are similar to what was reported in the 2008 Feeding Infants
and Toddler Study (FITS) [17], a cross-sectional consumer panel survey weighted to be nationally
representative. For example, FITS reported usual intake of zinc 7.2 mg/day and our analysis indicated a
usual intake of 7.1 mg/day. However, FITS data had slightly lower usual intakes of calories and calcium
and higher usual intakes of iron as compared to our results using NHANES (FITS: 1141 kcal/day;
892 mg/day calcium; 10.3 mg/day iron; NHANES: 1264 kcal/day; 1046 mg/day calcium; 9.5 mg/day
iron) [17]. The FITS 2008 findings assessed both the proportion below the EAR and the proportion
exceeding the UL and found similar results as those presented here. Although FITS is considered
nationally representative, it may not be truly representative if the consumer panel used as the sampling
frame is not representative of the US population. Although the surveys had slightly different estimates,
both came to similar conclusions in regard to nutrient intake of key minerals for children in the second
year of life (12–23 months of age).
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Our analysis expanded on the FITS assessment by looking at the proportion of children
12–23 months of age with usual intakes below the RDA. One in every four children, and one in
every three children who was Mexican American, reported having an iron intake below the RDA and
the intake value recommended by the AAP [1,2]. A recent study by Grimes et al. reported the top
food sources of iron for this age group and found ready-to-eat cereals, baby foods, breads, rolls and
tortillas, mixed dishes—grains, and cooked cereals were responsible for half of a child’s total daily iron
intake [18]. These sources are a combination of multiple foods and could represent fortified sources
(i.e., ready-to-eat cereals), as well as heme-rich sources (i.e., baby foods with meat) or non-heme
sources (i.e., baby foods with fruit and/or vegetables). Adequate intake of iron can help reduce the
likelihood of developing iron deficiency and iron deficiency anemia [2]. According to data from
NHANES 2007–2010, 13.5% of children 1–2 years of age were considered iron deficient [19]. Given the
importance of iron in optimal cognitive development at this age [1,2], the reported estimates of iron
deficiency [19] and iron intake suggest the need to ensure young children are consuming adequate
iron and to continue monitoring iron status.
Calcium has also been identified as a key mineral to ensuring adequate growth and development
of young children, especially for bone health [3]. With the development of the 2011 Institute of Medicine
report on calcium and vitamin D, there are now EARs and RDAs for calcium for children 1–3 years of
age; these values were not available in the previous 1997 IOM report for calcium and vitamin D [3,20].
Our data indicate that although very few children 12–23 months of age have a usual calcium intake
below the EAR, one in ten, and almost one in five non-Hispanic black children (17.4%), have an intake
below the RDA. Milk is the main food group that contributes to calcium intake for this age group with
over 50% of daily intake of calcium coming from milk [18]. However, trends in beverage consumption
indicate a significant decline in milk consumption among 1 year olds (3.8% decline) and an increase in
100% fruit juice consumption (21.9% increase) from 1988–1994 to 2001–2006 [21]. Continued support
for ensuring adequate calcium intake through sources like milk is important.
Ensuring adequate zinc intake for young children, especially during the transition from breast
milk to complementary foods, has been one of the cornerstones of AAP recommendations [4].
However, our data indicate that over half of children 12–23 months have usual zinc intakes that exceed
the UL, which is similar to what Butte et al. reported using FITS [17]. Milk and ready-to-eat cereals
were the top two food sources contributing 39.1% of total zinc intake among children 12–23 months of
age [18]. Ready-to-eat cereals may be fortified with zinc and could be one of the reasons for higher zinc
intakes in this age group. Data were not available on children 1–3 years of age to set a UL value for zinc
for this age group[1]; however, data were available from one study among 68 infants 0–6 months of age
receiving infant formula with 5.8 mg zinc/L of formula for six months found no adverse effects [22].
Using this study as a basis, the UL value for zinc among children 1–3 years of age was extrapolated and
then adjusted for body weight [1]. Two case reports of children receiving ě16 mg of zinc for ě6 months
developed a copper-induced anemia [23,24]; however, evidence of zinc toxicity in young children is
not often reported [25,26] and may not be a concern at the population level. Additionally, the potential
that the zinc UL for children is too low has been raised [27,28]. Therefore, interpreting whether the
proportion of children above the UL for zinc is of concern should be done with caution since limited
data are available supporting population-level indications of adverse health outcomes associated with
high intake and the relevance of the current UL value has been questioned. Continued monitoring of
zinc intake and the potential for adverse health outcomes could be warranted.
This analysis provides pediatricians, other health care providers, and public health practitioners
with evidence on the nutritional intake of young children, specifically for key minerals needed for
healthy growth and development. Compared with developing countries, children in the United States
may not be considered as at risk for specific nutritional deficiencies; however, this analysis indicates
that for specific minerals, such as iron, there may be a need for a renewed focus on ensuring children
are consuming adequate nutrients. A further assessment of nationally representative data on the
nutritional status of young children using biomarkers could help provide context to national level
policies and recommendations for foods and food groups to encourage. Biomarkers, with the exception
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of iron, on this age group are not routinely collected through surveys, such as NHANES, but specific
biomarkers may need to be considered given the assessment of current intake and the development of
the B24/P Guidance.
This study is subject to several limitations. First, we combined multiple survey years.
Although this provides a larger sample size and smaller standard errors, the data span a period
of ten years. Sociodemographic characteristics did not differ by survey year; however, we did find
that usual caloric intake was significantly higher in 2003–2004. We did not correct for this because
we were not assessing trends over time and recommendations, such as the EAR, RDA and UL are
set values and are not dependent on total caloric intake. Second, we did not include any nutrient
intake coming from dietary supplements, which could contribute to mineral intake. This decision was
based on a change in methodology for reporting supplement intake during the survey years included
in our analysis. When we assessed the frequency of supplement use in a subset of the population
with similar supplement intake methodology, we concluded that the inclusion of dietary supplements
would not change the overall interpretation of our results. Specifically, we found that among children
12–23 months of age surveyed in 2007–2012, 13.3% reported consuming any dietary supplement on
day 1 Lastly, we limited our analyses to children not reporting the consumption of breast milk during
the second year of life on day one or day two of the dietary intake recall. This was done because
nutrient intakes were not reported for children who reported consuming any breast milk. A total
of 94 children reported some consumption of breastmilk (6% of the original sample). As a result,
these findings may not be generalizable to children consuming breast milk during the second year
of life. There were also several strengths of this study. First, NHANES is a nationally representative
study. Second, usual dietary intake assessment was possible because two 24-h dietary recalls were
collected and nutrients examined were consumed on a daily basis and were not episodic. This allowed
for the estimation of the proportions of the population at specific cut-points (i.e., EAR, RDA, and UL).
Lastly, because we combined survey years, we were able to have adequate sample size to stratify by
different sociodemographic factors.
5. Conclusions
During 2003–2012, one in every four and one in every ten children 12–23 months of age is
not meeting the recommended iron and calcium intake, respectively. Efforts to ensure children are
consuming optimal amounts of both iron and calcium are important for their growth and development.
One in every two children 12–23 months of age is exceeding the UL for zinc, but the interpretation of
these estimates should be done with caution given the limited data on adverse health outcomes.
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